{
    "55046d5ff8aee20f27000007": [
        {
            "text": "single-molecule pull-down",
            "probability": 0.10318019538171612,
            "start_logit": -3.347893714904785,
            "end_logit": -3.6557095050811768,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "low- and high-affinity ligands and oncogenic EGFR mutants.We extended a single-molecule pull-down",
            "probability": 0.07590039836396452,
            "start_logit": -3.6549487113952637,
            "end_logit": -3.6557095050811768,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "pull-down",
            "probability": 0.07180796013720023,
            "start_logit": -3.7103753089904785,
            "end_logit": -3.6557095050811768,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "single-molecule pull",
            "probability": 0.0617495462163057,
            "start_logit": -3.347893714904785,
            "end_logit": -4.169099807739258,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "low- and high-affinity",
            "probability": 0.05653766416452802,
            "start_logit": -3.6549487113952637,
            "end_logit": -3.9502243995666504,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "in experiments comparing low- and high-affinity",
            "probability": 0.05650235856317957,
            "start_logit": -3.6555733680725098,
            "end_logit": -3.9502243995666504,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "single-molecule",
            "probability": 0.05222425437630933,
            "start_logit": -3.347893714904785,
            "end_logit": -4.336639404296875,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "single-molecule pull-down technique",
            "probability": 0.0487537145257378,
            "start_logit": -3.347893714904785,
            "end_logit": -4.405405044555664,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "low- and high-affinity ligands and oncogenic EGFR mutants.We extended a single-molecule pull",
            "probability": 0.04542359257290338,
            "start_logit": -3.6549487113952637,
            "end_logit": -4.169099807739258,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "in experiments comparing low- and high-affinity ligands and oncogenic EGFR mutants.We extended a single-molecule pull",
            "probability": 0.04539522728270451,
            "start_logit": -3.6555733680725098,
            "end_logit": -4.169099807739258,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "pull",
            "probability": 0.04297441904220722,
            "start_logit": -3.7103753089904785,
            "end_logit": -4.169099807739258,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "single",
            "probability": 0.04182562700833454,
            "start_logit": -3.347893714904785,
            "end_logit": -4.5586771965026855,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "low- and high-affinity ligands and oncogenic EGFR mutants.We extended a single-molecule",
            "probability": 0.03841669127257053,
            "start_logit": -3.6549487113952637,
            "end_logit": -4.336639404296875,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "in experiments comparing low- and high-affinity ligands and oncogenic EGFR mutants.We extended a single-molecule",
            "probability": 0.03839270152330801,
            "start_logit": -3.6555733680725098,
            "end_logit": -4.336639404296875,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "low- and high-affinity ligands",
            "probability": 0.03834953943316681,
            "start_logit": -3.6549487113952637,
            "end_logit": -4.338388919830322,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "in experiments comparing low- and high-affinity ligands",
            "probability": 0.0383255916176507,
            "start_logit": -3.6555733680725098,
            "end_logit": -4.338388919830322,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "low- and high-affinity ligands and oncogenic EGFR mutants",
            "probability": 0.03723501801955185,
            "start_logit": -3.6549487113952637,
            "end_logit": -4.367881774902344,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "in experiments comparing low- and high-affinity ligands and oncogenic EGFR mutants",
            "probability": 0.037211766179883074,
            "start_logit": -3.6555733680725098,
            "end_logit": -4.367881774902344,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "low- and high-affinity ligands and oncogenic EGFR mutants.We extended a single-molecule pull-down technique",
            "probability": 0.03586372695396379,
            "start_logit": -3.6549487113952637,
            "end_logit": -4.405405044555664,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "pull-down technique",
            "probability": 0.03393000736481443,
            "start_logit": -3.7103753089904785,
            "end_logit": -4.405405044555664,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        }
    ],
    "553fa78b1d53b76422000007": [
        {
            "text": "MEG3",
            "probability": 0.5486871889526257,
            "start_logit": 2.8837311267852783,
            "end_logit": 2.855959177017212,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 is associated with the\u00a0 development and progression of cancer, suggesting that MEG3",
            "probability": 0.44467426008605104,
            "start_logit": 2.8837311267852783,
            "end_logit": 2.645772695541382,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 is associated with the\u00a0 development and progression of cancer,",
            "probability": 0.0009922915121444607,
            "start_logit": 2.8837311267852783,
            "end_logit": -3.4593076705932617,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 may function as a potential biomarker and therapeutic target",
            "probability": 0.0005879113018371606,
            "start_logit": 2.9531571865081787,
            "end_logit": -4.0521745681762695,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "deregulation of MEG3",
            "probability": 0.0005865700154011214,
            "start_logit": -3.9572606086730957,
            "end_logit": 2.855959177017212,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 is associated with the\u00a0 development and progression of cancer, suggesting that MEG3 may function as a potential biomarker and therapeutic target",
            "probability": 0.0005484795686821163,
            "start_logit": 2.8837311267852783,
            "end_logit": -4.0521745681762695,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 may function as a potential biomarker and therapeutic target for human cancers.",
            "probability": 0.0005390212581162946,
            "start_logit": 2.9531571865081787,
            "end_logit": -4.13899564743042,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "deregulation of MEG3 is associated with the\u00a0 development and progression of cancer, suggesting that MEG3",
            "probability": 0.0004753757566037829,
            "start_logit": -3.9572606086730957,
            "end_logit": 2.645772695541382,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "Rb, inhibiting angiogenesis-related factor, or controlling miRNAs.However, deregulation of MEG3",
            "probability": 0.0003556739783439625,
            "start_logit": -4.45753812789917,
            "end_logit": 2.855959177017212,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "angiogenesis-related factor, or controlling miRNAs.However, deregulation of MEG3",
            "probability": 0.0003361661856875401,
            "start_logit": -4.513947010040283,
            "end_logit": 2.855959177017212,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "3",
            "probability": 0.0003326806202308252,
            "start_logit": -4.524369716644287,
            "end_logit": 2.855959177017212,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "suggesting that MEG3",
            "probability": 0.00032738407505369824,
            "start_logit": -4.3302321434021,
            "end_logit": 2.645772695541382,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "ME",
            "probability": 0.0002757852196306333,
            "start_logit": 2.9531571865081787,
            "end_logit": -4.809128284454346,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miRNAs.However, deregulation of MEG3",
            "probability": 0.00024350102323080983,
            "start_logit": -4.836431503295898,
            "end_logit": 2.855959177017212,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miRNAs.However, deregulation of MEG3 is associated with the\u00a0 development and progression of cancer, suggesting that MEG3",
            "probability": 0.0001973412893821102,
            "start_logit": -4.836431503295898,
            "end_logit": 2.645772695541382,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 may function as a potential biomarker and therapeutic",
            "probability": 0.00017773898787323158,
            "start_logit": 2.9531571865081787,
            "end_logit": -5.248434543609619,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 may function as a potential biomarker",
            "probability": 0.00017643235333518389,
            "start_logit": 2.9531571865081787,
            "end_logit": -5.255813121795654,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 is associated with the\u00a0 development and progression of cancer, suggesting that MEG3 may function as a potential biomarker and therapeutic",
            "probability": 0.00016581787610150015,
            "start_logit": 2.8837311267852783,
            "end_logit": -5.248434543609619,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 is associated with the\u00a0 development and progression of cancer, suggesting that MEG3 may function as a potential biomarker",
            "probability": 0.00016459887870237883,
            "start_logit": 2.8837311267852783,
            "end_logit": -5.255813121795654,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": ".However, deregulation of MEG3",
            "probability": 0.00015578106096662069,
            "start_logit": -5.2831010818481445,
            "end_logit": 2.855959177017212,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        }
    ],
    "5149199dd24251bc05000040": [
        {
            "text": "acetylcholinesterase inhibitors",
            "probability": 0.10434443847678551,
            "start_logit": -5.5660529136657715,
            "end_logit": -4.883050441741943,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitors",
            "probability": 0.09830496855573245,
            "start_logit": -5.743669033050537,
            "end_logit": -4.76505708694458,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor.",
            "probability": 0.07897997933033121,
            "start_logit": -5.743669033050537,
            "end_logit": -4.9839372634887695,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor.",
            "probability": 0.07242842688566993,
            "start_logit": -5.830264568328857,
            "end_logit": -4.9839372634887695,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "immunomodulatory treatment was unexpectedly poor.Nevertheless, response to acetylcholinesterase inhibitors",
            "probability": 0.051571992571111835,
            "start_logit": -6.270771503448486,
            "end_logit": -4.883050441741943,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitors",
            "probability": 0.04758416687781262,
            "start_logit": -6.46924352645874,
            "end_logit": -4.76505708694458,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitor",
            "probability": 0.046920708804262155,
            "start_logit": -5.5660529136657715,
            "end_logit": -5.682288646697998,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "immunomodulatory treatment was unexpectedly poor.",
            "probability": 0.046622904057018924,
            "start_logit": -6.270771503448486,
            "end_logit": -4.9839372634887695,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitors and immunomodulatory treatment",
            "probability": 0.046568668454921636,
            "start_logit": -5.5660529136657715,
            "end_logit": -5.689819812774658,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitors and immunomodulatory treatment was unexpectedly poor.Nevertheless, response to acetylcholinesterase inhibitors",
            "probability": 0.042288142283608214,
            "start_logit": -6.46924352645874,
            "end_logit": -4.883050441741943,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor",
            "probability": 0.0413850748241578,
            "start_logit": -5.5660529136657715,
            "end_logit": -5.807827472686768,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase",
            "probability": 0.04066514211570135,
            "start_logit": -5.5660529136657715,
            "end_logit": -5.825376510620117,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitors and immunomodulatory treatment was unexpectedly poor.",
            "probability": 0.03822997526650976,
            "start_logit": -6.46924352645874,
            "end_logit": -4.9839372634887695,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitor",
            "probability": 0.03714378732606641,
            "start_logit": -5.743669033050537,
            "end_logit": -5.738335132598877,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "poor.Nevertheless, response to acetylcholinesterase inhibitors",
            "probability": 0.036830488343456716,
            "start_logit": -6.607424259185791,
            "end_logit": -4.883050441741943,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inclusion body myositis",
            "probability": 0.03585044859560652,
            "start_logit": -6.289880275726318,
            "end_logit": -5.227564334869385,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor",
            "probability": 0.03522617447044674,
            "start_logit": -5.743669033050537,
            "end_logit": -5.791342258453369,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "immunomodulatory treatment was unexpectedly poor.A novel case of inclusion body myositis",
            "probability": 0.03380503453727364,
            "start_logit": -6.348626613616943,
            "end_logit": -5.227564334869385,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "poor.",
            "probability": 0.03329606320799787,
            "start_logit": -6.607424259185791,
            "end_logit": -4.9839372634887695,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase",
            "probability": 0.03195341501552875,
            "start_logit": -5.743669033050537,
            "end_logit": -5.888852596282959,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        }
    ],
    "5709e4b2cf1c32585100001c": [
        {
            "text": "Nlk2",
            "probability": 0.17305380715194182,
            "start_logit": 0.5141695141792297,
            "end_logit": -0.7228662371635437,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK, Xenopus nlk",
            "probability": 0.15205648624124177,
            "start_logit": 0.08765341341495514,
            "end_logit": -0.4257006347179413,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "nlk",
            "probability": 0.10922592819930096,
            "start_logit": -0.24318018555641174,
            "end_logit": -0.4257006347179413,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nemo",
            "probability": 0.07821981452884973,
            "start_logit": 0.12084683775901794,
            "end_logit": -1.1236231327056885,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse Nlk, human NLK, Xenopus nlk",
            "probability": 0.07798151230045515,
            "start_logit": -0.5801268815994263,
            "end_logit": -0.4257006347179413,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk2 gene encoded a 480-aa Nlk2",
            "probability": 0.06010286818005986,
            "start_logit": 0.5141695141792297,
            "end_logit": -1.7804112434387207,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK",
            "probability": 0.056833398965657575,
            "start_logit": 0.08765341341495514,
            "end_logit": -1.409828543663025,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK, Xenopus nlk and zebrafish nlk",
            "probability": 0.030778160443296947,
            "start_logit": 0.08765341341495514,
            "end_logit": -2.0231473445892334,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse Nlk, human NLK",
            "probability": 0.029146763219858207,
            "start_logit": -0.5801268815994263,
            "end_logit": -1.409828543663025,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk)",
            "probability": 0.02669824210621774,
            "start_logit": -0.5606712102890015,
            "end_logit": -1.5170303583145142,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Diego (Dgo) and Nemo",
            "probability": 0.025102815030841465,
            "start_logit": -1.0156961679458618,
            "end_logit": -1.1236231327056885,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse",
            "probability": 0.024515124303926206,
            "start_logit": -0.5801268815994263,
            "end_logit": -1.5828821659088135,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dsh), Prickle (Pk), Diego (Dgo) and Nemo",
            "probability": 0.022756134239817885,
            "start_logit": -1.1138414144515991,
            "end_logit": -1.1236231327056885,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nemo (Nmo",
            "probability": 0.022427124818583236,
            "start_logit": 0.12084683775901794,
            "end_logit": -2.3728749752044678,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "nlk and zebrafish nlk",
            "probability": 0.02210871253037225,
            "start_logit": -0.24318018555641174,
            "end_logit": -2.0231473445892334,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse Nemo-like kinase (Nlk)",
            "probability": 0.01898695113465842,
            "start_logit": -0.9015169739723206,
            "end_logit": -1.5170303583145142,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nemo (Nmo) are implicated in the PCP signaling pathway. Choi and Benzer identified Drosophila Nmo",
            "probability": 0.018522434711039648,
            "start_logit": 0.12084683775901794,
            "end_logit": -2.5641634464263916,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dgo) and Nemo",
            "probability": 0.018226104679536486,
            "start_logit": -1.335821270942688,
            "end_logit": -1.1236231327056885,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk, human NLK, Xenopus nlk",
            "probability": 0.017181411659097246,
            "start_logit": -2.092770576477051,
            "end_logit": -0.4257006347179413,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nemo-like kinase (Nlk)",
            "probability": 0.016076205555247407,
            "start_logit": -1.067928671836853,
            "end_logit": -1.5170303583145142,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        }
    ],
    "53061af558348c0f52000002": [
        {
            "text": "Cell-Cycle Arrest",
            "probability": 0.450460510052716,
            "start_logit": 5.567590236663818,
            "end_logit": 5.086862564086914,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Expansion and Cell-Cycle Arrest",
            "probability": 0.14529648368546078,
            "start_logit": 4.43609619140625,
            "end_logit": 5.086862564086914,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle arrest",
            "probability": 0.12456849427269683,
            "start_logit": 4.888006210327148,
            "end_logit": 4.481031894683838,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Expansion",
            "probability": 0.09201508620288605,
            "start_logit": 4.43609619140625,
            "end_logit": 4.630038738250732,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell expansion and cell-cycle arrest",
            "probability": 0.08252396314311958,
            "start_logit": 4.476239204406738,
            "end_logit": 4.481031894683838,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell expansion",
            "probability": 0.06386122993879784,
            "start_logit": 4.476239204406738,
            "end_logit": 4.224655628204346,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "irreversible cell-cycle arrest",
            "probability": 0.01813729567814593,
            "start_logit": 3.9778809547424316,
            "end_logit": 3.4642717838287354,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "expansion and cell-cycle arrest",
            "probability": 0.011680329191046012,
            "start_logit": 2.521056652069092,
            "end_logit": 4.481031894683838,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "expansion",
            "probability": 0.009038831386910104,
            "start_logit": 2.521056652069092,
            "end_logit": 4.224655628204346,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Cycle Arrest",
            "probability": 0.0006135710594111327,
            "start_logit": -1.0311393737792969,
            "end_logit": 5.086862564086914,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Arrest",
            "probability": 0.0003716038542522172,
            "start_logit": -1.532607078552246,
            "end_logit": 5.086862564086914,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Cell-Cycle",
            "probability": 0.0003226097216363155,
            "start_logit": 5.567590236663818,
            "end_logit": -2.154719829559326,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Cell",
            "probability": 0.0002714314863425095,
            "start_logit": 5.567590236663818,
            "end_logit": -2.327453374862671,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell",
            "probability": 0.0001919717750937101,
            "start_logit": 4.476239204406738,
            "end_logit": -1.5824637413024902,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "arrest",
            "probability": 0.00015644734994698015,
            "start_logit": -1.791885256767273,
            "end_logit": 4.481031894683838,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle arrest.",
            "probability": 0.00013461792832659248,
            "start_logit": 4.888006210327148,
            "end_logit": -2.3491384983062744,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Expansion and Cell-Cycle",
            "probability": 0.0001040580852492851,
            "start_logit": 4.43609619140625,
            "end_logit": -2.154719829559326,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell expansion and cell-cycle arrest.",
            "probability": 8.918149826317497e-05,
            "start_logit": 4.476239204406738,
            "end_logit": -2.3491384983062744,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Expansion and Cell",
            "probability": 8.755049476472309e-05,
            "start_logit": 4.43609619140625,
            "end_logit": -2.327453374862671,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cycle arrest",
            "probability": 7.473319493453111e-05,
            "start_logit": -2.5306804180145264,
            "end_logit": 4.481031894683838,
            "question_text": "Which are the major characteristics of cellular senescence?"
        }
    ],
    "53137541e3eabad021000010": [
        {
            "text": "Reprogramming",
            "probability": 0.21490222050756858,
            "start_logit": -4.124014854431152,
            "end_logit": -3.9725775718688965,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming",
            "probability": 0.10867085588968316,
            "start_logit": -4.805874347686768,
            "end_logit": -3.9725775718688965,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Reprogramming.",
            "probability": 0.0841374984705308,
            "start_logit": -4.124014854431152,
            "end_logit": -4.910308361053467,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "iPSC Reprogramming",
            "probability": 0.07486902501647184,
            "start_logit": -5.178457736968994,
            "end_logit": -3.9725775718688965,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Reprogramming.We recently developed a concept of reprogramome,",
            "probability": 0.05399913569689737,
            "start_logit": -4.124014854431152,
            "end_logit": -5.353792667388916,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming.",
            "probability": 0.0432966030729507,
            "start_logit": -4.825226783752441,
            "end_logit": -4.873474597930908,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming.",
            "probability": 0.04254629826352807,
            "start_logit": -4.805874347686768,
            "end_logit": -4.910308361053467,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramome,",
            "probability": 0.03995492386615822,
            "start_logit": -4.425230979919434,
            "end_logit": -5.353792667388916,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming legitimacy of a gene response to reprogramming.",
            "probability": 0.03851178912334436,
            "start_logit": -4.942336559295654,
            "end_logit": -4.873474597930908,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming",
            "probability": 0.03524069931606546,
            "start_logit": -4.825226783752441,
            "end_logit": -5.079347133636475,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming.This report also tallied 438 genes reprogrammed significantly but insufficiently up to 72 h,",
            "probability": 0.033017352761467965,
            "start_logit": -4.825226783752441,
            "end_logit": -5.144515514373779,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming legitimacy of a gene response to reprogramming",
            "probability": 0.03134616307733829,
            "start_logit": -4.942336559295654,
            "end_logit": -5.079347133636475,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Reprogramming) Response",
            "probability": 0.030565792428565833,
            "start_logit": -4.805874347686768,
            "end_logit": -5.2410197257995605,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "iPSC Reprogramming.",
            "probability": 0.029312365702576258,
            "start_logit": -5.178457736968994,
            "end_logit": -4.910308361053467,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Aberrant, and NO Reprogramming",
            "probability": 0.025654737019648016,
            "start_logit": -5.829569339752197,
            "end_logit": -4.392477989196777,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Human iPSC Reprogramming",
            "probability": 0.025326088584049715,
            "start_logit": -6.262362957000732,
            "end_logit": -3.9725775718688965,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming",
            "probability": 0.02500447588540444,
            "start_logit": -6.275143146514893,
            "end_logit": -3.9725775718688965,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "transcriptional responses to the Yamanaka factors in the perspective of reprogramming legitimacy of a gene response to reprogramming.",
            "probability": 0.023739212847446164,
            "start_logit": -5.426172733306885,
            "end_logit": -4.873474597930908,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "gene response to reprogramming.",
            "probability": 0.0205825431140343,
            "start_logit": -5.568857669830322,
            "end_logit": -4.873474597930908,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "transcriptional responses to the Yamanaka factors in the perspective of reprogramming legitimacy of a gene response to reprogramming",
            "probability": 0.01932221935627049,
            "start_logit": -5.426172733306885,
            "end_logit": -5.079347133636475,
            "question_text": "Which are the Yamanaka factors?"
        }
    ],
    "5718bbb37de986d80d00000b": [
        {
            "text": "ataxia-neuropathy syndrome",
            "probability": 0.259350187489302,
            "start_logit": 4.952935695648193,
            "end_logit": 4.229726791381836,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy syndromes",
            "probability": 0.19902589501220447,
            "start_logit": 4.952935695648193,
            "end_logit": 3.964982509613037,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome",
            "probability": 0.15020705532297512,
            "start_logit": 4.393515586853027,
            "end_logit": 4.242982387542725,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia",
            "probability": 0.08963951937910648,
            "start_logit": 4.393515586853027,
            "end_logit": 3.726763963699341,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndrome",
            "probability": 0.0541009875358494,
            "start_logit": 4.393515586853027,
            "end_logit": 3.221820116043091,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia",
            "probability": 0.04987349579612532,
            "start_logit": 4.952935695648193,
            "end_logit": 2.5810372829437256,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndromes",
            "probability": 0.045898045596033145,
            "start_logit": 4.393515586853027,
            "end_logit": 3.0573902130126953,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia",
            "probability": 0.04478358119427777,
            "start_logit": 3.6995608806610107,
            "end_logit": 3.726763963699341,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy syndrome",
            "probability": 0.027028658618254993,
            "start_logit": 3.6995608806610107,
            "end_logit": 3.221820116043091,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy syndromes",
            "probability": 0.022930498354364365,
            "start_logit": 3.6995608806610107,
            "end_logit": 3.0573902130126953,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy",
            "probability": 0.02184279177826719,
            "start_logit": 4.952935695648193,
            "end_logit": 1.7554185390472412,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia",
            "probability": 0.012873026350380403,
            "start_logit": 4.133656978607178,
            "end_logit": 2.0459604263305664,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy",
            "probability": 0.007721872271221883,
            "start_logit": 4.133656978607178,
            "end_logit": 1.5348831415176392,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia",
            "probability": 0.00555750622100451,
            "start_logit": 3.6995608806610107,
            "end_logit": 1.6400718688964844,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy",
            "probability": 0.0032926220086297183,
            "start_logit": 3.2812843322753906,
            "end_logit": 1.5348831415176392,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome,",
            "probability": 0.0022607245844092996,
            "start_logit": 4.393515586853027,
            "end_logit": 0.04665305092930794,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "neuropathy syndrome",
            "probability": 0.0017549687907425643,
            "start_logit": -0.04279245436191559,
            "end_logit": 4.229726791381836,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "neuropathy syndromes",
            "probability": 0.0013467668470855947,
            "start_logit": -0.04279245436191559,
            "end_logit": 3.964982509613037,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy syndromes.",
            "probability": 0.000361082426798333,
            "start_logit": 4.952935695648193,
            "end_logit": -2.3471014499664307,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "at",
            "probability": 0.00015071442296751502,
            "start_logit": 4.952935695648193,
            "end_logit": -3.220820903778076,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        }
    ],
    "52bf202003868f1b06000018": [
        {
            "text": "epilepsy",
            "probability": 0.8662124988409344,
            "start_logit": 3.7627909183502197,
            "end_logit": 3.7435216903686523,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood disorders in adult patients with epilepsy",
            "probability": 0.11191331351712101,
            "start_logit": 1.7163852453231812,
            "end_logit": 3.7435216903686523,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "pilepsy",
            "probability": 0.008357482841713934,
            "start_logit": -0.878182053565979,
            "end_logit": 3.7435216903686523,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood disorders",
            "probability": 0.003431721268808039,
            "start_logit": 1.7163852453231812,
            "end_logit": 0.2588590681552887,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epile",
            "probability": 0.0016005377705103335,
            "start_logit": 3.7627909183502197,
            "end_logit": -2.5502688884735107,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy: A systematic review.While more evidence is provided for older AEDs on their effect on mood",
            "probability": 0.0014976785309083812,
            "start_logit": 3.7627909183502197,
            "end_logit": -2.616692304611206,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "psy",
            "probability": 0.0012872431293953228,
            "start_logit": -2.7488365173339844,
            "end_logit": 3.7435216903686523,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy: A systematic review.While more evidence is provided for older AEDs on their effect on mood changes",
            "probability": 0.0011913826648968695,
            "start_logit": 3.7627909183502197,
            "end_logit": -2.845494031906128,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy.If lacosamide is used as add-on, two studies point towards a beneficial effect on depressive and anxiety",
            "probability": 0.0008741254699991739,
            "start_logit": 3.218937397003174,
            "end_logit": -2.6112864017486572,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy: A systematic review.",
            "probability": 0.0007864903185486997,
            "start_logit": 3.7627909183502197,
            "end_logit": -3.2607834339141846,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood in adult patients with epilepsy",
            "probability": 0.0005482073253631866,
            "start_logit": -2.807270050048828,
            "end_logit": 2.948350667953491,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood",
            "probability": 0.0005183446865689574,
            "start_logit": 1.7163852453231812,
            "end_logit": -1.6313177347183228,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "e",
            "probability": 0.0005177402240672689,
            "start_logit": 3.7627909183502197,
            "end_logit": -3.6788902282714844,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "disorders in adult patients with epilepsy",
            "probability": 0.00025857162336739115,
            "start_logit": -4.353921890258789,
            "end_logit": 3.7435216903686523,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood disorders in adult patients with epile",
            "probability": 0.00020678700151151885,
            "start_logit": 1.7163852453231812,
            "end_logit": -2.5502688884735107,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy.",
            "probability": 0.00020333840206085343,
            "start_logit": 3.218937397003174,
            "end_logit": -4.069638729095459,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood disorders in adult patients with epilepsy: A systematic review.While more evidence is provided for older AEDs on their effect on mood",
            "probability": 0.00019349774703284408,
            "start_logit": 1.7163852453231812,
            "end_logit": -2.616692304611206,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood disorders in adult patients with epilepsy: A systematic review.While more evidence is provided for older AEDs on their effect on mood changes",
            "probability": 0.000153924795444392,
            "start_logit": 1.7163852453231812,
            "end_logit": -2.845494031906128,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy.If lacosamide is used as add-on, two studies point towards a beneficial effect on depressive and anxiety symptoms",
            "probability": 0.00014550051047343838,
            "start_logit": 3.218937397003174,
            "end_logit": -4.404330730438232,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "mood disorders in adult patients with epilepsy: A systematic review.",
            "probability": 0.0001016133312734433,
            "start_logit": 1.7163852453231812,
            "end_logit": -3.2607834339141846,
            "question_text": "What are the main indications of lacosamide?"
        }
    ],
    "56be0da3ef6e394741000007": [
        {
            "text": "thrombocytopenia",
            "probability": 0.3940782221927592,
            "start_logit": 4.874338626861572,
            "end_logit": 4.792552471160889,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute kidney injury",
            "probability": 0.293318331861897,
            "start_logit": 4.874338626861572,
            "end_logit": 4.4972615242004395,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute kidney injury",
            "probability": 0.1791147573148433,
            "start_logit": 4.381106853485107,
            "end_logit": 4.4972615242004395,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.045903537102409644,
            "start_logit": 2.7243313789367676,
            "end_logit": 4.792552471160889,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury",
            "probability": 0.034166691207954014,
            "start_logit": 2.7243313789367676,
            "end_logit": 4.4972615242004395,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "kidney injury",
            "probability": 0.026324949690428142,
            "start_logit": 2.463597297668457,
            "end_logit": 4.4972615242004395,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia",
            "probability": 0.0060910104737968256,
            "start_logit": 2.7243313789367676,
            "end_logit": 2.772824287414551,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.005776766967797988,
            "start_logit": 0.6516333818435669,
            "end_logit": 4.792552471160889,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia, thrombocytopenia, and acute kidney injury",
            "probability": 0.004299734304324488,
            "start_logit": 0.6516333818435669,
            "end_logit": 4.4972615242004395,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia,",
            "probability": 0.004277068388838251,
            "start_logit": 4.874338626861572,
            "end_logit": 0.2692708671092987,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia, thrombocytopenia",
            "probability": 0.0017786127639213359,
            "start_logit": -0.5263770818710327,
            "end_logit": 4.792552471160889,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia, thrombocytopenia, and acute kidney injury",
            "probability": 0.0013238481589741347,
            "start_logit": -0.5263770818710327,
            "end_logit": 4.4972615242004395,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.0007665280352370494,
            "start_logit": 0.6516333818435669,
            "end_logit": 2.772824287414551,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute kidney injury (AKI)",
            "probability": 0.0006598521394566866,
            "start_logit": 4.874338626861572,
            "end_logit": -1.5997364521026611,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia,",
            "probability": 0.0004982070980328016,
            "start_logit": 2.7243313789367676,
            "end_logit": 0.2692708671092987,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute kidney injury (AKI)",
            "probability": 0.0004029385244087355,
            "start_logit": 4.381106853485107,
            "end_logit": -1.5997364521026611,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia,",
            "probability": 0.00034227499308128625,
            "start_logit": 2.7243313789367676,
            "end_logit": -0.10613049566745758,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute kidney",
            "probability": 0.0003352794068865997,
            "start_logit": 4.874338626861572,
            "end_logit": -2.2767879962921143,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute",
            "probability": 0.0003053825297781345,
            "start_logit": 4.874338626861572,
            "end_logit": -2.3701870441436768,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia",
            "probability": 0.0002360068451741355,
            "start_logit": -0.5263770818710327,
            "end_logit": 2.772824287414551,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        }
    ],
    "56a92be0a17756b72f000009": [
        {
            "text": "ccna1",
            "probability": 0.34584638754780606,
            "start_logit": 4.103272914886475,
            "end_logit": 2.850796937942505,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna1",
            "probability": 0.2675737645316289,
            "start_logit": 3.8466734886169434,
            "end_logit": 2.850796937942505,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog",
            "probability": 0.24456274500404399,
            "start_logit": 3.8466734886169434,
            "end_logit": 2.760873556137085,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog and ccna1",
            "probability": 0.055244383054771744,
            "start_logit": 2.269044876098633,
            "end_logit": 2.850796937942505,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog",
            "probability": 0.05049343305230069,
            "start_logit": 2.269044876098633,
            "end_logit": 2.760873556137085,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "microRNA activity.Furthermore, dynamic 3'-UTR structures contain RNA-decay elements, such as the regulatory elements in nanog",
            "probability": 0.015400245683830917,
            "start_logit": 1.5001040697097778,
            "end_logit": 2.3423545360565186,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "ccna1,",
            "probability": 0.007668414736426977,
            "start_logit": 4.103272914886475,
            "end_logit": -0.9580878615379333,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna1,",
            "probability": 0.005932884288785456,
            "start_logit": 3.8466734886169434,
            "end_logit": -0.9580878615379333,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA",
            "probability": 0.0015374160569714224,
            "start_logit": 2.269044876098633,
            "end_logit": -0.7308666110038757,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "ccna",
            "probability": 0.0014979132889633557,
            "start_logit": 4.103272914886475,
            "end_logit": -2.5911247730255127,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog and ccna1,",
            "probability": 0.0012249277609223817,
            "start_logit": 2.269044876098633,
            "end_logit": -0.9580878615379333,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna",
            "probability": 0.0011589026576559979,
            "start_logit": 3.8466734886169434,
            "end_logit": -2.5911247730255127,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "microRNA",
            "probability": 0.0004951887633461938,
            "start_logit": 1.5001040697097778,
            "end_logit": -1.094845175743103,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "na",
            "probability": 0.00032078371626000904,
            "start_logit": 3.8466734886169434,
            "end_logit": -3.87558650970459,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "cc",
            "probability": 0.00024719889386883313,
            "start_logit": 4.103272914886475,
            "end_logit": -4.392759799957275,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog and ccna",
            "probability": 0.0002392718226871344,
            "start_logit": 2.269044876098633,
            "end_logit": -2.5911247730255127,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and cc",
            "probability": 0.00019125236232630952,
            "start_logit": 3.8466734886169434,
            "end_logit": -4.392759799957275,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nano",
            "probability": 0.00019025763617172914,
            "start_logit": 3.8466734886169434,
            "end_logit": -4.397974491119385,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements,",
            "probability": 8.780869272825376e-05,
            "start_logit": 2.269044876098633,
            "end_logit": -3.593564510345459,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "microRNA activity.Furthermore, dynamic 3'-UTR structures contain RNA",
            "probability": 8.682044850364229e-05,
            "start_logit": 1.5001040697097778,
            "end_logit": -2.835942029953003,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        }
    ],
    "56c3327c50c68dd41600000c": [
        {
            "text": "negative DNA superhelicity",
            "probability": 0.5821518606618494,
            "start_logit": -0.6713434457778931,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA superhelicity",
            "probability": 0.14299359572828232,
            "start_logit": -2.07527494430542,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology, in particular negative DNA superhelicity",
            "probability": 0.06667835704458952,
            "start_logit": -2.8381943702697754,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "superhelicity",
            "probability": 0.04882227920735761,
            "start_logit": -3.149888038635254,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "topology, in particular negative DNA superhelicity",
            "probability": 0.027409914689010068,
            "start_logit": -3.727169990539551,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "negative DNA",
            "probability": 0.023296243427494333,
            "start_logit": -0.6713434457778931,
            "end_logit": -3.4818437099456787,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology",
            "probability": 0.020546073431534726,
            "start_logit": -2.8381943702697754,
            "end_logit": -1.4406150579452515,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "negative DNA superhelicity,",
            "probability": 0.018594266640153366,
            "start_logit": -0.6713434457778931,
            "end_logit": -3.707282543182373,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "negative",
            "probability": 0.012330703956513638,
            "start_logit": -0.6713434457778931,
            "end_logit": -4.118043422698975,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "topology",
            "probability": 0.008446010743424581,
            "start_logit": -3.727169990539551,
            "end_logit": -1.4406150579452515,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "Escherichia coli revealed that DNA topology, in particular negative DNA superhelicity",
            "probability": 0.008435668748655391,
            "start_logit": -4.905605792999268,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "work in Escherichia coli revealed that DNA topology, in particular negative DNA superhelicity",
            "probability": 0.007448620163392658,
            "start_logit": -5.030045986175537,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "negative DNA superhelicity, plays a key role in driving R-loops",
            "probability": 0.006978268477597336,
            "start_logit": -0.6713434457778931,
            "end_logit": -4.687335014343262,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA",
            "probability": 0.005722241634462039,
            "start_logit": -2.07527494430542,
            "end_logit": -3.4818437099456787,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA superhelicity,",
            "probability": 0.004567298030763163,
            "start_logit": -2.07527494430542,
            "end_logit": -3.707282543182373,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "in particular negative DNA superhelicity",
            "probability": 0.004153688536865671,
            "start_logit": -5.614078044891357,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "y",
            "probability": 0.0038620716510023713,
            "start_logit": -5.68687105178833,
            "end_logit": -0.2634044885635376,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology, in particular negative DNA",
            "probability": 0.002668299016153838,
            "start_logit": -2.8381943702697754,
            "end_logit": -3.4818437099456787,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "Escherichia coli revealed that DNA topology",
            "probability": 0.0025993422339136655,
            "start_logit": -4.905605792999268,
            "end_logit": -1.4406150579452515,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "work in Escherichia coli revealed that DNA topology",
            "probability": 0.0022951959769844667,
            "start_logit": -5.030045986175537,
            "end_logit": -1.4406150579452515,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        }
    ],
    "5314a7a4dae131f847000003": [
        {
            "text": "mutations in sarcomere proteins.",
            "probability": 0.2080692116554583,
            "start_logit": -4.9895758628845215,
            "end_logit": -3.6901180744171143,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "sarcomere proteins.",
            "probability": 0.0926377486947259,
            "start_logit": -5.798749923706055,
            "end_logit": -3.6901180744171143,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Hypertrophic cardiomyopathy",
            "probability": 0.08214960963847792,
            "start_logit": -4.754220008850098,
            "end_logit": -4.85480260848999,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in sarcomere proteins.Hypertrophic cardiomyopathy",
            "probability": 0.07238192468009512,
            "start_logit": -4.880805492401123,
            "end_logit": -4.85480260848999,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Hypertrophic cardiomyopathy (HCM) is a genetic form of left ventricular hypertrophy,",
            "probability": 0.07029302728133743,
            "start_logit": -4.754220008850098,
            "end_logit": -5.010672092437744,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "caused by mutations in sarcomere proteins.",
            "probability": 0.06211203704805098,
            "start_logit": -6.198506832122803,
            "end_logit": -3.6901180744171143,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "primarily caused by mutations in sarcomere proteins.",
            "probability": 0.060892908875922164,
            "start_logit": -6.218329906463623,
            "end_logit": -3.6901180744171143,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "sarcomere proteins.Hypertrophic cardiomyopathy",
            "probability": 0.046413800043741724,
            "start_logit": -5.325165271759033,
            "end_logit": -4.85480260848999,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "left ventricular hypertrophy, primarily caused by mutations in sarcomere proteins.",
            "probability": 0.04443729088641107,
            "start_logit": -6.53336763381958,
            "end_logit": -3.6901180744171143,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in sarcomere proteins",
            "probability": 0.040968707576197014,
            "start_logit": -4.880805492401123,
            "end_logit": -5.423950672149658,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations",
            "probability": 0.02910018820373037,
            "start_logit": -4.880805492401123,
            "end_logit": -5.766014575958252,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "left ventricular hypertrophy, primarily caused by mutations in sarcomere proteins.Hypertrophic cardiomyopathy",
            "probability": 0.02781142809997123,
            "start_logit": -5.837315082550049,
            "end_logit": -4.85480260848999,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "sarcomere proteins",
            "probability": 0.02627055594191801,
            "start_logit": -5.325165271759033,
            "end_logit": -5.423950672149658,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "HCM) is a genetic form of left ventricular hypertrophy, primarily caused by mutations in sarcomere proteins.",
            "probability": 0.02536778727182182,
            "start_logit": -7.093966484069824,
            "end_logit": -3.6901180744171143,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 0.02403899787000323,
            "start_logit": -4.754220008850098,
            "end_logit": -6.083667278289795,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in sarcomere proteins.Hypertrophic cardiomyopathy (HCM)",
            "probability": 0.021180732822332855,
            "start_logit": -4.880805492401123,
            "end_logit": -6.083667278289795,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Hypertrophic cardiomyopathy (HCM) is a genetic form of left ventricular hypertrophy",
            "probability": 0.02063782943101246,
            "start_logit": -4.754220008850098,
            "end_logit": -6.2362189292907715,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "left ventricular hypertrophy,",
            "probability": 0.015912918522357742,
            "start_logit": -5.837315082550049,
            "end_logit": -5.413118362426758,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "left ventricular hypertrophy, primarily caused by mutations in sarcomere proteins",
            "probability": 0.015741475100861498,
            "start_logit": -5.837315082550049,
            "end_logit": -5.423950672149658,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "sarcomere proteins.Hypertrophic cardiomyopathy (HCM)",
            "probability": 0.013581820355573095,
            "start_logit": -5.325165271759033,
            "end_logit": -6.083667278289795,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "56c6dd275795f9a73e000008": [
        {
            "text": "tri-methylation of lysine 9 on histone H3 (H3K9me3",
            "probability": 0.3689538474832474,
            "start_logit": 4.46687650680542,
            "end_logit": 3.380929708480835,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9",
            "probability": 0.16107881374586114,
            "start_logit": 4.46687650680542,
            "end_logit": 2.552151918411255,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9 on histone H3",
            "probability": 0.1493329280418503,
            "start_logit": 4.46687650680542,
            "end_logit": 2.4764363765716553,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3",
            "probability": 0.10903057056380408,
            "start_logit": 3.247833251953125,
            "end_logit": 3.380929708480835,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9 on histone H3 (H3K9me3)",
            "probability": 0.1070101971989164,
            "start_logit": 4.46687650680542,
            "end_logit": 2.1431822776794434,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3)",
            "probability": 0.03162287894903389,
            "start_logit": 3.247833251953125,
            "end_logit": 2.1431822776794434,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation",
            "probability": 0.01797344984392775,
            "start_logit": 4.46687650680542,
            "end_logit": 0.3591538071632385,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9 on histone H3 (H3K9me3",
            "probability": 0.01600352099304656,
            "start_logit": 1.329013705253601,
            "end_logit": 3.380929708480835,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3 (H3K9me3",
            "probability": 0.007077278775238444,
            "start_logit": 0.513094425201416,
            "end_logit": 3.380929708480835,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9",
            "probability": 0.006986858098651415,
            "start_logit": 1.329013705253601,
            "end_logit": 2.552151918411255,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9 on histone H3",
            "probability": 0.006477375599069679,
            "start_logit": 1.329013705253601,
            "end_logit": 2.4764363765716553,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9 on histone H3 (H3K9me3)",
            "probability": 0.004641610187899368,
            "start_logit": 1.329013705253601,
            "end_logit": 2.1431822776794434,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3",
            "probability": 0.0028645066836517677,
            "start_logit": 0.513094425201416,
            "end_logit": 2.4764363765716553,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "(H3K9me3",
            "probability": 0.0021304669665951903,
            "start_logit": -0.6874538660049438,
            "end_logit": 3.380929708480835,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3 (H3K9me3)",
            "probability": 0.0020526713640094483,
            "start_logit": 0.513094425201416,
            "end_logit": 2.1431822776794434,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9 on histone H3 (H3K9me3) is gaining increased attention",
            "probability": 0.0016652524183257986,
            "start_logit": 4.46687650680542,
            "end_logit": -2.0197651386260986,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3 (H3K9me3",
            "probability": 0.0016613093541305258,
            "start_logit": -0.9361889958381653,
            "end_logit": 3.380929708480835,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "t",
            "probability": 0.0012173363323985014,
            "start_logit": 4.46687650680542,
            "end_logit": -2.3330767154693604,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "methylation of lysine 9 on histone H3 (H3K9me3",
            "probability": 0.0011127511411023986,
            "start_logit": -1.3369596004486084,
            "end_logit": 3.380929708480835,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9 on histone H3 (H3K9me3) is gaining increased attention.",
            "probability": 0.001106376259239992,
            "start_logit": 4.46687650680542,
            "end_logit": -2.428651809692383,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        }
    ],
    "5322d9339b2d7acc7e000011": [
        {
            "text": "c-KIT levels",
            "probability": 0.23683424879215084,
            "start_logit": 3.975607395172119,
            "end_logit": 4.100404262542725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "c-KIT",
            "probability": 0.22220666517898258,
            "start_logit": 3.975607395172119,
            "end_logit": 4.036651611328125,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced c-KIT levels",
            "probability": 0.19053488106637798,
            "start_logit": 3.758082151412964,
            "end_logit": 4.100404262542725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced c-KIT",
            "probability": 0.17876688332856144,
            "start_logit": 3.758082151412964,
            "end_logit": 4.036651611328125,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "pigmented nodular adrenocortical disease",
            "probability": 0.09689664589727279,
            "start_logit": 3.281644344329834,
            "end_logit": 3.900651693344116,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "primary pigmented nodular adrenocortical disease",
            "probability": 0.044163738298229484,
            "start_logit": 2.495903491973877,
            "end_logit": 3.900651693344116,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "nodular adrenocortical disease",
            "probability": 0.013639191446388296,
            "start_logit": 1.3209468126296997,
            "end_logit": 3.900651693344116,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced",
            "probability": 0.007434129041837763,
            "start_logit": 3.758082151412964,
            "end_logit": 0.8566504120826721,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "levels",
            "probability": 0.0021817731642662726,
            "start_logit": -0.7116152048110962,
            "end_logit": 4.100404262542725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "Knockdown of PKA's catalytic subunit (PRKACA) by siRNA reduced c-KIT levels",
            "probability": 0.0014815233437594575,
            "start_logit": -1.0986822843551636,
            "end_logit": 4.100404262542725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "Knockdown of PKA's catalytic subunit (PRKACA) by siRNA reduced c-KIT",
            "probability": 0.0013900200806282836,
            "start_logit": -1.0986822843551636,
            "end_logit": 4.036651611328125,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "adrenocortical disease",
            "probability": 0.0011352512256500235,
            "start_logit": -1.1651465892791748,
            "end_logit": 3.900651693344116,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "siRNA reduced c-KIT levels",
            "probability": 0.0006012578885194581,
            "start_logit": -2.0004844665527344,
            "end_logit": 4.100404262542725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "siRNA reduced c-KIT",
            "probability": 0.000564122423179249,
            "start_logit": -2.0004844665527344,
            "end_logit": 4.036651611328125,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "KIT levels",
            "probability": 0.0005114370511615301,
            "start_logit": -2.1622838973999023,
            "end_logit": 4.100404262542725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "KIT",
            "probability": 0.0004798491863704754,
            "start_logit": -2.1622838973999023,
            "end_logit": 4.036651611328125,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "disease",
            "probability": 0.0004390163792202134,
            "start_logit": -2.1152191162109375,
            "end_logit": 3.900651693344116,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "pigmented nodular adrenocortical disease (PPNAD)",
            "probability": 0.0003479602137016391,
            "start_logit": 3.281644344329834,
            "end_logit": -1.7286603450775146,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "pigmented",
            "probability": 0.00020774453472143387,
            "start_logit": 3.281644344329834,
            "end_logit": -2.2444393634796143,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "by siRNA reduced c-KIT levels",
            "probability": 0.00018366145902088573,
            "start_logit": -3.1864142417907715,
            "end_logit": 4.100404262542725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        }
    ],
    "56c1f005ef6e39474100003a": [
        {
            "text": "interleukin-13",
            "probability": 0.36289772665252346,
            "start_logit": 5.647800922393799,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4",
            "probability": 0.3487376530438608,
            "start_logit": 5.371860980987549,
            "end_logit": 5.272758960723877,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13",
            "probability": 0.27538802644874016,
            "start_logit": 5.371860980987549,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4",
            "probability": 0.0024366380653191603,
            "start_logit": 0.4081602990627289,
            "end_logit": 5.272758960723877,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4 and interleukin-13",
            "probability": 0.0019241425241045757,
            "start_logit": 0.4081602990627289,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signaling",
            "probability": 0.001495925883586701,
            "start_logit": 5.647800922393799,
            "end_logit": -0.454755574464798,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signaling",
            "probability": 0.001135196080158924,
            "start_logit": 5.371860980987549,
            "end_logit": -0.454755574464798,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "-4",
            "probability": 0.0010112979856167373,
            "start_logit": -0.471224308013916,
            "end_logit": 5.272758960723877,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "13",
            "probability": 0.0009360801309385012,
            "start_logit": -0.3123743236064911,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "-4 and interleukin-13",
            "probability": 0.0007985927357707852,
            "start_logit": -0.471224308013916,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signaling.",
            "probability": 0.0006307298374512038,
            "start_logit": 5.647800922393799,
            "end_logit": -1.3183785676956177,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signaling.",
            "probability": 0.00047863470173880706,
            "start_logit": 5.371860980987549,
            "end_logit": -1.3183785676956177,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-4",
            "probability": 0.0004673320494904905,
            "start_logit": -1.2431741952896118,
            "end_logit": 5.272758960723877,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-4 and interleukin-13",
            "probability": 0.00036903858726503735,
            "start_logit": -1.2431741952896118,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "n-4",
            "probability": 0.0003187255569239993,
            "start_logit": -1.6258838176727295,
            "end_logit": 5.272758960723877,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "-13",
            "probability": 0.000305656001713691,
            "start_logit": -1.4316151142120361,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "n-4 and interleukin-13",
            "probability": 0.00025168834318282376,
            "start_logit": -1.6258838176727295,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "inter",
            "probability": 0.00016983164263937139,
            "start_logit": 5.371860980987549,
            "end_logit": -2.354508638381958,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-13",
            "probability": 0.00012355131943829305,
            "start_logit": -2.337418794631958,
            "end_logit": 5.036620140075684,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "Dupilumab is a monoclonal antibody that inhibits interleukin-4",
            "probability": 0.0001235324095364724,
            "start_logit": -2.5737106800079346,
            "end_logit": 5.272758960723877,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        }
    ],
    "513ce3c8bee46bd34c000008": [
        {
            "text": "CDC45",
            "probability": 0.5266946982045267,
            "start_logit": 4.819221019744873,
            "end_logit": 4.666978359222412,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45",
            "probability": 0.16498415715081605,
            "start_logit": 4.819221019744873,
            "end_logit": 3.506206750869751,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22A-LCR22B",
            "probability": 0.06539526859265289,
            "start_logit": 4.819221019744873,
            "end_logit": 2.5808072090148926,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45)",
            "probability": 0.045676956994178196,
            "start_logit": 4.819221019744873,
            "end_logit": 2.2219512462615967,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene",
            "probability": 0.03267180162051174,
            "start_logit": 4.819221019744873,
            "end_logit": 1.8868696689605713,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45",
            "probability": 0.02904833141778237,
            "start_logit": 3.0823326110839844,
            "end_logit": 3.506206750869751,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22A",
            "probability": 0.02599968967465514,
            "start_logit": 4.819221019744873,
            "end_logit": 1.6584419012069702,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "LCR22A-LCR22B",
            "probability": 0.01939699885206601,
            "start_logit": 3.6038894653320312,
            "end_logit": 2.5808072090148926,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22A-LCR22",
            "probability": 0.014604523998898318,
            "start_logit": 4.819221019744873,
            "end_logit": 1.081688642501831,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene,",
            "probability": 0.011875874721132855,
            "start_logit": 4.819221019744873,
            "end_logit": 0.8748663067817688,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene, located within the LCR22A-LCR22B",
            "probability": 0.011513974844856063,
            "start_logit": 3.0823326110839844,
            "end_logit": 2.5808072090148926,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "LCR22B",
            "probability": 0.010093551438954303,
            "start_logit": 2.9506678581237793,
            "end_logit": 2.5808072090148926,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45)",
            "probability": 0.008042223009993524,
            "start_logit": 3.0823326110839844,
            "end_logit": 2.2219512462615967,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "LCR22A",
            "probability": 0.007711810986124121,
            "start_logit": 3.6038894653320312,
            "end_logit": 1.6584419012069702,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22",
            "probability": 0.006006691722153412,
            "start_logit": 4.819221019744873,
            "end_logit": 0.19323143362998962,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene",
            "probability": 0.0057524391303893745,
            "start_logit": 3.0823326110839844,
            "end_logit": 1.8868696689605713,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene, located within the LCR22A",
            "probability": 0.00457769773456785,
            "start_logit": 3.0823326110839844,
            "end_logit": 1.6584419012069702,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "LCR22A-LCR22",
            "probability": 0.004331872035057715,
            "start_logit": 3.6038894653320312,
            "end_logit": 1.081688642501831,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "the CDC45",
            "probability": 0.0030500573172696755,
            "start_logit": -0.33223965764045715,
            "end_logit": 4.666978359222412,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene, located within the LCR22A-LCR22",
            "probability": 0.002571380553413678,
            "start_logit": 3.0823326110839844,
            "end_logit": 1.081688642501831,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        }
    ],
    "56d06e043975bb303a000011": [
        {
            "text": "Acute Lymphoblastic Leukemia",
            "probability": 0.8021186405486739,
            "start_logit": 2.5973939895629883,
            "end_logit": 2.5569992065429688,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "acute lymphoblastic leukemia",
            "probability": 0.16677693654221754,
            "start_logit": 2.039313554763794,
            "end_logit": 1.544480323791504,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "Lymphoblastic Leukemia",
            "probability": 0.010400039285038744,
            "start_logit": -1.748052954673767,
            "end_logit": 2.5569992065429688,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "Leukemia",
            "probability": 0.005507234042486476,
            "start_logit": -2.3838000297546387,
            "end_logit": 2.5569992065429688,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "lymphoblastic leukemia",
            "probability": 0.0050555616515845486,
            "start_logit": -1.4568547010421753,
            "end_logit": 1.544480323791504,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced breast cancer.Here, for the first time, we present a case of acute lymphoblastic leukemia",
            "probability": 0.004209178738371273,
            "start_logit": -1.0469578504562378,
            "end_logit": 0.9513620734214783,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment with letrozole",
            "probability": 0.001410319442251582,
            "start_logit": 2.039313554763794,
            "end_logit": -3.228360652923584,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "leukemia",
            "probability": 0.0013840270173798104,
            "start_logit": -2.7523462772369385,
            "end_logit": 1.544480323791504,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer",
            "probability": 0.0007951576168926837,
            "start_logit": -1.3287277221679688,
            "end_logit": -0.433350533246994,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer.Here, for the first time, we present a case of acute lymphoblastic leukemia",
            "probability": 0.0005365911229346026,
            "start_logit": -3.1067442893981934,
            "end_logit": 0.9513620734214783,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced breast cancer",
            "probability": 0.0004868028780295437,
            "start_logit": -1.1468616724014282,
            "end_logit": -1.1058976650238037,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "metastatic breast cancer",
            "probability": 0.0003835515314885618,
            "start_logit": -2.0577940940856934,
            "end_logit": -0.433350533246994,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced",
            "probability": 0.0002493396071834256,
            "start_logit": -1.1468616724014282,
            "end_logit": -1.774941086769104,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "leukemia that was diagnosed in a patient undergoing treatment with letrozole and palbociclib for metastatic breast cancer",
            "probability": 0.00019150650949362002,
            "start_logit": -2.7523462772369385,
            "end_logit": -0.433350533246994,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "letrozole and palbociclib for metastatic breast cancer",
            "probability": 0.00011495700873483797,
            "start_logit": -3.262709856033325,
            "end_logit": -0.433350533246994,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "neutropenia",
            "probability": 9.559527747501468e-05,
            "start_logit": -1.8219228982925415,
            "end_logit": -2.058572292327881,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced breast cancer.The common hematological toxicities associated with palbociclib are leukopenia and neutropenia",
            "probability": 8.422416776261452e-05,
            "start_logit": -1.9485644102096558,
            "end_logit": -2.058572292327881,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer.Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced",
            "probability": 7.32750686865582e-05,
            "start_logit": -2.371457099914551,
            "end_logit": -1.774941086769104,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced breast cancer.The common hematological toxicities associated with palbociclib are leukopenia",
            "probability": 6.425030431609637e-05,
            "start_logit": -1.9485644102096558,
            "end_logit": -2.329267740249634,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "leukopenia and neutropenia",
            "probability": 6.281163899861672e-05,
            "start_logit": -2.241905927658081,
            "end_logit": -2.058572292327881,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        }
    ],
    "571e1e11bb137a4b0c000004": [
        {
            "text": "Valproate intoxication",
            "probability": 0.7469568686808075,
            "start_logit": 2.8694167137145996,
            "end_logit": 3.3907158374786377,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "intoxication",
            "probability": 0.09854316046942245,
            "start_logit": 0.8439038991928101,
            "end_logit": 3.3907158374786377,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "Valproate",
            "probability": 0.09376181212722186,
            "start_logit": 2.8694167137145996,
            "end_logit": 1.315466046333313,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "Valproate intoxication in a patient with bipolar I disorder",
            "probability": 0.02732110583723889,
            "start_logit": 2.8694167137145996,
            "end_logit": 0.082367904484272,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight reduction could bring unexpected side effects of other drugs whose blood concentrations are affected by body weight.Valproate intoxication",
            "probability": 0.011645238692581454,
            "start_logit": -1.2916933298110962,
            "end_logit": 3.3907158374786377,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "Valproate intoxication in a patient with bipolar I disorder due to SGLT2 inhibitor-induced weight reduction",
            "probability": 0.011200718097566115,
            "start_logit": 2.8694167137145996,
            "end_logit": -0.8093137145042419,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "intoxication in a patient with bipolar I disorder",
            "probability": 0.00360436891286101,
            "start_logit": 0.8439038991928101,
            "end_logit": 0.082367904484272,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "intoxication in a patient with bipolar I disorder due to SGLT2 inhibitor-induced weight reduction",
            "probability": 0.0014776678642912146,
            "start_logit": 0.8439038991928101,
            "end_logit": -0.8093137145042419,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight reduction could bring unexpected side effects of other drugs whose blood concentrations are affected by body weight.Valproate",
            "probability": 0.0014617693848894278,
            "start_logit": -1.2916933298110962,
            "end_logit": 1.315466046333313,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "cation",
            "probability": 0.0009737917508967685,
            "start_logit": -3.773148536682129,
            "end_logit": 3.3907158374786377,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "Valproate intoxication in a patient with bipolar I disorder due to SGLT2 inhibitor-induced weight reduction.",
            "probability": 0.0008775927073519808,
            "start_logit": 2.8694167137145996,
            "end_logit": -3.3558642864227295,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "bipolar I disorder",
            "probability": 0.00039751488533781685,
            "start_logit": -1.3607656955718994,
            "end_logit": 0.082367904484272,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "te intoxication",
            "probability": 0.0003783893138700929,
            "start_logit": -4.7184224128723145,
            "end_logit": 3.3907158374786377,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "V",
            "probability": 0.00032809830864974555,
            "start_logit": 2.8694167137145996,
            "end_logit": -4.339733600616455,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "xication",
            "probability": 0.0003179365414539367,
            "start_logit": -4.892494201660156,
            "end_logit": 3.3907158374786377,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "unexpected side effects of other drugs whose blood concentrations are affected by body weight.Valproate intoxication",
            "probability": 0.0002815647060638177,
            "start_logit": -5.013983726501465,
            "end_logit": 3.3907158374786377,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "bipolar I disorder due to SGLT2 inhibitor-induced weight reduction",
            "probability": 0.0001629674946826814,
            "start_logit": -1.3607656955718994,
            "end_logit": -0.8093137145042419,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "intoxication in a patient with bipolar I disorder due to SGLT2 inhibitor-induced weight reduction.",
            "probability": 0.00011577744661497508,
            "start_logit": 0.8439038991928101,
            "end_logit": -3.3558642864227295,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight reduction",
            "probability": 0.00011342714317361356,
            "start_logit": -1.7231557369232178,
            "end_logit": -0.8093137145042419,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight loss effect.Reason for the report: SGLT2 inhibitor-induced weight reduction",
            "probability": 8.022963502482269e-05,
            "start_logit": -1.3148268461227417,
            "end_logit": -1.5639103651046753,
            "question_text": "List side effects of SGLT2 inhibitors?"
        }
    ],
    "56a3a386496b62f23f000007": [
        {
            "text": "JASPAR 2020",
            "probability": 0.2659165238257135,
            "start_logit": -0.6587417125701904,
            "end_logit": -0.6770457029342651,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR",
            "probability": 0.25475926882287886,
            "start_logit": -0.1249331384897232,
            "end_logit": -1.2537176609039307,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "2020",
            "probability": 0.08364096782688914,
            "start_logit": -1.815390706062317,
            "end_logit": -0.6770457029342651,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release of JASPAR",
            "probability": 0.07576737701285952,
            "start_logit": -1.337584376335144,
            "end_logit": -1.2537176609039307,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR,",
            "probability": 0.051249722776872064,
            "start_logit": -0.1249331384897232,
            "end_logit": -2.8573265075683594,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2020: update of the open-access database of transcription factor binding profiles.",
            "probability": 0.05103319316235034,
            "start_logit": -0.6587417125701904,
            "end_logit": -2.327751874923706,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th",
            "probability": 0.029934829946981732,
            "start_logit": -1.337584376335144,
            "end_logit": -2.1823627948760986,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2020: update of the open-access database of transcription factor binding profiles. JASPAR",
            "probability": 0.029158388399597116,
            "start_logit": -0.6587417125701904,
            "end_logit": -2.8874855041503906,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release",
            "probability": 0.023103436536165152,
            "start_logit": -1.337584376335144,
            "end_logit": -2.441404104232788,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "In this 8th release of JASPAR",
            "probability": 0.021589198733147383,
            "start_logit": -2.5930590629577637,
            "end_logit": -1.2537176609039307,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR, the CORE collection has been expanded with 245 new PFMs",
            "probability": 0.016086803092954318,
            "start_logit": -0.1249331384897232,
            "end_logit": -4.016037464141846,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "2020: update of the open-access database of transcription factor binding profiles.",
            "probability": 0.01605190082205344,
            "start_logit": -1.815390706062317,
            "end_logit": -2.327751874923706,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release of JASPAR,",
            "probability": 0.015242063950731036,
            "start_logit": -1.337584376335144,
            "end_logit": -2.8573265075683594,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2020: update of the open-access database of transcription factor binding profiles",
            "probability": 0.014887620629735664,
            "start_logit": -0.6587417125701904,
            "end_logit": -3.5596981048583984,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR, the CORE collection has been expanded with 245",
            "probability": 0.012402953755094525,
            "start_logit": -0.1249331384897232,
            "end_logit": -4.276102066040039,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR (http://jaspar.genereg.net)",
            "probability": 0.010032471745073015,
            "start_logit": -1.052775502204895,
            "end_logit": -3.5603673458099365,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "2020: update of the open-access database of transcription factor binding profiles. JASPAR",
            "probability": 0.009171433918161088,
            "start_logit": -1.815390706062317,
            "end_logit": -2.8874855041503906,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "In this 8th",
            "probability": 0.008529647168050615,
            "start_logit": -2.5930590629577637,
            "end_logit": -2.1823627948760986,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "In this 8th release",
            "probability": 0.0065831061132454426,
            "start_logit": -2.5930590629577637,
            "end_logit": -2.441404104232788,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "release of JASPAR",
            "probability": 0.004859091761445888,
            "start_logit": -4.084400653839111,
            "end_logit": -1.2537176609039307,
            "question_text": "List the releases of JASPAR database"
        }
    ],
    "571529efcb4ef8864c000001": [
        {
            "text": "penicillin",
            "probability": 0.8443917021874543,
            "start_logit": 3.2930140495300293,
            "end_logit": 3.170731544494629,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics",
            "probability": 0.1476895156959113,
            "start_logit": 3.2930140495300293,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin anti",
            "probability": 0.0018589185637511605,
            "start_logit": 3.2930140495300293,
            "end_logit": -2.947890043258667,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "MSMEG_1285 enhances Mycobacterium smegmatis resistance to penicillin",
            "probability": 0.0015021910571875368,
            "start_logit": -3.03867769241333,
            "end_logit": 3.170731544494629,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "llin",
            "probability": 0.0008649332391318573,
            "start_logit": -3.590705394744873,
            "end_logit": 3.170731544494629,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics,",
            "probability": 0.0006418593660076176,
            "start_logit": 3.2930140495300293,
            "end_logit": -4.011270999908447,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "pen",
            "probability": 0.000604147596974105,
            "start_logit": 3.2930140495300293,
            "end_logit": -4.071821689605713,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "Mycobacterium smegmatis resistance to penicillin",
            "probability": 0.0005046973262948276,
            "start_logit": -4.129398822784424,
            "end_logit": 3.170731544494629,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "resistance to penicillin",
            "probability": 0.00036701232640152875,
            "start_logit": -4.447962284088135,
            "end_logit": 3.170731544494629,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "antibiotics",
            "probability": 0.00027608778661686784,
            "start_logit": -2.9891345500946045,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "MSMEG_1285 enhances Mycobacterium smegmatis resistance to penicillin antibiotics",
            "probability": 0.0002627428350421,
            "start_logit": -3.03867769241333,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "icillin",
            "probability": 0.0001911860786675905,
            "start_logit": -5.1001105308532715,
            "end_logit": 3.170731544494629,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics, a phenotype that is exacerbated by the additional deletion of hbhA.",
            "probability": 0.00017998858490766629,
            "start_logit": 3.2930140495300293,
            "end_logit": -5.2827467918396,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "llin antibiotics",
            "probability": 0.00015128236204329886,
            "start_logit": -3.590705394744873,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "Deletion of MSMEG_1285 enhances Mycobacterium smegmatis resistance to penicillin",
            "probability": 0.00014557145138154005,
            "start_logit": -5.372690677642822,
            "end_logit": 3.170731544494629,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics, a phenotype that is exacerbated by the additional deletion of hbhA",
            "probability": 0.0001340802977090003,
            "start_logit": 3.2930140495300293,
            "end_logit": -5.5772013664245605,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "Mycobacterium smegmatis resistance to penicillin antibiotics",
            "probability": 8.827479415111176e-05,
            "start_logit": -4.129398822784424,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "resistance to penicillin antibiotics",
            "probability": 6.41928060167487e-05,
            "start_logit": -4.447962284088135,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "biotics",
            "probability": 4.817597494824738e-05,
            "start_logit": -4.734992980957031,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "icillin antibiotics",
            "probability": 3.3439669401142965e-05,
            "start_logit": -5.1001105308532715,
            "end_logit": 1.427227258682251,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        }
    ],
    "52b2d405f828ad283c000009": [
        {
            "text": "Fibroblast-like synoviocytes",
            "probability": 0.6981216712360376,
            "start_logit": 4.616972923278809,
            "end_logit": 4.493552207946777,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast",
            "probability": 0.12232585917615284,
            "start_logit": 4.616972923278809,
            "end_logit": 2.751847267150879,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes",
            "probability": 0.12174110798497427,
            "start_logit": 2.870476245880127,
            "end_logit": 4.493552207946777,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblast",
            "probability": 0.022134434185670477,
            "start_logit": 3.507572650909424,
            "end_logit": 2.15169358253479,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like",
            "probability": 0.011243639705300831,
            "start_logit": 4.616972923278809,
            "end_logit": 0.3649614155292511,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblast-like synoviocyte",
            "probability": 0.010468952553022253,
            "start_logit": 3.507572650909424,
            "end_logit": 1.4029730558395386,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocyte",
            "probability": 0.003056021362422163,
            "start_logit": 2.2762725353240967,
            "end_logit": 1.4029730558395386,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocytes are the major cell types",
            "probability": 0.002237744042693442,
            "start_logit": 4.616972923278809,
            "end_logit": -1.249372959136963,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocy",
            "probability": 0.0020819478825350748,
            "start_logit": 4.616972923278809,
            "end_logit": -1.3215372562408447,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblast-like synoviocyte cell",
            "probability": 0.0015109709878154123,
            "start_logit": 3.507572650909424,
            "end_logit": -0.5326884388923645,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocytes are the major cell types that make up the synovial intima structure,",
            "probability": 0.0012818321895204572,
            "start_logit": 4.616972923278809,
            "end_logit": -1.8065507411956787,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like s",
            "probability": 0.0012572892865907062,
            "start_logit": 4.616972923278809,
            "end_logit": -1.825883150100708,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fi",
            "probability": 0.0004776268292820457,
            "start_logit": 4.616972923278809,
            "end_logit": -2.793766736984253,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocyte cell",
            "probability": 0.00044107178759072573,
            "start_logit": 2.2762725353240967,
            "end_logit": -0.5326884388923645,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes are the major cell types",
            "probability": 0.0003902263034779321,
            "start_logit": 2.870476245880127,
            "end_logit": -1.249372959136963,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocy",
            "probability": 0.00036305797746979805,
            "start_logit": 2.870476245880127,
            "end_logit": -1.3215372562408447,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblast-like",
            "probability": 0.00026973733270377527,
            "start_logit": 3.507572650909424,
            "end_logit": -2.2557475566864014,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes are the major cell types that make up the synovial intima structure,",
            "probability": 0.0002235307646684761,
            "start_logit": 2.870476245880127,
            "end_logit": -1.8065507411956787,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "s",
            "probability": 0.000219250880059615,
            "start_logit": 2.870476245880127,
            "end_logit": -1.825883150100708,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "tes",
            "probability": 0.00015402753201218685,
            "start_logit": -3.80204439163208,
            "end_logit": 4.493552207946777,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        }
    ],
    "552faa43bc4f83e828000004": [
        {
            "text": "BCL11B",
            "probability": 0.9966235198045468,
            "start_logit": 5.844881534576416,
            "end_logit": 5.63007116317749,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "CL11B",
            "probability": 0.0007916300230735779,
            "start_logit": -1.2931526899337769,
            "end_logit": 5.63007116317749,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11",
            "probability": 0.0006855011895167703,
            "start_logit": 5.844881534576416,
            "end_logit": -1.651906967163086,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma",
            "probability": 0.0006157950557906507,
            "start_logit": 5.844881534576416,
            "end_logit": -1.7591429948806763,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "L11B",
            "probability": 0.00031646305317067127,
            "start_logit": -2.210040330886841,
            "end_logit": 5.63007116317749,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B,",
            "probability": 0.0001962087757239935,
            "start_logit": 4.658462047576904,
            "end_logit": -1.7164584398269653,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "B",
            "probability": 0.00016057527389553582,
            "start_logit": 5.844881534576416,
            "end_logit": -3.1032943725585938,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "11B",
            "probability": 0.00014450348365525398,
            "start_logit": -2.993943214416504,
            "end_logit": 5.63007116317749,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B is up-regulated",
            "probability": 0.00014172073052774227,
            "start_logit": 5.844881534576416,
            "end_logit": -3.228198766708374,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B, a zinc finger transcription factor, acts as a transcriptional repressor in Ewing's sarcoma",
            "probability": 0.00010875687302446811,
            "start_logit": 4.658462047576904,
            "end_logit": -2.306522846221924,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.",
            "probability": 9.376941882877407e-05,
            "start_logit": 5.844881534576416,
            "end_logit": -3.641218423843384,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing sarcoma cells lines.BCL11B",
            "probability": 5.4957525497509754e-05,
            "start_logit": -2.4201889038085938,
            "end_logit": 4.089573860168457,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B, a zinc finger transcription factor,",
            "probability": 4.176466789543553e-05,
            "start_logit": 4.658462047576904,
            "end_logit": -3.26358699798584,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B, a zinc finger transcription factor, acts as a transcriptional repressor",
            "probability": 2.2821629136958913e-05,
            "start_logit": 4.658462047576904,
            "end_logit": -3.867928981781006,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "CL11",
            "probability": 5.445018220928104e-07,
            "start_logit": -1.2931526899337769,
            "end_logit": -1.651906967163086,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "CL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma",
            "probability": 4.891334034739122e-07,
            "start_logit": -1.2931526899337769,
            "end_logit": -1.7591429948806763,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing sarcoma",
            "probability": 3.501232207844011e-07,
            "start_logit": -1.6275027990341187,
            "end_logit": -1.7591429948806763,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "L11",
            "probability": 2.176707603982179e-07,
            "start_logit": -2.210040330886841,
            "end_logit": -1.651906967163086,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing sarcoma cells lines.",
            "probability": 2.1552990020052074e-07,
            "start_logit": -2.4201889038085938,
            "end_logit": -1.451642394065857,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "L11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma",
            "probability": 1.9553660897058842e-07,
            "start_logit": -2.210040330886841,
            "end_logit": -1.7591429948806763,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        }
    ],
    "533c3af6c45e13371400000d": [
        {
            "text": "CYLD cutaneous syndrome",
            "probability": 0.7085376812937424,
            "start_logit": 4.86548376083374,
            "end_logit": 4.861264228820801,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous syndrome",
            "probability": 0.12904291191184475,
            "start_logit": 3.1624255180358887,
            "end_logit": 4.861264228820801,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "amyotrophic lateral sclerosis",
            "probability": 0.04361286375639498,
            "start_logit": 3.5377047061920166,
            "end_logit": 3.4011921882629395,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Frontotemporal dementia",
            "probability": 0.022538763897218053,
            "start_logit": 2.691432476043701,
            "end_logit": 3.5873489379882812,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous syndrome,",
            "probability": 0.021465728840376605,
            "start_logit": 4.86548376083374,
            "end_logit": 1.364518642425537,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Frontotemporal dementia and amyotrophic lateral sclerosis",
            "probability": 0.01871040744629017,
            "start_logit": 2.691432476043701,
            "end_logit": 3.4011921882629395,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous syndrome, a skin tumour disorder",
            "probability": 0.013617247824677024,
            "start_logit": 4.86548376083374,
            "end_logit": 0.9093981981277466,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous syndrome, a skin tumour disorder,",
            "probability": 0.012936867113033762,
            "start_logit": 4.86548376083374,
            "end_logit": 0.8581421375274658,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity.In contrast with CYLD cutaneous syndrome",
            "probability": 0.010223745638256855,
            "start_logit": 0.813064455986023,
            "end_logit": 4.6751933097839355,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous syndrome,",
            "probability": 0.003909460610216846,
            "start_logit": 3.1624255180358887,
            "end_logit": 1.364518642425537,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous",
            "probability": 0.0028150842360402098,
            "start_logit": 4.86548376083374,
            "end_logit": -0.6669468283653259,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous syndrome, a skin tumour disorder",
            "probability": 0.002480050613981475,
            "start_logit": 3.1624255180358887,
            "end_logit": 0.9093981981277466,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous syndrome, a skin tumour disorder,",
            "probability": 0.0023561358095087115,
            "start_logit": 3.1624255180358887,
            "end_logit": 0.8581421375274658,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "dementia",
            "probability": 0.0017356229805022263,
            "start_logit": 0.12756222486495972,
            "end_logit": 3.5873489379882812,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "a skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity.In contrast with CYLD cutaneous syndrome",
            "probability": 0.001603133599674987,
            "start_logit": -1.0396883487701416,
            "end_logit": 4.6751933097839355,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "dementia and amyotrophic lateral sclerosis",
            "probability": 0.0014408160663304814,
            "start_logit": 0.12756222486495972,
            "end_logit": 3.4011921882629395,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD",
            "probability": 0.0011208865268977812,
            "start_logit": 4.86548376083374,
            "end_logit": -1.5878190994262695,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous syndrome, a skin tumour",
            "probability": 0.0009764071990708112,
            "start_logit": 4.86548376083374,
            "end_logit": -1.7258145809173584,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous",
            "probability": 0.0005126991502166251,
            "start_logit": 3.1624255180358887,
            "end_logit": -0.6669468283653259,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "syndrome",
            "probability": 0.0003634854857252157,
            "start_logit": -2.70973539352417,
            "end_logit": 4.861264228820801,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        }
    ],
    "571f3b320fd6f91b68000007": [
        {
            "text": "Adrenocorticotropic hormone",
            "probability": 0.6079269027865,
            "start_logit": -0.556556224822998,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing syndrome",
            "probability": 0.05977253861070079,
            "start_logit": -0.556556224822998,
            "end_logit": -3.611738920211792,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs",
            "probability": 0.0494675886821218,
            "start_logit": -1.9959791898727417,
            "end_logit": -2.361544609069824,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing syndrome, known as Cushing disease (CD),",
            "probability": 0.04566911751167482,
            "start_logit": -0.556556224822998,
            "end_logit": -3.8808629512786865,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing syndrome,",
            "probability": 0.03949997402062659,
            "start_logit": -0.556556224822998,
            "end_logit": -4.025985240936279,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic",
            "probability": 0.03237058255573607,
            "start_logit": -0.556556224822998,
            "end_logit": -4.225035190582275,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Ad",
            "probability": 0.029613442057637555,
            "start_logit": -0.556556224822998,
            "end_logit": -4.314056873321533,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs and symptoms",
            "probability": 0.023319094384547514,
            "start_logit": -1.9959791898727417,
            "end_logit": -3.1135897636413574,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing",
            "probability": 0.018109931664214356,
            "start_logit": -0.556556224822998,
            "end_logit": -4.8058247566223145,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs and symptoms of which differ from those seen in adult patients.",
            "probability": 0.01726584737731315,
            "start_logit": -1.9959791898727417,
            "end_logit": -3.4141318798065186,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent",
            "probability": 0.015925071802609162,
            "start_logit": -0.556556224822998,
            "end_logit": -4.934390544891357,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenoc",
            "probability": 0.013060425702470244,
            "start_logit": -0.556556224822998,
            "end_logit": -5.1326985359191895,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocortico",
            "probability": 0.011273230776873148,
            "start_logit": -0.556556224822998,
            "end_logit": -5.2798542976379395,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "tropic hormone",
            "probability": 0.009083334562919166,
            "start_logit": -4.760169506072998,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "renocorticotropic hormone",
            "probability": 0.006629042563719258,
            "start_logit": -5.075150489807129,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Cushing syndrome, known as Cushing disease (CD), is a rare disease in paediatric patients, the signs",
            "probability": 0.004797011545988279,
            "start_logit": -4.329303741455078,
            "end_logit": -2.361544609069824,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs and symptoms of which differ from those seen in adult patients",
            "probability": 0.004503877475717542,
            "start_logit": -1.9959791898727417,
            "end_logit": -4.757923603057861,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Cushing disease (CD), is a rare disease in paediatric patients, the signs",
            "probability": 0.004423626786698247,
            "start_logit": -4.410336971282959,
            "end_logit": -2.361544609069824,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "ocorticotropic hormone",
            "probability": 0.003802785619373116,
            "start_logit": -5.6308770179748535,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "symptoms",
            "probability": 0.003486573512559446,
            "start_logit": -3.896332263946533,
            "end_logit": -3.1135897636413574,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        }
    ],
    "54d65b6b3706e8952800000c": [
        {
            "text": "PMP22",
            "probability": 0.8705462053167904,
            "start_logit": 4.9233574867248535,
            "end_logit": 4.74636173248291,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene",
            "probability": 0.11237148870898248,
            "start_logit": 4.9233574867248535,
            "end_logit": 2.6990511417388916,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the PMP22",
            "probability": 0.006516218636557779,
            "start_logit": 0.028530893847346306,
            "end_logit": 4.74636173248291,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "duplication of the PMP22",
            "probability": 0.0031818181750527742,
            "start_logit": -0.6883105635643005,
            "end_logit": 4.74636173248291,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy with liability to pressure palsy",
            "probability": 0.001266948674072459,
            "start_logit": 4.9233574867248535,
            "end_logit": -1.7861477136611938,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22",
            "probability": 0.0009134261197907313,
            "start_logit": -1.9363161325454712,
            "end_logit": 4.74636173248291,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the PMP22 gene",
            "probability": 0.0008411238650758965,
            "start_logit": 0.028530893847346306,
            "end_logit": 2.6990511417388916,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP",
            "probability": 0.0006983708112055095,
            "start_logit": 4.9233574867248535,
            "end_logit": -2.3817641735076904,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PM",
            "probability": 0.0005991208172034877,
            "start_logit": 4.9233574867248535,
            "end_logit": -2.535051107406616,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "hereditary neuropathy with liability to pressure palsy (HNPP) induced by deletion of the PMP22",
            "probability": 0.0004899459585919163,
            "start_logit": -1.3669613599777222,
            "end_logit": 3.5540995597839355,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy",
            "probability": 0.00044236369259536916,
            "start_logit": 4.9233574867248535,
            "end_logit": -2.8383820056915283,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "duplication of the PMP22 gene",
            "probability": 0.0004107141504360101,
            "start_logit": -0.6883105635643005,
            "end_logit": 2.6990511417388916,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "induced by duplication of the PMP22",
            "probability": 0.0003087449040805889,
            "start_logit": -3.021003246307373,
            "end_logit": 4.74636173248291,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy with liability to pressure palsy (HNPP)",
            "probability": 0.00028342213178680393,
            "start_logit": 4.9233574867248535,
            "end_logit": -3.2835769653320312,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22 gene and hereditary neuropathy with liability to pressure palsy (HNPP) induced by deletion of the PMP22",
            "probability": 0.00027725573847904697,
            "start_logit": -1.9363161325454712,
            "end_logit": 3.5540995597839355,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "Mutations in some 80 genes can lead to CMT.The two most common forms are CMT1A induced by duplication of the PMP22",
            "probability": 0.0002602529749626258,
            "start_logit": -3.191864490509033,
            "end_logit": 4.74636173248291,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "deletion of the PMP22",
            "probability": 0.00019152535258243306,
            "start_logit": -2.3062362670898438,
            "end_logit": 3.5540995597839355,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy with liability to pressure palsy (HNPP) induced by deletion of the PM",
            "probability": 0.0001615537976622121,
            "start_logit": 4.9233574867248535,
            "end_logit": -3.8456761837005615,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "by duplication of the PMP22",
            "probability": 0.00012159367782562468,
            "start_logit": -3.952833652496338,
            "end_logit": 4.74636173248291,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22 gene",
            "probability": 0.00011790649626598763,
            "start_logit": -1.9363161325454712,
            "end_logit": 2.6990511417388916,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        }
    ],
    "517a8c918ed59a060a000043": [
        {
            "text": "Polymer",
            "probability": 0.1833298702976078,
            "start_logit": -2.2697081565856934,
            "end_logit": -4.010879039764404,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction",
            "probability": 0.1470242888455874,
            "start_logit": -2.2697081565856934,
            "end_logit": -4.231568336486816,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Sequencing in Patients With Myocarditis.Polymer",
            "probability": 0.08765425840837243,
            "start_logit": -3.0075950622558594,
            "end_logit": -4.010879039764404,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Sequencing in Patients With Myocarditis.Polymerase chain reaction",
            "probability": 0.07029571878198436,
            "start_logit": -3.0075950622558594,
            "end_logit": -4.231568336486816,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Sequencing",
            "probability": 0.06745905021496579,
            "start_logit": -3.0075950622558594,
            "end_logit": -4.272758483886719,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences in up to 67% of cases of myocarditis.",
            "probability": 0.05385628681320011,
            "start_logit": -2.2697081565856934,
            "end_logit": -5.235846996307373,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences",
            "probability": 0.052655136453575405,
            "start_logit": -2.2697081565856934,
            "end_logit": -5.258402347564697,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "V",
            "probability": 0.04332067944034394,
            "start_logit": -3.0075950622558594,
            "end_logit": -4.715649127960205,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Se",
            "probability": 0.04206507553337827,
            "start_logit": -3.0075950622558594,
            "end_logit": -4.74506139755249,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses",
            "probability": 0.03680251198243614,
            "start_logit": -2.2697081565856934,
            "end_logit": -5.616600036621094,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome",
            "probability": 0.03547288421677725,
            "start_logit": -3.0075950622558594,
            "end_logit": -4.915510654449463,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Sequencing in Patients With Myocarditis.",
            "probability": 0.03216611240655354,
            "start_logit": -3.0075950622558594,
            "end_logit": -5.013365745544434,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain",
            "probability": 0.030312397861997332,
            "start_logit": -2.2697081565856934,
            "end_logit": -5.810609340667725,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Sequencing in Patients With Myocarditis.Polymerase chain reaction analyses of cardiac tissues have detected viral sequences",
            "probability": 0.025175640662033646,
            "start_logit": -3.0075950622558594,
            "end_logit": -5.258402347564697,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "giant cell myocarditis",
            "probability": 0.018528095150481257,
            "start_logit": -4.505420207977295,
            "end_logit": -4.067165851593018,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Sequencing in Patients With Myocarditis.Polymerase chain reaction analyses",
            "probability": 0.017596133625954857,
            "start_logit": -3.0075950622558594,
            "end_logit": -5.616600036621094,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Sequencing in Patients With Myocarditis.Polymer",
            "probability": 0.0162518639925725,
            "start_logit": -4.6927876472473145,
            "end_logit": -4.010879039764404,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Virome Sequencing in Patients With Myocarditis.Polymerase chain",
            "probability": 0.014493059700853234,
            "start_logit": -3.0075950622558594,
            "end_logit": -5.810609340667725,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Sequencing in Patients With Myocarditis.Polymerase chain reaction",
            "probability": 0.013033439351941543,
            "start_logit": -4.6927876472473145,
            "end_logit": -4.231568336486816,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Sequencing",
            "probability": 0.012507496259383384,
            "start_logit": -4.6927876472473145,
            "end_logit": -4.272758483886719,
            "question_text": "Which viruses are best known to cause myocarditis?"
        }
    ],
    "571f2b5bbb137a4b0c000010": [
        {
            "text": "CCM2",
            "probability": 0.5264835420175698,
            "start_logit": 5.174681186676025,
            "end_logit": 4.61220121383667,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 Gene Mutation Associated With Cerebral Cavernous Malformation.There are three genes considered to be associated with CCMs",
            "probability": 0.24393986910091683,
            "start_logit": 5.174681186676025,
            "end_logit": 3.842902898788452,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCMs,-A Novel CCM2",
            "probability": 0.10923428882561667,
            "start_logit": 3.828760862350464,
            "end_logit": 4.385396480560303,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCMs",
            "probability": 0.06349755698527905,
            "start_logit": 3.828760862350464,
            "end_logit": 3.842902898788452,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 Gene",
            "probability": 0.027991207497509767,
            "start_logit": 5.174681186676025,
            "end_logit": 1.677871584892273,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 Gene Mutation Associated With Cerebral Cavernous Malformation.There are three genes considered to be associated with CCMs,",
            "probability": 0.015855310384533902,
            "start_logit": 5.174681186676025,
            "end_logit": 1.1094856262207031,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCMs,",
            "probability": 0.004127137881855344,
            "start_logit": 3.828760862350464,
            "end_logit": 1.1094856262207031,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCMs,-A Novel CCM2 Gene",
            "probability": 0.004026797421476578,
            "start_logit": 3.235762119293213,
            "end_logit": 1.677871584892273,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM",
            "probability": 0.001484237976096145,
            "start_logit": 5.174681186676025,
            "end_logit": -1.2591173648834229,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 Gene Mutation",
            "probability": 0.0014224396486801545,
            "start_logit": 5.174681186676025,
            "end_logit": -1.3016453981399536,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 Gene Mutation Associated With Cerebral Cavernous Malformation",
            "probability": 0.0004608708248625704,
            "start_logit": 5.174681186676025,
            "end_logit": -2.4286563396453857,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 Gene Mutation Associated With Cerebral Cavernous Malformation.There are three",
            "probability": 0.00021827003976941363,
            "start_logit": 5.174681186676025,
            "end_logit": -3.1760411262512207,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCMs,-A Novel CCM",
            "probability": 0.00021352153727320587,
            "start_logit": 3.235762119293213,
            "end_logit": -1.2591173648834229,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCMs,-A Novel CCM2 Gene Mutation",
            "probability": 0.00020463126894475258,
            "start_logit": 3.235762119293213,
            "end_logit": -1.3016453981399536,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 Gene Mutation Associated With Cerebral Cavernous Malformation.",
            "probability": 0.00020204243745163293,
            "start_logit": 5.174681186676025,
            "end_logit": -3.253296375274658,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three genes considered to be associated with CCMs,-A Novel CCM2",
            "probability": 0.00014312379467898732,
            "start_logit": -3.0355842113494873,
            "end_logit": 4.61220121383667,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "A Novel CCM2",
            "probability": 0.00014152898229981823,
            "start_logit": -3.0467896461486816,
            "end_logit": 4.61220121383667,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "three genes considered to be associated with CCMs,-A Novel CCM2",
            "probability": 0.00014072924346857457,
            "start_logit": -3.0524563789367676,
            "end_logit": 4.61220121383667,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "Novel CCM2",
            "probability": 0.00011674204222830703,
            "start_logit": -3.2393274307250977,
            "end_logit": 4.61220121383667,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "Mutation Associated With Cerebral Cavernous Malformation.There are three genes considered to be associated with CCMs,-A Novel CCM2",
            "probability": 9.615208948868461e-05,
            "start_logit": -3.2065582275390625,
            "end_logit": 4.385396480560303,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        }
    ],
    "511a4d391159fa8212000003": [
        {
            "text": "Single-stranded DNA (ssDNA) plant viruses",
            "probability": 0.255875207182365,
            "start_logit": -2.150505304336548,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA (ssDNA",
            "probability": 0.1483941175452255,
            "start_logit": -2.150505304336548,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA (ssDNA)",
            "probability": 0.11669457694308052,
            "start_logit": -2.150505304336548,
            "end_logit": -4.277733325958252,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA",
            "probability": 0.07901750398610577,
            "start_logit": -2.150505304336548,
            "end_logit": -4.667623996734619,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "ssDNA) plant viruses",
            "probability": 0.05607833602647572,
            "start_logit": -3.668445587158203,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded",
            "probability": 0.05158707311556996,
            "start_logit": -2.150505304336548,
            "end_logit": -5.094022274017334,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA (ssDNA) plant viruses",
            "probability": 0.04425009799029237,
            "start_logit": -3.9053375720977783,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "ssDNA",
            "probability": 0.03252247562274578,
            "start_logit": -3.668445587158203,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "viruses",
            "probability": 0.0302503486921885,
            "start_logit": -4.285687446594238,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA (ssDNA",
            "probability": 0.025662721741849772,
            "start_logit": -3.9053375720977783,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "ssDNA)",
            "probability": 0.025575114409648488,
            "start_logit": -3.668445587158203,
            "end_logit": -4.277733325958252,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA (ssDNA) plant viruses belong to the families",
            "probability": 0.02173613568008741,
            "start_logit": -2.150505304336548,
            "end_logit": -5.958317279815674,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single",
            "probability": 0.021667340935855737,
            "start_logit": -2.150505304336548,
            "end_logit": -5.961487293243408,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA (ssDNA)",
            "probability": 0.020180722163467637,
            "start_logit": -3.9053375720977783,
            "end_logit": -4.277733325958252,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded D",
            "probability": 0.016312506213354477,
            "start_logit": -2.150505304336548,
            "end_logit": -6.245361328125,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA",
            "probability": 0.013664990574258655,
            "start_logit": -3.9053375720977783,
            "end_logit": -4.667623996734619,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "stranded DNA (ssDNA) plant viruses",
            "probability": 0.013582591378601204,
            "start_logit": -5.086406230926514,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "plant viruses",
            "probability": 0.010028698935385955,
            "start_logit": -5.389744281768799,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": ") plant viruses",
            "probability": 0.009042254621757567,
            "start_logit": -5.493286609649658,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "stranded DNA (ssDNA",
            "probability": 0.007877186241683784,
            "start_logit": -5.086406230926514,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        }
    ],
    "517137c18ed59a060a000001": [
        {
            "text": "CDYL2",
            "probability": 0.3583404821988032,
            "start_logit": 3.7829229831695557,
            "end_logit": 2.1707050800323486,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY",
            "probability": 0.24536721558590507,
            "start_logit": 2.9606406688690186,
            "end_logit": 2.614259719848633,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL",
            "probability": 0.14215373426671876,
            "start_logit": 3.1945645809173584,
            "end_logit": 1.8344889879226685,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL, and CDYL2",
            "probability": 0.07078485266325098,
            "start_logit": 3.1945645809173584,
            "end_logit": 1.1372249126434326,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL",
            "probability": 0.03952319357082342,
            "start_logit": 1.9145431518554688,
            "end_logit": 1.8344889879226685,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL, and CDY",
            "probability": 0.036193580838704,
            "start_logit": 3.1945645809173584,
            "end_logit": 0.4664616584777832,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL, and CDYL",
            "probability": 0.03307928204135792,
            "start_logit": 3.1945645809173584,
            "end_logit": 0.37648704648017883,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL, and CDYL2",
            "probability": 0.019680407610275997,
            "start_logit": 1.9145431518554688,
            "end_logit": 1.1372249126434326,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL2 chromodomain",
            "probability": 0.010941291465631563,
            "start_logit": 3.7829229831695557,
            "end_logit": -1.3182346820831299,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL, and CDY",
            "probability": 0.0100629498682417,
            "start_logit": 1.9145431518554688,
            "end_logit": 0.4664616584777832,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL, and CDYL",
            "probability": 0.009197077192860927,
            "start_logit": 1.9145431518554688,
            "end_logit": 0.37648704648017883,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY family chromodomains, we analyzed their specificity of methyllysine recognition.The CDY",
            "probability": 0.009171824536696871,
            "start_logit": -0.3259790241718292,
            "end_logit": 2.614259719848633,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY chromodomain",
            "probability": 0.0058273164840521256,
            "start_logit": 2.9606406688690186,
            "end_logit": -1.1259396076202393,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDY",
            "probability": 0.003848963220559751,
            "start_logit": 1.9145431518554688,
            "end_logit": -0.49459487199783325,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY chromodomain exhibits discriminatory binding to lysine-methylated ARK(S/T) motifs,",
            "probability": 0.00164429212153754,
            "start_logit": 2.9606406688690186,
            "end_logit": -2.391186237335205,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY) family of proteins adjacent to a putative catalytic motif.The human genome encodes three CDY family proteins, CDY",
            "probability": 0.001594690652654604,
            "start_logit": -0.24266359210014343,
            "end_logit": 0.7814878225326538,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY) family of proteins adjacent to a putative catalytic motif.To delineate the biochemical functions of the CDY",
            "probability": 0.0008438355314310238,
            "start_logit": 0.8415602445602417,
            "end_logit": -0.9392134547233582,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL chromodomain",
            "probability": 0.0006678893037807902,
            "start_logit": 2.1386499404907227,
            "end_logit": -2.4701383113861084,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "The CDY",
            "probability": 0.0005677459461072101,
            "start_logit": -3.108196496963501,
            "end_logit": 2.614259719848633,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY chromodomain exhibits discriminatory binding to lysine-methylated ARK",
            "probability": 0.0005093749006063442,
            "start_logit": 2.9606406688690186,
            "end_logit": -3.5630671977996826,
            "question_text": "In which proteins is the chromodomain present?"
        }
    ],
    "531d7430267d7dd053000008": [
        {
            "text": "psychotropic drugs",
            "probability": 0.7065555237361634,
            "start_logit": 2.952714204788208,
            "end_logit": 1.9382694959640503,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "psychotropic",
            "probability": 0.28643532690343637,
            "start_logit": 2.952714204788208,
            "end_logit": 1.035380482673645,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ps",
            "probability": 0.003486740692061097,
            "start_logit": 2.952714204788208,
            "end_logit": -3.3731648921966553,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "drugs",
            "probability": 0.0014097051400842775,
            "start_logit": -3.2643070220947266,
            "end_logit": 1.9382694959640503,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "psychotropic drugs.",
            "probability": 0.0006564054301402337,
            "start_logit": 2.952714204788208,
            "end_logit": -5.043108940124512,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "psychotropic drugs.Assessment of oral health-related quality of life",
            "probability": 0.00040159962618307993,
            "start_logit": 2.2399189472198486,
            "end_logit": -4.82163667678833,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "depression and, secondly, to analyse the changes in time after treatment with psychotropic drugs",
            "probability": 0.000187216727772164,
            "start_logit": -5.283175945281982,
            "end_logit": 1.9382694959640503,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment with psychotropic drugs",
            "probability": 0.00017697217268517932,
            "start_logit": -5.339450359344482,
            "end_logit": 1.9382694959640503,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ropic drugs",
            "probability": 0.00014919345106107648,
            "start_logit": -5.510199069976807,
            "end_logit": 1.9382694959640503,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "anxiety and depression and, secondly, to analyse the changes in time after treatment with psychotropic drugs",
            "probability": 0.00012199934200646965,
            "start_logit": -5.711427211761475,
            "end_logit": 1.9382694959640503,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "pain, anxiety and depression and, secondly, to analyse the changes in time after treatment with psychotropic drugs",
            "probability": 0.00011217373999487457,
            "start_logit": -5.795393943786621,
            "end_logit": 1.9382694959640503,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "depression and, secondly, to analyse the changes in time after treatment with psychotropic",
            "probability": 7.589705666392309e-05,
            "start_logit": -5.283175945281982,
            "end_logit": 1.035380482673645,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment with psychotropic",
            "probability": 7.174394712512276e-05,
            "start_logit": -5.339450359344482,
            "end_logit": 1.035380482673645,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ropic",
            "probability": 6.0482543113609256e-05,
            "start_logit": -5.510199069976807,
            "end_logit": 1.035380482673645,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "anxiety and depression and, secondly, to analyse the changes in time after treatment with psychotropic",
            "probability": 4.9458139149268246e-05,
            "start_logit": -5.711427211761475,
            "end_logit": 1.035380482673645,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "pain, anxiety and depression and, secondly, to analyse the changes in time after treatment with psychotropic",
            "probability": 4.547487183386723e-05,
            "start_logit": -5.795393943786621,
            "end_logit": 1.035380482673645,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "drugs.",
            "probability": 1.3096466983300402e-06,
            "start_logit": -3.2643070220947266,
            "end_logit": -5.043108940124512,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "drugs.Assessment of oral health-related quality of life",
            "probability": 9.796187239986643e-07,
            "start_logit": -3.7761285305023193,
            "end_logit": -4.82163667678833,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "depression and, secondly, to analyse the changes in time after treatment with ps",
            "probability": 9.238851881108268e-07,
            "start_logit": -5.283175945281982,
            "end_logit": -3.3731648921966553,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment with ps",
            "probability": 8.73329915533e-07,
            "start_logit": -5.339450359344482,
            "end_logit": -3.3731648921966553,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        }
    ],
    "52df8ce798d023950500000d": [
        {
            "text": "cocoa flavanols",
            "probability": 0.6960400548182989,
            "start_logit": 6.222995758056641,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "flavanols",
            "probability": 0.19631747014154094,
            "start_logit": 4.957321643829346,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa",
            "probability": 0.10223059884178866,
            "start_logit": 6.222995758056641,
            "end_logit": 4.238386631011963,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavan",
            "probability": 0.0017557806183598494,
            "start_logit": 6.222995758056641,
            "end_logit": 0.17406915128231049,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "coa flavanols",
            "probability": 0.0006335300365728458,
            "start_logit": -0.7788593173027039,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Antioxidants such as cocoa flavanols",
            "probability": 0.0006089479821203572,
            "start_logit": -0.8184338808059692,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "avanols",
            "probability": 0.0006043967356567147,
            "start_logit": -0.8259359002113342,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "flavan",
            "probability": 0.0004952163409761488,
            "start_logit": 4.957321643829346,
            "end_logit": 0.17406915128231049,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "ols",
            "probability": 0.0003618032162916644,
            "start_logit": -1.3390662670135498,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "co",
            "probability": 0.00025969244018136364,
            "start_logit": 6.222995758056641,
            "end_logit": -1.737101674079895,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa fl",
            "probability": 0.00018519152164944754,
            "start_logit": 6.222995758056641,
            "end_logit": -2.075209140777588,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavanols have been used as a supplement to prevent oxidative stress",
            "probability": 0.00014591109143189456,
            "start_logit": 6.222995758056641,
            "end_logit": -2.3136022090911865,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "coa",
            "probability": 9.304946543630953e-05,
            "start_logit": -0.7788593173027039,
            "end_logit": 4.238386631011963,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Antioxidants such as cocoa",
            "probability": 8.943898622603565e-05,
            "start_logit": -0.8184338808059692,
            "end_logit": 4.238386631011963,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "fl",
            "probability": 5.2233101773679897e-05,
            "start_logit": 4.957321643829346,
            "end_logit": -2.075209140777588,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "flavanols have been used as a supplement to prevent oxidative stress",
            "probability": 4.115409183308905e-05,
            "start_logit": 4.957321643829346,
            "end_logit": -2.3136022090911865,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavanols have been used as a supplement to prevent oxidative stress; however, the benefits of dietary antioxidants",
            "probability": 2.429485305303111e-05,
            "start_logit": 6.222995758056641,
            "end_logit": -4.106335163116455,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "such as cocoa flavanols",
            "probability": 2.0936003767904433e-05,
            "start_logit": -4.188696384429932,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "nts such as cocoa flavanols",
            "probability": 2.0450095362283953e-05,
            "start_logit": -4.212179183959961,
            "end_logit": 6.156562805175781,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavanols have been used",
            "probability": 1.984961767903015e-05,
            "start_logit": 6.222995758056641,
            "end_logit": -4.308414936065674,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        }
    ],
    "5505b9ff8e1671127b000001": [
        {
            "text": "Atg7",
            "probability": 0.2624784968700999,
            "start_logit": 4.598893642425537,
            "end_logit": 4.4948625564575195,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12",
            "probability": 0.16939549599057319,
            "start_logit": 4.598893642425537,
            "end_logit": 4.056929588317871,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12",
            "probability": 0.14317506695427118,
            "start_logit": 4.430725574493408,
            "end_logit": 4.056929588317871,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5",
            "probability": 0.1259879316911175,
            "start_logit": 4.198896884918213,
            "end_logit": 4.160876274108887,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5, Atg7",
            "probability": 0.08601593543533217,
            "start_logit": 4.198896884918213,
            "end_logit": 3.7792227268218994,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5, Atg7, Atg12",
            "probability": 0.04088322267693277,
            "start_logit": 4.198896884918213,
            "end_logit": 3.035409927368164,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12, Beclin-1",
            "probability": 0.04048505651720845,
            "start_logit": 4.598893642425537,
            "end_logit": 2.6256263256073,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12, Beclin-1",
            "probability": 0.034218446267434074,
            "start_logit": 4.430725574493408,
            "end_logit": 2.6256263256073,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Beclin-1",
            "probability": 0.025918763457575156,
            "start_logit": 4.152927875518799,
            "end_logit": 2.6256263256073,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12, Beclin-1 and LC3-II/LC3-I",
            "probability": 0.014631508262153486,
            "start_logit": 4.598893642425537,
            "end_logit": 1.6078706979751587,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12, Beclin-1 and LC3-II/LC3-I",
            "probability": 0.012366722992401026,
            "start_logit": 4.430725574493408,
            "end_logit": 1.6078706979751587,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Beclin-1 and LC3-II/LC3-I",
            "probability": 0.009367174812096861,
            "start_logit": 4.152927875518799,
            "end_logit": 1.6078706979751587,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5, Atg7, Atg12, Beclin-1",
            "probability": 0.009018412245852868,
            "start_logit": 4.198896884918213,
            "end_logit": 1.523958444595337,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12, Beclin-1 and LC3-II",
            "probability": 0.005270724652498354,
            "start_logit": 4.598893642425537,
            "end_logit": 0.586861252784729,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3-II/LC3-I",
            "probability": 0.004849556681831591,
            "start_logit": 3.4946036338806152,
            "end_logit": 1.6078706979751587,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12, Beclin-1 and LC3-II",
            "probability": 0.004454878511415528,
            "start_logit": 4.430725574493408,
            "end_logit": 0.586861252784729,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Beclin-1 and LC3-II",
            "probability": 0.0033743479019239502,
            "start_logit": 4.152927875518799,
            "end_logit": 0.586861252784729,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12, Beclin-1 and LC3-II/LC3",
            "probability": 0.003042401583552915,
            "start_logit": 4.598893642425537,
            "end_logit": 0.037340592592954636,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12, Beclin-1 and LC3-II/LC3",
            "probability": 0.0025714736267321426,
            "start_logit": 4.430725574493408,
            "end_logit": 0.037340592592954636,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3-I",
            "probability": 0.002494382868997065,
            "start_logit": 2.8297576904296875,
            "end_logit": 1.6078706979751587,
            "question_text": "List markers for autophagy."
        }
    ],
    "57090784cf1c325851000011": [
        {
            "text": "Weaver syndrome",
            "probability": 0.7939753092264548,
            "start_logit": 5.070913791656494,
            "end_logit": 4.8771843910217285,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590).EED-associated overgrowth (Cohen-Gibson syndrome",
            "probability": 0.15380365514856376,
            "start_logit": 5.070913791656494,
            "end_logit": 3.235808849334717,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Cohen-Gibson syndrome",
            "probability": 0.02403665217659915,
            "start_logit": 3.2148168087005615,
            "end_logit": 3.235808849334717,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver",
            "probability": 0.014394348310718882,
            "start_logit": 5.070913791656494,
            "end_logit": 0.8669676780700684,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "overgrowth",
            "probability": 0.004510660545221438,
            "start_logit": 2.5670952796936035,
            "end_logit": 2.2103941440582275,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590).EED-associated overgrowth",
            "probability": 0.0030558880661988846,
            "start_logit": 5.070913791656494,
            "end_logit": -0.6827977299690247,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "overgrowth (Cohen-Gibson syndrome",
            "probability": 0.0016779747958079526,
            "start_logit": 0.5528245568275452,
            "end_logit": 3.235808849334717,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590).EED-associated overgrowth (Cohen-Gibson",
            "probability": 0.0009207314236651811,
            "start_logit": 5.070913791656494,
            "end_logit": -1.8824548721313477,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590)",
            "probability": 0.000664347933488423,
            "start_logit": 5.070913791656494,
            "end_logit": -2.20881724357605,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "classical Weaver syndrome",
            "probability": 0.0005724480279631681,
            "start_logit": -2.1639719009399414,
            "end_logit": 4.8771843910217285,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "tall stature without obvious intellectual disability or dysmorphic features to classical Weaver syndrome",
            "probability": 0.00044499275182762794,
            "start_logit": -2.4158358573913574,
            "end_logit": 4.8771843910217285,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "EZH2-associated overgrowth",
            "probability": 0.00038821921504241685,
            "start_logit": 0.11446656286716461,
            "end_logit": 2.2103941440582275,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "dysmorphic features to classical Weaver syndrome",
            "probability": 0.0003504985783730481,
            "start_logit": -2.6545372009277344,
            "end_logit": 4.8771843910217285,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "EED-associated overgrowth (Cohen-Gibson syndrome",
            "probability": 0.00024398940442077864,
            "start_logit": -1.3753935098648071,
            "end_logit": 3.235808849334717,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "(Cohen-Gibson syndrome",
            "probability": 0.00021548680117653,
            "start_logit": -1.499618649482727,
            "end_logit": 3.235808849334717,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "syndrome",
            "probability": 0.0002114473476000466,
            "start_logit": -3.1599178314208984,
            "end_logit": 4.8771843910217285,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "overgrowth,",
            "probability": 0.00015675030575463742,
            "start_logit": 2.5670952796936035,
            "end_logit": -1.1491506099700928,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Cohen-Gibson",
            "probability": 0.0001438932056414888,
            "start_logit": 3.2148168087005615,
            "end_logit": -1.8824548721313477,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "EZH2), has a phenotypic spectrum ranging from tall stature without obvious intellectual disability or dysmorphic features to classical Weaver syndrome",
            "probability": 0.00012181588275634346,
            "start_logit": -3.711383104324341,
            "end_logit": 4.8771843910217285,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "classical Weaver syndrome (OMIM #277590).EED-associated overgrowth (Cohen-Gibson syndrome",
            "probability": 0.00011089085272576244,
            "start_logit": -2.1639719009399414,
            "end_logit": 3.235808849334717,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        }
    ],
    "56ebfa13107309bc2f000004": [
        {
            "text": "higher order chromatin folding",
            "probability": 0.680969562832166,
            "start_logit": 4.1171040534973145,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "folding",
            "probability": 0.208078055567955,
            "start_logit": 2.931499719619751,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "chromatin folding",
            "probability": 0.04892217531311286,
            "start_logit": 1.483817219734192,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "higher order",
            "probability": 0.028968102845694576,
            "start_logit": 4.1171040534973145,
            "end_logit": 1.301122784614563,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "higher",
            "probability": 0.008240752047736891,
            "start_logit": 4.1171040534973145,
            "end_logit": 0.04401906952261925,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "higher order chromatin",
            "probability": 0.006348194243497138,
            "start_logit": 4.1171040534973145,
            "end_logit": -0.21690213680267334,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "higher order chromatin folding in the eukaryotic nucleus.",
            "probability": 0.005690027516699326,
            "start_logit": 4.1171040534973145,
            "end_logit": -0.3263574540615082,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "order chromatin folding",
            "probability": 0.0033308432332198527,
            "start_logit": -1.2031880617141724,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "tin folding",
            "probability": 0.0030186497946015135,
            "start_logit": -1.30160391330719,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "folding in the eukaryotic nucleus.",
            "probability": 0.0017386531299266902,
            "start_logit": 2.931499719619751,
            "end_logit": -0.3263574540615082,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "romatin folding",
            "probability": 0.0008053108045466329,
            "start_logit": -2.6229405403137207,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "understanding of higher order chromatin folding",
            "probability": 0.0007505343207536304,
            "start_logit": -2.6933834552764893,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "higher order ch",
            "probability": 0.000736383464696016,
            "start_logit": 4.1171040534973145,
            "end_logit": -2.371076822280884,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "higher order chromatin folding in the eukaryotic nucleus",
            "probability": 0.0005653734076116431,
            "start_logit": 4.1171040534973145,
            "end_logit": -2.6353414058685303,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "chromatin",
            "probability": 0.00045606659776452335,
            "start_logit": 1.483817219734192,
            "end_logit": -0.21690213680267334,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "chromatin folding in the eukaryotic nucleus.",
            "probability": 0.0004087826224576916,
            "start_logit": 1.483817219734192,
            "end_logit": -0.3263574540615082,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "of higher order chromatin folding",
            "probability": 0.0003799427963263092,
            "start_logit": -3.37414813041687,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "higher order chroma",
            "probability": 0.0002781407393583285,
            "start_logit": 4.1171040534973145,
            "end_logit": -3.344700574874878,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "folding in the eukaryotic nucleus",
            "probability": 0.00017275632531413735,
            "start_logit": 2.931499719619751,
            "end_logit": -2.6353414058685303,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "order",
            "probability": 0.0001416923965610183,
            "start_logit": -1.2031880617141724,
            "end_logit": 1.301122784614563,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        }
    ],
    "533c2230c45e133714000002": [
        {
            "text": "tumour suppression",
            "probability": 0.09071306013088264,
            "start_logit": 4.260241508483887,
            "end_logit": 4.035778522491455,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "apoptosis",
            "probability": 0.08882240842238665,
            "start_logit": 4.138930320739746,
            "end_logit": 4.1360273361206055,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "autophagy",
            "probability": 0.08789352479888483,
            "start_logit": 4.085472106933594,
            "end_logit": 4.1789727210998535,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "autophagy, apoptosis",
            "probability": 0.08419880691200576,
            "start_logit": 4.085472106933594,
            "end_logit": 4.1360273361206055,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "apoptosis, DNA repair, and tumour suppression",
            "probability": 0.08034984407697705,
            "start_logit": 4.138930320739746,
            "end_logit": 4.035778522491455,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "autophagy, apoptosis, DNA repair, and tumour suppression",
            "probability": 0.07616727723341073,
            "start_logit": 4.085472106933594,
            "end_logit": 4.035778522491455,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "apoptosis, DNA repair",
            "probability": 0.0633652114059947,
            "start_logit": 4.138930320739746,
            "end_logit": 3.7983033657073975,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "DNA repair, and tumour suppression",
            "probability": 0.06284232158785708,
            "start_logit": 3.8931689262390137,
            "end_logit": 4.035778522491455,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "autophagy, apoptosis, DNA repair",
            "probability": 0.06006677025396981,
            "start_logit": 4.085472106933594,
            "end_logit": 3.7983033657073975,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "DNA repair",
            "probability": 0.04955849060320766,
            "start_logit": 3.8931689262390137,
            "end_logit": 3.7983033657073975,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy",
            "probability": 0.03282866918866394,
            "start_logit": 3.1006481647491455,
            "end_logit": 4.1789727210998535,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy, apoptosis",
            "probability": 0.03144867365962661,
            "start_logit": 3.1006481647491455,
            "end_logit": 4.1360273361206055,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy",
            "probability": 0.03016241470354506,
            "start_logit": 3.0159425735473633,
            "end_logit": 4.1789727210998535,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy, apoptosis",
            "probability": 0.028894498627000748,
            "start_logit": 3.0159425735473633,
            "end_logit": 4.1360273361206055,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy, apoptosis, DNA repair, and tumour suppression",
            "probability": 0.028448857330712268,
            "start_logit": 3.1006481647491455,
            "end_logit": 4.035778522491455,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy, apoptosis, DNA repair, and tumour suppression",
            "probability": 0.026138319153894824,
            "start_logit": 3.0159425735473633,
            "end_logit": 4.035778522491455,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy, apoptosis, DNA repair",
            "probability": 0.022435237799497985,
            "start_logit": 3.1006481647491455,
            "end_logit": 3.7983033657073975,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy, apoptosis, DNA repair",
            "probability": 0.020613109309797407,
            "start_logit": 3.0159425735473633,
            "end_logit": 3.7983033657073975,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation",
            "probability": 0.018268094677298903,
            "start_logit": 3.1006481647491455,
            "end_logit": 3.5928266048431396,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation",
            "probability": 0.016784410124385515,
            "start_logit": 3.0159425735473633,
            "end_logit": 3.5928266048431396,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        }
    ],
    "514241fcd24251bc05000006": [
        {
            "text": "SFPQ",
            "probability": 0.9860431008343034,
            "start_logit": 5.5675950050354,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "TERRA binding proteins NONO and SFPQ",
            "probability": 0.005189711578707353,
            "start_logit": 0.3205730617046356,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA binding proteins SFPQ",
            "probability": 0.0022340698443557433,
            "start_logit": 1.184712290763855,
            "end_logit": 3.1028215885162354,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA:DNA hybrid related telomere instability.Our data identify the RNA",
            "probability": 0.0017016835114893505,
            "start_logit": 5.5675950050354,
            "end_logit": -1.5522680282592773,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA:DNA",
            "probability": 0.0009749600986505439,
            "start_logit": 5.5675950050354,
            "end_logit": -2.1092448234558105,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA:DNA hybrid related telomere instability.Our data identify the RNA binding proteins SFPQ",
            "probability": 0.0008542976052682386,
            "start_logit": 0.2234116643667221,
            "end_logit": 3.1028215885162354,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA",
            "probability": 0.0007590126271609861,
            "start_logit": 5.5675950050354,
            "end_logit": -2.3596229553222656,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "NONO and SFPQ",
            "probability": 0.0005843282292607867,
            "start_logit": -1.863397479057312,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA:DNA hybrid related telomere instability.Our data identify the RNA binding proteins",
            "probability": 0.0005799990506094755,
            "start_logit": 5.5675950050354,
            "end_logit": -2.628614902496338,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "S",
            "probability": 0.0004233789703881161,
            "start_logit": 5.5675950050354,
            "end_logit": -2.943373680114746,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "Q",
            "probability": 0.0002032859618450056,
            "start_logit": -2.9192466735839844,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "proteins NONO and SFPQ",
            "probability": 0.0001458561065001728,
            "start_logit": -3.251239776611328,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "FPQ",
            "probability": 6.077453727027027e-05,
            "start_logit": -4.126689434051514,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "we identify the TERRA binding proteins NONO and SFPQ",
            "probability": 4.944378241813865e-05,
            "start_logit": -4.333024024963379,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ and NONO",
            "probability": 4.3555553220636685e-05,
            "start_logit": 3.4960694313049316,
            "end_logit": -3.146078586578369,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "Q as novel regulators of RNA:DNA hybrid related telomere instability.Our data identify the RNA binding proteins SFPQ",
            "probability": 3.6878225390510605e-05,
            "start_logit": -2.9192466735839844,
            "end_logit": 3.1028215885162354,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "Here, we identify the TERRA binding proteins NONO and SFPQ",
            "probability": 3.4617902992865246e-05,
            "start_logit": -4.689489364624023,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": ", we identify the TERRA binding proteins NONO and SFPQ",
            "probability": 3.0773918767312066e-05,
            "start_logit": -4.807192802429199,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "the TERRA binding proteins NONO and SFPQ",
            "probability": 2.9018819422292253e-05,
            "start_logit": -4.865915775299072,
            "end_logit": 4.809813976287842,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA",
            "probability": 2.1252841979173983e-05,
            "start_logit": 1.184712290763855,
            "end_logit": -1.5522680282592773,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        }
    ],
    "531376c8e3eabad021000012": [
        {
            "text": "phospholamban (PLN",
            "probability": 0.23152396406629258,
            "start_logit": -0.5739015340805054,
            "end_logit": -1.4160150289535522,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN",
            "probability": 0.18365450053092536,
            "start_logit": -0.8055286407470703,
            "end_logit": -1.4160150289535522,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban (PLN).",
            "probability": 0.09837034111743251,
            "start_logit": -0.5739015340805054,
            "end_logit": -2.271959066390991,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban (PLN)",
            "probability": 0.08094498230864106,
            "start_logit": -0.5739015340805054,
            "end_logit": -2.466928720474243,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN).",
            "probability": 0.07803147262892367,
            "start_logit": -0.8055286407470703,
            "end_logit": -2.271959066390991,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban",
            "probability": 0.07184784567439988,
            "start_logit": -0.5739015340805054,
            "end_logit": -2.5861477851867676,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN)",
            "probability": 0.06420894854807119,
            "start_logit": -0.8055286407470703,
            "end_logit": -2.466928720474243,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in the cardiac protein phospholamban (PLN",
            "probability": 0.03725517604865272,
            "start_logit": -2.40079402923584,
            "end_logit": -1.4160150289535522,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(PLN",
            "probability": 0.03053230445966225,
            "start_logit": -2.599799633026123,
            "end_logit": -1.4160150289535522,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in the cardiac protein phospholamban (PLN).",
            "probability": 0.015829049882916744,
            "start_logit": -2.40079402923584,
            "end_logit": -2.271959066390991,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Dilated cardiomyopathy (DCM) can be caused by mutations in the cardiac protein phospholamban (PLN",
            "probability": 0.01546483496990983,
            "start_logit": -3.2800161838531494,
            "end_logit": -1.4160150289535522,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "by mutations in the cardiac protein phospholamban (PLN",
            "probability": 0.015450314601291627,
            "start_logit": -3.2809555530548096,
            "end_logit": -1.4160150289535522,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in the cardiac protein phospholamban (PLN)",
            "probability": 0.013025086099942707,
            "start_logit": -2.40079402923584,
            "end_logit": -2.466928720474243,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(PLN).",
            "probability": 0.01297262344704107,
            "start_logit": -2.599799633026123,
            "end_logit": -2.271959066390991,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in the cardiac protein phospholamban",
            "probability": 0.011561240107956058,
            "start_logit": -2.40079402923584,
            "end_logit": -2.5861477851867676,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(PLN)",
            "probability": 0.010674648105203284,
            "start_logit": -2.599799633026123,
            "end_logit": -2.466928720474243,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "caused by mutations in the cardiac protein phospholamban (PLN",
            "probability": 0.007695779147508811,
            "start_logit": -3.9779129028320312,
            "end_logit": -1.4160150289535522,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "p",
            "probability": 0.007416223232371352,
            "start_logit": -0.5739015340805054,
            "end_logit": -4.857028484344482,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Dilated cardiomyopathy",
            "probability": 0.006976106041543475,
            "start_logit": -3.2800161838531494,
            "end_logit": -2.212092876434326,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "by mutations in the cardiac protein phospholamban (PLN).",
            "probability": 0.006564558981313588,
            "start_logit": -3.2809555530548096,
            "end_logit": -2.271959066390991,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "5312280ce3eabad02100000a": [
        {
            "text": "8",
            "probability": 0.13852026561153774,
            "start_logit": 0.8630204200744629,
            "end_logit": 0.357697993516922,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q.A novel susceptibility locus for moyamoya disease on chromosome 8",
            "probability": 0.10505977410575444,
            "start_logit": 0.58653324842453,
            "end_logit": 0.357697993516922,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6q, and 17q.A novel susceptibility locus for moyamoya disease on chromosome 8",
            "probability": 0.09569330413049054,
            "start_logit": 0.49315211176872253,
            "end_logit": 0.357697993516922,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6q, and 17q.A novel susceptibility locus for moyamoya disease on chromosome 8",
            "probability": 0.07589946549582163,
            "start_logit": 0.26141342520713806,
            "end_logit": 0.357697993516922,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17",
            "probability": 0.06719901231896709,
            "start_logit": 0.58653324842453,
            "end_logit": -0.08917292207479477,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6",
            "probability": 0.06488035368916999,
            "start_logit": 0.49315211176872253,
            "end_logit": -0.030905473977327347,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6q, and 17",
            "probability": 0.0612079702040334,
            "start_logit": 0.49315211176872253,
            "end_logit": -0.08917292207479477,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3",
            "probability": 0.05888117061022729,
            "start_logit": 0.26141342520713806,
            "end_logit": 0.10380970686674118,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6",
            "probability": 0.05146007038771292,
            "start_logit": 0.26141342520713806,
            "end_logit": -0.030905473977327347,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6q, and 17",
            "probability": 0.048547307095127036,
            "start_logit": 0.26141342520713806,
            "end_logit": -0.08917292207479477,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "8q23",
            "probability": 0.04513371027721086,
            "start_logit": 0.8630204200744629,
            "end_logit": -0.7636892199516296,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q.A novel susceptibility locus for moyamoya disease on chromosome 8q23",
            "probability": 0.03423136235946827,
            "start_logit": 0.58653324842453,
            "end_logit": -0.7636892199516296,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6q, and 17q.A novel susceptibility locus for moyamoya disease on chromosome 8q23",
            "probability": 0.03117950896951531,
            "start_logit": 0.49315211176872253,
            "end_logit": -0.7636892199516296,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "moyamoya disease on chromosome 8",
            "probability": 0.02824588771806353,
            "start_logit": -0.7270483374595642,
            "end_logit": 0.357697993516922,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6q, and 17q.A novel susceptibility locus for moyamoya disease on chromosome 8q23",
            "probability": 0.024730132235598643,
            "start_logit": 0.26141342520713806,
            "end_logit": -0.7636892199516296,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q",
            "probability": 0.015796285024695853,
            "start_logit": 0.58653324842453,
            "end_logit": -1.5370566844940186,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "8q23.",
            "probability": 0.014514010671206274,
            "start_logit": 0.8630204200744629,
            "end_logit": -1.8982042074203491,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6q, and 17q",
            "probability": 0.014387987408753994,
            "start_logit": 0.49315211176872253,
            "end_logit": -1.5370566844940186,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q.",
            "probability": 0.012636976468656353,
            "start_logit": 0.58653324842453,
            "end_logit": -1.7602043151855469,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q.A novel susceptibility locus for moyamoya",
            "probability": 0.011795445217988858,
            "start_logit": 0.58653324842453,
            "end_logit": -1.829118013381958,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        }
    ],
    "532ad23ad6d3ac6a34000011": [
        {
            "text": "N2",
            "probability": 0.5390863866388844,
            "start_logit": 0.3043539524078369,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "400 (N2",
            "probability": 0.11929877695893233,
            "start_logit": -1.2038908004760742,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "N2 numbering",
            "probability": 0.08517126057520495,
            "start_logit": 0.3043539524078369,
            "end_logit": -1.9076178073883057,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "150, 199, 367, 399, and 400 (N2",
            "probability": 0.04858135573468648,
            "start_logit": -2.1022820472717285,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "400",
            "probability": 0.040685882992049845,
            "start_logit": -1.2038908004760742,
            "end_logit": -1.1381559371948242,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "(N2",
            "probability": 0.022087256830574203,
            "start_logit": -2.8905210494995117,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "400 (N2 numbering",
            "probability": 0.01884823558989048,
            "start_logit": -1.2038908004760742,
            "end_logit": -1.9076178073883057,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "150, 199, 367, 399, and 400",
            "probability": 0.016568278446785958,
            "start_logit": -2.1022820472717285,
            "end_logit": -1.1381559371948242,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "199, 367, 399, and 400 (N2",
            "probability": 0.01611554423947579,
            "start_logit": -3.205737590789795,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "399, and 400 (N2",
            "probability": 0.015442133758969218,
            "start_logit": -3.248422145843506,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "367, 399, and 400 (N2",
            "probability": 0.013823473565782592,
            "start_logit": -3.3591537475585938,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "N8",
            "probability": 0.011537549451915638,
            "start_logit": -0.802993893623352,
            "end_logit": -2.7993271350860596,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "N8 NA epitope in host immune defense systems and in the kinetics analysis of the biosynthesis of the enzyme.Group 2",
            "probability": 0.011133552630089374,
            "start_logit": -0.802993893623352,
            "end_logit": -2.834970712661743,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "N2 numbering).",
            "probability": 0.007771057658094311,
            "start_logit": 0.3043539524078369,
            "end_logit": -4.301875591278076,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "150, 199, 367, 399, and 400 (N2 numbering",
            "probability": 0.0076754587222538,
            "start_logit": -2.1022820472717285,
            "end_logit": -1.9076178073883057,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "N8 NA epitope in host immune defense systems and in the kinetics analysis of the biosynthesis of the enzyme.Group 2 antibodies",
            "probability": 0.006038961243579396,
            "start_logit": -0.802993893623352,
            "end_logit": -3.446702003479004,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "199, 367, 399, and 400",
            "probability": 0.005496076020177691,
            "start_logit": -3.205737590789795,
            "end_logit": -1.1381559371948242,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "399, and 400",
            "probability": 0.00526641482235215,
            "start_logit": -3.248422145843506,
            "end_logit": -1.1381559371948242,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "367, 399, and 400",
            "probability": 0.0047143838552069425,
            "start_logit": -3.3591537475585938,
            "end_logit": -1.1381559371948242,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Group 2 antibodies recognized a novel epitope containing residues 150, 199, 367, 399, and 400 (N2",
            "probability": 0.0046579602650946355,
            "start_logit": -4.446944236755371,
            "end_logit": -0.062406037002801895,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        }
    ],
    "5156be75d24251bc05000088": [
        {
            "text": "ischemic cerebrovascular disease",
            "probability": 0.9137706563271148,
            "start_logit": 4.7749457359313965,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovascular",
            "probability": 0.055640798380309706,
            "start_logit": 4.7749457359313965,
            "end_logit": 1.814035177230835,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "cerebrovascular disease",
            "probability": 0.022408825125730537,
            "start_logit": 1.0668209791183472,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic",
            "probability": 0.003810094244151955,
            "start_logit": 4.7749457359313965,
            "end_logit": -0.8672276139259338,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "cerebrovascular",
            "probability": 0.0013645053188423258,
            "start_logit": 1.0668209791183472,
            "end_logit": 1.814035177230835,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "disease",
            "probability": 0.0007388670869006381,
            "start_logit": -2.345271110534668,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic c",
            "probability": 0.0005546861963843619,
            "start_logit": 4.7749457359313965,
            "end_logit": -2.794234275817871,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "is",
            "probability": 0.00029448319057965254,
            "start_logit": 4.7749457359313965,
            "end_logit": -3.427414894104004,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "cular disease",
            "probability": 0.00020430840388952325,
            "start_logit": -3.63075852394104,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "chemic cerebrovascular disease",
            "probability": 0.00017255673709688866,
            "start_logit": -3.7996630668640137,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebro",
            "probability": 0.00016830426508433356,
            "start_logit": 4.7749457359313965,
            "end_logit": -3.986863374710083,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovas",
            "probability": 0.0001607038760828889,
            "start_logit": 4.7749457359313965,
            "end_logit": -4.033073425292969,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cere",
            "probability": 0.00013753185407752307,
            "start_logit": 4.7749457359313965,
            "end_logit": -4.188781261444092,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "vascular disease",
            "probability": 0.00013385765078859245,
            "start_logit": -4.053612232208252,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "brovascular disease",
            "probability": 0.00011260721780410899,
            "start_logit": -4.226483345031738,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovascular disease remains unknown.",
            "probability": 9.949106758161031e-05,
            "start_logit": 4.7749457359313965,
            "end_logit": -4.512568950653076,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "erebrovascular disease",
            "probability": 9.606917419437613e-05,
            "start_logit": -4.385320663452148,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovascular disease remains unknown",
            "probability": 6.679087509958828e-05,
            "start_logit": 4.7749457359313965,
            "end_logit": -4.911070346832275,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "mic cerebrovascular disease",
            "probability": 5.126017929616642e-05,
            "start_logit": -5.013474941253662,
            "end_logit": 4.612698078155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "c",
            "probability": 1.3602828990367691e-05,
            "start_logit": 1.0668209791183472,
            "end_logit": -2.794234275817871,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        }
    ],
    "57169b63cb4ef8864c00000b": [
        {
            "text": "excitatory amino acid transporter 5",
            "probability": 0.4429516144375105,
            "start_logit": 3.092942714691162,
            "end_logit": 3.474379777908325,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "EAAT5",
            "probability": 0.3486746699808156,
            "start_logit": 2.7332024574279785,
            "end_logit": 3.5947988033294678,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "excitatory amino acid transporter 5 (hEAAT5",
            "probability": 0.09642437915997798,
            "start_logit": 3.092942714691162,
            "end_logit": 1.9496783018112183,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "hEAAT5v).We recently identified a human-specific splicing form of EAAT5",
            "probability": 0.028968838254678147,
            "start_logit": 0.24528385698795319,
            "end_logit": 3.5947988033294678,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "5 (hEAAT5v).We recently identified a human-specific splicing form of EAAT5",
            "probability": 0.02036425254600201,
            "start_logit": -0.10715581476688385,
            "end_logit": 3.5947988033294678,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "excitatory amino acid transporter 5 (hEAAT5v)",
            "probability": 0.01856097888752575,
            "start_logit": 3.092942714691162,
            "end_logit": 0.3019807040691376,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "5",
            "probability": 0.018053905131123222,
            "start_logit": -0.10715581476688385,
            "end_logit": 3.474379777908325,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "excitatory amino acid transporter 5 (hEAAT5v",
            "probability": 0.006306967269312674,
            "start_logit": 3.092942714691162,
            "end_logit": -0.7774258255958557,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "hEAAT5",
            "probability": 0.005590675987157239,
            "start_logit": 0.24528385698795319,
            "end_logit": 1.9496783018112183,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "5 (hEAAT5",
            "probability": 0.003930082963784494,
            "start_logit": -0.10715581476688385,
            "end_logit": 1.9496783018112183,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "(hEAAT5v).We recently identified a human-specific splicing form of EAAT5",
            "probability": 0.003136790865753475,
            "start_logit": -1.9777365922927856,
            "end_logit": 3.5947988033294678,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "transporter 5 (hEAAT5v).We recently identified a human-specific splicing form of EAAT5",
            "probability": 0.001408394106357247,
            "start_logit": -2.778486728668213,
            "end_logit": 3.5947988033294678,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "transporter 5",
            "probability": 0.0012486102068302398,
            "start_logit": -2.778486728668213,
            "end_logit": 3.474379777908325,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "hEAAT5v)",
            "probability": 0.0010761637240356008,
            "start_logit": 0.24528385698795319,
            "end_logit": 0.3019807040691376,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "5 (hEAAT5v)",
            "probability": 0.0007565118650751526,
            "start_logit": -0.10715581476688385,
            "end_logit": 0.3019807040691376,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "(hEAAT5",
            "probability": 0.0006053670918981407,
            "start_logit": -1.9777365922927856,
            "end_logit": 1.9496783018112183,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "EAAT",
            "probability": 0.0005195758373991434,
            "start_logit": 2.7332024574279785,
            "end_logit": -2.9140830039978027,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "excitatory amino acid transporter",
            "probability": 0.0005121556136081528,
            "start_logit": 3.092942714691162,
            "end_logit": -3.288207530975342,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "excitatory amino acid transporter 5 (hEAAT5v).",
            "probability": 0.00046487312859498306,
            "start_logit": 3.092942714691162,
            "end_logit": -3.3850715160369873,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ex",
            "probability": 0.00044519294255994195,
            "start_logit": 3.092942714691162,
            "end_logit": -3.428328275680542,
            "question_text": "Which are the human glutamate transporters?"
        }
    ],
    "55391ce8bc4f83e828000018": [
        {
            "text": "RAS",
            "probability": 0.11915081301446245,
            "start_logit": 2.9535250663757324,
            "end_logit": 1.7770354747772217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "RAS/MAPK/ERK",
            "probability": 0.11733838938078092,
            "start_logit": 2.9535250663757324,
            "end_logit": 1.7617074251174927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "RAS/MAPK",
            "probability": 0.06753880199655304,
            "start_logit": 2.9535250663757324,
            "end_logit": 1.2093477249145508,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT",
            "probability": 0.06077712593144478,
            "start_logit": 2.2230567932128906,
            "end_logit": 1.834327220916748,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR and RAS",
            "probability": 0.05739296608893071,
            "start_logit": 2.2230567932128906,
            "end_logit": 1.7770354747772217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR and RAS/MAPK/ERK",
            "probability": 0.05651995175092502,
            "start_logit": 2.2230567932128906,
            "end_logit": 1.7617074251174927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR and RAS",
            "probability": 0.05542335422704264,
            "start_logit": 2.188136100769043,
            "end_logit": 1.7770354747772217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR and RAS/MAPK/ERK",
            "probability": 0.05458029999587426,
            "start_logit": 2.188136100769043,
            "end_logit": 1.7617074251174927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT",
            "probability": 0.052825513718807504,
            "start_logit": 2.0828375816345215,
            "end_logit": 1.834327220916748,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "MAPK/ERK",
            "probability": 0.05225884016629922,
            "start_logit": 2.144672155380249,
            "end_logit": 1.7617074251174927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR and RAS",
            "probability": 0.04988411134994569,
            "start_logit": 2.0828375816345215,
            "end_logit": 1.7770354747772217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR and RAS/MAPK/ERK",
            "probability": 0.04912531550064781,
            "start_logit": 2.0828375816345215,
            "end_logit": 1.7617074251174927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR and RAS/MAPK",
            "probability": 0.03253231828308782,
            "start_logit": 2.2230567932128906,
            "end_logit": 1.2093477249145508,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR and RAS/MAPK",
            "probability": 0.03141587415497286,
            "start_logit": 2.188136100769043,
            "end_logit": 1.2093477249145508,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "MAPK",
            "probability": 0.030079665122276677,
            "start_logit": 2.144672155380249,
            "end_logit": 1.2093477249145508,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR and RAS/MAPK",
            "probability": 0.028276039701290546,
            "start_logit": 2.0828375816345215,
            "end_logit": 1.2093477249145508,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR",
            "probability": 0.02647176527883522,
            "start_logit": 2.2230567932128906,
            "end_logit": 1.00319242477417,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR",
            "probability": 0.02556330721417411,
            "start_logit": 2.188136100769043,
            "end_logit": 1.00319242477417,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR",
            "probability": 0.02300840288952637,
            "start_logit": 2.0828375816345215,
            "end_logit": 1.00319242477417,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "ERK",
            "probability": 0.009837144234122165,
            "start_logit": 0.4746285378932953,
            "end_logit": 1.7617074251174927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        }
    ],
    "51542dc3d24251bc0500007e": [
        {
            "text": "toxic epidermal necrolysis",
            "probability": 0.39910885016818587,
            "start_logit": 5.190403461456299,
            "end_logit": 4.20662260055542,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Stevens-Johnson syndrome",
            "probability": 0.22832186191715814,
            "start_logit": 4.441542625427246,
            "end_logit": 4.397005558013916,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis",
            "probability": 0.18874055574603188,
            "start_logit": 4.441542625427246,
            "end_logit": 4.20662260055542,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug-induced hypersensitivity syndrome (DIHS) and Stevens-Johnson syndrome",
            "probability": 0.06833621343786744,
            "start_logit": 3.2352261543273926,
            "end_logit": 4.397005558013916,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS) and Stevens-Johnson syndrome",
            "probability": 0.032798831882521744,
            "start_logit": 2.5011792182922363,
            "end_logit": 4.397005558013916,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug-induced hypersensitivity syndrome",
            "probability": 0.01518293568475637,
            "start_logit": 3.2352261543273926,
            "end_logit": 2.892737865447998,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "eosinophilia",
            "probability": 0.010518587271371038,
            "start_logit": 2.526043653488159,
            "end_logit": 3.2348921298980713,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Johnson syndrome",
            "probability": 0.007857794829281166,
            "start_logit": 1.0722923278808594,
            "end_logit": 4.397005558013916,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome",
            "probability": 0.0074707070308867194,
            "start_logit": 2.526043653488159,
            "end_logit": 2.892737865447998,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome",
            "probability": 0.007287242443718942,
            "start_logit": 2.5011792182922363,
            "end_logit": 2.892737865447998,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Johnson syndrome (SJS)/toxic epidermal necrolysis",
            "probability": 0.006495587196792085,
            "start_logit": 1.0722923278808594,
            "end_logit": 4.20662260055542,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "eosinophilia and systemic symptoms",
            "probability": 0.005666035446557565,
            "start_logit": 2.526043653488159,
            "end_logit": 2.6162378787994385,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "systemic symptoms",
            "probability": 0.0055268897338716155,
            "start_logit": 2.5011792182922363,
            "end_logit": 2.6162378787994385,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "epidermal necrolysis",
            "probability": 0.004832826839186726,
            "start_logit": 0.7766008377075195,
            "end_logit": 4.20662260055542,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug reaction with eosinophilia",
            "probability": 0.0029745180546364115,
            "start_logit": 1.2629817724227905,
            "end_logit": 3.2348921298980713,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Stevens-Johnson syndrome (SJS)",
            "probability": 0.0023703090287701405,
            "start_logit": 4.441542625427246,
            "end_logit": -0.17073041200637817,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug reaction with eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome",
            "probability": 0.0021126176330498085,
            "start_logit": 1.2629817724227905,
            "end_logit": 2.892737865447998,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "cutaneous adverse reactions include syndromes such as drug reaction with eosinophilia",
            "probability": 0.0018167361826723826,
            "start_logit": 0.7699413299560547,
            "end_logit": 3.2348921298980713,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug reaction with eosinophilia and systemic symptoms",
            "probability": 0.0016022802586680989,
            "start_logit": 1.2629817724227905,
            "end_logit": 2.6162378787994385,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "cutaneous adverse reactions include syndromes such as drug reaction with eosinophilia and systemic symptoms",
            "probability": 0.0009786192140157693,
            "start_logit": 0.7699413299560547,
            "end_logit": 2.6162378787994385,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        }
    ],
    "51595fb0d24251bc0500009c": [
        {
            "text": "Phgdh",
            "probability": 0.44040329488113533,
            "start_logit": -1.01598060131073,
            "end_logit": -1.2215783596038818,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Phgdh is generally associated with CK5 cells, and that oncogenic function may be determined by isoform expression.Analysis",
            "probability": 0.11962905548952465,
            "start_logit": -1.01598060131073,
            "end_logit": -2.5248734951019287,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "malignancy.Overexpression of Phgdh",
            "probability": 0.0582259869642003,
            "start_logit": -3.4082131385803223,
            "end_logit": -0.8527049422264099,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Analysis",
            "probability": 0.051416014384996364,
            "start_logit": -1.860426664352417,
            "end_logit": -2.5248734951019287,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "PHGDH",
            "probability": 0.050203306378184716,
            "start_logit": -1.7123973369598389,
            "end_logit": -2.6967716217041016,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Analysis of this database identified a number of proteins as being specifically overexpressed",
            "probability": 0.04584025274840723,
            "start_logit": -1.860426664352417,
            "end_logit": -2.639660596847534,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Overexpression of Phgdh",
            "probability": 0.0446166728820221,
            "start_logit": -3.6744372844696045,
            "end_logit": -0.8527049422264099,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Analysis of this database identified a number of proteins as being specifically overexpressed in TNBC",
            "probability": 0.03726457417125593,
            "start_logit": -1.860426664352417,
            "end_logit": -2.8467800617218018,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Analysis of this database identified a number of proteins as being specifically overexpressed in TNBC samples.High level PHGDH",
            "probability": 0.019673218342495982,
            "start_logit": -2.6492199897766113,
            "end_logit": -2.6967716217041016,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Analysis of this database identified a number of proteins",
            "probability": 0.0183149626510505,
            "start_logit": -1.860426664352417,
            "end_logit": -3.5571048259735107,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "overexpressed",
            "probability": 0.0178292222023377,
            "start_logit": -2.804750442504883,
            "end_logit": -2.639660596847534,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Analysis of this database identified a number of proteins as being specifically overexpressed in TNBC samples",
            "probability": 0.01647788690747786,
            "start_logit": -1.860426664352417,
            "end_logit": -3.662803888320923,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "TNBC",
            "probability": 0.014774137460094795,
            "start_logit": -2.7855916023254395,
            "end_logit": -2.8467800617218018,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "overexpressed in TNBC",
            "probability": 0.014493776393890006,
            "start_logit": -2.804750442504883,
            "end_logit": -2.8467800617218018,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "proteomic profiling of Phgdh",
            "probability": 0.012492229910072436,
            "start_logit": -3.2217888832092285,
            "end_logit": -2.5783541202545166,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "a number of proteins as being specifically overexpressed",
            "probability": 0.009318304928892775,
            "start_logit": -3.453608512878418,
            "end_logit": -2.639660596847534,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "immunohistochemistry",
            "probability": 0.008510170617027317,
            "start_logit": -2.7331104278564453,
            "end_logit": -3.4508774280548096,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "a number of proteins as being specifically overexpressed in TNBC",
            "probability": 0.0075750600041176635,
            "start_logit": -3.453608512878418,
            "end_logit": -2.8467800617218018,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "TNBC samples",
            "probability": 0.006532922262956035,
            "start_logit": -2.7855916023254395,
            "end_logit": -3.662803888320923,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "overexpressed in TNBC samples",
            "probability": 0.006408950419860457,
            "start_logit": -2.804750442504883,
            "end_logit": -3.662803888320923,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        }
    ],
    "5547d700f35db75526000007": [
        {
            "text": "Childhood Dysarthria",
            "probability": 0.14130116141667584,
            "start_logit": 5.422635078430176,
            "end_logit": 5.160855770111084,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Speech Motor Delay",
            "probability": 0.10851850917642822,
            "start_logit": 5.056991100311279,
            "end_logit": 5.262526988983154,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Speech Motor Delay (26.7%), Childhood Dysarthria",
            "probability": 0.09802764503139855,
            "start_logit": 5.056991100311279,
            "end_logit": 5.160855770111084,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria (37.8%), Speech Motor Delay",
            "probability": 0.0946807317764843,
            "start_logit": 4.920580863952637,
            "end_logit": 5.262526988983154,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria (37.8%), Speech Motor Delay (26.7%), Childhood Dysarthria",
            "probability": 0.08552761401106952,
            "start_logit": 4.920580863952637,
            "end_logit": 5.160855770111084,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria and Childhood Apraxia of Speech",
            "probability": 0.06943200784360741,
            "start_logit": 5.422635078430176,
            "end_logit": 4.450310230255127,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech (11.1%).Ataxia",
            "probability": 0.061129104951701485,
            "start_logit": 5.006643772125244,
            "end_logit": 4.738941669464111,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Speech Motor Delay (26.7%), Childhood Dysarthria and Childhood Apraxia of Speech",
            "probability": 0.048168437898679424,
            "start_logit": 5.056991100311279,
            "end_logit": 4.450310230255127,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech",
            "probability": 0.04327827215736886,
            "start_logit": 4.94993782043457,
            "end_logit": 4.450310230255127,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech (22.2%), and Childhood Apraxia of Speech (11.1%).Ataxia",
            "probability": 0.042266681802171385,
            "start_logit": 4.637654781341553,
            "end_logit": 4.738941669464111,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Ataxia",
            "probability": 0.04089343575401009,
            "start_logit": 4.604625225067139,
            "end_logit": 4.738941669464111,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria and Childhood Apraxia of Speech (22.2%), and Childhood Apraxia of Speech",
            "probability": 0.03898009906290435,
            "start_logit": 5.422635078430176,
            "end_logit": 3.873013496398926,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Apraxia of Speech (22.2%), and Childhood Apraxia of Speech (11.1%).Ataxia",
            "probability": 0.02473756921560609,
            "start_logit": 4.101978778839111,
            "end_logit": 4.738941669464111,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech (22.2%), and Childhood Apraxia of Speech",
            "probability": 0.02429702652075752,
            "start_logit": 4.94993782043457,
            "end_logit": 3.873013496398926,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Apraxia of Speech (11.1%).Ataxia",
            "probability": 0.015509678448602343,
            "start_logit": 3.635119915008545,
            "end_logit": 4.738941669464111,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Apraxia of Speech",
            "probability": 0.01342444738952679,
            "start_logit": 4.101978778839111,
            "end_logit": 4.1276960372924805,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Apraxia of Speech (22.2%), and Childhood Apraxia of Speech",
            "probability": 0.012779083182231898,
            "start_logit": 4.101978778839111,
            "end_logit": 4.078428268432617,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria and Childhood Apraxia",
            "probability": 0.012616445313684988,
            "start_logit": 5.422635078430176,
            "end_logit": 2.7449634075164795,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia",
            "probability": 0.012536844246522271,
            "start_logit": 5.006643772125244,
            "end_logit": 3.154625415802002,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Dysarthria (37.8%), Speech Motor Delay",
            "probability": 0.011895204800568828,
            "start_logit": 3.1404542922973633,
            "end_logit": 4.968278408050537,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        }
    ],
    "531b1e3cb166e2b80600003b": [
        {
            "text": "H3K27me3",
            "probability": 0.8973267370114418,
            "start_logit": 3.7225539684295654,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone met",
            "probability": 0.028680837037820078,
            "start_logit": 3.7225539684295654,
            "end_logit": -0.06472448259592056,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "PRC2), a widely conserved PcG protein complex which functions as a H3K27me3",
            "probability": 0.02863171894799799,
            "start_logit": 0.27764907479286194,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H",
            "probability": 0.009928649961586683,
            "start_logit": 3.7225539684295654,
            "end_logit": -1.125529170036316,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "met",
            "probability": 0.008623609372842907,
            "start_logit": 2.5208284854888916,
            "end_logit": -0.06472448259592056,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "K27me3",
            "probability": 0.003939178067489158,
            "start_logit": -1.7058939933776855,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "3",
            "probability": 0.0030935055738574016,
            "start_logit": -1.9475611448287964,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 his",
            "probability": 0.002877760110883026,
            "start_logit": 3.7225539684295654,
            "end_logit": -2.3639414310455322,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27",
            "probability": 0.0025691903545964874,
            "start_logit": 3.7225539684295654,
            "end_logit": -2.477362871170044,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "me3",
            "probability": 0.0023145658345402865,
            "start_logit": -2.2376439571380615,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3",
            "probability": 0.0020160027877455127,
            "start_logit": 3.7225539684295654,
            "end_logit": -2.719836950302124,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "3K27me3",
            "probability": 0.0017941625955272959,
            "start_logit": -2.4923276901245117,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me",
            "probability": 0.0016817700650543356,
            "start_logit": 3.7225539684295654,
            "end_logit": -2.901106834411621,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "27me3",
            "probability": 0.001455482605735904,
            "start_logit": -2.701528549194336,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "(PRC2), a widely conserved PcG protein complex which functions as a H3K27me3",
            "probability": 0.0011183239831625315,
            "start_logit": -2.9650349617004395,
            "end_logit": 3.3784663677215576,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone",
            "probability": 0.000965162890319419,
            "start_logit": 3.7225539684295654,
            "end_logit": -3.4564120769500732,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "PRC2), a widely conserved PcG protein complex which functions as a H3K27me3 histone met",
            "probability": 0.0009151423125930157,
            "start_logit": 0.27764907479286194,
            "end_logit": -0.06472448259592056,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K",
            "probability": 0.00084242634875732,
            "start_logit": 3.7225539684295654,
            "end_logit": -3.5924227237701416,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone methyl",
            "probability": 0.0006277647221158162,
            "start_logit": 3.7225539684295654,
            "end_logit": -3.8865435123443604,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone methyltransferase",
            "probability": 0.0005980094159330714,
            "start_logit": 3.7225539684295654,
            "end_logit": -3.9351024627685547,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        }
    ],
    "56bb616dac7ad10019000008": [
        {
            "text": "Rivaroxaban",
            "probability": 0.998862851542624,
            "start_logit": 6.4379754066467285,
            "end_logit": 6.025048732757568,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "ban",
            "probability": 0.00044455399136198554,
            "start_logit": -1.2793258428573608,
            "end_logit": 6.025048732757568,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "R",
            "probability": 0.0003946921154475411,
            "start_logit": 6.4379754066467285,
            "end_logit": -1.811218023300171,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dosage Criteria",
            "probability": 5.566321516630864e-05,
            "start_logit": 6.4379754066467285,
            "end_logit": -3.7700045108795166,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Riva",
            "probability": 4.466535455240688e-05,
            "start_logit": 6.4379754066467285,
            "end_logit": -3.990125894546509,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Comparisons of Rivaroxaban",
            "probability": 3.7659888974213124e-05,
            "start_logit": -3.7478017807006836,
            "end_logit": 6.025048732757568,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dosage",
            "probability": 2.990885174809664e-05,
            "start_logit": 6.4379754066467285,
            "end_logit": -4.391169548034668,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "xaban",
            "probability": 2.697933892238425e-05,
            "start_logit": -4.081326007843018,
            "end_logit": 6.025048732757568,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials)",
            "probability": 2.0302021775353008e-05,
            "start_logit": 6.4379754066467285,
            "end_logit": -4.778603553771973,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "ivaroxaban",
            "probability": 1.9168270869296465e-05,
            "start_logit": -4.423141002655029,
            "end_logit": 6.025048732757568,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "roxaban",
            "probability": 1.6265418102815405e-05,
            "start_logit": -4.587356090545654,
            "end_logit": 6.025048732757568,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxa",
            "probability": 7.060286556036028e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -5.834838390350342,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF",
            "probability": 6.462037098894472e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -5.923379421234131,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dos",
            "probability": 5.795256684301097e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -6.032284259796143,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dosage Criteria (ROCKET AF",
            "probability": 5.227049468220387e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -6.135477066040039,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "of Rivaroxaban",
            "probability": 5.205020377033366e-06,
            "start_logit": -5.726773738861084,
            "end_logit": 6.025048732757568,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials",
            "probability": 5.181356844538438e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -6.144257068634033,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different",
            "probability": 4.3986313001699455e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -6.308030605316162,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials) in Asian Patients",
            "probability": 4.154623201344677e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -6.365102291107178,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Following",
            "probability": 3.8057289252975106e-06,
            "start_logit": 6.4379754066467285,
            "end_logit": -6.452816486358643,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        }
    ],
    "56b3a3ce8525abca1e000005": [
        {
            "text": "indirect immunofluorescent detection of lipid droplet-associated proteins",
            "probability": 0.302346653730744,
            "start_logit": -1.0401769876480103,
            "end_logit": -0.9534665942192078,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "immunofluorescent detection of lipid droplet-associated proteins",
            "probability": 0.1893443152430665,
            "start_logit": -1.5081840753555298,
            "end_logit": -0.9534665942192078,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Associated Proteins",
            "probability": 0.07474526928350318,
            "start_logit": -2.164459228515625,
            "end_logit": -1.226672649383545,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "indirect immunofluorescent",
            "probability": 0.059949232165337325,
            "start_logit": -1.0401769876480103,
            "end_logit": -2.571542739868164,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "associated proteins",
            "probability": 0.041948286315497914,
            "start_logit": -3.0153136253356934,
            "end_logit": -0.9534665942192078,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "immunofluorescent",
            "probability": 0.037543151788285156,
            "start_logit": -1.5081840753555298,
            "end_logit": -2.571542739868164,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "indirect immunofluorescent detection",
            "probability": 0.036141912711513596,
            "start_logit": -1.0401769876480103,
            "end_logit": -3.077587604522705,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "indirect immunofluorescent detection of lipid droplet-associated",
            "probability": 0.03611938653179459,
            "start_logit": -1.0401769876480103,
            "end_logit": -3.0782110691070557,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Fluorescent Detection of Lipid Droplets and Associated Proteins",
            "probability": 0.02989914048745659,
            "start_logit": -3.0807154178619385,
            "end_logit": -1.226672649383545,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Proteins",
            "probability": 0.02538770626999031,
            "start_logit": -3.2442800998687744,
            "end_logit": -1.226672649383545,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "detection of lipid droplet-associated proteins",
            "probability": 0.02317892761717353,
            "start_logit": -3.6085076332092285,
            "end_logit": -0.9534665942192078,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "immunofluorescent detection",
            "probability": 0.02263383976470439,
            "start_logit": -1.5081840753555298,
            "end_logit": -3.077587604522705,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "immunofluorescent detection of lipid droplet-associated",
            "probability": 0.02261973276526746,
            "start_logit": -1.5081840753555298,
            "end_logit": -3.0782110691070557,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "indirect",
            "probability": 0.021839104981017134,
            "start_logit": -1.0401769876480103,
            "end_logit": -3.58133864402771,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "proteins",
            "probability": 0.021341061062718176,
            "start_logit": -3.6911182403564453,
            "end_logit": -0.9534665942192078,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Associated",
            "probability": 0.019783867250047747,
            "start_logit": -2.164459228515625,
            "end_logit": -2.555891752243042,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Detection of Lipid Droplets and Associated Proteins",
            "probability": 0.009687120457755634,
            "start_logit": -4.207747936248779,
            "end_logit": -1.226672649383545,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "indirect immunofluorescent detection of lipid droplet-associated proteins is described",
            "probability": 0.009060652965528203,
            "start_logit": -1.0401769876480103,
            "end_logit": -4.461099624633789,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Associated Proteins.This unit discusses techniques for the visualization of lipid droplets and associated proteins",
            "probability": 0.008516818349944357,
            "start_logit": -2.164459228515625,
            "end_logit": -3.3987157344818115,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Fluorescent Detection of Lipid Droplets and Associated",
            "probability": 0.00791382025865444,
            "start_logit": -3.0807154178619385,
            "end_logit": -2.555891752243042,
            "question_text": "List proteins of lipids droplets"
        }
    ],
    "535d59349a4572de6f000009": [
        {
            "text": "iron deficiency",
            "probability": 0.8064171058986332,
            "start_logit": 4.790495872497559,
            "end_logit": 3.6895558834075928,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anaemia types, inflammatory activity, anti-cytokine-specific treatment effects and iron deficiency",
            "probability": 0.10132722993768156,
            "start_logit": 2.716249942779541,
            "end_logit": 3.6895558834075928,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "inflammatory activity, anti-cytokine-specific treatment effects and iron deficiency",
            "probability": 0.048679661877755756,
            "start_logit": 1.9831560850143433,
            "end_logit": 3.6895558834075928,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron",
            "probability": 0.014763094352621834,
            "start_logit": 4.790495872497559,
            "end_logit": -0.3109147846698761,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anaemia",
            "probability": 0.013670464350034005,
            "start_logit": 2.716249942779541,
            "end_logit": 1.6864383220672607,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "deficiency",
            "probability": 0.002992042400723379,
            "start_logit": -0.8061490058898926,
            "end_logit": 3.6895558834075928,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anaemia types, inflammatory activity, anti-cytokine-specific treatment effects and iron",
            "probability": 0.0018549996585115046,
            "start_logit": 2.716249942779541,
            "end_logit": -0.3109147846698761,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anaemia types, inflammatory activity",
            "probability": 0.001821021911537884,
            "start_logit": 2.716249942779541,
            "end_logit": -0.3294014632701874,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anaemia types, inflammatory",
            "probability": 0.0016207939340939948,
            "start_logit": 2.716249942779541,
            "end_logit": -0.445883184671402,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anti-cytokine-specific treatment effects and iron deficiency",
            "probability": 0.001190550129771894,
            "start_logit": -1.7276897430419922,
            "end_logit": 3.6895558834075928,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anaemia types",
            "probability": 0.0011899151154791527,
            "start_logit": 2.716249942779541,
            "end_logit": -0.754917323589325,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron deficiency (ID) indices.",
            "probability": 0.0010498064614273884,
            "start_logit": 4.790495872497559,
            "end_logit": -2.954439401626587,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "inflammatory activity, anti-cytokine-specific treatment effects and iron",
            "probability": 0.0008911795596823219,
            "start_logit": 1.9831560850143433,
            "end_logit": -0.3109147846698761,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "inflammatory activity",
            "probability": 0.0008748559590563,
            "start_logit": 1.9831560850143433,
            "end_logit": -0.3294014632701874,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "inflammatory",
            "probability": 0.0007786623668064175,
            "start_logit": 1.9831560850143433,
            "end_logit": -0.445883184671402,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "cytokine-specific treatment effects and iron deficiency",
            "probability": 0.00024553282702685707,
            "start_logit": -3.306429862976074,
            "end_logit": 3.6895558834075928,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "an",
            "probability": 0.00024180746817805814,
            "start_logit": 2.716249942779541,
            "end_logit": -2.3484127521514893,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron deficiency (ID)",
            "probability": 0.0001381165333324169,
            "start_logit": 4.790495872497559,
            "end_logit": -4.982702732086182,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anaemia types, inflammatory activity, anti-cytokine-specific treatment effects and iron deficiency (ID) indices.",
            "probability": 0.00013190938030583895,
            "start_logit": 2.716249942779541,
            "end_logit": -2.954439401626587,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron deficiency (ID) indices",
            "probability": 0.00012124987733978958,
            "start_logit": 4.790495872497559,
            "end_logit": -5.1129469871521,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        }
    ],
    "5713bf261174fb1755000011": [
        {
            "text": "micro-fluid channel networks complex three-dimensional tissue structures",
            "probability": 0.24936576400022586,
            "start_logit": 1.045991063117981,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel networks",
            "probability": 0.24915531339144276,
            "start_logit": 1.045991063117981,
            "end_logit": 0.3658779263496399,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "three-dimensional tissue structures",
            "probability": 0.09591638446371756,
            "start_logit": 0.09054712951183319,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel",
            "probability": 0.056643539823391174,
            "start_logit": 1.045991063117981,
            "end_logit": -1.1154205799102783,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel networks complex three-dimensional tissue",
            "probability": 0.05347163568942878,
            "start_logit": 1.045991063117981,
            "end_logit": -1.1730471849441528,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "tissue structures",
            "probability": 0.04394113477996212,
            "start_logit": -0.6900787949562073,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "channel networks complex three-dimensional tissue structures",
            "probability": 0.03381386800494028,
            "start_logit": -0.9520586729049683,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "channel networks",
            "probability": 0.033785331011758866,
            "start_logit": -0.9520586729049683,
            "end_logit": 0.3658779263496399,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "fluid channel networks complex three-dimensional tissue structures",
            "probability": 0.03152737010329655,
            "start_logit": -1.0220736265182495,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "fluid channel networks",
            "probability": 0.031500762785094026,
            "start_logit": -1.0220736265182495,
            "end_logit": 0.3658779263496399,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "three-dimensional tissue",
            "probability": 0.02056740221438917,
            "start_logit": 0.09054712951183319,
            "end_logit": -1.1730471849441528,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel networks complex three-dimensional",
            "probability": 0.015356586435797157,
            "start_logit": 1.045991063117981,
            "end_logit": -2.420654058456421,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "manufacturing of micro-fluid channel networks complex three-dimensional tissue structures",
            "probability": 0.012336770813998149,
            "start_logit": -1.9603453874588013,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "manufacturing of micro-fluid channel networks",
            "probability": 0.012326359276798435,
            "start_logit": -1.9603453874588013,
            "end_logit": 0.3658779263496399,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel networks complex three",
            "probability": 0.011240825640652312,
            "start_logit": 1.045991063117981,
            "end_logit": -2.7326462268829346,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "complex three-dimensional tissue structures",
            "probability": 0.011104702098669752,
            "start_logit": -2.065561056137085,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "test the feasibility of our 3D printing scheme for the manufacturing of micro-fluid channel networks complex three-dimensional tissue structures",
            "probability": 0.00953870482294,
            "start_logit": -2.217571973800659,
            "end_logit": 0.3667222261428833,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "test the feasibility of our 3D printing scheme for the manufacturing of micro-fluid channel networks",
            "probability": 0.00953065469526895,
            "start_logit": -2.217571973800659,
            "end_logit": 0.3658779263496399,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel networks complex",
            "probability": 0.009454568643800185,
            "start_logit": 1.045991063117981,
            "end_logit": -2.905700445175171,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "tissue",
            "probability": 0.00942232130442772,
            "start_logit": -0.6900787949562073,
            "end_logit": -1.1730471849441528,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        }
    ],
    "5309f8f5970c65fa6b000001": [
        {
            "text": "KRAS",
            "probability": 0.6398535643975625,
            "start_logit": 4.480825901031494,
            "end_logit": 4.187036991119385,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS.In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic KRAS",
            "probability": 0.24256346711851584,
            "start_logit": 3.510849952697754,
            "end_logit": 4.187036991119385,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS",
            "probability": 0.07676860457746694,
            "start_logit": 3.510849952697754,
            "end_logit": 3.036569356918335,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "oncogenic KRAS",
            "probability": 0.026608686644699963,
            "start_logit": 1.3008242845535278,
            "end_logit": 4.187036991119385,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras",
            "probability": 0.007763784855801332,
            "start_logit": 2.523491859436035,
            "end_logit": 1.7326016426086426,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "oncogenic RAS",
            "probability": 0.004063115839991914,
            "start_logit": 0.5720043182373047,
            "end_logit": 3.036569356918335,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced senescence after reduction of ERK",
            "probability": 0.001075021401295594,
            "start_logit": 2.523491859436035,
            "end_logit": -0.24452774226665497,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "K",
            "probability": 0.0003151461217128864,
            "start_logit": 4.480825901031494,
            "end_logit": -3.4289212226867676,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "ERK",
            "probability": 0.00017895542536056408,
            "start_logit": 0.7305327653884888,
            "end_logit": -0.24452774226665497,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS.In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic",
            "probability": 0.00017873080838412203,
            "start_logit": 3.510849952697754,
            "end_logit": -3.0261008739471436,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS.In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic K",
            "probability": 0.00011946942266955156,
            "start_logit": 3.510849952697754,
            "end_logit": -3.4289212226867676,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "AS.In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic KRAS",
            "probability": 0.00010756319788431992,
            "start_logit": -4.210090160369873,
            "end_logit": 4.187036991119385,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "pancreatic ductal adenocarcinoma (PDAC), oncogenic KRAS",
            "probability": 9.388040285106355e-05,
            "start_logit": -4.346147060394287,
            "end_logit": 4.187036991119385,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "KRAS induces benign pancreatic intraepithelial neoplasias (PanINs),",
            "probability": 7.738429713163351e-05,
            "start_logit": 4.480825901031494,
            "end_logit": -4.833173751831055,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS.",
            "probability": 7.511459920813073e-05,
            "start_logit": 3.510849952697754,
            "end_logit": -3.8929667472839355,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS.In the context of pancreatic ductal adenocarcinoma (PDAC),",
            "probability": 4.3181359257761044e-05,
            "start_logit": 3.510849952697754,
            "end_logit": -4.446572780609131,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "R",
            "probability": 4.085637595880387e-05,
            "start_logit": 3.510849952697754,
            "end_logit": -4.501918792724609,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "AS",
            "probability": 3.404254030321311e-05,
            "start_logit": -4.210090160369873,
            "end_logit": 3.036569356918335,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced senescence after reduction of ERK signaling.Cellular senescence",
            "probability": 1.9824231620451085e-05,
            "start_logit": 2.523491859436035,
            "end_logit": -4.23771858215332,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "oncogenic",
            "probability": 1.9606382323531634e-05,
            "start_logit": 1.3008242845535278,
            "end_logit": -3.0261008739471436,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        }
    ],
    "56d1d94667f0cb3d66000005": [
        {
            "text": "development",
            "probability": 0.3564321268595397,
            "start_logit": 3.27673602104187,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "size of multiple organs, such as liver during development",
            "probability": 0.12135029940677443,
            "start_logit": 2.1992735862731934,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "liver during development",
            "probability": 0.1136421572279124,
            "start_logit": 2.1336467266082764,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "controlling the size of multiple organs, such as liver during development",
            "probability": 0.06952568548526084,
            "start_logit": 1.6422884464263916,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "the size of multiple organs, such as liver during development",
            "probability": 0.06850686623489684,
            "start_logit": 1.6275261640548706,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "size of multiple organs",
            "probability": 0.04063302512079854,
            "start_logit": 2.1992735862731934,
            "end_logit": 2.8991341590881348,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "multiple organs, such as liver during development",
            "probability": 0.03859459320246747,
            "start_logit": 1.0537043809890747,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organs, such as liver during development",
            "probability": 0.0381521924535882,
            "start_logit": 1.0421754121780396,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "controlling the size of multiple organs",
            "probability": 0.023280032588907096,
            "start_logit": 1.6422884464263916,
            "end_logit": 2.8991341590881348,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "the size of multiple organs",
            "probability": 0.022938890388220588,
            "start_logit": 1.6275261640548706,
            "end_logit": 2.8991341590881348,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "during development",
            "probability": 0.01913756303167018,
            "start_logit": 0.3522452414035797,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "size of multiple organs, such as liver",
            "probability": 0.013919236920818963,
            "start_logit": 2.1992735862731934,
            "end_logit": 1.8278248310089111,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "liver",
            "probability": 0.01303509029957916,
            "start_logit": 2.1336467266082764,
            "end_logit": 1.8278248310089111,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "multiple organs",
            "probability": 0.012923042487650551,
            "start_logit": 1.0537043809890747,
            "end_logit": 2.8991341590881348,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organs",
            "probability": 0.012774908689624933,
            "start_logit": 1.0421754121780396,
            "end_logit": 2.8991341590881348,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "functions in controlling the size of multiple organs, such as liver during development",
            "probability": 0.01051846672216017,
            "start_logit": -0.24627536535263062,
            "end_logit": 3.993234395980835,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "controlling the size of multiple organs, such as liver",
            "probability": 0.007974800994167676,
            "start_logit": 1.6422884464263916,
            "end_logit": 1.8278248310089111,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "the size of multiple organs, such as liver",
            "probability": 0.007857939424030371,
            "start_logit": 1.6275261640548706,
            "end_logit": 1.8278248310089111,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "multiple organs, such as liver",
            "probability": 0.004426913565717862,
            "start_logit": 1.0537043809890747,
            "end_logit": 1.8278248310089111,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organs, such as liver",
            "probability": 0.004376168896213943,
            "start_logit": 1.0421754121780396,
            "end_logit": 1.8278248310089111,
            "question_text": "List processes which are under the control of the YAP protein."
        }
    ],
    "56d29d4df22319765a000003": [
        {
            "text": "metabolomics",
            "probability": 0.1805867317934044,
            "start_logit": 0.0899379551410675,
            "end_logit": -0.7875621914863586,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics",
            "probability": 0.10687762468805381,
            "start_logit": -0.5365185141563416,
            "end_logit": -0.6856324076652527,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics, metabolomics",
            "probability": 0.09652043056337475,
            "start_logit": -0.5365185141563416,
            "end_logit": -0.7875621914863586,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics",
            "probability": 0.09564167603981784,
            "start_logit": -0.6917058229446411,
            "end_logit": -0.6415209174156189,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, proteomics",
            "probability": 0.0915144768450031,
            "start_logit": -0.6917058229446411,
            "end_logit": -0.6856324076652527,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "metabolomics, and meta-omics",
            "probability": 0.08875294970775498,
            "start_logit": 0.0899379551410675,
            "end_logit": -1.4979166984558105,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, proteomics, metabolomics",
            "probability": 0.08264607988475434,
            "start_logit": -0.6917058229446411,
            "end_logit": -0.7875621914863586,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics, metabolomics, and meta-omics",
            "probability": 0.04743688993365419,
            "start_logit": -0.5365185141563416,
            "end_logit": -1.4979166984558105,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "meta-omics",
            "probability": 0.045027930100792195,
            "start_logit": -0.5886357426643372,
            "end_logit": -1.4979166984558105,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, proteomics, metabolomics, and meta-omics",
            "probability": 0.040618063678931934,
            "start_logit": -0.6917058229446411,
            "end_logit": -1.4979166984558105,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics",
            "probability": 0.0291389694208179,
            "start_logit": -1.8802380561828613,
            "end_logit": -0.6415209174156189,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, proteomics",
            "probability": 0.027881543410411484,
            "start_logit": -1.8802380561828613,
            "end_logit": -0.6856324076652527,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, proteomics, metabolomics",
            "probability": 0.02517962560076563,
            "start_logit": -1.8802380561828613,
            "end_logit": -0.7875621914863586,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, proteomics, metabolomics, and meta-omics",
            "probability": 0.01237502900911612,
            "start_logit": -1.8802380561828613,
            "end_logit": -1.4979166984558105,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics",
            "probability": 0.010268438429387875,
            "start_logit": -1.8802380561828613,
            "end_logit": -1.6845223903656006,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "metabolomics, and meta",
            "probability": 0.006450334941580512,
            "start_logit": 0.0899379551410675,
            "end_logit": -4.119641304016113,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "meta",
            "probability": 0.00432104715381359,
            "start_logit": 0.0899379551410675,
            "end_logit": -4.520275592803955,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics, metabolomics, and meta",
            "probability": 0.003447590527035999,
            "start_logit": -0.5365185141563416,
            "end_logit": -4.119641304016113,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, proteomics, metabolomics, and meta",
            "probability": 0.0029520158627997025,
            "start_logit": -0.6917058229446411,
            "end_logit": -4.119641304016113,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genome-scale modeling methods used to interpret multiple omic data types, including genomics, transcriptomics",
            "probability": 0.0023625524087299743,
            "start_logit": -4.392571926116943,
            "end_logit": -0.6415209174156189,
            "question_text": "List omics technologies comprised in system biology."
        }
    ],
    "5318367cb166e2b806000012": [
        {
            "text": "DJ-1",
            "probability": 0.08305372933476873,
            "start_logit": 4.660044193267822,
            "end_logit": 4.058964729309082,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1, DJ-1",
            "probability": 0.06759036728903188,
            "start_logit": 4.45402193069458,
            "end_logit": 4.058964729309082,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1",
            "probability": 0.06478333716416476,
            "start_logit": 4.45402193069458,
            "end_logit": 4.016547679901123,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA, LRRK2",
            "probability": 0.06182777632181823,
            "start_logit": 4.266953468322754,
            "end_logit": 4.156920433044434,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2",
            "probability": 0.060944474991783584,
            "start_logit": 4.252563953399658,
            "end_logit": 4.156920433044434,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35 and autosomal recessive mutations in PINK1, DJ-1",
            "probability": 0.05747499038091329,
            "start_logit": 4.291906356811523,
            "end_logit": 4.058964729309082,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA, LRRK2, and VPS35 and autosomal recessive mutations in PINK1, DJ-1",
            "probability": 0.05605856875391936,
            "start_logit": 4.266953468322754,
            "end_logit": 4.058964729309082,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35 and autosomal recessive mutations in PINK1, DJ-1",
            "probability": 0.05525768909616751,
            "start_logit": 4.252563953399658,
            "end_logit": 4.058964729309082,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35 and autosomal recessive mutations in PINK1",
            "probability": 0.05508805218399877,
            "start_logit": 4.291906356811523,
            "end_logit": 4.016547679901123,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA, LRRK2, and VPS35 and autosomal recessive mutations in PINK1",
            "probability": 0.053730454592676724,
            "start_logit": 4.266953468322754,
            "end_logit": 4.016547679901123,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35 and autosomal recessive mutations in PINK1",
            "probability": 0.05296283549283972,
            "start_logit": 4.252563953399658,
            "end_logit": 4.016547679901123,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "DJ-1, and Parkin",
            "probability": 0.04789091568866375,
            "start_logit": 4.660044193267822,
            "end_logit": 3.5084028244018555,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35",
            "probability": 0.04401953105455712,
            "start_logit": 4.291906356811523,
            "end_logit": 3.792248249053955,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA, LRRK2, and VPS35",
            "probability": 0.042934707631663405,
            "start_logit": 4.266953468322754,
            "end_logit": 3.792248249053955,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35",
            "probability": 0.04232132176188381,
            "start_logit": 4.252563953399658,
            "end_logit": 3.792248249053955,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1, DJ-1, and Parkin",
            "probability": 0.03897434356207475,
            "start_logit": 4.45402193069458,
            "end_logit": 3.5084028244018555,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35 and autosomal recessive mutations in PINK1, DJ-1, and Parkin",
            "probability": 0.03314155716529383,
            "start_logit": 4.291906356811523,
            "end_logit": 3.5084028244018555,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35 and autosomal recessive mutations in PINK1, DJ-1, and Parkin",
            "probability": 0.031863004236549274,
            "start_logit": 4.252563953399658,
            "end_logit": 3.5084028244018555,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA",
            "probability": 0.029876560629795938,
            "start_logit": 4.266953468322754,
            "end_logit": 3.4296419620513916,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "Parkin",
            "probability": 0.02020578266743544,
            "start_logit": 3.7970871925354004,
            "end_logit": 3.5084028244018555,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        }
    ],
    "515d1ff7298dcd4e51000009": [
        {
            "text": "cancer cell killing system that kills the cancer cells",
            "probability": 0.28134130889211967,
            "start_logit": 0.8110926151275635,
            "end_logit": 0.023352818563580513,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer",
            "probability": 0.20890284659775565,
            "start_logit": 0.8110926151275635,
            "end_logit": -0.2743464410305023,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells",
            "probability": 0.19531686775595017,
            "start_logit": 0.44614726305007935,
            "end_logit": 0.023352818563580513,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer",
            "probability": 0.141851811744314,
            "start_logit": 0.8110926151275635,
            "end_logit": -0.6614328026771545,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing",
            "probability": 0.046367549811004515,
            "start_logit": 0.8110926151275635,
            "end_logit": -1.779615879058838,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell",
            "probability": 0.01574708840281659,
            "start_logit": 0.8110926151275635,
            "end_logit": -2.859560251235962,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug delivery",
            "probability": 0.01568413318082691,
            "start_logit": 0.8110926151275635,
            "end_logit": -2.8635661602020264,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug delivery through multifunctional mesoporous silica nanogates",
            "probability": 0.01268636873698361,
            "start_logit": 0.8110926151275635,
            "end_logit": -3.0756876468658447,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug",
            "probability": 0.01233356151481024,
            "start_logit": 0.8110926151275635,
            "end_logit": -3.103891611099243,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug delivery",
            "probability": 0.01088846774193736,
            "start_logit": 0.44614726305007935,
            "end_logit": -2.8635661602020264,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug delivery through multifunctional mesoporous silica nanogates",
            "probability": 0.008807315977387396,
            "start_logit": 0.44614726305007935,
            "end_logit": -3.0756876468658447,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug",
            "probability": 0.00856238500074577,
            "start_logit": 0.44614726305007935,
            "end_logit": -3.103891611099243,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system",
            "probability": 0.0071171171459879145,
            "start_logit": 0.8110926151275635,
            "end_logit": -3.6537129878997803,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cell killing system that kills the cancer cells",
            "probability": 0.0070760143397038105,
            "start_logit": -2.87176513671875,
            "end_logit": 0.023352818563580513,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug delivery through multifunctional mesoporous silica nanogates.",
            "probability": 0.006290805893200115,
            "start_logit": 0.8110926151275635,
            "end_logit": -3.7771265506744385,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "kills the cancer cells",
            "probability": 0.005654456726227522,
            "start_logit": -3.096031904220581,
            "end_logit": 0.023352818563580513,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug delivery through multifunctional mesoporous silica nanogates.",
            "probability": 0.004367295039462776,
            "start_logit": 0.44614726305007935,
            "end_logit": -3.7771265506744385,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cells",
            "probability": 0.00423461984433527,
            "start_logit": -3.3851823806762695,
            "end_logit": 0.023352818563580513,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cell killing system that kills the cancer",
            "probability": 0.0035677144531968373,
            "start_logit": -2.87176513671875,
            "end_logit": -0.6614328026771545,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "a two-photon-actuated cancer cell killing system that kills the cancer cells",
            "probability": 0.003202271201233773,
            "start_logit": -3.6646156311035156,
            "end_logit": 0.023352818563580513,
            "question_text": "Which cellular processes are regulated by Nanog?"
        }
    ],
    "56ed27202ac5ed145900000c": [
        {
            "text": "Osteosarcoma",
            "probability": 0.28920795184919024,
            "start_logit": 2.955678939819336,
            "end_logit": 2.296757221221924,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts",
            "probability": 0.18027088726349125,
            "start_logit": 3.3465161323547363,
            "end_logit": 1.433234691619873,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "Osteosarcoma Cells.Here, we wanted to investigate the role of lamin A in normal osteoblasts",
            "probability": 0.1219515038556161,
            "start_logit": 2.955678939819336,
            "end_logit": 1.433234691619873,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs) and OS",
            "probability": 0.08006951938977079,
            "start_logit": 3.3465161323547363,
            "end_logit": 0.6216692924499512,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs)",
            "probability": 0.07279153286558537,
            "start_logit": 3.3465161323547363,
            "end_logit": 0.5263736844062805,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "Osteosarcoma Cells.Here, we wanted to investigate the role of lamin A in normal osteoblasts (OBs)",
            "probability": 0.04924276479506423,
            "start_logit": 2.955678939819336,
            "end_logit": 0.5263736844062805,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "Osteosarcoma Cells",
            "probability": 0.045705325849398605,
            "start_logit": 2.955678939819336,
            "end_logit": 0.4518260657787323,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblast",
            "probability": 0.029497778131185336,
            "start_logit": 3.3465161323547363,
            "end_logit": -0.3769110143184662,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs) and OS cells.Thus, we studied the expression of lamin A/C in OS",
            "probability": 0.026489074734129304,
            "start_logit": 3.3465161323547363,
            "end_logit": -0.48449358344078064,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs",
            "probability": 0.021300419053738494,
            "start_logit": 3.3465161323547363,
            "end_logit": -0.7024992108345032,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "Osteosarcoma Cells.Here, we wanted to investigate the role of lamin A in normal osteoblast",
            "probability": 0.019954960327229095,
            "start_logit": 2.955678939819336,
            "end_logit": -0.3769110143184662,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs) and OS cells.Thus, we studied the expression of lamin A/C in OS cells",
            "probability": 0.015050331996011893,
            "start_logit": 3.3465161323547363,
            "end_logit": -1.04982590675354,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "Osteosarcoma Cells.Here, we wanted to investigate the role of lamin A in normal osteoblasts (OBs",
            "probability": 0.014409526550792666,
            "start_logit": 2.955678939819336,
            "end_logit": -0.7024992108345032,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs) and OS cells",
            "probability": 0.013489747081794495,
            "start_logit": 3.3465161323547363,
            "end_logit": -1.1592960357666016,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "OS",
            "probability": 0.00913199138416996,
            "start_logit": 1.175404667854309,
            "end_logit": 0.6216692924499512,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "OS cells.Thus, we studied the expression of lamin A/C in OS",
            "probability": 0.0030210997154755796,
            "start_logit": 1.175404667854309,
            "end_logit": -0.48449358344078064,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "OS cells.Thus, we studied the expression of lamin A/C in OS cells compared to OBs",
            "probability": 0.002758145441900305,
            "start_logit": 1.175404667854309,
            "end_logit": -0.5755559802055359,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "o",
            "probability": 0.0022257218088822476,
            "start_logit": 3.3465161323547363,
            "end_logit": -2.9611446857452393,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "OS cells.Thus, we studied the expression of lamin A/C in OS cells",
            "probability": 0.001716502149181584,
            "start_logit": 1.175404667854309,
            "end_logit": -1.04982590675354,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "oma",
            "probability": 0.0017152157573926497,
            "start_logit": -2.1719281673431396,
            "end_logit": 2.296757221221924,
            "question_text": "In which cells are A-type lamins expressed?"
        }
    ],
    "530cf4e0c8a0b4a00c000004": [
        {
            "text": "troponin T",
            "probability": 0.2483923141533098,
            "start_logit": -3.758126735687256,
            "end_logit": -2.3928885459899902,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Mutations in the genes for beta-myosin heavy chain, myosin binding protein-C, and cardiac troponin T",
            "probability": 0.15600843455559987,
            "start_logit": -4.223226070404053,
            "end_logit": -2.3928885459899902,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "cardiac troponin T",
            "probability": 0.12224700509053987,
            "start_logit": -4.467092514038086,
            "end_logit": -2.3928885459899902,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "beta-myosin heavy chain, myosin binding protein-C, and cardiac troponin T",
            "probability": 0.11882171010081756,
            "start_logit": -4.495512008666992,
            "end_logit": -2.3928885459899902,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "T",
            "probability": 0.08935814726545939,
            "start_logit": -4.780483722686768,
            "end_logit": -2.3928885459899902,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "myosin binding protein-C, and cardiac troponin T",
            "probability": 0.08494343905257015,
            "start_logit": -4.831150531768799,
            "end_logit": -2.3928885459899902,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "troponin T are the most common.Some mutations are more frequently associated with a given phenotype,",
            "probability": 0.02251850575690961,
            "start_logit": -3.758126735687256,
            "end_logit": -4.79356050491333,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "troponin T are the most common.",
            "probability": 0.02049788788729506,
            "start_logit": -3.758126735687256,
            "end_logit": -4.887576103210449,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Mutations",
            "probability": 0.0162580480691775,
            "start_logit": -4.223226070404053,
            "end_logit": -4.654210567474365,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes, all encoding sarcomeric proteins, have been identified as responsible for this disease.Mutations",
            "probability": 0.015033892108309601,
            "start_logit": -4.301506996154785,
            "end_logit": -4.654210567474365,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes, all encoding sarcomeric proteins, have been identified",
            "probability": 0.013003790149432119,
            "start_logit": -4.301506996154785,
            "end_logit": -4.799276828765869,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100",
            "probability": 0.012960395876014986,
            "start_logit": -4.301506996154785,
            "end_logit": -4.802619457244873,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "cardiac troponin T are the most common.Some mutations are more frequently associated with a given phenotype,",
            "probability": 0.011082548577558712,
            "start_logit": -4.467092514038086,
            "end_logit": -4.79356050491333,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes,",
            "probability": 0.011052720395217309,
            "start_logit": -4.301506996154785,
            "end_logit": -4.961841106414795,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes, all encoding sarcomeric proteins, have been identified as responsible for this disease.",
            "probability": 0.01016128513600958,
            "start_logit": -4.301506996154785,
            "end_logit": -5.045932769775391,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "cardiac troponin T are the most common.",
            "probability": 0.010088095573508248,
            "start_logit": -4.467092514038086,
            "end_logit": -4.887576103210449,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "troponin T are the most common.Some mutations are more frequently associated with a given phenotype",
            "probability": 0.009874179275689135,
            "start_logit": -3.758126735687256,
            "end_logit": -5.617974758148193,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "beta-myosin heavy chain, myosin binding protein-C, and cardiac troponin T are the most common.",
            "probability": 0.009805432589673303,
            "start_logit": -4.495512008666992,
            "end_logit": -4.887576103210449,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "troponin T are the most common.Some",
            "probability": 0.009077074062269366,
            "start_logit": -3.758126735687256,
            "end_logit": -5.702146053314209,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Mutations in the genes for beta",
            "probability": 0.00881509432463873,
            "start_logit": -4.223226070404053,
            "end_logit": -5.266333103179932,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        }
    ],
    "530cf4e0c8a0b4a00c000005": [
        {
            "text": "fibrillin 1",
            "probability": 0.22059079843535367,
            "start_logit": -2.4868407249450684,
            "end_logit": -3.8034679889678955,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin 1 (FBN1) gene.",
            "probability": 0.1898794972791141,
            "start_logit": -2.4868407249450684,
            "end_logit": -3.95338773727417,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin 1 (FBN1",
            "probability": 0.16963355410276848,
            "start_logit": -2.4868407249450684,
            "end_logit": -4.066136837005615,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin",
            "probability": 0.07892831750898137,
            "start_logit": -2.4868407249450684,
            "end_logit": -4.831237316131592,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1",
            "probability": 0.049388193078518015,
            "start_logit": -3.983438730239868,
            "end_logit": -3.8034679889678955,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin 1 (FBN1) gene",
            "probability": 0.036623885450478885,
            "start_logit": -2.4868407249450684,
            "end_logit": -5.599076747894287,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin 1 (FBN1)",
            "probability": 0.03531138477262286,
            "start_logit": -2.4868407249450684,
            "end_logit": -5.6355719566345215,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin-1",
            "probability": 0.02459241092370767,
            "start_logit": -3.7556135654449463,
            "end_logit": -4.728566646575928,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "FBN1) gene.",
            "probability": 0.021757628202261056,
            "start_logit": -4.653265953063965,
            "end_logit": -3.95338773727417,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "FBN1",
            "probability": 0.0194377163078899,
            "start_logit": -4.653265953063965,
            "end_logit": -4.066136837005615,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin-1 missense mutation.",
            "probability": 0.019374075746636847,
            "start_logit": -3.7556135654449463,
            "end_logit": -4.967068672180176,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "connective tissue disorder usually caused by a mutation in the fibrillin 1",
            "probability": 0.018189371501585335,
            "start_logit": -4.9823126792907715,
            "end_logit": -3.8034679889678955,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin",
            "probability": 0.017671303663368942,
            "start_logit": -3.983438730239868,
            "end_logit": -4.831237316131592,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin-1 missense mutation.Marfan syndrome",
            "probability": 0.01590395349357445,
            "start_logit": -3.7556135654449463,
            "end_logit": -5.1644368171691895,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene.",
            "probability": 0.01565699358741038,
            "start_logit": -4.9823126792907715,
            "end_logit": -3.95338773727417,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin-1 missense mutation.Marfan syndrome (MFS) is a heritable connective tissue disorder usually",
            "probability": 0.015392590550665209,
            "start_logit": -3.7556135654449463,
            "end_logit": -5.197118282318115,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1",
            "probability": 0.013987563201163058,
            "start_logit": -4.9823126792907715,
            "end_logit": -4.066136837005615,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "fibrillin-1 missense mutation.Marfan syndrome (MFS)",
            "probability": 0.012760467667319373,
            "start_logit": -3.7556135654449463,
            "end_logit": -5.384652614593506,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Marfan syndrome",
            "probability": 0.012663737077061204,
            "start_logit": -3.983438730239868,
            "end_logit": -5.1644368171691895,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Marfan syndrome (MFS) is a heritable connective tissue disorder usually",
            "probability": 0.01225655744951946,
            "start_logit": -3.983438730239868,
            "end_logit": -5.197118282318115,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        }
    ],
    "5518e817622b194345000006": [
        {
            "text": "VPS35",
            "probability": 0.8420481258919976,
            "start_logit": -0.9822609424591064,
            "end_logit": -1.634946346282959,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "VPS35 steers N-Ras",
            "probability": 0.04131666706152239,
            "start_logit": -0.9822609424591064,
            "end_logit": -4.64951753616333,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "VPS35 steers N-Ras through the cytosol. Ras",
            "probability": 0.02755998637282366,
            "start_logit": -0.9822609424591064,
            "end_logit": -5.054418563842773,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "VPS35 steers N-Ras through the cytosol.",
            "probability": 0.016546087503459258,
            "start_logit": -0.9822609424591064,
            "end_logit": -5.564633846282959,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes encode 4 isoforms",
            "probability": 0.015543803446449506,
            "start_logit": -3.440443515777588,
            "end_logit": -3.1689388751983643,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three",
            "probability": 0.011952426708349428,
            "start_logit": -3.440443515777588,
            "end_logit": -3.431666612625122,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes encode 4 isoforms",
            "probability": 0.006414528636453144,
            "start_logit": -4.325540065765381,
            "end_logit": -3.1689388751983643,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes encode 4",
            "probability": 0.006251526092923332,
            "start_logit": -3.440443515777588,
            "end_logit": -4.079775333404541,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "4 isoforms",
            "probability": 0.005473741168217649,
            "start_logit": -4.484143257141113,
            "end_logit": -3.1689388751983643,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes encode 4 isoforms.",
            "probability": 0.004738082601190779,
            "start_logit": -3.440443515777588,
            "end_logit": -4.356968402862549,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes",
            "probability": 0.0037773414734485634,
            "start_logit": -3.440443515777588,
            "end_logit": -4.583580493927002,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes encode 4 isoforms. All Ras isoforms have long been considered membrane bound,",
            "probability": 0.002686163126165924,
            "start_logit": -3.440443515777588,
            "end_logit": -4.924487113952637,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes encode 4",
            "probability": 0.0025798443272100477,
            "start_logit": -4.325540065765381,
            "end_logit": -4.079775333404541,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "4",
            "probability": 0.00220147120728277,
            "start_logit": -4.484143257141113,
            "end_logit": -4.079775333404541,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras",
            "probability": 0.002145476943513226,
            "start_logit": -3.899137496948242,
            "end_logit": -4.690545082092285,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "genes encode 4 isoforms",
            "probability": 0.0019577298088271243,
            "start_logit": -5.512320041656494,
            "end_logit": -3.1689388751983643,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes encode 4 isoforms.",
            "probability": 0.0019552850518166375,
            "start_logit": -4.325540065765381,
            "end_logit": -4.356968402862549,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "4 isoforms.",
            "probability": 0.0016685129789438874,
            "start_logit": -4.484143257141113,
            "end_logit": -4.356968402862549,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "isoforms",
            "probability": 0.0016243877465293409,
            "start_logit": -5.698974609375,
            "end_logit": -3.1689388751983643,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes",
            "probability": 0.0015588118528758463,
            "start_logit": -4.325540065765381,
            "end_logit": -4.583580493927002,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        }
    ],
    "5319abe4b166e2b80600002e": [
        {
            "text": "SNAI1",
            "probability": 0.3519402225179039,
            "start_logit": 6.202707767486572,
            "end_logit": 5.52556037902832,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interacted with HDAC1",
            "probability": 0.2867483331424094,
            "start_logit": 6.202707767486572,
            "end_logit": 5.320703983306885,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC1",
            "probability": 0.21402442457507362,
            "start_logit": 5.910192966461182,
            "end_logit": 5.320703983306885,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interacted with HDAC",
            "probability": 0.06877349023912166,
            "start_logit": 6.202707767486572,
            "end_logit": 3.8929173946380615,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC",
            "probability": 0.05133144633533886,
            "start_logit": 5.910192966461182,
            "end_logit": 3.8929173946380615,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI",
            "probability": 0.01923067332838893,
            "start_logit": 6.202707767486572,
            "end_logit": 2.618605613708496,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interacted with HDAC1 to repress E\u2011cadherin",
            "probability": 0.002634432761264743,
            "start_logit": 6.202707767486572,
            "end_logit": 0.6307669281959534,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC1 to repress E\u2011cadherin",
            "probability": 0.001966298982918201,
            "start_logit": 5.910192966461182,
            "end_logit": 0.6307669281959534,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "TGF\u2011\u03b22\u2011induced EMT in HLECs, suggesting that HDAC",
            "probability": 0.0008256847928238957,
            "start_logit": 1.6635819673538208,
            "end_logit": 4.009682655334473,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interacted",
            "probability": 0.0007468423591443465,
            "start_logit": 6.202707767486572,
            "end_logit": -0.6298021078109741,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interact",
            "probability": 0.0002591371085006316,
            "start_logit": 6.202707767486572,
            "end_logit": -1.6882989406585693,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interacted with HDAC1 to repress E\u2011cadherin in the TGF\u2011\u03b22",
            "probability": 0.00021086004234373588,
            "start_logit": 6.202707767486572,
            "end_logit": -1.8944616317749023,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "with HDAC1",
            "probability": 0.00020175212576852198,
            "start_logit": -1.0566126108169556,
            "end_logit": 5.320703983306885,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interacted with HDAC1 to repress",
            "probability": 0.00019282804736352858,
            "start_logit": 6.202707767486572,
            "end_logit": -1.9838573932647705,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "NAI1",
            "probability": 0.00018446573325142914,
            "start_logit": -1.3510451316833496,
            "end_logit": 5.52556037902832,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "interacted with HDAC1",
            "probability": 0.00016420792375731384,
            "start_logit": -1.2625190019607544,
            "end_logit": 5.320703983306885,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC1 to repress E\u2011cadherin in the TGF\u2011\u03b22",
            "probability": 0.00015738260353227918,
            "start_logit": 5.910192966461182,
            "end_logit": -1.8944616317749023,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "NAI1 interacted with HDAC1",
            "probability": 0.00015029609617595995,
            "start_logit": -1.3510451316833496,
            "end_logit": 5.320703983306885,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC1 to repress",
            "probability": 0.00014392380742599869,
            "start_logit": 5.910192966461182,
            "end_logit": -1.9838573932647705,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "E\u2011cadherin in the TGF\u2011\u03b22\u2011induced EMT in HLECs, suggesting that HDAC",
            "probability": 0.0001132974774927606,
            "start_logit": -0.32261422276496887,
            "end_logit": 4.009682655334473,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        }
    ],
    "54ff30dc6ad7dcbc1200000f": [
        {
            "text": "diseases",
            "probability": 0.23534564679045442,
            "start_logit": -1.6940830945968628,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "various diseases",
            "probability": 0.18081197213305672,
            "start_logit": -1.9576807022094727,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting",
            "probability": 0.06516233794158767,
            "start_logit": -2.01876163482666,
            "end_logit": -2.2248966693878174,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "monoallelic expression of specific genes, which precludes uniparental development and underlies various diseases",
            "probability": 0.049951918933754044,
            "start_logit": -3.244077444076538,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "underlies various diseases",
            "probability": 0.04835679110415293,
            "start_logit": -3.27653169631958,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "parent-of-origin monoallelic expression of specific genes, which precludes uniparental development and underlies various diseases",
            "probability": 0.04800532846141463,
            "start_logit": -3.2838263511657715,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprinting",
            "probability": 0.04742869997905398,
            "start_logit": -2.3364157676696777,
            "end_logit": -2.2248966693878174,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "expression of specific genes, which precludes uniparental development and underlies various diseases",
            "probability": 0.0428716807526968,
            "start_logit": -3.3969268798828125,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes",
            "probability": 0.03421914519940508,
            "start_logit": -2.01876163482666,
            "end_logit": -2.868993043899536,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "genes, which precludes uniparental development and underlies various diseases",
            "probability": 0.030161247642629226,
            "start_logit": -3.7485804557800293,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprint",
            "probability": 0.027677886171193558,
            "start_logit": -2.01876163482666,
            "end_logit": -3.0811445713043213,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes,",
            "probability": 0.025590671846833654,
            "start_logit": -2.01876163482666,
            "end_logit": -3.159550428390503,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "various",
            "probability": 0.02539693634241253,
            "start_logit": -1.9576807022094727,
            "end_logit": -3.2282307147979736,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes",
            "probability": 0.02490655833523222,
            "start_logit": -2.3364157676696777,
            "end_logit": -2.868993043899536,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression",
            "probability": 0.02279897395641925,
            "start_logit": -2.01876163482666,
            "end_logit": -3.2750627994537354,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprint",
            "probability": 0.020145473608462156,
            "start_logit": -2.3364157676696777,
            "end_logit": -3.0811445713043213,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes,",
            "probability": 0.01862628529955296,
            "start_logit": -2.3364157676696777,
            "end_logit": -3.159550428390503,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "uniparental development and underlies various diseases",
            "probability": 0.018053541870986026,
            "start_logit": -4.261796474456787,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism",
            "probability": 0.01764382734293606,
            "start_logit": -2.01876163482666,
            "end_logit": -3.5313923358917236,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "which precludes uniparental development and underlies various diseases",
            "probability": 0.016845076287765874,
            "start_logit": -4.331079959869385,
            "end_logit": -1.2654016017913818,
            "question_text": "List human diseases involving genomic imprinting."
        }
    ],
    "55031628e9bde69634000024": [
        {
            "text": "cervical small-cell carcinoma",
            "probability": 0.7401446681151258,
            "start_logit": 2.2197117805480957,
            "end_logit": 2.5848615169525146,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "small-cell carcinoma",
            "probability": 0.170943611784655,
            "start_logit": 0.7541998624801636,
            "end_logit": 2.5848615169525146,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Small-cell carcinoma",
            "probability": 0.05615365853633572,
            "start_logit": 0.40682458877563477,
            "end_logit": 1.8189948797225952,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervical small-cell carcinoma associated with Cushing's syndrome",
            "probability": 0.012928132253367045,
            "start_logit": 2.2197117805480957,
            "end_logit": -1.4625784158706665,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinoma",
            "probability": 0.0037195199971905815,
            "start_logit": -3.0735392570495605,
            "end_logit": 2.5848615169525146,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "small-cell carcinoma associated with Cushing's syndrome",
            "probability": 0.002985877918499713,
            "start_logit": 0.7541998624801636,
            "end_logit": -1.4625784158706665,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Small-cell carcinoma of the cervix",
            "probability": 0.0024184570717356853,
            "start_logit": 0.40682458877563477,
            "end_logit": -1.3259671926498413,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervical cancers and <1% of all neuroendocrine tumors.Small-cell carcinoma",
            "probability": 0.002383780225682912,
            "start_logit": -2.752579689025879,
            "end_logit": 1.8189948797225952,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervical",
            "probability": 0.0022781975239571928,
            "start_logit": 2.2197117805480957,
            "end_logit": -3.1985995769500732,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "vical small-cell carcinoma",
            "probability": 0.0018332714289917545,
            "start_logit": -3.781031847000122,
            "end_logit": 2.5848615169525146,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "oma",
            "probability": 0.0011765685969702807,
            "start_logit": -4.224531650543213,
            "end_logit": 2.5848615169525146,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "c",
            "probability": 0.0007307304400541994,
            "start_logit": 2.2197117805480957,
            "end_logit": -4.335694789886475,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cell carcinoma",
            "probability": 0.0006788027732152245,
            "start_logit": -4.7745585441589355,
            "end_logit": 2.5848615169525146,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Neuroendocrine carcinoma",
            "probability": 0.0004504424033481244,
            "start_logit": -1.6349244117736816,
            "end_logit": -0.9648730158805847,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinomas of the cervix",
            "probability": 0.0002725350352694774,
            "start_logit": -1.4792357683181763,
            "end_logit": -1.6230247020721436,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Neuroendocrine carcinomas of the cervix",
            "probability": 0.00023324246438620482,
            "start_logit": -1.6349244117736816,
            "end_logit": -1.6230247020721436,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cancers and <1% of all neuroendocrine tumors.Small-cell carcinoma",
            "probability": 0.0002311256552904141,
            "start_logit": -5.086061000823975,
            "end_logit": 1.8189948797225952,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinomas of the cervix are very rare, accounting for only 1-2% of all cervical cancer",
            "probability": 0.00016367028871690098,
            "start_logit": -1.4792357683181763,
            "end_logit": -2.1329379081726074,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinoma of the cervix",
            "probability": 0.00014534944796787313,
            "start_logit": -2.4049196243286133,
            "end_logit": -1.3259671926498413,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Small-cell carcinoma of the cervix is associated with poor prognosis,",
            "probability": 0.00012835803923981026,
            "start_logit": 0.40682458877563477,
            "end_logit": -4.262028694152832,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        }
    ],
    "54d670163706e8952800000f": [
        {
            "text": "IRX",
            "probability": 0.7167547677840875,
            "start_logit": 2.5856616497039795,
            "end_logit": 2.122081756591797,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX Family",
            "probability": 0.10524529991850294,
            "start_logit": 2.8170697689056396,
            "end_logit": -0.027766304090619087,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes in the etiology of AIS.This study aimed to validate the relationship between the IRX",
            "probability": 0.10078620171851022,
            "start_logit": 2.2817983627319336,
            "end_logit": 0.4642127454280853,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family",
            "probability": 0.029748235999421918,
            "start_logit": 2.5856616497039795,
            "end_logit": -1.0598821640014648,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes",
            "probability": 0.025451395966728005,
            "start_logit": 2.2817983627319336,
            "end_logit": -0.9120181202888489,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes in the etiology of AIS.This study aimed to validate the relationship between the IRX family",
            "probability": 0.006693219078347096,
            "start_logit": 2.2817983627319336,
            "end_logit": -2.2476937770843506,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX Family in Development of Female Adolescent Idiopathic Scoliosis",
            "probability": 0.004613749357041546,
            "start_logit": 2.8170697689056396,
            "end_logit": -3.1550192832946777,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family may have functional roles in the development of adolescent idiopathic scoliosis",
            "probability": 0.002500558684750787,
            "start_logit": 2.5856616497039795,
            "end_logit": -3.536137819290161,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family may have functional roles in the development of adolescent idiopathic scoliosis (AIS).",
            "probability": 0.0015992448653173474,
            "start_logit": 2.5856616497039795,
            "end_logit": -3.9831204414367676,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Role of IRX",
            "probability": 0.0012589004718862732,
            "start_logit": -3.4374818801879883,
            "end_logit": 1.8007302284240723,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "several variants located around the IRX",
            "probability": 0.0008857756165924842,
            "start_logit": -3.800649642944336,
            "end_logit": 1.8123676776885986,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "variants located around the IRX",
            "probability": 0.0007659911887677358,
            "start_logit": -4.255656719207764,
            "end_logit": 2.122081756591797,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Previous studies showed that several variants located around the IRX",
            "probability": 0.0006557734978718174,
            "start_logit": -4.101297855377197,
            "end_logit": 1.8123676776885986,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "5p13.3 and the role of IRX",
            "probability": 0.0005783247380868051,
            "start_logit": -3.271571159362793,
            "end_logit": 0.8569610714912415,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "adolescent idiopathic scoliosis (AIS).Investigating Role of IRX",
            "probability": 0.000566320206289635,
            "start_logit": -4.236316204071045,
            "end_logit": 1.8007302284240723,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "studies showed that several variants located around the IRX",
            "probability": 0.0005144999511796235,
            "start_logit": -4.3439178466796875,
            "end_logit": 1.8123676776885986,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "investigate the target gene of the region, which was associated with AIS.Investigating Role of IRX",
            "probability": 0.0004644749793658221,
            "start_logit": -4.10083532333374,
            "end_logit": 1.4669973850250244,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "role of IRX",
            "probability": 0.00035251190542985426,
            "start_logit": -3.766622304916382,
            "end_logit": 0.8569610714912415,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "target gene of the region, which was associated with AIS.Investigating Role of IRX",
            "probability": 0.00032673850701456534,
            "start_logit": -4.452582836151123,
            "end_logit": 1.4669973850250244,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "role of IRX genes in the etiology of AIS.This study aimed to validate the relationship between the IRX",
            "probability": 0.0002380155648084481,
            "start_logit": -3.766622304916382,
            "end_logit": 0.4642127454280853,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        }
    ],
    "5324cf139b2d7acc7e00001f": [
        {
            "text": "bupropion",
            "probability": 0.37549421006965006,
            "start_logit": 0.8148617744445801,
            "end_logit": -0.20592781901359558,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescriptions are common.We sought to compare the effects of selective serotonin reuptake inhibitors",
            "probability": 0.2074897571921063,
            "start_logit": 0.8148617744445801,
            "end_logit": -0.7990888953208923,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "depression, but off-label bupropion",
            "probability": 0.08197576860085089,
            "start_logit": -0.7069575786590576,
            "end_logit": -0.20592781901359558,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "depression",
            "probability": 0.07540630696885899,
            "start_logit": -0.7069575786590576,
            "end_logit": -0.28946059942245483,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitors",
            "probability": 0.06865649481285045,
            "start_logit": -0.2911044657230377,
            "end_logit": -0.7990888953208923,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescriptions are common",
            "probability": 0.03490584754325663,
            "start_logit": 0.8148617744445801,
            "end_logit": -2.5815165042877197,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescriptions",
            "probability": 0.027444449129491857,
            "start_logit": 0.8148617744445801,
            "end_logit": -2.822006940841675,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescriptions are common.We sought to compare the effects of selective serotonin reuptake inhibitor",
            "probability": 0.02065254525578234,
            "start_logit": 0.8148617744445801,
            "end_logit": -3.106332302093506,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "off-label bupropion",
            "probability": 0.013699352412300655,
            "start_logit": -2.49603271484375,
            "end_logit": -0.20592781901359558,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "prescriptions are common.We sought to compare the effects of selective serotonin reuptake inhibitors",
            "probability": 0.013404420657304805,
            "start_logit": -1.924635648727417,
            "end_logit": -0.7990888953208923,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescriptions are common.We sought to compare the effects of selective",
            "probability": 0.011581755320445399,
            "start_logit": 0.8148617744445801,
            "end_logit": -3.684739828109741,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescription",
            "probability": 0.01098701708468859,
            "start_logit": 0.8148617744445801,
            "end_logit": -3.7374565601348877,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescriptions are common.We sought to compare the effects of selective serotonin reuptake",
            "probability": 0.008046286349548633,
            "start_logit": 0.8148617744445801,
            "end_logit": -4.048960208892822,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "depression, but off-label bupropion prescriptions are common",
            "probability": 0.007620446878506651,
            "start_logit": -0.7069575786590576,
            "end_logit": -2.5815165042877197,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "off-label bupropion prescriptions are common.We sought to compare the effects of selective serotonin reuptake inhibitors",
            "probability": 0.007569957750320865,
            "start_logit": -2.49603271484375,
            "end_logit": -0.7990888953208923,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "pediatric depression, but off-label bupropion",
            "probability": 0.00746927269246342,
            "start_logit": -3.102583646774292,
            "end_logit": -0.20592781901359558,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "escitalopram are the only agents with Food and Drug Administration approval for pediatric depression, but off-label bupropion",
            "probability": 0.0072357728575675314,
            "start_logit": -3.1343441009521484,
            "end_logit": -0.20592781901359558,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "pediatric depression",
            "probability": 0.006870692145924768,
            "start_logit": -3.102583646774292,
            "end_logit": -0.28946059942245483,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitor",
            "probability": 0.006833741508083096,
            "start_logit": -0.2911044657230377,
            "end_logit": -3.106332302093506,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "escitalopram are the only agents with Food and Drug Administration approval for pediatric depression",
            "probability": 0.0066559047699982395,
            "start_logit": -3.1343441009521484,
            "end_logit": -0.28946059942245483,
            "question_text": "List the off-label use of SSRIs"
        }
    ],
    "56be0a18ef6e394741000006": [
        {
            "text": "pleural effusion",
            "probability": 0.39325955857626554,
            "start_logit": 2.89115309715271,
            "end_logit": 1.5787224769592285,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites",
            "probability": 0.3353480823312719,
            "start_logit": 2.1451830863952637,
            "end_logit": 2.165391683578491,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and pleural effusion",
            "probability": 0.18651279404348997,
            "start_logit": 2.1451830863952637,
            "end_logit": 1.5787224769592285,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myocarditis",
            "probability": 0.04518625423330777,
            "start_logit": 1.422171950340271,
            "end_logit": 0.8840267062187195,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myocarditis with the formation of secondary cardiomyopathy",
            "probability": 0.021741237022681263,
            "start_logit": 1.422171950340271,
            "end_logit": 0.15244455635547638,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "cardiomyopathy",
            "probability": 0.010716578359779853,
            "start_logit": 0.7147530913352966,
            "end_logit": 0.15244455635547638,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "p",
            "probability": 0.002846064063522753,
            "start_logit": 2.89115309715271,
            "end_logit": -3.3498103618621826,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and p",
            "probability": 0.0013498142611871266,
            "start_logit": 2.1451830863952637,
            "end_logit": -3.3498103618621826,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion are given.",
            "probability": 0.0007502047430096811,
            "start_logit": 2.89115309715271,
            "end_logit": -4.683156490325928,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "as",
            "probability": 0.0005291712423310267,
            "start_logit": 2.1451830863952637,
            "end_logit": -4.286220550537109,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and pleural effusion are given.",
            "probability": 0.00035580262366662475,
            "start_logit": 2.1451830863952637,
            "end_logit": -4.683156490325928,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "s",
            "probability": 0.00023926679046200623,
            "start_logit": -5.100162029266357,
            "end_logit": 2.165391683578491,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myocarditis with the formation of secondary cardiomyopathy and Demons-Meigs syndrome",
            "probability": 0.00023558440205929786,
            "start_logit": 1.422171950340271,
            "end_logit": -4.372452259063721,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "effusion",
            "probability": 0.0001993676502752006,
            "start_logit": -4.695921421051025,
            "end_logit": 1.5787224769592285,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "usion",
            "probability": 0.00014675977113064905,
            "start_logit": -5.002274990081787,
            "end_logit": 1.5787224769592285,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "s and pleural effusion",
            "probability": 0.00013307461697903243,
            "start_logit": -5.100162029266357,
            "end_logit": 1.5787224769592285,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myopathy",
            "probability": 0.00012451411307617355,
            "start_logit": -3.74037504196167,
            "end_logit": 0.15244455635547638,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "cardiomyopathy and Demons-Meigs syndrome",
            "probability": 0.00011612304775374696,
            "start_logit": 0.7147530913352966,
            "end_logit": -4.372452259063721,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "my",
            "probability": 0.00011324406153969084,
            "start_logit": 1.422171950340271,
            "end_logit": -5.104976177215576,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "cites",
            "probability": 9.65040462111751e-05,
            "start_logit": -6.0081562995910645,
            "end_logit": 2.165391683578491,
            "question_text": "List symptoms of Meigs' Syndrome."
        }
    ],
    "5311b99ae3eabad021000004": [
        {
            "text": "blood urea nitrogen",
            "probability": 0.19851680409283434,
            "start_logit": 5.062407970428467,
            "end_logit": 5.103514194488525,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine",
            "probability": 0.18615877110626164,
            "start_logit": 5.087037563323975,
            "end_logit": 5.014610767364502,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "blood urea nitrogen and creatinine",
            "probability": 0.1816297591657403,
            "start_logit": 5.062407970428467,
            "end_logit": 5.014610767364502,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride as well as blood urea nitrogen",
            "probability": 0.11737690221220215,
            "start_logit": 4.536924362182617,
            "end_logit": 5.103514194488525,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride as well as blood urea nitrogen and creatinine",
            "probability": 0.1073921100928728,
            "start_logit": 4.536924362182617,
            "end_logit": 5.014610767364502,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "urea nitrogen",
            "probability": 0.0364636229265402,
            "start_logit": 3.367849349975586,
            "end_logit": 5.103514194488525,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium and chloride as well as blood urea nitrogen",
            "probability": 0.033444766291000204,
            "start_logit": 3.2814295291900635,
            "end_logit": 5.103514194488525,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "urea nitrogen and creatinine",
            "probability": 0.033361805720792996,
            "start_logit": 3.367849349975586,
            "end_logit": 5.014610767364502,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium and chloride as well as blood urea nitrogen and creatinine",
            "probability": 0.030599751363860003,
            "start_logit": 3.2814295291900635,
            "end_logit": 5.014610767364502,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride",
            "probability": 0.0219934718110687,
            "start_logit": 4.536924362182617,
            "end_logit": 3.4288697242736816,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "chloride as well as blood urea nitrogen",
            "probability": 0.016050697265452447,
            "start_logit": 2.5472865104675293,
            "end_logit": 5.103514194488525,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "chloride as well as blood urea nitrogen and creatinine",
            "probability": 0.014685327481914487,
            "start_logit": 2.5472865104675293,
            "end_logit": 5.014610767364502,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium and chloride",
            "probability": 0.00626670589175275,
            "start_logit": 3.2814295291900635,
            "end_logit": 3.4288697242736816,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium",
            "probability": 0.005668254083959055,
            "start_logit": 4.536924362182617,
            "end_logit": 2.073005199432373,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "chloride",
            "probability": 0.0030074959485429996,
            "start_logit": 2.5472865104675293,
            "end_logit": 3.4288697242736816,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine,",
            "probability": 0.002066926950928673,
            "start_logit": 5.087037563323975,
            "end_logit": 0.5140737891197205,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "blood urea nitrogen and creatinine,",
            "probability": 0.00201664118257453,
            "start_logit": 5.062407970428467,
            "end_logit": 0.5140737891197205,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium",
            "probability": 0.0016150829468415684,
            "start_logit": 3.2814295291900635,
            "end_logit": 2.073005199432373,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride as well as blood urea nitrogen and creatinine,",
            "probability": 0.0011923781262036474,
            "start_logit": 4.536924362182617,
            "end_logit": 0.5140737891197205,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "nitrogen",
            "probability": 0.0004927253386566227,
            "start_logit": -0.9362691640853882,
            "end_logit": 5.103514194488525,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        }
    ],
    "5131fa145274a5fb07000009": [
        {
            "text": "Chorioangiomas",
            "probability": 0.5658986259802523,
            "start_logit": 2.728792428970337,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "chorioangioma",
            "probability": 0.3302845194116286,
            "start_logit": 3.03417706489563,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "Chorioangiomas are generally small and associated with favorable outcomes, but large tumors",
            "probability": 0.043460642594447194,
            "start_logit": 2.728792428970337,
            "end_logit": 1.4800978899002075,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "giant chorioangioma",
            "probability": 0.026402079972163303,
            "start_logit": 0.5076653957366943,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors",
            "probability": 0.017262224618336677,
            "start_logit": 1.8054572343826294,
            "end_logit": 1.4800978899002075,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "chorioangioma causing fetal cardiac failure",
            "probability": 0.0034827064156554804,
            "start_logit": 3.03417706489563,
            "end_logit": -1.3493328094482422,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "orioangiomas",
            "probability": 0.0019690746586194406,
            "start_logit": -2.932058811187744,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "a giant chorioangioma",
            "probability": 0.0019068575038939913,
            "start_logit": -2.1203207969665527,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "mas",
            "probability": 0.0018220535524139524,
            "start_logit": -3.0096583366394043,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "large tumors",
            "probability": 0.0015933349018452101,
            "start_logit": -0.5772340893745422,
            "end_logit": 1.4800978899002075,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "iomas",
            "probability": 0.001396857717423899,
            "start_logit": -3.275397300720215,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cardiac failure on ultrasonography are indications for urgent in utero interventions.We report a case of a giant chorioangioma",
            "probability": 0.001377537888200588,
            "start_logit": -2.44547963142395,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors can cause serious fetal complications, such as polyhydramnios",
            "probability": 0.0010705388633266014,
            "start_logit": 1.8054572343826294,
            "end_logit": -1.3002605438232422,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "Chorioangio",
            "probability": 0.000526459428194058,
            "start_logit": 2.728792428970337,
            "end_logit": -2.9333388805389404,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cardiac failure",
            "probability": 0.00034668162918080457,
            "start_logit": 0.34287136793136597,
            "end_logit": -0.9651852250099182,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "Chorioangiomas are generally small and associated with favorable outcomes, but large tumors can cause serious fetal complications",
            "probability": 0.0003043634574070323,
            "start_logit": 2.728792428970337,
            "end_logit": -3.481290578842163,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "giant chorioangioma causing fetal cardiac failure",
            "probability": 0.00027839843499024376,
            "start_logit": 0.5076653957366943,
            "end_logit": -1.3493328094482422,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors can cause serious fetal complications, such as polyhydramnios, fetal anemia, intrauterine growth restriction",
            "probability": 0.0002277508554217468,
            "start_logit": 1.8054572343826294,
            "end_logit": -2.8479256629943848,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors can cause serious fetal complications, such as polyhydramnios,",
            "probability": 0.00021419533019465228,
            "start_logit": 1.8054572343826294,
            "end_logit": -2.909289598464966,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cardiac failure, fetal hydrops, and intrauterine fetal death",
            "probability": 0.0001750967864041535,
            "start_logit": 0.34287136793136597,
            "end_logit": -1.6482532024383545,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        }
    ],
    "5505eed08e1671127b000006": [
        {
            "text": "trypsin",
            "probability": 0.9929756381870793,
            "start_logit": 5.106217861175537,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "tryps",
            "probability": 0.0025759375404456426,
            "start_logit": 5.106217861175537,
            "end_logit": -1.4140477180480957,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin dig",
            "probability": 0.001906445708178437,
            "start_logit": 5.106217861175537,
            "end_logit": -1.7150206565856934,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion parameters and comparison to in-solution protease",
            "probability": 0.0009198772057850362,
            "start_logit": 5.106217861175537,
            "end_logit": -2.4437763690948486,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "try",
            "probability": 0.0007142152433857135,
            "start_logit": 5.106217861175537,
            "end_logit": -2.6968321800231934,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion",
            "probability": 0.00019279260380013224,
            "start_logit": 5.106217861175537,
            "end_logit": -4.006401538848877,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "alkylation, and protease digestion are performed.Optimization of trypsin",
            "probability": 0.00013549009980561589,
            "start_logit": -3.7933449745178223,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion parameters and comparison to in-solution protease digestion",
            "probability": 0.00013390546248438103,
            "start_logit": 5.106217861175537,
            "end_logit": -4.370882511138916,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "protease digestion are performed.Optimization of trypsin",
            "probability": 8.613823082901487e-05,
            "start_logit": -4.24629020690918,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion parameters",
            "probability": 8.430360434297129e-05,
            "start_logit": 5.106217861175537,
            "end_logit": -4.833591938018799,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "Optimization of trypsin",
            "probability": 6.370571058811228e-05,
            "start_logit": -4.547969341278076,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "in",
            "probability": 6.225478143458782e-05,
            "start_logit": -4.571008205413818,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion parameters and comparison to in-solution",
            "probability": 4.523440275623081e-05,
            "start_logit": 5.106217861175537,
            "end_logit": -5.456158638000488,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "reduction, alkylation, and protease digestion are performed.Optimization of trypsin",
            "probability": 4.2555228942980135e-05,
            "start_logit": -4.951440811157227,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "psin",
            "probability": 3.674836634760292e-05,
            "start_logit": -5.09814977645874,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "in-gel reduction, alkylation, and protease digestion are performed.Optimization of trypsin",
            "probability": 2.2433617993978613e-05,
            "start_logit": -5.5916829109191895,
            "end_logit": 4.540444850921631,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "protease",
            "probability": 1.4889347022933994e-06,
            "start_logit": -1.319961428642273,
            "end_logit": -2.4437763690948486,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "alkylation, and protease digestion are performed.Optimization of tryps",
            "probability": 3.5148297805696775e-07,
            "start_logit": -3.7933449745178223,
            "end_logit": -1.4140477180480957,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "alkylation, and protease digestion are performed.Optimization of trypsin dig",
            "probability": 2.601317790098886e-07,
            "start_logit": -3.7933449745178223,
            "end_logit": -1.7150206565856934,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "protease digestion are performed.Optimization of tryps",
            "probability": 2.2345634064612118e-07,
            "start_logit": -4.24629020690918,
            "end_logit": -1.4140477180480957,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        }
    ],
    "54e1252fae9738404b000003": [
        {
            "text": "classification",
            "probability": 0.17202817389394512,
            "start_logit": -4.085059642791748,
            "end_logit": -3.1053450107574463,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "Hypermobile Ehlers-Danlos syndrome",
            "probability": 0.16206039930241742,
            "start_logit": -1.9378594160079956,
            "end_logit": -5.312234401702881,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "Hypermobile",
            "probability": 0.10769390104882982,
            "start_logit": -1.9378594160079956,
            "end_logit": -5.720910549163818,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "revised Ehlers-Danlos syndrome classification",
            "probability": 0.10532286103820492,
            "start_logit": -4.575687408447266,
            "end_logit": -3.1053450107574463,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification,",
            "probability": 0.05350413255379256,
            "start_logit": -4.085059642791748,
            "end_logit": -4.273244380950928,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification, an update much needed since Villefranche nosology,",
            "probability": 0.043289109869162866,
            "start_logit": -4.085059642791748,
            "end_logit": -4.48510217666626,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "a revised Ehlers-Danlos syndrome classification",
            "probability": 0.04311262151636201,
            "start_logit": -5.468902111053467,
            "end_logit": -3.1053450107574463,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification, an update much needed since Villefranche nosology, in 1998",
            "probability": 0.04272357536072123,
            "start_logit": -4.085059642791748,
            "end_logit": -4.4982523918151855,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification, an update much needed since Villefranche nosology",
            "probability": 0.04037775681278557,
            "start_logit": -4.085059642791748,
            "end_logit": -4.554724216461182,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "revised Ehlers-Danlos syndrome classification,",
            "probability": 0.03275747332763574,
            "start_logit": -4.575687408447266,
            "end_logit": -4.273244380950928,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "revised Ehlers-Danlos syndrome classification, an update much needed since Villefranche nosology,",
            "probability": 0.026503408133764426,
            "start_logit": -4.575687408447266,
            "end_logit": -4.48510217666626,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "revised Ehlers-Danlos syndrome classification, an update much needed since Villefranche nosology, in 1998",
            "probability": 0.026157164195363795,
            "start_logit": -4.575687408447266,
            "end_logit": -4.4982523918151855,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "revised Ehlers-Danlos syndrome classification, an update much needed since Villefranche nosology",
            "probability": 0.024720955722341297,
            "start_logit": -4.575687408447266,
            "end_logit": -4.554724216461182,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "proposed a revised Ehlers-Danlos syndrome classification",
            "probability": 0.020523706099473998,
            "start_logit": -6.211137294769287,
            "end_logit": -3.1053450107574463,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification, an update much needed since Villefranche nosology, in 1998.Hypermobile Ehlers-Danlos syndrome",
            "probability": 0.01893039581040502,
            "start_logit": -4.085059642791748,
            "end_logit": -5.312234401702881,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "revised",
            "probability": 0.018765326016395613,
            "start_logit": -4.575687408447266,
            "end_logit": -4.83036470413208,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "1998",
            "probability": 0.016780936568552726,
            "start_logit": -5.019567012786865,
            "end_logit": -4.4982523918151855,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "A recent international consortium proposed a revised Ehlers-Danlos syndrome classification",
            "probability": 0.01554573387354262,
            "start_logit": -6.488931655883789,
            "end_logit": -3.1053450107574463,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hypermobile Ehlers-Danlos syndrome",
            "probability": 0.015371879123044753,
            "start_logit": -4.047727108001709,
            "end_logit": -5.557796001434326,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification, an update",
            "probability": 0.01383048973325847,
            "start_logit": -4.085059642791748,
            "end_logit": -5.62612771987915,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        }
    ],
    "517a8bef8ed59a060a000041": [
        {
            "text": "iodothyronine deiodinase (Dlk1-Dio3",
            "probability": 0.21616592736935134,
            "start_logit": 3.618699789047241,
            "end_logit": 2.654893398284912,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk1-Dio3",
            "probability": 0.20040905554327565,
            "start_logit": 3.5430140495300293,
            "end_logit": 2.654893398284912,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk1",
            "probability": 0.17585121553118524,
            "start_logit": 3.618699789047241,
            "end_logit": 2.4484853744506836,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk1",
            "probability": 0.1630329832718058,
            "start_logit": 3.5430140495300293,
            "end_logit": 2.4484853744506836,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "type III iodothyronine deiodinase (Dlk1-Dio3",
            "probability": 0.05650729932671473,
            "start_logit": 2.2770233154296875,
            "end_logit": 2.654893398284912,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "type III iodothyronine deiodinase (Dlk1",
            "probability": 0.045968749071210895,
            "start_logit": 2.2770233154296875,
            "end_logit": 2.4484853744506836,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dio3",
            "probability": 0.03818071868156458,
            "start_logit": 1.8849841356277466,
            "end_logit": 2.654893398284912,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase",
            "probability": 0.014027763493521549,
            "start_logit": 3.618699789047241,
            "end_logit": -0.08011442422866821,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine",
            "probability": 0.012719648029269013,
            "start_logit": 3.618699789047241,
            "end_logit": -0.17800500988960266,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "type III",
            "probability": 0.011165413615884683,
            "start_logit": 2.2770233154296875,
            "end_logit": 1.0333445072174072,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk",
            "probability": 0.009840831459010626,
            "start_logit": 3.618699789047241,
            "end_logit": -0.4346126914024353,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "i",
            "probability": 0.009522885172970319,
            "start_logit": 3.618699789047241,
            "end_logit": -0.46745502948760986,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk",
            "probability": 0.009123508790037455,
            "start_logit": 3.5430140495300293,
            "end_logit": -0.4346126914024353,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk1-Dio3)",
            "probability": 0.007212648439707278,
            "start_logit": 3.618699789047241,
            "end_logit": -0.7453166842460632,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk1-Dio3)",
            "probability": 0.006686900564572328,
            "start_logit": 3.5430140495300293,
            "end_logit": -0.7453166842460632,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "(Dlk1-Dio3",
            "probability": 0.005914363694694144,
            "start_logit": 0.020037410780787468,
            "end_logit": 2.654893398284912,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "(Dlk1",
            "probability": 0.004811341257442491,
            "start_logit": 0.020037410780787468,
            "end_logit": 2.4484853744506836,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk1-Dio",
            "probability": 0.00476973402979376,
            "start_logit": 3.618699789047241,
            "end_logit": -1.1588623523712158,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk1-Dio",
            "probability": 0.004422056258988019,
            "start_logit": 3.5430140495300293,
            "end_logit": -1.1588623523712158,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "type III iodothyronine deiodinase",
            "probability": 0.0036669563989998686,
            "start_logit": 2.2770233154296875,
            "end_logit": -0.08011442422866821,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        }
    ],
    "5148885ad24251bc05000032": [
        {
            "text": "VKORC1 and CYP2C9",
            "probability": 0.13473327089363235,
            "start_logit": 4.407799243927002,
            "end_logit": 3.7183308601379395,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes.Studies implicate that polymorphisms in VKORC1 and CYP2C9",
            "probability": 0.1329709422804388,
            "start_logit": 4.394632816314697,
            "end_logit": 3.7183308601379395,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1",
            "probability": 0.13224368018057372,
            "start_logit": 4.407799243927002,
            "end_logit": 3.6996800899505615,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes.Studies implicate that polymorphisms in VKORC1",
            "probability": 0.1305139157359754,
            "start_logit": 4.394632816314697,
            "end_logit": 3.6996800899505615,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9",
            "probability": 0.12922427786036425,
            "start_logit": 4.36605167388916,
            "end_logit": 3.7183308601379395,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1 genes.Studies implicate that polymorphisms in VKORC1",
            "probability": 0.10946346491879559,
            "start_logit": 4.218743801116943,
            "end_logit": 3.6996800899505615,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1",
            "probability": 0.09214489328097872,
            "start_logit": 4.218743801116943,
            "end_logit": 3.527451515197754,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes.Effect of CYP2C9 and VKORC1",
            "probability": 0.036505850472652056,
            "start_logit": 3.770878791809082,
            "end_logit": 3.049426794052124,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes.Effect of CYP2C9",
            "probability": 0.025214205873795695,
            "start_logit": 3.770878791809082,
            "end_logit": 2.6793618202209473,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1 genes.Effect of CYP2C9 and VKORC1",
            "probability": 0.024472783140963274,
            "start_logit": 3.3709678649902344,
            "end_logit": 3.049426794052124,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1 genes.Effect of CYP2C9",
            "probability": 0.01690309318730348,
            "start_logit": 3.3709678649902344,
            "end_logit": 2.6793618202209473,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 and CYP2C9 genes",
            "probability": 0.009592160408839256,
            "start_logit": 4.407799243927002,
            "end_logit": 1.0759799480438232,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes.Studies implicate that polymorphisms in VKORC1 and CYP2C9 genes",
            "probability": 0.00946669370979218,
            "start_logit": 4.394632816314697,
            "end_logit": 1.0759799480438232,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 genes",
            "probability": 0.009199954797591212,
            "start_logit": 4.36605167388916,
            "end_logit": 1.0759799480438232,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC",
            "probability": 0.002048173592596199,
            "start_logit": 4.407799243927002,
            "end_logit": -0.46801772713661194,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes.Studies implicate that polymorphisms in VKORC",
            "probability": 0.002021383217041008,
            "start_logit": 4.394632816314697,
            "end_logit": -0.46801772713661194,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1 genes.Studies implicate that polymorphisms in VKORC",
            "probability": 0.0016953564653873873,
            "start_logit": 4.218743801116943,
            "end_logit": -0.46801772713661194,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC",
            "probability": 0.0010333809340426438,
            "start_logit": 4.218743801116943,
            "end_logit": -0.9630748629570007,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "polymorphisms in VKORC1 and CYP2C9",
            "probability": 0.00027883567639534935,
            "start_logit": -1.7726304531097412,
            "end_logit": 3.7183308601379395,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "polymorphisms in VKORC1",
            "probability": 0.0002736833728416761,
            "start_logit": -1.7726304531097412,
            "end_logit": 3.6996800899505615,
            "question_text": "Which genes are involved in patient response to warfarin?"
        }
    ],
    "571e189dbb137a4b0c000003": [
        {
            "text": "acute kidney injury",
            "probability": 0.4684696169006187,
            "start_logit": -1.9745490550994873,
            "end_logit": -2.5043718814849854,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "numerous reports of acute kidney injury",
            "probability": 0.06963084593274597,
            "start_logit": -3.880812644958496,
            "end_logit": -2.5043718814849854,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "acute kidney injury, including need for dialysis",
            "probability": 0.059584893077127034,
            "start_logit": -1.9745490550994873,
            "end_logit": -4.566441059112549,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "acute kidney injury, including need for dialysis and death",
            "probability": 0.05352625924292442,
            "start_logit": -1.9745490550994873,
            "end_logit": -4.673670768737793,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "reports of acute kidney injury",
            "probability": 0.05069359508744928,
            "start_logit": -4.198220729827881,
            "end_logit": -2.5043718814849854,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "kidney injury",
            "probability": 0.048664503689285585,
            "start_logit": -4.239070415496826,
            "end_logit": -2.5043718814849854,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "acute kidney injury, including need for dialysis and death, have been reported to the FDA adverse events reporting system",
            "probability": 0.04163789895657964,
            "start_logit": -1.9745490550994873,
            "end_logit": -4.924832344055176,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "acute kidney injury, including need for dialysis and death, have been reported to the FDA adverse events reporting system raising concern",
            "probability": 0.032923324545282885,
            "start_logit": -1.9745490550994873,
            "end_logit": -5.159661769866943,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "acute kidney injury, including need for dialysis and death,",
            "probability": 0.029927782357188893,
            "start_logit": -1.9745490550994873,
            "end_logit": -5.255055904388428,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium",
            "probability": 0.02433305238547277,
            "start_logit": -2.939647912979126,
            "end_logit": -4.496908664703369,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "acute kidney injury, including need for dialysis and death, have been reported to the FDA adverse events",
            "probability": 0.023879186328125933,
            "start_logit": -1.9745490550994873,
            "end_logit": -5.480835914611816,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "acute kidney injury,",
            "probability": 0.023570810669651086,
            "start_logit": -1.9745490550994873,
            "end_logit": -5.493834018707275,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor drugs are effective for treatment of type-2 diabetes mellitus",
            "probability": 0.014734482843370976,
            "start_logit": -2.939647912979126,
            "end_logit": -4.99855375289917,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor drugs",
            "probability": 0.012554091974532762,
            "start_logit": -2.939647912979126,
            "end_logit": -5.158697605133057,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2",
            "probability": 0.0102311675413901,
            "start_logit": -2.939647912979126,
            "end_logit": -5.363305568695068,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "numerous reports of acute kidney injury, including need for dialysis",
            "probability": 0.008856383338629053,
            "start_logit": -3.880812644958496,
            "end_logit": -4.566441059112549,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "numerous reports of acute kidney injury, including need for dialysis and death",
            "probability": 0.007955860052053182,
            "start_logit": -3.880812644958496,
            "end_logit": -4.673670768737793,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "reports of acute kidney injury, including need for dialysis",
            "probability": 0.006447744600738158,
            "start_logit": -4.198220729827881,
            "end_logit": -4.566441059112549,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "kidney injury, including need for dialysis",
            "probability": 0.006189663415445515,
            "start_logit": -4.239070415496826,
            "end_logit": -4.566441059112549,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "numerous reports of acute kidney injury, including need for dialysis and death, have been reported to the FDA adverse events reporting system",
            "probability": 0.006188837061388115,
            "start_logit": -3.880812644958496,
            "end_logit": -4.924832344055176,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        }
    ],
    "52bf1f4503868f1b06000016": [
        {
            "text": "deep venous thrombosis",
            "probability": 0.41226982647457383,
            "start_logit": -0.11965285241603851,
            "end_logit": -0.2543717324733734,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenic",
            "probability": 0.16292663752427883,
            "start_logit": 1.43256676197052,
            "end_logit": -2.7349693775177,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis and pulmonary embolism",
            "probability": 0.10183916760201471,
            "start_logit": -0.11965285241603851,
            "end_logit": -1.652655005455017,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenic patients",
            "probability": 0.08954250812621321,
            "start_logit": 1.43256676197052,
            "end_logit": -3.3335559368133545,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism",
            "probability": 0.07547562460003243,
            "start_logit": -0.41923788189888,
            "end_logit": -1.652655005455017,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schi",
            "probability": 0.0704133087974143,
            "start_logit": 1.43256676197052,
            "end_logit": -3.5738871097564697,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizo",
            "probability": 0.016151945629395134,
            "start_logit": 1.43256676197052,
            "end_logit": -5.046228885650635,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "s",
            "probability": 0.014806995669151161,
            "start_logit": 1.43256676197052,
            "end_logit": -5.133169651031494,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "venous thromboembolism",
            "probability": 0.009561733380994109,
            "start_logit": -1.0255805253982544,
            "end_logit": -3.1123530864715576,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "cardiovascular conditions in schizophrenic",
            "probability": 0.009395592826749706,
            "start_logit": -1.4204925298690796,
            "end_logit": -2.7349693775177,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "cardiovascular conditions",
            "probability": 0.007628909473774136,
            "start_logit": -1.4204925298690796,
            "end_logit": -2.943265199661255,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "thromboembolism",
            "probability": 0.006268139970057355,
            "start_logit": -1.7839769124984741,
            "end_logit": -2.7762460708618164,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "cardiovascular conditions in schizophrenic patients",
            "probability": 0.005163704105256929,
            "start_logit": -1.4204925298690796,
            "end_logit": -3.3335559368133545,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "thrombosis",
            "probability": 0.004875117966831343,
            "start_logit": -4.557186603546143,
            "end_logit": -0.2543717324733734,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "cardiovascular conditions in schi",
            "probability": 0.004060568542366879,
            "start_logit": -1.4204925298690796,
            "end_logit": -3.5738871097564697,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis and pulmonary embolism.Before atypical neuroleptic treatment is administered to hospitalized patients",
            "probability": 0.0025676839439033373,
            "start_logit": -0.11965285241603851,
            "end_logit": -5.333045482635498,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "is",
            "probability": 0.0021706300011742562,
            "start_logit": -5.366313457489014,
            "end_logit": -0.2543717324733734,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism.Before atypical neuroleptic treatment is administered to hospitalized patients",
            "probability": 0.0019029765659410703,
            "start_logit": -0.41923788189888,
            "end_logit": -5.333045482635498,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "venous thrombosis",
            "probability": 0.0017746739070336741,
            "start_logit": -5.567714214324951,
            "end_logit": -0.2543717324733734,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "thrombosis and pulmonary embolism",
            "probability": 0.0012042548928434616,
            "start_logit": -4.557186603546143,
            "end_logit": -1.652655005455017,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        }
    ],
    "52eeddfcc8da898910000010": [
        {
            "text": "periodic paralysis",
            "probability": 0.2194776967784509,
            "start_logit": 6.1606221199035645,
            "end_logit": 6.2418951988220215,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia",
            "probability": 0.1878427633382736,
            "start_logit": 6.1606221199035645,
            "end_logit": 6.086249828338623,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia",
            "probability": 0.14212419477989444,
            "start_logit": 5.881718158721924,
            "end_logit": 6.086249828338623,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia characterized by QT prolongation, and dysmorphic features",
            "probability": 0.11671027527608709,
            "start_logit": 6.1606221199035645,
            "end_logit": 5.610339164733887,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia characterized by QT prolongation, and dysmorphic features",
            "probability": 0.08830446061040229,
            "start_logit": 5.881718158721924,
            "end_logit": 5.610339164733887,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "dysmorphic features",
            "probability": 0.06263231917551289,
            "start_logit": 5.538208961486816,
            "end_logit": 5.610339164733887,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia characterized by QT prolongation",
            "probability": 0.0580219589217828,
            "start_logit": 6.1606221199035645,
            "end_logit": 4.911466121673584,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia characterized by QT prolongation",
            "probability": 0.04390014310245337,
            "start_logit": 5.881718158721924,
            "end_logit": 4.911466121673584,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "skeletal muscle channelopathy with autosomal dominant inheritance resulting in periodic paralysis",
            "probability": 0.021560604521148826,
            "start_logit": 3.8402392864227295,
            "end_logit": 6.2418951988220215,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "skeletal muscle channelopathy with autosomal dominant inheritance resulting in periodic paralysis, arrhythmia",
            "probability": 0.01845291613655167,
            "start_logit": 3.8402392864227295,
            "end_logit": 6.086249828338623,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia characterized by QT prolongation, and dysmorphic",
            "probability": 0.0068629358000564045,
            "start_logit": 6.1606221199035645,
            "end_logit": 2.776779890060425,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "QT prolongation, and dysmorphic features",
            "probability": 0.006494579284796619,
            "start_logit": 3.271895408630371,
            "end_logit": 5.610339164733887,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "skeletal muscle channelopathy with autosomal dominant inheritance resulting in periodic paralysis, arrhythmia characterized by QT prolongation",
            "probability": 0.005699843438386803,
            "start_logit": 3.8402392864227295,
            "end_logit": 4.911466121673584,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia characterized by QT prolongation, and dysmorphic",
            "probability": 0.005192583451578666,
            "start_logit": 5.881718158721924,
            "end_logit": 2.776779890060425,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "episodic paralytic attacks and/or arrhythmia",
            "probability": 0.00392696179625464,
            "start_logit": 3.8918285369873047,
            "end_logit": 4.487304210662842,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "dysmorphic",
            "probability": 0.003682979793281813,
            "start_logit": 5.538208961486816,
            "end_logit": 2.776779890060425,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "QT prolongation",
            "probability": 0.0032287492389621647,
            "start_logit": 3.271895408630371,
            "end_logit": 4.911466121673584,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "paralytic attacks and/or arrhythmia",
            "probability": 0.00212323810515796,
            "start_logit": 3.276904821395874,
            "end_logit": 4.487304210662842,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "episodic paralytic attacks",
            "probability": 0.002035876221945778,
            "start_logit": 3.8918285369873047,
            "end_logit": 3.830364465713501,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis,",
            "probability": 0.0017249202290209559,
            "start_logit": 6.1606221199035645,
            "end_logit": 1.3958253860473633,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        }
    ],
    "56f56a8609dd18d46b00000b": [
        {
            "text": "ABCA12",
            "probability": 0.671326132054309,
            "start_logit": 3.799251079559326,
            "end_logit": 2.766789197921753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ABCA12 gene",
            "probability": 0.3204384332910683,
            "start_logit": 3.799251079559326,
            "end_logit": 2.02722430229187,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "12",
            "probability": 0.0016572616899319657,
            "start_logit": -2.2048373222351074,
            "end_logit": 2.766789197921753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "BCA12",
            "probability": 0.0012825468765689596,
            "start_logit": -2.461156129837036,
            "end_logit": 2.766789197921753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "A",
            "probability": 0.0009904185041221963,
            "start_logit": 3.799251079559326,
            "end_logit": -3.752093553543091,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "the ABCA12",
            "probability": 0.0009443294531611758,
            "start_logit": -2.7672841548919678,
            "end_logit": 2.766789197921753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "12 gene",
            "probability": 0.0007910467269463396,
            "start_logit": -2.2048373222351074,
            "end_logit": 2.02722430229187,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "BCA12 gene",
            "probability": 0.0006121872695354325,
            "start_logit": -2.461156129837036,
            "end_logit": 2.02722430229187,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "the ABCA12 gene",
            "probability": 0.0004507488030528488,
            "start_logit": -2.7672841548919678,
            "end_logit": 2.02722430229187,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ABCA",
            "probability": 0.0003832396998143266,
            "start_logit": 3.799251079559326,
            "end_logit": -4.7015604972839355,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "CA12",
            "probability": 0.00036645347369689495,
            "start_logit": -3.7138876914978027,
            "end_logit": 2.766789197921753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "gene",
            "probability": 0.0002443751300304572,
            "start_logit": -3.3794898986816406,
            "end_logit": 2.02722430229187,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "CA12 gene",
            "probability": 0.00017491614191476643,
            "start_logit": -3.7138876914978027,
            "end_logit": 2.02722430229187,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ABCA12 gene have a premature termination codon mutation",
            "probability": 8.217909948619404e-05,
            "start_logit": 3.799251079559326,
            "end_logit": -6.2413201332092285,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ABCA12 gene have a premature termination codon mutation on one allele and a silent variant on the second.",
            "probability": 6.98834478668279e-05,
            "start_logit": 3.799251079559326,
            "end_logit": -6.403392314910889,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "keratinopathic ichthyosis",
            "probability": 4.3541129133365244e-05,
            "start_logit": -1.2582036256790161,
            "end_logit": -1.8190604448318481,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ichthyosis",
            "probability": 4.338128572904473e-05,
            "start_logit": -1.2618814706802368,
            "end_logit": -1.8190604448318481,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "autosomal recessive congenital ichthyosis, keratinopathic ichthyosis",
            "probability": 3.60429263737738e-05,
            "start_logit": -1.4471989870071411,
            "end_logit": -1.8190604448318481,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ichthyosis, keratinopathic ichthyosis",
            "probability": 3.3016845133075546e-05,
            "start_logit": -1.5348917245864868,
            "end_logit": -1.8190604448318481,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "autosomal recessive congenital ichthyosis",
            "probability": 2.9866152124905217e-05,
            "start_logit": -1.4471989870071411,
            "end_logit": -2.007045269012451,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        }
    ],
    "532c0c21d6d3ac6a3400001b": [
        {
            "text": "three-dimensional molecular alignment",
            "probability": 0.5330509183933069,
            "start_logit": 4.309594631195068,
            "end_logit": 4.484714984893799,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular alignment",
            "probability": 0.19668338954233655,
            "start_logit": 3.312572956085205,
            "end_logit": 4.484714984893799,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three-dimensional molecular alignment",
            "probability": 0.14805713067009052,
            "start_logit": 3.028575897216797,
            "end_logit": 4.484714984893799,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "alignment",
            "probability": 0.038354197853912905,
            "start_logit": 1.6778416633605957,
            "end_logit": 4.484714984893799,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.02130148740619586,
            "start_logit": 4.309594631195068,
            "end_logit": 1.2648749351501465,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular",
            "probability": 0.013886099854681876,
            "start_logit": 4.309594631195068,
            "end_logit": 0.8369863629341125,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.007859753357094304,
            "start_logit": 3.312572956085205,
            "end_logit": 1.2648749351501465,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.005916577564245741,
            "start_logit": 3.028575897216797,
            "end_logit": 1.2648749351501465,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three",
            "probability": 0.005818952339047827,
            "start_logit": 4.309594631195068,
            "end_logit": -0.032781731337308884,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular",
            "probability": 0.0051236478405746085,
            "start_logit": 3.312572956085205,
            "end_logit": 0.8369863629341125,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing.",
            "probability": 0.004409498522317019,
            "start_logit": 4.309594631195068,
            "end_logit": -0.310140997171402,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three-dimensional molecular",
            "probability": 0.0038569225373055356,
            "start_logit": 3.028575897216797,
            "end_logit": 0.8369863629341125,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "dimensional molecular alignment",
            "probability": 0.003312568439200845,
            "start_logit": -0.7712984681129456,
            "end_logit": 4.484714984893799,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional",
            "probability": 0.0022423608396540816,
            "start_logit": 4.309594631195068,
            "end_logit": -0.986372709274292,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods",
            "probability": 0.0020298699727518124,
            "start_logit": 3.028575897216797,
            "end_logit": 0.19508850574493408,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "superimposing",
            "probability": 0.0018640572967157474,
            "start_logit": 1.8735731840133667,
            "end_logit": 1.2648749351501465,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular alignment generally treat all pharmacophore features equally when superimposing.",
            "probability": 0.0016270023849979081,
            "start_logit": 3.312572956085205,
            "end_logit": -0.310140997171402,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three",
            "probability": 0.0016162384438286534,
            "start_logit": 3.028575897216797,
            "end_logit": -0.032781731337308884,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.0015326893442420683,
            "start_logit": 1.6778416633605957,
            "end_logit": 1.2648749351501465,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular alignment generally treat all pharmacophore features equally when super",
            "probability": 0.001456637397499054,
            "start_logit": 4.309594631195068,
            "end_logit": -1.417771339416504,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        }
    ],
    "5166f41a298dcd4e5100005b": [
        {
            "text": "SAHA",
            "probability": 0.3369207350746171,
            "start_logit": 5.499922275543213,
            "end_logit": 5.42368745803833,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5-Aza",
            "probability": 0.302037125764014,
            "start_logit": 5.589863300323486,
            "end_logit": 5.2244486808776855,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5-Aza",
            "probability": 0.27605742841285313,
            "start_logit": 5.499922275543213,
            "end_logit": 5.2244486808776855,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5-Aza)",
            "probability": 0.019628315031689193,
            "start_logit": 5.589863300323486,
            "end_logit": 2.4908719062805176,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5-Aza)",
            "probability": 0.017939987205278382,
            "start_logit": 5.499922275543213,
            "end_logit": 2.4908719062805176,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA)",
            "probability": 0.010801522139691386,
            "start_logit": 5.499922275543213,
            "end_logit": 1.9835268259048462,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(SAHA",
            "probability": 0.010711102084947337,
            "start_logit": 2.0513553619384766,
            "end_logit": 5.42368745803833,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(SAHA) and DNA methyltransferase inhibitor (5-Aza",
            "probability": 0.008776186768033904,
            "start_logit": 2.0513553619384766,
            "end_logit": 5.2244486808776855,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(5-Aza",
            "probability": 0.005796915693362243,
            "start_logit": 1.6366393566131592,
            "end_logit": 5.2244486808776855,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor",
            "probability": 0.0038018467697013138,
            "start_logit": 5.499922275543213,
            "end_logit": 0.9393267035484314,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5",
            "probability": 0.0014318242002877317,
            "start_logit": 5.589863300323486,
            "end_logit": -0.1271519660949707,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5",
            "probability": 0.0013086659650560573,
            "start_logit": 5.499922275543213,
            "end_logit": -0.1271519660949707,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "DNA methyltransferase inhibitor (5-Aza",
            "probability": 0.001130296205653883,
            "start_logit": 0.0017930847825482488,
            "end_logit": 5.2244486808776855,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA",
            "probability": 0.0007567583275676767,
            "start_logit": 5.499922275543213,
            "end_logit": -0.674871563911438,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "Aza",
            "probability": 0.0006189389645513111,
            "start_logit": -0.6004352569580078,
            "end_logit": 5.2244486808776855,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(SAHA) and DNA methyltransferase inhibitor (5-Aza)",
            "probability": 0.000570333061620055,
            "start_logit": 2.0513553619384766,
            "end_logit": 2.4908719062805176,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5-Aza),",
            "probability": 0.000514813320811872,
            "start_logit": 5.589863300323486,
            "end_logit": -1.1500521898269653,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5-Aza),",
            "probability": 0.0004705316973749956,
            "start_logit": 5.499922275543213,
            "end_logit": -1.1500521898269653,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(5-Aza)",
            "probability": 0.00037672086553478185,
            "start_logit": 1.6366393566131592,
            "end_logit": 2.4908719062805176,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "histone deacetylase inhibitor (SAHA",
            "probability": 0.0003499524473535097,
            "start_logit": -1.369883418083191,
            "end_logit": 5.42368745803833,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        }
    ],
    "517539af8ed59a060a000026": [
        {
            "text": "PGC-1\u03b1",
            "probability": 0.3580576811655907,
            "start_logit": 5.480105400085449,
            "end_logit": 3.8538413047790527,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1",
            "probability": 0.3061899544145187,
            "start_logit": 4.992107391357422,
            "end_logit": 4.1853508949279785,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1 regulated mitochondrial",
            "probability": 0.0873155335260305,
            "start_logit": 4.992107391357422,
            "end_logit": 2.930673599243164,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC-1",
            "probability": 0.08594734298004102,
            "start_logit": 5.480105400085449,
            "end_logit": 2.426882028579712,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1 regulated mitochondrial gene",
            "probability": 0.03265345830618885,
            "start_logit": 4.992107391357422,
            "end_logit": 1.9470959901809692,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial",
            "probability": 0.031040924907352226,
            "start_logit": 3.957885503768921,
            "end_logit": 2.930673599243164,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1 regulated mitochondrial gene expression",
            "probability": 0.020811646295339374,
            "start_logit": 4.992107391357422,
            "end_logit": 1.4966579675674438,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1 was induced in mouse and human failing hearts associated with induced expression of mitochondrial genes.SENP1",
            "probability": 0.020127975488831423,
            "start_logit": 3.1123549938201904,
            "end_logit": 3.343008279800415,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression by de-SUMOylation of MEF-2C, which enhanced MEF-2C-mediated PGC-1",
            "probability": 0.01875602288708376,
            "start_logit": 3.957885503768921,
            "end_logit": 2.426882028579712,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene",
            "probability": 0.01160839894479477,
            "start_logit": 3.957885503768921,
            "end_logit": 1.9470959901809692,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC-1\u03b1 transcription",
            "probability": 0.008135009513282573,
            "start_logit": 5.480105400085449,
            "end_logit": 0.06932412087917328,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression",
            "probability": 0.00739860049826547,
            "start_logit": 3.957885503768921,
            "end_logit": 1.4966579675674438,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MEF-2C-mediated PGC-1\u03b1",
            "probability": 0.005374771958356063,
            "start_logit": 1.2811274528503418,
            "end_logit": 3.8538413047790527,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC-1\u03b1 transcription.",
            "probability": 0.00166488218704696,
            "start_logit": 5.480105400085449,
            "end_logit": -1.5170984268188477,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1 regulated mitochondrial gene expression by de-SUMOylation of MEF-2C, which enhanced MEF-2C",
            "probability": 0.0015103062588638174,
            "start_logit": 4.992107391357422,
            "end_logit": -1.126542329788208,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MEF-2C-mediated PGC-1",
            "probability": 0.0012901479098019928,
            "start_logit": 1.2811274528503418,
            "end_logit": 2.426882028579712,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1 regulated mitochondrial gene expression by de-SUMOylation of MEF-2C,",
            "probability": 0.000739009138723187,
            "start_logit": 4.992107391357422,
            "end_logit": -1.8412997722625732,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression by de-SUMOylation of MEF-2C, which enhanced MEF-2C",
            "probability": 0.0005369182466773748,
            "start_logit": 3.957885503768921,
            "end_logit": -1.126542329788208,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC",
            "probability": 0.0004348814939055326,
            "start_logit": 5.480105400085449,
            "end_logit": -2.859534502029419,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial genes.SENP1",
            "probability": 0.0004065338793055617,
            "start_logit": -0.7898436784744263,
            "end_logit": 3.343008279800415,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        }
    ],
    "52d2818403868f1b06000033": [
        {
            "text": "Kymriah",
            "probability": 0.9801021521868949,
            "start_logit": 0.7199863195419312,
            "end_logit": 0.4596605598926544,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(e.g.Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122,",
            "probability": 0.004026462318436147,
            "start_logit": 0.7199863195419312,
            "end_logit": -5.0351080894470215,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(e.g.Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122, for \u03b2-thalassemia treatment)",
            "probability": 0.003243037590981914,
            "start_logit": 0.7199863195419312,
            "end_logit": -5.251485824584961,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah,",
            "probability": 0.003047765129812496,
            "start_logit": 0.7199863195419312,
            "end_logit": -5.313587665557861,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "K",
            "probability": 0.0021308446461765023,
            "start_logit": 0.7199863195419312,
            "end_logit": -5.671477794647217,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(e.g.Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122, for \u03b2-thalassemia",
            "probability": 0.0017027632904114626,
            "start_logit": 0.7199863195419312,
            "end_logit": -5.8957438468933105,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia treatment",
            "probability": 0.001684010801866596,
            "start_logit": 0.7199863195419312,
            "end_logit": -5.90681791305542,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia treatment;",
            "probability": 0.0016375868934308709,
            "start_logit": 0.7199863195419312,
            "end_logit": -5.934772491455078,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia",
            "probability": 0.0015222884132057462,
            "start_logit": 0.7199863195419312,
            "end_logit": -6.007781505584717,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "h",
            "probability": 0.0006808917291485449,
            "start_logit": -6.552022457122803,
            "end_logit": 0.4596605598926544,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LentiGlobin\u2122, for \u03b2-thalassemia treatment) reinforced the need to improve their bioprocess manufacturing.Kymriah,",
            "probability": 5.733371191357501e-05,
            "start_logit": -4.429274082183838,
            "end_logit": -4.13760232925415,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "manufacturing.Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122,",
            "probability": 3.885198434479698e-05,
            "start_logit": -3.2075772285461426,
            "end_logit": -5.748428821563721,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "manufacturing.Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122, for \u03b2-thalassemia treatment)",
            "probability": 3.0270395425409488e-05,
            "start_logit": -3.2075772285461426,
            "end_logit": -5.99801778793335,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LentiGlobin\u2122,",
            "probability": 2.336836141202532e-05,
            "start_logit": -4.429274082183838,
            "end_logit": -5.0351080894470215,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "\u03b2-thalassemia treatment) reinforced the need to improve their bioprocess manufacturing.Kymriah",
            "probability": 2.1859953301749852e-05,
            "start_logit": -5.3935065269470215,
            "end_logit": -4.13760232925415,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LentiGlobin\u2122, for \u03b2-thalassemia treatment)",
            "probability": 1.8821602812933693e-05,
            "start_logit": -4.429274082183838,
            "end_logit": -5.251485824584961,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LentiGlobin\u2122, for \u03b2-thalassemia",
            "probability": 9.882319719539554e-06,
            "start_logit": -4.429274082183838,
            "end_logit": -5.8957438468933105,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "treatment) reinforced the need to improve their bioprocess manufacturing.Kymriah",
            "probability": 9.402117752623267e-06,
            "start_logit": -6.237227916717529,
            "end_logit": -4.13760232925415,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "\u03b2-thalassemia treatment",
            "probability": 7.176220496154494e-06,
            "start_logit": -5.3935065269470215,
            "end_logit": -5.251485824584961,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LentiGlobin\u2122, for \u03b2-thalassemia treatment) reinforced the need to improve their bioprocess manufacturing.",
            "probability": 5.230332456203314e-06,
            "start_logit": -5.791576862335205,
            "end_logit": -5.169713497161865,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        }
    ],
    "571cd9537de986d80d00000e": [
        {
            "text": "gasdermin D reveals a region recognized by inflammatory caspase-11",
            "probability": 0.3800433566635954,
            "start_logit": 3.5390548706054688,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-11",
            "probability": 0.2921892414527911,
            "start_logit": 3.2761712074279785,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D",
            "probability": 0.23641183673150412,
            "start_logit": 3.5390548706054688,
            "end_logit": 2.9189915657043457,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin",
            "probability": 0.05967899383032378,
            "start_logit": 3.5390548706054688,
            "end_logit": 1.5423963069915771,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "11",
            "probability": 0.01905147839923329,
            "start_logit": 0.5459142327308655,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D reveals a region recognized by inflammatory caspase-11.",
            "probability": 0.0030979276514879854,
            "start_logit": 3.5390548706054688,
            "end_logit": -1.4158504009246826,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D, but caspase-1",
            "probability": 0.002422286091219465,
            "start_logit": 3.071035861968994,
            "end_logit": -1.1938530206680298,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-11.",
            "probability": 0.0023817838535858007,
            "start_logit": 3.2761712074279785,
            "end_logit": -1.4158504009246826,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D,",
            "probability": 0.0008277428972758372,
            "start_logit": 3.071035861968994,
            "end_logit": -2.2676174640655518,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "D reveals a region recognized by inflammatory caspase-11",
            "probability": 0.0006201345371636492,
            "start_logit": -2.879049301147461,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "-11",
            "probability": 0.0004961207460974416,
            "start_logit": -3.1021664142608643,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "pyroptosis effector protein gasdermin D reveals a region recognized by inflammatory caspase-11",
            "probability": 0.0004905506561360623,
            "start_logit": -3.113457202911377,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D reveals a region recognized by inflammatory ca",
            "probability": 0.00046669188408755233,
            "start_logit": 3.5390548706054688,
            "end_logit": -3.3086698055267334,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "D",
            "probability": 0.000385764261842557,
            "start_logit": -2.879049301147461,
            "end_logit": 2.9189915657043457,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "ca",
            "probability": 0.0003588073445115376,
            "start_logit": 3.2761712074279785,
            "end_logit": -3.3086698055267334,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "pyroptosis effector protein gasdermin D",
            "probability": 0.0003051546082665152,
            "start_logit": -3.113457202911377,
            "end_logit": 2.9189915657043457,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D reveals a region recognized by inflammatory caspase",
            "probability": 0.00021806783782954783,
            "start_logit": 3.5390548706054688,
            "end_logit": -4.069532871246338,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gas",
            "probability": 0.00019776819007977136,
            "start_logit": 3.5390548706054688,
            "end_logit": -4.167243480682373,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "ling of the pyroptosis effector protein gasdermin D reveals a region recognized by inflammatory caspase-11",
            "probability": 0.00018045876846401016,
            "start_logit": -4.113483428955078,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "profiling of the pyroptosis effector protein gasdermin D reveals a region recognized by inflammatory caspase-11",
            "probability": 0.00017583359450461998,
            "start_logit": -4.1394476890563965,
            "end_logit": 3.3937015533447266,
            "question_text": "List inflammatory caspase proteins?"
        }
    ],
    "553d061cf321868558000013": [
        {
            "text": "OncoBase",
            "probability": 0.6910095132088484,
            "start_logit": 2.780423641204834,
            "end_logit": 2.4711763858795166,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase",
            "probability": 0.17632731366459006,
            "start_logit": 2.780423641204834,
            "end_logit": 1.1053647994995117,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase",
            "probability": 0.03928378483675022,
            "start_logit": 1.2788934707641602,
            "end_logit": 1.1053647994995117,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/)",
            "probability": 0.025005774935472104,
            "start_logit": 2.780423641204834,
            "end_logit": -0.847870409488678,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/),",
            "probability": 0.021044974623339114,
            "start_logit": 2.780423641204834,
            "end_logit": -1.020315408706665,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/), an integrated database",
            "probability": 0.006961996917052708,
            "start_logit": 2.780423641204834,
            "end_logit": -2.1265108585357666,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (",
            "probability": 0.006792526239972263,
            "start_logit": 2.780423641204834,
            "end_logit": -2.1511542797088623,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/)",
            "probability": 0.0055710114435807735,
            "start_logit": 1.2788934707641602,
            "end_logit": -0.847870409488678,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/),",
            "probability": 0.004688588726365568,
            "start_logit": 1.2788934707641602,
            "end_logit": -1.020315408706665,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols",
            "probability": 0.0044977892417656954,
            "start_logit": 2.780423641204834,
            "end_logit": -2.5633912086486816,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/), an integrated",
            "probability": 0.004276920257759926,
            "start_logit": 2.780423641204834,
            "end_logit": -2.613744020462036,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "we present OncoBase",
            "probability": 0.003791534305179091,
            "start_logit": -2.424959182739258,
            "end_logit": 2.4711763858795166,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Herein, we present OncoBase",
            "probability": 0.0017362265771326125,
            "start_logit": -3.2060158252716064,
            "end_logit": 2.4711763858795166,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase integrates local chromatin signatures, 3D chromatin interactions in different cell types and reconstruction of enhancer-target networks",
            "probability": 0.0016877261160640259,
            "start_logit": 1.3680367469787598,
            "end_logit": -2.1312081813812256,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/), an integrated database",
            "probability": 0.0015510562898034992,
            "start_logit": 1.2788934707641602,
            "end_logit": -2.1265108585357666,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase is a useful resource for the functional annotation of regulatory noncoding regions",
            "probability": 0.001510190315213226,
            "start_logit": 1.9533863067626953,
            "end_logit": -2.8277041912078857,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase integrates local chromatin signatures",
            "probability": 0.0012551873582679217,
            "start_logit": 1.3680367469787598,
            "end_logit": -2.4273054599761963,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/), an integrated database for annotating 81 385 242 somatic mutations",
            "probability": 0.0010383279360677254,
            "start_logit": 1.2788934707641602,
            "end_logit": -2.5278353691101074,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols",
            "probability": 0.00100205794066978,
            "start_logit": 1.2788934707641602,
            "end_logit": -2.5633912086486816,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "we present OncoBase (http://www.oncobase",
            "probability": 0.0009674990661051963,
            "start_logit": -2.424959182739258,
            "end_logit": 1.1053647994995117,
            "question_text": "List available databases containing information about conserved noncoding elements."
        }
    ],
    "56c1f043ef6e394741000057": [
        {
            "text": "MT2 receptors shall lead to the development of highly selective melatonin receptor agonists.Selective melatonin receptor",
            "probability": 0.2606048160301966,
            "start_logit": -0.6189279556274414,
            "end_logit": -0.8625101447105408,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor",
            "probability": 0.2271236419427051,
            "start_logit": -0.7564385533332825,
            "end_logit": -0.8625101447105408,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptors shall lead to the development of highly selective melatonin receptor agonists.Selective melatonin",
            "probability": 0.11738087726721597,
            "start_logit": -0.6189279556274414,
            "end_logit": -1.6600912809371948,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin",
            "probability": 0.10230038241607418,
            "start_logit": -0.7564385533332825,
            "end_logit": -1.6600912809371948,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1 and MT2 receptors shall lead to the development of highly selective melatonin receptor agonists.Selective melatonin",
            "probability": 0.09349082005534383,
            "start_logit": -0.8464887142181396,
            "end_logit": -1.6600912809371948,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1",
            "probability": 0.0779505527466696,
            "start_logit": -0.8464887142181396,
            "end_logit": -1.8418798446655273,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor agonists.Selective melatonin receptor",
            "probability": 0.017324224670971514,
            "start_logit": -3.329827308654785,
            "end_logit": -0.8625101447105408,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2",
            "probability": 0.015668832919129988,
            "start_logit": -0.6189279556274414,
            "end_logit": -3.673841714859009,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "receptor",
            "probability": 0.015195566488607962,
            "start_logit": -3.4609293937683105,
            "end_logit": -0.8625101447105408,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1 and MT2",
            "probability": 0.012479818459567506,
            "start_logit": -0.8464887142181396,
            "end_logit": -3.673841714859009,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor agonists.Selective melatonin",
            "probability": 0.007803127819469593,
            "start_logit": -3.329827308654785,
            "end_logit": -1.6600912809371948,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "Selective melatonin receptor",
            "probability": 0.007668777636336989,
            "start_logit": -4.144775867462158,
            "end_logit": -0.8625101447105408,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptors shall lead to the development of highly selective melatonin receptor agonists.Selective melatonin receptor ago",
            "probability": 0.0067384014544109375,
            "start_logit": -0.6189279556274414,
            "end_logit": -4.517692565917969,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptors shall lead to the development of highly selective melatonin",
            "probability": 0.006551200553935253,
            "start_logit": -0.6189279556274414,
            "end_logit": -4.545866966247559,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor ago",
            "probability": 0.0058726860942604295,
            "start_logit": -0.7564385533332825,
            "end_logit": -4.517692565917969,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptors shall lead to the development of highly selective melatonin receptor agonists.Selective melatonin receptor agonist",
            "probability": 0.005555463600694118,
            "start_logit": -0.6189279556274414,
            "end_logit": -4.710733413696289,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1 and MT2 receptors shall lead to the development of highly selective melatonin",
            "probability": 0.005217861089418626,
            "start_logit": -0.8464887142181396,
            "end_logit": -4.545866966247559,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptors shall lead to the development of highly selective melatonin receptor",
            "probability": 0.005167405968751219,
            "start_logit": -0.6189279556274414,
            "end_logit": -4.783144474029541,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptors shall lead to the development of highly selective melatonin receptor agonists.Selective me",
            "probability": 0.0050638167395371005,
            "start_logit": -0.6189279556274414,
            "end_logit": -4.803394794464111,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor agonist",
            "probability": 0.004841726046703521,
            "start_logit": -0.7564385533332825,
            "end_logit": -4.710733413696289,
            "question_text": "Which receptors are bound by Tasimelteon?"
        }
    ],
    "5318380bb166e2b806000013": [
        {
            "text": "RBR family",
            "probability": 0.19730946824059284,
            "start_logit": 1.9224177598953247,
            "end_logit": 0.48468440771102905,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin",
            "probability": 0.1812085450589981,
            "start_logit": 1.8077830076217651,
            "end_logit": 0.5141943097114563,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "RBR",
            "probability": 0.1355052432061355,
            "start_logit": 1.9224177598953247,
            "end_logit": 0.1089213415980339,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin-binding interface, provide a model for the phosphoubiquitin",
            "probability": 0.0979022551600478,
            "start_logit": 1.5307224988937378,
            "end_logit": 0.175575852394104,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin-parkin",
            "probability": 0.0906537248093247,
            "start_logit": 1.6923271417617798,
            "end_logit": -0.06295134872198105,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin-binding interface, provide a model for the phosphoubiquitin-parkin",
            "probability": 0.0771261492691806,
            "start_logit": 1.5307224988937378,
            "end_logit": -0.06295134872198105,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin-parkin complex and show how phosphorylation of the Ubl domain",
            "probability": 0.028362638628768932,
            "start_logit": 1.6923271417617798,
            "end_logit": -1.2249256372451782,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "E3 ubiquitin ligase of the RBR family",
            "probability": 0.02670251815612175,
            "start_logit": -0.07759776711463928,
            "end_logit": 0.48468440771102905,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin-binding interface",
            "probability": 0.024489117314541026,
            "start_logit": 1.5307224988937378,
            "end_logit": -1.2101649045944214,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "RBR family.",
            "probability": 0.022659055304791436,
            "start_logit": 1.9224177598953247,
            "end_logit": -1.6795294284820557,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin-parkin complex",
            "probability": 0.02134445698721311,
            "start_logit": 1.6923271417617798,
            "end_logit": -1.5092062950134277,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "E3 ubiquitin ligase of the RBR",
            "probability": 0.01833835572730574,
            "start_logit": -0.07759776711463928,
            "end_logit": 0.1089213415980339,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin-binding interface, provide a model for the phosphoubiquitin-parkin complex",
            "probability": 0.018159383733298874,
            "start_logit": 1.5307224988937378,
            "end_logit": -1.5092062950134277,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "Ubl domain primes parkin for optimal phosphoubiquitin",
            "probability": 0.011438689197082606,
            "start_logit": -0.9548641443252563,
            "end_logit": 0.5141943097114563,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "parkin complex and show how phosphorylation of the Ubl domain primes parkin for optimal phosphoubiquitin",
            "probability": 0.011110756976348937,
            "start_logit": -0.9839518070220947,
            "end_logit": 0.5141943097114563,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin recruitment, release of inhibition by the Ubl domain",
            "probability": 0.010484787429667972,
            "start_logit": 0.5574225187301636,
            "end_logit": -1.0851683616638184,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin binding",
            "probability": 0.00950169496189611,
            "start_logit": 1.8077830076217651,
            "end_logit": -2.4339840412139893,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "parkin",
            "probability": 0.00623867660640562,
            "start_logit": -0.9839518070220947,
            "end_logit": -0.06295134872198105,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "Ubl domain",
            "probability": 0.005832894240365429,
            "start_logit": -0.028989555314183235,
            "end_logit": -1.0851683616638184,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "phosphoubiquitin recruitment, release of inhibition by the Ubl domain and engagement with an E2~Ub",
            "probability": 0.005631588991913034,
            "start_logit": 0.5574225187301636,
            "end_logit": -1.7067021131515503,
            "question_text": "List Parkin binding partners"
        }
    ],
    "5173b5ea8ed59a060a00001f": [
        {
            "text": "HDACs",
            "probability": 0.2017758887385635,
            "start_logit": -5.06033182144165,
            "end_logit": -4.3013596534729,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and histone modifications is beginning to be recognized, a lack of knowledge exists regarding the role of HDACs",
            "probability": 0.17795557078411076,
            "start_logit": -5.18595552444458,
            "end_logit": -4.3013596534729,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in splicing.Emerging roles of histone modifications and HDACs",
            "probability": 0.07942098582396971,
            "start_logit": -5.06033182144165,
            "end_logit": -5.233754634857178,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing",
            "probability": 0.05506049509703397,
            "start_logit": -4.824801921844482,
            "end_logit": -5.8356146812438965,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing.",
            "probability": 0.0487120691953073,
            "start_logit": -4.824801921844482,
            "end_logit": -5.958120346069336,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA",
            "probability": 0.04795637834449008,
            "start_logit": -5.18595552444458,
            "end_logit": -5.6126017570495605,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in splicing.Emerging roles of histone modifications and HDACs in RNA splicing",
            "probability": 0.043506162382715395,
            "start_logit": -5.06033182144165,
            "end_logit": -5.8356146812438965,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in splicing.Emerging roles of histone modifications and HDACs in RNA splicing.",
            "probability": 0.03848994072200543,
            "start_logit": -5.06033182144165,
            "end_logit": -5.958120346069336,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and, thus, further support the potential link between HDACs",
            "probability": 0.03301865814455792,
            "start_logit": -5.435020923614502,
            "end_logit": -5.73675537109375,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and histone modifications is beginning to be recognized",
            "probability": 0.03234358616569636,
            "start_logit": -5.18595552444458,
            "end_logit": -6.0064778327941895,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs and dysregulated RNA splicing and, thus, further support the potential link between HDACs",
            "probability": 0.02844226306988245,
            "start_logit": -5.584217548370361,
            "end_logit": -5.73675537109375,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in RNA splicing and discuss the convergence of two parallel fields,",
            "probability": 0.027710735064756332,
            "start_logit": -5.439822196960449,
            "end_logit": -5.907207012176514,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and histone modifications is beginning to be recognized,",
            "probability": 0.027638828116643293,
            "start_logit": -5.18595552444458,
            "end_logit": -6.163671970367432,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs and dysregulated RNA",
            "probability": 0.026967129809505788,
            "start_logit": -5.584217548370361,
            "end_logit": -5.790012836456299,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in splicing.Emerging roles of histone modifications and HDACs in RNA",
            "probability": 0.026416512917517045,
            "start_logit": -5.06033182144165,
            "end_logit": -6.334527969360352,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDAC",
            "probability": 0.025292875010230854,
            "start_logit": -5.967211723327637,
            "end_logit": -5.471114635467529,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and discuss the convergence of two parallel fields,",
            "probability": 0.02358862955794078,
            "start_logit": -5.600877285003662,
            "end_logit": -5.907207012176514,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in splicing.Recent studies however, reveal that HDACs",
            "probability": 0.020107521876329457,
            "start_logit": -6.192502975463867,
            "end_logit": -5.475252151489258,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in RNA splicing",
            "probability": 0.018665160917776397,
            "start_logit": -5.906575679779053,
            "end_logit": -5.8356146812438965,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in RNA",
            "probability": 0.01693060826096701,
            "start_logit": -5.439822196960449,
            "end_logit": -6.399903774261475,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        }
    ],
    "5324cca79b2d7acc7e00001d": [
        {
            "text": "Otolaryngology",
            "probability": 0.9849934247875669,
            "start_logit": 5.962179183959961,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature, Apple App",
            "probability": 0.003131673437420733,
            "start_logit": 5.962179183959961,
            "end_logit": -0.7198465466499329,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngo",
            "probability": 0.0019789266081247196,
            "start_logit": 5.962179183959961,
            "end_logit": -1.1788594722747803,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "O",
            "probability": 0.0016713266829285099,
            "start_logit": 5.962179183959961,
            "end_logit": -1.3477963209152222,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature, Apple App Store and the Google Play Store",
            "probability": 0.0013081540377100883,
            "start_logit": 5.962179183959961,
            "end_logit": -1.592797040939331,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "laryngology",
            "probability": 0.001286180398890442,
            "start_logit": -0.678778886795044,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature, Apple App Store",
            "probability": 0.0011615206645167297,
            "start_logit": 5.962179183959961,
            "end_logit": -1.711683988571167,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature, Apple App Store and the Google Play Store.",
            "probability": 0.0009633247050088522,
            "start_logit": 5.962179183959961,
            "end_logit": -1.8987787961959839,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature, Apple App Store and the Google Play",
            "probability": 0.0007871224585320769,
            "start_logit": 5.962179183959961,
            "end_logit": -2.100785493850708,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Mobile Applications in Otolaryngology",
            "probability": 0.00048405793763406585,
            "start_logit": -1.6560064554214478,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "tolaryngology",
            "probability": 0.00042494343196533525,
            "start_logit": -1.7862550020217896,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "in Otolaryngology",
            "probability": 0.00035080518579873326,
            "start_logit": -1.9779800176620483,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "logy",
            "probability": 0.000319335726079304,
            "start_logit": -2.0719680786132812,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature, Apple",
            "probability": 0.00024509486210574243,
            "start_logit": 5.962179183959961,
            "end_logit": -3.267524003982544,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "ngology",
            "probability": 0.0002436825369139733,
            "start_logit": -2.3423447608947754,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology:",
            "probability": 0.00023277815595148716,
            "start_logit": 5.962179183959961,
            "end_logit": -3.3190834522247314,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature, Apple App Store and the Google",
            "probability": 0.00019961048347967136,
            "start_logit": 5.962179183959961,
            "end_logit": -3.472801446914673,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology: A Systematic Review of the Literature,",
            "probability": 0.0001685173511254104,
            "start_logit": 5.962179183959961,
            "end_logit": -3.6421306133270264,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Applications in Otolaryngology",
            "probability": 4.3740232840022394e-05,
            "start_logit": -4.059942722320557,
            "end_logit": 5.03122091293335,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Apple App",
            "probability": 5.780315406964016e-06,
            "start_logit": -0.33268535137176514,
            "end_logit": -0.7198465466499329,
            "question_text": "What are the mobile applications fields of use for patients ?"
        }
    ],
    "54f431d664850a5854000006": [
        {
            "text": "NPM1",
            "probability": 0.8507582109007691,
            "start_logit": 3.6604392528533936,
            "end_logit": 2.600975513458252,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Npm1",
            "probability": 0.08715108856480777,
            "start_logit": 2.472916603088379,
            "end_logit": 1.510013461112976,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 mutations lead to altered rRNA",
            "probability": 0.04369158628190875,
            "start_logit": 3.6604392528533936,
            "end_logit": -0.3679969012737274,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 mutations",
            "probability": 0.0052865206110078635,
            "start_logit": 3.6604392528533936,
            "end_logit": -2.479992151260376,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM",
            "probability": 0.0035911793224490222,
            "start_logit": 3.6604392528533936,
            "end_logit": -2.8666718006134033,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita.Here,",
            "probability": 0.0021053815398252725,
            "start_logit": 3.6604392528533936,
            "end_logit": -3.400655746459961,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 mutations lead to altered rRNA 2'-O-methylation",
            "probability": 0.001039756514758442,
            "start_logit": 3.6604392528533936,
            "end_logit": -4.106165885925293,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "rRNA",
            "probability": 0.0010395072219683639,
            "start_logit": -0.0779695212841034,
            "end_logit": -0.3679969012737274,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "N",
            "probability": 0.0009577448165271221,
            "start_logit": 3.6604392528533936,
            "end_logit": -4.188326358795166,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita.Here",
            "probability": 0.0007728675179775118,
            "start_logit": 3.6604392528533936,
            "end_logit": -4.4028000831604,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita.",
            "probability": 0.000673195402661296,
            "start_logit": 3.6604392528533936,
            "end_logit": -4.540872097015381,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Germline NPM1",
            "probability": 0.000617626431496916,
            "start_logit": -3.5675601959228516,
            "end_logit": 2.600975513458252,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "RNA binding.Mice harboring a dyskeratosis congenita germline Npm1",
            "probability": 0.0005542923114130603,
            "start_logit": -2.584789752960205,
            "end_logit": 1.510013461112976,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Npm1 mutation",
            "probability": 0.00048763787670644607,
            "start_logit": 2.472916603088379,
            "end_logit": -3.675812005996704,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 germline mutations",
            "probability": 0.0002800560504692056,
            "start_logit": 2.735504627227783,
            "end_logit": -4.492983341217041,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "1",
            "probability": 0.0002609619136044773,
            "start_logit": -4.429069519042969,
            "end_logit": 2.600975513458252,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "rRNA 2'-O-methylation and cause dyskeratosis congenita.Here, we link ribosomal RNA",
            "probability": 0.00023219887412511528,
            "start_logit": -0.0779695212841034,
            "end_logit": -1.8669047355651855,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "germline Npm1",
            "probability": 0.00022713339587740732,
            "start_logit": -3.4769444465637207,
            "end_logit": 1.510013461112976,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "RNA",
            "probability": 0.0001484459766641056,
            "start_logit": -0.5253426432609558,
            "end_logit": -1.8669047355651855,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Mice harboring a dyskeratosis congenita germline Npm1",
            "probability": 0.0001246084749829844,
            "start_logit": -4.077305316925049,
            "end_logit": 1.510013461112976,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        }
    ],
    "570a5343cf1c325851000022": [
        {
            "text": "Val60Leu",
            "probability": 0.36316507348992494,
            "start_logit": 2.791594982147217,
            "end_logit": 2.2364065647125244,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r' Val60Leu",
            "probability": 0.28800312487909807,
            "start_logit": 2.1982498168945312,
            "end_logit": 2.597865581512451,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60Leu variant",
            "probability": 0.1070346908826251,
            "start_logit": 2.791594982147217,
            "end_logit": 1.0147020816802979,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "r' Val60Leu",
            "probability": 0.10612102402621969,
            "start_logit": 1.1998586654663086,
            "end_logit": 2.597865581512451,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r' Val60Leu variant",
            "probability": 0.0523460830463355,
            "start_logit": 2.1982498168945312,
            "end_logit": 0.8927713632583618,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60",
            "probability": 0.02211096501612589,
            "start_logit": 2.791594982147217,
            "end_logit": -0.5623772740364075,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "r' Val60Leu variant",
            "probability": 0.019288054388196738,
            "start_logit": 1.1998586654663086,
            "end_logit": 0.8927713632583618,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "(P\u2009=\u20090.017).The Val60Leu",
            "probability": 0.013707250703316482,
            "start_logit": -0.4853375554084778,
            "end_logit": 2.2364065647125244,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "the 'r' Val60Leu",
            "probability": 0.01307776872410688,
            "start_logit": -0.8938077688217163,
            "end_logit": 2.597865581512451,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "(P\u2009=\u20090.017).The Val60Leu variant",
            "probability": 0.0040399020968100545,
            "start_logit": -0.4853375554084778,
            "end_logit": 1.0147020816802979,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r' Val60",
            "probability": 0.0039147059007085825,
            "start_logit": 2.1982498168945312,
            "end_logit": -1.7003655433654785,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "the 'r' Val60Leu variant",
            "probability": 0.00237695326389339,
            "start_logit": -0.8938077688217163,
            "end_logit": 0.8927713632583618,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "r' Val60",
            "probability": 0.001442458650818721,
            "start_logit": 1.1998586654663086,
            "end_logit": -1.7003655433654785,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60Leu variant of the MC1R gene",
            "probability": 0.0007807209114303673,
            "start_logit": 2.791594982147217,
            "end_logit": -3.9059884548187256,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r",
            "probability": 0.0006686384737457179,
            "start_logit": 2.1982498168945312,
            "end_logit": -3.4676175117492676,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "al60Leu",
            "probability": 0.0005153685735377413,
            "start_logit": -4.127594470977783,
            "end_logit": 2.597865581512451,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V",
            "probability": 0.0003978407398726094,
            "start_logit": 2.791594982147217,
            "end_logit": -4.5801544189453125,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "60Leu",
            "probability": 0.00037122163499031286,
            "start_logit": -4.455677509307861,
            "end_logit": 2.597865581512451,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Leu",
            "probability": 0.00034041488511337895,
            "start_logit": -4.542311668395996,
            "end_logit": 2.597865581512451,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r' Val",
            "probability": 0.00029773971312959427,
            "start_logit": 2.1982498168945312,
            "end_logit": -4.276641368865967,
            "question_text": "List variants of the MC1R gene."
        }
    ],
    "5141bcd423fec9037500000d": [
        {
            "text": "Navarixin",
            "probability": 0.998426361007919,
            "start_logit": 6.529545307159424,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarix",
            "probability": 0.0004501998263213957,
            "start_logit": 6.529545307159424,
            "end_logit": -1.370859146118164,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "antagonist Navarixin",
            "probability": 0.0002886368033263665,
            "start_logit": -1.6192212104797363,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarixin)",
            "probability": 0.00017574136954090724,
            "start_logit": 6.529545307159424,
            "end_logit": -2.311537265777588,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Na",
            "probability": 0.00016220584173217434,
            "start_logit": 6.529545307159424,
            "end_logit": -2.3916845321655273,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "in",
            "probability": 0.00010325584238588479,
            "start_logit": -2.6471805572509766,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "varixin",
            "probability": 8.670280098600974e-05,
            "start_logit": -2.821904182434082,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CS-2) and clinically relevant (CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 7.800882307772417e-05,
            "start_logit": -2.9275684356689453,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "phase-II antagonist Navarixin",
            "probability": 6.088030772587635e-05,
            "start_logit": -3.175480604171753,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navar",
            "probability": 4.386022741341696e-05,
            "start_logit": 6.529545307159424,
            "end_logit": -3.699542760848999,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "ixin",
            "probability": 3.17771901097358e-05,
            "start_logit": -3.825641632080078,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarixin) CCR7 modulators with implications for multi-target strategies against cancer.",
            "probability": 1.913760620792975e-05,
            "start_logit": 6.529545307159424,
            "end_logit": -4.528895378112793,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CXCR2 phase-II antagonist Navarixin",
            "probability": 1.64327575063387e-05,
            "start_logit": -4.485113620758057,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 1.617799121516433e-05,
            "start_logit": -4.500738620758057,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "(CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 1.148094302893652e-05,
            "start_logit": -4.8437018394470215,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarixin) CCR7 modulators with implications for multi-target strategies against cancer",
            "probability": 1.137036769093905e-05,
            "start_logit": 6.529545307159424,
            "end_logit": -5.049540042877197,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "clinically relevant (CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 1.0683295503039613e-05,
            "start_logit": -4.915709018707275,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "2) and clinically relevant (CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 6.769394285766666e-06,
            "start_logit": -5.371978759765625,
            "end_logit": 6.333384990692139,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "antagonist",
            "probability": 1.874549768173364e-07,
            "start_logit": -1.6192212104797363,
            "end_logit": -1.0060007572174072,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "antagonist Navarix",
            "probability": 1.3014904634159837e-07,
            "start_logit": -1.6192212104797363,
            "end_logit": -1.370859146118164,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        }
    ],
    "52bf1af803868f1b06000008": [
        {
            "text": "catecholaminergic polymorphic ventricular tachycardia",
            "probability": 0.6590285180635872,
            "start_logit": 3.8475732803344727,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic ventricular tachycardia",
            "probability": 0.2873976457308439,
            "start_logit": 3.0176732540130615,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ventricular tachycardia",
            "probability": 0.04507415415536751,
            "start_logit": 1.165115475654602,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "catecholaminergic",
            "probability": 0.0016450928370879826,
            "start_logit": 3.8475732803344727,
            "end_logit": -2.220418691635132,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "tachycardia",
            "probability": 0.0013068425130859649,
            "start_logit": -2.375579595565796,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "cat",
            "probability": 0.0010009794706883253,
            "start_logit": 3.8475732803344727,
            "end_logit": -2.7172365188598633,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "catecholaminergic p",
            "probability": 0.0007343633834565364,
            "start_logit": 3.8475732803344727,
            "end_logit": -3.0269668102264404,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "catecholaminergic polymorphic",
            "probability": 0.0005711709909790191,
            "start_logit": 3.8475732803344727,
            "end_logit": -3.2782821655273438,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ia",
            "probability": 0.0005627223080695465,
            "start_logit": -3.2181625366210938,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "catecholaminergic polymorphic ventricular tachycard",
            "probability": 0.0004983054781990267,
            "start_logit": 3.8475732803344727,
            "end_logit": -3.414757490158081,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CASQ2 mutations and long-term course of catecholaminergic polymorphic ventricular tachycardia",
            "probability": 0.0003682035106674634,
            "start_logit": -3.642313003540039,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "catecholaminergic polymorphic vent",
            "probability": 0.0003220876180664273,
            "start_logit": 3.8475732803344727,
            "end_logit": -3.851147174835205,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "p",
            "probability": 0.00032025064429151413,
            "start_logit": 3.0176732540130615,
            "end_logit": -3.0269668102264404,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "catecholaminergic polymorphic ventricular tachycardia.",
            "probability": 0.00025059927716950534,
            "start_logit": 3.8475732803344727,
            "end_logit": -4.102115631103516,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic",
            "probability": 0.00024908360354336696,
            "start_logit": 3.0176732540130615,
            "end_logit": -3.2782821655273438,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic ventricular tachycard",
            "probability": 0.00021730747208023655,
            "start_logit": 3.0176732540130615,
            "end_logit": -3.414757490158081,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic vent",
            "probability": 0.0001404601176036133,
            "start_logit": 3.0176732540130615,
            "end_logit": -3.851147174835205,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "mutations and long-term course of catecholaminergic polymorphic ventricular tachycardia",
            "probability": 0.00011409812532783705,
            "start_logit": -4.813889980316162,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic ventricular tachycardia.",
            "probability": 0.00010928456099591424,
            "start_logit": 3.0176732540130615,
            "end_logit": -4.102115631103516,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "cardia",
            "probability": 8.883013888889714e-05,
            "start_logit": -5.064222812652588,
            "end_logit": 3.7725512981414795,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        }
    ],
    "550303a5e9bde6963400000c": [
        {
            "text": "Seasonal Allergic Rhinitis",
            "probability": 0.6125271402433995,
            "start_logit": 3.786284923553467,
            "end_logit": 3.632284164428711,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Seasonal Allergic Rhinitis: Observational Study. Complete diagnosis and therapy of seasonal allergic rhinoconjunctivitis",
            "probability": 0.21540895538714355,
            "start_logit": 3.786284923553467,
            "end_logit": 2.5872292518615723,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal allergic rhinoconjunctivitis",
            "probability": 0.06902223199181702,
            "start_logit": 2.6481752395629883,
            "end_logit": 2.5872292518615723,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Allergic Rhinitis",
            "probability": 0.05221771560311837,
            "start_logit": 1.3241134881973267,
            "end_logit": 3.632284164428711,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Allergic Rhinitis: Observational Study. Complete diagnosis and therapy of seasonal allergic rhinoconjunctivitis",
            "probability": 0.01836353498769214,
            "start_logit": 1.3241134881973267,
            "end_logit": 2.5872292518615723,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Rhinitis",
            "probability": 0.013512393568083841,
            "start_logit": -0.02770102210342884,
            "end_logit": 3.632284164428711,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic rhinoconjunctivitis",
            "probability": 0.005700146087285282,
            "start_logit": 0.15423838794231415,
            "end_logit": 2.5872292518615723,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Rhinitis: Observational Study. Complete diagnosis and therapy of seasonal allergic rhinoconjunctivitis",
            "probability": 0.004751937329869626,
            "start_logit": -0.02770102210342884,
            "end_logit": 2.5872292518615723,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "rhinoconjunctivitis",
            "probability": 0.002745618039572569,
            "start_logit": -0.5762472152709961,
            "end_logit": 2.5872292518615723,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Seasonal",
            "probability": 0.0010575679362444354,
            "start_logit": 3.786284923553467,
            "end_logit": -2.729337215423584,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Seasonal Allergic",
            "probability": 0.001023845159398858,
            "start_logit": 3.786284923553467,
            "end_logit": -2.7617437839508057,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Seasonal Allergic Rhinitis: Observational Study.",
            "probability": 0.0008297370379093656,
            "start_logit": 3.786284923553467,
            "end_logit": -2.9719555377960205,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "itis",
            "probability": 0.0006925684626175985,
            "start_logit": -2.9986565113067627,
            "end_logit": 3.632284164428711,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Seasonal Allergic Rhinitis: Observational Study. Complete diagnosis and therapy of seasonal",
            "probability": 0.0005093807116982522,
            "start_logit": 3.786284923553467,
            "end_logit": -3.4598686695098877,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Seasonal Allergic Rhinitis: Observational Study",
            "probability": 0.0004022188398014866,
            "start_logit": 3.786284923553467,
            "end_logit": -3.696068048477173,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Seasonal Allergic Rhinitis: Observational Study. Complete diagnosis and therapy of seasonal allergic",
            "probability": 0.00033844003740225736,
            "start_logit": 3.786284923553467,
            "end_logit": -3.8687174320220947,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "hinitis",
            "probability": 0.00031938709429415145,
            "start_logit": -3.7726597785949707,
            "end_logit": 3.632284164428711,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "itis: Observational Study. Complete diagnosis and therapy of seasonal allergic rhinoconjunctivitis",
            "probability": 0.00024355728793871103,
            "start_logit": -2.9986565113067627,
            "end_logit": 2.5872292518615723,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal allergic rhinoconjunctivitis require evidence that exposure to the sensitizing pollen triggers allergic symptoms. Electronic clinical diaries",
            "probability": 0.00017040631181748845,
            "start_logit": 2.6481752395629883,
            "end_logit": -3.416769027709961,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal",
            "probability": 0.00016321788289537398,
            "start_logit": 2.6481752395629883,
            "end_logit": -3.4598686695098877,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        }
    ],
    "51bdf045047fa84d1d000003": [
        {
            "text": "Atg4",
            "probability": 0.5110300234218428,
            "start_logit": -4.768289089202881,
            "end_logit": -1.8237937688827515,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4",
            "probability": 0.3986355861803162,
            "start_logit": -5.016669750213623,
            "end_logit": -1.8237937688827515,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs are cysteine proteases, which play key roles in the macroautophagy",
            "probability": 0.014463309835093528,
            "start_logit": -4.768289089202881,
            "end_logit": -5.388607025146484,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases, which play key roles in the macroautophagy/autophagy",
            "probability": 0.012056678526191848,
            "start_logit": -5.016669750213623,
            "end_logit": -5.322222709655762,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases, which play key roles in the macroautophagy",
            "probability": 0.011282292096291741,
            "start_logit": -5.016669750213623,
            "end_logit": -5.388607025146484,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "autophagy",
            "probability": 0.010670130466379763,
            "start_logit": -5.138840198516846,
            "end_logit": -5.322222709655762,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs are cysteine proteases,",
            "probability": 0.007005792116630235,
            "start_logit": -4.768289089202881,
            "end_logit": -6.113484859466553,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases,",
            "probability": 0.00546495884599911,
            "start_logit": -5.016669750213623,
            "end_logit": -6.113484859466553,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs",
            "probability": 0.005301221371505292,
            "start_logit": -4.768289089202881,
            "end_logit": -6.392284870147705,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "macroautophagy/autophagy",
            "probability": 0.0052765644023877395,
            "start_logit": -5.843013286590576,
            "end_logit": -5.322222709655762,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "macroautophagy",
            "probability": 0.004937656811808261,
            "start_logit": -5.843013286590576,
            "end_logit": -5.388607025146484,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs",
            "probability": 0.004135286366838746,
            "start_logit": -5.016669750213623,
            "end_logit": -6.392284870147705,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Human Atg4",
            "probability": 0.001883626109563522,
            "start_logit": -7.36886739730835,
            "end_logit": -4.82644510269165,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "deconjugation of Atg8 homologs from membranes.Human Atg4",
            "probability": 0.0015451964631403147,
            "start_logit": -7.566915035247803,
            "end_logit": -4.82644510269165,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg8 homologs from membranes.Human Atg4",
            "probability": 0.00152388818932762,
            "start_logit": -7.580801010131836,
            "end_logit": -4.82644510269165,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "cysteine proteases, which play key roles in the macroautophagy/autophagy",
            "probability": 0.0014709880466597103,
            "start_logit": -7.120354175567627,
            "end_logit": -5.322222709655762,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "cysteine proteases, which play key roles in the macroautophagy",
            "probability": 0.0013765081963921643,
            "start_logit": -7.120354175567627,
            "end_logit": -5.388607025146484,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "cysteine proteases,",
            "probability": 0.0006667581888733538,
            "start_logit": -7.120354175567627,
            "end_logit": -6.113484859466553,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "deconjugation of Atg8 homologs from membranes.",
            "probability": 0.0006411881778917769,
            "start_logit": -7.566915035247803,
            "end_logit": -5.706028461456299,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg8 homologs from membranes.",
            "probability": 0.0006323461868661088,
            "start_logit": -7.580801010131836,
            "end_logit": -5.706028461456299,
            "question_text": "Which are the Atg8 homologs in human?"
        }
    ],
    "515db020298dcd4e51000011": [
        {
            "text": "randomized controlled trial",
            "probability": 0.28108601955929025,
            "start_logit": -1.7358819246292114,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in a large randomized controlled trial",
            "probability": 0.20654645517643505,
            "start_logit": -2.0440173149108887,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "large randomized controlled trial",
            "probability": 0.12757081575649418,
            "start_logit": -2.5258710384368896,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "in a large randomized controlled trial",
            "probability": 0.09170243371108773,
            "start_logit": -2.8559937477111816,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "a large randomized controlled trial",
            "probability": 0.06600783934656076,
            "start_logit": -3.1847691535949707,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "trial",
            "probability": 0.038206796961201286,
            "start_logit": -3.7315292358398438,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "evaluated in a large randomized controlled trial",
            "probability": 0.03561718500443256,
            "start_logit": -3.8017144203186035,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "the impact of a polypill in preventing clinical CV events has not been evaluated in a large randomized controlled trial",
            "probability": 0.020861118130412342,
            "start_logit": -4.336655616760254,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "controlled trial",
            "probability": 0.018001853947504757,
            "start_logit": -4.484067916870117,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated",
            "probability": 0.015920065325249203,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.298905611038208,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "randomized controlled",
            "probability": 0.014185480632801244,
            "start_logit": -1.7358819246292114,
            "end_logit": -3.722402334213257,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "has not been evaluated in a large randomized controlled trial",
            "probability": 0.013063352891076987,
            "start_logit": -4.804731845855713,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not",
            "probability": 0.01193196720981686,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.5872647762298584,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in",
            "probability": 0.011430178985209608,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.6302287578582764,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in a large randomized controlled",
            "probability": 0.01042371564502889,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.722402334213257,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "impact of a polypill in preventing clinical CV events has not been evaluated in a large randomized controlled trial",
            "probability": 0.010134752651392784,
            "start_logit": -5.058572292327881,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "However, the impact of a polypill in preventing clinical CV events has not been evaluated in a large randomized controlled trial",
            "probability": 0.008032517209420897,
            "start_logit": -5.29104471206665,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "large randomized controlled",
            "probability": 0.006438076639534501,
            "start_logit": -2.5258710384368896,
            "end_logit": -3.722402334213257,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "been evaluated in a large randomized controlled trial",
            "probability": 0.0064237097619901,
            "start_logit": -5.514546871185303,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in a large",
            "probability": 0.006415665455060119,
            "start_logit": -2.0440173149108887,
            "end_logit": -4.207743167877197,
            "question_text": "List all clinical trials of the polypill."
        }
    ],
    "56c1f007ef6e39474100003b": [
        {
            "text": "fractionated scheme",
            "probability": 0.3222950221811385,
            "start_logit": -2.2719240188598633,
            "end_logit": -2.5377118587493896,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme,",
            "probability": 0.1512791552524112,
            "start_logit": -2.2719240188598633,
            "end_logit": -3.2940523624420166,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields",
            "probability": 0.10636935417283376,
            "start_logit": -2.2719240188598633,
            "end_logit": -3.646261692047119,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields,",
            "probability": 0.06382952479504887,
            "start_logit": -2.2719240188598633,
            "end_logit": -4.156963348388672,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy,",
            "probability": 0.05021775609149306,
            "start_logit": -2.2719240188598633,
            "end_logit": -4.396810531616211,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "The fractionated scheme",
            "probability": 0.03568819600170524,
            "start_logit": -4.47257137298584,
            "end_logit": -2.5377118587493896,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically applicable",
            "probability": 0.03353570265270262,
            "start_logit": -2.2719240188598633,
            "end_logit": -4.800568580627441,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fraction",
            "probability": 0.030876996570034697,
            "start_logit": -2.2719240188598633,
            "end_logit": -4.883167743682861,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy",
            "probability": 0.024692505171384157,
            "start_logit": -2.2719240188598633,
            "end_logit": -5.106679439544678,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "radiotherapy",
            "probability": 0.0211192593636705,
            "start_logit": -4.02819299697876,
            "end_logit": -3.5067248344421387,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "scheme",
            "probability": 0.020509266998424487,
            "start_logit": -5.026514530181885,
            "end_logit": -2.5377118587493896,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically applicable for cancer",
            "probability": 0.020004019783644127,
            "start_logit": -2.2719240188598633,
            "end_logit": -5.317245960235596,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "The fractionated scheme,",
            "probability": 0.016751360623206063,
            "start_logit": -4.47257137298584,
            "end_logit": -3.2940523624420166,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically applicable for cancer treatment",
            "probability": 0.01595717569434673,
            "start_logit": -2.2719240188598633,
            "end_logit": -5.543270587921143,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method",
            "probability": 0.01582715353124562,
            "start_logit": -2.2719240188598633,
            "end_logit": -5.551452159881592,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "Fractionated Therapy",
            "probability": 0.015528909038565583,
            "start_logit": -4.3759989738464355,
            "end_logit": -3.4664008617401123,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated",
            "probability": 0.015463039395280537,
            "start_logit": -2.2719240188598633,
            "end_logit": -5.574726581573486,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically",
            "probability": 0.013813966650056407,
            "start_logit": -2.2719240188598633,
            "end_logit": -5.687499046325684,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "24 h/d.The fractionated scheme",
            "probability": 0.013561926901953972,
            "start_logit": -5.440124988555908,
            "end_logit": -2.5377118587493896,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time",
            "probability": 0.012679709130853927,
            "start_logit": -2.2719240188598633,
            "end_logit": -5.773176193237305,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        }
    ],
    "56e46ad951531f7e3300001a": [
        {
            "text": "Hedgehog",
            "probability": 0.20157562953502547,
            "start_logit": 3.682994842529297,
            "end_logit": 3.6311471462249756,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT",
            "probability": 0.11772562466000633,
            "start_logit": 3.682994842529297,
            "end_logit": 3.093339204788208,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.10251391916190161,
            "start_logit": 3.682994842529297,
            "end_logit": 2.9549810886383057,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor",
            "probability": 0.06296580840972286,
            "start_logit": 3.1955881118774414,
            "end_logit": 2.9549810886383057,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT",
            "probability": 0.05503772573889314,
            "start_logit": 2.922657012939453,
            "end_logit": 3.093339204788208,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT, bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.04792612469499637,
            "start_logit": 2.922657012939453,
            "end_logit": 2.9549810886383057,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein",
            "probability": 0.045478444724669505,
            "start_logit": 3.682994842529297,
            "end_logit": 2.142220973968506,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein (BMP), fibroblast growth factor (FGF)",
            "probability": 0.039770821062260896,
            "start_logit": 3.682994842529297,
            "end_logit": 2.0081160068511963,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "platelet-derived growth factor",
            "probability": 0.03719847707776641,
            "start_logit": 3.2028005123138428,
            "end_logit": 2.4214446544647217,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor (FGF), insulin-like growth factor (IGF), and platelet-derived growth factor",
            "probability": 0.03693115195220828,
            "start_logit": 3.1955881118774414,
            "end_logit": 2.4214446544647217,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein (BMP)",
            "probability": 0.03579098289025906,
            "start_logit": 3.682994842529297,
            "end_logit": 1.9026784896850586,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch",
            "probability": 0.030218427974820033,
            "start_logit": 3.682994842529297,
            "end_logit": 1.7334344387054443,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.027211120296939395,
            "start_logit": 2.3566219806671143,
            "end_logit": 2.9549810886383057,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Notch, WNT",
            "probability": 0.026441119776470342,
            "start_logit": 2.189558506011963,
            "end_logit": 3.093339204788208,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor (FGF), insulin-like growth factor",
            "probability": 0.025304311969145645,
            "start_logit": 3.1955881118774414,
            "end_logit": 2.0433640480041504,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor (FGF)",
            "probability": 0.024427920810917107,
            "start_logit": 3.1955881118774414,
            "end_logit": 2.0081160068511963,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Notch, WNT, bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.023024577895793288,
            "start_logit": 2.189558506011963,
            "end_logit": 2.9549810886383057,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT, bone morphogenetic protein",
            "probability": 0.02126155775360349,
            "start_logit": 2.922657012939453,
            "end_logit": 2.142220973968506,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor (FGF), insulin-like growth factor (IGF)",
            "probability": 0.02060305822186601,
            "start_logit": 3.1955881118774414,
            "end_logit": 1.8378287553787231,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT, bone morphogenetic protein (BMP), fibroblast growth factor (FGF)",
            "probability": 0.018593195392735257,
            "start_logit": 2.922657012939453,
            "end_logit": 2.0081160068511963,
            "question_text": "List angiocrine factors"
        }
    ],
    "56cf2be73975bb303a000005": [
        {
            "text": "anti-IL-5 monoclonal antibodies",
            "probability": 0.6300695858304858,
            "start_logit": 5.1645636558532715,
            "end_logit": 5.567570209503174,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal antibodies",
            "probability": 0.2539019390826554,
            "start_logit": 4.25568151473999,
            "end_logit": 5.567570209503174,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5",
            "probability": 0.047417067912620806,
            "start_logit": 5.1645636558532715,
            "end_logit": 2.980722188949585,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two anti-IL-5 monoclonal antibodies",
            "probability": 0.022686162660161834,
            "start_logit": 1.8404885530471802,
            "end_logit": 5.567570209503174,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 monoclonal antibodies",
            "probability": 0.016750467582303145,
            "start_logit": 1.5371595621109009,
            "end_logit": 5.567570209503174,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal antibodies (mAbs",
            "probability": 0.01619359117855144,
            "start_logit": 5.1645636558532715,
            "end_logit": 1.9063555002212524,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal antibodies (mAbs",
            "probability": 0.0065256033514561294,
            "start_logit": 4.25568151473999,
            "end_logit": 1.9063555002212524,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two anti-IL-5",
            "probability": 0.0017072897021616687,
            "start_logit": 1.8404885530471802,
            "end_logit": 2.980722188949585,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5",
            "probability": 0.0016035028866158178,
            "start_logit": 1.8760414123535156,
            "end_logit": 2.8824527263641357,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "antibodies",
            "probability": 0.0008120310136952225,
            "start_logit": -1.48948335647583,
            "end_logit": 5.567570209503174,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two anti-IL-5 monoclonal antibodies (mAbs",
            "probability": 0.0005830632866440521,
            "start_logit": 1.8404885530471802,
            "end_logit": 1.9063555002212524,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 monoclonal antibodies (mAbs",
            "probability": 0.00043050835999307123,
            "start_logit": 1.5371595621109009,
            "end_logit": 1.9063555002212524,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "lonal antibodies",
            "probability": 0.0004256062167365309,
            "start_logit": -2.135507345199585,
            "end_logit": 5.567570209503174,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal",
            "probability": 0.0002030431367332077,
            "start_logit": 4.792571067810059,
            "end_logit": -2.100604295730591,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal antibodies (mAbs, mepolizumab",
            "probability": 0.00018809885102208932,
            "start_logit": 5.1645636558532715,
            "end_logit": -2.5490477085113525,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "mAbs",
            "probability": 0.00011557604052480159,
            "start_logit": 0.2221214920282364,
            "end_logit": 1.9063555002212524,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 mon",
            "probability": 0.00011536112704788298,
            "start_logit": 5.1645636558532715,
            "end_logit": -3.0379478931427,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti",
            "probability": 9.39986058304812e-05,
            "start_logit": 5.1645636558532715,
            "end_logit": -3.2427353858947754,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal",
            "probability": 9.276243466447438e-05,
            "start_logit": 4.009194374084473,
            "end_logit": -2.100604295730591,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "5 monoclonal antibodies",
            "probability": 8.474074009623167e-05,
            "start_logit": -3.7494254112243652,
            "end_logit": 5.567570209503174,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        }
    ],
    "5713bc991174fb1755000010": [
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP2",
            "probability": 0.38885106947025605,
            "start_logit": 4.365320682525635,
            "end_logit": 3.6633622646331787,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2",
            "probability": 0.3470678674705729,
            "start_logit": 4.365320682525635,
            "end_logit": 3.5496861934661865,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP2)",
            "probability": 0.11643891434642659,
            "start_logit": 4.365320682525635,
            "end_logit": 2.4575326442718506,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "IGHMBP2",
            "probability": 0.10298426608344635,
            "start_logit": 3.036700487136841,
            "end_logit": 3.6633622646331787,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "IGHMBP2)",
            "probability": 0.030837966200931988,
            "start_logit": 3.036700487136841,
            "end_logit": 2.4575326442718506,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "(IGHMBP2",
            "probability": 0.004565173715507305,
            "start_logit": -0.07941916584968567,
            "end_logit": 3.6633622646331787,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein",
            "probability": 0.0014399624095100857,
            "start_logit": 4.365320682525635,
            "end_logit": -1.9352171421051025,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "(IGHMBP2)",
            "probability": 0.0013670114678112602,
            "start_logit": -0.07941916584968567,
            "end_logit": 2.4575326442718506,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mu-binding protein 2 (IGHMBP2",
            "probability": 0.0009986371938432784,
            "start_logit": -1.599239468574524,
            "end_logit": 3.6633622646331787,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "Rare variants (RV) in immunoglobulin mu-binding protein 2 (IGHMBP2",
            "probability": 0.0008958782452686326,
            "start_logit": -1.7078264951705933,
            "end_logit": 3.6633622646331787,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mu-binding protein 2",
            "probability": 0.0008913306621894103,
            "start_logit": -1.599239468574524,
            "end_logit": 3.5496861934661865,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "Rare variants (RV) in immunoglobulin mu-binding protein 2",
            "probability": 0.0007996134677532287,
            "start_logit": -1.7078264951705933,
            "end_logit": 3.5496861934661865,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "2 (IGHMBP2",
            "probability": 0.00050920143223753,
            "start_logit": -2.27278733253479,
            "end_logit": 3.6633622646331787,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "2",
            "probability": 0.0004544862264115726,
            "start_logit": -2.27278733253479,
            "end_logit": 3.5496861934661865,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "im",
            "probability": 0.00044979079369557784,
            "start_logit": 4.365320682525635,
            "end_logit": -3.098806858062744,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP",
            "probability": 0.00037051658184567373,
            "start_logit": 4.365320682525635,
            "end_logit": -3.292691230773926,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "IGHMBP2) [OMIM 600502] can cause an autosomal recessive",
            "probability": 0.00035853690654862497,
            "start_logit": 3.036700487136841,
            "end_logit": -1.99693763256073,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mu-binding protein 2 (IGHMBP2)",
            "probability": 0.0002990353886270275,
            "start_logit": -1.599239468574524,
            "end_logit": 2.4575326442718506,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "Rare variants (RV) in immunoglobulin mu-binding protein 2 (IGHMBP2)",
            "probability": 0.00026826489228324083,
            "start_logit": -1.7078264951705933,
            "end_logit": 2.4575326442718506,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "2 (IGHMBP2)",
            "probability": 0.00015247704483404732,
            "start_logit": -2.27278733253479,
            "end_logit": 2.4575326442718506,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        }
    ],
    "515de993298dcd4e51000024": [
        {
            "text": "tics",
            "probability": 0.381284725123632,
            "start_logit": 1.1296318769454956,
            "end_logit": 1.0246639251708984,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression.On anxiety symptoms, no effect was reported",
            "probability": 0.17548227201178151,
            "start_logit": 1.1296318769454956,
            "end_logit": 0.2486555427312851,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression.On anxiety symptoms, no effect",
            "probability": 0.06891978883409429,
            "start_logit": 1.1296318769454956,
            "end_logit": -0.6859391331672668,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "oppositional defiant behavior, tics",
            "probability": 0.052082114811116874,
            "start_logit": -0.8610929250717163,
            "end_logit": 1.0246639251708984,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "no effect was reported",
            "probability": 0.039506952298709395,
            "start_logit": -0.36142948269844055,
            "end_logit": 0.2486555427312851,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression.On anxiety",
            "probability": 0.036204103696213165,
            "start_logit": 1.1296318769454956,
            "end_logit": -1.3297100067138672,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression.On anxiety symptoms",
            "probability": 0.03571902522244785,
            "start_logit": 1.1296318769454956,
            "end_logit": -1.3431990146636963,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "no effect was reported.Most prevalent comorbid disorders are oppositional defiant behavior, tics",
            "probability": 0.02969744553521082,
            "start_logit": -0.36142948269844055,
            "end_logit": -0.03676008805632591,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "oppositional defiant behavior, tics, autism spectrum disorder, anxiety and depression.On anxiety symptoms, no effect was reported",
            "probability": 0.023970243851939663,
            "start_logit": -0.8610929250717163,
            "end_logit": 0.2486555427312851,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "oppositional defiant behavior",
            "probability": 0.02009304215317114,
            "start_logit": -0.8610929250717163,
            "end_logit": 0.07221591472625732,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "anxiety symptoms, no effect was reported",
            "probability": 0.019972481816137908,
            "start_logit": -1.043550729751587,
            "end_logit": 0.2486555427312851,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression",
            "probability": 0.017727015161084467,
            "start_logit": 1.1296318769454956,
            "end_logit": -2.043792724609375,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "no effect",
            "probability": 0.015516158861465408,
            "start_logit": -0.36142948269844055,
            "end_logit": -0.6859391331672668,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "anxiety symptoms, no effect was reported.Most prevalent comorbid disorders are oppositional defiant behavior, tics",
            "probability": 0.015013349712554781,
            "start_logit": -1.043550729751587,
            "end_logit": -0.03676008805632591,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression.On anxiety symptoms,",
            "probability": 0.014357845241281258,
            "start_logit": 1.1296318769454956,
            "end_logit": -2.2545859813690186,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression.On anxiety symptoms, no",
            "probability": 0.013429892829795887,
            "start_logit": 1.1296318769454956,
            "end_logit": -2.321399450302124,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "depression.On anxiety symptoms, no effect was reported",
            "probability": 0.01204769193481953,
            "start_logit": -1.5490330457687378,
            "end_logit": 0.2486555427312851,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression.",
            "probability": 0.010505385729281495,
            "start_logit": 1.1296318769454956,
            "end_logit": -2.5669944286346436,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "oppositional defiant behavior, tics, autism spectrum disorder, anxiety and depression.On anxiety symptoms, no effect",
            "probability": 0.009414193956108085,
            "start_logit": -0.8610929250717163,
            "end_logit": -0.6859391331672668,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "depression.On anxiety symptoms, no effect was reported.Most prevalent comorbid disorders are oppositional defiant behavior, tics",
            "probability": 0.00905627121915425,
            "start_logit": -1.5490330457687378,
            "end_logit": -0.03676008805632591,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        }
    ],
    "54fc9b236ad7dcbc12000005": [
        {
            "text": "Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.Therefore, in the past decades,",
            "probability": 0.14710876967523134,
            "start_logit": -4.808791637420654,
            "end_logit": -5.20250940322876,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A Receptor",
            "probability": 0.08464535997620222,
            "start_logit": -4.808791637420654,
            "end_logit": -5.755211353302002,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "agonists",
            "probability": 0.08390974766564174,
            "start_logit": -5.208189964294434,
            "end_logit": -5.364541530609131,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.Therefore,",
            "probability": 0.06632985442626806,
            "start_logit": -4.808791637420654,
            "end_logit": -5.999041557312012,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A",
            "probability": 0.06166073158307588,
            "start_logit": -4.808791637420654,
            "end_logit": -6.0720343589782715,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "agonists and antagonists",
            "probability": 0.05905102919050404,
            "start_logit": -5.208189964294434,
            "end_logit": -5.71588134765625,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Ad",
            "probability": 0.05297228913157023,
            "start_logit": -4.808791637420654,
            "end_logit": -6.223912715911865,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.",
            "probability": 0.05254885372428947,
            "start_logit": -4.808791637420654,
            "end_logit": -6.231938362121582,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "agonists and antagonists identified",
            "probability": 0.05024071232840878,
            "start_logit": -5.208189964294434,
            "end_logit": -5.877457618713379,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A Receptor as a Potential Drug Target",
            "probability": 0.043283692249699184,
            "start_logit": -4.808791637420654,
            "end_logit": -6.425905704498291,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A Receptor as a Potential Drug",
            "probability": 0.041474706405107774,
            "start_logit": -4.808791637420654,
            "end_logit": -6.468597888946533,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives",
            "probability": 0.03613267966956434,
            "start_logit": -4.808791637420654,
            "end_logit": -6.6064839363098145,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "agonists and antagonists identified that can interact with these receptors.",
            "probability": 0.035005583913540556,
            "start_logit": -5.208189964294434,
            "end_logit": -6.238775730133057,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "in the past decades,",
            "probability": 0.03176608543899311,
            "start_logit": -6.341564655303955,
            "end_logit": -5.20250940322876,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Drug Target - Current Status and Future Perspectives.Therefore, in the past decades,",
            "probability": 0.031505145946911284,
            "start_logit": -6.349812984466553,
            "end_logit": -5.20250940322876,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "investigations of ARs with a high number of agonists",
            "probability": 0.029576650962385466,
            "start_logit": -6.250946521759033,
            "end_logit": -5.364541530609131,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "in the past decades, there have been extensive investigations of ARs with a high number of agonists",
            "probability": 0.0270143200509877,
            "start_logit": -6.341564655303955,
            "end_logit": -5.364541530609131,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "there have been extensive investigations of ARs with a high number of agonists",
            "probability": 0.024548192430859008,
            "start_logit": -6.437293529510498,
            "end_logit": -5.364541530609131,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "investigations of ARs with a high number of agonists and antagonists",
            "probability": 0.02081440747857618,
            "start_logit": -6.250946521759033,
            "end_logit": -5.71588134765625,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "as a Potential Drug Target - Current Status and Future Perspectives.Therefore, in the past decades,",
            "probability": 0.02041118775218367,
            "start_logit": -6.783880710601807,
            "end_logit": -5.20250940322876,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        }
    ],
    "54fe09036ad7dcbc12000009": [
        {
            "text": "fish fillet",
            "probability": 0.2933758423528059,
            "start_logit": -1.0115197896957397,
            "end_logit": -2.915937900543213,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish",
            "probability": 0.1446063326186692,
            "start_logit": -1.0115197896957397,
            "end_logit": -3.6233773231506348,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fillet",
            "probability": 0.12699267775019077,
            "start_logit": -1.8488448858261108,
            "end_logit": -2.915937900543213,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste of fish fillet",
            "probability": 0.06945920279622682,
            "start_logit": -2.4522347450256348,
            "end_logit": -2.915937900543213,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing",
            "probability": 0.061555117641908776,
            "start_logit": -1.0115197896957397,
            "end_logit": -4.47745943069458,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste of fish",
            "probability": 0.03423676776665148,
            "start_logit": -2.4522347450256348,
            "end_logit": -3.6233773231506348,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "waste of fish fillet",
            "probability": 0.030328197485995242,
            "start_logit": -3.2808964252471924,
            "end_logit": -2.915937900543213,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fillet processing",
            "probability": 0.02664517008586354,
            "start_logit": -1.8488448858261108,
            "end_logit": -4.47745943069458,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": ".",
            "probability": 0.02614730195041548,
            "start_logit": -3.735086679458618,
            "end_logit": -2.610079526901245,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution, but these materials can still be used as raw material for fish feed.",
            "probability": 0.02458737700643322,
            "start_logit": -1.0115197896957397,
            "end_logit": -5.3951592445373535,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution",
            "probability": 0.023380605036108525,
            "start_logit": -1.0115197896957397,
            "end_logit": -5.445485591888428,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution, but these materials can still be used as raw material for fish feed",
            "probability": 0.020010204933583013,
            "start_logit": -1.0115197896957397,
            "end_logit": -5.601150035858154,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": ".Waste of fish catching and waste of fish fillet",
            "probability": 0.019257250432286696,
            "start_logit": -3.735086679458618,
            "end_logit": -2.915937900543213,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching",
            "probability": 0.018034954609733967,
            "start_logit": -2.4522347450256348,
            "end_logit": -4.2643656730651855,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "waste of fish",
            "probability": 0.014948911192593868,
            "start_logit": -3.2808964252471924,
            "end_logit": -3.6233773231506348,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution,",
            "probability": 0.014655906189707697,
            "start_logit": -1.0115197896957397,
            "end_logit": -5.912549018859863,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste of fish fillet processing",
            "probability": 0.014573692793332503,
            "start_logit": -2.4522347450256348,
            "end_logit": -4.47745943069458,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "Fish Waste as Fish Feed Material as an Alternative Effort to Reduce and Use Waste.",
            "probability": 0.012645573696636922,
            "start_logit": -4.4615254402160645,
            "end_logit": -2.610079526901245,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fill",
            "probability": 0.012498586514156543,
            "start_logit": -1.0115197896957397,
            "end_logit": -6.071776866912842,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": ".Waste of fish",
            "probability": 0.012060327146699749,
            "start_logit": -3.735086679458618,
            "end_logit": -3.383904218673706,
            "question_text": "List fish anti-freeze proteins."
        }
    ],
    "517295c18ed59a060a000016": [
        {
            "text": "MicroRNAs",
            "probability": 0.44966937789936307,
            "start_logit": 5.045073986053467,
            "end_logit": 5.1933064460754395,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs",
            "probability": 0.29286368026729853,
            "start_logit": 5.045073986053467,
            "end_logit": 4.764501094818115,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs",
            "probability": 0.16962545507127896,
            "start_logit": 4.498959541320801,
            "end_logit": 4.764501094818115,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs)",
            "probability": 0.05112388179933836,
            "start_logit": 5.045073986053467,
            "end_logit": 3.01904559135437,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs)",
            "probability": 0.029610744860230326,
            "start_logit": 4.498959541320801,
            "end_logit": 3.01904559135437,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "(miRNAs",
            "probability": 0.004467372815552971,
            "start_logit": 0.862167239189148,
            "end_logit": 4.764501094818115,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "(miRNAs)",
            "probability": 0.000779848971260127,
            "start_logit": 0.862167239189148,
            "end_logit": 3.01904559135437,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "Micro",
            "probability": 0.0004024330117010715,
            "start_logit": 5.045073986053467,
            "end_logit": -1.8254327774047852,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs) are a class of naturally occurring small non-coding RNAs that post-transcriptionally regulate gene expression in organisms.",
            "probability": 0.0003086273128352805,
            "start_logit": 4.498959541320801,
            "end_logit": -1.5447125434875488,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (mi",
            "probability": 0.00017100711017439666,
            "start_logit": 5.045073986053467,
            "end_logit": -2.6812562942504883,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs) are a class",
            "probability": 0.00013784346251700756,
            "start_logit": 5.045073986053467,
            "end_logit": -2.8968427181243896,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs) are",
            "probability": 0.00012743051479086937,
            "start_logit": 5.045073986053467,
            "end_logit": -2.9753901958465576,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNA",
            "probability": 0.00012586773608805205,
            "start_logit": 5.045073986053467,
            "end_logit": -2.987729787826538,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs) are a class of naturally occurring small non-coding RNAs that post-transcriptionally regulate gene expression",
            "probability": 0.00011745955584850286,
            "start_logit": 5.045073986053467,
            "end_logit": -3.0568673610687256,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "mi",
            "probability": 9.904662420851012e-05,
            "start_logit": 4.498959541320801,
            "end_logit": -2.6812562942504883,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs) are a class",
            "probability": 7.983837407461216e-05,
            "start_logit": 4.498959541320801,
            "end_logit": -2.8968427181243896,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "s",
            "probability": 7.75963322253624e-05,
            "start_logit": -3.619673728942871,
            "end_logit": 5.1933064460754395,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs) are",
            "probability": 7.380723701088506e-05,
            "start_logit": 4.498959541320801,
            "end_logit": -2.9753901958465576,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNA",
            "probability": 7.064894614614465e-05,
            "start_logit": 5.045073986053467,
            "end_logit": -3.5652382373809814,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs) are a class of naturally occurring small non-coding RNAs that post-transcriptionally regulate gene expression",
            "probability": 6.803209805697903e-05,
            "start_logit": 4.498959541320801,
            "end_logit": -3.0568673610687256,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        }
    ],
    "5505c9008e1671127b000002": [
        {
            "text": "RICTOR and SIN1",
            "probability": 0.37678921507923174,
            "start_logit": 3.6979098320007324,
            "end_logit": 2.7669408321380615,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR",
            "probability": 0.33821694840541183,
            "start_logit": 3.6979098320007324,
            "end_logit": 2.658942461013794,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN1",
            "probability": 0.18909895794131537,
            "start_logit": 3.0084943771362305,
            "end_logit": 2.7669408321380615,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR and SIN1",
            "probability": 0.02983389421572069,
            "start_logit": 1.1618690490722656,
            "end_logit": 2.7669408321380615,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR",
            "probability": 0.026779770377899775,
            "start_logit": 1.1618690490722656,
            "end_logit": 2.658942461013794,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR and SIN1, thus abrogating mTORC2",
            "probability": 0.016020067916242695,
            "start_logit": 3.6979098320007324,
            "end_logit": -0.39090290665626526,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN1, thus abrogating mTORC2",
            "probability": 0.008039981050077487,
            "start_logit": 3.0084943771362305,
            "end_logit": -0.39090290665626526,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR and SIN",
            "probability": 0.003783365081873061,
            "start_logit": 3.6979098320007324,
            "end_logit": -1.8341312408447266,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN",
            "probability": 0.00189875496925599,
            "start_logit": 3.0084943771362305,
            "end_logit": -1.8341312408447266,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR and SIN1,",
            "probability": 0.0017890428748352965,
            "start_logit": 3.6979098320007324,
            "end_logit": -2.583064317703247,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2",
            "probability": 0.0012992993266324024,
            "start_logit": 1.1618690490722656,
            "end_logit": -0.3668791651725769,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR and SIN1, thus abrogating mTORC2",
            "probability": 0.0012684572498746906,
            "start_logit": 1.1618690490722656,
            "end_logit": -0.39090290665626526,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN1,",
            "probability": 0.000897865782258524,
            "start_logit": 3.0084943771362305,
            "end_logit": -2.583064317703247,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mLST8",
            "probability": 0.0008855377769222671,
            "start_logit": 1.0672136545181274,
            "end_logit": -0.6556090712547302,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2",
            "probability": 0.0008627492100623733,
            "start_logit": 1.0672136545181274,
            "end_logit": -0.6816801428794861,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mLST8 Selectively Inhibits mTORC2",
            "probability": 0.0005885037412526776,
            "start_logit": 1.0672136545181274,
            "end_logit": -1.064220905303955,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "R",
            "probability": 0.0005730660173945785,
            "start_logit": 3.6979098320007324,
            "end_logit": -3.721499443054199,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "cofactors RICTOR and SIN1",
            "probability": 0.0005343259239378251,
            "start_logit": -2.860525369644165,
            "end_logit": 2.7669408321380615,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "cofactors RICTOR",
            "probability": 0.0004796264760660725,
            "start_logit": -2.860525369644165,
            "end_logit": 2.658942461013794,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC1",
            "probability": 0.00036057058373421304,
            "start_logit": 0.18497732281684875,
            "end_logit": -0.6718801259994507,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        }
    ],
    "5326c6fed6d3ac6a3400000c": [
        {
            "text": "abdominal obesity",
            "probability": 0.11222188860844814,
            "start_logit": 5.7273335456848145,
            "end_logit": 5.663691520690918,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abdominal obesity, lipid abnormalities and high blood pressure",
            "probability": 0.08923406975492368,
            "start_logit": 5.7273335456848145,
            "end_logit": 5.434476375579834,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia, abdominal obesity",
            "probability": 0.08845402380477338,
            "start_logit": 5.489338397979736,
            "end_logit": 5.663691520690918,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "cardiovascular diseases (CVD), two of the main causes of morbidity and mortality worldwide, which include hyperglycemia",
            "probability": 0.08065494465770173,
            "start_logit": 5.742198467254639,
            "end_logit": 5.318528652191162,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "lipid abnormalities and high blood pressure",
            "probability": 0.07835990582189728,
            "start_logit": 5.59738302230835,
            "end_logit": 5.434476375579834,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "type 2 diabetes mellitus",
            "probability": 0.07184200820418465,
            "start_logit": 5.6350483894348145,
            "end_logit": 5.309967994689941,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia, abdominal obesity, lipid abnormalities and high blood pressure",
            "probability": 0.07033487520280984,
            "start_logit": 5.489338397979736,
            "end_logit": 5.434476375579834,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "high blood pressure",
            "probability": 0.0663957109035824,
            "start_logit": 5.431703090667725,
            "end_logit": 5.434476375579834,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia",
            "probability": 0.06263473794808931,
            "start_logit": 5.489338397979736,
            "end_logit": 5.318528652191162,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abdominal obesity, lipid abnormalities",
            "probability": 0.04798098509267013,
            "start_logit": 5.7273335456848145,
            "end_logit": 4.814018249511719,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "type 2 diabetes",
            "probability": 0.043930695034545865,
            "start_logit": 5.6350483894348145,
            "end_logit": 4.818111896514893,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "cardiovascular diseases",
            "probability": 0.0421829385893411,
            "start_logit": 5.742198467254639,
            "end_logit": 4.6703643798828125,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "lipid abnormalities",
            "probability": 0.0421339683758628,
            "start_logit": 5.59738302230835,
            "end_logit": 4.814018249511719,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "type 2 diabetes mellitus and cardiovascular diseases",
            "probability": 0.03789676539396528,
            "start_logit": 5.6350483894348145,
            "end_logit": 4.6703643798828125,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia, abdominal obesity, lipid abnormalities",
            "probability": 0.03781892507950557,
            "start_logit": 5.489338397979736,
            "end_logit": 4.814018249511719,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.008618699835737622,
            "start_logit": 3.5145132541656494,
            "end_logit": 5.309967994689941,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "blood pressure",
            "probability": 0.0061737668611796,
            "start_logit": 3.056379795074463,
            "end_logit": 5.434476375579834,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetes",
            "probability": 0.005270251814258526,
            "start_logit": 3.5145132541656494,
            "end_logit": 4.818111896514893,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetes mellitus and cardiovascular diseases",
            "probability": 0.004546376887846111,
            "start_logit": 3.5145132541656494,
            "end_logit": 4.6703643798828125,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abdominal obesity, lipid",
            "probability": 0.003314462128676923,
            "start_logit": 5.7273335456848145,
            "end_logit": 2.1415088176727295,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        }
    ],
    "5319a6c9b166e2b806000022": [
        {
            "text": "small molecule inhibitors",
            "probability": 0.6532840499427626,
            "start_logit": 0.06942218542098999,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "small molecule",
            "probability": 0.10285983476271579,
            "start_logit": 0.06942218542098999,
            "end_logit": -2.7039222717285156,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "small molecule inhibitor",
            "probability": 0.0630852707288918,
            "start_logit": 0.06942218542098999,
            "end_logit": -3.1928021907806396,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "small",
            "probability": 0.041785070506833964,
            "start_logit": 0.06942218542098999,
            "end_logit": -3.604750394821167,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "small molecule inhibitors.",
            "probability": 0.027473007685723933,
            "start_logit": 0.06942218542098999,
            "end_logit": -4.024085521697998,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "inhibitors",
            "probability": 0.024548131091112636,
            "start_logit": -3.211954116821289,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ten of which we confirmed with small molecule inhibitors",
            "probability": 0.021435680655322455,
            "start_logit": -3.3475329875946045,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "with small molecule inhibitors",
            "probability": 0.016291873005783383,
            "start_logit": -3.6219234466552734,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": ", ten of which we confirmed with small molecule inhibitors",
            "probability": 0.009610381307232569,
            "start_logit": -4.149745941162109,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": ",",
            "probability": 0.007219389514046433,
            "start_logit": -4.149745941162109,
            "end_logit": -1.1413509845733643,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "molecule inhibitors",
            "probability": 0.005019834354778216,
            "start_logit": -4.799192905426025,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "multiple combination-based therapies with high fidelity, ten of which we confirmed with small molecule inhibitors",
            "probability": 0.0037792633137840774,
            "start_logit": -5.0830607414245605,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "s",
            "probability": 0.0034760435064984134,
            "start_logit": -5.1666951179504395,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ten of which we confirmed with small molecule",
            "probability": 0.0033750564864181067,
            "start_logit": -3.3475329875946045,
            "end_logit": -2.7039222717285156,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "Our resource predicts multiple combination-based therapies with high fidelity, ten of which we confirmed with small molecule inhibitors",
            "probability": 0.0032034298217733462,
            "start_logit": -5.248367786407471,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "we confirmed with small molecule inhibitors",
            "probability": 0.0031899747886665183,
            "start_logit": -5.25257682800293,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "multiple combination-based therapies with high fidelity,",
            "probability": 0.0028390105518310495,
            "start_logit": -5.0830607414245605,
            "end_logit": -1.1413509845733643,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "with small molecule",
            "probability": 0.0025651619161631938,
            "start_logit": -3.6219234466552734,
            "end_logit": -2.7039222717285156,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "confirmed with small molecule inhibitors",
            "probability": 0.002553095885754025,
            "start_logit": -5.475283145904541,
            "end_logit": -0.8552774786949158,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "Our resource predicts multiple combination-based therapies with high fidelity,",
            "probability": 0.0024064401739074992,
            "start_logit": -5.248367786407471,
            "end_logit": -1.1413509845733643,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        }
    ],
    "56a37e33496b62f23f000003": [
        {
            "text": "triplets",
            "probability": 0.353914590511904,
            "start_logit": 2.282400369644165,
            "end_logit": 1.2507286071777344,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triplets Markov model",
            "probability": 0.22455560086672324,
            "start_logit": 2.282400369644165,
            "end_logit": 0.7957963347434998,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triplets Markov model.",
            "probability": 0.1119671510779898,
            "start_logit": 2.282400369644165,
            "end_logit": 0.09987852722406387,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "genome signature\" for bacterial genomes based on a triplets",
            "probability": 0.05405819972210303,
            "start_logit": 0.4034059941768646,
            "end_logit": 1.2507286071777344,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "genome signature\" for bacterial genomes based on a triplets Markov model",
            "probability": 0.03429943790339968,
            "start_logit": 0.4034059941768646,
            "end_logit": 0.7957963347434998,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triplets Markov",
            "probability": 0.033534372672186535,
            "start_logit": 2.282400369644165,
            "end_logit": -1.1057560443878174,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "genome signature",
            "probability": 0.03324380639659562,
            "start_logit": 0.4034059941768646,
            "end_logit": 0.7645358443260193,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "based on a triplets",
            "probability": 0.02225576744087549,
            "start_logit": -0.4840540587902069,
            "end_logit": 1.2507286071777344,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "genome signature\" for bacterial genomes based on a triplets Markov model.",
            "probability": 0.01710226924110175,
            "start_logit": 0.4034059941768646,
            "end_logit": 0.09987852722406387,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "a triplets",
            "probability": 0.01649801754873862,
            "start_logit": -0.7834150195121765,
            "end_logit": 1.2507286071777344,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "based on a triplets Markov model",
            "probability": 0.014121082782168467,
            "start_logit": -0.4840540587902069,
            "end_logit": 0.7957963347434998,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triple",
            "probability": 0.01254762724547996,
            "start_logit": 2.282400369644165,
            "end_logit": -2.0887954235076904,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "genome signature\"",
            "probability": 0.01193734548193407,
            "start_logit": 0.4034059941768646,
            "end_logit": -0.25966086983680725,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "signature\" for bacterial genomes based on a triplets",
            "probability": 0.010845005461009522,
            "start_logit": -1.2029505968093872,
            "end_logit": 1.2507286071777344,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "a \"genome signature\" for bacterial genomes based on a triplets",
            "probability": 0.010615045348798494,
            "start_logit": -1.2243828773498535,
            "end_logit": 1.2507286071777344,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "a triplets Markov model",
            "probability": 0.01046784264646511,
            "start_logit": -0.7834150195121765,
            "end_logit": 0.7957963347434998,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "\"genome signature\" for bacterial genomes based on a triplets",
            "probability": 0.007304372653524736,
            "start_logit": -1.5981820821762085,
            "end_logit": 1.2507286071777344,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "based on a triplets Markov model.",
            "probability": 0.0070410063394244155,
            "start_logit": -0.4840540587902069,
            "end_logit": 0.09987852722406387,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "signature\" for bacterial genomes based on a triplets Markov model",
            "probability": 0.006881057698631319,
            "start_logit": -1.2029505968093872,
            "end_logit": 0.7957963347434998,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "Markov model",
            "probability": 0.006810400960946018,
            "start_logit": -1.213271975517273,
            "end_logit": 0.7957963347434998,
            "question_text": "List types of avoided words in bacterial genomes"
        }
    ],
    "571ce13f7de986d80d000011": [
        {
            "text": "chorioamniotic membranes",
            "probability": 0.6246702378299486,
            "start_logit": 0.3529931306838989,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "chorioamniotic membrane",
            "probability": 0.26660284958834446,
            "start_logit": 0.3529931306838989,
            "end_logit": -2.235227584838867,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "membranes",
            "probability": 0.031262808513899246,
            "start_logit": -2.641801595687866,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "chorioamniotic membranes from these patients.",
            "probability": 0.025505885367913123,
            "start_logit": 0.3529931306838989,
            "end_logit": -4.582078456878662,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "ch",
            "probability": 0.014878650152851591,
            "start_logit": 0.3529931306838989,
            "end_logit": -5.121060371398926,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "membrane",
            "probability": 0.013342645977331213,
            "start_logit": -2.641801595687866,
            "end_logit": -2.235227584838867,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "chorio",
            "probability": 0.007446927360496513,
            "start_logit": 0.3529931306838989,
            "end_logit": -5.813186168670654,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "chorioamniotic membranes from these patients",
            "probability": 0.0038660521359571627,
            "start_logit": 0.3529931306838989,
            "end_logit": -6.468753814697266,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "chorioamniotic",
            "probability": 0.003317411712800513,
            "start_logit": 0.3529931306838989,
            "end_logit": -6.621802806854248,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "orioamniotic membranes",
            "probability": 0.001875804656665135,
            "start_logit": -5.455193042755127,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "membranes from these patients.",
            "probability": 0.0012764904776071653,
            "start_logit": -2.641801595687866,
            "end_logit": -4.582078456878662,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "s",
            "probability": 0.0009350310629801075,
            "start_logit": -6.151406288146973,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "amniotic membranes",
            "probability": 0.0008246923499279803,
            "start_logit": -6.276975631713867,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "orioamniotic membrane",
            "probability": 0.0008005741853098337,
            "start_logit": -5.455193042755127,
            "end_logit": -2.235227584838867,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "the chorioamniotic membranes",
            "probability": 0.0007800055582178182,
            "start_logit": -6.3326849937438965,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "niotic membranes",
            "probability": 0.0006792651784679369,
            "start_logit": -6.470974445343018,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "tic membranes",
            "probability": 0.0006674353481540322,
            "start_logit": -6.488543510437012,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "whether gasdermin D is expressed in the chorioamniotic membranes",
            "probability": 0.0005415729112594872,
            "start_logit": -6.697508335113525,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "in the chorioamniotic membranes",
            "probability": 0.00037368939667940435,
            "start_logit": -7.06856107711792,
            "end_logit": -1.3837637901306152,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "amniotic membrane",
            "probability": 0.0003519702351888913,
            "start_logit": -6.276975631713867,
            "end_logit": -2.235227584838867,
            "question_text": "In which cells are gasdermins expressed?"
        }
    ],
    "533c3533c45e133714000004": [
        {
            "text": "miR-223",
            "probability": 0.07053490240399202,
            "start_logit": 4.162395477294922,
            "end_logit": 3.968806028366089,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-142, miR-223",
            "probability": 0.06903385633838943,
            "start_logit": 4.140884876251221,
            "end_logit": 3.968806028366089,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96, miR-142, miR-223",
            "probability": 0.0642589670098573,
            "start_logit": 4.069209098815918,
            "end_logit": 3.968806028366089,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96",
            "probability": 0.062401696050550404,
            "start_logit": 4.069209098815918,
            "end_logit": 3.9394772052764893,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-142",
            "probability": 0.059414259493632444,
            "start_logit": 4.140884876251221,
            "end_logit": 3.8187432289123535,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a, miR-96, miR-142, miR-223",
            "probability": 0.05756536846051725,
            "start_logit": 3.9592089653015137,
            "end_logit": 3.968806028366089,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a, miR-96",
            "probability": 0.055901561958817354,
            "start_logit": 3.9592089653015137,
            "end_logit": 3.9394772052764893,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96, miR-142",
            "probability": 0.05530473224618788,
            "start_logit": 4.069209098815918,
            "end_logit": 3.8187432289123535,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22, miR-27a, miR-96, miR-142, miR-223",
            "probability": 0.0517461702308439,
            "start_logit": 3.8526382446289062,
            "end_logit": 3.968806028366089,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22, miR-27a, miR-96",
            "probability": 0.05025055547546891,
            "start_logit": 3.8526382446289062,
            "end_logit": 3.9394772052764893,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a, miR-96, miR-142",
            "probability": 0.049543860374750295,
            "start_logit": 3.9592089653015137,
            "end_logit": 3.8187432289123535,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22, miR-27a, miR-96, miR-142",
            "probability": 0.044535544571444485,
            "start_logit": 3.8526382446289062,
            "end_logit": 3.8187432289123535,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-223, miR-296",
            "probability": 0.04264763142821571,
            "start_logit": 4.162395477294922,
            "end_logit": 3.465670108795166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-142, miR-223, miR-296",
            "probability": 0.04174005153257855,
            "start_logit": 4.140884876251221,
            "end_logit": 3.465670108795166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-223, miR-296, miR-298",
            "probability": 0.03967240294237564,
            "start_logit": 4.162395477294922,
            "end_logit": 3.3933541774749756,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96, miR-142, miR-223, miR-296",
            "probability": 0.038853002522041685,
            "start_logit": 4.069209098815918,
            "end_logit": 3.465670108795166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-142, miR-223, miR-296, miR-298",
            "probability": 0.038828138580761055,
            "start_logit": 4.140884876251221,
            "end_logit": 3.3933541774749756,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-296",
            "probability": 0.03665010154962411,
            "start_logit": 4.010839939117432,
            "end_logit": 3.465670108795166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96, miR-142, miR-223, miR-296, miR-298",
            "probability": 0.0361424988904727,
            "start_logit": 4.069209098815918,
            "end_logit": 3.3933541774749756,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a",
            "probability": 0.03497469793947893,
            "start_logit": 3.9592089653015137,
            "end_logit": 3.4705097675323486,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        }
    ],
    "52f112bb2059c6d71c000002": [
        {
            "text": "m7G) is present at mRNA caps",
            "probability": 0.17928243201449717,
            "start_logit": -5.107760906219482,
            "end_logit": -6.365970134735107,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "m7G",
            "probability": 0.14700709267443335,
            "start_logit": -5.107760906219482,
            "end_logit": -6.564451694488525,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "m7G) is present at mRNA caps and at defined internal positions within tRNAs",
            "probability": 0.10492935833992106,
            "start_logit": -5.107760906219482,
            "end_logit": -6.901645183563232,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "m7G) is present at mRNA caps and at defined internal positions within tRNAs and rRNAs.",
            "probability": 0.09990529725212827,
            "start_logit": -5.107760906219482,
            "end_logit": -6.950709819793701,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "m7G) is present at mRNA caps and at defined internal positions within tRNAs and rRNAs",
            "probability": 0.09738032457197622,
            "start_logit": -5.107760906219482,
            "end_logit": -6.976308345794678,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "m7G)",
            "probability": 0.08530029345250102,
            "start_logit": -5.107760906219482,
            "end_logit": -7.108754634857178,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "caps",
            "probability": 0.029852633829159897,
            "start_logit": -6.900450229644775,
            "end_logit": -6.365970134735107,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "7-methylguanosine (m7G) is present at mRNA caps",
            "probability": 0.027169495952881113,
            "start_logit": -6.994628429412842,
            "end_logit": -6.365970134735107,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "(m7G) is present at mRNA caps",
            "probability": 0.025253872816841674,
            "start_logit": -7.06774377822876,
            "end_logit": -6.365970134735107,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "7-methylguanosine (m7G",
            "probability": 0.02227830448629715,
            "start_logit": -6.994628429412842,
            "end_logit": -6.564451694488525,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methylguanosine (m7G) is present at mRNA caps",
            "probability": 0.022267450299168663,
            "start_logit": -7.193597316741943,
            "end_logit": -6.365970134735107,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "(m7G",
            "probability": 0.020707541613857607,
            "start_logit": -7.06774377822876,
            "end_logit": -6.564451694488525,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "guanosine (m7G) is present at mRNA caps",
            "probability": 0.02023520305273121,
            "start_logit": -7.289299488067627,
            "end_logit": -6.365970134735107,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methylguanosine (m7G",
            "probability": 0.018258750135030106,
            "start_logit": -7.193597316741943,
            "end_logit": -6.564451694488525,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "caps and at defined internal positions within tRNAs",
            "probability": 0.0174719724473454,
            "start_logit": -6.900450229644775,
            "end_logit": -6.901645183563232,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "tRNAs and rRNAs.7-methylguanosine (m7G) is present at mRNA caps",
            "probability": 0.01667918001498432,
            "start_logit": -7.279736518859863,
            "end_logit": -6.568795680999756,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "caps and at defined internal positions within tRNAs and rRNAs.",
            "probability": 0.016651882953136025,
            "start_logit": -7.224989414215088,
            "end_logit": -6.625180721282959,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "guanosine (m7G",
            "probability": 0.01659235842036263,
            "start_logit": -7.289299488067627,
            "end_logit": -6.564451694488525,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "caps and at defined internal positions within tRNAs and rRNAs.7-methylguanosine (m7G",
            "probability": 0.016561586147027824,
            "start_logit": -6.900450229644775,
            "end_logit": -6.955157279968262,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "caps and at defined internal positions within tRNAs and rRNAs",
            "probability": 0.01621496952571949,
            "start_logit": -6.900450229644775,
            "end_logit": -6.976308345794678,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        }
    ],
    "5358e067f1005d6b5800000b": [
        {
            "text": "Drebrin",
            "probability": 0.16843904956996303,
            "start_logit": 4.884286880493164,
            "end_logit": 4.534993648529053,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer tetramer promotes actin bundling activity of Drebrin",
            "probability": 0.07292186882359679,
            "start_logit": 4.514023303985596,
            "end_logit": 4.0680718421936035,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1b in promoting Drebrin-stimulated actin bundling.Homer",
            "probability": 0.0657359825544698,
            "start_logit": 4.637558937072754,
            "end_logit": 3.840794086456299,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a antagonizes Homer1b in promoting Drebrin-stimulated actin bundling.Homer",
            "probability": 0.06380133008056121,
            "start_logit": 4.607686519622803,
            "end_logit": 3.840794086456299,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1b",
            "probability": 0.06281818763967206,
            "start_logit": 4.637558937072754,
            "end_logit": 3.7953922748565674,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a antagonizes Homer1b",
            "probability": 0.060969407756860654,
            "start_logit": 4.607686519622803,
            "end_logit": 3.7953922748565674,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin is an actin bundling protein that plays critical roles in synaptic spine development and plasticity.Homer",
            "probability": 0.060578103175700254,
            "start_logit": 4.884286880493164,
            "end_logit": 3.5123531818389893,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer",
            "probability": 0.05809681378437072,
            "start_logit": 4.514023303985596,
            "end_logit": 3.840794086456299,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "bundling.Homer tetramer promotes actin bundling activity of Drebrin in\u00a0vitro and stimulates Drebrin-induced",
            "probability": 0.04636285772490335,
            "start_logit": 4.514023303985596,
            "end_logit": 3.6151819229125977,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin-stimulated actin bundling.Homer tetramer promotes actin bundling activity of Drebrin",
            "probability": 0.045057714797757505,
            "start_logit": 4.032578945159912,
            "end_logit": 4.0680718421936035,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer Tetramer Promotes Actin Bundling Activity of Drebrin.Drebrin",
            "probability": 0.04499231840471729,
            "start_logit": 3.564204692840576,
            "end_logit": 4.534993648529053,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1b in promoting Drebrin",
            "probability": 0.03732097992567585,
            "start_logit": 4.637558937072754,
            "end_logit": 3.27470326423645,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a",
            "probability": 0.03679908434034373,
            "start_logit": 4.607686519622803,
            "end_logit": 3.2904930114746094,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a antagonizes Homer1b in promoting Drebrin",
            "probability": 0.03622259935332991,
            "start_logit": 4.607686519622803,
            "end_logit": 3.27470326423645,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin-stimulated actin bundling.Homer",
            "probability": 0.03589745721529751,
            "start_logit": 4.032578945159912,
            "end_logit": 3.840794086456299,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin.Drebrin",
            "probability": 0.032501909607631586,
            "start_logit": 3.239011764526367,
            "end_logit": 4.534993648529053,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin in\u00a0vitro and stimulates Drebrin-induced",
            "probability": 0.02955248763863221,
            "start_logit": 4.063692569732666,
            "end_logit": 3.6151819229125977,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "plasticity.Homer tetramer promotes actin bundling activity of Drebrin in\u00a0vitro and stimulates Drebrin-induced",
            "probability": 0.0211475757180057,
            "start_logit": 4.1601433753967285,
            "end_logit": 3.1840884685516357,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1b in promoting Drebrin-stimulated actin bundling.Homer tetramer",
            "probability": 0.010646220758162413,
            "start_logit": 4.637558937072754,
            "end_logit": 2.020352602005005,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer Tetramer Promotes Actin Bundling Activity of Drebrin",
            "probability": 0.010138051130348666,
            "start_logit": 3.564204692840576,
            "end_logit": 3.044797658920288,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        }
    ],
    "52f893f92059c6d71c00003c": [
        {
            "text": "drugs aiming at the treatment of sarcopenia in older adults.",
            "probability": 0.137575601852379,
            "start_logit": -3.7855892181396484,
            "end_logit": -4.1288323402404785,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs",
            "probability": 0.1287722504603019,
            "start_logit": -3.7855892181396484,
            "end_logit": -4.194960594177246,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults.",
            "probability": 0.10458143033870422,
            "start_logit": -4.0597968101501465,
            "end_logit": -4.1288323402404785,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "ESCEO recommendation for the conduct of clinical trials for drugs",
            "probability": 0.09788934927228421,
            "start_logit": -4.0597968101501465,
            "end_logit": -4.194960594177246,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs aiming at the treatment of sarcopenia",
            "probability": 0.06798137396896035,
            "start_logit": -3.7855892181396484,
            "end_logit": -4.8337721824646,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "ESCEO recommendation",
            "probability": 0.056290078695835605,
            "start_logit": -4.0597968101501465,
            "end_logit": -4.748280048370361,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia",
            "probability": 0.051677690159719895,
            "start_logit": -4.0597968101501465,
            "end_logit": -4.8337721824646,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs aiming at the treatment of sarcopenia in older adults.In 2016,",
            "probability": 0.045029635394909374,
            "start_logit": -3.859200954437256,
            "end_logit": -5.1720733642578125,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs to prevent or treat sarcopenia.",
            "probability": 0.0350421025481367,
            "start_logit": -5.522039890289307,
            "end_logit": -3.760004997253418,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults.",
            "probability": 0.031987467796560955,
            "start_logit": -5.244418621063232,
            "end_logit": -4.1288323402404785,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Update on the ESCEO recommendation for the conduct of clinical trials for drugs",
            "probability": 0.029940615626813348,
            "start_logit": -5.244418621063232,
            "end_logit": -4.194960594177246,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs aiming at the treatment of sarcopenia in older adults.In 2016",
            "probability": 0.028774722560276682,
            "start_logit": -3.859200954437256,
            "end_logit": -5.61989688873291,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs aiming at the treatment of sarcopenia in older adults",
            "probability": 0.028089907852102445,
            "start_logit": -3.7855892181396484,
            "end_logit": -5.71759557723999,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": ".",
            "probability": 0.027256145554875526,
            "start_logit": -5.773311138153076,
            "end_logit": -3.760004997253418,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs aiming at the treatment",
            "probability": 0.025094025493944707,
            "start_logit": -3.859200954437256,
            "end_logit": -5.7567644119262695,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs to prevent or treat sarcopenia.Update on the ESCEO recommendation for the conduct of clinical trials for drugs",
            "probability": 0.022682521990925308,
            "start_logit": -5.522039890289307,
            "end_logit": -4.194960594177246,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults",
            "probability": 0.0213532247120929,
            "start_logit": -4.0597968101501465,
            "end_logit": -5.71759557723999,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults.In 2016,",
            "probability": 0.02090467931729694,
            "start_logit": -4.626548767089844,
            "end_logit": -5.1720733642578125,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Update",
            "probability": 0.01954261302702845,
            "start_logit": -5.244418621063232,
            "end_logit": -4.621579170227051,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials for drugs",
            "probability": 0.019534563376851593,
            "start_logit": -5.674570560455322,
            "end_logit": -4.191839218139648,
            "question_text": "List clinical trials for prevention of sarcopenia"
        }
    ],
    "56f96333cf1c325851000004": [
        {
            "text": "hydrogen bonds",
            "probability": 0.486000337946025,
            "start_logit": 3.8400259017944336,
            "end_logit": 4.4373345375061035,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide bonds",
            "probability": 0.11127854681126752,
            "start_logit": 3.685425281524658,
            "end_logit": 3.117762327194214,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "ionic",
            "probability": 0.1064200290174052,
            "start_logit": 3.9587295055389404,
            "end_logit": 2.7998154163360596,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen bonds and ionic",
            "probability": 0.0945085397453456,
            "start_logit": 3.8400259017944336,
            "end_logit": 2.7998154163360596,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen",
            "probability": 0.08705038146113216,
            "start_logit": 3.8400259017944336,
            "end_logit": 2.7176122665405273,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "ionic linkages",
            "probability": 0.04479317189536478,
            "start_logit": 3.9587295055389404,
            "end_logit": 1.9344773292541504,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen bonds and ionic linkages",
            "probability": 0.039779516182060146,
            "start_logit": 3.8400259017944336,
            "end_logit": 1.9344773292541504,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide",
            "probability": 0.02171284161502661,
            "start_logit": 3.685425281524658,
            "end_logit": 1.4836297035217285,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "ionic link",
            "probability": 0.0018066667830955424,
            "start_logit": 3.9587295055389404,
            "end_logit": -1.2760947942733765,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen bonds and ionic link",
            "probability": 0.0016044483454224108,
            "start_logit": 3.8400259017944336,
            "end_logit": -1.2760947942733765,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "ion",
            "probability": 0.0014125534447909035,
            "start_logit": 3.9587295055389404,
            "end_logit": -1.522179365158081,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen bonds and ion",
            "probability": 0.0012544477257905278,
            "start_logit": 3.8400259017944336,
            "end_logit": -1.522179365158081,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "water is needed to interrupt hydrogen bonds",
            "probability": 0.0005174968467388735,
            "start_logit": -3.0049352645874023,
            "end_logit": 4.4373345375061035,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "bonds",
            "probability": 0.00047245108150426274,
            "start_logit": -3.0960044860839844,
            "end_logit": 4.4373345375061035,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "sulfide bonds",
            "probability": 0.00036021458973317227,
            "start_logit": -2.047666549682617,
            "end_logit": 3.117762327194214,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "ionic linkages,",
            "probability": 0.00029899791903743276,
            "start_logit": 3.9587295055389404,
            "end_logit": -3.074897050857544,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "di",
            "probability": 0.00027050189784156865,
            "start_logit": 3.685425281524658,
            "end_logit": -2.901750326156616,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen bonds and ionic linkages,",
            "probability": 0.00026553137577610707,
            "start_logit": 3.8400259017944336,
            "end_logit": -3.074897050857544,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "water is needed to interrupt hydrogen bonds and ionic",
            "probability": 0.00010063341008117472,
            "start_logit": -3.0049352645874023,
            "end_logit": 2.7998154163360596,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "water is needed to interrupt hydrogen",
            "probability": 9.269190656109176e-05,
            "start_logit": -3.0049352645874023,
            "end_logit": 2.7176122665405273,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        }
    ],
    "54c90dabf693c3b16b000004": [
        {
            "text": "sarcoplasmic reticulum calcium-ATPase",
            "probability": 0.638297302246711,
            "start_logit": 3.118521213531494,
            "end_logit": 2.7508323192596436,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Sarcoplasmic Reticulum Calcium-ATPase",
            "probability": 0.17044623364389214,
            "start_logit": 2.4570469856262207,
            "end_logit": 2.0919222831726074,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium",
            "probability": 0.04338251082585756,
            "start_logit": 3.118521213531494,
            "end_logit": 0.062084536999464035,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "intracoronary sarcoplasmic reticulum calcium-ATPase",
            "probability": 0.029149443264095885,
            "start_logit": 0.03215286135673523,
            "end_logit": 2.7508323192596436,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium-ATPase",
            "probability": 0.024780588668229603,
            "start_logit": -0.13022232055664062,
            "end_logit": 2.7508323192596436,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Calcium-ATPase",
            "probability": 0.020023834184793164,
            "start_logit": 0.3155503571033478,
            "end_logit": 2.0919222831726074,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Intracoronary Sarcoplasmic Reticulum Calcium-ATPase",
            "probability": 0.018482615817056517,
            "start_logit": 0.23545768857002258,
            "end_logit": 2.0919222831726074,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Sarcoplasmic Reticulum Calcium",
            "probability": 0.016166165118642606,
            "start_logit": 2.4570469856262207,
            "end_logit": -0.2635771334171295,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Intracoronary sarcoplasmic reticulum calcium-ATPase",
            "probability": 0.015928879220672543,
            "start_logit": -0.24513426423072815,
            "end_logit": 2.4238173961639404,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "ATPase",
            "probability": 0.006107505909266254,
            "start_logit": -1.5307644605636597,
            "end_logit": 2.7508323192596436,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium-ATPase gene therapy",
            "probability": 0.002867062590940779,
            "start_logit": 3.118521213531494,
            "end_logit": -2.654683828353882,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium-ATPase gene",
            "probability": 0.002867043451296969,
            "start_logit": 3.118521213531494,
            "end_logit": -2.6546905040740967,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "intracoronary sarcoplasmic reticulum calcium",
            "probability": 0.001981170895633182,
            "start_logit": 0.03215286135673523,
            "end_logit": 0.062084536999464035,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Calcium",
            "probability": 0.0018991831196223474,
            "start_logit": 0.3155503571033478,
            "end_logit": -0.2635771334171295,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Intracoronary Sarcoplasmic Reticulum Calcium",
            "probability": 0.0017530045266194018,
            "start_logit": 0.23545768857002258,
            "end_logit": -0.2635771334171295,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium",
            "probability": 0.001684237348938495,
            "start_logit": -0.13022232055664062,
            "end_logit": 0.062084536999464035,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sa",
            "probability": 0.0012503201948131921,
            "start_logit": 3.118521213531494,
            "end_logit": -3.484572172164917,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Sarcoplasmic Reticulum Calcium-ATPase Gene Therapy",
            "probability": 0.0011627599526388673,
            "start_logit": 2.4570469856262207,
            "end_logit": -2.8957011699676514,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Sarcoplasmic Reticulum Calcium-ATPase Gene",
            "probability": 0.0011462670806561,
            "start_logit": 2.4570469856262207,
            "end_logit": -2.909986972808838,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Intracoronary sarcoplasmic reticulum calcium",
            "probability": 0.0006238719396232841,
            "start_logit": -0.24513426423072815,
            "end_logit": -0.8161265254020691,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        }
    ],
    "52f8995b2059c6d71c00004a": [
        {
            "text": "BTBD9",
            "probability": 0.9480991151882621,
            "start_logit": 3.0900399684906006,
            "end_logit": 3.1121647357940674,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.",
            "probability": 0.014822776744422832,
            "start_logit": 3.0900399684906006,
            "end_logit": -1.0461293458938599,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 and dopaminergic dysfunction",
            "probability": 0.011434477248692643,
            "start_logit": 3.0900399684906006,
            "end_logit": -1.3056612014770508,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome",
            "probability": 0.007507687942556638,
            "start_logit": 3.0900399684906006,
            "end_logit": -1.7263667583465576,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "dop-1",
            "probability": 0.0020754769728767585,
            "start_logit": 0.45699939131736755,
            "end_logit": -0.3790627419948578,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "dop-1, dop-3",
            "probability": 0.0019779350932433437,
            "start_logit": 0.45699939131736755,
            "end_logit": -0.4272003173828125,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "dop-3",
            "probability": 0.0019080091692823633,
            "start_logit": 0.42100635170936584,
            "end_logit": -0.4272003173828125,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 and dopaminergic dysfunction in the pathogenesis",
            "probability": 0.001840909554729085,
            "start_logit": 3.0900399684906006,
            "end_logit": -3.1320345401763916,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "9",
            "probability": 0.00169644460495278,
            "start_logit": -3.235884428024292,
            "end_logit": 3.1121647357940674,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "D9",
            "probability": 0.001383193811190155,
            "start_logit": -3.440023899078369,
            "end_logit": 3.1121647357940674,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "hpo-9 and genes for dopamine receptors (dop-1",
            "probability": 0.0010841849312292387,
            "start_logit": -0.19236311316490173,
            "end_logit": -0.3790627419948578,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "hpo-9 and genes for dopamine receptors (dop-1, dop-3",
            "probability": 0.001033231132442571,
            "start_logit": -0.19236311316490173,
            "end_logit": -0.4272003173828125,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.Analysis",
            "probability": 0.0009548015391788805,
            "start_logit": 3.0900399684906006,
            "end_logit": -3.788546085357666,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "hpo-9",
            "probability": 0.0008703018704400827,
            "start_logit": -0.19236311316490173,
            "end_logit": -0.5988063812255859,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "TBD9",
            "probability": 0.000868987830757301,
            "start_logit": -3.9048452377319336,
            "end_logit": 3.1121647357940674,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "B",
            "probability": 0.0008656563105100638,
            "start_logit": 3.0900399684906006,
            "end_logit": -3.886561632156372,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 and dopaminergic dysfunction in",
            "probability": 0.0006446536455797824,
            "start_logit": 3.0900399684906006,
            "end_logit": -4.181336402893066,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "dopaminergic dysfunction in the pathogenesis of restless legs syndrome.Analysis of genetic interactions between hpo-9",
            "probability": 0.0004000532316874443,
            "start_logit": -0.9696056246757507,
            "end_logit": -0.5988063812255859,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "dop-1, dop-3) indicated that hpo-9 and dop-1",
            "probability": 0.0002708390748355451,
            "start_logit": 0.45699939131736755,
            "end_logit": -2.4154841899871826,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "dop-3) indicated that hpo-9 and dop-1",
            "probability": 0.00026126410313030186,
            "start_logit": 0.42100635170936584,
            "end_logit": -2.4154841899871826,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        }
    ],
    "52bf1dea03868f1b06000012": [
        {
            "text": "sedation or anhedonia",
            "probability": 0.34998714292549415,
            "start_logit": 6.130473613739014,
            "end_logit": 6.328593730926514,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation",
            "probability": 0.33730218153436803,
            "start_logit": 6.130473613739014,
            "end_logit": 6.2916765213012695,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhedonia",
            "probability": 0.30929970264851003,
            "start_logit": 6.006887912750244,
            "end_logit": 6.328593730926514,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhedonia)",
            "probability": 0.0013082461183000305,
            "start_logit": 6.130473613739014,
            "end_logit": 0.7393847107887268,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhedonia)",
            "probability": 0.0011561571433708563,
            "start_logit": 6.006887912750244,
            "end_logit": 0.7393847107887268,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "dation or anhedonia",
            "probability": 0.0002569526681680304,
            "start_logit": -1.086286187171936,
            "end_logit": 6.328593730926514,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "dation",
            "probability": 0.0002476396555590153,
            "start_logit": -1.086286187171936,
            "end_logit": 6.2916765213012695,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "hedonia",
            "probability": 0.00015915797930110385,
            "start_logit": -1.565280795097351,
            "end_logit": 6.328593730926514,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "onia",
            "probability": 7.556645296563522e-05,
            "start_logit": -2.3101656436920166,
            "end_logit": 6.328593730926514,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "se",
            "probability": 6.223364988862207e-05,
            "start_logit": 6.130473613739014,
            "end_logit": -2.306162118911743,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhed",
            "probability": 3.3627322061089184e-05,
            "start_logit": 6.130473613739014,
            "end_logit": -2.9217190742492676,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhed",
            "probability": 2.97180080028675e-05,
            "start_logit": 6.006887912750244,
            "end_logit": -2.9217190742492676,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or an",
            "probability": 2.635848570931676e-05,
            "start_logit": 6.130473613739014,
            "end_logit": -3.1652677059173584,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "an",
            "probability": 2.3294203678482637e-05,
            "start_logit": 6.006887912750244,
            "end_logit": -3.1652677059173584,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fewer side effects (e.g., sedation or anhedonia",
            "probability": 9.012402805376813e-06,
            "start_logit": -4.4365763664245605,
            "end_logit": 6.328593730926514,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fewer side effects (e.g., sedation",
            "probability": 8.685756572969874e-06,
            "start_logit": -4.4365763664245605,
            "end_logit": 6.2916765213012695,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhedonia) than classic KOP-r full agonists.Nalmefene (NMF",
            "probability": 4.869527163304071e-06,
            "start_logit": 6.130473613739014,
            "end_logit": -4.854061126708984,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhedonia) than classic KOP-r full agonists.Nalmefene (NMF",
            "probability": 4.3034246660010085e-06,
            "start_logit": 6.006887912750244,
            "end_logit": -4.854061126708984,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhedonia) than classic KOP-r full agonists.Nalmefene (NMF,",
            "probability": 2.733963967720183e-06,
            "start_logit": 6.130473613739014,
            "end_logit": -5.431305408477783,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhedonia) than classic KOP-r full agonists.Nalmefene (NMF,",
            "probability": 2.4161294474969015e-06,
            "start_logit": 6.006887912750244,
            "end_logit": -5.431305408477783,
            "question_text": "What are the side effects of Nalmefene?"
        }
    ],
    "530cf4d5e2bfff940c000004": [
        {
            "text": "protein-protein interaction",
            "probability": 0.41813753385067326,
            "start_logit": 3.0300116539001465,
            "end_logit": 1.6877602338790894,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI) networks",
            "probability": 0.20029092749290148,
            "start_logit": 3.0300116539001465,
            "end_logit": 0.9517207741737366,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI) networks.",
            "probability": 0.13188597691211362,
            "start_logit": 3.0300116539001465,
            "end_logit": 0.5338875651359558,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI)",
            "probability": 0.10145898431915328,
            "start_logit": 3.0300116539001465,
            "end_logit": 0.2716044485569,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "interaction",
            "probability": 0.016506634679811824,
            "start_logit": -0.20203635096549988,
            "end_logit": 1.6877602338790894,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "(PPI) networks",
            "probability": 0.015081058010331326,
            "start_logit": 0.4436802268028259,
            "end_logit": 0.9517207741737366,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein",
            "probability": 0.014269362082532825,
            "start_logit": 3.0300116539001465,
            "end_logit": -1.6899354457855225,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI) networks.Better performance was achieved after comparing our method with other existing methods.",
            "probability": 0.010326215520203507,
            "start_logit": 3.0300116539001465,
            "end_logit": -2.013364315032959,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "(PPI) networks.",
            "probability": 0.009930455130731248,
            "start_logit": 0.4436802268028259,
            "end_logit": 0.5338875651359558,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "methods have been developed to prioritize candidate genes in protein-protein interaction",
            "probability": 0.009923329421760848,
            "start_logit": -0.7109102606773376,
            "end_logit": 1.6877602338790894,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "networks",
            "probability": 0.00953863937279476,
            "start_logit": -0.014408441260457039,
            "end_logit": 0.9517207741737366,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI) networks.Better performance was achieved after comparing our method with other existing methods",
            "probability": 0.009342636005711023,
            "start_logit": 3.0300116539001465,
            "end_logit": -2.11346173286438,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Many methods have been developed to prioritize candidate genes in protein-protein interaction",
            "probability": 0.009063422560697058,
            "start_logit": -0.8015519380569458,
            "end_logit": 1.6877602338790894,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "interaction (PPI) networks",
            "probability": 0.00790679836693804,
            "start_logit": -0.20203635096549988,
            "end_logit": 0.9517207741737366,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "(PPI)",
            "probability": 0.007639431537610088,
            "start_logit": 0.4436802268028259,
            "end_logit": 0.2716044485569,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein interaction",
            "probability": 0.006369319906045342,
            "start_logit": -1.1543060541152954,
            "end_logit": 1.6877602338790894,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "networks.",
            "probability": 0.006280927388176248,
            "start_logit": -0.014408441260457039,
            "end_logit": 0.5338875651359558,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "in protein-protein interaction",
            "probability": 0.006088594592963904,
            "start_logit": -1.1993814706802368,
            "end_logit": 1.6877602338790894,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "interaction (PPI) networks.",
            "probability": 0.00520640570156472,
            "start_logit": -0.20203635096549988,
            "end_logit": 0.5338875651359558,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "methods have been developed to prioritize candidate genes in protein-protein interaction (PPI) networks",
            "probability": 0.004753347147285466,
            "start_logit": -0.7109102606773376,
            "end_logit": 0.9517207741737366,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        }
    ],
    "55439140ed966d112c00000a": [
        {
            "text": "phycobiliproteins (PBPs",
            "probability": 0.33698365994802176,
            "start_logit": -4.103819847106934,
            "end_logit": -3.680880308151245,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycobiliproteins",
            "probability": 0.14861217930756207,
            "start_logit": -4.103819847106934,
            "end_logit": -4.499574661254883,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs",
            "probability": 0.1368095766180404,
            "start_logit": -5.0052642822265625,
            "end_logit": -3.680880308151245,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycobiliproteins (PBPs)",
            "probability": 0.09952104739973863,
            "start_logit": -4.103819847106934,
            "end_logit": -4.900545597076416,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(PBPs",
            "probability": 0.07653765165439398,
            "start_logit": -5.586071491241455,
            "end_logit": -3.680880308151245,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycobiliproteins (PBPs) are a class of water-soluble macromolecules of cyanobacteria",
            "probability": 0.04640347678866323,
            "start_logit": -4.103819847106934,
            "end_logit": -5.663540363311768,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs)",
            "probability": 0.04040383548995311,
            "start_logit": -5.0052642822265625,
            "end_logit": -4.900545597076416,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(PBPs)",
            "probability": 0.022603788146097446,
            "start_logit": -5.586071491241455,
            "end_logit": -4.900545597076416,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are a class of water-soluble macromolecules of cyanobacteria",
            "probability": 0.018839014372510822,
            "start_logit": -5.0052642822265625,
            "end_logit": -5.663540363311768,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are a class of water-soluble macromolecules of cyanobacteria with a wide range of applications",
            "probability": 0.013095599952202382,
            "start_logit": -5.0052642822265625,
            "end_logit": -6.027194023132324,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(PBPs) are a class of water-soluble macromolecules of cyanobacteria",
            "probability": 0.010539422423482738,
            "start_logit": -5.586071491241455,
            "end_logit": -5.663540363311768,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Ultrasound-Assisted Extraction",
            "probability": 0.00959284034239003,
            "start_logit": -5.747025012969971,
            "end_logit": -5.5966925621032715,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Ultrasound-Assisted Extraction and Assessment of Biological Activity",
            "probability": 0.007922917789563418,
            "start_logit": -5.747025012969971,
            "end_logit": -5.787950038909912,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(PBPs) are a class of water-soluble macromolecules of cyanobacteria with a wide range of applications",
            "probability": 0.007326288788578818,
            "start_logit": -5.586071491241455,
            "end_logit": -6.027194023132324,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Ultrasound-Assisted Extraction and Assessment of Biological Activity of Phycobiliprotein-Rich Aqueous Extracts",
            "probability": 0.006430993162388694,
            "start_logit": -5.747025012969971,
            "end_logit": -5.996580600738525,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Extraction",
            "probability": 0.00420538271865411,
            "start_logit": -6.571676731109619,
            "end_logit": -5.5966925621032715,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "water-soluble macromolecules of cyanobacteria",
            "probability": 0.0038401177502268738,
            "start_logit": -6.762118339538574,
            "end_logit": -5.497113227844238,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Assessment of Biological Activity",
            "probability": 0.0034880242759096395,
            "start_logit": -6.56744909286499,
            "end_logit": -5.787950038909912,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Extraction and Assessment of Biological Activity",
            "probability": 0.0034733092978013547,
            "start_logit": -6.571676731109619,
            "end_logit": -5.787950038909912,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Phycobiliprotein-Rich Aqueous Extracts from Wild Cyanobacteria",
            "probability": 0.0033708737738202916,
            "start_logit": -6.395267009735107,
            "end_logit": -5.994295597076416,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        }
    ],
    "554143ad182542114d000004": [
        {
            "text": "consensus methods",
            "probability": 0.7152162287163227,
            "start_logit": 2.9119558334350586,
            "end_logit": 2.618208646774292,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus",
            "probability": 0.21580696580798595,
            "start_logit": 2.9119558334350586,
            "end_logit": 1.4200080633163452,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology prediction methods",
            "probability": 0.03699447488551059,
            "start_logit": 2.9119558334350586,
            "end_logit": -0.34360769391059875,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology prediction",
            "probability": 0.007823500220733562,
            "start_logit": 2.9119558334350586,
            "end_logit": -1.8972442150115967,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "transmembrane helix prediction methods, consensus methods",
            "probability": 0.0063458603459344625,
            "start_logit": -1.81282639503479,
            "end_logit": 2.618208646774292,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "different transmembrane helix prediction methods, consensus methods",
            "probability": 0.0021055309749498778,
            "start_logit": -2.9160614013671875,
            "end_logit": 2.618208646774292,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "helix prediction methods, consensus methods",
            "probability": 0.001958589028338284,
            "start_logit": -2.9884047508239746,
            "end_logit": 2.618208646774292,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "transmembrane helix prediction methods, consensus",
            "probability": 0.001914778792359466,
            "start_logit": -1.81282639503479,
            "end_logit": 1.4200080633163452,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods,",
            "probability": 0.001565892357268247,
            "start_logit": 2.9119558334350586,
            "end_logit": -3.50592041015625,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology",
            "probability": 0.0014205352466816897,
            "start_logit": 2.9119558334350586,
            "end_logit": -3.6033425331115723,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology prediction methods which can enable topology prediction of these proteins.Topology prediction of insect olfactory receptors",
            "probability": 0.0013825750177900878,
            "start_logit": 2.9119558334350586,
            "end_logit": -3.6304285526275635,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "topology prediction methods",
            "probability": 0.0013652636520541533,
            "start_logit": -0.5181198120117188,
            "end_logit": -0.21295306086540222,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "methods",
            "probability": 0.0012293880823519806,
            "start_logit": -3.4541125297546387,
            "end_logit": 2.618208646774292,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "methods, consensus methods",
            "probability": 0.0011491490159710445,
            "start_logit": -3.5216073989868164,
            "end_logit": 2.618208646774292,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "prediction methods, consensus methods",
            "probability": 0.0009145625580270488,
            "start_logit": -3.749938488006592,
            "end_logit": 2.618208646774292,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "different transmembrane helix prediction methods, consensus",
            "probability": 0.0006353159126914724,
            "start_logit": -2.9160614013671875,
            "end_logit": 1.4200080633163452,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "olfactory receptors.In this review, we discuss different transmembrane helix prediction methods, consensus methods",
            "probability": 0.0006065223011742565,
            "start_logit": -3.652618169784546,
            "end_logit": 2.1101839542388916,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "helix prediction methods, consensus",
            "probability": 0.0005909781384982295,
            "start_logit": -2.9884047508239746,
            "end_logit": 1.4200080633163452,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "Topology prediction of insect olfactory receptors.In this review, we discuss different transmembrane helix prediction methods, consensus methods",
            "probability": 0.0005051187872630253,
            "start_logit": -3.8355660438537598,
            "end_logit": 2.1101839542388916,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "topology prediction",
            "probability": 0.00046877015809363863,
            "start_logit": -0.5181198120117188,
            "end_logit": -1.2819433212280273,
            "question_text": "List available methods for transmembrane protein topology prediction."
        }
    ],
    "5319abffb166e2b80600002f": [
        {
            "text": "transforming growth factor \u03b21",
            "probability": 0.80110915043628,
            "start_logit": 4.9243340492248535,
            "end_logit": 3.4053280353546143,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21)",
            "probability": 0.12381632470386554,
            "start_logit": 4.9243340492248535,
            "end_logit": 1.5381300449371338,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21",
            "probability": 0.033877137152338394,
            "start_logit": 4.9243340492248535,
            "end_logit": 0.24207119643688202,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b2",
            "probability": 0.01831700236154857,
            "start_logit": 4.9243340492248535,
            "end_logit": -0.37283945083618164,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21).The majority of studies on TGF\u03b21",
            "probability": 0.011088227120362944,
            "start_logit": 4.9243340492248535,
            "end_logit": -0.8747852444648743,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming",
            "probability": 0.004994711633690307,
            "start_logit": 4.9243340492248535,
            "end_logit": -1.672289490699768,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "TGF\u03b21)",
            "probability": 0.0014842208703772454,
            "start_logit": 0.5004248023033142,
            "end_logit": 1.5381300449371338,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (",
            "probability": 0.0014531678188188155,
            "start_logit": 4.9243340492248535,
            "end_logit": -2.906923294067383,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor",
            "probability": 0.0011475759844181439,
            "start_logit": 4.9243340492248535,
            "end_logit": -3.143017292022705,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth",
            "probability": 0.0008464370215264412,
            "start_logit": 4.9243340492248535,
            "end_logit": -3.4473886489868164,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "growth factor \u03b21",
            "probability": 0.0004061307309765763,
            "start_logit": -2.662743330001831,
            "end_logit": 3.4053280353546143,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "TGF\u03b21",
            "probability": 0.0004060947060930102,
            "start_logit": 0.5004248023033142,
            "end_logit": 0.24207119643688202,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21).",
            "probability": 0.0003752550648450122,
            "start_logit": 4.9243340492248535,
            "end_logit": -4.2608184814453125,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "TGF\u03b21).The majority of studies on TGF\u03b21",
            "probability": 0.00013291767581445475,
            "start_logit": 0.5004248023033142,
            "end_logit": -0.8747852444648743,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "\u03b21",
            "probability": 0.00012700509145712691,
            "start_logit": -3.8251912593841553,
            "end_logit": 3.4053280353546143,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "1",
            "probability": 0.00010355135545893323,
            "start_logit": -4.029350757598877,
            "end_logit": 3.4053280353546143,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "(TGF\u03b21)",
            "probability": 0.00010280990923167449,
            "start_logit": -2.1693387031555176,
            "end_logit": 1.5381300449371338,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "triggered by many factors including transforming growth factor \u03b21",
            "probability": 0.0001013690521178695,
            "start_logit": -4.050650596618652,
            "end_logit": 3.4053280353546143,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "growth factor \u03b21 (TGF\u03b21)",
            "probability": 6.276999136937675e-05,
            "start_logit": -2.662743330001831,
            "end_logit": 1.5381300449371338,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "by many factors including transforming growth factor \u03b21",
            "probability": 4.814131940924836e-05,
            "start_logit": -4.7952775955200195,
            "end_logit": 3.4053280353546143,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        }
    ],
    "5171651e8ed59a060a000009": [
        {
            "text": "prostate cancer",
            "probability": 0.21492451328205378,
            "start_logit": -0.4283111095428467,
            "end_logit": -3.3520638942718506,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate Specific Antigen Monitoring after Holmium Laser Enucleation of the Prostate. Prostate specific antigen screening for prostate cancer",
            "probability": 0.1645270037029975,
            "start_logit": -0.6955232620239258,
            "end_logit": -3.3520638942718506,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer has recently been challenged due to poor sensitivity. In addition to prostate cancer",
            "probability": 0.1154625360124003,
            "start_logit": -0.4283111095428467,
            "end_logit": -3.9734046459198,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate specific antigen screening for prostate cancer",
            "probability": 0.09360937066732088,
            "start_logit": -1.2594674825668335,
            "end_logit": -3.3520638942718506,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate Specific Antigen Monitoring after Holmium Laser Enucleation of the Prostate. Prostate specific antigen",
            "probability": 0.0609757605866934,
            "start_logit": -0.6955232620239258,
            "end_logit": -4.344662189483643,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate Specific Antigen Monitoring after Holmium Laser Enucleation of the Prostate.",
            "probability": 0.05282032083996318,
            "start_logit": -0.6955232620239258,
            "end_logit": -4.4882426261901855,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate specific antigen screening for prostate cancer has recently been challenged due to poor sensitivity. In addition to prostate cancer",
            "probability": 0.05028916974951765,
            "start_logit": -1.2594674825668335,
            "end_logit": -3.9734046459198,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate Specific Antigen",
            "probability": 0.03899394181574265,
            "start_logit": -0.6955232620239258,
            "end_logit": -4.791732311248779,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate specific antigen",
            "probability": 0.03469280085344195,
            "start_logit": -1.2594674825668335,
            "end_logit": -4.344662189483643,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer, a number of conditions elevate prostate specific antigen,",
            "probability": 0.033667169574971206,
            "start_logit": -1.8362129926681519,
            "end_logit": -3.7979257106781006,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate specific antigen density for prostate cancer risk following holmium laser enucleation of the prostate.",
            "probability": 0.02751101756978724,
            "start_logit": -1.0983867645263672,
            "end_logit": -4.7376885414123535,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate specific antigen",
            "probability": 0.021384285428833454,
            "start_logit": -1.0983867645263672,
            "end_logit": -4.98961877822876,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Pro",
            "probability": 0.017333036880279207,
            "start_logit": -0.6955232620239258,
            "end_logit": -5.602524280548096,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate Specific Antigen Monitoring after Holmium Laser Enucleation of the Prostate. Pro",
            "probability": 0.017300016493946472,
            "start_logit": -0.6955232620239258,
            "end_logit": -5.60443115234375,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "pro",
            "probability": 0.012210027122568898,
            "start_logit": -0.4283111095428467,
            "end_logit": -6.220093250274658,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer has recently been challenged due to poor sensitivity.",
            "probability": 0.011890385170576511,
            "start_logit": -0.4283111095428467,
            "end_logit": -6.2466206550598145,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate Specific Antigen Monitoring after Holmium Laser Enucleation of the Prostate",
            "probability": 0.010358610121626838,
            "start_logit": -0.6955232620239258,
            "end_logit": -6.117320537567139,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate Specific Antigen Monitoring after Holmium Laser Enucleation of the Prostate. Prostate specific antigen screening for pro",
            "probability": 0.00934690578999829,
            "start_logit": -0.6955232620239258,
            "end_logit": -6.220093250274658,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer, a number of conditions elevate prostate specific antigen",
            "probability": 0.006659067419157153,
            "start_logit": -1.8362129926681519,
            "end_logit": -5.418469429016113,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer, a number of conditions elevate prostate specific antigen, of which benign prostatic hyperplasia",
            "probability": 0.006044060918123333,
            "start_logit": -1.8362129926681519,
            "end_logit": -5.5153727531433105,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        }
    ],
    "55414c65472cfd8617000001": [
        {
            "text": "MLBioMedLAT",
            "probability": 0.7032014680879803,
            "start_logit": 3.761884927749634,
            "end_logit": 2.9817380905151367,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA",
            "probability": 0.1279063616022819,
            "start_logit": 3.761884927749634,
            "end_logit": 1.277393102645874,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA",
            "probability": 0.04186915498651648,
            "start_logit": 2.6451358795166016,
            "end_logit": 1.277393102645874,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMed",
            "probability": 0.03127110178698139,
            "start_logit": 3.761884927749634,
            "end_logit": -0.13121093809604645,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT)",
            "probability": 0.024747577929538512,
            "start_logit": 3.761884927749634,
            "end_logit": -0.365177720785141,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "multi-labeled corpus (MLBioMedLAT",
            "probability": 0.015540770236827825,
            "start_logit": -0.050291597843170166,
            "end_logit": 2.9817380905151367,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering",
            "probability": 0.011353226823439611,
            "start_logit": 3.761884927749634,
            "end_logit": -1.144403338432312,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "(MLBioMedLAT",
            "probability": 0.008134582398531853,
            "start_logit": -0.6976341009140015,
            "end_logit": 2.9817380905151367,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA)",
            "probability": 0.007197930978531166,
            "start_logit": 3.761884927749634,
            "end_logit": -1.600111722946167,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA) system",
            "probability": 0.005418480990092303,
            "start_logit": 3.761884927749634,
            "end_logit": -1.8840898275375366,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA) system for the task of biomedical question classification",
            "probability": 0.004577640106585984,
            "start_logit": 3.761884927749634,
            "end_logit": -2.0527217388153076,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "multi-labeled corpus (MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA",
            "probability": 0.00282673382763897,
            "start_logit": -0.050291597843170166,
            "end_logit": 1.277393102645874,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement",
            "probability": 0.002680328544679305,
            "start_logit": 3.761884927749634,
            "end_logit": -2.587965965270996,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA)",
            "probability": 0.0023561868537818925,
            "start_logit": 2.6451358795166016,
            "end_logit": -1.600111722946167,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question",
            "probability": 0.002347460962270167,
            "start_logit": 3.761884927749634,
            "end_logit": -2.7205710411071777,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "(OAQA",
            "probability": 0.0020893847152112024,
            "start_logit": -0.3525438904762268,
            "end_logit": 1.277393102645874,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA) system",
            "probability": 0.0017736977076331793,
            "start_logit": 2.6451358795166016,
            "end_logit": -1.8840898275375366,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "a multi-labeled corpus (MLBioMedLAT",
            "probability": 0.0017298451934582128,
            "start_logit": -2.2457265853881836,
            "end_logit": 2.9817380905151367,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA) system for the task of biomedical question classification",
            "probability": 0.0014984549688865755,
            "start_logit": 2.6451358795166016,
            "end_logit": -2.0527217388153076,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "(MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA",
            "probability": 0.0014796112991334028,
            "start_logit": -0.6976341009140015,
            "end_logit": 1.277393102645874,
            "question_text": "List available biomedical question answering systems."
        }
    ],
    "530e1c985937551c09000004": [
        {
            "text": "coronary syndromes",
            "probability": 0.22668757260446204,
            "start_logit": 0.26078328490257263,
            "end_logit": -1.2390204668045044,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary syndrome",
            "probability": 0.21069729028469245,
            "start_logit": 0.26078328490257263,
            "end_logit": -1.3121707439422607,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary",
            "probability": 0.11839869548892529,
            "start_logit": 0.26078328490257263,
            "end_logit": -1.888535499572754,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary syndromes",
            "probability": 0.09375812849742492,
            "start_logit": -0.6220710873603821,
            "end_logit": -1.2390204668045044,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary syndrome",
            "probability": 0.08714453725718967,
            "start_logit": -0.6220710873603821,
            "end_logit": -1.3121707439422607,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary",
            "probability": 0.04896977799902399,
            "start_logit": -0.6220710873603821,
            "end_logit": -1.888535499572754,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary syndromes in the emergency department",
            "probability": 0.030114498241579007,
            "start_logit": 0.26078328490257263,
            "end_logit": -3.2575864791870117,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary syndromes in the emergency department.",
            "probability": 0.029474302253740547,
            "start_logit": 0.26078328490257263,
            "end_logit": -3.2790744304656982,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "symptoms of acute coronary syndromes",
            "probability": 0.02365743501346847,
            "start_logit": -1.9991120100021362,
            "end_logit": -1.2390204668045044,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "symptoms of acute coronary syndrome",
            "probability": 0.021988666582624564,
            "start_logit": -1.9991120100021362,
            "end_logit": -1.3121707439422607,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "symptoms",
            "probability": 0.016930184499295443,
            "start_logit": -1.9991120100021362,
            "end_logit": -1.5735998153686523,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary syndromes in the emergency department",
            "probability": 0.012455376196100591,
            "start_logit": -0.6220710873603821,
            "end_logit": -3.2575864791870117,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "symptoms of acute coronary",
            "probability": 0.012356254963725164,
            "start_logit": -1.9991120100021362,
            "end_logit": -1.888535499572754,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary syndromes in the emergency department.",
            "probability": 0.012190590716236517,
            "start_logit": -0.6220710873603821,
            "end_logit": -3.2790744304656982,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "co",
            "probability": 0.01132027682841016,
            "start_logit": 0.26078328490257263,
            "end_logit": -4.235997676849365,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute",
            "probability": 0.009919227124313649,
            "start_logit": -0.6220710873603821,
            "end_logit": -3.4852638244628906,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "corona",
            "probability": 0.009713813253912445,
            "start_logit": 0.26078328490257263,
            "end_logit": -4.389044284820557,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary syndromes in the emergency",
            "probability": 0.008670808306234496,
            "start_logit": 0.26078328490257263,
            "end_logit": -4.502631187438965,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "ronary syndromes",
            "probability": 0.008060573775698241,
            "start_logit": -3.0758047103881836,
            "end_logit": -1.2390204668045044,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "ronary syndrome",
            "probability": 0.00749199011294209,
            "start_logit": -3.0758047103881836,
            "end_logit": -1.3121707439422607,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        }
    ],
    "5713b0a51174fb175500000e": [
        {
            "text": "nonsyndromic sensorineural deafness",
            "probability": 0.13035863338003378,
            "start_logit": 4.399615287780762,
            "end_logit": 4.550184726715088,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.12879101579670765,
            "start_logit": 4.449985027313232,
            "end_logit": 4.4877166748046875,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.12246451549253237,
            "start_logit": 4.399615287780762,
            "end_logit": 4.4877166748046875,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease-5",
            "probability": 0.09973942566495744,
            "start_logit": 4.449985027313232,
            "end_logit": 4.232086658477783,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.0987130358605564,
            "start_logit": 4.121542930603027,
            "end_logit": 4.550184726715088,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease-5",
            "probability": 0.09484000389314974,
            "start_logit": 4.399615287780762,
            "end_logit": 4.232086658477783,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.0927352780250271,
            "start_logit": 4.121542930603027,
            "end_logit": 4.4877166748046875,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts Syndrome",
            "probability": 0.07967381106982786,
            "start_logit": 3.9697349071502686,
            "end_logit": 4.4877166748046875,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease-5",
            "probability": 0.07181683684905603,
            "start_logit": 4.121542930603027,
            "end_logit": 4.232086658477783,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease",
            "probability": 0.014388178251518047,
            "start_logit": 4.449985027313232,
            "end_logit": 2.2959325313568115,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease",
            "probability": 0.013681399028435905,
            "start_logit": 4.399615287780762,
            "end_logit": 2.2959325313568115,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease",
            "probability": 0.010360130341190177,
            "start_logit": 4.121542930603027,
            "end_logit": 2.2959325313568115,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness",
            "probability": 0.007664731506241374,
            "start_logit": 1.565955400466919,
            "end_logit": 4.550184726715088,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness, Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.007200578940987624,
            "start_logit": 1.565955400466919,
            "end_logit": 4.4877166748046875,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness, Charcot-Marie-Tooth disease-5",
            "probability": 0.005576333128414167,
            "start_logit": 1.565955400466919,
            "end_logit": 4.232086658477783,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease-5,",
            "probability": 0.00538353511737256,
            "start_logit": 4.449985027313232,
            "end_logit": 1.3128708600997925,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease-5,",
            "probability": 0.0051190839338260555,
            "start_logit": 4.399615287780762,
            "end_logit": 1.3128708600997925,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness,",
            "probability": 0.004334683613687311,
            "start_logit": 4.399615287780762,
            "end_logit": 1.1465439796447754,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease-5,",
            "probability": 0.0038763854976893784,
            "start_logit": 4.121542930603027,
            "end_logit": 1.3128708600997925,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness,",
            "probability": 0.0032824046087891775,
            "start_logit": 4.121542930603027,
            "end_logit": 1.1465439796447754,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        }
    ],
    "56c8605b5795f9a73e000014": [
        {
            "text": "Janus kinase (JAK)1/JAK2",
            "probability": 0.4168977017627467,
            "start_logit": 4.258037090301514,
            "end_logit": 4.330785274505615,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK2",
            "probability": 0.3438768287474528,
            "start_logit": 4.065479755401611,
            "end_logit": 4.330785274505615,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)1",
            "probability": 0.07354347587722818,
            "start_logit": 4.258037090301514,
            "end_logit": 2.5958211421966553,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK)1/JAK2",
            "probability": 0.055839411312310766,
            "start_logit": 2.983768939971924,
            "end_logit": 3.5946924686431885,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase",
            "probability": 0.024349982554395126,
            "start_logit": 4.258037090301514,
            "end_logit": 1.4904755353927612,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)1/JAK",
            "probability": 0.01858465951905787,
            "start_logit": 4.258037090301514,
            "end_logit": 1.2202808856964111,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK)1",
            "probability": 0.01718316950959627,
            "start_logit": 2.983768939971924,
            "end_logit": 2.4161429405212402,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK",
            "probability": 0.015329501102411346,
            "start_logit": 4.065479755401611,
            "end_logit": 1.2202808856964111,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "(JAK)1/JAK2",
            "probability": 0.008642735251714138,
            "start_logit": 1.1180081367492676,
            "end_logit": 3.5946924686431885,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "1/JAK2",
            "probability": 0.004524833115898902,
            "start_logit": -0.26522308588027954,
            "end_logit": 4.330785274505615,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK",
            "probability": 0.0035183258246852672,
            "start_logit": 4.31215238571167,
            "end_logit": -0.4981856346130371,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "AAK1",
            "probability": 0.003053592743672849,
            "start_logit": 2.302689552307129,
            "end_logit": 1.3696107864379883,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)",
            "probability": 0.0028745383127562222,
            "start_logit": 4.31215238571167,
            "end_logit": -0.7002788186073303,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "(JAK)1",
            "probability": 0.002659583641133869,
            "start_logit": 1.1180081367492676,
            "end_logit": 2.4161429405212402,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus",
            "probability": 0.0026247704418171543,
            "start_logit": 4.258037090301514,
            "end_logit": -0.7370621562004089,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "AAK1, BIKE, and GAK",
            "probability": 0.0015817650723314422,
            "start_logit": 2.302689552307129,
            "end_logit": 0.7118332982063293,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK)1/JAK",
            "probability": 0.0015601025103908154,
            "start_logit": 2.983768939971924,
            "end_logit": 0.016964083537459373,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)1/JAK2 inhibitor",
            "probability": 0.00144160233068606,
            "start_logit": 4.31215238571167,
            "end_logit": -1.3904156684875488,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "AAK",
            "probability": 0.0009695783266046098,
            "start_logit": 2.302689552307129,
            "end_logit": 0.22239792346954346,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "kinase (JAK)1/JAK2",
            "probability": 0.0009438420431100853,
            "start_logit": -1.8326002359390259,
            "end_logit": 4.330785274505615,
            "question_text": "Which kinases does baricitinib inhibit?"
        }
    ],
    "550b0408c2af5d5b7000000c": [
        {
            "text": "shell",
            "probability": 0.6443127704306306,
            "start_logit": 3.15004563331604,
            "end_logit": 3.2741446495056152,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic, shell",
            "probability": 0.1141502420453453,
            "start_logit": 1.4193768501281738,
            "end_logit": 3.2741446495056152,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid",
            "probability": 0.09243058678050527,
            "start_logit": 3.15004563331604,
            "end_logit": 1.3324183225631714,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid (magnetic material dispersed in matrix)",
            "probability": 0.023138205146650936,
            "start_logit": 3.15004563331604,
            "end_logit": -0.05255447328090668,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "superparamagnetic/paramagnetic, shell",
            "probability": 0.021069073977329825,
            "start_logit": -0.27033236622810364,
            "end_logit": 3.2741446495056152,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "solid",
            "probability": 0.01820199609005888,
            "start_logit": 1.5251189470291138,
            "end_logit": 1.3324183225631714,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic, shell (coated with magnetic material), and solid",
            "probability": 0.01637554668726519,
            "start_logit": 1.4193768501281738,
            "end_logit": 1.3324183225631714,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material)",
            "probability": 0.01199715085426852,
            "start_logit": 3.15004563331604,
            "end_logit": -0.7093704342842102,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid (magnetic material",
            "probability": 0.008157180431184121,
            "start_logit": 3.15004563331604,
            "end_logit": -1.095141053199768,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "paramagnetic, shell",
            "probability": 0.007422849535126094,
            "start_logit": -1.3135756254196167,
            "end_logit": 3.2741446495056152,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic",
            "probability": 0.006928467717826886,
            "start_logit": 1.4193768501281738,
            "end_logit": 0.47226783633232117,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic",
            "probability": 0.006774000260268467,
            "start_logit": 1.4193768501281738,
            "end_logit": 0.44972094893455505,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material",
            "probability": 0.0066705353241432504,
            "start_logit": 3.15004563331604,
            "end_logit": -1.296339511871338,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid (magnetic material dispersed in matrix",
            "probability": 0.006073307716031084,
            "start_logit": 3.15004563331604,
            "end_logit": -1.3901362419128418,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "solid (magnetic material dispersed in matrix)",
            "probability": 0.004556516779564019,
            "start_logit": 1.5251189470291138,
            "end_logit": -0.05255447328090668,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic",
            "probability": 0.00331192699688879,
            "start_logit": 1.4193768501281738,
            "end_logit": -0.26584064960479736,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "superparamagnetic/paramagnetic, shell (coated with magnetic material), and solid",
            "probability": 0.003022486841825119,
            "start_logit": -0.27033236622810364,
            "end_logit": 1.3324183225631714,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic, shell (coated with magnetic material)",
            "probability": 0.002125485845878816,
            "start_logit": 1.4193768501281738,
            "end_logit": -0.7093704342842102,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid (magnetic material dispersed in matrix).",
            "probability": 0.0016753087115283728,
            "start_logit": 3.15004563331604,
            "end_logit": -2.67804217338562,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "solid (magnetic material",
            "probability": 0.0016063618276805506,
            "start_logit": 1.5251189470291138,
            "end_logit": -1.095141053199768,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        }
    ],
    "53188992b166e2b806000019": [
        {
            "text": "2",
            "probability": 0.40770273755889935,
            "start_logit": -4.022818088531494,
            "end_logit": 0.14304065704345703,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "cyclo-oxygenase-2",
            "probability": 0.34295819547249334,
            "start_logit": -4.1957478523254395,
            "end_logit": 0.14304065704345703,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "oxygenase-2",
            "probability": 0.13086930282512396,
            "start_logit": -5.1591572761535645,
            "end_logit": 0.14304065704345703,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "imatinib mesylate) and cyclo-oxygenase-2",
            "probability": 0.04978938712399876,
            "start_logit": -6.12555456161499,
            "end_logit": 0.14304065704345703,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "clo-oxygenase-2",
            "probability": 0.04216583404972595,
            "start_logit": -6.291746139526367,
            "end_logit": 0.14304065704345703,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": ") and cyclo-oxygenase-2",
            "probability": 0.015193649248111769,
            "start_logit": -6.9215312004089355,
            "end_logit": -0.24790702760219574,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "2 inhibitors are discussed in",
            "probability": 0.0013225942139183753,
            "start_logit": -4.022818088531494,
            "end_logit": -5.587902545928955,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "cyclo-oxygenase-2 inhibitors are discussed in",
            "probability": 0.0011125618818840473,
            "start_logit": -4.1957478523254395,
            "end_logit": -5.587902545928955,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "cyclo-oxygenase-2 inhibitors are discussed in relation to their potential synergistic and additive effects.",
            "probability": 0.0010234231639739838,
            "start_logit": -4.381539821624756,
            "end_logit": -5.485622882843018,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "2 inhibitors are discussed in relation",
            "probability": 0.0010176197191531866,
            "start_logit": -4.022818088531494,
            "end_logit": -5.85003137588501,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "2 inhibitors are discussed in relation to their potential synergistic and additive effects.imatinib mesylate",
            "probability": 0.0009918761482773696,
            "start_logit": -4.022818088531494,
            "end_logit": -5.875654697418213,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "cyclo-oxygenase-2 inhibitors are discussed in relation",
            "probability": 0.0008560183447568425,
            "start_logit": -4.1957478523254395,
            "end_logit": -5.85003137588501,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "2 inhibitors are discussed in relation to their potential synergistic and additive effects.imatinib mesylate)",
            "probability": 0.0007942610300264214,
            "start_logit": -4.022818088531494,
            "end_logit": -6.097840785980225,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "in",
            "probability": 0.0007397624281067672,
            "start_logit": -4.60383939743042,
            "end_logit": -5.587902545928955,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "2 inhibitors are discussed in relation to their potential synergistic and additive effects.",
            "probability": 0.0006474423409063674,
            "start_logit": -4.839418411254883,
            "end_logit": -5.485622882843018,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "cyclo-oxygenase",
            "probability": 0.0006042099467391213,
            "start_logit": -4.1957478523254395,
            "end_logit": -6.19840145111084,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "in relation",
            "probability": 0.0005691820109357798,
            "start_logit": -4.60383939743042,
            "end_logit": -5.85003137588501,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "in relation to their potential synergistic and additive effects.",
            "probability": 0.0005670348979701222,
            "start_logit": -4.97202730178833,
            "end_logit": -5.485622882843018,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "in relation to their potential synergistic and additive effects.imatinib mesylate",
            "probability": 0.0005547829410632359,
            "start_logit": -4.60383939743042,
            "end_logit": -5.875654697418213,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "2 inhibitors are",
            "probability": 0.0005201246539355545,
            "start_logit": -4.022818088531494,
            "end_logit": -6.52118444442749,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        }
    ],
    "52ebb2c698d0239505000029": [
        {
            "text": "Pulmonary lymphangioleiomyomatosis",
            "probability": 0.6517084393288957,
            "start_logit": 5.148334503173828,
            "end_logit": 5.2082061767578125,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphangioleiomyomatosis",
            "probability": 0.33290644994609875,
            "start_logit": 4.476598739624023,
            "end_logit": 5.2082061767578125,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangioleiomyomatosis (PLAM)",
            "probability": 0.007750418097810319,
            "start_logit": 5.148334503173828,
            "end_logit": 0.7763556838035583,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphangioleiomyomatosis (PLAM)",
            "probability": 0.0039590774322287164,
            "start_logit": 4.476598739624023,
            "end_logit": 0.7763556838035583,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangioleiomyomatosis (PLAM",
            "probability": 0.0004903018627547089,
            "start_logit": 5.148334503173828,
            "end_logit": -1.9841251373291016,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymph",
            "probability": 0.0004274871064534216,
            "start_logit": 5.148334503173828,
            "end_logit": -2.1212222576141357,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary",
            "probability": 0.0003677891820464984,
            "start_logit": 5.148334503173828,
            "end_logit": -2.271636486053467,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphang",
            "probability": 0.0002981991024978129,
            "start_logit": 5.148334503173828,
            "end_logit": -2.4813849925994873,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "angioleiomyomatosis",
            "probability": 0.00027226461033268184,
            "start_logit": -2.6322436332702637,
            "end_logit": 5.2082061767578125,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphangioleiomyomatosis (PLAM",
            "probability": 0.0002504565579965666,
            "start_logit": 4.476598739624023,
            "end_logit": -1.9841251373291016,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "tosis",
            "probability": 0.00022236079423063778,
            "start_logit": -2.834716796875,
            "end_logit": 5.2082061767578125,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymph",
            "probability": 0.0002183694523791763,
            "start_logit": 4.476598739624023,
            "end_logit": -2.1212222576141357,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "ymphangioleiomyomatosis",
            "probability": 0.00016699715241507332,
            "start_logit": -3.1210412979125977,
            "end_logit": 5.2082061767578125,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "omyomatosis",
            "probability": 0.00016340087248682328,
            "start_logit": -3.1428115367889404,
            "end_logit": 5.2082061767578125,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphang",
            "probability": 0.0001523264064094162,
            "start_logit": 4.476598739624023,
            "end_logit": -2.4813849925994873,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangiolei",
            "probability": 0.00014929732947743807,
            "start_logit": 5.148334503173828,
            "end_logit": -3.1732065677642822,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary l",
            "probability": 0.00013912531455872012,
            "start_logit": 5.148334503173828,
            "end_logit": -3.2437713146209717,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangiol",
            "probability": 0.0001370756928219123,
            "start_logit": 5.148334503173828,
            "end_logit": -3.258613109588623,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangioleiomyomatosis (PLAM) is a disease strongly associated with tuberous sclerosis.In PLAM",
            "probability": 0.00013095939631730717,
            "start_logit": 5.148334503173828,
            "end_logit": -3.3042590618133545,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangioleiomy",
            "probability": 8.920436178835563e-05,
            "start_logit": 5.148334503173828,
            "end_logit": -3.6882164478302,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        }
    ],
    "57220e400fd6f91b68000015": [
        {
            "text": "Thymic Small Cell Carcinoma",
            "probability": 0.4869094763441712,
            "start_logit": -1.277305006980896,
            "end_logit": 0.7724356055259705,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "thymic epithelial tumors",
            "probability": 0.19475540946390305,
            "start_logit": -1.9126590490341187,
            "end_logit": 0.49145588278770447,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "Anticholinesterase treatment alleviated his symptoms.Thymic Small Cell Carcinoma",
            "probability": 0.08465006331069576,
            "start_logit": -3.026857376098633,
            "end_logit": 0.7724356055259705,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "Small Cell Carcinoma",
            "probability": 0.058279732487353644,
            "start_logit": -3.4001288414001465,
            "end_logit": 0.7724356055259705,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "symptoms had not improved.Anticholinesterase treatment alleviated his symptoms.Thymic Small Cell Carcinoma",
            "probability": 0.033801788466825855,
            "start_logit": -3.9448695182800293,
            "end_logit": 0.7724356055259705,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "thymic small cell carcinoma",
            "probability": 0.029654822963568587,
            "start_logit": -2.5463273525238037,
            "end_logit": -0.7569954991340637,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "thymic small cell carcinoma.Based on radiologic findings thymoma",
            "probability": 0.013207171837705893,
            "start_logit": -2.5463273525238037,
            "end_logit": -1.5658602714538574,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "associated with thymic epithelial tumors",
            "probability": 0.012428544211878821,
            "start_logit": -4.664407730102539,
            "end_logit": 0.49145588278770447,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "small cell carcinoma",
            "probability": 0.012185488187453068,
            "start_logit": -3.435706377029419,
            "end_logit": -0.7569954991340637,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "surgery the patient's symptoms had not improved.Anticholinesterase treatment alleviated his symptoms.Thymic Small Cell Carcinoma",
            "probability": 0.012065773855358338,
            "start_logit": -4.975010395050049,
            "end_logit": 0.7724356055259705,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "thymoma",
            "probability": 0.010558482249581893,
            "start_logit": -2.770157814025879,
            "end_logit": -1.5658602714538574,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "Carcinoma",
            "probability": 0.009861589421890929,
            "start_logit": -5.176735877990723,
            "end_logit": 0.7724356055259705,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "tumors",
            "probability": 0.009790697684196822,
            "start_logit": -4.902970790863037,
            "end_logit": 0.49145588278770447,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "rare paraneoplastic syndrome associated with thymic epithelial tumors",
            "probability": 0.009271520574939938,
            "start_logit": -4.957456111907959,
            "end_logit": 0.49145588278770447,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "paraneoplastic syndrome associated with thymic epithelial tumors",
            "probability": 0.006250063502000916,
            "start_logit": -5.35181188583374,
            "end_logit": 0.49145588278770447,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "small cell carcinoma.Based on radiologic findings thymoma",
            "probability": 0.005426970062028027,
            "start_logit": -3.435706377029419,
            "end_logit": -1.5658602714538574,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "Thymic Small Cell Carcinoma Associated With Lambert-Eaton Myasthenic Syndrome.",
            "probability": 0.005009707838883056,
            "start_logit": -1.277305006980896,
            "end_logit": -3.804265022277832,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "tumors.We report an extremely rare case of Lambert-Eaton myasthenic syndrome associated with thymic small cell carcinoma",
            "probability": 0.002809429216931733,
            "start_logit": -4.902970790863037,
            "end_logit": -0.7569954991340637,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "associated with thymic small cell carcinoma",
            "probability": 0.0019549121331379677,
            "start_logit": -5.265606880187988,
            "end_logit": -0.7569954991340637,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "thymic small cell carcinoma.",
            "probability": 0.0011283561874946765,
            "start_logit": -2.5463273525238037,
            "end_logit": -4.025858402252197,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        }
    ],
    "5162c8a8298dcd4e51000047": [
        {
            "text": "PDE12",
            "probability": 0.3119094903420432,
            "start_logit": 3.7239880561828613,
            "end_logit": 1.9044142961502075,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12/CNOT6L",
            "probability": 0.26788295262087136,
            "start_logit": 3.7239880561828613,
            "end_logit": 1.752251386642456,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT6L",
            "probability": 0.10304351174686752,
            "start_logit": 2.7685892581939697,
            "end_logit": 1.752251386642456,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "NOCT",
            "probability": 0.07584235189643365,
            "start_logit": 2.152315139770508,
            "end_logit": 2.0620310306549072,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "NOCT and absent in the deadenylases PDE12",
            "probability": 0.0647827998851877,
            "start_logit": 2.152315139770508,
            "end_logit": 1.9044142961502075,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "NOCT, an unexpectedly narrow active site pocket, and conserved structural elements in the vicinity of the catalytic center, which are unique to NOCT",
            "probability": 0.05901397281141812,
            "start_logit": 1.9014325141906738,
            "end_logit": 2.0620310306549072,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "NOCT and absent in the deadenylases PDE12/CNOT6L",
            "probability": 0.05563860109950591,
            "start_logit": 2.152315139770508,
            "end_logit": 1.752251386642456,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12/CNOT6L.Our work thus reveals the structure of an intriguing circadian protein and suggests that NOCT",
            "probability": 0.0234692287936795,
            "start_logit": 3.7239880561828613,
            "end_logit": -0.6826086044311523,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT6L.Our work thus reveals the structure of an intriguing circadian protein and suggests that NOCT",
            "probability": 0.009027643339119354,
            "start_logit": 2.7685892581939697,
            "end_logit": -0.6826086044311523,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12/CNOT6",
            "probability": 0.008512313662527889,
            "start_logit": 3.7239880561828613,
            "end_logit": -1.6967849731445312,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12/CNOT",
            "probability": 0.0054466713385972285,
            "start_logit": 3.7239880561828613,
            "end_logit": -2.143294095993042,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT6",
            "probability": 0.0032743356167165578,
            "start_logit": 2.7685892581939697,
            "end_logit": -1.6967849731445312,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12/CNOT6L.",
            "probability": 0.0021592347788163737,
            "start_logit": 3.7239880561828613,
            "end_logit": -3.068544864654541,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT",
            "probability": 0.0020951095863661995,
            "start_logit": 2.7685892581939697,
            "end_logit": -2.143294095993042,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE",
            "probability": 0.0018493372864902204,
            "start_logit": 3.7239880561828613,
            "end_logit": -3.2234714031219482,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "NOCT and absent in the deadenylases PDE12/CNOT6",
            "probability": 0.0017679856805728038,
            "start_logit": 2.152315139770508,
            "end_logit": -1.6967849731445312,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12/C",
            "probability": 0.0012988417390464083,
            "start_logit": 3.7239880561828613,
            "end_logit": -3.5768258571624756,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "NOCT and absent in the deadenylases PDE12/CNOT",
            "probability": 0.0011312596451675519,
            "start_logit": 2.152315139770508,
            "end_logit": -2.143294095993042,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "P",
            "probability": 0.0009707817616002244,
            "start_logit": 3.7239880561828613,
            "end_logit": -3.867952346801758,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "deadenylases PDE12",
            "probability": 0.0008835763689722068,
            "start_logit": -2.142502546310425,
            "end_logit": 1.9044142961502075,
            "question_text": "What are the known families of deadenylases?"
        }
    ],
    "56a3bf0f496b62f23f00000a": [
        {
            "text": "CNVRanger",
            "probability": 0.9828399116166991,
            "start_logit": 4.574653148651123,
            "end_logit": 4.105411052703857,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "association analysis of CNVs with gene expression and quantitative phenotypes.We present the CNVRanger",
            "probability": 0.004160984687393264,
            "start_logit": -0.8900413513183594,
            "end_logit": 4.105411052703857,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVs with gene expression and quantitative phenotypes.We present the CNVRanger",
            "probability": 0.0025475347582265607,
            "start_logit": -1.380666971206665,
            "end_logit": 4.105411052703857,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "C",
            "probability": 0.0017819368972300808,
            "start_logit": 4.574653148651123,
            "end_logit": -2.207334280014038,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R",
            "probability": 0.0017010050935789061,
            "start_logit": 4.191734790802002,
            "end_logit": -1.8708975315093994,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRang",
            "probability": 0.0015401456065738492,
            "start_logit": 4.574653148651123,
            "end_logit": -2.3531582355499268,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNV",
            "probability": 0.0010321339283295811,
            "start_logit": 4.574653148651123,
            "end_logit": -2.7534067630767822,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes.We present the C",
            "probability": 0.0006305840288574385,
            "start_logit": 3.5358433723449707,
            "end_logit": -2.207334280014038,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes.We present the CNVRang",
            "probability": 0.0005450199853485736,
            "start_logit": 3.5358433723449707,
            "end_logit": -2.3531582355499268,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R/Bioconductor package",
            "probability": 0.0004622699999971006,
            "start_logit": 4.574653148651123,
            "end_logit": -3.5566413402557373,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "gene expression and quantitative phenotypes.We present the CNVRanger",
            "probability": 0.0004022434111850083,
            "start_logit": -3.2264909744262695,
            "end_logit": 4.105411052703857,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "the CNVRanger",
            "probability": 0.0003959316799432862,
            "start_logit": -3.242306709289551,
            "end_logit": 4.105411052703857,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes.We present the CNV",
            "probability": 0.0003652470364456939,
            "start_logit": 3.5358433723449707,
            "end_logit": -2.7534067630767822,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger: association",
            "probability": 0.00035481728968000443,
            "start_logit": 3.5358433723449707,
            "end_logit": -2.7823777198791504,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes",
            "probability": 0.00033314711566287235,
            "start_logit": 3.5358433723449707,
            "end_logit": -2.8453965187072754,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger: association analysis",
            "probability": 0.0002654126230283595,
            "start_logit": 3.5358433723449707,
            "end_logit": -3.072695016860962,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R/Bioconductor",
            "probability": 0.00023642504293626626,
            "start_logit": 4.191734790802002,
            "end_logit": -3.84424090385437,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "er",
            "probability": 0.00014587845117449206,
            "start_logit": -4.240774631500244,
            "end_logit": 4.105411052703857,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "genome-wide association analysis with gene expression and quantitative phenotypes.We present the CNVRanger",
            "probability": 0.00014261402642114866,
            "start_logit": -4.095983982086182,
            "end_logit": 3.937988519668579,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "association analysis with gene expression and quantitative phenotypes.We present the CNVRanger",
            "probability": 0.00011675672128828832,
            "start_logit": -4.2960333824157715,
            "end_logit": 3.937988519668579,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        }
    ],
    "56c3326750c68dd41600000b": [
        {
            "text": "H2B",
            "probability": 0.427941544614178,
            "start_logit": 3.608985662460327,
            "end_logit": 2.3321592807769775,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitination",
            "probability": 0.27564051500323067,
            "start_logit": 3.608985662460327,
            "end_logit": 1.8922702074050903,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub1 levels are negatively correlated with the accessibility of enhancers to transcriptional activators.Histone H2B",
            "probability": 0.09821232170443656,
            "start_logit": 2.1371307373046875,
            "end_logit": 2.3321592807769775,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H2B",
            "probability": 0.08004873662984438,
            "start_logit": 1.932634711265564,
            "end_logit": 2.3321592807769775,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H2B monoubiquitination",
            "probability": 0.051560020913373285,
            "start_logit": 1.932634711265564,
            "end_logit": 1.8922702074050903,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "monoubiquitination",
            "probability": 0.027401227932022022,
            "start_logit": 1.3004759550094604,
            "end_logit": 1.8922702074050903,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub1",
            "probability": 0.026588147859655166,
            "start_logit": 2.1371307373046875,
            "end_logit": 1.0254931449890137,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B mon",
            "probability": 0.0031390744503244816,
            "start_logit": 3.608985662460327,
            "end_logit": -2.582899332046509,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H",
            "probability": 0.0017007279215209311,
            "start_logit": 3.608985662460327,
            "end_logit": -3.1957709789276123,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitination has mainly been described as a regulator of transcription elongation,",
            "probability": 0.0014401681339494467,
            "start_logit": 3.608985662460327,
            "end_logit": -3.362067461013794,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitination has mainly been described as a regulator",
            "probability": 0.0007960390543210901,
            "start_logit": 3.608985662460327,
            "end_logit": -3.9549343585968018,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub1 levels are negatively correlated with the accessibility of enhancers to transcriptional activators.Histone H2B mon",
            "probability": 0.0007204156587493686,
            "start_logit": 2.1371307373046875,
            "end_logit": -2.582899332046509,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitination has mainly been described as a regulator of transcription elongation",
            "probability": 0.0007096414327817095,
            "start_logit": 3.608985662460327,
            "end_logit": -4.069822788238525,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "tone H2B",
            "probability": 0.0006844103234935383,
            "start_logit": -2.8291985988616943,
            "end_logit": 2.3321592807769775,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub",
            "probability": 0.0006589881661359102,
            "start_logit": 2.1371307373046875,
            "end_logit": -2.6720221042633057,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitina",
            "probability": 0.000655622274994514,
            "start_logit": 3.608985662460327,
            "end_logit": -4.148997783660889,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub1 levels are negatively correlated with the accessibility of enhancers to transcriptional activators.Histone",
            "probability": 0.0005906790927956119,
            "start_logit": 2.1371307373046875,
            "end_logit": -2.7814548015594482,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H2B mon",
            "probability": 0.0005871805322431248,
            "start_logit": 1.932634711265564,
            "end_logit": -2.582899332046509,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone",
            "probability": 0.00048143770874541314,
            "start_logit": 1.932634711265564,
            "end_logit": -2.7814548015594482,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub1 levels are negatively correlated with the accessibility of enhancers to transcriptional activators.His",
            "probability": 0.00044310059320490185,
            "start_logit": 2.1371307373046875,
            "end_logit": -3.0689308643341064,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        }
    ],
    "534df8c9aeec6fbd07000016": [
        {
            "text": "autoimmune diseases",
            "probability": 0.27027990941931035,
            "start_logit": 4.476626873016357,
            "end_logit": 3.371772289276123,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases and cancers",
            "probability": 0.2634701146358837,
            "start_logit": 4.476626873016357,
            "end_logit": 3.3462541103363037,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune",
            "probability": 0.15500334311610964,
            "start_logit": 4.476626873016357,
            "end_logit": 2.815760850906372,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "cancers",
            "probability": 0.1375395124379311,
            "start_logit": 3.8265981674194336,
            "end_logit": 3.3462541103363037,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases and cancer",
            "probability": 0.09355302130116566,
            "start_logit": 4.476626873016357,
            "end_logit": 2.310842514038086,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "cancer",
            "probability": 0.04883755774213808,
            "start_logit": 3.8265981674194336,
            "end_logit": 2.310842514038086,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune diseases",
            "probability": 0.006690643989599394,
            "start_logit": 0.7778788805007935,
            "end_logit": 3.371772289276123,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune diseases and cancers",
            "probability": 0.0065220709253415755,
            "start_logit": 0.7778788805007935,
            "end_logit": 3.3462541103363037,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune",
            "probability": 0.0038370302410406136,
            "start_logit": 0.7778788805007935,
            "end_logit": 2.815760850906372,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases and cancers.",
            "probability": 0.0025934496173893227,
            "start_logit": 4.476626873016357,
            "end_logit": -1.274696946144104,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune diseases and cancer",
            "probability": 0.002315858256066102,
            "start_logit": 0.7778788805007935,
            "end_logit": 2.310842514038086,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "diseases",
            "probability": 0.0016130612371487928,
            "start_logit": -0.6446974873542786,
            "end_logit": 3.371772289276123,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "diseases and cancers",
            "probability": 0.00157241960743357,
            "start_logit": -0.6446974873542786,
            "end_logit": 3.3462541103363037,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "cancers.",
            "probability": 0.0013538605560673516,
            "start_logit": 3.8265981674194336,
            "end_logit": -1.274696946144104,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "in many autoimmune diseases",
            "probability": 0.0010030650537181053,
            "start_logit": -1.119770884513855,
            "end_logit": 3.371772289276123,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "in many autoimmune diseases and cancers",
            "probability": 0.0009777924865305453,
            "start_logit": -1.119770884513855,
            "end_logit": 3.3462541103363037,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases and cancers.Peptidyl arginine deiminases",
            "probability": 0.0008054576216141749,
            "start_logit": 4.476626873016357,
            "end_logit": -2.444030523300171,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "auto",
            "probability": 0.0007201259293596902,
            "start_logit": 4.476626873016357,
            "end_logit": -2.5560150146484375,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "ne diseases",
            "probability": 0.0006642205450101962,
            "start_logit": -1.5319722890853882,
            "end_logit": 3.371772289276123,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "ne diseases and cancers",
            "probability": 0.0006474852811418117,
            "start_logit": -1.5319722890853882,
            "end_logit": 3.3462541103363037,
            "question_text": "List diseases where protein citrullination plays an important role."
        }
    ],
    "56e30dd551531f7e33000016": [
        {
            "text": "clock",
            "probability": 0.6628161352606703,
            "start_logit": 1.2438288927078247,
            "end_logit": 2.0840675830841064,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock",
            "probability": 0.2767144000440298,
            "start_logit": 0.3703171908855438,
            "end_logit": 2.0840675830841064,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes set the pace for a wide range of physiological functions, including regeneration.Here we investigated if core clock",
            "probability": 0.012184209913274093,
            "start_logit": 0.5819748044013977,
            "end_logit": -1.2504351139068604,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock at mRNA levels might not be paralleled by modulation of protein levels.Core circadian clock",
            "probability": 0.009827673212560792,
            "start_logit": -1.6622098684310913,
            "end_logit": 0.7788109183311462,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock gene expression in human dental pulp-derived cells in response to L-mimosine, hypoxia and echinomycin.",
            "probability": 0.007457803181362222,
            "start_logit": 1.2438288927078247,
            "end_logit": -2.4031691551208496,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "core circadian clock",
            "probability": 0.005288455983759025,
            "start_logit": -2.377948045730591,
            "end_logit": 0.8748732209205627,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock gene",
            "probability": 0.0052589113022780964,
            "start_logit": 1.2438288927078247,
            "end_logit": -2.7525060176849365,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes.Our results suggest a potential role of the core circadian clock",
            "probability": 0.004943549884232415,
            "start_logit": -0.9953203797340393,
            "end_logit": -0.5751971006393433,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock genes set the pace for a wide range of physiological functions, including regeneration.Here we investigated if core clock",
            "probability": 0.003623373684029524,
            "start_logit": -0.6307604908943176,
            "end_logit": -1.2504351139068604,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock gene expression",
            "probability": 0.0030178355510649484,
            "start_logit": 1.2438288927078247,
            "end_logit": -3.3078901767730713,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock gene",
            "probability": 0.0021955055232962127,
            "start_logit": 0.3703171908855438,
            "end_logit": -2.7525060176849365,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes",
            "probability": 0.001537649015211543,
            "start_logit": 0.5819748044013977,
            "end_logit": -3.3203213214874268,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock gene expression",
            "probability": 0.0012598947272399522,
            "start_logit": 0.3703171908855438,
            "end_logit": -3.3078901767730713,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "core clock",
            "probability": 0.0008984340472706067,
            "start_logit": -3.3450450897216797,
            "end_logit": 0.06934195756912231,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock in the response of dental pulp to hypoxia.Future studies need to consider that regulation of the core circadian clock",
            "probability": 0.0008652827220082098,
            "start_logit": -1.641294240951538,
            "end_logit": -1.6720058917999268,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock in the response of dental pulp to hypoxia.Future studies need to consider that regulation of the core circadian clock",
            "probability": 0.0006140249866660757,
            "start_logit": -1.9843149185180664,
            "end_logit": -1.6720058917999268,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circa",
            "probability": 0.0004759031141946332,
            "start_logit": 0.3703171908855438,
            "end_logit": -4.281459331512451,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock genes",
            "probability": 0.00045727027165885987,
            "start_logit": -0.6307604908943176,
            "end_logit": -3.3203213214874268,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes were analysed using quantitative PCR (qPCR)",
            "probability": 0.00029148068644299586,
            "start_logit": 0.2847635746002197,
            "end_logit": -4.686146259307861,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes were analysed using quantitative PCR (qPCR) and their protein levels were analysed by western blot.",
            "probability": 0.0002722068887499494,
            "start_logit": 0.2847635746002197,
            "end_logit": -4.7545576095581055,
            "question_text": "List core circadian clock genes."
        }
    ],
    "52e6c92598d0239505000019": [
        {
            "text": "deltaE50-MD dog model of DMD",
            "probability": 0.34688895474033854,
            "start_logit": -1.6487581729888916,
            "end_logit": -1.5615148544311523,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "DMD",
            "probability": 0.32332877442642555,
            "start_logit": -1.7190932035446167,
            "end_logit": -1.5615148544311523,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "The deltaE50-MD dog model of DMD",
            "probability": 0.06588273577104585,
            "start_logit": -3.3098864555358887,
            "end_logit": -1.5615148544311523,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50",
            "probability": 0.0430682316753752,
            "start_logit": -1.6487581729888916,
            "end_logit": -3.6477339267730713,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "dog model of DMD",
            "probability": 0.036626765210803616,
            "start_logit": -3.8969836235046387,
            "end_logit": -1.5615148544311523,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model of DMD harbors a mutation corresponding to a mutational \"hotspot\" in the human",
            "probability": 0.025826458382640305,
            "start_logit": -1.6487581729888916,
            "end_logit": -4.159120082855225,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "DMD harbors a mutation corresponding to a mutational \"hotspot\" in the human",
            "probability": 0.024072363857433398,
            "start_logit": -1.7190932035446167,
            "end_logit": -4.159120082855225,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD",
            "probability": 0.02071811030323719,
            "start_logit": -1.6487581729888916,
            "end_logit": -4.37951135635376,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model",
            "probability": 0.01761043488801312,
            "start_logit": -1.6487581729888916,
            "end_logit": -4.542027950286865,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "humanThe deltaE50-MD dog model of DMD",
            "probability": 0.012165461690370302,
            "start_logit": -3.6184535026550293,
            "end_logit": -2.942223310470581,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "DMD harbors a mutation corresponding to a mutational \"hotspot\" in the humanThe deltaE50",
            "probability": 0.012120412510331581,
            "start_logit": -1.7190932035446167,
            "end_logit": -4.8452935218811035,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog",
            "probability": 0.011203074035996548,
            "start_logit": -1.6487581729888916,
            "end_logit": -4.994331359863281,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model of DMD harbors a mutation",
            "probability": 0.008390002606338402,
            "start_logit": -1.6487581729888916,
            "end_logit": -5.283478736877441,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "The deltaE50",
            "probability": 0.008179715406963271,
            "start_logit": -3.3098864555358887,
            "end_logit": -3.6477339267730713,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "DMD harbors a mutation corresponding to a mutational \"hotspot\" in the humanThe deltaE50-MD dog model",
            "probability": 0.008125131956931441,
            "start_logit": -1.7190932035446167,
            "end_logit": -5.245222568511963,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model of DMD harbors a mutation corresponding to a mutational \"hotspot",
            "probability": 0.007976322739808526,
            "start_logit": -1.6487581729888916,
            "end_logit": -5.334042072296143,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "DMD harbors a mutation",
            "probability": 0.007820166145596958,
            "start_logit": -1.7190932035446167,
            "end_logit": -5.283478736877441,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "DMD harbors a mutation corresponding to a mutational \"hotspot",
            "probability": 0.007434582798470461,
            "start_logit": -1.7190932035446167,
            "end_logit": -5.334042072296143,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "DMD harbors a mutation corresponding to a mutational \"hotspot\" in the humanThe deltaE50-MD",
            "probability": 0.00723547928028968,
            "start_logit": -1.7190932035446167,
            "end_logit": -5.361187934875488,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "mutational \"hotspot\" in the humanThe deltaE50-MD dog model of DMD",
            "probability": 0.005326821573590023,
            "start_logit": -4.444299697875977,
            "end_logit": -2.942223310470581,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        }
    ],
    "531778ddb166e2b80600000f": [
        {
            "text": "239 patients diagnosed before 46 years and without Chompret criteria for LFS",
            "probability": 0.18313886189394163,
            "start_logit": -4.146181583404541,
            "end_logit": -4.6738409996032715,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239 patients diagnosed before 46 years and without Chompret criteria for LFS or LFL",
            "probability": 0.15086855151655265,
            "start_logit": -4.146181583404541,
            "end_logit": -4.867676734924316,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239",
            "probability": 0.14865290791720878,
            "start_logit": -4.146181583404541,
            "end_logit": -4.882471561431885,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "LFL",
            "probability": 0.0515811973527271,
            "start_logit": -5.219433307647705,
            "end_logit": -4.867676734924316,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "315 patients unselected for age of diagnosis and family history (FH) and 2) 239",
            "probability": 0.04888388082717075,
            "start_logit": -5.258347988128662,
            "end_logit": -4.882471561431885,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239 patients diagnosed before 46 years",
            "probability": 0.04558956264983966,
            "start_logit": -4.146181583404541,
            "end_logit": -6.064406871795654,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "LFS",
            "probability": 0.03999843814186606,
            "start_logit": -5.667585849761963,
            "end_logit": -4.6738409996032715,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "family history (FH) and 2) 239 patients diagnosed before 46 years and without Chompret criteria for LFS",
            "probability": 0.03441589241312492,
            "start_logit": -5.817907810211182,
            "end_logit": -4.6738409996032715,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239 patients diagnosed before 46 years and without",
            "probability": 0.03317033900371061,
            "start_logit": -4.146181583404541,
            "end_logit": -6.382429599761963,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239 patients diagnosed before 46 years and without Chompret criteria",
            "probability": 0.03306612765355147,
            "start_logit": -4.146181583404541,
            "end_logit": -6.385576248168945,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "LFS or LFL",
            "probability": 0.03295044188317843,
            "start_logit": -5.667585849761963,
            "end_logit": -4.867676734924316,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "family history (FH) and 2) 239 patients diagnosed before 46 years and without Chompret criteria for LFS or LFL",
            "probability": 0.028351578599000973,
            "start_logit": -5.817907810211182,
            "end_logit": -4.867676734924316,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "family history (FH) and 2) 239",
            "probability": 0.027935209561035637,
            "start_logit": -5.817907810211182,
            "end_logit": -4.882471561431885,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "without Chompret criteria for LFS",
            "probability": 0.023032596602726996,
            "start_logit": -6.219515800476074,
            "end_logit": -4.6738409996032715,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "46 years and without Chompret criteria for LFS",
            "probability": 0.022895457939053846,
            "start_logit": -6.22548770904541,
            "end_logit": -4.6738409996032715,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "age of diagnosis and family history (FH) and 2) 239 patients diagnosed before 46 years and without Chompret criteria for LFS",
            "probability": 0.020449845920270562,
            "start_logit": -6.338450908660889,
            "end_logit": -4.6738409996032715,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "before 46 years and without Chompret criteria for LFS",
            "probability": 0.0189763044973048,
            "start_logit": -6.413235187530518,
            "end_logit": -4.6738409996032715,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "without Chompret criteria for LFS or LFL",
            "probability": 0.018974096765605405,
            "start_logit": -6.219515800476074,
            "end_logit": -4.867676734924316,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "46 years and without Chompret criteria for LFS or LFL",
            "probability": 0.018861122865192804,
            "start_logit": -6.22548770904541,
            "end_logit": -4.867676734924316,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "315",
            "probability": 0.018207585996937007,
            "start_logit": -5.258347988128662,
            "end_logit": -5.870080947875977,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        }
    ],
    "52fb42752059c6d71c00005e": [
        {
            "text": "4,4'-methylenediphenol",
            "probability": 0.27320364038190453,
            "start_logit": 3.45137357711792,
            "end_logit": 2.5799381732940674,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-ethylidenebisphenol, 4,4'-methylenediphenol",
            "probability": 0.170017493114609,
            "start_logit": 2.977057456970215,
            "end_logit": 2.5799381732940674,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-(hexafluoroisopropylidene)diphenol",
            "probability": 0.0961096426124023,
            "start_logit": 2.90305233001709,
            "end_logit": 2.083531618118286,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-ethylidenebisphenol",
            "probability": 0.09108503263309502,
            "start_logit": 2.977057456970215,
            "end_logit": 1.9558303356170654,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "methylenediphenol",
            "probability": 0.06970899300003754,
            "start_logit": 2.0854854583740234,
            "end_logit": 2.5799381732940674,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-cyclohexylidenebisphenol",
            "probability": 0.06905132367995641,
            "start_logit": 3.137662649154663,
            "end_logit": 1.5182816982269287,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "bisphenol A",
            "probability": 0.05801756652629503,
            "start_logit": 2.693380117416382,
            "end_logit": 1.7884600162506104,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-(1,4-phenylenediisopropylidene)bisphenol",
            "probability": 0.04906265896848087,
            "start_logit": 2.508448839187622,
            "end_logit": 1.80574369430542,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-dihydroxydiphenyl sulfone",
            "probability": 0.04486386744156245,
            "start_logit": 2.9130759239196777,
            "end_logit": 1.3116511106491089,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "2,2-bis(4-hydroxyphenyl)butane",
            "probability": 0.03143908332459516,
            "start_logit": 2.4009361267089844,
            "end_logit": 1.468209981918335,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "bisphenol",
            "probability": 0.011187377131892657,
            "start_logit": 1.0301367044448853,
            "end_logit": 1.80574369430542,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-methylenediphenol (BPF)",
            "probability": 0.007244852726036603,
            "start_logit": 3.45137357711792,
            "end_logit": -1.049988031387329,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "bisphenol (BPP), 4,4'-dihydroxydiphenyl sulfone",
            "probability": 0.006825690562425004,
            "start_logit": 1.0301367044448853,
            "end_logit": 1.3116511106491089,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-cyclohexylidenebisphenol (BPZ)",
            "probability": 0.006402893210579242,
            "start_logit": 3.137662649154663,
            "end_logit": -0.8598183989524841,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-ethylidenebisphenol, 4,4'-methylenediphenol (BPF)",
            "probability": 0.0045085478976175045,
            "start_logit": 2.977057456970215,
            "end_logit": -1.049988031387329,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-(hexafluoroisopropylidene)diphenol (BPAF)",
            "probability": 0.004442100598423538,
            "start_logit": 2.90305233001709,
            "end_logit": -0.990830659866333,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "2,2-bis(4-hydroxyphenyl)butane (BPB)",
            "probability": 0.002483507568776444,
            "start_logit": 2.4009361267089844,
            "end_logit": -1.0701699256896973,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "methylenediphenol (BPF)",
            "probability": 0.0018485529228659532,
            "start_logit": 2.0854854583740234,
            "end_logit": -1.049988031387329,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "cyclohexylidenebisphenol",
            "probability": 0.0012663131848240571,
            "start_logit": -0.8610777258872986,
            "end_logit": 1.5182816982269287,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-dihydroxydiphenyl sulfone (BPS)",
            "probability": 0.0012308625136208885,
            "start_logit": 2.9130759239196777,
            "end_logit": -2.284266471862793,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        }
    ],
    "5509b6d22e93f0133a000005": [
        {
            "text": "minimally invasive surgery",
            "probability": 0.9794851117955797,
            "start_logit": 5.605489253997803,
            "end_logit": 5.909621238708496,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery",
            "probability": 0.018610019276524063,
            "start_logit": 1.6421623229980469,
            "end_logit": 5.909621238708496,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice",
            "probability": 0.0009105187302481639,
            "start_logit": 5.605489253997803,
            "end_logit": -1.0711466073989868,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimal",
            "probability": 0.0003196981575135502,
            "start_logit": 5.605489253997803,
            "end_logit": -2.117783784866333,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment",
            "probability": 0.0002006315609719059,
            "start_logit": 5.605489253997803,
            "end_logit": -2.583690881729126,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "invasive surgery",
            "probability": 0.00018766127466728487,
            "start_logit": -2.9546544551849365,
            "end_logit": 5.909621238708496,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Rectal locations are very rare, and minimally invasive surgery",
            "probability": 9.11573148295561e-05,
            "start_logit": -3.676706314086914,
            "end_logit": 5.909621238708496,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive",
            "probability": 5.371734537751028e-05,
            "start_logit": 5.605489253997803,
            "end_logit": -3.9014251232147217,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of rectal GISTs",
            "probability": 4.355546274935939e-05,
            "start_logit": 5.605489253997803,
            "end_logit": -4.111125946044922,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of rectal GISTs.Gastrointestinal stromal tumors",
            "probability": 3.1252913397895546e-05,
            "start_logit": 5.605489253997803,
            "end_logit": -4.443048477172852,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice",
            "probability": 1.7299671957740737e-05,
            "start_logit": 1.6421623229980469,
            "end_logit": -1.0711466073989868,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of rectal GISTs.",
            "probability": 1.70548645302989e-05,
            "start_logit": 5.605489253997803,
            "end_logit": -5.048725605010986,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "mesenchymal tumors of the gastrointestinal tract.Rectal locations are very rare, and minimally invasive surgery",
            "probability": 1.1953680253632487e-05,
            "start_logit": -5.708253860473633,
            "end_logit": 5.909621238708496,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of rectal",
            "probability": 7.089849371883477e-06,
            "start_logit": 5.605489253997803,
            "end_logit": -5.926496982574463,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "ly invasive surgery",
            "probability": 4.385064807489221e-06,
            "start_logit": -6.71108865737915,
            "end_logit": 5.909621238708496,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice for the treatment",
            "probability": 3.8119591326116286e-06,
            "start_logit": 1.6421623229980469,
            "end_logit": -2.583690881729126,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "gastrointestinal tract.Rectal locations are very rare, and minimally invasive surgery",
            "probability": 3.335695069806625e-06,
            "start_logit": -6.984611988067627,
            "end_logit": 5.909621238708496,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice for the treatment of rectal GISTs",
            "probability": 8.2754499440791e-07,
            "start_logit": 1.6421623229980469,
            "end_logit": -4.111125946044922,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice for the treatment of rectal GISTs.Gastrointestinal stromal tumors",
            "probability": 5.93799041739552e-07,
            "start_logit": 1.6421623229980469,
            "end_logit": -4.443048477172852,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice for the treatment of rectal GISTs.",
            "probability": 3.240389811393164e-07,
            "start_logit": 1.6421623229980469,
            "end_logit": -5.048725605010986,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        }
    ],
    "56be0e4aef6e394741000008": [
        {
            "text": "bronchiectasis, and situs inversus",
            "probability": 0.18993921988847046,
            "start_logit": 4.581449508666992,
            "end_logit": 5.031538486480713,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis",
            "probability": 0.17147145904237882,
            "start_logit": 4.581449508666992,
            "end_logit": 4.929251194000244,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus",
            "probability": 0.15327749196041307,
            "start_logit": 4.366995334625244,
            "end_logit": 5.031538486480713,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.09961803066743044,
            "start_logit": 3.9360885620117188,
            "end_logit": 5.031538486480713,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 0.08993218501951745,
            "start_logit": 3.9360885620117188,
            "end_logit": 4.929251194000244,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.08257278119158362,
            "start_logit": 3.7484254837036133,
            "end_logit": 5.031538486480713,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis",
            "probability": 0.07454424250253225,
            "start_logit": 3.7484254837036133,
            "end_logit": 4.929251194000244,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis",
            "probability": 0.06431529051833389,
            "start_logit": 3.9360885620117188,
            "end_logit": 4.593992710113525,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis",
            "probability": 0.053310554080043836,
            "start_logit": 3.7484254837036133,
            "end_logit": 4.593992710113525,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis, and situs inversus,",
            "probability": 0.004129799624668456,
            "start_logit": 4.581449508666992,
            "end_logit": 1.2030632495880127,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus,",
            "probability": 0.003332673100057627,
            "start_logit": 4.366995334625244,
            "end_logit": 1.2030632495880127,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis,",
            "probability": 0.002525850933658258,
            "start_logit": 4.581449508666992,
            "end_logit": 0.7114123702049255,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis, and situs inversus,",
            "probability": 0.002165969229009861,
            "start_logit": 3.9360885620117188,
            "end_logit": 1.2030632495880127,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis,",
            "probability": 0.0020547872407988307,
            "start_logit": 3.9360885620117188,
            "end_logit": 1.1503676176071167,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis, and situs inversus,",
            "probability": 0.0017953587519895472,
            "start_logit": 3.7484254837036133,
            "end_logit": 1.2030632495880127,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis,",
            "probability": 0.0017032006765539504,
            "start_logit": 3.7484254837036133,
            "end_logit": 1.1503676176071167,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis,",
            "probability": 0.001324741124651738,
            "start_logit": 3.9360885620117188,
            "end_logit": 0.7114123702049255,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis,",
            "probability": 0.0010980698804069415,
            "start_logit": 3.7484254837036133,
            "end_logit": 0.7114123702049255,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis, and situs",
            "probability": 0.00049159021503748,
            "start_logit": 4.581449508666992,
            "end_logit": -0.925275444984436,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs",
            "probability": 0.0003967043524632213,
            "start_logit": 4.366995334625244,
            "end_logit": -0.925275444984436,
            "question_text": "List Kartagener Syndrome Triad."
        }
    ],
    "54dfc6501388e8454a000009": [
        {
            "text": "antiviral and proliferative",
            "probability": 0.12148865874003577,
            "start_logit": 3.7745494842529297,
            "end_logit": 2.544750452041626,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "antiviral",
            "probability": 0.10139270693862443,
            "start_logit": 3.7745494842529297,
            "end_logit": 2.3639307022094727,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle",
            "probability": 0.09418005877527864,
            "start_logit": 3.1900196075439453,
            "end_logit": 2.8746678829193115,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "innate immune protection from viral infections",
            "probability": 0.08766543418316272,
            "start_logit": 2.9800872802734375,
            "end_logit": 3.0129194259643555,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair",
            "probability": 0.07965375172718321,
            "start_logit": 3.1900196075439453,
            "end_logit": 2.707148551940918,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair genes, whereas the other APOBEC3 members display specificity for immune processes",
            "probability": 0.07064875487925427,
            "start_logit": 3.1900196075439453,
            "end_logit": 2.5871798992156982,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune processes",
            "probability": 0.061653930638631775,
            "start_logit": 3.0538361072540283,
            "end_logit": 2.5871798992156982,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "proliferative",
            "probability": 0.05145865898033148,
            "start_logit": 2.9155073165893555,
            "end_logit": 2.544750452041626,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "innate immune protection",
            "probability": 0.04479877439607911,
            "start_logit": 2.9800872802734375,
            "end_logit": 2.3415725231170654,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune protection from viral infections",
            "probability": 0.041617525383223906,
            "start_logit": 2.2350809574127197,
            "end_logit": 3.0129194259643555,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "DNA repair",
            "probability": 0.030527473188590157,
            "start_logit": 2.230957508087158,
            "end_logit": 2.707148551940918,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune processes and immune cell populations.We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral and proliferative",
            "probability": 0.029177266306045495,
            "start_logit": 3.0538361072540283,
            "end_logit": 1.839032769203186,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "DNA repair genes, whereas the other APOBEC3 members display specificity for immune processes",
            "probability": 0.027076288606851545,
            "start_logit": 2.230957508087158,
            "end_logit": 2.5871798992156982,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune processes and immune cell populations.We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral",
            "probability": 0.026735248464750398,
            "start_logit": 3.0538361072540283,
            "end_logit": 1.7516257762908936,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "protection from viral infections",
            "probability": 0.023188100129845346,
            "start_logit": 1.6501988172531128,
            "end_logit": 3.0129194259643555,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune cell populations.We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral and proliferative",
            "probability": 0.023039041594399526,
            "start_logit": 2.817636489868164,
            "end_logit": 1.839032769203186,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair genes, whereas the other APOBEC3 members display specificity for immune processes and immune cell populations",
            "probability": 0.022574941242139372,
            "start_logit": 3.1900196075439453,
            "end_logit": 1.4462999105453491,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune protection",
            "probability": 0.021267380329979907,
            "start_logit": 2.2350809574127197,
            "end_logit": 2.3415725231170654,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune cell populations.We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral",
            "probability": 0.021110768053289673,
            "start_logit": 2.817636489868164,
            "end_logit": 1.7516257762908936,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair genes, whereas the other APOBEC3 members display specificity for immune",
            "probability": 0.020745237442303475,
            "start_logit": 3.1900196075439453,
            "end_logit": 1.3617761135101318,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        }
    ],
    "52e0c9a298d0239505000010": [
        {
            "text": "H3K9me2",
            "probability": 0.6478208046314538,
            "start_logit": 4.492995262145996,
            "end_logit": 3.2972123622894287,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3",
            "probability": 0.29130745474938124,
            "start_logit": 4.492995262145996,
            "end_logit": 2.4979774951934814,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3.",
            "probability": 0.018738349092449903,
            "start_logit": 4.492995262145996,
            "end_logit": -0.24582958221435547,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3",
            "probability": 0.015595263118093264,
            "start_logit": 1.5655832290649414,
            "end_logit": 2.4979774951934814,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me",
            "probability": 0.0070183779486792,
            "start_logit": 4.492995262145996,
            "end_logit": -1.2278696298599243,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H",
            "probability": 0.0052203804013183815,
            "start_logit": 4.492995262145996,
            "end_logit": -1.5238314867019653,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "K9me2",
            "probability": 0.003012389918808774,
            "start_logit": -0.877885103225708,
            "end_logit": 3.2972123622894287,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "2",
            "probability": 0.001694686947824216,
            "start_logit": -1.4531208276748657,
            "end_logit": 3.2972123622894287,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3K9me2",
            "probability": 0.0013567396322687506,
            "start_logit": -1.6755343675613403,
            "end_logit": 3.2972123622894287,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "K9me2 and 3",
            "probability": 0.0013545900867757844,
            "start_logit": -0.877885103225708,
            "end_logit": 2.4979774951934814,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "me2",
            "probability": 0.0010704274335573646,
            "start_logit": -1.9125608205795288,
            "end_logit": 3.2972123622894287,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3.",
            "probability": 0.0010031651429821882,
            "start_logit": 1.5655832290649414,
            "end_logit": -0.24582958221435547,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3",
            "probability": 0.0008672212406025738,
            "start_logit": 4.492995262145996,
            "end_logit": -3.3188629150390625,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "9me2",
            "probability": 0.0007897999466125269,
            "start_logit": -2.2165944576263428,
            "end_logit": 3.2972123622894287,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "2 and 3",
            "probability": 0.0007620547809490654,
            "start_logit": -1.4531208276748657,
            "end_logit": 2.4979774951934814,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9",
            "probability": 0.0006868325174229108,
            "start_logit": 4.492995262145996,
            "end_logit": -3.5520665645599365,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3K9me2 and 3",
            "probability": 0.0006100890342023937,
            "start_logit": -1.6755343675613403,
            "end_logit": 2.4979774951934814,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "me2 and 3",
            "probability": 0.00048134219977838654,
            "start_logit": -1.9125608205795288,
            "end_logit": 2.4979774951934814,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "9me2 and 3",
            "probability": 0.0003551516261349189,
            "start_logit": -2.2165944576263428,
            "end_logit": 2.4979774951934814,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K",
            "probability": 0.0002548795507042384,
            "start_logit": 4.492995262145996,
            "end_logit": -4.543365955352783,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        }
    ],
    "51487ef9d24251bc05000031": [
        {
            "text": "Opicapone",
            "probability": 0.9934941931825574,
            "start_logit": 5.865170955657959,
            "end_logit": 5.635537624359131,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "opicapone",
            "probability": 0.004082138556122781,
            "start_logit": 3.5963101387023926,
            "end_logit": 2.4097912311553955,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone",
            "probability": 0.0019486474270744545,
            "start_logit": 3.678866386413574,
            "end_logit": 1.5877494812011719,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Op",
            "probability": 0.00020647535387796859,
            "start_logit": 5.865170955657959,
            "end_logit": -2.8432648181915283,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "ne",
            "probability": 8.60536558406433e-05,
            "start_logit": -3.4888415336608887,
            "end_logit": 5.635537624359131,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapo",
            "probability": 6.903063612337088e-05,
            "start_logit": 5.865170955657959,
            "end_logit": -3.9388954639434814,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapone is a recent and selective third-generation COMT inhibitor",
            "probability": 2.610562829729169e-05,
            "start_logit": 5.865170955657959,
            "end_logit": -4.911294937133789,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapone is a recent and selective third-generation COMT inhibitor which achieves marked increase in the bioavailability of le",
            "probability": 1.424078427651894e-05,
            "start_logit": 5.865170955657959,
            "end_logit": -5.517335891723633,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "levodopa",
            "probability": 1.3766548223267557e-05,
            "start_logit": 1.112568736076355,
            "end_logit": -0.7986020445823669,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opica",
            "probability": 1.1935983778023136e-05,
            "start_logit": 5.865170955657959,
            "end_logit": -5.693888187408447,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapone is a recent and selective third-generation",
            "probability": 9.19069277449514e-06,
            "start_logit": 5.865170955657959,
            "end_logit": -5.955254554748535,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "en",
            "probability": 7.941877317958006e-06,
            "start_logit": 3.678866386413574,
            "end_logit": -3.914991617202759,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "motor fluctuation includes the addition of catechol-O-methyl transferase (COMT) inhibitors.Opicapone",
            "probability": 6.819321093933121e-06,
            "start_logit": -6.024052619934082,
            "end_logit": 5.635537624359131,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "pone",
            "probability": 6.6221250006319e-06,
            "start_logit": -6.053396224975586,
            "end_logit": 5.635537624359131,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "icapone",
            "probability": 5.861293550937882e-06,
            "start_logit": -6.175442218780518,
            "end_logit": 5.635537624359131,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "addition of catechol-O-methyl transferase (COMT) inhibitors.Opicapone",
            "probability": 4.8903097649462805e-06,
            "start_logit": -6.3565568923950195,
            "end_logit": 5.635537624359131,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "op",
            "probability": 4.5993493103919955e-06,
            "start_logit": 3.5963101387023926,
            "end_logit": -4.3786702156066895,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "one",
            "probability": 1.2262042172111363e-06,
            "start_logit": -3.692101001739502,
            "end_logit": 1.5877494812011719,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "ne is a recent and selective third-generation COMT inhibitor which achieves marked increase in the bioavailability of levodopa",
            "probability": 1.3818406722363556e-07,
            "start_logit": -3.4888415336608887,
            "end_logit": -0.7986020445823669,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "le",
            "probability": 1.2288673033009685e-07,
            "start_logit": 1.112568736076355,
            "end_logit": -5.517335891723633,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        }
    ],
    "5505db6a8e1671127b000003": [
        {
            "text": "desmosoma",
            "probability": 0.918625495900732,
            "start_logit": 1.709966778755188,
            "end_logit": -1.0713820457458496,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "des",
            "probability": 0.04145905604388663,
            "start_logit": 1.709966778755188,
            "end_logit": -4.169554233551025,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal",
            "probability": 0.02339004576802454,
            "start_logit": 1.709966778755188,
            "end_logit": -4.741950035095215,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmos",
            "probability": 0.008468437603671402,
            "start_logit": 1.709966778755188,
            "end_logit": -5.7579145431518555,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal proteins",
            "probability": 0.0019667280300844203,
            "start_logit": 1.709966778755188,
            "end_logit": -7.217889308929443,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal proteins involved in maintaining skin structure",
            "probability": 0.0015548220727255892,
            "start_logit": 1.709966778755188,
            "end_logit": -7.45289945602417,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal proteins involved in maintaining skin structure.",
            "probability": 0.001520337886381538,
            "start_logit": 1.709966778755188,
            "end_logit": -7.475327968597412,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3, keratins, and desmosoma",
            "probability": 0.001186280363845852,
            "start_logit": -4.942089080810547,
            "end_logit": -1.0713820457458496,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "mosoma",
            "probability": 0.0006461878607148176,
            "start_logit": -5.549576759338379,
            "end_logit": -1.0713820457458496,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "oma",
            "probability": 0.0005355366649435463,
            "start_logit": -5.73739767074585,
            "end_logit": -1.0713820457458496,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "glycerol transporter aquaporin-3, keratins, and desmosoma",
            "probability": 0.00022750498148413144,
            "start_logit": -6.593494892120361,
            "end_logit": -1.0713820457458496,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "keratins, and desmosoma",
            "probability": 0.0001498690272629556,
            "start_logit": -7.0109052658081055,
            "end_logit": -1.0713820457458496,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "3, keratins, and desmosoma",
            "probability": 0.000119734562961779,
            "start_logit": -7.235389709472656,
            "end_logit": -1.0713820457458496,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3, keratins, and des",
            "probability": 5.3538753613868874e-05,
            "start_logit": -4.942089080810547,
            "end_logit": -4.169554233551025,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3, keratins, and desmosomal",
            "probability": 3.0205075003776816e-05,
            "start_logit": -4.942089080810547,
            "end_logit": -4.741950035095215,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "mosomal",
            "probability": 1.6453237695130044e-05,
            "start_logit": -5.549576759338379,
            "end_logit": -4.741950035095215,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3",
            "probability": 1.4926822463135966e-05,
            "start_logit": -4.942089080810547,
            "end_logit": -5.446800231933594,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "omal",
            "probability": 1.3635836539897617e-05,
            "start_logit": -5.73739767074585,
            "end_logit": -4.741950035095215,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3, keratins, and desmos",
            "probability": 1.0935839780757386e-05,
            "start_logit": -4.942089080810547,
            "end_logit": -5.7579145431518555,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "glycerol transporter aquaporin-3, keratins, and des",
            "probability": 1.0267668184373198e-05,
            "start_logit": -6.593494892120361,
            "end_logit": -4.169554233551025,
            "question_text": "What are the structures formed when keratin molecules come together?"
        }
    ],
    "54c225bcf693c3b16b000002": [
        {
            "text": "CASQ2",
            "probability": 0.6026426799880225,
            "start_logit": 2.7089200019836426,
            "end_logit": 2.3652665615081787,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin",
            "probability": 0.09044100319187462,
            "start_logit": 2.060333013534546,
            "end_logit": 1.1172268390655518,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor",
            "probability": 0.07047929222050948,
            "start_logit": 1.8894850015640259,
            "end_logit": 1.038696050643921,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2) or Triadin",
            "probability": 0.06518376597326674,
            "start_logit": 2.060333013534546,
            "end_logit": 0.7897395491600037,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "Triadin",
            "probability": 0.05368879735529752,
            "start_logit": 1.866326928138733,
            "end_logit": 0.7897395491600037,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2",
            "probability": 0.02470600311226713,
            "start_logit": 2.060333013534546,
            "end_logit": -0.18042464554309845,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2)",
            "probability": 0.017379639597840557,
            "start_logit": 1.8894850015640259,
            "end_logit": -0.3613235056400299,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2",
            "probability": 0.014592186319512493,
            "start_logit": 1.8894850015640259,
            "end_logit": -0.5361366868019104,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2) gene, <5% of cases are accounted for by recessive mutations in cardiac calsequestrin",
            "probability": 0.009590214827113782,
            "start_logit": -0.18362143635749817,
            "end_logit": 1.1172268390655518,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "CASQ2 mutations",
            "probability": 0.008988004396594362,
            "start_logit": 2.7089200019836426,
            "end_logit": -1.8401670455932617,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2) gene",
            "probability": 0.007614584918917009,
            "start_logit": 1.8894850015640259,
            "end_logit": -1.186557412147522,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2) or Triadin (TRDN",
            "probability": 0.007036888464310452,
            "start_logit": 2.060333013534546,
            "end_logit": -1.4363048076629639,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "Triadin (TRDN",
            "probability": 0.005795953534306983,
            "start_logit": 1.866326928138733,
            "end_logit": -1.4363048076629639,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "CASQ2) or Triadin",
            "probability": 0.005458934283204191,
            "start_logit": -0.41962385177612305,
            "end_logit": 0.7897395491600037,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2) or Triadin (TRDN)",
            "probability": 0.00533493536166451,
            "start_logit": 2.060333013534546,
            "end_logit": -1.7131941318511963,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "Triadin (TRDN)",
            "probability": 0.004394134939265189,
            "start_logit": 1.866326928138733,
            "end_logit": -1.7131941318511963,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2)",
            "probability": 0.0021862613636040884,
            "start_logit": -0.18362143635749817,
            "end_logit": -0.3613235056400299,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2",
            "probability": 0.001835615346409497,
            "start_logit": -0.18362143635749817,
            "end_logit": -0.5361366868019104,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "(RYR2) gene, <5% of cases are accounted for by recessive mutations in cardiac calsequestrin",
            "probability": 0.001377137439812006,
            "start_logit": -2.1243577003479004,
            "end_logit": 1.1172268390655518,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "Compound heterozygous CASQ2",
            "probability": 0.0012739673662068944,
            "start_logit": -2.994472026824951,
            "end_logit": 1.9094700813293457,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        }
    ],
    "532c0d7fd6d3ac6a3400001c": [
        {
            "text": "Flexi-pharma",
            "probability": 0.9718722149633972,
            "start_logit": 3.300867795944214,
            "end_logit": 3.078148126602173,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma,",
            "probability": 0.01602772309839744,
            "start_logit": 3.300867795944214,
            "end_logit": -1.0267562866210938,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma approach",
            "probability": 0.0035907158174813374,
            "start_logit": 2.9646687507629395,
            "end_logit": -2.186525583267212,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "virtual screening protocol, Flexi-pharma",
            "probability": 0.0017213752116243717,
            "start_logit": -3.0352330207824707,
            "end_logit": 3.078148126602173,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Fl",
            "probability": 0.0017144749381045128,
            "start_logit": 3.300867795944214,
            "end_logit": -3.2619693279266357,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma, that overcomes these limitations. The protocol uses molecular dynamics",
            "probability": 0.0015155865233059617,
            "start_logit": 3.300867795944214,
            "end_logit": -3.3852736949920654,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharmacophore-based virtual screening protocol, Flexi-pharma",
            "probability": 0.000656652613761048,
            "start_logit": -3.9989566802978516,
            "end_logit": 3.078148126602173,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma, that overcomes these limitations. The protocol uses molecular dynamics (MD) simulations",
            "probability": 0.0005721939113477797,
            "start_logit": 3.300867795944214,
            "end_logit": -4.359353542327881,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma, that overcomes these limitations. The protocol uses molecular dynamics (MD) simulation",
            "probability": 0.0005179533882221764,
            "start_logit": 3.300867795944214,
            "end_logit": -4.458946228027344,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-phar",
            "probability": 0.0004989978731514299,
            "start_logit": 3.300867795944214,
            "end_logit": -4.496229648590088,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma:",
            "probability": 0.00042211197177542307,
            "start_logit": 2.561356544494629,
            "end_logit": -3.9240496158599854,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the Flexi-pharma",
            "probability": 0.00033370857998574237,
            "start_logit": -4.221255302429199,
            "end_logit": 2.6235597133636475,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "ma",
            "probability": 0.0002581069374968823,
            "start_logit": -4.932737827301025,
            "end_logit": 3.078148126602173,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "a pharmacophore-based virtual screening protocol, Flexi-pharma",
            "probability": 0.0002116015507643448,
            "start_logit": -5.131406784057617,
            "end_logit": 3.078148126602173,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "virtual screening protocol, Flexi-pharma,",
            "probability": 2.8388223076631342e-05,
            "start_logit": -3.0352330207824707,
            "end_logit": -1.0267562866210938,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharmacophore-filtering",
            "probability": 1.8134156865425247e-05,
            "start_logit": -2.1241068840026855,
            "end_logit": -2.386059522628784,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharmacophore-based virtual screening protocol, Flexi-pharma,",
            "probability": 1.082924905472e-05,
            "start_logit": -3.9989566802978516,
            "end_logit": -1.0267562866210938,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "filtering",
            "probability": 9.846574355581733e-06,
            "start_logit": -2.7347805500030518,
            "end_logit": -2.386059522628784,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "vote is a general strategy that can be applied with any pharmacophore-filtering",
            "probability": 9.708232007047291e-06,
            "start_logit": -2.748929977416992,
            "end_logit": -2.386059522628784,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharmacophore-filtering program",
            "probability": 9.67618582470232e-06,
            "start_logit": -2.1241068840026855,
            "end_logit": -3.0141890048980713,
            "question_text": "List programs suitable for pharmacophore modelling"
        }
    ],
    "530c844e970c65fa6b000014": [
        {
            "text": "Mitochondrial neuro-gastro-intestinal encephalomyopathy",
            "probability": 0.28030745955532926,
            "start_logit": 3.529268980026245,
            "end_logit": 3.885474443435669,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "neuro-gastro-intestinal encephalomyopathy",
            "probability": 0.1514176791906895,
            "start_logit": 2.913424015045166,
            "end_logit": 3.885474443435669,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Alpers-Huttenlocher hepatopathic poliodystrophy",
            "probability": 0.08742005736777061,
            "start_logit": 3.1597142219543457,
            "end_logit": 3.089866876602173,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "mitochondrial DNA depletion syndrome",
            "probability": 0.06266628014672816,
            "start_logit": 3.026553153991699,
            "end_logit": 2.8901267051696777,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ataxia-Epilepsy syndrome.Mitochondrial neuro-gastro-intestinal encephalomyopathy",
            "probability": 0.053637935816270584,
            "start_logit": 2.2929153442382812,
            "end_logit": 3.4681975841522217,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "gastro-intestinal encephalomyopathy",
            "probability": 0.04598777598473512,
            "start_logit": 1.904854655265808,
            "end_logit": 3.7023773193359375,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ophthalmoplegia and juvenile SpinoCerebellar Ataxia-Epilepsy syndrome",
            "probability": 0.04098559892649959,
            "start_logit": 2.81691837310791,
            "end_logit": 2.675158739089966,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Epilepsy syndrome.Mitochondrial neuro-gastro-intestinal encephalomyopathy",
            "probability": 0.03957761608355035,
            "start_logit": 1.9889224767684937,
            "end_logit": 3.4681975841522217,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ophthalmoplegia and juvenile SpinoCerebellar Ataxia",
            "probability": 0.030089360268724427,
            "start_logit": 2.81691837310791,
            "end_logit": 2.366109609603882,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ophthalmoplegia",
            "probability": 0.02669580625445042,
            "start_logit": 2.81691837310791,
            "end_logit": 2.2464444637298584,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ataxia-Epilepsy syndrome",
            "probability": 0.02426943477526648,
            "start_logit": 2.2929153442382812,
            "end_logit": 2.675158739089966,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Sensory-Ataxic Neuropathy Dysarthria",
            "probability": 0.021014284446944153,
            "start_logit": 2.369314670562744,
            "end_logit": 2.4547441005706787,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Sensory-Ataxic Neuropathy Dysarthria and Ophthalmoplegia and juvenile SpinoCerebellar Ataxia",
            "probability": 0.019231853239704624,
            "start_logit": 2.369314670562744,
            "end_logit": 2.366109609603882,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "SpinoCerebellar Ataxia-Epilepsy syndrome",
            "probability": 0.018464797122877907,
            "start_logit": 2.019563674926758,
            "end_logit": 2.675158739089966,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Epilepsy syndrome",
            "probability": 0.017907593897543234,
            "start_logit": 1.9889224767684937,
            "end_logit": 2.675158739089966,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ataxia",
            "probability": 0.017817276936244835,
            "start_logit": 2.2929153442382812,
            "end_logit": 2.366109609603882,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Sensory-Ataxic Neuropathy Dysarthria and Ophthalmoplegia",
            "probability": 0.017062836278869956,
            "start_logit": 2.369314670562744,
            "end_logit": 2.2464444637298584,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "poliodystrophy",
            "probability": 0.016381878626199782,
            "start_logit": 1.4851652383804321,
            "end_logit": 3.089866876602173,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "encephalomyopathy",
            "probability": 0.01550864211901494,
            "start_logit": 1.0520561933517456,
            "end_logit": 3.4681975841522217,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "SpinoCerebellar Ataxia",
            "probability": 0.013555832962586176,
            "start_logit": 2.019563674926758,
            "end_logit": 2.366109609603882,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        }
    ],
    "571653aecb4ef8864c000005": [
        {
            "text": "gefitinib",
            "probability": 0.8932362058427004,
            "start_logit": 0.0054730381816625595,
            "end_logit": -1.8650076389312744,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "gefitinib as first-line treatment.Detection of EGFR mutations",
            "probability": 0.026428513289036337,
            "start_logit": -0.8144266605377197,
            "end_logit": -4.565515518188477,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "gefitinib as first-line treatment.Detection of EGFR mutations in plasma circulating tumour DNA",
            "probability": 0.022111509675404744,
            "start_logit": -0.8144266605377197,
            "end_logit": -4.743860721588135,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "gefitinib as first-line treatment.Detection of EGFR mutations in plasma",
            "probability": 0.01768194634218031,
            "start_logit": -0.8144266605377197,
            "end_logit": -4.967414855957031,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "EGFR mutation detection as a selection criterion for patients with lung adenocarcinoma receiving gefitinib",
            "probability": 0.009030832729325802,
            "start_logit": -4.375137805938721,
            "end_logit": -2.0786032676696777,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "plasma circulating tumour DNA as a selection criterion for first-line gefitinib",
            "probability": 0.006762802405568287,
            "start_logit": -4.877940654754639,
            "end_logit": -1.8650076389312744,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA",
            "probability": 0.0033551453177742374,
            "start_logit": -3.3746180534362793,
            "end_logit": -4.069272518157959,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib",
            "probability": 0.0032236690112703013,
            "start_logit": -5.6188578605651855,
            "end_logit": -1.8650076389312744,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "tissue is scant",
            "probability": 0.0028760622472796082,
            "start_logit": -3.999091148376465,
            "end_logit": -3.598872423171997,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib",
            "probability": 0.0028008255943988087,
            "start_logit": -5.759463787078857,
            "end_logit": -1.8650076389312744,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "tissue is scant, another strategy is to use circulating tumour DNA",
            "probability": 0.00179682638321186,
            "start_logit": -3.999091148376465,
            "end_logit": -4.069272518157959,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA as a selection criterion for first-line gefitinib",
            "probability": 0.001536308791723,
            "start_logit": -6.359995365142822,
            "end_logit": -1.8650076389312744,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "mutation detection as a selection criterion for patients with lung adenocarcinoma receiving gefitinib",
            "probability": 0.0014911016961628159,
            "start_logit": -6.176267147064209,
            "end_logit": -2.0786032676696777,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "b",
            "probability": 0.0014507959869540148,
            "start_logit": -6.203670024871826,
            "end_logit": -2.0786032676696777,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "scant",
            "probability": 0.0012165077005386524,
            "start_logit": -4.8595290184021,
            "end_logit": -3.598872423171997,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA (ctDNA),",
            "probability": 0.001209444108404638,
            "start_logit": -3.3746180534362793,
            "end_logit": -5.089606761932373,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "if tissue is scant",
            "probability": 0.0011509236204718019,
            "start_logit": -4.914948463439941,
            "end_logit": -3.598872423171997,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA (ctDNA",
            "probability": 0.0009283588608408439,
            "start_logit": -3.3746180534362793,
            "end_logit": -5.354104518890381,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA (ctDNA)",
            "probability": 0.0009134462137718916,
            "start_logit": -3.3746180534362793,
            "end_logit": -5.370298385620117,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating",
            "probability": 0.0007987741829815976,
            "start_logit": -3.3746180534362793,
            "end_logit": -5.504444599151611,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        }
    ],
    "517a8bab8ed59a060a000040": [
        {
            "text": "deiodinase",
            "probability": 0.1653196259410352,
            "start_logit": -2.8761467933654785,
            "end_logit": -3.9453229904174805,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase genes",
            "probability": 0.15302118314766197,
            "start_logit": -2.8761467933654785,
            "end_logit": -4.022627353668213,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase genes and prognosis of brain tumor patients.Thyroid hormone",
            "probability": 0.09568435842182052,
            "start_logit": -2.8761467933654785,
            "end_logit": -4.4921488761901855,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase genes and prognosis of brain tumor patients.",
            "probability": 0.09129651419530849,
            "start_logit": -2.8761467933654785,
            "end_logit": -4.539091110229492,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase gene single-nucleotide polymorphisms",
            "probability": 0.07654272153600472,
            "start_logit": -3.160261869430542,
            "end_logit": -4.431239604949951,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase genes and prognosis of brain tumor patients.Thyroid hormone (TH) metabolism can have prognostic significance in brain tumors",
            "probability": 0.050915885246992136,
            "start_logit": -2.8761467933654785,
            "end_logit": -5.123028755187988,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinas",
            "probability": 0.050282184741234685,
            "start_logit": -2.8761467933654785,
            "end_logit": -5.135552883148193,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase genes and prognosis of brain tumor patients.Thyroid hormone (TH) metabolism",
            "probability": 0.04796093067254037,
            "start_logit": -2.8761467933654785,
            "end_logit": -5.182816982269287,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase gene single-nucleotide polymorphism",
            "probability": 0.03912414661571895,
            "start_logit": -3.160261869430542,
            "end_logit": -5.102348804473877,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "dei",
            "probability": 0.038536091754039874,
            "start_logit": -2.8761467933654785,
            "end_logit": -5.401608467102051,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase gene single-nucleotide polymorphisms (SNPs)",
            "probability": 0.03445864843304258,
            "start_logit": -3.160261869430542,
            "end_logit": -5.229328632354736,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "Thyroid hormone",
            "probability": 0.027469351952712495,
            "start_logit": -4.124130725860596,
            "end_logit": -4.4921488761901855,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "single-nucleotide polymorphisms",
            "probability": 0.021796649157706394,
            "start_logit": -4.416354656219482,
            "end_logit": -4.431239604949951,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "Thyroid hormone (TH) metabolism can have prognostic significance in brain tumors.We studied the association of common variations in three deiodinase",
            "probability": 0.01995383214557979,
            "start_logit": -4.124130725860596,
            "end_logit": -4.811798572540283,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "Thyroid hormone (TH) metabolism can have prognostic significance in brain tumors.",
            "probability": 0.019734758630301576,
            "start_logit": -4.124130725860596,
            "end_logit": -4.822838306427002,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "Thyroid hormone (TH) metabolism can have prognostic significance in brain tumors",
            "probability": 0.014617084703309212,
            "start_logit": -4.124130725860596,
            "end_logit": -5.123028755187988,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "single-nucleotide polymorphisms (SNPs) with circulating TH concentrations and prognosis of brain tumor patients.",
            "probability": 0.014003451275229254,
            "start_logit": -4.416354656219482,
            "end_logit": -4.873692035675049,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "genes",
            "probability": 0.013981193290451529,
            "start_logit": -5.269010066986084,
            "end_logit": -4.022627353668213,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "Thyroid hormone (TH) metabolism",
            "probability": 0.013768767501326672,
            "start_logit": -4.124130725860596,
            "end_logit": -5.182816982269287,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "brain tumor patients.Thyroid hormone",
            "probability": 0.011532620637983873,
            "start_logit": -4.9920220375061035,
            "end_logit": -4.4921488761901855,
            "question_text": "Which deiodinases are best known to be present in brain?"
        }
    ],
    "56c33e5695c1e7cc5b000001": [
        {
            "text": "nuclear envelope",
            "probability": 0.31392074108952905,
            "start_logit": 0.7746678590774536,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the nuclear envelope",
            "probability": 0.18452845757140016,
            "start_logit": 0.24333101511001587,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "envelope",
            "probability": 0.15159281277476588,
            "start_logit": 0.04672538489103317,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.11013646462901396,
            "start_logit": -0.2727524936199188,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.07278880515195718,
            "start_logit": -0.6869105100631714,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the nuclear interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.05171268275002849,
            "start_logit": -1.028769612312317,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "interior",
            "probability": 0.04689598978796953,
            "start_logit": -0.2727524936199188,
            "end_logit": 1.2303532361984253,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear interior",
            "probability": 0.03099339600724251,
            "start_logit": -0.6869105100631714,
            "end_logit": 1.2303532361984253,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the nuclear interior",
            "probability": 0.02201920544955444,
            "start_logit": -1.028769612312317,
            "end_logit": 1.2303532361984253,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin and heterochromatin, are spatially segregated in such a way that the transcriptionally active genome occupies the nuclear interior",
            "probability": 0.009356537699961595,
            "start_logit": -1.884609341621399,
            "end_logit": 1.2303532361984253,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "interior,",
            "probability": 0.001041192153312037,
            "start_logit": -0.2727524936199188,
            "end_logit": -2.5772125720977783,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "transcriptionally active genome occupies the nuclear interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.0006947151554890946,
            "start_logit": -5.338726043701172,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear interior,",
            "probability": 0.000688120260882348,
            "start_logit": -0.6869105100631714,
            "end_logit": -2.5772125720977783,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear envelope.The inversion and dense compaction of heterochromatin",
            "probability": 0.0006675680329768388,
            "start_logit": 0.7746678590774536,
            "end_logit": -4.069113254547119,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin",
            "probability": 0.0005870905763437925,
            "start_logit": -1.884609341621399,
            "end_logit": -1.53829824924469,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "occupies the nuclear interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.0005306295455412317,
            "start_logit": -5.608163833618164,
            "end_logit": 2.084141254425049,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the nuclear interior,",
            "probability": 0.000488873868317907,
            "start_logit": -1.028769612312317,
            "end_logit": -2.5772125720977783,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear envelope.",
            "probability": 0.00047844053448831147,
            "start_logit": 0.7746678590774536,
            "end_logit": -4.402222633361816,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear",
            "probability": 0.0004660211508536865,
            "start_logit": 0.7746678590774536,
            "end_logit": -4.428523540496826,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "heterochromatin, are spatially segregated in such a way that the transcriptionally active genome occupies the nuclear interior",
            "probability": 0.00041225581037203336,
            "start_logit": -5.006795883178711,
            "end_logit": 1.2303532361984253,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        }
    ],
    "570921e4cf1c325851000017": [
        {
            "text": "promoter region",
            "probability": 0.3263061948140345,
            "start_logit": 0.5915408134460449,
            "end_logit": 0.12076910585165024,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "promoter",
            "probability": 0.2773515739967407,
            "start_logit": 0.5915408134460449,
            "end_logit": -0.04178116098046303,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter region",
            "probability": 0.06786607412654092,
            "start_logit": -0.9787591099739075,
            "end_logit": 0.12076910585165024,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.05768435530530735,
            "start_logit": -0.9787591099739075,
            "end_logit": -0.04178116098046303,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "normal and cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter region",
            "probability": 0.05236840471121285,
            "start_logit": -1.2379919290542603,
            "end_logit": 0.12076910585165024,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "normal and cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.04451174910311117,
            "start_logit": -1.2379919290542603,
            "end_logit": -0.04178116098046303,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter region",
            "probability": 0.021380384458093163,
            "start_logit": -2.133821487426758,
            "end_logit": 0.12076910585165024,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "the promoter region",
            "probability": 0.019201476223503152,
            "start_logit": -2.2413082122802734,
            "end_logit": 0.12076910585165024,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.01817275729468482,
            "start_logit": -2.133821487426758,
            "end_logit": -0.04178116098046303,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "the promoter",
            "probability": 0.01632074333337339,
            "start_logit": -2.2413082122802734,
            "end_logit": -0.04178116098046303,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer",
            "probability": 0.013383973836644567,
            "start_logit": -0.9787591099739075,
            "end_logit": -1.502709150314331,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer tissues",
            "probability": 0.011609225456574515,
            "start_logit": -0.9787591099739075,
            "end_logit": -1.6449670791625977,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "in normal and cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.0114012231832496,
            "start_logit": -2.600024461746216,
            "end_logit": -0.04178116098046303,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "normal and cancer",
            "probability": 0.010327654392013542,
            "start_logit": -1.2379919290542603,
            "end_logit": -1.502709150314331,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genome-wide study in normal and cancer",
            "probability": 0.009931696781561115,
            "start_logit": -1.277085781097412,
            "end_logit": -1.502709150314331,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "normal and cancer tissues",
            "probability": 0.008958181608678771,
            "start_logit": -1.2379919290542603,
            "end_logit": -1.6449670791625977,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "upstream of the promoter region",
            "probability": 0.008838935321060875,
            "start_logit": -3.0171289443969727,
            "end_logit": 0.12076910585165024,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genome-wide study in normal and cancer tissues",
            "probability": 0.008614728966952659,
            "start_logit": -1.277085781097412,
            "end_logit": -1.6449670791625977,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer tissues,",
            "probability": 0.008205204154061667,
            "start_logit": -0.9787591099739075,
            "end_logit": -1.991998553276062,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter region",
            "probability": 0.00756546293260096,
            "start_logit": -3.172701835632324,
            "end_logit": 0.12076910585165024,
            "question_text": "In which genomic regions are Alu enriched?"
        }
    ],
    "56bcc455d36b5da378000003": [
        {
            "text": "Myelofibrosis",
            "probability": 0.6494069501521975,
            "start_logit": 3.4587225914001465,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Primary Myelofibrosis",
            "probability": 0.3110321192789095,
            "start_logit": 2.7225592136383057,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Myelofibrosis.",
            "probability": 0.01381035329773241,
            "start_logit": 3.4587225914001465,
            "end_logit": -0.8952367305755615,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Primary Myelofibrosis.",
            "probability": 0.006614440226082408,
            "start_logit": 2.7225592136383057,
            "end_logit": -0.8952367305755615,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Myelofibrosis.Therefore, this condition may be termed \"acquired gray platelet syndrome.",
            "probability": 0.004750405811905671,
            "start_logit": 3.4587225914001465,
            "end_logit": -1.9624252319335938,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Primary Myelofibrosis.Therefore, this condition may be termed \"acquired gray platelet syndrome.",
            "probability": 0.0022751970652078644,
            "start_logit": 2.7225592136383057,
            "end_logit": -1.9624252319335938,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Myelo",
            "probability": 0.0016718581811569042,
            "start_logit": 3.4587225914001465,
            "end_logit": -3.0067195892333984,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "A Case of Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis",
            "probability": 0.0013831900251901703,
            "start_logit": -2.6929445266723633,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis",
            "probability": 0.0012536826139332912,
            "start_logit": -2.7912516593933105,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Associated with Primary Myelofibrosis",
            "probability": 0.0011961616494882185,
            "start_logit": -2.838219165802002,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "My",
            "probability": 0.0011646281027522293,
            "start_logit": 3.4587225914001465,
            "end_logit": -3.368253469467163,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Primary Myelo",
            "probability": 0.000800733027413928,
            "start_logit": 2.7225592136383057,
            "end_logit": -3.0067195892333984,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "fibrosis",
            "probability": 0.0007927924481104469,
            "start_logit": -3.249530792236328,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "elofibrosis",
            "probability": 0.0007898046388947278,
            "start_logit": -3.2533066272735596,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "with Primary Myelofibrosis",
            "probability": 0.0007547801295269114,
            "start_logit": -3.298665761947632,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Primary My",
            "probability": 0.0005577962275979742,
            "start_logit": 2.7225592136383057,
            "end_logit": -3.368253469467163,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "sis",
            "probability": 0.0005380900284702253,
            "start_logit": -3.63706636428833,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Case of Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis",
            "probability": 0.0005040321556074875,
            "start_logit": -3.7024521827697754,
            "end_logit": 2.955404281616211,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Myelofibrosis.Therefore",
            "probability": 0.0004129216071299009,
            "start_logit": 3.4587225914001465,
            "end_logit": -4.405152797698975,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Myelofi",
            "probability": 0.00029006333269217846,
            "start_logit": 3.4587225914001465,
            "end_logit": -4.7583112716674805,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        }
    ],
    "52f89fd32059c6d71c000051": [
        {
            "text": "LSD1 and MYEF2",
            "probability": 0.31504806305523264,
            "start_logit": 4.330248832702637,
            "end_logit": 3.9218175411224365,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF2",
            "probability": 0.2618810128538511,
            "start_logit": 4.145413875579834,
            "end_logit": 3.9218175411224365,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1",
            "probability": 0.16759720621638544,
            "start_logit": 4.330248832702637,
            "end_logit": 3.2906558513641357,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1 interacts with two novel protein partners, LSD1 and MYEF2",
            "probability": 0.06759051630873919,
            "start_logit": 2.7909913063049316,
            "end_logit": 3.9218175411224365,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1 interacts with two novel protein partners, LSD1",
            "probability": 0.03595636040486229,
            "start_logit": 2.7909913063049316,
            "end_logit": 3.2906558513641357,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF2,",
            "probability": 0.032466915748901884,
            "start_logit": 4.330248832702637,
            "end_logit": 1.6493139266967773,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF2,",
            "probability": 0.026987846546679024,
            "start_logit": 4.145413875579834,
            "end_logit": 1.6493139266967773,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF2, in erythroid cells.",
            "probability": 0.018035923870628738,
            "start_logit": 4.330248832702637,
            "end_logit": 1.061457872390747,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF2, in erythroid cells.",
            "probability": 0.014992207745035858,
            "start_logit": 4.145413875579834,
            "end_logit": 1.061457872390747,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF",
            "probability": 0.011397025217774609,
            "start_logit": 4.330248832702637,
            "end_logit": 0.6024447083473206,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF",
            "probability": 0.00947367991603377,
            "start_logit": 4.145413875579834,
            "end_logit": 0.6024447083473206,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1",
            "probability": 0.008039551673691293,
            "start_logit": 2.7909913063049316,
            "end_logit": 1.7927231788635254,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1 interacts with two novel protein partners, LSD1 and MYEF2,",
            "probability": 0.0069654629110857055,
            "start_logit": 2.7909913063049316,
            "end_logit": 1.6493139266967773,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF2, in erythroid cells",
            "probability": 0.004733106940460565,
            "start_logit": 4.330248832702637,
            "end_logit": -0.2763258218765259,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF2, in erythroid cells",
            "probability": 0.0039343547377915485,
            "start_logit": 4.145413875579834,
            "end_logit": -0.2763258218765259,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1 interacts with two novel protein partners, LSD1 and MYEF2, in erythroid cells.",
            "probability": 0.0038694331102971766,
            "start_logit": 2.7909913063049316,
            "end_logit": 1.061457872390747,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD",
            "probability": 0.003166739201769116,
            "start_logit": 4.330248832702637,
            "end_logit": -0.6782052516937256,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "protein partners, LSD1 and MYEF2",
            "probability": 0.0027765910300250178,
            "start_logit": -0.4012524485588074,
            "end_logit": 3.9218175411224365,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "interacts with two novel protein partners, LSD1 and MYEF2",
            "probability": 0.0026428809271382726,
            "start_logit": -0.4506067931652069,
            "end_logit": 3.9218175411224365,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1 interacts with two novel protein partners, LSD1 and MYEF",
            "probability": 0.0024451215836170876,
            "start_logit": 2.7909913063049316,
            "end_logit": 0.6024447083473206,
            "question_text": "List interaction partners for the protein GATA1."
        }
    ],
    "551829a76487737b43000009": [
        {
            "text": "tuberculosis",
            "probability": 0.5499072077218663,
            "start_logit": 3.421013355255127,
            "end_logit": 3.2564494609832764,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis based upon mycobacterial CO dehydrogenase. One of the major hurdles in treating tuberculosis",
            "probability": 0.21913504878789447,
            "start_logit": 3.421013355255127,
            "end_logit": 2.336388111114502,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Tuberculosis",
            "probability": 0.20872551318811428,
            "start_logit": 2.8875060081481934,
            "end_logit": 2.8212273120880127,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Tuberculosis (TB)",
            "probability": 0.013523859260334982,
            "start_logit": 2.8875060081481934,
            "end_logit": 0.08466273546218872,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis based upon mycobacterial CO dehydrogenase. One of the major hurdles in treating tuberculosis (TB)",
            "probability": 0.005097136265097459,
            "start_logit": 3.421013355255127,
            "end_logit": -1.4246212244033813,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis (TB)",
            "probability": 0.001804319161446937,
            "start_logit": 2.3825178146362305,
            "end_logit": -1.4246212244033813,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis based upon mycobacterial CO dehydrogenase.",
            "probability": 0.0009583140815954694,
            "start_logit": 3.421013355255127,
            "end_logit": -3.0958797931671143,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial CO dehydrogenase. One of the major hurdles in treating tuberculosis",
            "probability": 0.000315271080160044,
            "start_logit": -3.122997283935547,
            "end_logit": 2.336388111114502,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis (TB) is the time-consuming and difficult methodology for diagnosis.",
            "probability": 0.00013680627035997207,
            "start_logit": 2.3825178146362305,
            "end_logit": -4.003993988037109,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "studies of a rapid and selective breath test for tuberculosis",
            "probability": 0.00013345958256601466,
            "start_logit": -4.902692794799805,
            "end_logit": 3.2564494609832764,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis based upon mycobacterial CO dehydrogenase",
            "probability": 9.671129757868163e-05,
            "start_logit": 3.421013355255127,
            "end_logit": -5.389325141906738,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "CO dehydrogenase. One of the major hurdles in treating tuberculosis",
            "probability": 7.35317425488456e-05,
            "start_logit": -4.5787129402160645,
            "end_logit": 2.336388111114502,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": ". One of the major hurdles in treating tuberculosis",
            "probability": 4.297736634002638e-05,
            "start_logit": -5.115756511688232,
            "end_logit": 2.336388111114502,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis (TB) is the time-consuming and difficult methodology for diagnosis. Stable-isotope breath tests",
            "probability": 3.3539569472044186e-05,
            "start_logit": 2.3825178146362305,
            "end_logit": -5.409833908081055,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial CO dehydrogenase. One of the major hurdles in treating tuberculosis (TB)",
            "probability": 7.333284496975372e-06,
            "start_logit": -3.122997283935547,
            "end_logit": -1.4246212244033813,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": ")",
            "probability": 3.891471827083804e-06,
            "start_logit": -5.2659173011779785,
            "end_logit": 0.08466273546218872,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "CO dehydrogenase. One of the major hurdles in treating tuberculosis (TB)",
            "probability": 1.7103667973456364e-06,
            "start_logit": -4.5787129402160645,
            "end_logit": -1.4246212244033813,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial CO dehydrogenase.",
            "probability": 1.3787329653944176e-06,
            "start_logit": -3.122997283935547,
            "end_logit": -3.0958797931671143,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": ". One of the major hurdles in treating tuberculosis (TB)",
            "probability": 9.996643337605096e-07,
            "start_logit": -5.115756511688232,
            "end_logit": -1.4246212244033813,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial conversion of labeled CO to labeled CO2",
            "probability": 9.911042038824413e-07,
            "start_logit": -2.760347843170166,
            "end_logit": -3.7886297702789307,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        }
    ],
    "52bf209303868f1b0600001a": [
        {
            "text": "myocardial infarction",
            "probability": 0.5656219829352077,
            "start_logit": 5.474039077758789,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute myocardial infarction",
            "probability": 0.40596352900346805,
            "start_logit": 5.14237642288208,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "intravenous alteplase in the early treatment of patients with acute myocardial infarction",
            "probability": 0.011017864084924826,
            "start_logit": 1.8463777303695679,
            "end_logit": 5.284104347229004,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "management of acute myocardial infarction",
            "probability": 0.010075747127514368,
            "start_logit": 1.4462443590164185,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "infarction",
            "probability": 0.002318938152719924,
            "start_logit": -0.022777514532208443,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "patients with acute myocardial infarction",
            "probability": 0.0013273254810925693,
            "start_logit": -0.2699742317199707,
            "end_logit": 5.284104347229004,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ardial infarction",
            "probability": 0.0008847648685377095,
            "start_logit": -0.9863202571868896,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ction",
            "probability": 0.0005491867964830132,
            "start_logit": -1.4632035493850708,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "farction",
            "probability": 0.00039893746349757423,
            "start_logit": -1.7828375101089478,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ial infarction",
            "probability": 0.0003100699084323768,
            "start_logit": -2.034844398498535,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "treatment of patients with acute myocardial infarction",
            "probability": 0.00028244766258660615,
            "start_logit": -1.8174022436141968,
            "end_logit": 5.284104347229004,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "first-line option in the management of acute myocardial infarction",
            "probability": 0.00023993512822053894,
            "start_logit": -2.291273593902588,
            "end_logit": 5.594851016998291,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "early treatment of patients with acute myocardial infarction",
            "probability": 0.00018909963008417995,
            "start_logit": -2.2186214923858643,
            "end_logit": 5.284104347229004,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "my",
            "probability": 0.00016247852939531228,
            "start_logit": 5.474039077758789,
            "end_logit": -2.560284376144409,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "myocardial infarction has been unequivocally proven,",
            "probability": 0.00013573356148149782,
            "start_logit": 5.059507846832275,
            "end_logit": -2.3256051540374756,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "myocardial infar",
            "probability": 0.00012921566526563743,
            "start_logit": 5.474039077758789,
            "end_logit": -2.7893474102020264,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute my",
            "probability": 0.00011661561815246931,
            "start_logit": 5.14237642288208,
            "end_logit": -2.560284376144409,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute myocardial infarction has been unequivocally proven,",
            "probability": 9.360503451752519e-05,
            "start_logit": 4.6878981590271,
            "end_logit": -2.3256051540374756,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute myocardial infar",
            "probability": 9.274188248758e-05,
            "start_logit": 5.14237642288208,
            "end_logit": -2.7893474102020264,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "myocardial",
            "probability": 8.978146593044708e-05,
            "start_logit": 5.474039077758789,
            "end_logit": -3.153451681137085,
            "question_text": "What are the indications for alteplase?"
        }
    ],
    "55152bd246478f2f2c000002": [
        {
            "text": "DG",
            "probability": 0.27207863743035926,
            "start_logit": 3.918240547180176,
            "end_logit": 3.6843907833099365,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b1-DG and transmembrane \u03b2-DG",
            "probability": 0.22853374706314764,
            "start_logit": 3.4308555126190186,
            "end_logit": 3.997368574142456,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b1-DG",
            "probability": 0.17895154380891518,
            "start_logit": 3.5946719646453857,
            "end_logit": 3.5889832973480225,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b2-DG",
            "probability": 0.17720487053301054,
            "start_logit": 3.3577070236206055,
            "end_logit": 3.8161396980285645,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "transmembrane \u03b2-DG",
            "probability": 0.05449624837995812,
            "start_logit": 2.178532361984253,
            "end_logit": 3.8161396980285645,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG and transmembrane \u03b2-DG",
            "probability": 0.03502143450945186,
            "start_logit": 1.736360788345337,
            "end_logit": 3.8161396980285645,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "extracellular \u03b1-DG and transmembrane \u03b2-DG",
            "probability": 0.023941312579728483,
            "start_logit": 1.3560060262680054,
            "end_logit": 3.8161396980285645,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "extracellular \u03b1-DG",
            "probability": 0.01907634576330329,
            "start_logit": 1.3560060262680054,
            "end_logit": 3.5889832973480225,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "Dystroglycan",
            "probability": 0.0037922057475414405,
            "start_logit": 1.6234124898910522,
            "end_logit": 1.7060755491256714,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG by siRNA led to no obvious effect of scratched-injury on the ERK signaling pathway.It demonstrated that DG",
            "probability": 0.0029621290538630334,
            "start_logit": -0.6309356689453125,
            "end_logit": 3.7133841514587402,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG may act as the scaffold in scratch mechanical force activating ERK pathway which can regulate the expression of AQP4",
            "probability": 0.0011063984404076257,
            "start_logit": 3.6511521339416504,
            "end_logit": -1.553501844406128,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG may act as the scaffold in scratch mechanical force",
            "probability": 0.0007503928729473818,
            "start_logit": 3.918240547180176,
            "end_logit": -2.2088587284088135,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG may act as the scaffold in scratch mechanical force activating ERK",
            "probability": 0.0007329390903376585,
            "start_logit": 3.918240547180176,
            "end_logit": -2.2323930263519287,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b1-DG and transmembrane \u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 0.0005567975690693752,
            "start_logit": 3.4308555126190186,
            "end_logit": -2.019868850708008,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 0.00033524609973045044,
            "start_logit": 3.3577070236206055,
            "end_logit": -2.454057216644287,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG may act as the scaffold in scratch mechanical force activating ERK pathway which may regulate the expression of AQP4",
            "probability": 0.00022907823164182212,
            "start_logit": 1.8648464679718018,
            "end_logit": -1.3419979810714722,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "transmembrane \u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 0.00010309905514656542,
            "start_logit": 2.178532361984253,
            "end_logit": -2.454057216644287,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG and transmembrane \u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 8.05639735162767e-05,
            "start_logit": 1.497705340385437,
            "end_logit": -2.019868850708008,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "extracellular \u03b1-DG and transmembrane \u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 4.529351614681708e-05,
            "start_logit": 1.3560060262680054,
            "end_logit": -2.454057216644287,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "scratch mechanical force activating ERK pathway which can regulate the expression of AQP4",
            "probability": 1.7162817772335846e-06,
            "start_logit": -2.8175530433654785,
            "end_logit": -1.553501844406128,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        }
    ],
    "516c3960298dcd4e51000073": [
        {
            "text": "DNMT1",
            "probability": 0.22306726407504845,
            "start_logit": 4.295800685882568,
            "end_logit": 3.4958033561706543,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3",
            "probability": 0.1819002719298614,
            "start_logit": 4.295800685882568,
            "end_logit": 3.2917885780334473,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3",
            "probability": 0.1773564262744694,
            "start_logit": 4.270503520965576,
            "end_logit": 3.2917885780334473,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3",
            "probability": 0.13149113344289662,
            "start_logit": 4.295800685882568,
            "end_logit": 2.9672694206237793,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3",
            "probability": 0.12820650165494932,
            "start_logit": 4.270503520965576,
            "end_logit": 2.9672694206237793,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s",
            "probability": 0.03524638819299716,
            "start_logit": 4.295800685882568,
            "end_logit": 1.6506930589675903,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s",
            "probability": 0.034365937899218796,
            "start_logit": 4.270503520965576,
            "end_logit": 1.6506930589675903,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methylation is performed by DNMT1",
            "probability": 0.014830829908170378,
            "start_logit": 1.5850354433059692,
            "end_logit": 3.4958033561706543,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methylation is performed by DNMT1 and DNMT3s (DNMT3",
            "probability": 0.012093804998361804,
            "start_logit": 1.5850354433059692,
            "end_logit": 3.2917885780334473,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3A",
            "probability": 0.011435617895651198,
            "start_logit": 4.295800685882568,
            "end_logit": 0.5250628590583801,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3A",
            "probability": 0.011149957615209649,
            "start_logit": 4.270503520965576,
            "end_logit": 0.5250628590583801,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methylation is performed by DNMT1 and DNMT3",
            "probability": 0.008742307584263179,
            "start_logit": 1.5850354433059692,
            "end_logit": 2.9672694206237793,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3A and 3B",
            "probability": 0.006281180573327985,
            "start_logit": 4.295800685882568,
            "end_logit": -0.07411205023527145,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3A and 3B",
            "probability": 0.006124277481562108,
            "start_logit": 4.270503520965576,
            "end_logit": -0.07411205023527145,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3A and 3B).",
            "probability": 0.0038497896109445547,
            "start_logit": 4.295800685882568,
            "end_logit": -0.5636515021324158,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3A and 3B).",
            "probability": 0.003753622356150077,
            "start_logit": 4.270503520965576,
            "end_logit": -0.5636515021324158,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3A",
            "probability": 0.003361171002207461,
            "start_logit": 3.071357250213623,
            "end_logit": 0.5250628590583801,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methylation is performed by DNMT1 and DNMT3s",
            "probability": 0.002343388171882621,
            "start_logit": 1.5850354433059692,
            "end_logit": 1.6506930589675903,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3A and 3",
            "probability": 0.002227890881835844,
            "start_logit": 4.295800685882568,
            "end_logit": -1.1106146574020386,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3A and 3",
            "probability": 0.0021722384509916468,
            "start_logit": 4.270503520965576,
            "end_logit": -1.1106146574020386,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        }
    ],
    "54e0ac041388e8454a00000f": [
        {
            "text": "L1",
            "probability": 0.5673407967919363,
            "start_logit": 1.8162561655044556,
            "end_logit": 1.1324455738067627,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I",
            "probability": 0.10406896814955136,
            "start_logit": 1.8162561655044556,
            "end_logit": -0.5634607672691345,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I",
            "probability": 0.057498369536650704,
            "start_logit": 1.2229589223861694,
            "end_logit": -0.5634607672691345,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retroviruses",
            "probability": 0.04324777857550376,
            "start_logit": 1.8162561655044556,
            "end_logit": -1.4415687322616577,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retroviruses (ERVs)",
            "probability": 0.04117387143011157,
            "start_logit": 1.8162561655044556,
            "end_logit": -1.490710735321045,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retroviruses (ERVs",
            "probability": 0.024478526314531436,
            "start_logit": 1.8162561655044556,
            "end_logit": -2.01071834564209,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retroviruses",
            "probability": 0.023894507636513743,
            "start_logit": 1.2229589223861694,
            "end_logit": -1.4415687322616577,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retroviruses (ERVs)",
            "probability": 0.022748668665004974,
            "start_logit": 1.2229589223861694,
            "end_logit": -1.490710735321045,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L",
            "probability": 0.022206390188148323,
            "start_logit": 1.8162561655044556,
            "end_logit": -2.1081345081329346,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class",
            "probability": 0.017390221525321967,
            "start_logit": 1.8162561655044556,
            "end_logit": -2.3526065349578857,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retroviruses (ERVs",
            "probability": 0.013524448034528,
            "start_logit": 1.2229589223861694,
            "end_logit": -2.01071834564209,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II",
            "probability": 0.013301470093435776,
            "start_logit": 1.8162561655044556,
            "end_logit": -2.6206400394439697,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class",
            "probability": 0.009608141613840824,
            "start_logit": 1.2229589223861694,
            "end_logit": -2.3526065349578857,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retrovirus",
            "probability": 0.009406929936831798,
            "start_logit": 1.8162561655044556,
            "end_logit": -2.9670679569244385,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II",
            "probability": 0.00734909605055381,
            "start_logit": 1.2229589223861694,
            "end_logit": -2.6206400394439697,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retrovirus",
            "probability": 0.00519735271071455,
            "start_logit": 1.2229589223861694,
            "end_logit": -2.9670679569244385,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "endogenous retroviruses",
            "probability": 0.00505425607593746,
            "start_logit": -0.33045902848243713,
            "end_logit": -1.4415687322616577,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III",
            "probability": 0.004837580674118902,
            "start_logit": 1.8162561655044556,
            "end_logit": -3.6320998668670654,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "endogenous retroviruses (ERVs)",
            "probability": 0.004811883909417309,
            "start_logit": -0.33045902848243713,
            "end_logit": -1.490710735321045,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "endogenous retroviruses (ERVs",
            "probability": 0.002860742087347185,
            "start_logit": -0.33045902848243713,
            "end_logit": -2.01071834564209,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        }
    ],
    "55192f20622b194345000014": [
        {
            "text": "dimers",
            "probability": 0.12361411738522797,
            "start_logit": -2.0460519790649414,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "dimers amongst themselves in various combinations.",
            "probability": 0.09827366973229641,
            "start_logit": -2.0460519790649414,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "five members forming dimers",
            "probability": 0.06945215616304386,
            "start_logit": -2.6225786209106445,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "forming dimers",
            "probability": 0.06898821492953065,
            "start_logit": -2.6292810440063477,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "family comprises of five members forming dimers",
            "probability": 0.058918817878800184,
            "start_logit": -2.7870562076568604,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "comprises of five members forming dimers",
            "probability": 0.05632815763876867,
            "start_logit": -2.832022190093994,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "five members forming dimers amongst themselves in various combinations.",
            "probability": 0.05521471496408938,
            "start_logit": -2.6225786209106445,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "forming dimers amongst themselves in various combinations.",
            "probability": 0.05484588000800272,
            "start_logit": -2.6292810440063477,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "family comprises of five members forming dimers amongst themselves in various combinations.",
            "probability": 0.04684067298878326,
            "start_logit": -2.7870562076568604,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "members forming dimers",
            "probability": 0.045017938977757375,
            "start_logit": -3.0561556816101074,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "comprises of five members forming dimers amongst themselves in various combinations.",
            "probability": 0.04478108874223609,
            "start_logit": -2.832022190093994,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "members forming dimers amongst themselves in various combinations.",
            "probability": 0.03578942406183038,
            "start_logit": -3.0561556816101074,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "The family comprises of five members forming dimers",
            "probability": 0.033872302623333295,
            "start_logit": -3.3406190872192383,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "five",
            "probability": 0.03370429208388783,
            "start_logit": -2.6225786209106445,
            "end_logit": -2.4517745971679688,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "of five members forming dimers",
            "probability": 0.03295344563668269,
            "start_logit": -3.3681209087371826,
            "end_logit": -1.7287616729736328,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "in various combinations.",
            "probability": 0.032350430485137714,
            "start_logit": -3.1571807861328125,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "family comprises of five",
            "probability": 0.028592590305801704,
            "start_logit": -2.7870562076568604,
            "end_logit": -2.4517745971679688,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "comprises of five",
            "probability": 0.02733537419842621,
            "start_logit": -2.832022190093994,
            "end_logit": -2.4517745971679688,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "The family comprises of five members forming dimers amongst themselves in various combinations.",
            "probability": 0.026928602909522082,
            "start_logit": -3.3406190872192383,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "of five members forming dimers amongst themselves in various combinations.",
            "probability": 0.0261981082868415,
            "start_logit": -3.3681209087371826,
            "end_logit": -1.9581702947616577,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        }
    ],
    "52fa73e82059c6d71c000059": [
        {
            "text": "In utero electroporation",
            "probability": 0.5265588552331565,
            "start_logit": 4.0146613121032715,
            "end_logit": 4.713921546936035,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation",
            "probability": 0.4349586937446034,
            "start_logit": 3.823549270629883,
            "end_logit": 4.713921546936035,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "transgenic mouse lines are quite costly and many novel disease-associated genes do not yet have commercially available genetic lines.In utero electroporation",
            "probability": 0.015634357347233122,
            "start_logit": 0.4977690875530243,
            "end_logit": 4.713921546936035,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero",
            "probability": 0.010786665627861009,
            "start_logit": 4.0146613121032715,
            "end_logit": 0.8258691430091858,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electroporation offers a relatively quick and easy method to manipulate gene expression in a cell-type specific manner in vivo",
            "probability": 0.0017490648666829852,
            "start_logit": 4.0146613121032715,
            "end_logit": -0.9933602809906006,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation offers a relatively quick and easy method to manipulate gene expression in a cell-type specific manner in vivo",
            "probability": 0.0014447975988365936,
            "start_logit": 3.823549270629883,
            "end_logit": -0.9933602809906006,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DNA plasmid",
            "probability": 0.0014423604887031658,
            "start_logit": 1.800154447555542,
            "end_logit": 1.028346300125122,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electroporation offers a relatively quick and easy method",
            "probability": 0.0011902951915755257,
            "start_logit": 4.0146613121032715,
            "end_logit": -1.3782402276992798,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation offers a relatively quick and easy method",
            "probability": 0.0009832314784050612,
            "start_logit": 3.823549270629883,
            "end_logit": -1.3782402276992798,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electro",
            "probability": 0.0008473773634439393,
            "start_logit": 4.0146613121032715,
            "end_logit": -1.7180507183074951,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electro",
            "probability": 0.0006999676246050782,
            "start_logit": 3.823549270629883,
            "end_logit": -1.7180507183074951,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "poration",
            "probability": 0.0005111047304229811,
            "start_logit": -2.922882556915283,
            "end_logit": 4.713921546936035,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electroporation offers",
            "probability": 0.0004832562777506486,
            "start_logit": 4.0146613121032715,
            "end_logit": -2.2796497344970703,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "in",
            "probability": 0.00045800366175893044,
            "start_logit": 4.0146613121032715,
            "end_logit": -2.333319664001465,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electroporation offers a relatively quick and easy method to manipulate gene expression in a cell-type specific manner",
            "probability": 0.00043111109959020384,
            "start_logit": 4.0146613121032715,
            "end_logit": -2.3938310146331787,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electroporation offers a relatively quick and easy method to manipulate gene expression",
            "probability": 0.0004081403435385614,
            "start_logit": 4.0146613121032715,
            "end_logit": -2.4485857486724854,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation offers",
            "probability": 0.0003991890312455724,
            "start_logit": 3.823549270629883,
            "end_logit": -2.2796497344970703,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation offers a relatively quick and easy method to manipulate gene expression in a cell-type specific manner",
            "probability": 0.000356115026597595,
            "start_logit": 3.823549270629883,
            "end_logit": -2.3938310146331787,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation offers a relatively quick and easy method to manipulate gene expression",
            "probability": 0.0003371402625284877,
            "start_logit": 3.823549270629883,
            "end_logit": -2.4485857486724854,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "transgenic mouse lines are quite costly and many novel disease-associated genes do not yet have commercially available genetic lines.In utero",
            "probability": 0.0003202730014604389,
            "start_logit": 0.4977690875530243,
            "end_logit": 0.8258691430091858,
            "question_text": "List the existing methods for genetic manipulation of cells."
        }
    ],
    "551910d3622b194345000008": [
        {
            "text": "NRTN",
            "probability": 0.45381055540449944,
            "start_logit": 0.7597870826721191,
            "end_logit": -0.28502199053764343,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NRTN, and ARTN",
            "probability": 0.15521527198327612,
            "start_logit": 0.7597870826721191,
            "end_logit": -1.3578888177871704,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK",
            "probability": 0.119396191808378,
            "start_logit": 0.7982585430145264,
            "end_logit": -1.6587259769439697,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NRTN",
            "probability": 0.10755852712459882,
            "start_logit": -0.679857611656189,
            "end_logit": -0.28502199053764343,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TrkA.This suggests a physical association between RET and TRK",
            "probability": 0.03691399178073136,
            "start_logit": -0.37559810280799866,
            "end_logit": -1.6587259769439697,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NRTN, and ARTN",
            "probability": 0.03678787512309958,
            "start_logit": -0.679857611656189,
            "end_logit": -1.3578888177871704,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF",
            "probability": 0.03137801456832783,
            "start_logit": -0.679857611656189,
            "end_logit": -1.5169496536254883,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TrkA",
            "probability": 0.021018461145253874,
            "start_logit": -0.37559810280799866,
            "end_logit": -2.2219154834747314,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK proteins, and cross\u2011talk between these two receptor pathways.RET receptor expression and interaction with TRK",
            "probability": 0.012150293254262258,
            "start_logit": 0.059796832501888275,
            "end_logit": -3.2053582668304443,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN",
            "probability": 0.00847445983284573,
            "start_logit": -2.1479690074920654,
            "end_logit": -1.3578888177871704,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN in NBLS cells led to phosphorylation of TrkA.This suggests a physical association between RET and TRK",
            "probability": 0.006826353526064066,
            "start_logit": -1.9586682319641113,
            "end_logit": -1.763455867767334,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TrkA.",
            "probability": 0.0031959430846701543,
            "start_logit": -0.37559810280799866,
            "end_logit": -4.105434417724609,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK inhibitor (CEP\u2011701).Conversely, RET activation by ARTN",
            "probability": 0.0018958503642888304,
            "start_logit": -2.986931324005127,
            "end_logit": -2.0163159370422363,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN in NBLS cells led to phosphorylation of TrkA",
            "probability": 0.0017833303437063857,
            "start_logit": -1.9586682319641113,
            "end_logit": -3.1057639122009277,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK proteins, and cross\u2011talk between these two receptor pathways.",
            "probability": 0.0012449106361469369,
            "start_logit": 0.059796832501888275,
            "end_logit": -5.48364782333374,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK proteins, and cross\u2011talk between these two receptor pathways.RET receptor expression and interaction with TRK receptors",
            "probability": 0.0010147146295393194,
            "start_logit": 0.059796832501888275,
            "end_logit": -5.688104152679443,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NGF",
            "probability": 0.0004106604940260872,
            "start_logit": -3.3115954399108887,
            "end_logit": -3.2213077545166016,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TrkA by its cognate ligand NGF",
            "probability": 0.0003671001694461457,
            "start_logit": -3.423727512359619,
            "end_logit": -3.2213077545166016,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN in NBLS cells led to phosphorylation of TrkA.",
            "probability": 0.0003267877260116164,
            "start_logit": -1.9586682319641113,
            "end_logit": -4.8026909828186035,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK receptors",
            "probability": 0.00023070700082753287,
            "start_logit": -1.4214173555374146,
            "end_logit": -5.688104152679443,
            "question_text": "Which proteins have been identified as RET ligands?"
        }
    ],
    "52fb78d82059c6d71c000068": [
        {
            "text": "C5607T",
            "probability": 0.8289075502621452,
            "start_logit": 3.7365822792053223,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism",
            "probability": 0.11681050464903842,
            "start_logit": 3.7365822792053223,
            "end_logit": 1.1028778553009033,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "a C5607T",
            "probability": 0.02740018014664737,
            "start_logit": 0.3270232379436493,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.006659626807383166,
            "start_logit": -1.0874629020690918,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "a C5607T polymorphism",
            "probability": 0.0038612615718028286,
            "start_logit": 0.3270232379436493,
            "end_logit": 1.1028778553009033,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "novel single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.0025315347442512754,
            "start_logit": -2.0547006130218506,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.0020792656455122147,
            "start_logit": -2.251511573791504,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "a novel single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.001891292688182082,
            "start_logit": -2.3462657928466797,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C",
            "probability": 0.0017346810616354733,
            "start_logit": 3.7365822792053223,
            "end_logit": -3.106851577758789,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "detected a C5607T",
            "probability": 0.0012890707746136488,
            "start_logit": -2.729604721069336,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "single missense mutation associated with Brugada syndrome in the family and detected a C5607T polymorphism",
            "probability": 0.0009384814602046677,
            "start_logit": -1.0874629020690918,
            "end_logit": 1.1028778553009033,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "5607T",
            "probability": 0.0009179628583306106,
            "start_logit": -3.069124698638916,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607",
            "probability": 0.0009059823533730204,
            "start_logit": 3.7365822792053223,
            "end_logit": -3.756410598754883,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "polymorphism",
            "probability": 0.0007057142736235682,
            "start_logit": -1.3725155591964722,
            "end_logit": 1.1028778553009033,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "analysis, we identified a novel single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.0006663997595259642,
            "start_logit": -3.3893918991088867,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T p",
            "probability": 0.0006274916004555938,
            "start_logit": 3.7365822792053223,
            "end_logit": -4.123700141906738,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism in Korean subjects",
            "probability": 0.0005391873869210188,
            "start_logit": 3.7365822792053223,
            "end_logit": -4.275367259979248,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "identified a novel single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.0005233276121331657,
            "start_logit": -3.6310739517211914,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "T",
            "probability": 0.0005111946250564858,
            "start_logit": -3.654531240463257,
            "end_logit": 3.0624334812164307,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism in Korean subjects.This finding is the first report of a novel mutation",
            "probability": 0.0004992897191639998,
            "start_logit": 3.7365822792053223,
            "end_logit": -4.352243900299072,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        }
    ],
    "55031270e9bde6963400001a": [
        {
            "text": "hypocellular",
            "probability": 0.2827590108711179,
            "start_logit": 2.54379940032959,
            "end_logit": 1.105663776397705,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular bone marrow failure",
            "probability": 0.19804934944096475,
            "start_logit": 2.54379940032959,
            "end_logit": 0.7495850324630737,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular bone marrow failure-A focus on genomics.Hypocellular",
            "probability": 0.1913714320348305,
            "start_logit": 2.54379940032959,
            "end_logit": 0.7152850031852722,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular",
            "probability": 0.18060510729297685,
            "start_logit": 2.485896110534668,
            "end_logit": 0.7152850031852722,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular bone marrow failure-A focus on genomics.Hypocellular bone marrow failure (BMF)",
            "probability": 0.04174439012649823,
            "start_logit": 2.54379940032959,
            "end_logit": -0.807366132736206,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone marrow failure (BMF)",
            "probability": 0.03939590135012376,
            "start_logit": 2.485896110534668,
            "end_logit": -0.807366132736206,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular bone marrow failure-A focus on genomics.Hypocellular bone marrow failure",
            "probability": 0.025891060180495706,
            "start_logit": 2.54379940032959,
            "end_logit": -1.2850334644317627,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone marrow failure",
            "probability": 0.02443446052583378,
            "start_logit": 2.485896110534668,
            "end_logit": -1.2850334644317627,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular bone marrow failure-A focus on genomics.Hypocellular bone marrow failure (BMF",
            "probability": 0.006163243087208627,
            "start_logit": 2.54379940032959,
            "end_logit": -2.7203280925750732,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone marrow failure (BMF",
            "probability": 0.005816506503621818,
            "start_logit": 2.485896110534668,
            "end_logit": -2.7203280925750732,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular bone marrow failure-A focus on genomics.H",
            "probability": 0.0012002166794961733,
            "start_logit": 2.54379940032959,
            "end_logit": -4.356429100036621,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "H",
            "probability": 0.0011326939442861802,
            "start_logit": 2.485896110534668,
            "end_logit": -4.356429100036621,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "h",
            "probability": 0.0008403217830184015,
            "start_logit": 2.54379940032959,
            "end_logit": -4.712901592254639,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "BMF)",
            "probability": 0.00014442339271273155,
            "start_logit": -3.122771739959717,
            "end_logit": -0.807366132736206,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "failure",
            "probability": 0.00011822755976119214,
            "start_logit": -4.879860877990723,
            "end_logit": 0.7495850324630737,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "failure-A focus on genomics.Hypocellular",
            "probability": 0.00011424110950804761,
            "start_logit": -4.879860877990723,
            "end_logit": 0.7152850031852722,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "BMF",
            "probability": 7.280167030912933e-05,
            "start_logit": -1.3922241926193237,
            "end_logit": -3.222923994064331,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "bone marrow failure",
            "probability": 5.0265905583654296e-05,
            "start_logit": -5.735145092010498,
            "end_logit": 0.7495850324630737,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "bone marrow failure-A focus on genomics.Hypocellular",
            "probability": 4.857101707844239e-05,
            "start_logit": -5.735145092010498,
            "end_logit": 0.7152850031852722,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "cellular",
            "probability": 4.777552457422318e-05,
            "start_logit": -6.142037391662598,
            "end_logit": 1.105663776397705,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        }
    ],
    "56d2ac03f22319765a000004": [
        {
            "text": "ESBL isolates.",
            "probability": 0.3322461267726203,
            "start_logit": -4.97610330581665,
            "end_logit": -4.636244297027588,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESBL",
            "probability": 0.07647565832672534,
            "start_logit": -4.97610330581665,
            "end_logit": -6.105147838592529,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "healthcare associated infections (HAIs) and admission swab positivity with ESKAPE or ESBL isolates.",
            "probability": 0.07384891289109052,
            "start_logit": -6.4799580574035645,
            "end_logit": -4.636244297027588,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE organisms",
            "probability": 0.062011365970394826,
            "start_logit": -5.86694860458374,
            "end_logit": -5.423957347869873,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE",
            "probability": 0.048868557412229306,
            "start_logit": -5.86694860458374,
            "end_logit": -5.662140846252441,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE organisms were associated with 50-90% of clinical infections;",
            "probability": 0.04055425856740681,
            "start_logit": -5.86694860458374,
            "end_logit": -5.848634243011475,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "infections (HAIs) and admission swab positivity with ESKAPE or ESBL isolates.",
            "probability": 0.03464830373605792,
            "start_logit": -7.236730575561523,
            "end_logit": -4.636244297027588,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE organisms were associated with 50-90% of clinical infections; however, there was no correlation between healthcare associated infections",
            "probability": 0.033081117922629126,
            "start_logit": -5.86694860458374,
            "end_logit": -6.05231237411499,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "HAIs) and admission swab positivity with ESKAPE or ESBL isolates.",
            "probability": 0.030839844926654182,
            "start_logit": -7.3531718254089355,
            "end_logit": -4.636244297027588,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE organisms were associated with 50-90% of clinical infections",
            "probability": 0.03073965711214748,
            "start_logit": -5.86694860458374,
            "end_logit": -6.125721454620361,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": ",",
            "probability": 0.03004361445953063,
            "start_logit": -7.050149440765381,
            "end_logit": -4.965424060821533,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESBL isolates",
            "probability": 0.027298131870043874,
            "start_logit": -4.97610330581665,
            "end_logit": -7.1353020668029785,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Bokamoso hospital,",
            "probability": 0.026674266453311692,
            "start_logit": -7.169100284576416,
            "end_logit": -4.965424060821533,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE or ESBL isolates.",
            "probability": 0.0262357631077646,
            "start_logit": -7.514855861663818,
            "end_logit": -4.636244297027588,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "organisms",
            "probability": 0.026218954803345178,
            "start_logit": -6.727783679962158,
            "end_logit": -5.423957347869873,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Lenmed Bokamoso hospital,",
            "probability": 0.023731576016652118,
            "start_logit": -7.2859930992126465,
            "end_logit": -4.965424060821533,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "admission swab positivity with ESKAPE or ESBL isolates.",
            "probability": 0.022422667691176772,
            "start_logit": -7.6719069480896,
            "end_logit": -4.636244297027588,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": ", ESKAPE organisms",
            "probability": 0.018993880610632546,
            "start_logit": -7.050149440765381,
            "end_logit": -5.423957347869873,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "healthcare associated infections",
            "probability": 0.01792064161441839,
            "start_logit": -6.4799580574035645,
            "end_logit": -6.05231237411499,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "organisms were associated with 50-90% of clinical infections;",
            "probability": 0.017146699735168615,
            "start_logit": -6.727783679962158,
            "end_logit": -5.848634243011475,
            "question_text": "Which ones are the ESKAPE organisms?"
        }
    ],
    "51716a438ed59a060a00000a": [
        {
            "text": "Comparative analysis",
            "probability": 0.35659324183817287,
            "start_logit": -0.40111419558525085,
            "end_logit": -0.9366043210029602,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Comparative",
            "probability": 0.25885879426754316,
            "start_logit": -0.40111419558525085,
            "end_logit": -1.2569173574447632,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Comparative analysis of genomic sequences",
            "probability": 0.11852728937648684,
            "start_logit": -0.40111419558525085,
            "end_logit": -2.0380568504333496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "analysis",
            "probability": 0.10261540926937507,
            "start_logit": -1.6467218399047852,
            "end_logit": -0.9366043210029602,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "analysis of genomic sequences",
            "probability": 0.034108123435714094,
            "start_logit": -1.6467218399047852,
            "end_logit": -2.0380568504333496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "UTY",
            "probability": 0.02986330455347156,
            "start_logit": -1.4027470350265503,
            "end_logit": -2.4149367809295654,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Comparative analysis of genomic sequences provides a powerful tool for identifying regions of potential biologic function;",
            "probability": 0.022191764929947514,
            "start_logit": -0.40111419558525085,
            "end_logit": -3.7134788036346436,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Comparative analysis of genomic sequences provides a powerful tool",
            "probability": 0.016285422885219506,
            "start_logit": -0.40111419558525085,
            "end_logit": -4.022929668426514,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Comparative analysis of genomic sequences provides a powerful tool for identifying regions of potential biologic function",
            "probability": 0.012909284221824744,
            "start_logit": -0.40111419558525085,
            "end_logit": -4.255253314971924,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "sequences",
            "probability": 0.008220327972313724,
            "start_logit": -3.0696473121643066,
            "end_logit": -2.0380568504333496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "analysis of genomic sequences provides a powerful tool for identifying regions of potential biologic function;",
            "probability": 0.006386035329659339,
            "start_logit": -1.6467218399047852,
            "end_logit": -3.7134788036346436,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "genomic sequences",
            "probability": 0.005767779650971284,
            "start_logit": -3.4239702224731445,
            "end_logit": -2.0380568504333496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "analysis of genomic sequences provides a powerful tool",
            "probability": 0.004686390930678467,
            "start_logit": -1.6467218399047852,
            "end_logit": -4.022929668426514,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Comparative analysis of g",
            "probability": 0.004674400802868069,
            "start_logit": -0.40111419558525085,
            "end_logit": -5.271099090576172,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "analysis of two unannotated orthologous genomic sequences from human and mouse containing parts of the UTY",
            "probability": 0.00401206518013515,
            "start_logit": -3.41007137298584,
            "end_logit": -2.4149367809295654,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "analysis of genomic sequences provides a powerful tool for identifying regions of potential biologic function",
            "probability": 0.003714853026851238,
            "start_logit": -1.6467218399047852,
            "end_logit": -4.255253314971924,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "UTY locus",
            "probability": 0.0032994885652693315,
            "start_logit": -1.4027470350265503,
            "end_logit": -4.617799758911133,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "UTY locus is presented.",
            "probability": 0.0029512606082756766,
            "start_logit": -1.4027470350265503,
            "end_logit": -4.729334831237793,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "UTY locus is presented",
            "probability": 0.0027956780469046857,
            "start_logit": -1.4027470350265503,
            "end_logit": -4.783492565155029,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "sequences provides a powerful tool for identifying regions of potential biologic function;",
            "probability": 0.0015390851083180769,
            "start_logit": -3.0696473121643066,
            "end_logit": -3.7134788036346436,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        }
    ],
    "53215fca9b2d7acc7e000005": [
        {
            "text": "MICOS",
            "probability": 0.38796194947086204,
            "start_logit": 4.4873366355896,
            "end_logit": 3.5906436443328857,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MICOS",
            "probability": 0.2036457039246771,
            "start_logit": 3.842811107635498,
            "end_logit": 3.5906436443328857,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MICOS)",
            "probability": 0.1041853098012918,
            "start_logit": 4.4873366355896,
            "end_logit": 2.275907516479492,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MICOS) complex",
            "probability": 0.09630878367922717,
            "start_logit": 4.4873366355896,
            "end_logit": 2.197295904159546,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system",
            "probability": 0.06956950363910705,
            "start_logit": 3.842811107635498,
            "end_logit": 2.5165882110595703,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MICOS)",
            "probability": 0.05468807129676548,
            "start_logit": 3.842811107635498,
            "end_logit": 2.275907516479492,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MICOS) complex",
            "probability": 0.05055359184898285,
            "start_logit": 3.842811107635498,
            "end_logit": 2.197295904159546,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MICOS complex",
            "probability": 0.013910400963915655,
            "start_logit": 3.2235169410705566,
            "end_logit": 1.5261929035186768,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MICOS",
            "probability": 0.004044784024330609,
            "start_logit": -0.07614247500896454,
            "end_logit": 3.5906436443328857,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MI",
            "probability": 0.0034791879489284284,
            "start_logit": 4.4873366355896,
            "end_logit": -1.1234647035598755,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system (MICOS",
            "probability": 0.003097346788568331,
            "start_logit": -0.34302476048469543,
            "end_logit": 3.5906436443328857,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MI",
            "probability": 0.0018262659003341177,
            "start_logit": 3.842811107635498,
            "end_logit": -1.1234647035598755,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "c",
            "probability": 0.001132860006684889,
            "start_logit": 3.842811107635498,
            "end_logit": -1.6009926795959473,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MICOS)",
            "probability": 0.0010862072356037848,
            "start_logit": -0.07614247500896454,
            "end_logit": 2.275907516479492,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system",
            "probability": 0.001058116496081751,
            "start_logit": -0.34302476048469543,
            "end_logit": 2.5165882110595703,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MICOS) complex",
            "probability": 0.0010040887518988704,
            "start_logit": -0.07614247500896454,
            "end_logit": 2.197295904159546,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system (MICOS)",
            "probability": 0.0008317775368670893,
            "start_logit": -0.34302476048469543,
            "end_logit": 2.275907516479492,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system (MICOS) complex",
            "probability": 0.0007688942233809975,
            "start_logit": -0.34302476048469543,
            "end_logit": 2.197295904159546,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "CHCHD3), two core components of the mitochondrial contact site and cristae organizing system (MICOS",
            "probability": 0.0005579319814476365,
            "start_logit": -2.057088851928711,
            "end_logit": 3.5906436443328857,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "the mitochondrial contact site and cristae organizing system (MICOS",
            "probability": 0.0002892244810443307,
            "start_logit": -2.714122772216797,
            "end_logit": 3.5906436443328857,
            "question_text": "Which protein complexes contain mitofilin?"
        }
    ],
    "56ae40110a360a5e45000009": [
        {
            "text": "CS-Rosetta",
            "probability": 0.49563102649217367,
            "start_logit": 4.253541469573975,
            "end_logit": 3.0449626445770264,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo structure prediction framework",
            "probability": 0.2517437266652045,
            "start_logit": 4.253541469573975,
            "end_logit": 2.3675425052642822,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo structure prediction",
            "probability": 0.15357143675394835,
            "start_logit": 4.253541469573975,
            "end_logit": 1.8732967376708984,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "de novo structure prediction framework",
            "probability": 0.03063577607583284,
            "start_logit": 2.1472983360290527,
            "end_logit": 2.3675425052642822,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "de novo structure prediction",
            "probability": 0.01868876817850084,
            "start_logit": 2.1472983360290527,
            "end_logit": 1.8732967376708984,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "chemical shift-based CS-Rosetta",
            "probability": 0.008943454980125535,
            "start_logit": 0.2386316955089569,
            "end_logit": 3.0449626445770264,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo",
            "probability": 0.006384101586967828,
            "start_logit": 4.253541469573975,
            "end_logit": -1.307058334350586,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo structure",
            "probability": 0.00525231650790913,
            "start_logit": 4.253541469573975,
            "end_logit": -1.5021998882293701,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "chemical shift-based CS-Rosetta de novo structure prediction framework",
            "probability": 0.004542610461443411,
            "start_logit": 0.2386316955089569,
            "end_logit": 2.3675425052642822,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "C",
            "probability": 0.004263142099957576,
            "start_logit": 4.253541469573975,
            "end_logit": -1.710862636566162,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "chemical shift-based CS-Rosetta de novo structure prediction",
            "probability": 0.0027711324703838342,
            "start_logit": 0.2386316955089569,
            "end_logit": 1.8732967376708984,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "structure prediction framework",
            "probability": 0.002674955351816632,
            "start_logit": -0.2909374535083771,
            "end_logit": 2.3675425052642822,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "the chemical shift-based CS-Rosetta",
            "probability": 0.002656845978620421,
            "start_logit": -0.9751505851745605,
            "end_logit": 3.0449626445770264,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo structure prediction framework to generate reliable structural models",
            "probability": 0.0023183458022396695,
            "start_logit": 4.253541469573975,
            "end_logit": -2.3200151920318604,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de",
            "probability": 0.0022552923602277104,
            "start_logit": 4.253541469573975,
            "end_logit": -2.3475894927978516,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS",
            "probability": 0.0016717909838561817,
            "start_logit": 4.253541469573975,
            "end_logit": -2.6469736099243164,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "structure prediction",
            "probability": 0.001631805257167201,
            "start_logit": -0.2909374535083771,
            "end_logit": 1.8732967376708984,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "sPRE data in the chemical shift-based CS-Rosetta",
            "probability": 0.0016052669574145432,
            "start_logit": -1.479000210762024,
            "end_logit": 3.0449626445770264,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "framework",
            "probability": 0.0014087247331564731,
            "start_logit": -0.9321852922439575,
            "end_logit": 2.3675425052642822,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "the chemical shift-based CS-Rosetta de novo structure prediction framework",
            "probability": 0.0013494803030534824,
            "start_logit": -0.9751505851745605,
            "end_logit": 2.3675425052642822,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        }
    ],
    "52f509232059c6d71c00001f": [
        {
            "text": "KCNQ1",
            "probability": 0.5167907979299154,
            "start_logit": 4.503072738647461,
            "end_logit": 3.5009171962738037,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene in heterogeneous cardiovascular disorders in the Iranian population The KCNQ1",
            "probability": 0.33668282290103757,
            "start_logit": 4.074575901031494,
            "end_logit": 3.5009171962738037,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene",
            "probability": 0.06693901643853403,
            "start_logit": 4.503072738647461,
            "end_logit": 1.4570610523223877,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene in heterogeneous cardiovascular disorders in the Iranian population The KCNQ1 gene",
            "probability": 0.04360994256674242,
            "start_logit": 4.074575901031494,
            "end_logit": 1.4570610523223877,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "The KCNQ1",
            "probability": 0.011312984125487403,
            "start_logit": 0.6813856959342957,
            "end_logit": 3.5009171962738037,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "the KCNQ1 gene in heterogeneous cardiovascular disorders in the Iranian population The KCNQ1",
            "probability": 0.005335648631504013,
            "start_logit": -0.07015495002269745,
            "end_logit": 3.5009171962738037,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene has a significant role in long QT syndrome, Jervell and Lange-Nielsen syndrome",
            "probability": 0.0038744072673619055,
            "start_logit": 4.503072738647461,
            "end_logit": -1.3923282623291016,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "the KCNQ1",
            "probability": 0.0037855138633941447,
            "start_logit": -0.07015495002269745,
            "end_logit": 3.1576883792877197,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "Characterization and haplotype study of 6 novel STR markers related to the KCNQ1",
            "probability": 0.002175775765918963,
            "start_logit": -0.6239513158798218,
            "end_logit": 3.1576883792877197,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "study of 6 novel STR markers related to the KCNQ1",
            "probability": 0.0018358159277043862,
            "start_logit": -0.7938475608825684,
            "end_logit": 3.1576883792877197,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "The KCNQ1 gene",
            "probability": 0.001465351227959702,
            "start_logit": 0.6813856959342957,
            "end_logit": 1.4570610523223877,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "haplotype study of 6 novel STR markers related to the KCNQ1",
            "probability": 0.0010898380343219653,
            "start_logit": -1.3153074979782104,
            "end_logit": 3.1576883792877197,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "the KCNQ1 gene",
            "probability": 0.000987484276897696,
            "start_logit": -0.07015495002269745,
            "end_logit": 1.813912034034729,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "6 novel STR markers related to the KCNQ1",
            "probability": 0.0007658000160866311,
            "start_logit": -1.6681708097457886,
            "end_logit": 3.1576883792877197,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "STR markers related to the KCNQ1",
            "probability": 0.000753132142317466,
            "start_logit": -1.6848511695861816,
            "end_logit": 3.1576883792877197,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "the KCNQ1 gene in heterogeneous cardiovascular disorders in the Iranian population The KCNQ1 gene",
            "probability": 0.000691117320364759,
            "start_logit": -0.07015495002269745,
            "end_logit": 1.4570610523223877,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "Characterization and haplotype study of 6 novel STR markers related to the KCNQ1 gene",
            "probability": 0.00056757006748183,
            "start_logit": -0.6239513158798218,
            "end_logit": 1.813912034034729,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "study of 6 novel STR markers related to the KCNQ1 gene",
            "probability": 0.00047888858139354996,
            "start_logit": -0.7938475608825684,
            "end_logit": 1.813912034034729,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "novel STR markers related to the KCNQ1",
            "probability": 0.00043441950731953763,
            "start_logit": -2.235081195831299,
            "end_logit": 3.1576883792877197,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene in heterogeneous cardiovascular disorders in the Iranian population The",
            "probability": 0.00042367340825656794,
            "start_logit": 4.074575901031494,
            "end_logit": -3.177016496658325,
            "question_text": "Which genes are implicated in short QT syndrome?"
        }
    ],
    "56be1723ef6e39474100000c": [
        {
            "text": "headache",
            "probability": 0.10569876814912944,
            "start_logit": 4.234165668487549,
            "end_logit": 4.4085822105407715,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "headache, photophobia",
            "probability": 0.09347844730070838,
            "start_logit": 4.234165668487549,
            "end_logit": 4.285719871520996,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache",
            "probability": 0.08280655388378962,
            "start_logit": 3.990079641342163,
            "end_logit": 4.4085822105407715,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "headache, photophobia and irritability along with abducens nerve palsy",
            "probability": 0.07662834536442427,
            "start_logit": 4.234165668487549,
            "end_logit": 4.086956024169922,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "headache, photophobia and irritability",
            "probability": 0.07532886390817208,
            "start_logit": 4.234165668487549,
            "end_logit": 4.069852352142334,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "photophobia",
            "probability": 0.07345847155462926,
            "start_logit": 3.993155002593994,
            "end_logit": 4.285719871520996,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache, photophobia",
            "probability": 0.07323290724124537,
            "start_logit": 3.990079641342163,
            "end_logit": 4.285719871520996,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever",
            "probability": 0.060842017406647284,
            "start_logit": 3.990079641342163,
            "end_logit": 4.100355625152588,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "photophobia and irritability along with abducens nerve palsy",
            "probability": 0.06021710127600942,
            "start_logit": 3.993155002593994,
            "end_logit": 4.086956024169922,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache, photophobia and irritability along with abducens nerve palsy",
            "probability": 0.06003219640641668,
            "start_logit": 3.990079641342163,
            "end_logit": 4.086956024169922,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "photophobia and irritability",
            "probability": 0.059195925546776426,
            "start_logit": 3.993155002593994,
            "end_logit": 4.069852352142334,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache, photophobia and irritability",
            "probability": 0.05901415633733743,
            "start_logit": 3.990079641342163,
            "end_logit": 4.069852352142334,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "irritability along with abducens nerve palsy",
            "probability": 0.03474450820590382,
            "start_logit": 3.4432201385498047,
            "end_logit": 4.086956024169922,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "irritability",
            "probability": 0.034155302685342816,
            "start_logit": 3.4432201385498047,
            "end_logit": 4.069852352142334,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy",
            "probability": 0.032434432697606735,
            "start_logit": 3.3744192123413086,
            "end_logit": 4.086956024169922,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever, headache",
            "probability": 0.004563761607890658,
            "start_logit": 1.091719627380371,
            "end_logit": 4.4085822105407715,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever, headache, photophobia",
            "probability": 0.004036124133010691,
            "start_logit": 1.091719627380371,
            "end_logit": 4.285719871520996,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "headache,",
            "probability": 0.0034703115160984142,
            "start_logit": 4.234165668487549,
            "end_logit": 0.9922333359718323,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever",
            "probability": 0.0033532184369941395,
            "start_logit": 1.091719627380371,
            "end_logit": 4.100355625152588,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever, headache, photophobia and irritability along with abducens nerve palsy",
            "probability": 0.0033085863418667086,
            "start_logit": 1.091719627380371,
            "end_logit": 4.086956024169922,
            "question_text": "List symptoms of Gradenigo's syndrome."
        }
    ],
    "516ec97f298dcd4e51000087": [
        {
            "text": "phylogeny reconstruction",
            "probability": 0.14125023449612217,
            "start_logit": 0.17256389558315277,
            "end_logit": -0.2093968689441681,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny reconstruction methods.We also evaluate the phylogenetic utility of different genes and gene partitions",
            "probability": 0.10760488534960266,
            "start_logit": 0.17256389558315277,
            "end_logit": -0.48146384954452515,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny reconstruction methods",
            "probability": 0.10213743586342738,
            "start_logit": 0.17256389558315277,
            "end_logit": -0.5336105823516846,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "different genes and gene partitions",
            "probability": 0.09796043330888166,
            "start_logit": 0.07866150140762329,
            "end_logit": -0.48146384954452515,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny reconstruction methods.We also evaluate the phylogenetic utility of different genes",
            "probability": 0.08644707765335201,
            "start_logit": 0.17256389558315277,
            "end_logit": -0.7003974914550781,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "different genes",
            "probability": 0.07869896573650477,
            "start_logit": 0.07866150140762329,
            "end_logit": -0.7003974914550781,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "reconstruction",
            "probability": 0.07052961679360063,
            "start_logit": -0.5219364166259766,
            "end_logit": -0.2093968689441681,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "reconstruction methods.We also evaluate the phylogenetic utility of different genes and gene partitions",
            "probability": 0.053729690119807626,
            "start_logit": -0.5219364166259766,
            "end_logit": -0.48146384954452515,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "reconstruction methods",
            "probability": 0.05099966196464093,
            "start_logit": -0.5219364166259766,
            "end_logit": -0.5336105823516846,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "reconstruction methods.We also evaluate the phylogenetic utility of different genes",
            "probability": 0.04316509124085695,
            "start_logit": -0.5219364166259766,
            "end_logit": -0.7003974914550781,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "genes and gene partitions",
            "probability": 0.03702541004805749,
            "start_logit": -0.89429771900177,
            "end_logit": -0.48146384954452515,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "genes",
            "probability": 0.029745289790259925,
            "start_logit": -0.89429771900177,
            "end_logit": -0.7003974914550781,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "gene partitions",
            "probability": 0.017848008773938117,
            "start_logit": -1.6240102052688599,
            "end_logit": -0.48146384954452515,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny reconstruction methods.We also evaluate the phylogenetic utility",
            "probability": 0.017263625684618217,
            "start_logit": 0.17256389558315277,
            "end_logit": -2.311328172683716,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "all phylogeny reconstruction",
            "probability": 0.013848863427488886,
            "start_logit": -2.149765968322754,
            "end_logit": -0.2093968689441681,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny",
            "probability": 0.010737612244536019,
            "start_logit": 0.17256389558315277,
            "end_logit": -2.786177158355713,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny reconstruction methods.We also evaluate the phylogenetic utility of different",
            "probability": 0.010669575318039566,
            "start_logit": 0.17256389558315277,
            "end_logit": -2.7925336360931396,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "all phylogeny reconstruction methods.We also evaluate the phylogenetic utility of different genes and gene partitions",
            "probability": 0.010550108937186638,
            "start_logit": -2.149765968322754,
            "end_logit": -0.48146384954452515,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "all phylogeny reconstruction methods",
            "probability": 0.010014053464423408,
            "start_logit": -2.149765968322754,
            "end_logit": -0.5336105823516846,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "evaluate the phylogenetic utility of different genes and gene partitions",
            "probability": 0.009774359784654593,
            "start_logit": -2.226139545440674,
            "end_logit": -0.48146384954452515,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        }
    ],
    "54fc9ca16ad7dcbc12000006": [
        {
            "text": "orexin",
            "probability": 0.7465160513044082,
            "start_logit": 5.587219715118408,
            "end_logit": 4.358345985412598,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor",
            "probability": 0.0871762440025383,
            "start_logit": 5.587219715118408,
            "end_logit": 2.2108607292175293,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist,",
            "probability": 0.07241347338901563,
            "start_logit": 5.587219715118408,
            "end_logit": 2.0253212451934814,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist",
            "probability": 0.07189662553132584,
            "start_logit": 5.587219715118408,
            "end_logit": 2.018158197402954,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin",
            "probability": 0.014460120970291411,
            "start_logit": 1.6431971788406372,
            "end_logit": 4.358345985412598,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin receptor",
            "probability": 0.0016886161145627083,
            "start_logit": 1.6431971788406372,
            "end_logit": 2.2108607292175293,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin receptor antagonist,",
            "probability": 0.0014026591702274909,
            "start_logit": 1.6431971788406372,
            "end_logit": 2.0253212451934814,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin receptor antagonist",
            "probability": 0.0013926477544885102,
            "start_logit": 1.6431971788406372,
            "end_logit": 2.018158197402954,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "ore",
            "probability": 0.000832122157504969,
            "start_logit": 5.587219715118408,
            "end_logit": -2.440847158432007,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin",
            "probability": 0.0007786342422805252,
            "start_logit": -1.2784112691879272,
            "end_logit": 4.358345985412598,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist, has been FDA approved for the treatment of insomnia",
            "probability": 0.0005115542899066879,
            "start_logit": 5.587219715118408,
            "end_logit": -2.927372694015503,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": ", a dual orexin",
            "probability": 0.00016645287853847996,
            "start_logit": -2.8212404251098633,
            "end_logit": 4.358345985412598,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual",
            "probability": 0.00014581943132919357,
            "start_logit": 1.6431971788406372,
            "end_logit": -0.2384347915649414,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "antagonist,",
            "probability": 0.0001019593803099531,
            "start_logit": -0.9783534407615662,
            "end_logit": 2.0253212451934814,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "antagonist",
            "probability": 0.00010123164989158908,
            "start_logit": -0.9783534407615662,
            "end_logit": 2.018158197402954,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "xin",
            "probability": 9.4069402225346e-05,
            "start_logit": -3.3919198513031006,
            "end_logit": 4.358345985412598,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin receptor",
            "probability": 9.092692457874519e-05,
            "start_logit": -1.2784112691879272,
            "end_logit": 2.2108607292175293,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist, has been FDA approved for the treatment of insomnia.",
            "probability": 8.027249364774534e-05,
            "start_logit": 5.587219715118408,
            "end_logit": -4.779399394989014,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin receptor antagonist,",
            "probability": 7.552899885358998e-05,
            "start_logit": -1.2784112691879272,
            "end_logit": 2.0253212451934814,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin receptor antagonist",
            "probability": 7.498991407524742e-05,
            "start_logit": -1.2784112691879272,
            "end_logit": 2.018158197402954,
            "question_text": "Which receptors are targeted by suvorexant?"
        }
    ],
    "56c1f030ef6e39474100004d": [
        {
            "text": "neonatal diabetes mellitus",
            "probability": 0.3584604540142182,
            "start_logit": 5.230316162109375,
            "end_logit": 4.963682651519775,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy and neonatal diabetes mellitus",
            "probability": 0.1678997176756935,
            "start_logit": 4.471864700317383,
            "end_logit": 4.963682651519775,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy",
            "probability": 0.14523658604085027,
            "start_logit": 4.471864700317383,
            "end_logit": 4.8186798095703125,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.09121317772331339,
            "start_logit": 3.861697196960449,
            "end_logit": 4.963682651519775,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy and neonatal diabetes mellitus",
            "probability": 0.08908225684503084,
            "start_logit": 3.8380579948425293,
            "end_logit": 4.963682651519775,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy",
            "probability": 0.07705791909654562,
            "start_logit": 3.8380579948425293,
            "end_logit": 4.8186798095703125,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes",
            "probability": 0.023307860117015602,
            "start_logit": 5.230316162109375,
            "end_logit": 2.2306549549102783,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay",
            "probability": 0.014704538355093461,
            "start_logit": 3.8380579948425293,
            "end_logit": 3.162278652191162,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy and neonatal diabetes",
            "probability": 0.010917196274923687,
            "start_logit": 4.471864700317383,
            "end_logit": 2.2306549549102783,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes",
            "probability": 0.0059308745592314225,
            "start_logit": 3.861697196960449,
            "end_logit": 2.2306549549102783,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy and neonatal diabetes",
            "probability": 0.005792317557488999,
            "start_logit": 3.8380579948425293,
            "end_logit": 2.2306549549102783,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus (DEND) syndrome.",
            "probability": 0.0027676458047031205,
            "start_logit": 5.230316162109375,
            "end_logit": 0.09986137598752975,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal",
            "probability": 0.002290738063622392,
            "start_logit": 5.230316162109375,
            "end_logit": -0.08926162868738174,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy and neonatal diabetes mellitus (DEND) syndrome.",
            "probability": 0.0012963409046442256,
            "start_logit": 4.471864700317383,
            "end_logit": 0.09986137598752975,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy and neonatal",
            "probability": 0.0010729615215404175,
            "start_logit": 4.471864700317383,
            "end_logit": -0.08926162868738174,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes mellitus (DEND) syndrome.",
            "probability": 0.0007042499830387294,
            "start_logit": 3.861697196960449,
            "end_logit": 0.09986137598752975,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy and neonatal diabetes mellitus (DEND) syndrome.",
            "probability": 0.0006877973055874558,
            "start_logit": 3.8380579948425293,
            "end_logit": 0.09986137598752975,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy and neonatal",
            "probability": 0.0005692793005841708,
            "start_logit": 3.8380579948425293,
            "end_logit": -0.08926162868738174,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "pilepsy and neonatal diabetes mellitus",
            "probability": 0.0005405244695434949,
            "start_logit": -1.266717553138733,
            "end_logit": 4.963682651519775,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "pilepsy",
            "probability": 0.00046756438733073336,
            "start_logit": -1.266717553138733,
            "end_logit": 4.8186798095703125,
            "question_text": "List features of the DEND syndrome."
        }
    ],
    "550312b4e9bde6963400001c": [
        {
            "text": "RPL35A",
            "probability": 0.8872547646598684,
            "start_logit": 2.1309750080108643,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35",
            "probability": 0.06655156143757623,
            "start_logit": 2.1309750080108643,
            "end_logit": -2.337611436843872,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "R",
            "probability": 0.010371329571971283,
            "start_logit": 2.1309750080108643,
            "end_logit": -4.196543216705322,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL",
            "probability": 0.0066116971649425186,
            "start_logit": 2.1309750080108643,
            "end_logit": -4.646748065948486,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35A in South Africa.",
            "probability": 0.006253068886546743,
            "start_logit": 2.1309750080108643,
            "end_logit": -4.702516078948975,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "heterozygous whole gene deletion in RPL35A",
            "probability": 0.004932821986629744,
            "start_logit": -3.061245918273926,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "whole gene deletion in RPL35A",
            "probability": 0.0047888456745056466,
            "start_logit": -3.090867757797241,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "deletion in RPL35A",
            "probability": 0.002442588919496158,
            "start_logit": -3.764098644256592,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "sporadic heterozygous whole gene deletion in RPL35A",
            "probability": 0.0022531581167563415,
            "start_logit": -3.8448243141174316,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35A in South Africa",
            "probability": 0.0018645840424134905,
            "start_logit": 2.1309750080108643,
            "end_logit": -5.912550449371338,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "A",
            "probability": 0.0015005969829987467,
            "start_logit": -4.251294136047363,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "gene deletion in RPL35A",
            "probability": 0.001394079185385442,
            "start_logit": -4.324923038482666,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "a sporadic heterozygous whole gene deletion in RPL35A",
            "probability": 0.0008711910816918129,
            "start_logit": -4.795051097869873,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "in RPL35A",
            "probability": 0.0005781839120059369,
            "start_logit": -5.205020427703857,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "girl\u00a0secondary to a sporadic heterozygous whole gene deletion in RPL35A",
            "probability": 0.0005144453410013918,
            "start_logit": -5.3218231201171875,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "35A",
            "probability": 0.00044086745598817366,
            "start_logit": -5.476168155670166,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "L35A",
            "probability": 0.00042740527955560366,
            "start_logit": -5.5071797370910645,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "heterozygous whole gene deletion in RPL35",
            "probability": 0.0003700030910847416,
            "start_logit": -3.061245918273926,
            "end_logit": -2.337611436843872,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "whole gene deletion in RPL35",
            "probability": 0.0003592036580881143,
            "start_logit": -3.090867757797241,
            "end_logit": -2.337611436843872,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "on in RPL35A",
            "probability": 0.0002196035514930309,
            "start_logit": -6.173088550567627,
            "end_logit": 0.25254371762275696,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        }
    ],
    "54edaee3445c3b5a5f000003": [
        {
            "text": "Borrelia miyamotoi",
            "probability": 0.6973848486389052,
            "start_logit": 4.193267345428467,
            "end_logit": 4.6561102867126465,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "miyamotoi",
            "probability": 0.18895201644132031,
            "start_logit": 2.887423038482666,
            "end_logit": 4.6561102867126465,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. miyamotoi",
            "probability": 0.06279257933657037,
            "start_logit": 2.6963977813720703,
            "end_logit": 3.7454793453216553,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "relapsing fever group Borrelia.Borrelia miyamotoi",
            "probability": 0.018781125130793844,
            "start_logit": 0.6920778751373291,
            "end_logit": 4.5428147315979,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Lyme borreliosis and relapsing fever group Borrelia.Borrelia miyamotoi",
            "probability": 0.010783363681236207,
            "start_logit": 0.1372300386428833,
            "end_logit": 4.5428147315979,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "relapsing fever group Borrelia.As all Borrelia species B. miyamotoi",
            "probability": 0.008682607389924454,
            "start_logit": 1.0631181001663208,
            "end_logit": 3.4002439975738525,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia",
            "probability": 0.0038527649466710803,
            "start_logit": 4.193267345428467,
            "end_logit": -0.5424360632896423,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia miyamotoi belongs to the relapsing fever",
            "probability": 0.002446968452612025,
            "start_logit": 3.717960834503174,
            "end_logit": -0.5210707187652588,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "fever group Borrelia.Borrelia miyamotoi",
            "probability": 0.0011813327586264744,
            "start_logit": -2.0741312503814697,
            "end_logit": 4.5428147315979,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "miyamotoi belongs to the relapsing fever",
            "probability": 0.0011495549274506349,
            "start_logit": 2.9624857902526855,
            "end_logit": -0.5210707187652588,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B",
            "probability": 0.0008489371837384212,
            "start_logit": 4.193267345428467,
            "end_logit": -2.054997205734253,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "relapsing fever",
            "probability": 0.0007673762257345969,
            "start_logit": 1.0631181001663208,
            "end_logit": 0.9741440415382385,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia mi",
            "probability": 0.0006673586630243154,
            "start_logit": 4.193267345428467,
            "end_logit": -2.295654773712158,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "fever group Borrelia.As all Borrelia species B. miyamotoi",
            "probability": 0.0004947636252579228,
            "start_logit": -1.8018789291381836,
            "end_logit": 3.4002439975738525,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Lyme borreliosis and relapsing fever",
            "probability": 0.0003089885869330902,
            "start_logit": 0.15344524383544922,
            "end_logit": 0.9741440415382385,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "mi",
            "probability": 0.00020174777911540626,
            "start_logit": 2.9624857902526855,
            "end_logit": -2.2611825466156006,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. miyamotoi possess an unusual and complex genome consisting of a linear chromosome and a number of linear and circular plasmids.B",
            "probability": 0.00019001739697366258,
            "start_logit": 2.6963977813720703,
            "end_logit": -2.054997205734253,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "relapsing fever group Borrelia",
            "probability": 0.00018049988468378148,
            "start_logit": 1.0631181001663208,
            "end_logit": -0.47310301661491394,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Lyme borreliosis",
            "probability": 0.00017590024876470287,
            "start_logit": 0.15344524383544922,
            "end_logit": 0.41075676679611206,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "relapsing fever group Borrelia.Borrelia",
            "probability": 0.00015724870166345826,
            "start_logit": 0.6920778751373291,
            "end_logit": -0.2399642914533615,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        }
    ],
    "5335d4e8d6d3ac6a34000053": [
        {
            "text": "ETB",
            "probability": 0.48675842823272814,
            "start_logit": 1.717491626739502,
            "end_logit": -0.4406837522983551,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETB receptor",
            "probability": 0.40403832316872035,
            "start_logit": 1.717491626739502,
            "end_logit": -0.626941978931427,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETB receptor, has led to the renaissance of the modified peptide agonist IRL1620",
            "probability": 0.04960612789257698,
            "start_logit": 1.717491626739502,
            "end_logit": -2.724337339401245,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETB receptor,",
            "probability": 0.016301156394101218,
            "start_logit": 1.717491626739502,
            "end_logit": -3.8372156620025635,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETB receptor, has led to the renaissance of the modified peptide agonist",
            "probability": 0.013450381823918682,
            "start_logit": 1.717491626739502,
            "end_logit": -4.029444217681885,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "the ETB",
            "probability": 0.007201040273590937,
            "start_logit": -2.4960508346557617,
            "end_logit": -0.4406837522983551,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "the ETB receptor",
            "probability": 0.005977289900815075,
            "start_logit": -2.4960508346557617,
            "end_logit": -0.626941978931427,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETB receptor, has led to the renaissance of the modified peptide",
            "probability": 0.0040660603696335415,
            "start_logit": 1.717491626739502,
            "end_logit": -5.2257771492004395,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ET",
            "probability": 0.003046776453786597,
            "start_logit": 1.717491626739502,
            "end_logit": -5.514367580413818,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonists, being more potent than bosentan",
            "probability": 0.0024984011081401335,
            "start_logit": -2.7318878173828125,
            "end_logit": -1.2634212970733643,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonists,",
            "probability": 0.0010546540185311778,
            "start_logit": -2.7318878173828125,
            "end_logit": -2.125859498977661,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "bosentan",
            "probability": 0.000937424164869163,
            "start_logit": -3.712158203125,
            "end_logit": -1.2634212970733643,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonists, being more potent than bosentan,",
            "probability": 0.0009335290871176181,
            "start_logit": -2.7318878173828125,
            "end_logit": -2.2478554248809814,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonist",
            "probability": 0.0007845971969335537,
            "start_logit": -2.7318878173828125,
            "end_logit": -2.421657085418701,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "IRL1620",
            "probability": 0.0007537017194303851,
            "start_logit": -2.469381332397461,
            "end_logit": -2.724337339401245,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "the ETB receptor, has led to the renaissance of the modified peptide agonist IRL1620",
            "probability": 0.0007338665425235494,
            "start_logit": -2.4960508346557617,
            "end_logit": -2.724337339401245,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "activating the ETB",
            "probability": 0.0006107434735443263,
            "start_logit": -4.963354587554932,
            "end_logit": -0.4406837522983551,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "activating the ETB receptor",
            "probability": 0.0005069532536560559,
            "start_logit": -4.963354587554932,
            "end_logit": -0.626941978931427,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "Macitentan represents the next generation of antagonists, being more potent than bosentan",
            "probability": 0.00037455971366498323,
            "start_logit": -4.629542827606201,
            "end_logit": -1.2634212970733643,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "peptide agonist IRL1620",
            "probability": 0.00036598521171743226,
            "start_logit": -3.1917850971221924,
            "end_logit": -2.724337339401245,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        }
    ],
    "518ba4b5310faafe08000005": [
        {
            "text": "corticosteroids",
            "probability": 0.38979139750779457,
            "start_logit": 4.835836887359619,
            "end_logit": 4.565429210662842,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "budesonide",
            "probability": 0.3682239045516645,
            "start_logit": 4.753735065460205,
            "end_logit": 4.590610504150391,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical corticosteroids",
            "probability": 0.21560646631846142,
            "start_logit": 4.243680000305176,
            "end_logit": 4.565429210662842,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "budesonide effervescent tablet in Europe; (2) biologics",
            "probability": 0.019170593317127626,
            "start_logit": 4.753735065460205,
            "end_logit": 1.6352968215942383,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "swallowed topical corticosteroids",
            "probability": 0.001947795594560982,
            "start_logit": -0.46307656168937683,
            "end_logit": 4.565429210662842,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "steroid formulations optimizing mucosal deposition have been developed, which has culminated in recent approval of a budesonide",
            "probability": 0.0012484268918534181,
            "start_logit": -0.9330718517303467,
            "end_logit": 4.590610504150391,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "biologics",
            "probability": 0.0010847186721407915,
            "start_logit": 1.8816782236099243,
            "end_logit": 1.6352968215942383,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "drugs (particularly swallowed topical corticosteroids",
            "probability": 0.0005277635866516516,
            "start_logit": -1.5716217756271362,
            "end_logit": 4.36816930770874,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "corticosteroids), dietary restriction, and endoscopic dilation",
            "probability": 0.0004472240477114344,
            "start_logit": 4.835836887359619,
            "end_logit": -2.204878091812134,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "corticosteroids), dietary restriction",
            "probability": 0.0003977857090298196,
            "start_logit": 4.835836887359619,
            "end_logit": -2.322024345397949,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "budesonide effervescent tablet",
            "probability": 0.00025820055099024474,
            "start_logit": 4.753735065460205,
            "end_logit": -2.6720993518829346,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical corticosteroids), dietary restriction, and endoscopic dilation",
            "probability": 0.00024737435765953043,
            "start_logit": 4.243680000305176,
            "end_logit": -2.204878091812134,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical corticosteroids), dietary restriction",
            "probability": 0.00022002838344883707,
            "start_logit": 4.243680000305176,
            "end_logit": -2.322024345397949,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "co",
            "probability": 0.0001996951980719073,
            "start_logit": 4.835836887359619,
            "end_logit": -3.01114559173584,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "steroids",
            "probability": 0.00013268966424008111,
            "start_logit": -3.149517059326172,
            "end_logit": 4.565429210662842,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical co",
            "probability": 0.00011045799438451743,
            "start_logit": 4.243680000305176,
            "end_logit": -3.01114559173584,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "budesonide effervescent tablet in Europe; (2) bio",
            "probability": 0.00010820742736460653,
            "start_logit": 4.753735065460205,
            "end_logit": -3.541785955429077,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "de",
            "probability": 0.00010068600655649235,
            "start_logit": -3.450704574584961,
            "end_logit": 4.590610504150391,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "b",
            "probability": 9.093061235551978e-05,
            "start_logit": 4.753735065460205,
            "end_logit": -3.7157392501831055,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "oids",
            "probability": 8.565360793222083e-05,
            "start_logit": -3.587218761444092,
            "end_logit": 4.565429210662842,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        }
    ],
    "56f8077a8b98c98849000002": [
        {
            "text": "small-cell lung cancer",
            "probability": 0.5549102206207038,
            "start_logit": 1.3865875005722046,
            "end_logit": 1.585251808166504,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity is often associated with small-cell lung cancer",
            "probability": 0.1951550902775689,
            "start_logit": 0.3415757417678833,
            "end_logit": 1.585251808166504,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological autoimmunity is often associated with small-cell lung cancer",
            "probability": 0.08685670050832453,
            "start_logit": -0.4679591953754425,
            "end_logit": 1.585251808166504,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity",
            "probability": 0.040858616226981205,
            "start_logit": 0.3415757417678833,
            "end_logit": 0.021574953570961952,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "small-cell lung cancer (SCLC)",
            "probability": 0.02765612635808509,
            "start_logit": 1.3865875005722046,
            "end_logit": -1.4137072563171387,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "lung cancer",
            "probability": 0.022809174822830788,
            "start_logit": -1.8050559759140015,
            "end_logit": 1.585251808166504,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological autoimmunity",
            "probability": 0.01818474008422715,
            "start_logit": -0.4679591953754425,
            "end_logit": 0.021574953570961952,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "autoimmunity is often associated with small-cell lung cancer",
            "probability": 0.012633213208289494,
            "start_logit": -2.3958895206451416,
            "end_logit": 1.585251808166504,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity is often associated with small-cell lung cancer (SCLC)",
            "probability": 0.009726319025270042,
            "start_logit": 0.3415757417678833,
            "end_logit": -1.4137072563171387,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cancer",
            "probability": 0.00959188311642797,
            "start_logit": -2.6713016033172607,
            "end_logit": 1.585251808166504,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological autoimmunity is often associated with small-cell lung cancer (SCLC)",
            "probability": 0.004328844189637824,
            "start_logit": -0.4679591953754425,
            "end_logit": -1.4137072563171387,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "small-cell lung cancer (SCLC),",
            "probability": 0.003703807645972851,
            "start_logit": 1.3865875005722046,
            "end_logit": -3.4241931438446045,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological",
            "probability": 0.0034366051939321803,
            "start_logit": 0.3415757417678833,
            "end_logit": -2.4540586471557617,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "autoimmunity",
            "probability": 0.002644950789943395,
            "start_logit": -2.3958895206451416,
            "end_logit": 0.021574953570961952,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "small-cell lung",
            "probability": 0.002097541062806052,
            "start_logit": 1.3865875005722046,
            "end_logit": -3.992788791656494,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological",
            "probability": 0.0015295126951091812,
            "start_logit": -0.4679591953754425,
            "end_logit": -2.4540586471557617,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity is often associated with small-cell lung cancer (SCLC),",
            "probability": 0.0013025835327236596,
            "start_logit": 0.3415757417678833,
            "end_logit": -3.4241931438446045,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "lung cancer (SCLC)",
            "probability": 0.0011367846501696341,
            "start_logit": -1.8050559759140015,
            "end_logit": -1.4137072563171387,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity is often associated with small-cell lung",
            "probability": 0.0007376793583202387,
            "start_logit": 0.3415757417678833,
            "end_logit": -3.992788791656494,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "nity is often associated with small-cell lung cancer",
            "probability": 0.0006996066326757885,
            "start_logit": -5.289455890655518,
            "end_logit": 1.585251808166504,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        }
    ],
    "5503145ee9bde69634000022": [
        {
            "text": "medullary thyroid cancer",
            "probability": 0.22848515208625927,
            "start_logit": 4.742870807647705,
            "end_logit": 4.544320583343506,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic thyroid cancer",
            "probability": 0.20068245592302203,
            "start_logit": 4.779463291168213,
            "end_logit": 4.377980709075928,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC), and anaplastic thyroid cancer",
            "probability": 0.19347172040792512,
            "start_logit": 4.742870807647705,
            "end_logit": 4.377980709075928,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary thyroid cancer",
            "probability": 0.09808438550868985,
            "start_logit": 3.8972277641296387,
            "end_logit": 4.544320583343506,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary thyroid cancer (MTC), and anaplastic thyroid cancer",
            "probability": 0.08305377673887634,
            "start_logit": 3.8972277641296387,
            "end_logit": 4.377980709075928,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer",
            "probability": 0.050733213077218044,
            "start_logit": 3.8972277641296387,
            "end_logit": 3.885073184967041,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic thyroid cancer (ATC)",
            "probability": 0.03293545153122064,
            "start_logit": 4.779463291168213,
            "end_logit": 2.5708065032958984,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC), and anaplastic thyroid cancer (ATC)",
            "probability": 0.031752045493210916,
            "start_logit": 4.742870807647705,
            "end_logit": 2.5708065032958984,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC)",
            "probability": 0.02530944000634613,
            "start_logit": 4.742870807647705,
            "end_logit": 2.344026803970337,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary",
            "probability": 0.020493536299408116,
            "start_logit": 4.742870807647705,
            "end_logit": 2.1329588890075684,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary thyroid cancer (MTC)",
            "probability": 0.01086486735757042,
            "start_logit": 3.8972277641296387,
            "end_logit": 2.344026803970337,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary",
            "probability": 0.008797490324748147,
            "start_logit": 3.8972277641296387,
            "end_logit": 2.1329588890075684,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic",
            "probability": 0.002634140424527294,
            "start_logit": 4.779463291168213,
            "end_logit": 0.04481378570199013,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC), and anaplastic",
            "probability": 0.0025394929386594847,
            "start_logit": 4.742870807647705,
            "end_logit": 0.04481378570199013,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC)",
            "probability": 0.0022104349074720613,
            "start_logit": 3.8972277641296387,
            "end_logit": 0.7516816854476929,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated",
            "probability": 0.001968108994282489,
            "start_logit": 3.8972277641296387,
            "end_logit": 0.6355655789375305,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "(DTC), medullary thyroid cancer",
            "probability": 0.0018608656623953605,
            "start_logit": -0.06755863130092621,
            "end_logit": 4.544320583343506,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "(DTC), medullary thyroid cancer (MTC), and anaplastic thyroid cancer",
            "probability": 0.0015757036195321109,
            "start_logit": -0.06755863130092621,
            "end_logit": 4.377980709075928,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "(MTC), and anaplastic thyroid cancer",
            "probability": 0.0014575620643086193,
            "start_logit": -0.14549532532691956,
            "end_logit": 4.377980709075928,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary thyroid cancer (MTC), and anaplastic",
            "probability": 0.0010901566343271027,
            "start_logit": 3.8972277641296387,
            "end_logit": 0.04481378570199013,
            "question_text": "List the different subtypes of thyroid cancer."
        }
    ],
    "5333f728d6d3ac6a34000041": [
        {
            "text": "protein-protein interaction",
            "probability": 0.18088683908818445,
            "start_logit": -2.0260825157165527,
            "end_logit": -3.010035276412964,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in-silico methods predict protein complexes from the ever-increasing protein-protein interaction",
            "probability": 0.14406552082531365,
            "start_logit": -2.25368595123291,
            "end_logit": -3.010035276412964,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein",
            "probability": 0.06940452309817216,
            "start_logit": -2.0260825157165527,
            "end_logit": -3.9679548740386963,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "computational",
            "probability": 0.05984088135681478,
            "start_logit": -2.715270519256592,
            "end_logit": -3.427029848098755,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data.These computational approaches usually use the PPI data in the format of a huge protein-protein interaction network",
            "probability": 0.057050858194578474,
            "start_logit": -2.0260825157165527,
            "end_logit": -4.163963794708252,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in-silico methods predict protein complexes from the ever-increasing protein",
            "probability": 0.05527654094776986,
            "start_logit": -2.25368595123291,
            "end_logit": -3.9679548740386963,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in-silico methods",
            "probability": 0.0469378419600167,
            "start_logit": -2.25368595123291,
            "end_logit": -4.131479263305664,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data.",
            "probability": 0.04038713583713006,
            "start_logit": -2.0260825157165527,
            "end_logit": -4.509395599365234,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data.These computational approaches usually use the PPI data in the format of a huge protein-protein interaction",
            "probability": 0.03422769091084391,
            "start_logit": -2.0260825157165527,
            "end_logit": -4.674871921539307,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data.These computational",
            "probability": 0.03276442611262862,
            "start_logit": -2.0260825157165527,
            "end_logit": -4.718563556671143,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in-silico methods predict protein complexes from the ever-increasing protein-protein interaction (PPI) data.",
            "probability": 0.032165931962481235,
            "start_logit": -2.25368595123291,
            "end_logit": -4.509395599365234,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI)",
            "probability": 0.030539424617320052,
            "start_logit": -2.0260825157165527,
            "end_logit": -4.788888454437256,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in",
            "probability": 0.030140899177630975,
            "start_logit": -2.25368595123291,
            "end_logit": -4.57442045211792,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "computational methods have been proposed to predict protein complexes, in the last decade.Almost all of these in-silico methods",
            "probability": 0.029584176683940696,
            "start_logit": -2.715270519256592,
            "end_logit": -4.131479263305664,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in-silico",
            "probability": 0.029522101293419593,
            "start_logit": -2.25368595123291,
            "end_logit": -4.5951642990112305,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data",
            "probability": 0.027406670645629384,
            "start_logit": -2.0260825157165527,
            "end_logit": -4.897120475769043,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in-silico methods predict protein complexes from the ever-increasing protein-protein interaction (PPI) data.These computational",
            "probability": 0.026094900747075277,
            "start_logit": -2.25368595123291,
            "end_logit": -4.718563556671143,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data.These computational approaches",
            "probability": 0.02592308331790876,
            "start_logit": -2.0260825157165527,
            "end_logit": -4.952773094177246,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "in-silico methods predict protein complexes from the ever-increasing protein-protein interaction (PPI)",
            "probability": 0.024322820473714646,
            "start_logit": -2.25368595123291,
            "end_logit": -4.788888454437256,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "computational methods",
            "probability": 0.023457732749426655,
            "start_logit": -2.715270519256592,
            "end_logit": -4.363518714904785,
            "question_text": "List algorithms suitable for predicting protein complexes"
        }
    ],
    "51601071298dcd4e51000038": [
        {
            "text": "recombinant protein",
            "probability": 0.3951219817557566,
            "start_logit": -0.939828634262085,
            "end_logit": -1.8392119407653809,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology",
            "probability": 0.1553240037845193,
            "start_logit": -0.939828634262085,
            "end_logit": -2.772893190383911,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology and reverse vaccinology",
            "probability": 0.11284580988289629,
            "start_logit": -0.939828634262085,
            "end_logit": -3.092384099960327,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology and reverse vaccinology.",
            "probability": 0.04205776708817597,
            "start_logit": -0.939828634262085,
            "end_logit": -4.079362392425537,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "vaccine development using chemical conjugation, as well as recombinant protein",
            "probability": 0.03927535431625376,
            "start_logit": -3.2484259605407715,
            "end_logit": -1.8392119407653809,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "protein",
            "probability": 0.03227330545888874,
            "start_logit": -3.4447827339172363,
            "end_logit": -1.8392119407653809,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "re",
            "probability": 0.02769322680749348,
            "start_logit": -0.939828634262085,
            "end_logit": -4.497218608856201,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation, as well as recombinant protein",
            "probability": 0.027587161919878166,
            "start_logit": -3.601672649383545,
            "end_logit": -1.8392119407653809,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology and reverse",
            "probability": 0.02669250223536471,
            "start_logit": -0.939828634262085,
            "end_logit": -4.534023761749268,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant",
            "probability": 0.021140431799536258,
            "start_logit": -0.939828634262085,
            "end_logit": -4.767219066619873,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA",
            "probability": 0.017329532283031593,
            "start_logit": -0.939828634262085,
            "end_logit": -4.965994358062744,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "reverse vaccinology",
            "probability": 0.017303889394160256,
            "start_logit": -2.8149197101593018,
            "end_logit": -3.092384099960327,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "vaccine development using chemical conjugation, as well as recombinant protein DNA technology",
            "probability": 0.015439296126599915,
            "start_logit": -3.2484259605407715,
            "end_logit": -2.772893190383911,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "protein DNA technology",
            "probability": 0.012686763204012378,
            "start_logit": -3.4447827339172363,
            "end_logit": -2.772893190383911,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology and reverse vaccin",
            "probability": 0.011393656145521682,
            "start_logit": -0.939828634262085,
            "end_logit": -5.385349750518799,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "vaccine development using chemical conjugation, as well as recombinant protein DNA technology and reverse vaccinology",
            "probability": 0.011216938998334506,
            "start_logit": -3.2484259605407715,
            "end_logit": -3.092384099960327,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation, as well as recombinant protein DNA technology",
            "probability": 0.010844621763149665,
            "start_logit": -3.601672649383545,
            "end_logit": -2.772893190383911,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "protein DNA technology and reverse vaccinology",
            "probability": 0.009217172063987146,
            "start_logit": -3.4447827339172363,
            "end_logit": -3.092384099960327,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation, as well as recombinant protein DNA technology and reverse vaccinology",
            "probability": 0.007878821662581147,
            "start_logit": -3.601672649383545,
            "end_logit": -3.092384099960327,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "DNA technology",
            "probability": 0.00667776330985852,
            "start_logit": -4.086558818817139,
            "end_logit": -2.772893190383911,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        }
    ],
    "515993f3d24251bc050000a0": [
        {
            "text": "antibodies",
            "probability": 0.6155669813123209,
            "start_logit": -2.700446128845215,
            "end_logit": -3.0438740253448486,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "TSH analogs, antibodies",
            "probability": 0.14243746682286362,
            "start_logit": -4.164086818695068,
            "end_logit": -3.0438740253448486,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds.A number of different TSHR ligands have been reported,",
            "probability": 0.03933626224956946,
            "start_logit": -2.700446128845215,
            "end_logit": -5.794270992279053,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds",
            "probability": 0.03280799092001497,
            "start_logit": -2.700446128845215,
            "end_logit": -5.975745677947998,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "A number of different TSHR ligands have been reported, including TSH analogs, antibodies",
            "probability": 0.022743572961845475,
            "start_logit": -5.998707294464111,
            "end_logit": -3.0438740253448486,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "TSH",
            "probability": 0.018249881594617722,
            "start_logit": -4.164086818695068,
            "end_logit": -5.098618507385254,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds.",
            "probability": 0.015355488526782497,
            "start_logit": -3.773745536804199,
            "end_logit": -5.661645412445068,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds.A number of different TSHR ligands have been reported, including TSH analogs",
            "probability": 0.011834813611234016,
            "start_logit": -2.700446128845215,
            "end_logit": -6.995372295379639,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds.A number of different TSHR ligands have been reported, including TSH",
            "probability": 0.01089973668952855,
            "start_logit": -2.700446128845215,
            "end_logit": -7.07767915725708,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug",
            "probability": 0.009330781799541188,
            "start_logit": -2.700446128845215,
            "end_logit": -7.233098983764648,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds.A number of different TSHR ligands have been reported",
            "probability": 0.009257696725170553,
            "start_logit": -2.700446128845215,
            "end_logit": -7.240962505340576,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "TSH analogs, antibodies and small-molecule, drug-like compounds.A number of different TSHR ligands have been reported,",
            "probability": 0.009102108656256425,
            "start_logit": -4.164086818695068,
            "end_logit": -5.794270992279053,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "drug-like compounds.A number of different TSHR ligands have been reported, including TSH analogs, antibodies",
            "probability": 0.009001592655542352,
            "start_logit": -5.934830188751221,
            "end_logit": -4.034632205963135,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "TSH analogs",
            "probability": 0.008883579549638074,
            "start_logit": -4.164086818695068,
            "end_logit": -5.818572521209717,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule",
            "probability": 0.008877079636748126,
            "start_logit": -2.700446128845215,
            "end_logit": -7.282945156097412,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "reported, including TSH analogs, antibodies",
            "probability": 0.008037826081838829,
            "start_logit": -7.0388312339782715,
            "end_logit": -3.0438740253448486,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "TSHR ligands have been reported, including TSH analogs, antibodies",
            "probability": 0.007922763381756985,
            "start_logit": -7.053249835968018,
            "end_logit": -3.0438740253448486,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "TSH analogs, antibodies and small-molecule, drug-like compounds",
            "probability": 0.007591516861791284,
            "start_logit": -4.164086818695068,
            "end_logit": -5.975745677947998,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "small-molecule, drug-like compounds.A number of different TSHR ligands have been reported, including TSH analogs, antibodies",
            "probability": 0.00646640030601762,
            "start_logit": -6.2656121253967285,
            "end_logit": -4.034632205963135,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "including TSH analogs, antibodies",
            "probability": 0.006296459656921266,
            "start_logit": -7.2830023765563965,
            "end_logit": -3.0438740253448486,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        }
    ],
    "53357c98d6d3ac6a3400004a": [
        {
            "text": "predisposition to cancer of other types.This study investigates the utility of a custom-designed multi-gene panel",
            "probability": 0.09075629383053212,
            "start_logit": -3.9817802906036377,
            "end_logit": -4.6264824867248535,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panel",
            "probability": 0.08528731021931649,
            "start_logit": -4.0439324378967285,
            "end_logit": -4.6264824867248535,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels (MGPs) are commercially available,",
            "probability": 0.0829192111245964,
            "start_logit": -3.7599594593048096,
            "end_logit": -4.938614368438721,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels (MGPs) are commercially available, but many include genes with weak/unproven associaton with breast cancer",
            "probability": 0.07205252128608695,
            "start_logit": -3.7599594593048096,
            "end_logit": -5.079085826873779,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene",
            "probability": 0.07013550948017627,
            "start_logit": -3.7599594593048096,
            "end_logit": -5.106051921844482,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels (MGPs)",
            "probability": 0.06238614944644817,
            "start_logit": -3.7599594593048096,
            "end_logit": -5.223137855529785,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "a custom-designed multi-gene panel",
            "probability": 0.060197355453600235,
            "start_logit": -4.392329692840576,
            "end_logit": -4.6264824867248535,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels",
            "probability": 0.04439865352252838,
            "start_logit": -3.7599594593048096,
            "end_logit": -5.563271999359131,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene cancer panel",
            "probability": 0.04432549421042565,
            "start_logit": -4.2002129554748535,
            "end_logit": -5.124667644500732,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi",
            "probability": 0.04413421477997071,
            "start_logit": -3.7599594593048096,
            "end_logit": -5.5692458152771,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "predisposition to cancer of other types.This study investigates the utility of a custom-designed multi",
            "probability": 0.041188919636499045,
            "start_logit": -3.9817802906036377,
            "end_logit": -5.4164910316467285,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels (MGPs) are commercially available, but many include genes with weak",
            "probability": 0.04028882261124497,
            "start_logit": -3.7599594593048096,
            "end_logit": -5.660407066345215,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "predisposition to cancer of other types.This study investigates the utility of a",
            "probability": 0.039562352434588985,
            "start_logit": -3.9817802906036377,
            "end_logit": -5.456782341003418,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "custom-designed multi-gene panel",
            "probability": 0.03868295837838465,
            "start_logit": -4.834558963775635,
            "end_logit": -4.6264824867248535,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "investigates the utility of a custom-designed multi-gene panel",
            "probability": 0.03508080831766304,
            "start_logit": -4.9323039054870605,
            "end_logit": -4.6264824867248535,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "(MGPs) are commercially available,",
            "probability": 0.03302934133143546,
            "start_logit": -4.680429935455322,
            "end_logit": -4.938614368438721,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "This study investigates the utility of a custom-designed multi-gene panel",
            "probability": 0.03174910671287612,
            "start_logit": -5.032093524932861,
            "end_logit": -4.6264824867248535,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "(MGPs) are commercially available, but many include genes with weak/unproven associaton with breast cancer",
            "probability": 0.028700795473954394,
            "start_logit": -4.680429935455322,
            "end_logit": -5.079085826873779,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene cancer panel in Irish patients with breast cancer.",
            "probability": 0.027804158735753388,
            "start_logit": -4.2002129554748535,
            "end_logit": -5.5910420417785645,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "a custom-designed multi",
            "probability": 0.027320023013918726,
            "start_logit": -4.392329692840576,
            "end_logit": -5.4164910316467285,
            "question_text": "What genes are related to breast cancer?"
        }
    ],
    "5523e47f7b523f2123000004": [
        {
            "text": "green fluorescent protein",
            "probability": 0.26515923142476655,
            "start_logit": 2.9375393390655518,
            "end_logit": 2.7716524600982666,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein, DsRed",
            "probability": 0.141525949044671,
            "start_logit": 2.950059652328491,
            "end_logit": 2.131284713745117,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent protein, DsRed",
            "probability": 0.13976504635737322,
            "start_logit": 2.9375393390655518,
            "end_logit": 2.131284713745117,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein",
            "probability": 0.0867120611024745,
            "start_logit": 2.950059652328491,
            "end_logit": 1.6413946151733398,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent protein",
            "probability": 0.08563316707316625,
            "start_logit": 2.9375393390655518,
            "end_logit": 1.6413946151733398,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "DsRed",
            "probability": 0.08210551153178881,
            "start_logit": 2.4055817127227783,
            "end_logit": 2.131284713745117,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green",
            "probability": 0.03540700770098308,
            "start_logit": 2.9375393390655518,
            "end_logit": 0.7582316994667053,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent",
            "probability": 0.03150198314967358,
            "start_logit": 2.9375393390655518,
            "end_logit": 0.6413724422454834,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP",
            "probability": 0.031407316761556475,
            "start_logit": 2.9375393390655518,
            "end_logit": 0.6383628249168396,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP)",
            "probability": 0.018635587291244638,
            "start_logit": 2.9375393390655518,
            "end_logit": 0.11639498919248581,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red",
            "probability": 0.014455391718044061,
            "start_logit": 2.950059652328491,
            "end_logit": -0.15013089776039124,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red",
            "probability": 0.014275533972562971,
            "start_logit": 2.9375393390655518,
            "end_logit": -0.15013089776039124,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein, DsRed,",
            "probability": 0.011063614221748706,
            "start_logit": 2.950059652328491,
            "end_logit": -0.4175366461277008,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent protein, DsRed,",
            "probability": 0.010925957854518453,
            "start_logit": 2.9375393390655518,
            "end_logit": -0.4175366461277008,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP) and red fluorescent protein, DsRed",
            "probability": 0.008386806559504377,
            "start_logit": 0.12423638999462128,
            "end_logit": 2.131284713745117,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "DsRed,",
            "probability": 0.006418495768435586,
            "start_logit": 2.4055817127227783,
            "end_logit": -0.4175366461277008,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP) and red fluorescent protein",
            "probability": 0.0051385437635386106,
            "start_logit": 0.12423638999462128,
            "end_logit": 1.6413946151733398,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent",
            "probability": 0.004829118879729247,
            "start_logit": 2.950059652328491,
            "end_logit": -1.2465343475341797,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent",
            "probability": 0.004769033725946518,
            "start_logit": 2.9375393390655518,
            "end_logit": -1.2465343475341797,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP",
            "probability": 0.0018846420982735052,
            "start_logit": 0.12423638999462128,
            "end_logit": 0.6383628249168396,
            "question_text": "List fluorescent reporter proteins."
        }
    ],
    "54fb5720d176fff445000002": [
        {
            "text": "Klf4",
            "probability": 0.09118713778032363,
            "start_logit": 5.112112522125244,
            "end_logit": 4.930372714996338,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4",
            "probability": 0.08673991340912929,
            "start_logit": 5.062112808227539,
            "end_logit": 4.930372714996338,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Myc",
            "probability": 0.07989822739692576,
            "start_logit": 5.193612575531006,
            "end_logit": 4.716712474822998,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4",
            "probability": 0.07870082710545438,
            "start_logit": 4.964852333068848,
            "end_logit": 4.930372714996338,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4",
            "probability": 0.07816854419888913,
            "start_logit": 5.062112808227539,
            "end_logit": 4.8263258934021,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4 and Myc",
            "probability": 0.07364480571803342,
            "start_logit": 5.112112522125244,
            "end_logit": 4.716712474822998,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4 and Myc",
            "probability": 0.07005312620298913,
            "start_logit": 5.062112808227539,
            "end_logit": 4.716712474822998,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2",
            "probability": 0.06895357118387034,
            "start_logit": 5.062112808227539,
            "end_logit": 4.700891971588135,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4 and Myc",
            "probability": 0.06356057732607513,
            "start_logit": 4.964852333068848,
            "end_logit": 4.716712474822998,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2",
            "probability": 0.06256292946073273,
            "start_logit": 4.964852333068848,
            "end_logit": 4.700891971588135,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Myc, termed OSKM",
            "probability": 0.05508029742000973,
            "start_logit": 5.193612575531006,
            "end_logit": 4.344750881195068,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4 and Myc, termed OSKM",
            "probability": 0.05076930908912994,
            "start_logit": 5.112112522125244,
            "end_logit": 4.344750881195068,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4 and Myc, termed OSKM",
            "probability": 0.050625809471093276,
            "start_logit": 4.99215841293335,
            "end_logit": 4.461874485015869,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "OSKM",
            "probability": 0.04620138934110733,
            "start_logit": 4.900706768035889,
            "end_logit": 4.461874485015869,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4 and Myc, termed OSKM",
            "probability": 0.04385353489623664,
            "start_logit": 4.848552227020264,
            "end_logit": 4.461874485015869,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        }
    ],
    "5363bad27d100faa0900000e": [
        {
            "text": "RNA",
            "probability": 0.637913988746606,
            "start_logit": 2.9292092323303223,
            "end_logit": 1.956141710281372,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region.The high abundance of lincRNA with respect to reduced Pi15",
            "probability": 0.19110551361729305,
            "start_logit": 2.9292092323303223,
            "end_logit": 0.7507639527320862,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "protease inhibitor 15 (Pi15) gene and a putative long intergenic noncoding RNA",
            "probability": 0.0417389443023355,
            "start_logit": 0.20244038105010986,
            "end_logit": 1.956141710281372,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15",
            "probability": 0.025580008337883785,
            "start_logit": 0.9181946516036987,
            "end_logit": 0.7507639527320862,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "protease inhibitor 15",
            "probability": 0.02536946492300203,
            "start_logit": 0.20244038105010986,
            "end_logit": 1.4582533836364746,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15) gene and a putative long intergenic noncoding RNA",
            "probability": 0.02360618102588815,
            "start_logit": -0.3674856424331665,
            "end_logit": 1.956141710281372,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region.The high abundance of lincRNA with respect to reduced Pi15 expression",
            "probability": 0.009392060760265985,
            "start_logit": 2.9292092323303223,
            "end_logit": -2.2621970176696777,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression, in conjunction with exertion of longitudinal strain, may be related to RIEL",
            "probability": 0.008118193251982323,
            "start_logit": 0.9181946516036987,
            "end_logit": -0.39693954586982727,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RIEL",
            "probability": 0.007982151908097139,
            "start_logit": 0.9012950658798218,
            "end_logit": -0.39693954586982727,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "R",
            "probability": 0.006721121197578523,
            "start_logit": 2.9292092323303223,
            "end_logit": -2.596806764602661,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "protease inhibitor 15 (Pi15",
            "probability": 0.005316916186261021,
            "start_logit": 0.20244038105010986,
            "end_logit": -0.1043994277715683,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region.The high abundance",
            "probability": 0.002728861420558053,
            "start_logit": 2.9292092323303223,
            "end_logit": -3.4981772899627686,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression,",
            "probability": 0.002675989226480087,
            "start_logit": 0.9181946516036987,
            "end_logit": -1.5067280530929565,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region.The high abundance of lincRNA",
            "probability": 0.002384758483184929,
            "start_logit": 2.9292092323303223,
            "end_logit": -3.6329638957977295,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression, in conjunction with exertion of longitudinal strain, may be related to RIEL,",
            "probability": 0.0023542235550097594,
            "start_logit": 0.9181946516036987,
            "end_logit": -1.634836196899414,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RIEL,",
            "probability": 0.0023147724448564647,
            "start_logit": 0.9012950658798218,
            "end_logit": -1.634836196899414,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression",
            "probability": 0.0012571536425612314,
            "start_logit": 0.9181946516036987,
            "end_logit": -2.2621970176696777,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region.The high",
            "probability": 0.0012165037087257338,
            "start_logit": 2.9292092323303223,
            "end_logit": -4.3060808181762695,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "15 (Pi15) gene and a putative long intergenic noncoding RNA",
            "probability": 0.0011626971518031949,
            "start_logit": -3.378251791000366,
            "end_logit": 1.956141710281372,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression, in conjunction with exertion of longitudinal strain",
            "probability": 0.001060496109627043,
            "start_logit": 0.9181946516036987,
            "end_logit": -2.4323103427886963,
            "question_text": "Which are the most abundant human lincRNA?"
        }
    ],
    "5720a8da0fd6f91b68000010": [
        {
            "text": "narcolepsy",
            "probability": 0.3620719195252434,
            "start_logit": 3.307762384414673,
            "end_logit": 3.2219059467315674,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness in narcolepsy",
            "probability": 0.1511594328819892,
            "start_logit": 2.4342546463012695,
            "end_logit": 3.2219059467315674,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness",
            "probability": 0.14550709822980362,
            "start_logit": 2.4342546463012695,
            "end_logit": 3.183795690536499,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy and central nervous system hypersomnias.Excessive daytime sleepiness",
            "probability": 0.10974073362602901,
            "start_logit": 3.307762384414673,
            "end_logit": 2.028183698654175,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias.Excessive daytime sleepiness",
            "probability": 0.04581506094345838,
            "start_logit": 2.4342546463012695,
            "end_logit": 2.028183698654175,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "central nervous system hypersomnias.Excessive daytime sleepiness",
            "probability": 0.04070704333572175,
            "start_logit": 2.316042900085449,
            "end_logit": 2.028183698654175,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy and central nervous system hypersomnias.Excessive daytime sleepiness (EDS) is the core complaint of central nervous system",
            "probability": 0.038755734784065354,
            "start_logit": 3.307762384414673,
            "end_logit": 0.9873418211936951,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy and central nervous system",
            "probability": 0.03081716069976977,
            "start_logit": 3.307762384414673,
            "end_logit": 0.7581347823143005,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "central nervous system hypersomnias.Excessive daytime sleepiness (EDS) is the core complaint of central nervous system",
            "probability": 0.014375987140188885,
            "start_logit": 2.316042900085449,
            "end_logit": 0.9873418211936951,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness in narcolepsy and central nervous system",
            "probability": 0.012865688508842094,
            "start_logit": 2.4342546463012695,
            "end_logit": 0.7581347823143005,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "central nervous system",
            "probability": 0.011431265808413409,
            "start_logit": 2.316042900085449,
            "end_logit": 0.7581347823143005,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint of central nervous system",
            "probability": 0.011344056755297519,
            "start_logit": 2.0791776180267334,
            "end_logit": 0.9873418211936951,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy and central nervous system hypersomnias",
            "probability": 0.009375572293000246,
            "start_logit": 3.307762384414673,
            "end_logit": -0.4318293035030365,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias",
            "probability": 0.003914156592458979,
            "start_logit": 2.4342546463012695,
            "end_logit": -0.4318293035030365,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "central nervous system hypersomnias",
            "probability": 0.0034777590327483513,
            "start_logit": 2.316042900085449,
            "end_logit": -0.4318293035030365,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy and central nervous system hypersomnias.Excessive daytime sleepiness (EDS)",
            "probability": 0.00307664329271662,
            "start_logit": 3.307762384414673,
            "end_logit": -1.546097755432129,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy and central nervous system hypersomnias.",
            "probability": 0.001901010798495685,
            "start_logit": 3.307762384414673,
            "end_logit": -2.0275511741638184,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias.Excessive daytime sleepiness (EDS)",
            "probability": 0.0012844510447455348,
            "start_logit": 2.4342546463012695,
            "end_logit": -1.546097755432129,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleepiness in narcolepsy",
            "probability": 0.0012122778260930888,
            "start_logit": -2.3915793895721436,
            "end_logit": 3.2219059467315674,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleepiness",
            "probability": 0.0011669468809191168,
            "start_logit": -2.3915793895721436,
            "end_logit": 3.183795690536499,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        }
    ],
    "54d8d60d014675820d000007": [
        {
            "text": "V600R",
            "probability": 0.7025051255692889,
            "start_logit": -3.1308703422546387,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V600R,",
            "probability": 0.07963977496645554,
            "start_logit": -3.1308703422546387,
            "end_logit": -4.919700622558594,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V600R, were not included in BRAF/MEK inhibitors clinical trials,",
            "probability": 0.03686785760772033,
            "start_logit": -3.1308703422546387,
            "end_logit": -5.689874172210693,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "inhibitors.Patients with the third most common pathologic variant in the BRAF gene, V600R",
            "probability": 0.024818440829543077,
            "start_logit": -6.473936080932617,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "R",
            "probability": 0.018295608165858443,
            "start_logit": -6.778861999511719,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V",
            "probability": 0.01563796708412599,
            "start_logit": -3.1308703422546387,
            "end_logit": -6.547512531280518,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V600R, were not included in BRAF/MEK inhibitors clinical trials",
            "probability": 0.014429071291220077,
            "start_logit": -3.1308703422546387,
            "end_logit": -6.627969264984131,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V600R, were not included in BRAF/MEK inhibitors",
            "probability": 0.012758547944546792,
            "start_logit": -3.1308703422546387,
            "end_logit": -6.751012802124023,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four",
            "probability": 0.012501523800479985,
            "start_logit": -4.937561511993408,
            "end_logit": -4.964672565460205,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "s.Patients with the third most common pathologic variant in the BRAF gene, V600R",
            "probability": 0.012293953992431049,
            "start_logit": -7.17641544342041,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Patients with the third most common pathologic variant in the BRAF gene, V600R",
            "probability": 0.010219897294425675,
            "start_logit": -7.361186504364014,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "BRAF inhibitors.Patients with the third most common pathologic variant in the BRAF gene, V600R",
            "probability": 0.009702089336700321,
            "start_logit": -7.413181781768799,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "received BRAF inhibitors.Patients with the third most common pathologic variant in the BRAF gene, V600R",
            "probability": 0.009248462027697085,
            "start_logit": -7.461065769195557,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V600R, were not",
            "probability": 0.008582425983165956,
            "start_logit": -3.1308703422546387,
            "end_logit": -7.147497653961182,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "gene, V600R",
            "probability": 0.007664860960257308,
            "start_logit": -7.648876667022705,
            "end_logit": -2.7425615787506104,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors",
            "probability": 0.007535943823195474,
            "start_logit": -4.937561511993408,
            "end_logit": -5.470839023590088,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors.Three patients demonstrated partial objective response to BRAF/MEK targeted therapy",
            "probability": 0.007309864072060078,
            "start_logit": -4.937561511993408,
            "end_logit": -5.501298427581787,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors.Three patients demonstrated partial objective response",
            "probability": 0.004290277967409667,
            "start_logit": -4.937561511993408,
            "end_logit": -6.0341715812683105,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "inhibitors",
            "probability": 0.0028847547971195702,
            "start_logit": -6.473936080932617,
            "end_logit": -4.894708633422852,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "inhibitors.Patients with the third most common pathologic variant in the BRAF gene, V600R,",
            "probability": 0.0028135524862987703,
            "start_logit": -6.473936080932617,
            "end_logit": -4.919700622558594,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        }
    ],
    "531375a6e3eabad021000011": [
        {
            "text": "syncope",
            "probability": 0.7925851187080878,
            "start_logit": 3.884920835494995,
            "end_logit": 3.2390520572662354,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history",
            "probability": 0.07321578493211942,
            "start_logit": 3.884920835494995,
            "end_logit": 0.8571631908416748,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD (FH-SCD) as well as family history",
            "probability": 0.05615395502668012,
            "start_logit": 3.884920835494995,
            "end_logit": 0.5918492674827576,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history",
            "probability": 0.0382281302132067,
            "start_logit": 3.235081434249878,
            "end_logit": 0.8571631908416748,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD (FH-SCD) as well as family history",
            "probability": 0.02931964339024317,
            "start_logit": 3.235081434249878,
            "end_logit": 0.5918492674827576,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD (FH-SCD) as well as family",
            "probability": 0.0029496113211173514,
            "start_logit": 3.884920835494995,
            "end_logit": -2.35457444190979,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family",
            "probability": 0.0023841783201109384,
            "start_logit": 3.884920835494995,
            "end_logit": -2.5673933029174805,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD (FH-SCD) as well as family",
            "probability": 0.0015400794482578347,
            "start_logit": 3.235081434249878,
            "end_logit": -2.35457444190979,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family",
            "probability": 0.0014353017643721428,
            "start_logit": 3.1646225452423096,
            "end_logit": -2.35457444190979,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "s",
            "probability": 0.0005158296522967854,
            "start_logit": 3.884920835494995,
            "end_logit": -4.098226547241211,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of HCM (FH-HCM) are documented in electronic health records (EHRs) as clinical narratives",
            "probability": 0.00043101061146471665,
            "start_logit": 3.1646225452423096,
            "end_logit": -3.55757212638855,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD (FH-SCD)",
            "probability": 0.0003938365054743098,
            "start_logit": 3.884920835494995,
            "end_logit": -4.368067264556885,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "ope",
            "probability": 0.0002309591006783535,
            "start_logit": -4.255893707275391,
            "end_logit": 3.2390520572662354,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD (FH-SCD)",
            "probability": 0.00020563370628266496,
            "start_logit": 3.235081434249878,
            "end_logit": -4.368067264556885,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of HCM (FH-HCM) are documented in electronic health records",
            "probability": 0.00018566183869913604,
            "start_logit": 3.1646225452423096,
            "end_logit": -4.399777889251709,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of HCM (FH-HCM)",
            "probability": 0.00011812650171435558,
            "start_logit": 3.1646225452423096,
            "end_logit": -4.8519487380981445,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "SCD (FH-SCD) as well as family history",
            "probability": 5.2567935003482956e-05,
            "start_logit": -3.088825225830078,
            "end_logit": 0.5918492674827576,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "ope and family history",
            "probability": 2.133506098492623e-05,
            "start_logit": -4.255893707275391,
            "end_logit": 0.8571631908416748,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "history",
            "probability": 1.6872715087074258e-05,
            "start_logit": -4.4905476570129395,
            "end_logit": 0.8571631908416748,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "ope and family history of SCD (FH-SCD) as well as family history",
            "probability": 1.6363248118554927e-05,
            "start_logit": -4.255893707275391,
            "end_logit": 0.5918492674827576,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        }
    ],
    "56d1e23c67f0cb3d66000009": [
        {
            "text": "TAZ",
            "probability": 0.94016773877391,
            "start_logit": 5.249016284942627,
            "end_logit": 5.087304592132568,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ binding motif",
            "probability": 0.023422200545086046,
            "start_logit": 5.249016284942627,
            "end_logit": 1.3949306011199951,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ",
            "probability": 0.02007096392910764,
            "start_logit": 5.249016284942627,
            "end_logit": 1.2405204772949219,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "PDZ binding motif",
            "probability": 0.0032230613983158796,
            "start_logit": 3.2656636238098145,
            "end_logit": 1.3949306011199951,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "PDZ",
            "probability": 0.0027619074024395683,
            "start_logit": 3.2656636238098145,
            "end_logit": 1.2405204772949219,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein",
            "probability": 0.0022579409176219792,
            "start_logit": 5.249016284942627,
            "end_logit": -0.9443004131317139,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes",
            "probability": 0.00190151469950044,
            "start_logit": 5.249016284942627,
            "end_logit": -1.116102933883667,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator",
            "probability": 0.001790386664423419,
            "start_logit": 5.249016284942627,
            "end_logit": -1.176322102546692,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ binding motif)",
            "probability": 0.0016393664207107765,
            "start_logit": 5.249016284942627,
            "end_logit": -1.2644438743591309,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "YAP/TAZ",
            "probability": 0.0013672437971581767,
            "start_logit": -1.2842451333999634,
            "end_logit": 5.087304592132568,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "transcriptional coactivator with PDZ binding motif",
            "probability": 0.00035207248664479015,
            "start_logit": 1.0514137744903564,
            "end_logit": 1.3949306011199951,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "transcriptional coactivator with PDZ",
            "probability": 0.0003016981331995872,
            "start_logit": 1.0514137744903564,
            "end_logit": 1.2405204772949219,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "PDZ binding motif)",
            "probability": 0.00022558848038711313,
            "start_logit": 3.2656636238098145,
            "end_logit": -1.2644438743591309,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Z",
            "probability": 0.0001796190852623123,
            "start_logit": -3.3139588832855225,
            "end_logit": 5.087304592132568,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Yes-associated protein/transcriptional coactivator with PDZ binding motif",
            "probability": 8.835370613179789e-05,
            "start_logit": -0.33107516169548035,
            "end_logit": 1.3949306011199951,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "PDZ binding motif) pathway contributes to the pathogenesis of lymphatic malformations (LMs).",
            "probability": 8.446897267944729e-05,
            "start_logit": 3.2656636238098145,
            "end_logit": -2.246772050857544,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Yes-associated protein/transcriptional coactivator with PDZ",
            "probability": 7.571210251405425e-05,
            "start_logit": -0.33107516169548035,
            "end_logit": 1.2405204772949219,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "YAP/TAZ (Yes-associated protein/transcriptional coactivator with PDZ binding motif",
            "probability": 3.4061856294735935e-05,
            "start_logit": -1.2842451333999634,
            "end_logit": 1.3949306011199951,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "YAP/TAZ (Yes-associated protein/transcriptional coactivator with PDZ",
            "probability": 2.918830311157603e-05,
            "start_logit": -1.2842451333999634,
            "end_logit": 1.2405204772949219,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "transcriptional coactivator",
            "probability": 2.6912325500153336e-05,
            "start_logit": 1.0514137744903564,
            "end_logit": -1.176322102546692,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        }
    ],
    "531b3ff3b166e2b80600003d": [
        {
            "text": "E-cadherin",
            "probability": 0.978053061274158,
            "start_logit": 5.270517826080322,
            "end_logit": 4.56386137008667,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cadherin",
            "probability": 0.01210513962307853,
            "start_logit": 0.8785840272903442,
            "end_logit": 4.56386137008667,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "the cell-adhesion protein E-cadherin",
            "probability": 0.0020305070170809156,
            "start_logit": -0.906760573387146,
            "end_logit": 4.56386137008667,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cell-adhesion protein E-cadherin",
            "probability": 0.0016220125371747955,
            "start_logit": -1.131378412246704,
            "end_logit": 4.56386137008667,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadherin.",
            "probability": 0.001609025645518771,
            "start_logit": 5.270517826080322,
            "end_logit": -1.8460737466812134,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "loss of the cell-adhesion protein E-cadherin",
            "probability": 0.0011417159066199056,
            "start_logit": -1.3850373029708862,
            "end_logit": 4.4663848876953125,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E",
            "probability": 0.0009039213974141884,
            "start_logit": 5.270517826080322,
            "end_logit": -2.422715425491333,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadheri",
            "probability": 0.0008507154940157778,
            "start_logit": 5.270517826080322,
            "end_logit": -2.483380079269409,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "protein E-cadherin",
            "probability": 0.000461048798509751,
            "start_logit": -2.3892974853515625,
            "end_logit": 4.56386137008667,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "dherin",
            "probability": 0.00044903975773919114,
            "start_logit": -2.4156899452209473,
            "end_logit": 4.56386137008667,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "n",
            "probability": 0.0002954600875096532,
            "start_logit": -2.7367911338806152,
            "end_logit": 4.4663848876953125,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadh",
            "probability": 0.00026618042590554085,
            "start_logit": 5.270517826080322,
            "end_logit": -3.6452834606170654,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "adhesion protein E-cadherin",
            "probability": 0.00012847944058749336,
            "start_logit": -3.667032480239868,
            "end_logit": 4.56386137008667,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cadherin.",
            "probability": 1.991454335897125e-05,
            "start_logit": 0.8785840272903442,
            "end_logit": -1.8460737466812134,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "epithelial-to-mesenchymal transition (EMT), characterized by loss of the cell-adhesion protein",
            "probability": 1.6983915091524217e-05,
            "start_logit": -0.2881314754486084,
            "end_logit": -0.8385418057441711,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "epithelial-to-mesenchymal transition (EMT),",
            "probability": 1.0826794424783264e-05,
            "start_logit": -0.2881314754486084,
            "end_logit": -1.2887845039367676,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cadheri",
            "probability": 1.0529111601738115e-05,
            "start_logit": 0.8785840272903442,
            "end_logit": -2.483380079269409,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "the cell-adhesion protein",
            "probability": 9.148936354572112e-06,
            "start_logit": -0.906760573387146,
            "end_logit": -0.8385418057441711,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "epithelial-to-mesenchymal transition",
            "probability": 8.980927352214442e-06,
            "start_logit": -0.2881314754486084,
            "end_logit": -1.4757053852081299,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cell-adhesion protein",
            "probability": 7.308366503585873e-06,
            "start_logit": -1.131378412246704,
            "end_logit": -0.8385418057441711,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        }
    ],
    "52f5417b2059c6d71c000024": [
        {
            "text": "Pten",
            "probability": 0.47889899204187913,
            "start_logit": 0.16800692677497864,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "PTEN",
            "probability": 0.249845981793154,
            "start_logit": -0.4401346743106842,
            "end_logit": -0.4804004430770874,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "Pten (Pten",
            "probability": 0.0570028704643122,
            "start_logit": -1.9603811502456665,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mouse model with predominantly cytoplasmic localization of Pten (Pten",
            "probability": 0.04214262662492863,
            "start_logit": -2.262423038482666,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "cytoplasmic localization of Pten (Pten",
            "probability": 0.029036041249766782,
            "start_logit": -2.6349449157714844,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "PTEN account for ~10% of cases of autism spectrum disorder (ASD) with coincident macrocephaly",
            "probability": 0.022831218764431456,
            "start_logit": -0.4401346743106842,
            "end_logit": -2.8731162548065186,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "generated a mouse model with predominantly cytoplasmic localization of Pten (Pten",
            "probability": 0.02273993921507988,
            "start_logit": -2.8793599605560303,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "predominantly cytoplasmic localization of Pten (Pten",
            "probability": 0.021606726534105607,
            "start_logit": -2.930478096008301,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "Germline mutations in PTEN",
            "probability": 0.011671442916731287,
            "start_logit": -3.5038342475891113,
            "end_logit": -0.4804004430770874,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "a mouse model with predominantly cytoplasmic localization of Pten (Pten",
            "probability": 0.01043614602180865,
            "start_logit": -3.658207416534424,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mouse model with predominantly cytoplasmic localization of Pten",
            "probability": 0.008839332503383512,
            "start_logit": -2.262423038482666,
            "end_logit": -1.9997453689575195,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "with predominantly cytoplasmic localization of Pten (Pten",
            "probability": 0.007087644095870997,
            "start_logit": -4.045129776000977,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "previously generated a mouse model with predominantly cytoplasmic localization of Pten (Pten",
            "probability": 0.006695842630256202,
            "start_logit": -4.101995944976807,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "cytoplasmic localization of Pten",
            "probability": 0.006090252168497402,
            "start_logit": -2.6349449157714844,
            "end_logit": -1.9997453689575195,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "generated a mouse model with predominantly cytoplasmic localization of Pten",
            "probability": 0.004769657231329761,
            "start_logit": -2.8793599605560303,
            "end_logit": -1.9997453689575195,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "predominantly cytoplasmic localization of Pten",
            "probability": 0.004531968114955201,
            "start_logit": -2.930478096008301,
            "end_logit": -1.9997453689575195,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "PTEN account for ~10% of cases of autism spectrum disorder (ASD) with coincident macrocephaly.",
            "probability": 0.00406928866282218,
            "start_logit": -0.4401346743106842,
            "end_logit": -4.597776889801025,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "macrocephaly.Germline mutations in PTEN",
            "probability": 0.004026618405651546,
            "start_logit": -3.2498459815979004,
            "end_logit": -1.7986068725585938,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "(Pten",
            "probability": 0.004001089088470872,
            "start_logit": -4.616916179656982,
            "end_logit": -0.4378969967365265,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mutations in PTEN",
            "probability": 0.0036763214725647627,
            "start_logit": -4.659066677093506,
            "end_logit": -0.4804004430770874,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        }
    ],
    "5717ab7ccb4ef8864c00000c": [
        {
            "text": "mitophagy",
            "probability": 0.49842610169812357,
            "start_logit": 4.390363693237305,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitophagy block causes mitochondrial clustering",
            "probability": 0.2540730257011589,
            "start_logit": 4.390363693237305,
            "end_logit": 3.784611463546753,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial clustering",
            "probability": 0.14961070274521396,
            "start_logit": 3.860778570175171,
            "end_logit": 3.784611463546753,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "signaling",
            "probability": 0.0337164327047966,
            "start_logit": 3.3855948448181152,
            "end_logit": 2.7697439193725586,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "signaling roles",
            "probability": 0.024539802567323375,
            "start_logit": 3.3855948448181152,
            "end_logit": 2.452054977416992,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "clustering",
            "probability": 0.014360145804023481,
            "start_logit": 1.5171986818313599,
            "end_logit": 3.784611463546753,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitophagy block causes mitochondrial",
            "probability": 0.01022426875569282,
            "start_logit": 4.390363693237305,
            "end_logit": 0.5717539191246033,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial",
            "probability": 0.006020552671318699,
            "start_logit": 3.860778570175171,
            "end_logit": 0.5717539191246033,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "RNA-binding proteins G3BP1 and G3BP2.In the absence of CLUH, a mitophagy",
            "probability": 0.002350262276475738,
            "start_logit": -0.9665647149085999,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mit",
            "probability": 0.0012393472371492783,
            "start_logit": 4.390363693237305,
            "end_logit": -1.5384254455566406,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "CLUH granules play signaling",
            "probability": 0.0009287944668561882,
            "start_logit": -0.20625829696655273,
            "end_logit": 2.7697439193725586,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "signaling roles, by recruiting mTOR kinase",
            "probability": 0.000917890465062517,
            "start_logit": 3.3855948448181152,
            "end_logit": -0.8339186310768127,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "gy",
            "probability": 0.0007449759651557208,
            "start_logit": -2.115494966506958,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "CLUH granules play signaling roles",
            "probability": 0.0006760036876330252,
            "start_logit": -0.20625829696655273,
            "end_logit": 2.452054977416992,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "signaling roles,",
            "probability": 0.000553379282864255,
            "start_logit": 3.3855948448181152,
            "end_logit": -1.339953064918518,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitophagy block causes mitochondrial cluster",
            "probability": 0.0004946688509487563,
            "start_logit": 4.390363693237305,
            "end_logit": -2.4568769931793213,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "gy block causes mitochondrial clustering",
            "probability": 0.0003797519770671908,
            "start_logit": -2.115494966506958,
            "end_logit": 3.784611463546753,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial cluster",
            "probability": 0.0002912853665294598,
            "start_logit": 3.860778570175171,
            "end_logit": -2.4568769931793213,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "a mitophagy",
            "probability": 0.00029027291386193215,
            "start_logit": -3.058025360107422,
            "end_logit": 4.458445072174072,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "signaling roles, by recruiting mTOR kinase and the RNA",
            "probability": 0.00016233486274418675,
            "start_logit": 3.3855948448181152,
            "end_logit": -2.566335439682007,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        }
    ],
    "530a3e18970c65fa6b000005": [
        {
            "text": "Leifsonia",
            "probability": 0.9309631213654235,
            "start_logit": 2.6390442848205566,
            "end_logit": 2.168017625808716,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp.",
            "probability": 0.03974225838018139,
            "start_logit": 2.6390442848205566,
            "end_logit": -0.9857869744300842,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp",
            "probability": 0.02396444434441371,
            "start_logit": 2.6390442848205566,
            "end_logit": -1.4916307926177979,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Le",
            "probability": 0.003011936674752765,
            "start_logit": 2.6390442848205566,
            "end_logit": -3.5656187534332275,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia s",
            "probability": 0.0014868211971179272,
            "start_logit": 2.6390442848205566,
            "end_logit": -4.271561622619629,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifson",
            "probability": 0.0002950658814781824,
            "start_logit": 2.6390442848205566,
            "end_logit": -5.888758659362793,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "ia",
            "probability": 0.0002656159676910618,
            "start_logit": -5.522879123687744,
            "end_logit": 2.168017625808716,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp.The results demonstrated that cells",
            "probability": 0.00022498833272370934,
            "start_logit": 2.6390442848205566,
            "end_logit": -6.159908771514893,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "ia sp.",
            "probability": 1.1338986664044834e-05,
            "start_logit": -5.522879123687744,
            "end_logit": -0.9857869744300842,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "bacteria",
            "probability": 8.776995760009803e-06,
            "start_logit": -3.596168041229248,
            "end_logit": -3.1686108112335205,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "ia sp",
            "probability": 6.8373697396134615e-06,
            "start_logit": -5.522879123687744,
            "end_logit": -1.4916307926177979,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": ".",
            "probability": 4.814585652934611e-06,
            "start_logit": -6.379476070404053,
            "end_logit": -0.9857869744300842,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "sp.",
            "probability": 3.832062995560728e-06,
            "start_logit": -6.607722759246826,
            "end_logit": -0.9857869744300842,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "p.",
            "probability": 2.4454470322668224e-06,
            "start_logit": -7.05689811706543,
            "end_logit": -0.9857869744300842,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "sp",
            "probability": 2.310720732146355e-06,
            "start_logit": -6.607722759246826,
            "end_logit": -1.4916307926177979,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "immobilization via the action of bacteria",
            "probability": 1.8445429302711979e-06,
            "start_logit": -5.156070709228516,
            "end_logit": -3.1686108112335205,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "p",
            "probability": 1.4745961022485426e-06,
            "start_logit": -7.05689811706543,
            "end_logit": -1.4916307926177979,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Bioremediation approaches (i.e., immobilization via the action of bacteria",
            "probability": 8.878677599579886e-07,
            "start_logit": -5.887234687805176,
            "end_logit": -3.1686108112335205,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "via the action of bacteria",
            "probability": 6.50319877515382e-07,
            "start_logit": -6.1985931396484375,
            "end_logit": -3.1686108112335205,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "bacteria) resulting in uranium bearing solid is supposed as an economic and clean in-situ approach",
            "probability": 5.343609711412043e-07,
            "start_logit": -3.596168041229248,
            "end_logit": -5.967428684234619,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        }
    ],
    "570a922dcf1c325851000028": [
        {
            "text": "necroptosis",
            "probability": 0.7681748803579016,
            "start_logit": 2.888032913208008,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.15587878110412973,
            "start_logit": 1.2930941581726074,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death",
            "probability": 0.024217648704330286,
            "start_logit": 1.2930941581726074,
            "end_logit": 1.5563067197799683,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "MLKL necroptosis",
            "probability": 0.018583119713558572,
            "start_logit": -0.8337308764457703,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.009399844716504901,
            "start_logit": -1.5152913331985474,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "cell death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.006772179966997323,
            "start_logit": -1.8431614637374878,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.004201303028313139,
            "start_logit": -2.320589780807495,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis signaling",
            "probability": 0.0021156310323740854,
            "start_logit": 2.888032913208008,
            "end_logit": -2.476360559463501,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation",
            "probability": 0.0015032645409728035,
            "start_logit": 1.2930941581726074,
            "end_logit": -1.2231358289718628,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "RIP3/MLKL necroptosis",
            "probability": 0.0014083991098209738,
            "start_logit": -3.4135308265686035,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "tosis",
            "probability": 0.0011986420088507435,
            "start_logit": -3.5747952461242676,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "cell death",
            "probability": 0.0010521398373886772,
            "start_logit": -1.8431614637374878,
            "end_logit": 1.5563067197799683,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway",
            "probability": 0.0010302709550217867,
            "start_logit": 1.2930941581726074,
            "end_logit": -1.6009531021118164,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.0009351682654406181,
            "start_logit": -3.8230133056640625,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation, RIP1/RIP3/MLKL",
            "probability": 0.0007641807140164996,
            "start_logit": 1.2930941581726074,
            "end_logit": -1.8997259140014648,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "death",
            "probability": 0.0006527230975212637,
            "start_logit": -2.320589780807495,
            "end_logit": 1.5563067197799683,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "As a recently defined programmed cell death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.0006214589624962176,
            "start_logit": -4.231669902801514,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation,",
            "probability": 0.0005616483678663641,
            "start_logit": 1.2930941581726074,
            "end_logit": -2.2076542377471924,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "roptosis",
            "probability": 0.0004994096448433731,
            "start_logit": -4.450313091278076,
            "end_logit": 3.4183037281036377,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis signaling",
            "probability": 0.0004293058716511205,
            "start_logit": 1.2930941581726074,
            "end_logit": -2.476360559463501,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        }
    ],
    "51bdb644047fa84d1d000001": [
        {
            "text": "PNET1",
            "probability": 0.37763870788055987,
            "start_logit": 3.329244613647461,
            "end_logit": 2.916123151779175,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM209",
            "probability": 0.29548542915600107,
            "start_logit": 3.329244613647461,
            "end_logit": 2.670804738998413,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM209",
            "probability": 0.17521279957198094,
            "start_logit": 2.806626319885254,
            "end_logit": 2.670804738998413,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET",
            "probability": 0.09622428558724495,
            "start_logit": 3.329244613647461,
            "end_logit": 1.5488669872283936,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1,",
            "probability": 0.013352293771851438,
            "start_logit": 3.329244613647461,
            "end_logit": -0.4261265993118286,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM209,",
            "probability": 0.009320354408467365,
            "start_logit": 3.329244613647461,
            "end_logit": -0.7856141328811646,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM209, a critical driver for lung cancer.",
            "probability": 0.006268594259318491,
            "start_logit": 3.329244613647461,
            "end_logit": -1.182262659072876,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM209,",
            "probability": 0.005526652849093474,
            "start_logit": 2.806626319885254,
            "end_logit": -0.7856141328811646,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "209",
            "probability": 0.00490787280251441,
            "start_logit": -0.7685343027114868,
            "end_logit": 2.670804738998413,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM",
            "probability": 0.00438787071499256,
            "start_logit": 3.329244613647461,
            "end_logit": -1.538970708847046,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM209, a critical driver for lung cancer.",
            "probability": 0.003717062979021464,
            "start_logit": 2.806626319885254,
            "end_logit": -1.182262659072876,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM",
            "probability": 0.0026018579472081634,
            "start_logit": 2.806626319885254,
            "end_logit": -1.538970708847046,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "named PNET1",
            "probability": 0.0009689258581032917,
            "start_logit": -2.636260509490967,
            "end_logit": 2.916123151779175,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "NET1",
            "probability": 0.0008660309101475493,
            "start_logit": -2.748528003692627,
            "end_logit": 2.916123151779175,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "named PNET1, is a homologue of human TMEM209",
            "probability": 0.0007581412260645441,
            "start_logit": -2.636260509490967,
            "end_logit": 2.670804738998413,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "NET1, is a homologue of human TMEM209",
            "probability": 0.0006776305230560399,
            "start_logit": -2.748528003692627,
            "end_logit": 2.670804738998413,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "P",
            "probability": 0.0006529584876906327,
            "start_logit": 3.329244613647461,
            "end_logit": -3.444056510925293,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "One of the candidates, named PNET1",
            "probability": 0.000587612626410744,
            "start_logit": -3.136380672454834,
            "end_logit": 2.916123151779175,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "One of the candidates, named PNET1, is a homologue of human TMEM209",
            "probability": 0.0004597806460755604,
            "start_logit": -3.136380672454834,
            "end_logit": 2.670804738998413,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM209, a critical driver for lung cancer",
            "probability": 0.0003851377941975391,
            "start_logit": 3.329244613647461,
            "end_logit": -3.97196888923645,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        }
    ],
    "534ab91eaeec6fbd07000012": [
        {
            "text": "RGS2",
            "probability": 0.5555322622509135,
            "start_logit": 4.442363262176514,
            "end_logit": 3.956899881362915,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 expression by increasing the methylation of CpG nucleotides of the RGS2",
            "probability": 0.3157039901552789,
            "start_logit": 3.877241611480713,
            "end_logit": 3.956899881362915,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 by UHRF1 contributes to bladder cancer progression.In bladder cancer cells, UHRF1 inhibits RGS2",
            "probability": 0.0879550718954372,
            "start_logit": 2.9524877071380615,
            "end_logit": 3.60367488861084,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 promoter",
            "probability": 0.01723300551036657,
            "start_logit": 4.442363262176514,
            "end_logit": 0.48379966616630554,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 expression by increasing the methylation of CpG nucleotides of the RGS2 promoter",
            "probability": 0.009793362099163466,
            "start_logit": 3.877241611480713,
            "end_logit": 0.48379966616630554,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 promoter.Furthermore, Kaplan-Meier analysis showed that low TGS2",
            "probability": 0.00448773002469461,
            "start_logit": 4.234647274017334,
            "end_logit": -0.6539638042449951,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "the RGS2",
            "probability": 0.0017607904437203063,
            "start_logit": -1.3118005990982056,
            "end_logit": 3.956899881362915,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "methylation of CpG nucleotides of the RGS2",
            "probability": 0.0015346811189455541,
            "start_logit": -1.449240803718567,
            "end_logit": 3.956899881362915,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "TGS2 expression is significantly correlated with reduced overall survival in patients with bladder cancer.These results demonstrate that epigenetic repression of RGS2",
            "probability": 0.0013770736608778712,
            "start_logit": -0.12222272902727127,
            "end_logit": 2.521519899368286,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 expression",
            "probability": 0.000697299040806643,
            "start_logit": 3.877241611480713,
            "end_logit": -2.1584460735321045,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "UHRF1 inhibits RGS2 expression by increasing the methylation of CpG nucleotides of the RGS2",
            "probability": 0.0006906034614411942,
            "start_logit": -2.2477529048919678,
            "end_logit": 3.956899881362915,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "CpG nucleotides of the RGS2",
            "probability": 0.0005588458653813638,
            "start_logit": -2.459444999694824,
            "end_logit": 3.956899881362915,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "UHRF1 inhibits RGS2",
            "probability": 0.00048509308696826405,
            "start_logit": -2.2477529048919678,
            "end_logit": 3.60367488861084,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS",
            "probability": 0.0004610200512719065,
            "start_logit": 4.442363262176514,
            "end_logit": -3.137340545654297,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 by UHRF1",
            "probability": 0.0003961217956104814,
            "start_logit": 2.9524877071380615,
            "end_logit": -1.799184799194336,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "2",
            "probability": 0.0003176712155978931,
            "start_logit": -2.9936249256134033,
            "end_logit": 3.926223039627075,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 expression by increasing the methylation of CpG nucleotides",
            "probability": 0.000278776139204815,
            "start_logit": 3.877241611480713,
            "end_logit": -3.075251340866089,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 by UHRF1 contributes to bladder cancer progression.In bladder cancer cells, UHRF1 inhibits RGS2 expression",
            "probability": 0.00027656903223423124,
            "start_logit": 2.9524877071380615,
            "end_logit": -2.1584460735321045,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 expression by increasing the methylation of CpG nucleotides of the RGS",
            "probability": 0.0002619935503626869,
            "start_logit": 3.877241611480713,
            "end_logit": -3.137340545654297,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 by UHRF1 contributes to bladder cancer progression.In bladder cancer cells, UHRF1",
            "probability": 0.00019803960172257208,
            "start_logit": 2.9524877071380615,
            "end_logit": -2.4924395084381104,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        }
    ],
    "51740da48ed59a060a000024": [
        {
            "text": "ExPasy ProtParam",
            "probability": 0.1820816648469614,
            "start_logit": 4.889216899871826,
            "end_logit": 4.426765441894531,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment (SOPMA), PSIPRED",
            "probability": 0.15198780567320436,
            "start_logit": 4.889216899871826,
            "end_logit": 4.246110439300537,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment (SOPMA",
            "probability": 0.14097036150402237,
            "start_logit": 4.889216899871826,
            "end_logit": 4.1708598136901855,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "PSIPRED",
            "probability": 0.10849572304024095,
            "start_logit": 4.552127361297607,
            "end_logit": 4.246110439300537,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA), PSIPRED",
            "probability": 0.10452630651903376,
            "start_logit": 4.51485538482666,
            "end_logit": 4.246110439300537,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA",
            "probability": 0.09694929900067804,
            "start_logit": 4.51485538482666,
            "end_logit": 4.1708598136901855,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools",
            "probability": 0.06099220468541593,
            "start_logit": 4.889216899871826,
            "end_logit": 3.3330562114715576,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment",
            "probability": 0.044171620748409204,
            "start_logit": 4.889216899871826,
            "end_logit": 3.010392665863037,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment (SOPMA)",
            "probability": 0.03125597609696929,
            "start_logit": 4.889216899871826,
            "end_logit": 2.664520740509033,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA)",
            "probability": 0.021495617517421618,
            "start_logit": 4.51485538482666,
            "end_logit": 2.664520740509033,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "alignment (SOPMA), PSIPRED",
            "probability": 0.011645759765429036,
            "start_logit": 2.3203587532043457,
            "end_logit": 4.246110439300537,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "alignment (SOPMA",
            "probability": 0.010801570276311748,
            "start_logit": 2.3203587532043457,
            "end_logit": 4.1708598136901855,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "self-optimized prediction method with alignment (SOPMA), PSIPRED",
            "probability": 0.005463353609753144,
            "start_logit": 1.5634794235229492,
            "end_logit": 4.246110439300537,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "PSIPRED, and SWISS-MODEL",
            "probability": 0.005357004544241246,
            "start_logit": 4.552127361297607,
            "end_logit": 1.237804651260376,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA), PSIPRED, and SWISS-MODEL",
            "probability": 0.005161013571083655,
            "start_logit": 4.51485538482666,
            "end_logit": 1.237804651260376,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "self-optimized prediction method with alignment (SOPMA",
            "probability": 0.005067320565487895,
            "start_logit": 1.5634794235229492,
            "end_logit": 4.1708598136901855,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "(SOPMA), PSIPRED",
            "probability": 0.003563367327325311,
            "start_logit": 1.1361225843429565,
            "end_logit": 4.246110439300537,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "alignment",
            "probability": 0.0033845615535214335,
            "start_logit": 2.3203587532043457,
            "end_logit": 3.010392665863037,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SWISS-MODEL",
            "probability": 0.0033244067642560905,
            "start_logit": 4.075013637542725,
            "end_logit": 1.237804651260376,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "(SOPMA",
            "probability": 0.0033050623902338,
            "start_logit": 1.1361225843429565,
            "end_logit": 4.1708598136901855,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        }
    ],
    "552435602c8b63434a000009": [
        {
            "text": "retinoblastoma protein",
            "probability": 0.5542819289874107,
            "start_logit": 4.551450729370117,
            "end_logit": 2.9711830615997314,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma",
            "probability": 0.4163980823279265,
            "start_logit": 4.551450729370117,
            "end_logit": 2.6851513385772705,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB)",
            "probability": 0.01671150373644321,
            "start_logit": 4.551450729370117,
            "end_logit": -0.5303930640220642,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB",
            "probability": 0.006096918406682929,
            "start_logit": 3.304788589477539,
            "end_logit": -0.2920447885990143,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB) is required for activity of the CDK4/6 inhibitor, and that loss of pRB",
            "probability": 0.0019031571517981105,
            "start_logit": 4.551450729370117,
            "end_logit": -2.7029762268066406,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "re",
            "probability": 0.0017782987323652247,
            "start_logit": 4.551450729370117,
            "end_logit": -2.7708332538604736,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "pRB",
            "probability": 0.0016817713973360604,
            "start_logit": 0.9693167209625244,
            "end_logit": 0.7554912567138672,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "pRB)",
            "probability": 0.0003230661201827058,
            "start_logit": 0.5305807590484619,
            "end_logit": -0.4555186927318573,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "protein",
            "probability": 0.00014966124392771994,
            "start_logit": -3.6656036376953125,
            "end_logit": 2.9711830615997314,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblast",
            "probability": 0.00014959028921291356,
            "start_logit": 4.551450729370117,
            "end_logit": -5.246345520019531,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "blastoma protein",
            "probability": 0.00012791460046258135,
            "start_logit": -3.822615146636963,
            "end_logit": 2.9711830615997314,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "blastoma",
            "probability": 9.609440890787465e-05,
            "start_logit": -3.822615146636963,
            "end_logit": 2.6851513385772705,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB) is required for activity of the CDK4/6 inhibitor,",
            "probability": 6.807954579961401e-05,
            "start_logit": 4.551450729370117,
            "end_logit": -6.033568859100342,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "oma protein",
            "probability": 4.993194088360191e-05,
            "start_logit": -4.763317108154297,
            "end_logit": 2.9711830615997314,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "tinoblastoma protein",
            "probability": 4.5386590293222426e-05,
            "start_logit": -4.858761310577393,
            "end_logit": 2.9711830615997314,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "oma",
            "probability": 3.751081055235966e-05,
            "start_logit": -4.763317108154297,
            "end_logit": 2.6851513385772705,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "tinoblastoma",
            "probability": 3.4096166901970834e-05,
            "start_logit": -4.858761310577393,
            "end_logit": 2.6851513385772705,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "KRAS",
            "probability": 2.489151356351471e-05,
            "start_logit": -1.124430537223816,
            "end_logit": -1.363837480545044,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "expression of retinoblastoma protein",
            "probability": 2.1935572747306084e-05,
            "start_logit": -5.5858683586120605,
            "end_logit": 2.9711830615997314,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "pRB) is required for activity of the CDK4/6 inhibitor, and that loss of pRB",
            "probability": 2.0180456601766508e-05,
            "start_logit": 0.5305807590484619,
            "end_logit": -3.228661060333252,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        }
    ],
    "54f21b69c409818c32000007": [
        {
            "text": "Hemochromatosis type 4",
            "probability": 0.7689038309049034,
            "start_logit": 3.7393710613250732,
            "end_logit": 4.654104232788086,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hemochromatosis",
            "probability": 0.21010915475169076,
            "start_logit": 3.7393710613250732,
            "end_logit": 3.3567655086517334,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "type 4",
            "probability": 0.014391112226722694,
            "start_logit": -0.23898403346538544,
            "end_logit": 4.654104232788086,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "4",
            "probability": 0.001452183939339844,
            "start_logit": -2.5325262546539307,
            "end_logit": 4.654104232788086,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "DMT1 deficiency",
            "probability": 0.0011083699795577668,
            "start_logit": 1.0149199962615967,
            "end_logit": 0.8364798426628113,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Atransferrinemia and DMT1 deficiency",
            "probability": 0.0010844658340698262,
            "start_logit": 0.993117094039917,
            "end_logit": 0.8364798426628113,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Atransferrinemia",
            "probability": 0.0009937778952581876,
            "start_logit": 0.993117094039917,
            "end_logit": 0.7491507530212402,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "tosis type 4",
            "probability": 0.000830292720685735,
            "start_logit": -3.091571807861328,
            "end_logit": 4.654104232788086,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hem",
            "probability": 0.0005256776408383932,
            "start_logit": 3.7393710613250732,
            "end_logit": -2.6339287757873535,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "tosis",
            "probability": 0.00022688416252843112,
            "start_logit": -3.091571807861328,
            "end_logit": 3.3567655086517334,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hemochromatosis type",
            "probability": 9.873625547417381e-05,
            "start_logit": 3.7393710613250732,
            "end_logit": -4.306164741516113,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "DMT1",
            "probability": 7.499398325177468e-05,
            "start_logit": 1.0149199962615967,
            "end_logit": -1.8567579984664917,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Atransferrinemia and DMT1",
            "probability": 7.337659274189651e-05,
            "start_logit": 0.993117094039917,
            "end_logit": -1.8567579984664917,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hemochromatosis type 4 is",
            "probability": 6.416097967587483e-05,
            "start_logit": 3.7393710613250732,
            "end_logit": -4.737221717834473,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hepcidin resistance.Atransferrinemia and DMT1 deficiency",
            "probability": 2.48530353934033e-05,
            "start_logit": -2.782745838165283,
            "end_logit": 0.8364798426628113,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hepcidin resistance.Atransferrinemia",
            "probability": 2.2774712146849716e-05,
            "start_logit": -2.782745838165283,
            "end_logit": 0.7491507530212402,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "deficiency",
            "probability": 5.897286701052565e-06,
            "start_logit": -4.221233367919922,
            "end_logit": 0.8364798426628113,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "At",
            "probability": 4.606642845697404e-06,
            "start_logit": 0.993117094039917,
            "end_logit": -4.624863624572754,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "mia and DMT1 deficiency",
            "probability": 2.5310573185353335e-06,
            "start_logit": -5.067088603973389,
            "end_logit": 0.8364798426628113,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "mia",
            "probability": 2.3193988558886413e-06,
            "start_logit": -5.067088603973389,
            "end_logit": 0.7491507530212402,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        }
    ],
    "52e203bc98d0239505000011": [
        {
            "text": "TEBPs",
            "probability": 0.9968965682358252,
            "start_logit": 3.6652731895446777,
            "end_logit": 3.236656904220581,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes, but it remains undetermined in trypanosomatids.",
            "probability": 0.0005417435336565438,
            "start_logit": 2.8868093490600586,
            "end_logit": -3.502488851547241,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TE",
            "probability": 0.0005018618847517993,
            "start_logit": 3.6652731895446777,
            "end_logit": -4.357420444488525,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "Ps",
            "probability": 0.00044790254989121196,
            "start_logit": -4.042553424835205,
            "end_logit": 3.236656904220581,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes, but it remains undetermined",
            "probability": 0.00038212623187460577,
            "start_logit": 3.6652731895446777,
            "end_logit": -4.6299943923950195,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes, but it remains undetermined in trypanosomatids",
            "probability": 0.0003409197832436602,
            "start_logit": 3.6652731895446777,
            "end_logit": -4.74409818649292,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes,",
            "probability": 0.0002889289763288941,
            "start_logit": 3.6652731895446777,
            "end_logit": -4.90956449508667,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "trypanosomatids.The nature of TEBPs",
            "probability": 9.302683387500144e-05,
            "start_logit": -4.723045825958252,
            "end_logit": 2.34546160697937,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "BPs",
            "probability": 7.448892084598868e-05,
            "start_logit": -5.8364787101745605,
            "end_logit": 3.236656904220581,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes",
            "probability": 6.679562328240156e-05,
            "start_logit": 3.6652731895446777,
            "end_logit": -6.374107837677002,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known",
            "probability": 6.41094878765296e-05,
            "start_logit": 3.6652731895446777,
            "end_logit": -6.4151530265808105,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well",
            "probability": 5.475263803193412e-05,
            "start_logit": 3.6652731895446777,
            "end_logit": -6.572919845581055,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is",
            "probability": 4.5986372956952414e-05,
            "start_logit": 3.6652731895446777,
            "end_logit": -6.747400283813477,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "undetermined in trypanosomatids.The nature of TEBPs",
            "probability": 4.596009974343899e-05,
            "start_logit": -5.428160190582275,
            "end_logit": 2.34546160697937,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "nature of TEBPs",
            "probability": 4.4590323562361425e-05,
            "start_logit": -6.349612236022949,
            "end_logit": 3.236656904220581,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "it remains undetermined in trypanosomatids.The nature of TEBPs",
            "probability": 4.238242271400991e-05,
            "start_logit": -5.509200096130371,
            "end_logit": 2.34546160697937,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEB",
            "probability": 4.2122771229594206e-05,
            "start_logit": 3.6652731895446777,
            "end_logit": -6.8351569175720215,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "mined in trypanosomatids.The nature of TEBPs",
            "probability": 1.4074993259556713e-05,
            "start_logit": -6.611534118652344,
            "end_logit": 2.34546160697937,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": ".The nature of TEBPs",
            "probability": 1.1389567731588096e-05,
            "start_logit": -6.823235988616943,
            "end_logit": 2.34546160697937,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "Ps is well known in higher and some primitive eukaryotes, but it remains undetermined in trypanosomatids.",
            "probability": 2.687493184199698e-07,
            "start_logit": -4.721959590911865,
            "end_logit": -3.502488851547241,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        }
    ],
    "56be2570ef6e39474100000d": [
        {
            "text": "Neuroticism",
            "probability": 0.12765547028287264,
            "start_logit": 5.08809757232666,
            "end_logit": 4.510343074798584,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness, Agreeableness, and Conscientiousness",
            "probability": 0.10712233036740575,
            "start_logit": 5.08809757232666,
            "end_logit": 4.33497953414917,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion",
            "probability": 0.10229963708322323,
            "start_logit": 5.08809757232666,
            "end_logit": 4.288914203643799,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness, Agreeableness",
            "probability": 0.09190435513406917,
            "start_logit": 5.08809757232666,
            "end_logit": 4.181756496429443,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Conscientiousness",
            "probability": 0.08527624700892704,
            "start_logit": 4.860022068023682,
            "end_logit": 4.33497953414917,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness",
            "probability": 0.0822226084934013,
            "start_logit": 5.08809757232666,
            "end_logit": 4.070438385009766,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness, Agreeableness, and Conscientiousness",
            "probability": 0.05507329242879126,
            "start_logit": 4.422791004180908,
            "end_logit": 4.33497953414917,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Agreeableness, and Conscientiousness",
            "probability": 0.05091091576609725,
            "start_logit": 4.344203472137451,
            "end_logit": 4.33497953414917,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness, Agreeableness",
            "probability": 0.0472494895174362,
            "start_logit": 4.422791004180908,
            "end_logit": 4.181756496429443,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion, Openness, Agreeableness, and Conscientiousness",
            "probability": 0.04565494652635999,
            "start_logit": 4.235238075256348,
            "end_logit": 4.33497953414917,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Agreeableness",
            "probability": 0.043678426960283415,
            "start_logit": 4.344203472137451,
            "end_logit": 4.181756496429443,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion",
            "probability": 0.04359954124113869,
            "start_logit": 4.235238075256348,
            "end_logit": 4.288914203643799,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness",
            "probability": 0.04227194970725663,
            "start_logit": 4.422791004180908,
            "end_logit": 4.070438385009766,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion, Openness, Agreeableness",
            "probability": 0.039169129394352825,
            "start_logit": 4.235238075256348,
            "end_logit": 4.181756496429443,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion, Openness",
            "probability": 0.03504282236158544,
            "start_logit": 4.235238075256348,
            "end_logit": 4.070438385009766,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness, Agreeableness,",
            "probability": 0.0002421137371494538,
            "start_logit": 5.08809757232666,
            "end_logit": -1.757339596748352,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness,",
            "probability": 0.0002044641782079442,
            "start_logit": 5.08809757232666,
            "end_logit": -1.9263544082641602,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion,",
            "probability": 0.00018271841389307528,
            "start_logit": 5.08809757232666,
            "end_logit": -2.0388009548187256,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness, Agreeableness,",
            "probability": 0.0001244745199374091,
            "start_logit": 4.422791004180908,
            "end_logit": -1.757339596748352,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Agreeableness,",
            "probability": 0.00011506687761136841,
            "start_logit": 4.344203472137451,
            "end_logit": -1.757339596748352,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        }
    ],
    "56c1f000ef6e394741000037": [
        {
            "text": "fluoropyrimidine (trifluridine",
            "probability": 0.23773367951354232,
            "start_logit": 5.879978656768799,
            "end_logit": 5.720053672790527,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine",
            "probability": 0.18912270859961453,
            "start_logit": 5.651223659515381,
            "end_logit": 5.720053672790527,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine",
            "probability": 0.14590867416154163,
            "start_logit": 5.879978656768799,
            "end_logit": 5.231883525848389,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil",
            "probability": 0.12926261996098573,
            "start_logit": 5.746551990509033,
            "end_logit": 5.244175434112549,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine, TFT) and a potent inhibitor of thymidine phosphorylase (tipiracil",
            "probability": 0.11750933973817411,
            "start_logit": 5.651223659515381,
            "end_logit": 5.244175434112549,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil hydrochloride",
            "probability": 0.052082379091506384,
            "start_logit": 5.746551990509033,
            "end_logit": 4.335155963897705,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine (trifluridine, TFT) and a potent inhibitor of thymidine phosphorylase",
            "probability": 0.02366845772138814,
            "start_logit": 5.879978656768799,
            "end_logit": 3.413045883178711,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine, TFT) and a potent inhibitor of thymidine phosphorylase",
            "probability": 0.018828812315544886,
            "start_logit": 5.651223659515381,
            "end_logit": 3.413045883178711,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase (tipiracil",
            "probability": 0.0167334497266182,
            "start_logit": 3.702115535736084,
            "end_logit": 5.244175434112549,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine (trifluridine, TFT)",
            "probability": 0.010510101302552593,
            "start_logit": 5.879978656768799,
            "end_logit": 2.6012394428253174,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "TFT) and a potent inhibitor of thymidine phosphorylase (tipiracil",
            "probability": 0.008795357964226976,
            "start_logit": 3.058929920196533,
            "end_logit": 5.244175434112549,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine, TFT)",
            "probability": 0.008361031680754577,
            "start_logit": 5.651223659515381,
            "end_logit": 2.6012394428253174,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine (trifluridine, TFT",
            "probability": 0.007739573667828274,
            "start_logit": 5.879978656768799,
            "end_logit": 2.2952492237091064,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluroropyrimidine drug combination.TAS-102 is a preconstituted drug combination comprising an oral fluoropyrimidine",
            "probability": 0.007065644545279521,
            "start_logit": 2.8522419929504395,
            "end_logit": 5.231883525848389,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase (tipiracil hydrochloride",
            "probability": 0.00674222658053377,
            "start_logit": 3.702115535736084,
            "end_logit": 4.335155963897705,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine, TFT",
            "probability": 0.006157012075281309,
            "start_logit": 5.651223659515381,
            "end_logit": 2.2952492237091064,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil hydrochloride, TPI)",
            "probability": 0.003875936417270019,
            "start_logit": 5.746551990509033,
            "end_logit": 1.7371165752410889,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "oral fluoropyrimidine (trifluridine",
            "probability": 0.003584575286879076,
            "start_logit": 1.6854676008224487,
            "end_logit": 5.720053672790527,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "TFT) and a potent inhibitor of thymidine phosphorylase (tipiracil hydrochloride",
            "probability": 0.0035438177554859146,
            "start_logit": 3.058929920196533,
            "end_logit": 4.335155963897705,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "(trifluridine",
            "probability": 0.002774601894992221,
            "start_logit": 1.4293348789215088,
            "end_logit": 5.720053672790527,
            "question_text": "Which drugs are included in TAS-102?"
        }
    ],
    "54cf6d40f693c3b16b00000e": [
        {
            "text": "aspirin",
            "probability": 0.4318535100482147,
            "start_logit": -4.13046407699585,
            "end_logit": -4.921580791473389,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "aspirin or non-steroid anti-inflammatory drugs",
            "probability": 0.29466004333853585,
            "start_logit": -4.13046407699585,
            "end_logit": -5.303844928741455,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "non-steroid anti-inflammatory drugs",
            "probability": 0.0642748691037832,
            "start_logit": -5.653117656707764,
            "end_logit": -5.303844928741455,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "anti-inflammatory drugs",
            "probability": 0.04933965802795697,
            "start_logit": -5.917558193206787,
            "end_logit": -5.303844928741455,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "aspirin or non-steroid anti-inflammatory drugs with ACE inhibitor which has proved to be the most common cause,",
            "probability": 0.029654005984468428,
            "start_logit": -4.13046407699585,
            "end_logit": -7.600069999694824,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "as",
            "probability": 0.027379465052357308,
            "start_logit": -4.13046407699585,
            "end_logit": -7.679873943328857,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "aspirin or non-steroid anti-inflammatory drugs with ACE inhibitor",
            "probability": 0.02717170800249152,
            "start_logit": -4.13046407699585,
            "end_logit": -7.687490940093994,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ACE inhibitor will most likely develop AE soon after the addition of another medication, including the combination of aspirin",
            "probability": 0.014696746919896916,
            "start_logit": -7.510924339294434,
            "end_logit": -4.921580791473389,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "drugs",
            "probability": 0.01275032589380604,
            "start_logit": -7.2707295417785645,
            "end_logit": -5.303844928741455,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "rin",
            "probability": 0.01206096049778194,
            "start_logit": -7.708576679229736,
            "end_logit": -4.921580791473389,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "rin or non-steroid anti-inflammatory drugs",
            "probability": 0.008229371905727983,
            "start_logit": -7.708576679229736,
            "end_logit": -5.303844928741455,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "non-steroid anti-inflammatory drugs with ACE inhibitor which has proved to be the most common cause,",
            "probability": 0.006468496140362996,
            "start_logit": -5.653117656707764,
            "end_logit": -7.600069999694824,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "non-steroid anti-inflammatory drugs with ACE inhibitor",
            "probability": 0.0059270268048520255,
            "start_logit": -5.653117656707764,
            "end_logit": -7.687490940093994,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "anti-inflammatory drugs with ACE inhibitor which has proved to be the most common cause,",
            "probability": 0.004965445935103187,
            "start_logit": -5.917558193206787,
            "end_logit": -7.600069999694824,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "anti-inflammatory drugs with ACE inhibitor",
            "probability": 0.0045497949626585946,
            "start_logit": -5.917558193206787,
            "end_logit": -7.687490940093994,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "drugs with ACE inhibitor which has proved to be the most common cause,",
            "probability": 0.0012831676669661277,
            "start_logit": -7.2707295417785645,
            "end_logit": -7.600069999694824,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ACE inhibitor will most likely develop AE soon after the addition of another medication,",
            "probability": 0.0012634499022415328,
            "start_logit": -7.510924339294434,
            "end_logit": -7.37536096572876,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ACE inhibitor which has proved to be the most common cause,",
            "probability": 0.001198251235223944,
            "start_logit": -7.339198112487793,
            "end_logit": -7.600069999694824,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "drugs with ACE inhibitor",
            "probability": 0.001175755383043466,
            "start_logit": -7.2707295417785645,
            "end_logit": -7.687490940093994,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ACE inhibitor",
            "probability": 0.001097947194526859,
            "start_logit": -7.339198112487793,
            "end_logit": -7.687490940093994,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        }
    ],
    "530cf4fe960c95ad0c000007": [
        {
            "text": "ischemic heart failure",
            "probability": 0.6039899973615991,
            "start_logit": 5.398477077484131,
            "end_logit": 5.475278377532959,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ischemic heart failure-induced cardiac remodeling",
            "probability": 0.12781575978588638,
            "start_logit": 5.398477077484131,
            "end_logit": 3.9223105907440186,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "heart failure",
            "probability": 0.07732055675726315,
            "start_logit": 3.342879295349121,
            "end_logit": 5.475278377532959,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "fibrosis",
            "probability": 0.03220095682291829,
            "start_logit": 3.603515148162842,
            "end_logit": 4.33867883682251,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "improves cardiac function and reduces fibrosis",
            "probability": 0.028147243005119758,
            "start_logit": 3.468968391418457,
            "end_logit": 4.33867883682251,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "cardiac function and reduces fibrosis",
            "probability": 0.027632087624614173,
            "start_logit": 3.4504966735839844,
            "end_logit": 4.33867883682251,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "cardiac remodeling",
            "probability": 0.02319993878304046,
            "start_logit": 3.6920368671417236,
            "end_logit": 3.9223105907440186,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "improves cardiac function",
            "probability": 0.01742608860666196,
            "start_logit": 3.468968391418457,
            "end_logit": 3.8591978549957275,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "cardiac function",
            "probability": 0.01710715352285087,
            "start_logit": 3.4504966735839844,
            "end_logit": 3.8591978549957275,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "heart failure-induced cardiac remodeling",
            "probability": 0.016362498968804404,
            "start_logit": 3.342879295349121,
            "end_logit": 3.9223105907440186,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "reduces fibrosis",
            "probability": 0.01595991374759397,
            "start_logit": 2.901599168777466,
            "end_logit": 4.33867883682251,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "chemic heart failure",
            "probability": 0.0031856201028026537,
            "start_logit": 0.1535664051771164,
            "end_logit": 5.475278377532959,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "modulates ischemic heart failure",
            "probability": 0.002141520270828444,
            "start_logit": -0.24356457591056824,
            "end_logit": 5.475278377532959,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.",
            "probability": 0.0018186304962637305,
            "start_logit": 5.398477077484131,
            "end_logit": -0.33019551634788513,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ischemic heart failure-induced",
            "probability": 0.0013874947541292213,
            "start_logit": 5.398477077484131,
            "end_logit": -0.6007794737815857,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway",
            "probability": 0.0011855633108274202,
            "start_logit": 5.398477077484131,
            "end_logit": -0.7580612301826477,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ischemic",
            "probability": 0.0011118877340664292,
            "start_logit": 5.398477077484131,
            "end_logit": -0.8222200274467468,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "failure",
            "probability": 0.0007326407629211418,
            "start_logit": -1.3161803483963013,
            "end_logit": 5.475278377532959,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "chemic heart failure-induced cardiac remodeling",
            "probability": 0.0006741377433526388,
            "start_logit": 0.1535664051771164,
            "end_logit": 3.9223105907440186,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ischemic heart",
            "probability": 0.0006003098384557213,
            "start_logit": 5.398477077484131,
            "end_logit": -1.4385886192321777,
            "question_text": "What are the indications for hydrochlorothiazide?"
        }
    ],
    "5539029cbc4f83e828000012": [
        {
            "text": "DDX3X",
            "probability": 0.6096543888296675,
            "start_logit": 4.864607334136963,
            "end_logit": 4.452181816101074,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Hox gene expression and cell stress signaling.Thus, DDX3X",
            "probability": 0.19810633531069693,
            "start_logit": 3.8399429321289062,
            "end_logit": 4.352757930755615,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3x",
            "probability": 0.0952715147309836,
            "start_logit": 4.034041404724121,
            "end_logit": 3.426586389541626,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3x regulates hindbrain patterning and development by controlling Hox",
            "probability": 0.04404579114687682,
            "start_logit": 4.034041404724121,
            "end_logit": 2.655085325241089,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Hox",
            "probability": 0.03627509174957889,
            "start_logit": 3.8399429321289062,
            "end_logit": 2.655085325241089,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3",
            "probability": 0.009867584098685102,
            "start_logit": 4.864607334136963,
            "end_logit": 0.32854464650154114,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Hox gene expression and cell stress signaling.Thus, DDX3",
            "probability": 0.0034050932525450175,
            "start_logit": 3.8399429321289062,
            "end_logit": 0.28922632336616516,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3X)",
            "probability": 0.001143062590135752,
            "start_logit": 3.1484291553497314,
            "end_logit": -0.11082108318805695,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3",
            "probability": 0.000823336102013831,
            "start_logit": 4.034041404724121,
            "end_logit": -1.3245352506637573,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3x regulates hindbrain patterning and development by controlling Hox gene",
            "probability": 0.0004979584864461231,
            "start_logit": 4.034041404724121,
            "end_logit": -1.827383041381836,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Hox gene",
            "probability": 0.0004101070570643023,
            "start_logit": 3.8399429321289062,
            "end_logit": -1.827383041381836,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "(DDX3X",
            "probability": 0.0001486120676832357,
            "start_logit": -1.1168993711471558,
            "end_logit": 2.114380359649658,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "X",
            "probability": 0.00010883873375725318,
            "start_logit": -3.7661728858947754,
            "end_logit": 4.452181816101074,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "3X",
            "probability": 8.324392260112347e-05,
            "start_logit": -4.034265041351318,
            "end_logit": 4.452181816101074,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "x gene expression and cell stress signaling.Thus, DDX3X",
            "probability": 7.354820129877574e-05,
            "start_logit": -4.058675289154053,
            "end_logit": 4.352757930755615,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "we show that Ddx3x",
            "probability": 2.85452764208232e-05,
            "start_logit": -4.078953266143799,
            "end_logit": 3.426586389541626,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "(DDX3X)",
            "probability": 1.6056887661686532e-05,
            "start_logit": -1.1168993711471558,
            "end_logit": -0.11082108318805695,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "(DDX3",
            "probability": 1.4227192304793012e-05,
            "start_logit": -1.1168993711471558,
            "end_logit": -0.23180389404296875,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "x",
            "probability": 1.3467351995307578e-05,
            "start_logit": -4.058675289154053,
            "end_logit": 2.655085325241089,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "we show that Ddx3x regulates hindbrain patterning and development by controlling Hox",
            "probability": 1.3197011583280256e-05,
            "start_logit": -4.078953266143799,
            "end_logit": 2.655085325241089,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        }
    ],
    "5300aad02059c6d71c000080": [
        {
            "text": "football, cricket, and rugby",
            "probability": 0.18523461650500697,
            "start_logit": 4.265773296356201,
            "end_logit": 4.534510612487793,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "cricket, and rugby",
            "probability": 0.1396363983590101,
            "start_logit": 3.983191967010498,
            "end_logit": 4.534510612487793,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "rugby",
            "probability": 0.1283557549884281,
            "start_logit": 3.898955821990967,
            "end_logit": 4.534510612487793,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football",
            "probability": 0.09774203322725805,
            "start_logit": 4.265773296356201,
            "end_logit": 3.895219087600708,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football, cricket",
            "probability": 0.09509075770980269,
            "start_logit": 4.265773296356201,
            "end_logit": 3.8677191734313965,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "cricket",
            "probability": 0.07168277276870226,
            "start_logit": 3.983191967010498,
            "end_logit": 3.8677191734313965,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports such as football, cricket, and rugby",
            "probability": 0.051786032223470675,
            "start_logit": 2.9912705421447754,
            "end_logit": 4.534510612487793,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Football, Cricket, Rugby",
            "probability": 0.03492495833083153,
            "start_logit": 3.564784049987793,
            "end_logit": 3.5670783519744873,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Cricket, Rugby",
            "probability": 0.03033919906821708,
            "start_logit": 3.424022912979126,
            "end_logit": 3.5670783519744873,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports such as football",
            "probability": 0.02827074230914554,
            "start_logit": 3.11026668548584,
            "end_logit": 3.8102214336395264,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Football",
            "probability": 0.027555540730724467,
            "start_logit": 3.564784049987793,
            "end_logit": 3.330080270767212,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Football, Cricket",
            "probability": 0.027093078677198002,
            "start_logit": 3.564784049987793,
            "end_logit": 3.313154935836792,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports such as football, cricket",
            "probability": 0.026584518249487005,
            "start_logit": 2.9912705421447754,
            "end_logit": 3.8677191734313965,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Rugby",
            "probability": 0.02603315918906124,
            "start_logit": 3.270953416824341,
            "end_logit": 3.5670783519744873,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Cricket",
            "probability": 0.023535670381394185,
            "start_logit": 3.424022912979126,
            "end_logit": 3.313154935836792,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball",
            "probability": 0.003594724596643226,
            "start_logit": 3.11026668548584,
            "end_logit": 1.747861385345459,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports",
            "probability": 0.002380154409916571,
            "start_logit": 3.11026668548584,
            "end_logit": 1.335559368133545,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Football, Cricket, Rugby)",
            "probability": 6.116380606977067e-05,
            "start_logit": 3.564784049987793,
            "end_logit": -2.780323028564453,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Cricket, Rugby)",
            "probability": 5.3132801778676165e-05,
            "start_logit": 3.424022912979126,
            "end_logit": -2.780323028564453,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "Rugby)",
            "probability": 4.559166785368929e-05,
            "start_logit": 3.270953416824341,
            "end_logit": -2.780323028564453,
            "question_text": "Which sports have a risk for commotio cordis?"
        }
    ],
    "56c1f034ef6e394741000050": [
        {
            "text": "parkinsonism",
            "probability": 0.3514196733177438,
            "start_logit": 4.22257661819458,
            "end_logit": 4.384934902191162,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation",
            "probability": 0.12007573397810593,
            "start_logit": 4.22257661819458,
            "end_logit": 3.3110764026641846,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss, and psychiatric symptoms",
            "probability": 0.11693992526781202,
            "start_logit": 4.22257661819458,
            "end_logit": 3.284614086151123,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss",
            "probability": 0.10547801947180119,
            "start_logit": 4.22257661819458,
            "end_logit": 3.1814563274383545,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss, and psychiatric",
            "probability": 0.05721871136731598,
            "start_logit": 4.22257661819458,
            "end_logit": 2.5698347091674805,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation",
            "probability": 0.034223196606485935,
            "start_logit": 2.967357635498047,
            "end_logit": 3.3110764026641846,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "psychiatric symptoms",
            "probability": 0.03343689770068777,
            "start_logit": 2.970576286315918,
            "end_logit": 3.284614086151123,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation, weight loss, and psychiatric symptoms",
            "probability": 0.03332944901521751,
            "start_logit": 2.967357635498047,
            "end_logit": 3.284614086151123,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation, weight loss",
            "probability": 0.030062651948514398,
            "start_logit": 2.967357635498047,
            "end_logit": 3.1814563274383545,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "weight loss, and psychiatric symptoms",
            "probability": 0.02526289566668529,
            "start_logit": 2.6902530193328857,
            "end_logit": 3.284614086151123,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "weight loss",
            "probability": 0.022786744518111746,
            "start_logit": 2.6902530193328857,
            "end_logit": 3.1814563274383545,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "psychiatric",
            "probability": 0.016360675741604415,
            "start_logit": 2.970576286315918,
            "end_logit": 2.5698347091674805,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation, weight loss, and psychiatric",
            "probability": 0.016308101094351646,
            "start_logit": 2.967357635498047,
            "end_logit": 2.5698347091674805,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "weight loss, and psychiatric",
            "probability": 0.012361136131601096,
            "start_logit": 2.6902530193328857,
            "end_logit": 2.5698347091674805,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism,",
            "probability": 0.00774277867351074,
            "start_logit": 4.22257661819458,
            "end_logit": 0.569714367389679,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "characterized by parkinsonism",
            "probability": 0.005935776117982161,
            "start_logit": 0.14159324765205383,
            "end_logit": 4.384934902191162,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation,",
            "probability": 0.005196264263091117,
            "start_logit": 4.22257661819458,
            "end_logit": 0.17089369893074036,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "characterized by parkinsonism, hypoventilation",
            "probability": 0.0020281809136279585,
            "start_logit": 0.14159324765205383,
            "end_logit": 3.3110764026641846,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "characterized by parkinsonism, hypoventilation, weight loss, and psychiatric symptoms",
            "probability": 0.0019752144468465345,
            "start_logit": 0.14159324765205383,
            "end_logit": 3.284614086151123,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss,",
            "probability": 0.0018579737589021809,
            "start_logit": 4.22257661819458,
            "end_logit": -0.8575597405433655,
            "question_text": "List features of the Perry syndrome."
        }
    ],
    "516e5f25298dcd4e5100007d": [
        {
            "text": "Methotrexate",
            "probability": 0.8740644851818826,
            "start_logit": 5.620070457458496,
            "end_logit": 5.374282360076904,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (MTX)",
            "probability": 0.09668236869058947,
            "start_logit": 5.620070457458496,
            "end_logit": 3.1725592613220215,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (MTX",
            "probability": 0.013594595486404425,
            "start_logit": 5.620070457458496,
            "end_logit": 1.2108005285263062,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "MTX)",
            "probability": 0.007940271514806885,
            "start_logit": 3.12058687210083,
            "end_logit": 3.1725592613220215,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine",
            "probability": 0.005219738777199686,
            "start_logit": 3.140172004699707,
            "end_logit": 2.733474016189575,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "MTX",
            "probability": 0.0011164887740956438,
            "start_logit": 3.12058687210083,
            "end_logit": 1.2108005285263062,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Met",
            "probability": 0.0003780962354459349,
            "start_logit": 5.620070457458496,
            "end_logit": -2.371478319168091,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "te",
            "probability": 0.00027003524939977244,
            "start_logit": -2.4622864723205566,
            "end_logit": 5.374282360076904,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (MTX) is a widely used anticancer drug",
            "probability": 0.00014866776177670422,
            "start_logit": 5.620070457458496,
            "end_logit": -3.30491304397583,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine (Pyr)",
            "probability": 0.00013767341164207383,
            "start_logit": 3.140172004699707,
            "end_logit": -0.901844322681427,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (",
            "probability": 0.00013076853604013523,
            "start_logit": 5.620070457458496,
            "end_logit": -3.4331982135772705,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "(MTX)",
            "probability": 7.801982473040437e-05,
            "start_logit": -1.502152919769287,
            "end_logit": 3.1725592613220215,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (M",
            "probability": 6.596013038320659e-05,
            "start_logit": 5.620070457458496,
            "end_logit": -4.117576599121094,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "hotrexate",
            "probability": 3.97398036602439e-05,
            "start_logit": -4.378485679626465,
            "end_logit": 5.374282360076904,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexa",
            "probability": 3.8418600382947646e-05,
            "start_logit": 5.620070457458496,
            "end_logit": -4.658085346221924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "te (MTX)",
            "probability": 2.9869246473835826e-05,
            "start_logit": -2.4622864723205566,
            "end_logit": 3.1725592613220215,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine (Pyr),",
            "probability": 2.160037233859103e-05,
            "start_logit": 3.140172004699707,
            "end_logit": -2.7540180683135986,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "unclear.Methotrexate",
            "probability": 2.0022267822392887e-05,
            "start_logit": -5.06399393081665,
            "end_logit": 5.374282360076904,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "MTX) is a widely used anticancer drug",
            "probability": 1.220969665920649e-05,
            "start_logit": 3.12058687210083,
            "end_logit": -3.30491304397583,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "(MTX",
            "probability": 1.0970438265992313e-05,
            "start_logit": -1.502152919769287,
            "end_logit": 1.2108005285263062,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        }
    ],
    "52fc8b772059c6d71c00006e": [
        {
            "text": "inhibitors",
            "probability": 0.12027193747167841,
            "start_logit": -4.056219577789307,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "development of TPL2 inhibitors",
            "probability": 0.10470185428154583,
            "start_logit": -4.194858074188232,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "RAS- and MAP3K8-mutant cancers and strongly prompts development of TPL2 inhibitors",
            "probability": 0.10144326366583564,
            "start_logit": -4.226475238800049,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "study",
            "probability": 0.07699929248904644,
            "start_logit": -3.5897107124328613,
            "end_logit": -3.9454104900360107,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "strongly prompts development of TPL2 inhibitors",
            "probability": 0.0672047615692863,
            "start_logit": -4.638230800628662,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "study establishes TPL2 as a promising therapeutic target in RAS",
            "probability": 0.05661169129722124,
            "start_logit": -3.5897107124328613,
            "end_logit": -4.252991199493408,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "our study",
            "probability": 0.04402233135527775,
            "start_logit": -4.148809909820557,
            "end_logit": -3.9454104900360107,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "inhibitors for pre-clinical and clinical studies.",
            "probability": 0.041062028663411555,
            "start_logit": -4.056219577789307,
            "end_logit": -4.107614040374756,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "study establishes TPL2 as a promising therapeutic target",
            "probability": 0.038200340099685995,
            "start_logit": -3.5897107124328613,
            "end_logit": -4.6463623046875,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "promising therapeutic target in RAS- and MAP3K8-mutant cancers and strongly prompts development of TPL2 inhibitors",
            "probability": 0.03763817531290927,
            "start_logit": -5.217956066131592,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "study establishes TPL2 as a promising therapeutic target in RAS- and MAP3K8-mutant cancers and strongly prompts development",
            "probability": 0.03666774399068523,
            "start_logit": -3.5897107124328613,
            "end_logit": -4.687309265136719,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "prompts development of TPL2 inhibitors",
            "probability": 0.036200974411304085,
            "start_logit": -5.2568888664245605,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "development of TPL2 inhibitors for pre-clinical and clinical studies.",
            "probability": 0.03574624831028073,
            "start_logit": -4.194858074188232,
            "end_logit": -4.107614040374756,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "target in RAS- and MAP3K8-mutant cancers and strongly prompts development of TPL2 inhibitors",
            "probability": 0.03279833930416739,
            "start_logit": -5.355597019195557,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "our study establishes TPL2 as a promising therapeutic target in RAS",
            "probability": 0.03236625366685665,
            "start_logit": -4.148809909820557,
            "end_logit": -4.252991199493408,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "RAS",
            "probability": 0.029947654197367023,
            "start_logit": -4.226475238800049,
            "end_logit": -4.252991199493408,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "a promising therapeutic target in RAS- and MAP3K8-mutant cancers and strongly prompts development of TPL2 inhibitors",
            "probability": 0.029049045716749752,
            "start_logit": -5.476989269256592,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "therapeutic target in RAS- and MAP3K8-mutant cancers and strongly prompts development of TPL2 inhibitors",
            "probability": 0.027647155233727825,
            "start_logit": -5.52645206451416,
            "end_logit": -3.032942533493042,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "inhibitor",
            "probability": 0.027489834701786755,
            "start_logit": -4.056219577789307,
            "end_logit": -4.508881568908691,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "development of TPL2 inhibitor",
            "probability": 0.023931074261176053,
            "start_logit": -4.194858074188232,
            "end_logit": -4.508881568908691,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        }
    ],
    "5324d0429b2d7acc7e000023": [
        {
            "text": "androgenetic alopecia",
            "probability": 0.718154515862293,
            "start_logit": 3.498852252960205,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "alopecia",
            "probability": 0.2599417334317654,
            "start_logit": 2.4826250076293945,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic",
            "probability": 0.00795236174388856,
            "start_logit": 3.498852252960205,
            "end_logit": -1.0240039825439453,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia (AGA)",
            "probability": 0.007037108084060806,
            "start_logit": 3.498852252960205,
            "end_logit": -1.1462756395339966,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "alopecia (AGA)",
            "probability": 0.0025471371874910193,
            "start_logit": 2.4826250076293945,
            "end_logit": -1.1462756395339966,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "opecia",
            "probability": 0.0007191742799586261,
            "start_logit": -3.4074840545654297,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "rogenetic alopecia",
            "probability": 0.0006678300624859763,
            "start_logit": -3.4815540313720703,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "and",
            "probability": 0.0005507632182441543,
            "start_logit": 3.498852252960205,
            "end_logit": -3.693923234939575,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "cia",
            "probability": 0.0005467635980153209,
            "start_logit": -3.6815712451934814,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia (AGA",
            "probability": 0.00030030750994900407,
            "start_logit": 3.498852252960205,
            "end_logit": -4.300421237945557,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "laser therapy with topical minoxidil may yield therapeutic benefits for patients with androgenetic alopecia",
            "probability": 0.00026522765135850006,
            "start_logit": -4.404999256134033,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgen",
            "probability": 0.0002442179053456451,
            "start_logit": 3.498852252960205,
            "end_logit": -4.507167339324951,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "may yield therapeutic benefits for patients with androgenetic alopecia",
            "probability": 0.00019870089963206858,
            "start_logit": -4.693787097930908,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic al",
            "probability": 0.0001701697002306773,
            "start_logit": 3.498852252960205,
            "end_logit": -4.86843204498291,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia (",
            "probability": 0.00013201684172568494,
            "start_logit": 3.498852252960205,
            "end_logit": -5.122298717498779,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia (AGA).",
            "probability": 0.00012295029328573555,
            "start_logit": 3.498852252960205,
            "end_logit": -5.193448066711426,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alope",
            "probability": 0.00011711508326868481,
            "start_logit": 3.498852252960205,
            "end_logit": -5.242071151733398,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "fractional Er:Glass laser therapy with topical minoxidil may yield therapeutic benefits for patients with androgenetic alopecia",
            "probability": 0.0001154143456459657,
            "start_logit": -5.237059116363525,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "alopecia (AGA",
            "probability": 0.00010869868945263281,
            "start_logit": 2.4826250076293945,
            "end_logit": -4.300421237945557,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "etic alopecia",
            "probability": 0.0001077936119027452,
            "start_logit": -5.3053693771362305,
            "end_logit": 3.4792118072509766,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        }
    ],
    "52ee065d98d0239505000033": [
        {
            "text": "treatment",
            "probability": 0.4795961479026175,
            "start_logit": 2.2010655403137207,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis or treatment",
            "probability": 0.3096085048686308,
            "start_logit": 1.7634297609329224,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis",
            "probability": 0.08861761199447259,
            "start_logit": 1.7634297609329224,
            "end_logit": 1.412440299987793,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "diagnosis, prognosis or treatment",
            "probability": 0.08752007638823257,
            "start_logit": 0.4999893605709076,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "diagnosis, prognosis",
            "probability": 0.025050410596407384,
            "start_logit": 0.4999893605709076,
            "end_logit": 1.412440299987793,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "diagnosis",
            "probability": 0.005506858880316223,
            "start_logit": 0.4999893605709076,
            "end_logit": -0.10245553404092789,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "which types of algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.0006400328273182015,
            "start_logit": -4.41811466217041,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "treatment) are studied",
            "probability": 0.0005341871306562222,
            "start_logit": 2.2010655403137207,
            "end_logit": -4.136535167694092,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "sis or treatment",
            "probability": 0.00040804718049775626,
            "start_logit": -4.868251323699951,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis or treatment) are studied",
            "probability": 0.0003448503070047994,
            "start_logit": 1.7634297609329224,
            "end_logit": -4.136535167694092,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "treatment)",
            "probability": 0.0002963112111693321,
            "start_logit": 2.2010655403137207,
            "end_logit": -4.7258710861206055,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "treatment) are studied.",
            "probability": 0.00027832026560224786,
            "start_logit": 2.2010655403137207,
            "end_logit": -4.788508892059326,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "pro",
            "probability": 0.00026797178450096054,
            "start_logit": 1.7634297609329224,
            "end_logit": -4.388763904571533,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "machine learning is applied, which types of algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis",
            "probability": 0.0002117992157592114,
            "start_logit": -4.273017406463623,
            "end_logit": 1.412440299987793,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "types of algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.00020512070510425739,
            "start_logit": -5.55603551864624,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis or treatment)",
            "probability": 0.00019128692227231574,
            "start_logit": 1.7634297609329224,
            "end_logit": -4.7258710861206055,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "which types of algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis",
            "probability": 0.00018319322584202136,
            "start_logit": -4.41811466217041,
            "end_logit": 1.412440299987793,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "which medical applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.00018123646681005956,
            "start_logit": -5.679831504821777,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis or treatment) are studied.",
            "probability": 0.00017967267186067796,
            "start_logit": 1.7634297609329224,
            "end_logit": -4.788508892059326,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.00017835945492506746,
            "start_logit": -5.695833206176758,
            "end_logit": 2.6634182929992676,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        }
    ],
    "56d094f33975bb303a000012": [
        {
            "text": "cell division",
            "probability": 0.8784097541701632,
            "start_logit": 4.08078145980835,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "critical for cell division",
            "probability": 0.03262419476271484,
            "start_logit": 0.7877224683761597,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division",
            "probability": 0.025559781277025972,
            "start_logit": 0.5436883568763733,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "functionally critical for cell division",
            "probability": 0.01585020478244437,
            "start_logit": 0.06585070490837097,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "for cell division",
            "probability": 0.013423890702924443,
            "start_logit": -0.10029570758342743,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division in Caulobacter",
            "probability": 0.010416501779842047,
            "start_logit": 4.08078145980835,
            "end_logit": -0.3928651511669159,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division in Caulobacter.",
            "probability": 0.008483356759251638,
            "start_logit": 4.08078145980835,
            "end_logit": -0.5981501936912537,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "was found to be functionally critical for cell division",
            "probability": 0.0032201925385464086,
            "start_logit": -1.5278905630111694,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "FzlA is conserved in \u03b1-proteobacteria and was found to be functionally critical for cell division",
            "probability": 0.003098970830558386,
            "start_logit": -1.566261649131775,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "be functionally critical for cell division",
            "probability": 0.002729913399083308,
            "start_logit": -1.6930618286132812,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell",
            "probability": 0.0014435154917605347,
            "start_logit": 4.08078145980835,
            "end_logit": -2.3691749572753906,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "found to be functionally critical for cell division",
            "probability": 0.0012077615331256431,
            "start_logit": -2.5085630416870117,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "to be functionally critical for cell division",
            "probability": 0.0007112615024621922,
            "start_logit": -3.0380468368530273,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "conserved in \u03b1-proteobacteria and was found to be functionally critical for cell division",
            "probability": 0.0006493726212952837,
            "start_logit": -3.129080295562744,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "is conserved in \u03b1-proteobacteria and was found to be functionally critical for cell division",
            "probability": 0.0005696270573188641,
            "start_logit": -3.2601051330566406,
            "end_logit": 4.04185676574707,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "critical for cell division in Caulobacter",
            "probability": 0.0003868695460158811,
            "start_logit": 0.7877224683761597,
            "end_logit": -0.3928651511669159,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division in",
            "probability": 0.00034981474266323516,
            "start_logit": 4.08078145980835,
            "end_logit": -3.7866079807281494,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "critical for cell division in Caulobacter.",
            "probability": 0.0003150724156255272,
            "start_logit": 0.7877224683761597,
            "end_logit": -0.5981501936912537,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division in Caulobacter",
            "probability": 0.0003030971661010705,
            "start_logit": 0.5436883568763733,
            "end_logit": -0.3928651511669159,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division in Caulobacter.",
            "probability": 0.00024684692107761755,
            "start_logit": 0.5436883568763733,
            "end_logit": -0.5981501936912537,
            "question_text": "List functional roles of the FtsZ protein."
        }
    ],
    "56acc7ca0a360a5e45000002": [
        {
            "text": "web-based genome browsers",
            "probability": 0.37349193889378407,
            "start_logit": 2.0736746788024902,
            "end_logit": 1.7562103271484375,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browsers",
            "probability": 0.16071524057639922,
            "start_logit": 1.2304123640060425,
            "end_logit": 1.7562103271484375,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browser",
            "probability": 0.13148731712579909,
            "start_logit": 2.0736746788024902,
            "end_logit": 0.7122243046760559,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browser",
            "probability": 0.056579576703067076,
            "start_logit": 1.2304123640060425,
            "end_logit": 0.7122243046760559,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "browsers",
            "probability": 0.0427764834847342,
            "start_logit": -0.09323324263095856,
            "end_logit": 1.7562103271484375,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome",
            "probability": 0.040253783380382276,
            "start_logit": 2.0736746788024902,
            "end_logit": -0.4714820981025696,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based",
            "probability": 0.03813593251767727,
            "start_logit": 2.0736746788024902,
            "end_logit": -0.525529146194458,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browsers available nowadays, none of the existing tools",
            "probability": 0.02315119706118815,
            "start_logit": 2.0736746788024902,
            "end_logit": -1.02463960647583,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browsers available nowadays, none",
            "probability": 0.022849013772399805,
            "start_logit": 2.0736746788024902,
            "end_logit": -1.0377781391143799,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome",
            "probability": 0.01732138181951018,
            "start_logit": 1.2304123640060425,
            "end_logit": -0.4714820981025696,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "browser",
            "probability": 0.015059401458951707,
            "start_logit": -0.09323324263095856,
            "end_logit": 0.7122243046760559,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web",
            "probability": 0.01150037759066622,
            "start_logit": 2.0736746788024902,
            "end_logit": -1.7243062257766724,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browsers available nowadays,",
            "probability": 0.010097610495499322,
            "start_logit": 2.0736746788024902,
            "end_logit": -1.8543872833251953,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browsers available nowadays, none of the existing tools",
            "probability": 0.009962062946634598,
            "start_logit": 1.2304123640060425,
            "end_logit": -1.02463960647583,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browsers available nowadays, none",
            "probability": 0.009832032134993446,
            "start_logit": 1.2304123640060425,
            "end_logit": -1.0377781391143799,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "large number of web-based genome browsers",
            "probability": 0.009508419151616597,
            "start_logit": -1.5970441102981567,
            "end_logit": 1.7562103271484375,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browsers available",
            "probability": 0.008746130068097479,
            "start_logit": 2.0736746788024902,
            "end_logit": -1.9980747699737549,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browsers available nowadays, none of the existing tools provide means for creating multiple visualisation instances",
            "probability": 0.008438615531323024,
            "start_logit": 2.0736746788024902,
            "end_logit": -2.033867835998535,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browsers available nowadays",
            "probability": 0.005249840409264044,
            "start_logit": 2.0736746788024902,
            "end_logit": -2.508488416671753,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "web-based genome browsers available nowadays, none of the existing tools provide means for creating multiple visualisation",
            "probability": 0.004843644878012285,
            "start_logit": 2.0736746788024902,
            "end_logit": -2.5890185832977295,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        }
    ],
    "5321badd9b2d7acc7e00000a": [
        {
            "text": "melanoma",
            "probability": 0.45576954735154074,
            "start_logit": 5.258216381072998,
            "end_logit": 5.119883060455322,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non-small cell lung cancer",
            "probability": 0.2614574989132466,
            "start_logit": 5.258216381072998,
            "end_logit": 4.564167499542236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non-small cell lung cancer",
            "probability": 0.21673954993413497,
            "start_logit": 5.070641040802002,
            "end_logit": 4.564167499542236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non-small cell lung",
            "probability": 0.02975398674722186,
            "start_logit": 5.258216381072998,
            "end_logit": 2.3908588886260986,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non-small cell lung",
            "probability": 0.024665063052862982,
            "start_logit": 5.070641040802002,
            "end_logit": 2.3908588886260986,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non-small cell lung cancer (NSCLC)",
            "probability": 0.005470844483205125,
            "start_logit": 5.258216381072998,
            "end_logit": 0.6973287463188171,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non-small cell lung cancer (NSCLC)",
            "probability": 0.004535147685486594,
            "start_logit": 5.070641040802002,
            "end_logit": 0.6973287463188171,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lung cancer",
            "probability": 0.000400412792904816,
            "start_logit": -1.223314642906189,
            "end_logit": 4.564167499542236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "me",
            "probability": 0.00018701340407858681,
            "start_logit": 5.258216381072998,
            "end_logit": -2.6786792278289795,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non",
            "probability": 0.00015501708479894138,
            "start_logit": 5.258216381072998,
            "end_logit": -2.8663241863250732,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "oma",
            "probability": 0.00012912058367204343,
            "start_logit": -2.9107794761657715,
            "end_logit": 5.119883060455322,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non",
            "probability": 0.00012850399522322498,
            "start_logit": 5.070641040802002,
            "end_logit": -2.8663241863250732,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lanoma",
            "probability": 0.0001229566452423531,
            "start_logit": -2.9596943855285645,
            "end_logit": 5.119883060455322,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "cancer",
            "probability": 0.00011491110708881271,
            "start_logit": -2.471651792526245,
            "end_logit": 4.564167499542236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "small cell lung cancer",
            "probability": 8.235366858659584e-05,
            "start_logit": -2.8047876358032227,
            "end_logit": 4.564167499542236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melan",
            "probability": 7.431692696312855e-05,
            "start_logit": 5.258216381072998,
            "end_logit": -3.6015207767486572,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "oma and non-small cell lung cancer",
            "probability": 7.407152378057393e-05,
            "start_logit": -2.9107794761657715,
            "end_logit": 4.564167499542236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lanoma and non-small cell lung cancer",
            "probability": 7.053550884792415e-05,
            "start_logit": -2.9596943855285645,
            "end_logit": 4.564167499542236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lung",
            "probability": 4.5567164770673084e-05,
            "start_logit": -1.223314642906189,
            "end_logit": 2.3908588886260986,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "tumors such as melanoma",
            "probability": 2.3581426343460668e-05,
            "start_logit": -4.611066818237305,
            "end_logit": 5.119883060455322,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        }
    ],
    "56cdf3745795f9a73e000039": [
        {
            "text": "RHEB-mTOR",
            "probability": 0.19589596400877746,
            "start_logit": 4.174510478973389,
            "end_logit": 2.685541868209839,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR",
            "probability": 0.1069740802416242,
            "start_logit": 3.5695133209228516,
            "end_logit": 2.685541868209839,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Sestin2-GATOR2, Rag A/C-mTOR, and RHEB-mTOR",
            "probability": 0.09655003102030936,
            "start_logit": 3.4669880867004395,
            "end_logit": 2.685541868209839,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "RHEB",
            "probability": 0.09024703335893612,
            "start_logit": 4.174510478973389,
            "end_logit": 1.9105088710784912,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Sestin2-GATOR2, Rag A/C-mTOR",
            "probability": 0.08994192891560827,
            "start_logit": 3.4669880867004395,
            "end_logit": 2.614644765853882,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, and RHEB-mTOR",
            "probability": 0.061610427639187004,
            "start_logit": 3.0177578926086426,
            "end_logit": 2.685541868209839,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Sestin2-GATOR2, Rag A/C-mTOR, and RHEB",
            "probability": 0.04447949662661635,
            "start_logit": 3.4669880867004395,
            "end_logit": 1.9105088710784912,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Sestin2-GATOR2",
            "probability": 0.04014911402758379,
            "start_logit": 3.4669880867004395,
            "end_logit": 1.8080809116363525,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Sestin2",
            "probability": 0.03588028286827637,
            "start_logit": 3.4669880867004395,
            "end_logit": 1.6956684589385986,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "GATOR2, Rag A/C-mTOR, and RHEB-mTOR",
            "probability": 0.03136008114887766,
            "start_logit": 2.3424625396728516,
            "end_logit": 2.685541868209839,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "GATOR2, Rag A/C-mTOR",
            "probability": 0.029213726393176917,
            "start_logit": 2.3424625396728516,
            "end_logit": 2.614644765853882,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, and RHEB",
            "probability": 0.028383220382033475,
            "start_logit": 3.0177578926086426,
            "end_logit": 1.9105088710784912,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "C-mTOR, and RHEB-mTOR",
            "probability": 0.02673518762612955,
            "start_logit": 2.1829073429107666,
            "end_logit": 2.685541868209839,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "RHEB-mTOR Complex",
            "probability": 0.02524088760374483,
            "start_logit": 4.174510478973389,
            "end_logit": 0.6364233493804932,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "C-mTOR",
            "probability": 0.02490537102477971,
            "start_logit": 2.1829073429107666,
            "end_logit": 2.614644765853882,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Rag A/C-mTOR, and RHEB-mTOR",
            "probability": 0.016132988489733078,
            "start_logit": 1.6777929067611694,
            "end_logit": 2.685541868209839,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Rag A/C-mTOR",
            "probability": 0.015028810333936335,
            "start_logit": 1.6777929067611694,
            "end_logit": 2.614644765853882,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "GATOR2, Rag A/C-mTOR, and RHEB",
            "probability": 0.014447231232670497,
            "start_logit": 2.3424625396728516,
            "end_logit": 1.9105088710784912,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR Complex",
            "probability": 0.01378344239788336,
            "start_logit": 3.5695133209228516,
            "end_logit": 0.6364233493804932,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "GATOR2",
            "probability": 0.01304069466011587,
            "start_logit": 2.3424625396728516,
            "end_logit": 1.8080809116363525,
            "question_text": "Which are the main components of mTORC1?"
        }
    ],
    "5508685b4b2a315d4100000a": [
        {
            "text": "Inflammatory bowel disease",
            "probability": 0.45668558819870586,
            "start_logit": 5.2753472328186035,
            "end_logit": 5.19130277633667,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory Bowel Disease.Inflammatory bowel disease",
            "probability": 0.25134181943925976,
            "start_logit": 4.70921516418457,
            "end_logit": 5.160253524780273,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory Bowel Disease",
            "probability": 0.1899964374737,
            "start_logit": 4.70921516418457,
            "end_logit": 4.8804450035095215,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD)",
            "probability": 0.048260652257022814,
            "start_logit": 5.201089382171631,
            "end_logit": 3.0181820392608643,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory Bowel Disease.Inflammatory bowel disease (IBD)",
            "probability": 0.029510388609206975,
            "start_logit": 4.70921516418457,
            "end_logit": 3.0181820392608643,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel",
            "probability": 0.011194618220845894,
            "start_logit": 5.2753472328186035,
            "end_logit": 1.4827407598495483,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory Bowel Disease.Inflammatory bowel",
            "probability": 0.005527014261083961,
            "start_logit": 4.70921516418457,
            "end_logit": 1.3430874347686768,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory Bowel",
            "probability": 0.00297003356888524,
            "start_logit": 4.70921516418457,
            "end_logit": 0.7220129370689392,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "bowel disease",
            "probability": 0.0006666663224284174,
            "start_logit": -1.2230643033981323,
            "end_logit": 5.160253524780273,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Bowel Disease.Inflammatory bowel disease",
            "probability": 0.0006462035312082591,
            "start_logit": -1.2542394399642944,
            "end_logit": 5.160253524780273,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory Bowel Disease.",
            "probability": 0.0006369682159238793,
            "start_logit": 4.70921516418457,
            "end_logit": -0.8175958395004272,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Bowel Disease",
            "probability": 0.0004884836478322891,
            "start_logit": -1.2542394399642944,
            "end_logit": 4.8804450035095215,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Disease.Inflammatory bowel disease",
            "probability": 0.0003702873564964656,
            "start_logit": -1.8110746145248413,
            "end_logit": 5.160253524780273,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "disease",
            "probability": 0.00033214355374109065,
            "start_logit": -1.950835943222046,
            "end_logit": 5.19130277633667,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory",
            "probability": 0.00031054770177435336,
            "start_logit": 5.201089382171631,
            "end_logit": -2.0278522968292236,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Disease",
            "probability": 0.00027991075553140986,
            "start_logit": -1.8110746145248413,
            "end_logit": 4.8804450035095215,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD",
            "probability": 0.00021306292105623394,
            "start_logit": 5.2753472328186035,
            "end_logit": -2.4788601398468018,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "(IBD)",
            "probability": 0.00020149922264879816,
            "start_logit": -0.1398874670267105,
            "end_logit": 2.880572557449341,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory Bowel Disease.Inflammatory",
            "probability": 0.00018989348325112405,
            "start_logit": 4.70921516418457,
            "end_logit": -2.0278522968292236,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Anti-TNF Refractory Inflammatory Bowel Disease.Inflammatory bowel disease",
            "probability": 0.00017778125939709005,
            "start_logit": -2.544800043106079,
            "end_logit": 5.160253524780273,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        }
    ],
    "52bf1d6003868f1b0600000e": [
        {
            "text": "craniosynostosis",
            "probability": 0.3777519053381131,
            "start_logit": 0.38195493817329407,
            "end_logit": -0.49513760209083557,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia",
            "probability": 0.1716541031048194,
            "start_logit": 0.38195493817329407,
            "end_logit": -1.2838938236236572,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia",
            "probability": 0.09772830347972214,
            "start_logit": -0.18133527040481567,
            "end_logit": -1.2838938236236572,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs and toes",
            "probability": 0.08634598418005603,
            "start_logit": 0.38195493817329407,
            "end_logit": -1.9710129499435425,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes",
            "probability": 0.04915959708257556,
            "start_logit": -0.18133527040481567,
            "end_logit": -1.9710129499435425,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs",
            "probability": 0.03565916355725955,
            "start_logit": 0.38195493817329407,
            "end_logit": -2.8553690910339355,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis,",
            "probability": 0.025255405735858837,
            "start_logit": 0.38195493817329407,
            "end_logit": -3.2003350257873535,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs and toes.",
            "probability": 0.024203870193517035,
            "start_logit": 0.38195493817329407,
            "end_logit": -3.2428627014160156,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant inherited disorder associated with craniosynostosis",
            "probability": 0.02399502046991676,
            "start_logit": -2.374436378479004,
            "end_logit": -0.49513760209083557,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs",
            "probability": 0.020301929839852843,
            "start_logit": -0.18133527040481567,
            "end_logit": -2.8553690910339355,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "Pfeiffer syndrome is a rare autosomal dominant inherited disorder associated with craniosynostosis",
            "probability": 0.017867809597037255,
            "start_logit": -2.6692819595336914,
            "end_logit": -0.49513760209083557,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes.",
            "probability": 0.013780056106269808,
            "start_logit": -0.18133527040481567,
            "end_logit": -3.2428627014160156,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "broad thumbs and toes",
            "probability": 0.012423501320640707,
            "start_logit": -1.5568174123764038,
            "end_logit": -1.9710129499435425,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant inherited disorder associated with craniosynostosis, midfacial hypoplasia",
            "probability": 0.010903568346157523,
            "start_logit": -2.374436378479004,
            "end_logit": -1.2838938236236572,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "Pfeiffer syndrome is a rare autosomal dominant inherited disorder associated with craniosynostosis, midfacial hypoplasia",
            "probability": 0.008119304727482107,
            "start_logit": -2.6692819595336914,
            "end_logit": -1.2838938236236572,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "clinical subtypes based on clinical findings.Pfeiffer syndrome is a rare autosomal dominant inherited disorder associated with craniosynostosis",
            "probability": 0.006986636039633647,
            "start_logit": -3.608283519744873,
            "end_logit": -0.49513760209083557,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant inherited disorder associated with craniosynostosis, midfacial hypoplasia, and broad thumbs and toes",
            "probability": 0.005484747075044104,
            "start_logit": -2.374436378479004,
            "end_logit": -1.9710129499435425,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "broad thumbs",
            "probability": 0.005130657433039981,
            "start_logit": -1.5568174123764038,
            "end_logit": -2.8553690910339355,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "based on clinical findings.Pfeiffer syndrome is a rare autosomal dominant inherited disorder associated with craniosynostosis",
            "probability": 0.003650000198974813,
            "start_logit": -4.2575554847717285,
            "end_logit": -0.49513760209083557,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "associated with craniosynostosis",
            "probability": 0.003598436174028611,
            "start_logit": -4.271783351898193,
            "end_logit": -0.49513760209083557,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        }
    ],
    "553f96191d53b76422000004": [
        {
            "text": "autophagic vacuole formation",
            "probability": 0.3813415353961594,
            "start_logit": 1.5136100053787231,
            "end_logit": -1.3850581645965576,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagic",
            "probability": 0.32831070063071544,
            "start_logit": 1.5136100053787231,
            "end_logit": -1.5347931385040283,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagic vacuole",
            "probability": 0.18299990176200828,
            "start_logit": 1.5136100053787231,
            "end_logit": -2.1192679405212402,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagic vacuole formation.",
            "probability": 0.04342741097807378,
            "start_logit": 1.5136100053787231,
            "end_logit": -3.5576627254486084,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "auto",
            "probability": 0.020233546543123503,
            "start_logit": 1.5136100053787231,
            "end_logit": -4.321411609649658,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "vacuole formation",
            "probability": 0.009727513737171643,
            "start_logit": -2.1551270484924316,
            "end_logit": -1.3850581645965576,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "vacuole",
            "probability": 0.004668083313929315,
            "start_logit": -2.1551270484924316,
            "end_logit": -2.1192679405212402,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "epithelial nuclei and autophagic vacuole formation",
            "probability": 0.004112638733634576,
            "start_logit": -3.0160205364227295,
            "end_logit": -1.3850581645965576,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dying cells showed both DNA fragmentation derived from epithelial nuclei and autophagic vacuole formation",
            "probability": 0.004105959893175498,
            "start_logit": -3.017645835876465,
            "end_logit": -1.3850581645965576,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "epithelial nuclei and autophagic",
            "probability": 0.0035407192208367676,
            "start_logit": -3.0160205364227295,
            "end_logit": -1.5347931385040283,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dying cells showed both DNA fragmentation derived from epithelial nuclei and autophagic",
            "probability": 0.0035349691658676887,
            "start_logit": -3.017645835876465,
            "end_logit": -1.5347931385040283,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagy",
            "probability": 0.002206565762839741,
            "start_logit": -2.747626304626465,
            "end_logit": -2.2760798931121826,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "epithelial nuclei and autophagic vacuole",
            "probability": 0.0019735916871890203,
            "start_logit": -3.0160205364227295,
            "end_logit": -2.1192679405212402,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dying cells showed both DNA fragmentation derived from epithelial nuclei and autophagic vacuole",
            "probability": 0.001970386615004513,
            "start_logit": -3.017645835876465,
            "end_logit": -2.1192679405212402,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "nuclei and autophagic vacuole formation",
            "probability": 0.001631954287790385,
            "start_logit": -3.940307140350342,
            "end_logit": -1.3850581645965576,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "nuclei and autophagic",
            "probability": 0.0014050083872063773,
            "start_logit": -3.940307140350342,
            "end_logit": -1.5347931385040283,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "DNA fragmentation derived from epithelial nuclei and autophagic vacuole formation",
            "probability": 0.001242989059543268,
            "start_logit": -4.212566375732422,
            "end_logit": -1.3850581645965576,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "epithelial nuclei",
            "probability": 0.0012303738096650664,
            "start_logit": -3.0160205364227295,
            "end_logit": -2.5918049812316895,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dying cells showed both DNA fragmentation derived from epithelial nuclei",
            "probability": 0.0012283757079809637,
            "start_logit": -3.017645835876465,
            "end_logit": -2.5918049812316895,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "vacuole formation.",
            "probability": 0.0011077753080848006,
            "start_logit": -2.1551270484924316,
            "end_logit": -3.5576627254486084,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        }
    ],
    "5306158358348c0f52000001": [
        {
            "text": "deletions",
            "probability": 0.33959969454350697,
            "start_logit": 2.413956642150879,
            "end_logit": 1.8385857343673706,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy",
            "probability": 0.25863457828920483,
            "start_logit": 2.413956642150879,
            "end_logit": 1.5662343502044678,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy",
            "probability": 0.15371255175916665,
            "start_logit": 1.8936247825622559,
            "end_logit": 1.5662343502044678,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting defects",
            "probability": 0.06256187806377782,
            "start_logit": 2.413956642150879,
            "end_logit": 0.14697429537773132,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting defects at chromosome 15. The loss of function of specific genes",
            "probability": 0.04001248356077352,
            "start_logit": 2.413956642150879,
            "end_logit": -0.29999032616615295,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects",
            "probability": 0.0371819807840076,
            "start_logit": 1.8936247825622559,
            "end_logit": 0.14697429537773132,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects at chromosome 15. The loss of function of specific genes",
            "probability": 0.023780350605211085,
            "start_logit": 1.8936247825622559,
            "end_logit": -0.29999032616615295,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting defects",
            "probability": 0.01479261589035956,
            "start_logit": 0.9719286561012268,
            "end_logit": 0.14697429537773132,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting defects at chromosome 15",
            "probability": 0.010318025446721713,
            "start_logit": 2.413956642150879,
            "end_logit": -1.6552894115447998,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting defects at chromosome 15. The loss of function of specific genes",
            "probability": 0.00946086208490186,
            "start_logit": 0.9719286561012268,
            "end_logit": -0.29999032616615295,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting",
            "probability": 0.007732764928448417,
            "start_logit": 2.413956642150879,
            "end_logit": -1.9437153339385986,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting defects at chromosome 15. The loss of function",
            "probability": 0.006227394942946805,
            "start_logit": 2.413956642150879,
            "end_logit": -2.1602237224578857,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects at chromosome 15",
            "probability": 0.0061322427612835895,
            "start_logit": 1.8936247825622559,
            "end_logit": -1.6552894115447998,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "loss of function of specific genes",
            "probability": 0.005611069503587647,
            "start_logit": 0.4495064914226532,
            "end_logit": -0.29999032616615295,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting defects at chromosome 15. The loss of function of specific genes caused by genetic alterations in paternal allele",
            "probability": 0.005399763936891994,
            "start_logit": 0.9719286561012268,
            "end_logit": -0.8607985973358154,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting",
            "probability": 0.0045957622417234535,
            "start_logit": 1.8936247825622559,
            "end_logit": -1.9437153339385986,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects at chromosome 15. The loss of function",
            "probability": 0.0037010858092691367,
            "start_logit": 1.8936247825622559,
            "end_logit": -2.1602237224578857,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects at chromosome 15. The loss of function of specific genes caused by genetic alterations",
            "probability": 0.0036777160972059513,
            "start_logit": 1.8936247825622559,
            "end_logit": -2.166558027267456,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "loss of function of specific genes caused by genetic alterations in paternal allele causes PWS while the absence in maternal allele",
            "probability": 0.0036646745308923753,
            "start_logit": 0.4495064914226532,
            "end_logit": -0.7259921431541443,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "loss of function of specific genes caused by genetic alterations in paternal allele",
            "probability": 0.0032025042201195273,
            "start_logit": 0.4495064914226532,
            "end_logit": -0.8607985973358154,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        }
    ],
    "514a11add24251bc05000054": [
        {
            "text": "recurrence score",
            "probability": 0.15404309092131874,
            "start_logit": -0.9656887054443359,
            "end_logit": -1.4255895614624023,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "clinical and histopathologic features",
            "probability": 0.11002782402491575,
            "start_logit": -1.3834445476531982,
            "end_logit": -1.3443328142166138,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "clinical and histopathologic features and recurrence score",
            "probability": 0.10144091717932315,
            "start_logit": -1.3834445476531982,
            "end_logit": -1.4255895614624023,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "clinical",
            "probability": 0.0744066273825997,
            "start_logit": -1.3834445476531982,
            "end_logit": -1.7355210781097412,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical and histopathologic features",
            "probability": 0.06700593980941967,
            "start_logit": -1.8793965578079224,
            "end_logit": -1.3443328142166138,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "recurrence",
            "probability": 0.06416899936603908,
            "start_logit": -0.9656887054443359,
            "end_logit": -2.3013017177581787,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical and histopathologic features and recurrence score",
            "probability": 0.06177659197541562,
            "start_logit": -1.8793965578079224,
            "end_logit": -1.4255895614624023,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "recurrence score,",
            "probability": 0.049023060314935425,
            "start_logit": -0.9656887054443359,
            "end_logit": -2.570531129837036,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical",
            "probability": 0.04531295642719779,
            "start_logit": -1.8793965578079224,
            "end_logit": -1.7355210781097412,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "clinical and histopathologic features and recurrence",
            "probability": 0.04225676147653532,
            "start_logit": -1.3834445476531982,
            "end_logit": -2.3013017177581787,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "histopathologic features",
            "probability": 0.03944309117026239,
            "start_logit": -2.4093189239501953,
            "end_logit": -1.3443328142166138,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "histopathologic features and recurrence score",
            "probability": 0.03636483207913866,
            "start_logit": -2.4093189239501953,
            "end_logit": -1.4255895614624023,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "clinical and histopathologic features and recurrence score,",
            "probability": 0.03228281237114608,
            "start_logit": -1.3834445476531982,
            "end_logit": -2.570531129837036,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical and histopathologic features and recurrence",
            "probability": 0.02573398175534716,
            "start_logit": -1.8793965578079224,
            "end_logit": -2.3013017177581787,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical and histopathologic features and recurrence score,",
            "probability": 0.019659937854719006,
            "start_logit": -1.8793965578079224,
            "end_logit": -2.570531129837036,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "clinical and histopathologic",
            "probability": 0.01707551804844812,
            "start_logit": -1.3834445476531982,
            "end_logit": -3.2074203491210938,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "re",
            "probability": 0.01601210070789899,
            "start_logit": -0.9656887054443359,
            "end_logit": -3.6894772052764893,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "histopathologic features and recurrence",
            "probability": 0.015148325528109895,
            "start_logit": -2.4093189239501953,
            "end_logit": -2.3013017177581787,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "features",
            "probability": 0.014993380361633973,
            "start_logit": -3.3765690326690674,
            "end_logit": -1.3443328142166138,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "features and recurrence score",
            "probability": 0.013823251245595707,
            "start_logit": -3.3765690326690674,
            "end_logit": -1.4255895614624023,
            "question_text": "Which diseases can Oncotype DX be used for?"
        }
    ],
    "5165932e298dcd4e51000059": [
        {
            "text": "methyltransferase inhibitors",
            "probability": 0.17088453968368414,
            "start_logit": -5.080652713775635,
            "end_logit": -4.807404041290283,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "screening",
            "probability": 0.11794446201920732,
            "start_logit": -5.010387897491455,
            "end_logit": -5.248443126678467,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitors have been used for disease treatment. Therefore, the detection of DNA methyltransferases and screening",
            "probability": 0.10994156930566727,
            "start_logit": -5.080652713775635,
            "end_logit": -5.248443126678467,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "met",
            "probability": 0.10234471682030084,
            "start_logit": -5.080652713775635,
            "end_logit": -5.320045471191406,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA methyltransferase inhibitors",
            "probability": 0.07411808339674601,
            "start_logit": -5.915981292724609,
            "end_logit": -4.807404041290283,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitor",
            "probability": 0.059347955036361776,
            "start_logit": -5.080652713775635,
            "end_logit": -5.864974498748779,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "inhibitors",
            "probability": 0.049171302653382466,
            "start_logit": -6.326330661773682,
            "end_logit": -4.807404041290283,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA met",
            "probability": 0.04439017286493399,
            "start_logit": -5.915981292724609,
            "end_logit": -5.320045471191406,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitors have been used for disease treatment. Therefore, the detection",
            "probability": 0.0346154574076477,
            "start_logit": -5.080652713775635,
            "end_logit": -6.404091835021973,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "screening of their inhibitors",
            "probability": 0.033809157507556684,
            "start_logit": -5.010387897491455,
            "end_logit": -6.497925281524658,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase",
            "probability": 0.032982501845798394,
            "start_logit": -5.080652713775635,
            "end_logit": -6.4524149894714355,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "inhibitors have been used for disease treatment. Therefore, the detection of DNA methyltransferases and screening",
            "probability": 0.03163522100082027,
            "start_logit": -6.326330661773682,
            "end_logit": -5.248443126678467,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA methyltransferase inhibitor",
            "probability": 0.02574110384095433,
            "start_logit": -5.915981292724609,
            "end_logit": -5.864974498748779,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "detection of DNA methyltransferases and screening",
            "probability": 0.023728305583407678,
            "start_logit": -6.613933086395264,
            "end_logit": -5.248443126678467,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "inhibitor",
            "probability": 0.01707712274237356,
            "start_logit": -6.326330661773682,
            "end_logit": -5.864974498748779,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "nanomaterials have been widely used as powerful building materials to construct efficient biosensors for DNA methyltransferase assay",
            "probability": 0.015693581410804694,
            "start_logit": -5.706167697906494,
            "end_logit": -6.569625377655029,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "nanomaterials",
            "probability": 0.014914603769652784,
            "start_logit": -5.706167697906494,
            "end_logit": -6.6205363273620605,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA methyltransferase",
            "probability": 0.014305564604997571,
            "start_logit": -5.915981292724609,
            "end_logit": -6.4524149894714355,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase assay. DNA met",
            "probability": 0.013678678404710957,
            "start_logit": -6.082827568054199,
            "end_logit": -6.330379009246826,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase assay.",
            "probability": 0.01367590010099159,
            "start_logit": -6.082827568054199,
            "end_logit": -6.330582141876221,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        }
    ],
    "5131bef65274a5fb07000008": [
        {
            "text": "histone marks",
            "probability": 0.25173021194832995,
            "start_logit": -3.76910400390625,
            "end_logit": -4.199443340301514,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modification marks can represent enhancer regions in which histone marks",
            "probability": 0.10051295820269034,
            "start_logit": -4.687175273895264,
            "end_logit": -4.199443340301514,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone marks indicate active or repressed enhancers",
            "probability": 0.09171900691886233,
            "start_logit": -3.76910400390625,
            "end_logit": -5.209071636199951,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "modification marks can represent enhancer regions in which histone marks",
            "probability": 0.06672750636989144,
            "start_logit": -5.096844673156738,
            "end_logit": -4.199443340301514,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modification marks",
            "probability": 0.04023483194422114,
            "start_logit": -4.687175273895264,
            "end_logit": -5.114996910095215,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "marks",
            "probability": 0.03911086777058918,
            "start_logit": -5.631061553955078,
            "end_logit": -4.199443340301514,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone marks was generated to provide a deeper insight into how histone modification marks can represent enhancer regions in which histone marks",
            "probability": 0.038022779664705665,
            "start_logit": -5.659276485443115,
            "end_logit": -4.199443340301514,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modification marks can represent enhancer regions in which histone marks indicate active or repressed enhancers",
            "probability": 0.03662233721362041,
            "start_logit": -4.687175273895264,
            "end_logit": -5.209071636199951,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modification",
            "probability": 0.036261924579733956,
            "start_logit": -4.687175273895264,
            "end_logit": -5.218961715698242,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "ChromHMM",
            "probability": 0.03382072438540138,
            "start_logit": -4.654692649841309,
            "end_logit": -5.321138858795166,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "Enhancers are known to be associated with certain epigenetic signatures.",
            "probability": 0.033199974748303905,
            "start_logit": -5.48859167098999,
            "end_logit": -4.505764484405518,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "epigenetic signatures.",
            "probability": 0.030394386814881443,
            "start_logit": -5.576882839202881,
            "end_logit": -4.505764484405518,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "ChromHMM, and RFECS,",
            "probability": 0.029453420804312628,
            "start_logit": -4.654692649841309,
            "end_logit": -5.459402561187744,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "modification marks",
            "probability": 0.026710685396757798,
            "start_logit": -5.096844673156738,
            "end_logit": -5.114996910095215,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "optimized virtual input histone marks was generated to provide a deeper insight into how histone modification marks",
            "probability": 0.025912633904894237,
            "start_logit": -5.127177715301514,
            "end_logit": -5.114996910095215,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "modification marks can represent enhancer regions in which histone marks indicate active or repressed enhancers",
            "probability": 0.024312459641017303,
            "start_logit": -5.096844673156738,
            "end_logit": -5.209071636199951,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "modification",
            "probability": 0.02407319261760576,
            "start_logit": -5.096844673156738,
            "end_logit": -5.218961715698242,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "CSI-ANN, ChromHMM",
            "probability": 0.024002997805561657,
            "start_logit": -4.99758768081665,
            "end_logit": -5.321138858795166,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "optimized virtual input histone marks",
            "probability": 0.023823156157232833,
            "start_logit": -5.127177715301514,
            "end_logit": -5.199069499969482,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "optimized virtual input histone marks was generated to provide a deeper insight into how histone modification",
            "probability": 0.02335394311138638,
            "start_logit": -5.127177715301514,
            "end_logit": -5.218961715698242,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        }
    ],
    "5160412d298dcd4e5100003c": [
        {
            "text": "H3K37",
            "probability": 0.2991471914406062,
            "start_logit": 5.083055019378662,
            "end_logit": 5.257225513458252,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3 lysine 37",
            "probability": 0.18830414680784266,
            "start_logit": 4.495764255523682,
            "end_logit": 5.381639003753662,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3 lysine 37 (H3K37",
            "probability": 0.16627531979721555,
            "start_logit": 4.495764255523682,
            "end_logit": 5.257225513458252,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3K37) mark.Set7 forms a dimer with its substrate-binding site structurally specific to K37",
            "probability": 0.0784142632281956,
            "start_logit": 5.083055019378662,
            "end_logit": 3.9182956218719482,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3K37)",
            "probability": 0.054969021784627044,
            "start_logit": 5.083055019378662,
            "end_logit": 3.5630595684051514,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K36",
            "probability": 0.031483699443274414,
            "start_logit": 4.041588306427002,
            "end_logit": 4.047226428985596,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3 lysine 37 (H3K37)",
            "probability": 0.030553493188966337,
            "start_logit": 4.495764255523682,
            "end_logit": 3.5630595684051514,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K37, not the neighboring well-studied K36",
            "probability": 0.026736347904326482,
            "start_logit": 3.8781423568725586,
            "end_logit": 4.047226428985596,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K37",
            "probability": 0.023502179869074036,
            "start_logit": 3.8781423568725586,
            "end_logit": 3.9182956218719482,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "histone H3 lysine 37",
            "probability": 0.021298360943872195,
            "start_logit": 2.316335916519165,
            "end_logit": 5.381639003753662,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "histone H3 lysine 37 (H3K37",
            "probability": 0.01880676467902076,
            "start_logit": 2.316335916519165,
            "end_logit": 5.257225513458252,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "lysine 37",
            "probability": 0.01301303717967231,
            "start_logit": 1.823657512664795,
            "end_logit": 5.381639003753662,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "lysine 37 (H3K37",
            "probability": 0.011490702436792812,
            "start_logit": 1.823657512664795,
            "end_logit": 5.257225513458252,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "(H3K37",
            "probability": 0.008645646199787478,
            "start_logit": 1.5391751527786255,
            "end_logit": 5.257225513458252,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3K37) mark",
            "probability": 0.0065804425295996425,
            "start_logit": 5.083055019378662,
            "end_logit": 1.4403917789459229,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3K37) mark.",
            "probability": 0.005344272997352906,
            "start_logit": 5.083055019378662,
            "end_logit": 1.2323153018951416,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "37",
            "probability": 0.004419352870735805,
            "start_logit": 0.7436990737915039,
            "end_logit": 5.381639003753662,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "37 (H3K37",
            "probability": 0.0039023533168826307,
            "start_logit": 0.7436990737915039,
            "end_logit": 5.257225513458252,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3 lysine 37 (H3K37) mark",
            "probability": 0.0036576147706658922,
            "start_logit": 4.495764255523682,
            "end_logit": 1.4403917789459229,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "histone H3 lysine 37 (H3K37)",
            "probability": 0.0034557886114892676,
            "start_logit": 2.316335916519165,
            "end_logit": 3.5630595684051514,
            "question_text": "Which histone marks are deposited by Set7?"
        }
    ],
    "551adceb622b194345000018": [
        {
            "text": "transient ischaemic attack",
            "probability": 0.48904101680477835,
            "start_logit": -0.08131322264671326,
            "end_logit": -0.7397039532661438,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk",
            "probability": 0.15491416526531235,
            "start_logit": -0.08131322264671326,
            "end_logit": -1.8892791271209717,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk factors",
            "probability": 0.091531052613264,
            "start_logit": -0.08131322264671326,
            "end_logit": -2.4154720306396484,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke",
            "probability": 0.06409801895395298,
            "start_logit": -0.08131322264671326,
            "end_logit": -2.7717368602752686,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk",
            "probability": 0.048965446438101995,
            "start_logit": -1.2330695390701294,
            "end_logit": -1.8892791271209717,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk factors to prevent recurrent stroke",
            "probability": 0.037855864835776666,
            "start_logit": -0.08131322264671326,
            "end_logit": -3.2983644008636475,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors",
            "probability": 0.028931239738354843,
            "start_logit": -1.2330695390701294,
            "end_logit": -2.4154720306396484,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "stroke need rapid treatment of risk",
            "probability": 0.013973314137672393,
            "start_logit": -2.487035036087036,
            "end_logit": -1.8892791271209717,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors to prevent recurrent stroke",
            "probability": 0.011965525030003874,
            "start_logit": -1.2330695390701294,
            "end_logit": -3.2983644008636475,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment",
            "probability": 0.009009631006408487,
            "start_logit": -0.08131322264671326,
            "end_logit": -4.733856201171875,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "attack",
            "probability": 0.008522770173896233,
            "start_logit": -4.131018161773682,
            "end_logit": -0.7397039532661438,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "stroke need rapid treatment of risk factors",
            "probability": 0.008256134287826443,
            "start_logit": -2.487035036087036,
            "end_logit": -2.4154720306396484,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors to prevent recurrent stroke.ABCD2 score or magnetic resonance diffusion-weighted brain imaging",
            "probability": 0.005788535518011016,
            "start_logit": -1.2330695390701294,
            "end_logit": -4.024514675140381,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "stroke",
            "probability": 0.005781664658697396,
            "start_logit": -2.487035036087036,
            "end_logit": -2.7717368602752686,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "ischaemic attack",
            "probability": 0.005653052132914329,
            "start_logit": -4.541563987731934,
            "end_logit": -0.7397039532661438,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk factors to prevent recurrent stroke.",
            "probability": 0.004384327971670076,
            "start_logit": -0.08131322264671326,
            "end_logit": -5.454113960266113,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA)",
            "probability": 0.0034231337828219814,
            "start_logit": -0.08131322264671326,
            "end_logit": -5.70159387588501,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "stroke need rapid treatment of risk factors to prevent recurrent stroke",
            "probability": 0.0034146127979816075,
            "start_logit": -2.487035036087036,
            "end_logit": -3.2983644008636475,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "attack (TIA) or minor stroke need rapid treatment of risk",
            "probability": 0.0026997691029345488,
            "start_logit": -4.131018161773682,
            "end_logit": -1.8892791271209717,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "ischaemic attack (TIA) or minor stroke need rapid treatment of risk",
            "probability": 0.001790724749620143,
            "start_logit": -4.541563987731934,
            "end_logit": -1.8892791271209717,
            "question_text": "Which factors are considered in the ABCD2 score?"
        }
    ],
    "532f0b2cd6d3ac6a3400002c": [
        {
            "text": "eyes",
            "probability": 0.9862805707868083,
            "start_logit": 1.234100580215454,
            "end_logit": 1.6773804426193237,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal, and cardiovascular system",
            "probability": 0.005728868440705057,
            "start_logit": 1.234100580215454,
            "end_logit": -3.4710423946380615,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardinal features affect eyes",
            "probability": 0.0016326991352335494,
            "start_logit": -5.169605731964111,
            "end_logit": 1.6773804426193237,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal,",
            "probability": 0.0010268751075186609,
            "start_logit": 1.234100580215454,
            "end_logit": -5.190040111541748,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal",
            "probability": 0.0008009015679481495,
            "start_logit": 1.234100580215454,
            "end_logit": -5.438577651977539,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes",
            "probability": 0.000771036842765418,
            "start_logit": -5.919859409332275,
            "end_logit": 1.6773804426193237,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal, and cardiovascular",
            "probability": 0.0007416978857707402,
            "start_logit": 1.234100580215454,
            "end_logit": -5.515373706817627,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "features affect eyes",
            "probability": 0.0006849495056203153,
            "start_logit": -6.03825044631958,
            "end_logit": 1.6773804426193237,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "connective tissue, whose cardinal features affect eyes",
            "probability": 0.0006320367335896891,
            "start_logit": -6.118648052215576,
            "end_logit": 1.6773804426193237,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "Marfan syndrome is an autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes",
            "probability": 0.0005623091792113548,
            "start_logit": -6.235543727874756,
            "end_logit": 1.6773804426193237,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal, and cardiovascular system.",
            "probability": 0.0005021353236993572,
            "start_logit": 1.234100580215454,
            "end_logit": -5.9054460525512695,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes,",
            "probability": 0.00048716709847101557,
            "start_logit": 1.234100580215454,
            "end_logit": -5.935708522796631,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardiovascular system",
            "probability": 9.347927183219708e-05,
            "start_logit": -2.8814330101013184,
            "end_logit": -3.4710423946380615,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardiovascular",
            "probability": 1.210245600836244e-05,
            "start_logit": -2.8814330101013184,
            "end_logit": -5.515373706817627,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardinal features affect eyes, musculoskeletal, and cardiovascular system",
            "probability": 9.483628519158723e-06,
            "start_logit": -5.169605731964111,
            "end_logit": -3.4710423946380615,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "musculoskeletal, and cardiovascular system",
            "probability": 9.339822318297458e-06,
            "start_logit": -5.184885501861572,
            "end_logit": -3.4710423946380615,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardiovascular system.",
            "probability": 8.19345825558243e-06,
            "start_logit": -2.8814330101013184,
            "end_logit": -5.9054460525512695,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "system",
            "probability": 7.696573774109846e-06,
            "start_logit": -5.378397464752197,
            "end_logit": -3.4710423946380615,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes, musculoskeletal, and cardiovascular system",
            "probability": 4.478612644286261e-06,
            "start_logit": -5.919859409332275,
            "end_logit": -3.4710423946380615,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "features affect eyes, musculoskeletal, and cardiovascular system",
            "probability": 3.978569306190817e-06,
            "start_logit": -6.03825044631958,
            "end_logit": -3.4710423946380615,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        }
    ],
    "5512c1ee6a8cde6b72000009": [
        {
            "text": "MKK6",
            "probability": 0.9418302169102546,
            "start_logit": 3.785707950592041,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "B-Raf, MKK6",
            "probability": 0.047928576188639306,
            "start_logit": 0.8075948357582092,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "M",
            "probability": 0.0052724346900490885,
            "start_logit": 3.785707950592041,
            "end_logit": -2.712054967880249,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "B-Raf",
            "probability": 0.0020488544577550397,
            "start_logit": 0.8075948357582092,
            "end_logit": -0.6791532635688782,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK",
            "probability": 0.0004204410272076271,
            "start_logit": 3.785707950592041,
            "end_logit": -5.240998268127441,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "6",
            "probability": 0.00039186451162492923,
            "start_logit": -3.9989562034606934,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6 activation rapidly and potently inhibited the pro-proliferative extracellular signal-regulated kinase (ERK)",
            "probability": 0.0003151771435140656,
            "start_logit": 3.785707950592041,
            "end_logit": -5.529167652130127,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6 activation rapidly and potently inhibited the pro-proliferative extracellular signal-regulated kinase (ERK) pathway;",
            "probability": 0.00030143068113396606,
            "start_logit": 3.785707950592041,
            "end_logit": -5.5737624168396,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "af, MKK6",
            "probability": 0.0002816292519703914,
            "start_logit": -4.329280853271484,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "B-Raf, M",
            "probability": 0.0002683076877387148,
            "start_logit": 0.8075948357582092,
            "end_logit": -2.712054967880249,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6 activation rapidly and potently inhibited the pro-proliferative extracellular signal-regulated kinase",
            "probability": 0.00015717184830336072,
            "start_logit": 3.785707950592041,
            "end_logit": -6.2249627113342285,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "K6",
            "probability": 0.0001320822865045141,
            "start_logit": -5.086447238922119,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6 activation",
            "probability": 0.00011847282260176355,
            "start_logit": 3.785707950592041,
            "end_logit": -6.5076189041137695,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "Raf, MKK6",
            "probability": 0.00011416350474841701,
            "start_logit": -5.232240676879883,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "mutant B-Raf, MKK6",
            "probability": 0.00011383463307455347,
            "start_logit": -5.235125541687012,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6 activation rapidly and potently inhibited the pro-proliferative extracellular signal-regulated kinase (ERK) pathway",
            "probability": 0.00011061168274082281,
            "start_logit": 3.785707950592041,
            "end_logit": -6.576276779174805,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "B",
            "probability": 7.144863278923685e-05,
            "start_logit": 0.8075948357582092,
            "end_logit": -4.035210609436035,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "melanoma cell line expressing mutant B-Raf, MKK6",
            "probability": 5.160891695421928e-05,
            "start_logit": -6.026177883148193,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "B-Raf,",
            "probability": 4.7435024442761165e-05,
            "start_logit": 0.8075948357582092,
            "end_logit": -4.444828510284424,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": ", MKK6",
            "probability": 2.423809795230114e-05,
            "start_logit": -6.781946659088135,
            "end_logit": 2.4732778072357178,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        }
    ],
    "515db70c298dcd4e51000017": [
        {
            "text": "bacterial bronchitis",
            "probability": 0.20607064316472828,
            "start_logit": 2.553870916366577,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "Persistent bacterial bronchitis",
            "probability": 0.18966328696501022,
            "start_logit": 2.47090220451355,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "wet cough",
            "probability": 0.18294855868672333,
            "start_logit": 3.318636417388916,
            "end_logit": 3.359955310821533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough",
            "probability": 0.10080794948532555,
            "start_logit": 2.7226486206054688,
            "end_logit": 3.359955310821533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bacterial bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.08515213772795545,
            "start_logit": 2.553870916366577,
            "end_logit": 3.359955310821533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "Persistent bacterial bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.07837231973246743,
            "start_logit": 2.47090220451355,
            "end_logit": 3.359955310821533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough in adults and children.Children are not small adults and a pursuit of an underlying cause for cough is advocated.Persistent bacterial bronchitis",
            "probability": 0.060781327019305505,
            "start_logit": 1.3329344987869263,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "chronic cough in adults and children.Children are not small adults and a pursuit of an underlying cause for cough is advocated.Persistent bacterial bronchitis",
            "probability": 0.029634567718327835,
            "start_logit": 0.6145933866500854,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough is advocated.Persistent bacterial bronchitis",
            "probability": 0.02130312333722845,
            "start_logit": 0.28450557589530945,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bronchitis",
            "probability": 0.019798594370110983,
            "start_logit": 0.21126282215118408,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough is advocated.Persistent bacterial bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.008802838019956209,
            "start_logit": 0.28450557589530945,
            "end_logit": 3.359955310821533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.008181139286666606,
            "start_logit": 0.21126282215118408,
            "end_logit": 3.359955310821533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "chronic cough",
            "probability": 0.0022750828275233037,
            "start_logit": 0.6145933866500854,
            "end_logit": 1.6768097877502441,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough in adults and children.Children are not small adults and a pursuit of an underlying cause for cough",
            "probability": 0.0019431428384680742,
            "start_logit": 1.3329344987869263,
            "end_logit": 0.8007588982582092,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "onchitis",
            "probability": 0.0011930443162385786,
            "start_logit": -2.597839832305908,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "chronic cough in adults and children.Children are not small adults and a pursuit of an underlying cause for cough",
            "probability": 0.0009473994869291994,
            "start_logit": 0.6145933866500854,
            "end_logit": 0.8007588982582092,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "chitis",
            "probability": 0.000681877901706049,
            "start_logit": -3.157252788543701,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "tis",
            "probability": 0.0005842264214196146,
            "start_logit": -3.311814785003662,
            "end_logit": 4.243734836578369,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "onchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.0004929876103249354,
            "start_logit": -2.597839832305908,
            "end_logit": 3.359955310821533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "wet cough in children.",
            "probability": 0.00036575308358424285,
            "start_logit": 3.318636417388916,
            "end_logit": -2.855046510696411,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        }
    ],
    "54fb5c69d176fff445000003": [
        {
            "text": "Mef2C, Tbx5",
            "probability": 0.19237800445792916,
            "start_logit": 4.024566173553467,
            "end_logit": 3.326000928878784,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4",
            "probability": 0.18227076537387685,
            "start_logit": 3.8988442420959473,
            "end_logit": 3.397753953933716,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5",
            "probability": 0.17689815223472466,
            "start_logit": 3.940678119659424,
            "end_logit": 3.326000928878784,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5",
            "probability": 0.16965047282612772,
            "start_logit": 3.8988442420959473,
            "end_logit": 3.326000928878784,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C",
            "probability": 0.1224000694138118,
            "start_logit": 4.024566173553467,
            "end_logit": 2.873833656311035,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C",
            "probability": 0.10793972891295449,
            "start_logit": 3.8988442420959473,
            "end_logit": 2.873833656311035,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5 and Hand2",
            "probability": 0.009411560761159447,
            "start_logit": 4.024566173553467,
            "end_logit": 0.308477520942688,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 and Hand2",
            "probability": 0.008654251888022036,
            "start_logit": 3.940678119659424,
            "end_logit": 0.308477520942688,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5 and Hand2",
            "probability": 0.008299679257311898,
            "start_logit": 3.8988442420959473,
            "end_logit": 0.308477520942688,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2",
            "probability": 0.004361390501555899,
            "start_logit": 3.255418300628662,
            "end_logit": 0.308477520942688,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5 and Hand2 (GMTH",
            "probability": 0.002968065300358038,
            "start_logit": 3.789497137069702,
            "end_logit": -0.6104819178581238,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 and Hand2 (GMTH",
            "probability": 0.002722414351906813,
            "start_logit": 3.703105926513672,
            "end_logit": -0.6104819178581238,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5 and Hand2 (GMTH",
            "probability": 0.002394258287113709,
            "start_logit": 3.574660301208496,
            "end_logit": -0.6104819178581238,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5 and Hand",
            "probability": 0.0023472496406231167,
            "start_logit": 4.024566173553467,
            "end_logit": -1.0802170038223267,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 and Hand",
            "probability": 0.0021583762937444104,
            "start_logit": 3.940678119659424,
            "end_logit": -1.0802170038223267,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5 and Hand",
            "probability": 0.002069945639028366,
            "start_logit": 3.8988442420959473,
            "end_logit": -1.0802170038223267,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2 (GMTH",
            "probability": 0.0011674337423581438,
            "start_logit": 2.8563947677612305,
            "end_logit": -0.6104819178581238,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand",
            "probability": 0.0010877337507762088,
            "start_logit": 3.255418300628662,
            "end_logit": -1.0802170038223267,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "4",
            "probability": 0.00042493476729960804,
            "start_logit": -2.162468671798706,
            "end_logit": 3.397753953933716,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "4, Mef2C, Tbx5",
            "probability": 0.0003955125993176473,
            "start_logit": -2.162468671798706,
            "end_logit": 3.326000928878784,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        }
    ],
    "513f45abbee46bd34c000013": [
        {
            "text": "pancreatic",
            "probability": 0.3158062965244859,
            "start_logit": 6.4315571784973145,
            "end_logit": 4.468738079071045,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells",
            "probability": 0.24835978789873803,
            "start_logit": 6.4315571784973145,
            "end_logit": 4.228487491607666,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic Thyrotropin (TSH) is a modulator of glucose metabolism by binding to its receptor on pancreatic",
            "probability": 0.18009173608863074,
            "start_logit": 5.869894504547119,
            "end_logit": 4.468738079071045,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic Thyrotropin (TSH) is a modulator of glucose metabolism by binding to its receptor on pancreatic cells",
            "probability": 0.1416296820852649,
            "start_logit": 5.869894504547119,
            "end_logit": 4.228487491607666,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic",
            "probability": 0.10246280486153281,
            "start_logit": 5.869894504547119,
            "end_logit": 3.904771566390991,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic Thyrotropin",
            "probability": 0.005088134615843157,
            "start_logit": 5.869894504547119,
            "end_logit": 0.9021829962730408,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancre",
            "probability": 0.0015546485702518798,
            "start_logit": 5.869894504547119,
            "end_logit": -0.2834787666797638,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic Thyrotropin (TSH)",
            "probability": 0.001232638790025315,
            "start_logit": 5.869894504547119,
            "end_logit": -0.5155710577964783,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pan",
            "probability": 0.0009571909557928993,
            "start_logit": 6.4315571784973145,
            "end_logit": -1.3301433324813843,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic Thyrotropin (TSH) is a modulator of glucose metabolism by binding to its receptor on pan",
            "probability": 0.0005458478279064758,
            "start_logit": 5.869894504547119,
            "end_logit": -1.3301433324813843,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancre",
            "probability": 0.00047803537310551905,
            "start_logit": 6.4315571784973145,
            "end_logit": -2.024461507797241,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pan",
            "probability": 0.00045663016403297153,
            "start_logit": 5.869894504547119,
            "end_logit": -1.5086097717285156,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We used thyrotropin receptor (TSHR) knockout mice",
            "probability": 0.0002792216120869767,
            "start_logit": 6.4315571784973145,
            "end_logit": -2.562140464782715,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic Thyrotropin (TSH) is a modulator of glucose metabolism by binding to its receptor on pancre",
            "probability": 0.00027260450852877244,
            "start_logit": 5.869894504547119,
            "end_logit": -2.024461507797241,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells.",
            "probability": 0.00023578975469659133,
            "start_logit": 6.4315571784973145,
            "end_logit": -2.731205701828003,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "cells",
            "probability": 0.00015776670244165627,
            "start_logit": -0.9299591779708862,
            "end_logit": 4.228487491607666,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Pancreatic Thyrotropin (TSH) is a modulator of glucose metabolism by binding to its receptor on pancreatic cells.",
            "probability": 0.00013446149346148042,
            "start_logit": 5.869894504547119,
            "end_logit": -2.731205701828003,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "creatic",
            "probability": 0.00010912108280520363,
            "start_logit": -1.538869023323059,
            "end_logit": 4.468738079071045,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "creatic cells",
            "probability": 8.58161768116606e-05,
            "start_logit": -1.538869023323059,
            "end_logit": 4.228487491607666,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Thyrotropin (TSH) is a modulator of glucose metabolism by binding to its receptor on pancreatic",
            "probability": 6.178491355712456e-05,
            "start_logit": -2.107667922973633,
            "end_logit": 4.468738079071045,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        }
    ],
    "56ddbbaf51531f7e33000009": [
        {
            "text": "dimethylation of H3 Lys4",
            "probability": 0.317810882009025,
            "start_logit": 4.0413007736206055,
            "end_logit": 2.9609875679016113,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "dimethylation",
            "probability": 0.2245540929386519,
            "start_logit": 4.0413007736206055,
            "end_logit": 2.613647699356079,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4 and the dimethylation of H3 Lys4",
            "probability": 0.1178978193499168,
            "start_logit": 3.0496625900268555,
            "end_logit": 2.9609875679016113,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4 and the dimethylation",
            "probability": 0.0833024901986012,
            "start_logit": 3.0496625900268555,
            "end_logit": 2.613647699356079,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation",
            "probability": 0.06480196592429172,
            "start_logit": 3.0496625900268555,
            "end_logit": 2.3625051975250244,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4",
            "probability": 0.042088215956414,
            "start_logit": 3.0496625900268555,
            "end_logit": 1.9309370517730713,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 Lys4",
            "probability": 0.023135087261015944,
            "start_logit": 1.4211946725845337,
            "end_logit": 2.9609875679016113,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 and H4 and the dimethylation of H3 Lys4",
            "probability": 0.022469455950069658,
            "start_logit": 1.3920011520385742,
            "end_logit": 2.9609875679016113,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3",
            "probability": 0.02217964776840863,
            "start_logit": 3.0496625900268555,
            "end_logit": 1.2903443574905396,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "dimethylation of H3",
            "probability": 0.016603204997041952,
            "start_logit": 4.0413007736206055,
            "end_logit": 0.009126821532845497,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 and H4 and the dimethylation",
            "probability": 0.01587613447279506,
            "start_logit": 1.3920011520385742,
            "end_logit": 2.613647699356079,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 and H4",
            "probability": 0.008021346956747853,
            "start_logit": 1.3920011520385742,
            "end_logit": 1.9309370517730713,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H4 and the dimethylation of H3 Lys4",
            "probability": 0.00761235568118838,
            "start_logit": 0.30961695313453674,
            "end_logit": 2.9609875679016113,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation in H3 and H4 histones and dimethylation",
            "probability": 0.007223063655303074,
            "start_logit": 2.0396151542663574,
            "end_logit": 1.1784958839416504,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4 and the dimethylation of H3",
            "probability": 0.0061592656959911785,
            "start_logit": 3.0496625900268555,
            "end_logit": 0.009126821532845497,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H4 and the dimethylation",
            "probability": 0.00537862521984728,
            "start_logit": 0.30961695313453674,
            "end_logit": 2.613647699356079,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "histones H3 and H4 and the dimethylation of H3 Lys4",
            "probability": 0.0046536341870408796,
            "start_logit": -0.18250726163387299,
            "end_logit": 2.9609875679016113,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3",
            "probability": 0.0042270893666081204,
            "start_logit": 1.3920011520385742,
            "end_logit": 1.2903443574905396,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "histones H3 and H4 and the dimethylation",
            "probability": 0.0032880957289234364,
            "start_logit": -0.18250726163387299,
            "end_logit": 2.613647699356079,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H4",
            "probability": 0.0027175266821177014,
            "start_logit": 0.30961695313453674,
            "end_logit": 1.9309370517730713,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        }
    ],
    "517843638ed59a060a000036": [
        {
            "text": "Long interspersed element class 1",
            "probability": 0.23779144473383904,
            "start_logit": 3.9847512245178223,
            "end_logit": 3.1361849308013916,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1",
            "probability": 0.1539557013722967,
            "start_logit": 3.9847512245178223,
            "end_logit": 2.70145583152771,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1 or L1) retrotransposons",
            "probability": 0.15362599547130626,
            "start_logit": 3.9847512245178223,
            "end_logit": 2.6993119716644287,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1 or L1",
            "probability": 0.06619572810392474,
            "start_logit": 3.9847512245178223,
            "end_logit": 1.8574068546295166,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1",
            "probability": 0.05517107784592529,
            "start_logit": 2.9585251808166504,
            "end_logit": 2.70145583152771,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1 or L1) retrotransposons",
            "probability": 0.05505292548282563,
            "start_logit": 2.9585251808166504,
            "end_logit": 2.6993119716644287,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element",
            "probability": 0.047245868982457334,
            "start_logit": 3.9847512245178223,
            "end_logit": 1.5201561450958252,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1) retrotransposons",
            "probability": 0.03922890116836719,
            "start_logit": 2.6196439266204834,
            "end_logit": 2.6993119716644287,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "in\u00a0vivo.Long interspersed element class 1",
            "probability": 0.0338192165789303,
            "start_logit": 3.113234043121338,
            "end_logit": 2.0573372840881348,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1 or L1)",
            "probability": 0.028844582939751624,
            "start_logit": 3.9847512245178223,
            "end_logit": 1.0267131328582764,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1 or L1",
            "probability": 0.023721691601779844,
            "start_logit": 2.9585251808166504,
            "end_logit": 1.8574068546295166,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1",
            "probability": 0.016903296005277887,
            "start_logit": 2.6196439266204834,
            "end_logit": 1.8574068546295166,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "in\u00a0vivo.Long interspersed element class 1 (LINE-1",
            "probability": 0.016463704880989933,
            "start_logit": 3.113234043121338,
            "end_logit": 1.3374663591384888,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "in\u00a0vivo.Long interspersed element class 1 (LINE-1 or L1) retrotransposons",
            "probability": 0.013718785986857133,
            "start_logit": 3.113234043121338,
            "end_logit": 1.1550742387771606,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "class 1",
            "probability": 0.013713733510672236,
            "start_logit": 1.131754994392395,
            "end_logit": 3.1361849308013916,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1 or L1)",
            "probability": 0.010336653443927896,
            "start_logit": 2.9585251808166504,
            "end_logit": 1.0267131328582764,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "in\u00a0vivo.Long interspersed element class 1 (LINE-1 or L1)",
            "probability": 0.009106507492533519,
            "start_logit": 3.113234043121338,
            "end_logit": 0.745297372341156,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "class 1 (LINE-1",
            "probability": 0.00887882010823185,
            "start_logit": 1.131754994392395,
            "end_logit": 2.70145583152771,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "class 1 (LINE-1 or L1) retrotransposons",
            "probability": 0.008859805551723565,
            "start_logit": 1.131754994392395,
            "end_logit": 2.6993119716644287,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1)",
            "probability": 0.0073655587383818265,
            "start_logit": 2.6196439266204834,
            "end_logit": 1.0267131328582764,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        }
    ],
    "55031286e9bde6963400001b": [
        {
            "text": "congenital erythroid aplasia",
            "probability": 0.6719850589900545,
            "start_logit": 5.481678009033203,
            "end_logit": 3.7093729972839355,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "erythroid aplasia",
            "probability": 0.23143875397422828,
            "start_logit": 4.415757179260254,
            "end_logit": 3.7093729972839355,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital erythroid aplasia,",
            "probability": 0.023441348434239784,
            "start_logit": 5.481678009033203,
            "end_logit": 0.3536383807659149,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "rare congenital erythroid aplasia",
            "probability": 0.01563444720109893,
            "start_logit": 1.7209185361862183,
            "end_logit": 3.7093729972839355,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital erythroid aplasia, underlied by haploinsufficient mutations",
            "probability": 0.011668850496599754,
            "start_logit": 5.481678009033203,
            "end_logit": -0.3439401686191559,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital erythroid",
            "probability": 0.009149443382258307,
            "start_logit": 5.481678009033203,
            "end_logit": -0.5871700644493103,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "erythroid aplasia,",
            "probability": 0.008073448063339273,
            "start_logit": 4.415757179260254,
            "end_logit": 0.3536383807659149,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital",
            "probability": 0.005420366622658409,
            "start_logit": 5.481678009033203,
            "end_logit": -1.1106996536254883,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "a rare congenital erythroid aplasia",
            "probability": 0.005247679162904019,
            "start_logit": 0.6292278170585632,
            "end_logit": 3.7093729972839355,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "aplasia",
            "probability": 0.004840668321808047,
            "start_logit": 0.5484946966171265,
            "end_logit": 3.7093729972839355,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "erythroid aplasia, underlied by haploinsufficient mutations",
            "probability": 0.004018875394794412,
            "start_logit": 4.415757179260254,
            "end_logit": -0.3439401686191559,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "erythroid",
            "probability": 0.0031511649665695194,
            "start_logit": 4.415757179260254,
            "end_logit": -0.5871700644493103,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "con",
            "probability": 0.0013767630555269307,
            "start_logit": 5.481678009033203,
            "end_logit": -2.481127977371216,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital er",
            "probability": 0.0010926291859703432,
            "start_logit": 5.481678009033203,
            "end_logit": -2.7122762203216553,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital erythroid aplasia, underlied by haploinsufficient mutations in genes coding for ribosomal proteins",
            "probability": 0.0009091724543680655,
            "start_logit": 5.481678009033203,
            "end_logit": -2.8960835933685303,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital erythroid ap",
            "probability": 0.0007254758183979222,
            "start_logit": 5.481678009033203,
            "end_logit": -3.121790647506714,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "rare congenital erythroid aplasia,",
            "probability": 0.000545387906344967,
            "start_logit": 1.7209185361862183,
            "end_logit": 0.3536383807659149,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital erythroid a",
            "probability": 0.0005342383307500471,
            "start_logit": 5.481678009033203,
            "end_logit": -3.427776336669922,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "er",
            "probability": 0.0003763130354965142,
            "start_logit": 4.415757179260254,
            "end_logit": -2.7122762203216553,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "ital erythroid aplasia",
            "probability": 0.00036991520259179437,
            "start_logit": -2.0230395793914795,
            "end_logit": 3.7093729972839355,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        }
    ],
    "533ec7abc45e133714000015": [
        {
            "text": "M1BP",
            "probability": 0.24492969436101766,
            "start_logit": 4.613002300262451,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Ubx and AbdA collaborate with the transcription pausing factor M1BP",
            "probability": 0.1752305086798926,
            "start_logit": 4.278133392333984,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "AbdA collaborate with the transcription pausing factor M1BP",
            "probability": 0.1728976563474318,
            "start_logit": 4.264730930328369,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Ubx and AbdA",
            "probability": 0.10146845944634698,
            "start_logit": 4.278133392333984,
            "end_logit": 3.5033750534057617,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "AbdA",
            "probability": 0.10011760488298421,
            "start_logit": 4.264730930328369,
            "end_logit": 3.5033750534057617,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Ubx",
            "probability": 0.0779578394271664,
            "start_logit": 4.278133392333984,
            "end_logit": 3.239795207977295,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Hox proteins Ubx and AbdA collaborate with the transcription pausing factor M1BP",
            "probability": 0.060783437233781504,
            "start_logit": 3.219348430633545,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Hox proteins Ubx and AbdA",
            "probability": 0.03519707716669579,
            "start_logit": 3.219348430633545,
            "end_logit": 3.5033750534057617,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Hox proteins Ubx",
            "probability": 0.02704178327963803,
            "start_logit": 3.219348430633545,
            "end_logit": 3.239795207977295,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Hox proteins",
            "probability": 0.002073458190586024,
            "start_logit": 3.219348430633545,
            "end_logit": 0.6716298460960388,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription pausing factor M1BP",
            "probability": 0.0003985474722717085,
            "start_logit": -1.8078975677490234,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Hox",
            "probability": 0.00037493389822803203,
            "start_logit": 3.219348430633545,
            "end_logit": -1.0385935306549072,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Ubx and AbdA collaborate with the transcription pausing",
            "probability": 0.00028330335893075707,
            "start_logit": 4.278133392333984,
            "end_logit": -2.377609968185425,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "AbdA collaborate with the transcription pausing",
            "probability": 0.00027953172745713665,
            "start_logit": 4.264730930328369,
            "end_logit": -2.377609968185425,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "The Hox proteins Ubx and AbdA collaborate with the transcription pausing factor M1BP",
            "probability": 0.0002446060218698998,
            "start_logit": -2.2960753440856934,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "pausing factor M1BP",
            "probability": 0.00017869154556464245,
            "start_logit": -2.610063076019287,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "M",
            "probability": 0.0001459252126239366,
            "start_logit": 4.613002300262451,
            "end_logit": -3.3759028911590576,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "The Hox proteins Ubx and AbdA",
            "probability": 0.00014164083867255372,
            "start_logit": -2.2960753440856934,
            "end_logit": 3.5033750534057617,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "the transcription pausing factor M1BP",
            "probability": 0.00013762547170926643,
            "start_logit": -2.871188163757324,
            "end_logit": 4.049729347229004,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "Ubx and AbdA collaborate with the transcription pausing factor",
            "probability": 0.00011767543713127456,
            "start_logit": 4.278133392333984,
            "end_logit": -3.256197929382324,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        }
    ],
    "54ecb640445c3b5a5f000001": [
        {
            "text": "cytopenia",
            "probability": 0.29717254419325045,
            "start_logit": 5.417061805725098,
            "end_logit": 5.130075931549072,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects",
            "probability": 0.1922147937353809,
            "start_logit": 5.417061805725098,
            "end_logit": 4.694376468658447,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects, and tumor predisposition",
            "probability": 0.1648301412311891,
            "start_logit": 5.417061805725098,
            "end_logit": 4.54067850112915,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects",
            "probability": 0.11424916718244457,
            "start_logit": 4.896830081939697,
            "end_logit": 4.694376468658447,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects, and tumor predisposition",
            "probability": 0.09797220076698879,
            "start_logit": 4.896830081939697,
            "end_logit": 4.54067850112915,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "tumor predisposition",
            "probability": 0.08656288095626868,
            "start_logit": 4.773017406463623,
            "end_logit": 4.54067850112915,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects, and tumor",
            "probability": 0.01791593120267577,
            "start_logit": 5.417061805725098,
            "end_logit": 2.321453332901001,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects, and tumor",
            "probability": 0.010648921341723508,
            "start_logit": 4.896830081939697,
            "end_logit": 2.321453332901001,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "tumor",
            "probability": 0.009408804775230454,
            "start_logit": 4.773017406463623,
            "end_logit": 2.321453332901001,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects,",
            "probability": 0.0034587949308846288,
            "start_logit": 5.417061805725098,
            "end_logit": 0.676683247089386,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects,",
            "probability": 0.002055848213496233,
            "start_logit": 4.896830081939697,
            "end_logit": 0.676683247089386,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia,",
            "probability": 0.0019577215464373077,
            "start_logit": 5.417061805725098,
            "end_logit": 0.10754432529211044,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental",
            "probability": 0.00044260838043864867,
            "start_logit": 5.417061805725098,
            "end_logit": -1.3793069124221802,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental",
            "probability": 0.00026307880819361845,
            "start_logit": 4.896830081939697,
            "end_logit": -1.3793069124221802,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "c",
            "probability": 0.00018549673170614546,
            "start_logit": 5.417061805725098,
            "end_logit": -2.248955011367798,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "openia",
            "probability": 0.00016397047881070117,
            "start_logit": -2.085319995880127,
            "end_logit": 5.130075931549072,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects, and tumor predisposition are similar in each group,",
            "probability": 0.00015156989884704473,
            "start_logit": 5.417061805725098,
            "end_logit": -2.4509453773498535,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "sensitivity to DNA interstrand crosslinking agents",
            "probability": 0.0001485194419583793,
            "start_logit": 0.7998839616775513,
            "end_logit": 2.1459014415740967,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "openia, developmental defects",
            "probability": 0.00010605808773099442,
            "start_logit": -2.085319995880127,
            "end_logit": 4.694376468658447,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "openia, developmental defects, and tumor predisposition",
            "probability": 9.094809634411522e-05,
            "start_logit": -2.085319995880127,
            "end_logit": 4.54067850112915,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        }
    ],
    "513f3d1fbee46bd34c000010": [
        {
            "text": "hypothyroidism",
            "probability": 0.42376393208572216,
            "start_logit": -0.8655619025230408,
            "end_logit": -1.9304536581039429,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Levothyroxine malabsorption",
            "probability": 0.13414595531326198,
            "start_logit": -0.8804804086685181,
            "end_logit": -3.0657832622528076,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Levothyroxine malabsorption has been reported following gastric bypass",
            "probability": 0.09391356813943207,
            "start_logit": -0.8804804086685181,
            "end_logit": -3.4223368167877197,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine",
            "probability": 0.08528661503426224,
            "start_logit": -1.3616276979446411,
            "end_logit": -3.0375468730926514,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "iatrogenic hypothyroidism",
            "probability": 0.0749256400634428,
            "start_logit": -2.5982422828674316,
            "end_logit": -1.9304536581039429,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "hypothyroidism treated with thyroxine,",
            "probability": 0.043673112828338134,
            "start_logit": -0.8655619025230408,
            "end_logit": -4.202897548675537,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "le",
            "probability": 0.0412973771775157,
            "start_logit": -0.8804804086685181,
            "end_logit": -4.243912696838379,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Levo",
            "probability": 0.03714613035714633,
            "start_logit": -0.8804804086685181,
            "end_logit": -4.349852085113525,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets.",
            "probability": 0.019852165630671412,
            "start_logit": -3.2779622077941895,
            "end_logit": -2.5789167881011963,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "food, and other factors.Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets.",
            "probability": 0.010079016636457784,
            "start_logit": -3.955819606781006,
            "end_logit": -2.5789167881011963,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "iatrogenic hypothyroidism treated with thyroxine,",
            "probability": 0.007721836816362787,
            "start_logit": -2.5982422828674316,
            "end_logit": -4.202897548675537,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Hypothyroidism",
            "probability": 0.004089138844880395,
            "start_logit": -3.2779622077941895,
            "end_logit": -4.158895492553711,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets.Le",
            "probability": 0.0037558596442114896,
            "start_logit": -3.2779622077941895,
            "end_logit": -4.243912696838379,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "gastric sleeve surgery resolved by ingesting crushed thyroxine tablets.",
            "probability": 0.0035303980127284677,
            "start_logit": -5.004864692687988,
            "end_logit": -2.5789167881011963,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets.Levo",
            "probability": 0.0033783174981626765,
            "start_logit": -3.2779622077941895,
            "end_logit": -4.349852085113525,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "crushed thyroxine tablets.",
            "probability": 0.003237267879296748,
            "start_logit": -5.091545581817627,
            "end_logit": -2.5789167881011963,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": ".",
            "probability": 0.002909127923576212,
            "start_logit": -5.198421955108643,
            "end_logit": -2.5789167881011963,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "gastric bypass",
            "probability": 0.002558961019185872,
            "start_logit": -4.4832539558410645,
            "end_logit": -3.4223368167877197,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets",
            "probability": 0.0023688587579866163,
            "start_logit": -3.2779622077941895,
            "end_logit": -4.704821586608887,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "food",
            "probability": 0.0023667203373578436,
            "start_logit": -3.955819606781006,
            "end_logit": -4.027867317199707,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        }
    ],
    "553f7a71ab98a37113000009": [
        {
            "text": "homologous recombination",
            "probability": 0.44385706919392615,
            "start_logit": 3.797802448272705,
            "end_logit": 2.6737518310546875,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non-homologous end joining",
            "probability": 0.25904661013812513,
            "start_logit": 3.969007968902588,
            "end_logit": 1.9640517234802246,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "homologous recombination and non-homologous end joining",
            "probability": 0.21828520483595124,
            "start_logit": 3.797802448272705,
            "end_logit": 1.9640517234802246,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide damage repair",
            "probability": 0.03360199614884501,
            "start_logit": 1.9178802967071533,
            "end_logit": 1.9727568626403809,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide damage repair/removal",
            "probability": 0.010634823728383206,
            "start_logit": 1.9178802967071533,
            "end_logit": 0.8223052620887756,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombination",
            "probability": 0.008928223665264195,
            "start_logit": -0.10848268866539001,
            "end_logit": 2.6737518310546875,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombination and non-homologous end joining",
            "probability": 0.004390825936675318,
            "start_logit": -0.10848268866539001,
            "end_logit": 1.9640517234802246,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "end joining",
            "probability": 0.0040210009561075484,
            "start_logit": -0.19646917283535004,
            "end_logit": 1.9640517234802246,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non",
            "probability": 0.0037386349514092684,
            "start_logit": 3.969007968902588,
            "end_logit": -2.274235725402832,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "homologous recombination and non",
            "probability": 0.0031503546629700176,
            "start_logit": 3.797802448272705,
            "end_logit": -2.274235725402832,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide damage",
            "probability": 0.002761293054359942,
            "start_logit": 1.9178802967071533,
            "end_logit": -0.5261295437812805,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "ho",
            "probability": 0.0017869787261643646,
            "start_logit": 3.797802448272705,
            "end_logit": -2.841224431991577,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "polY2, which are involved in nucleotide damage repair",
            "probability": 0.0009726988267750844,
            "start_logit": -1.624385952949524,
            "end_logit": 1.9727568626403809,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recA, Ku and ligD and their associated DNA repair mechanisms, namely, homologous recombination",
            "probability": 0.0009295667224038208,
            "start_logit": -2.370736837387085,
            "end_logit": 2.6737518310546875,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non-homologous end",
            "probability": 0.0007183989522729174,
            "start_logit": 3.969007968902588,
            "end_logit": -3.9236865043640137,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "splB, polY1 and polY2, which are involved in nucleotide damage repair",
            "probability": 0.0006715420008098871,
            "start_logit": -1.9948838949203491,
            "end_logit": 1.9727568626403809,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nfo, uvrAB, splB, polY1 and polY2, which are involved in nucleotide damage repair",
            "probability": 0.0006677287666944616,
            "start_logit": -2.0005784034729004,
            "end_logit": 1.9727568626403809,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "damage repair",
            "probability": 0.0006303579003551015,
            "start_logit": -2.0581727027893066,
            "end_logit": 1.9727568626403809,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "homologous recombination and non-homologous end",
            "probability": 0.0006053577090517086,
            "start_logit": 3.797802448272705,
            "end_logit": -3.9236865043640137,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "repair",
            "probability": 0.0006013331234554384,
            "start_logit": -2.105311393737793,
            "end_logit": 1.9727568626403809,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        }
    ],
    "53355befd6d3ac6a34000046": [
        {
            "text": "MDockPeP, HPEPDOCK",
            "probability": 0.07369406962138456,
            "start_logit": 2.639141082763672,
            "end_logit": 1.7130300998687744,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HawkDock), three small molecule dock",
            "probability": 0.07101711035319658,
            "start_logit": 2.6757922172546387,
            "end_logit": 1.639377474784851,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HawkDock), three small molecule docking programs (GOLD, Surflex-Dock",
            "probability": 0.06344479701418111,
            "start_logit": 2.6757922172546387,
            "end_logit": 1.5266268253326416,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "MDockPeP, HPEPDOCK, CABS-dock",
            "probability": 0.05657232006247237,
            "start_logit": 2.639141082763672,
            "end_logit": 1.4486275911331177,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "FRODOCK",
            "probability": 0.055520196810273766,
            "start_logit": 2.4221177101135254,
            "end_logit": 1.6468780040740967,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "FRODOCK, and HawkDock), three small molecule dock",
            "probability": 0.055105323776613785,
            "start_logit": 2.4221177101135254,
            "end_logit": 1.639377474784851,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK",
            "probability": 0.05437622177740096,
            "start_logit": 2.3031463623046875,
            "end_logit": 1.7450294494628906,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HawkDock",
            "probability": 0.05301980677611182,
            "start_logit": 2.6757922172546387,
            "end_logit": 1.3471221923828125,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK",
            "probability": 0.04929267615094658,
            "start_logit": 2.3031463623046875,
            "end_logit": 1.6468780040740967,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "FRODOCK, and HawkDock), three small molecule docking programs (GOLD, Surflex-Dock",
            "probability": 0.04922963021193418,
            "start_logit": 2.4221177101135254,
            "end_logit": 1.5266268253326416,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK, and HawkDock), three small molecule dock",
            "probability": 0.0489243380817959,
            "start_logit": 2.3031463623046875,
            "end_logit": 1.639377474784851,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "GalaxyPepDock, MDockPeP, HPEPDOCK",
            "probability": 0.04793947081466115,
            "start_logit": 2.209157943725586,
            "end_logit": 1.7130300998687744,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HPEPDOCK",
            "probability": 0.04767476190616673,
            "start_logit": 2.2036209106445312,
            "end_logit": 1.7130300998687744,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK, and HawkDock), three small molecule docking programs (GOLD, Surflex-Dock",
            "probability": 0.04370770203427458,
            "start_logit": 2.3031463623046875,
            "end_logit": 1.5266268253326416,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "MDockPeP",
            "probability": 0.042998997737498094,
            "start_logit": 2.639141082763672,
            "end_logit": 1.17428457736969,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "FRODOCK, and HawkDock",
            "probability": 0.04114041819556568,
            "start_logit": 2.4221177101135254,
            "end_logit": 1.3471221923828125,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "GalaxyPepDock, MDockPeP, HPEPDOCK, CABS-dock",
            "probability": 0.036801429212501804,
            "start_logit": 2.209157943725586,
            "end_logit": 1.4486275911331177,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HPEPDOCK, CABS-dock",
            "probability": 0.03659822158437553,
            "start_logit": 2.2036209106445312,
            "end_logit": 1.4486275911331177,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK, and HawkDock",
            "probability": 0.03652583073072377,
            "start_logit": 2.3031463623046875,
            "end_logit": 1.3471221923828125,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "GalaxyPepDock",
            "probability": 0.03641667714792113,
            "start_logit": 2.209157943725586,
            "end_logit": 1.4381177425384521,
            "question_text": "List programs suitable for protein docking"
        }
    ],
    "52f89f4f2059c6d71c00004e": [
        {
            "text": "NBEAL2",
            "probability": 0.957627912409072,
            "start_logit": 5.020859241485596,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene",
            "probability": 0.034062772181241235,
            "start_logit": 5.020859241485596,
            "end_logit": 1.7715405225753784,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL",
            "probability": 0.0023084761551929664,
            "start_logit": 5.020859241485596,
            "end_logit": -0.9200769066810608,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the human NBEAL2",
            "probability": 0.0017074417161273535,
            "start_logit": -1.3086038827896118,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "Mutations in the human NBEAL2",
            "probability": 0.0013213144861261381,
            "start_logit": -1.564972996711731,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "human NBEAL2",
            "probability": 0.0009529256991643135,
            "start_logit": -1.8918184041976929,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "2",
            "probability": 0.0007096922499368211,
            "start_logit": -2.186523914337158,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "BEAL2",
            "probability": 0.000320537245560257,
            "start_logit": -2.9813568592071533,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene cause gray platelet syndrome (GPS),",
            "probability": 0.00020286271995418573,
            "start_logit": 5.020859241485596,
            "end_logit": -3.3518903255462646,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "N",
            "probability": 0.00018773055053082776,
            "start_logit": 5.020859241485596,
            "end_logit": -3.4294121265411377,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "in the human NBEAL2",
            "probability": 0.00011474657690016913,
            "start_logit": -4.008629322052002,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "AL2",
            "probability": 0.00011112724374472901,
            "start_logit": -4.040679454803467,
            "end_logit": 5.107794761657715,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene cause gray platelet syndrome",
            "probability": 7.144624762780657e-05,
            "start_logit": 5.020859241485596,
            "end_logit": -4.395474433898926,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene cause gray platelet syndrome (GPS)",
            "probability": 6.840679363379788e-05,
            "start_logit": 5.020859241485596,
            "end_logit": -4.438947677612305,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the human NBEAL2 gene",
            "probability": 6.0733607944741284e-05,
            "start_logit": -1.3086038827896118,
            "end_logit": 1.7715405225753784,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "Mutations in the human NBEAL2 gene",
            "probability": 4.699908360802089e-05,
            "start_logit": -1.564972996711731,
            "end_logit": 1.7715405225753784,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBE",
            "probability": 3.453937995688583e-05,
            "start_logit": 5.020859241485596,
            "end_logit": -5.12231969833374,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "human NBEAL2 gene",
            "probability": 3.389551471471556e-05,
            "start_logit": -1.8918184041976929,
            "end_logit": 1.7715405225753784,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene cause gray platelet syndrome (GPS), a bleeding diathesis characterized by a lack of \u03b1 granules",
            "probability": 3.119642466135941e-05,
            "start_logit": 5.020859241485596,
            "end_logit": -5.224116325378418,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "2 gene",
            "probability": 2.5243714301911404e-05,
            "start_logit": -2.186523914337158,
            "end_logit": 1.7715405225753784,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        }
    ],
    "550712739d0faaa527000008": [
        {
            "text": "ryanodine receptor",
            "probability": 0.18932766706604318,
            "start_logit": 1.8876984119415283,
            "end_logit": 0.2953544557094574,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel",
            "probability": 0.15416765937530594,
            "start_logit": 1.7154186964035034,
            "end_logit": 0.2621956765651703,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor",
            "probability": 0.15316502060451212,
            "start_logit": 1.6757351160049438,
            "end_logit": 0.2953544557094574,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene",
            "probability": 0.07048993671042489,
            "start_logit": 1.8876984119415283,
            "end_logit": -0.6926547884941101,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene",
            "probability": 0.057025963378594884,
            "start_logit": 1.6757351160049438,
            "end_logit": -0.6926547884941101,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT.Mutations in the cardiac calcium release channel",
            "probability": 0.049763205492690366,
            "start_logit": 0.5846538543701172,
            "end_logit": 0.2621956765651703,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene (RYR2)",
            "probability": 0.0354433809242969,
            "start_logit": 1.8876984119415283,
            "end_logit": -1.380188226699829,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT.Mutations in the cardiac calcium release channel/ryanodine receptor",
            "probability": 0.034575242389195716,
            "start_logit": 0.5846538543701172,
            "end_logit": -0.10194230079650879,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene (RYR2) are identified in the majority of patients with CPVT.Mutations",
            "probability": 0.034249630280188306,
            "start_logit": 1.8876984119415283,
            "end_logit": -1.4144489765167236,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene (RYR2)",
            "probability": 0.02867349634467221,
            "start_logit": 1.6757351160049438,
            "end_logit": -1.380188226699829,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene (RYR2) are identified in the majority of patients with CPVT.Mutations in the cardiac calcium",
            "probability": 0.02852004735734556,
            "start_logit": 1.8876984119415283,
            "end_logit": -1.597517490386963,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene (RYR2) are identified in the majority of patients with CPVT.Mutations",
            "probability": 0.027707758770048416,
            "start_logit": 1.6757351160049438,
            "end_logit": -1.4144489765167236,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene (RYR2",
            "probability": 0.027677503102208987,
            "start_logit": 1.8876984119415283,
            "end_logit": -1.627504825592041,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium",
            "probability": 0.024006569942802616,
            "start_logit": 1.7154186964035034,
            "end_logit": -1.597517490386963,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.02239094475004817,
            "start_logit": 1.6757351160049438,
            "end_logit": -1.627504825592041,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "cardiac calcium release channel",
            "probability": 0.01943238972490968,
            "start_logit": -0.35568076372146606,
            "end_logit": 0.2621956765651703,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "cardiac calcium release channel/ryanodine receptor",
            "probability": 0.015027983631707221,
            "start_logit": -0.6458667516708374,
            "end_logit": 0.2953544557094574,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2)",
            "probability": 0.009630084131383259,
            "start_logit": 0.5846538543701172,
            "end_logit": -1.380188226699829,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "Mutations in the cardiac calcium release channel",
            "probability": 0.009419777900854602,
            "start_logit": -1.0798105001449585,
            "end_logit": 0.2621956765651703,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT.Mutations",
            "probability": 0.009305738122767073,
            "start_logit": 0.5846538543701172,
            "end_logit": -1.4144489765167236,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        }
    ],
    "511a20f3df1ebcce7d00000c": [
        {
            "text": "Psychosis",
            "probability": 0.6372493055699399,
            "start_logit": 5.435629367828369,
            "end_logit": 5.648037433624268,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroid-induced Psychosis",
            "probability": 0.18222108509486623,
            "start_logit": 4.183689117431641,
            "end_logit": 5.648037433624268,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychosis",
            "probability": 0.14103666791782699,
            "start_logit": 4.7532172203063965,
            "end_logit": 4.822308540344238,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "steroid-induced psychosis",
            "probability": 0.035883786106375624,
            "start_logit": 3.3844828605651855,
            "end_logit": 4.822308540344238,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroid",
            "probability": 0.0007110927236104643,
            "start_logit": 4.183689117431641,
            "end_logit": 0.1018642857670784,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "azathioprine is used as maintenance therapy.Steroid-induced Psychosis",
            "probability": 0.0004963560627058187,
            "start_logit": -1.721993327140808,
            "end_logit": 5.648037433624268,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Ps",
            "probability": 0.00042283194428849807,
            "start_logit": 5.435629367828369,
            "end_logit": -1.6699039936065674,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "steroids are usually used as induction therapy, and azathioprine is used as maintenance therapy.Steroid-induced Psychosis",
            "probability": 0.0003615578345339287,
            "start_logit": -2.038864850997925,
            "end_logit": 5.648037433624268,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "induced Psychosis",
            "probability": 0.00030940762418559805,
            "start_logit": -2.194627285003662,
            "end_logit": 5.648037433624268,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "ychosis",
            "probability": 0.00024968655701906216,
            "start_logit": -2.4090805053710938,
            "end_logit": 5.648037433624268,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Psych",
            "probability": 0.00021779985384319192,
            "start_logit": 5.435629367828369,
            "end_logit": -2.3333022594451904,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychosis in a 16-year-old female with Crohn's disease administered with steroids",
            "probability": 0.0001570380205286242,
            "start_logit": 4.7532172203063965,
            "end_logit": -1.9779787063598633,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "osis",
            "probability": 0.00013408358786579398,
            "start_logit": -3.0308234691619873,
            "end_logit": 5.648037433624268,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroid-induced Ps",
            "probability": 0.00012090855969173876,
            "start_logit": 4.183689117431641,
            "end_logit": -1.6699039936065674,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "ps",
            "probability": 0.00011649986711364263,
            "start_logit": 4.7532172203063965,
            "end_logit": -2.276576519012451,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroid-induced",
            "probability": 8.969172995426482e-05,
            "start_logit": 4.183689117431641,
            "end_logit": -1.968559980392456,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "steroid",
            "probability": 6.422800775413241e-05,
            "start_logit": 3.3844828605651855,
            "end_logit": -1.5032929182052612,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroid-induced Psych",
            "probability": 6.227974727302997e-05,
            "start_logit": 4.183689117431641,
            "end_logit": -2.3333022594451904,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psych",
            "probability": 5.325287468225498e-05,
            "start_logit": 4.7532172203063965,
            "end_logit": -3.059414863586426,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "induced psychosis",
            "probability": 4.244031594139959e-05,
            "start_logit": -3.355459213256836,
            "end_logit": 4.822308540344238,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        }
    ],
    "518cca6f310faafe0800000a": [
        {
            "text": "IGF1/PI3K/AKT",
            "probability": 0.24275517266409596,
            "start_logit": 0.9507302045822144,
            "end_logit": 0.4008358418941498,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1",
            "probability": 0.18026129226898713,
            "start_logit": 0.9507302045822144,
            "end_logit": 0.1031898483633995,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "mTOR",
            "probability": 0.11651208894883551,
            "start_logit": 1.0978573560714722,
            "end_logit": -0.48034968972206116,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "AKT",
            "probability": 0.10956495481083763,
            "start_logit": 0.15519435703754425,
            "end_logit": 0.4008358418941498,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K/AKT/mTOR",
            "probability": 0.10057139606990863,
            "start_logit": 0.9507302045822144,
            "end_logit": -0.48034968972206116,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K/AKT",
            "probability": 0.06493335761155514,
            "start_logit": -0.36796173453330994,
            "end_logit": 0.4008358418941498,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "AKT/mTOR",
            "probability": 0.04539182561893208,
            "start_logit": 0.15519435703754425,
            "end_logit": -0.48034968972206116,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K",
            "probability": 0.04047870031186922,
            "start_logit": 0.9507302045822144,
            "end_logit": -1.390441656112671,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K/AKT/mTOR",
            "probability": 0.026901335839038934,
            "start_logit": -0.36796173453330994,
            "end_logit": -0.48034968972206116,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "mTOR axis",
            "probability": 0.016515001194932242,
            "start_logit": 1.0978573560714722,
            "end_logit": -2.4340755939483643,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K/AKT/mTOR axis",
            "probability": 0.014255488346792234,
            "start_logit": 0.9507302045822144,
            "end_logit": -2.4340755939483643,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K",
            "probability": 0.010827443527386972,
            "start_logit": -0.36796173453330994,
            "end_logit": -1.390441656112671,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "AKT/mTOR axis",
            "probability": 0.006434062431633294,
            "start_logit": 0.15519435703754425,
            "end_logit": -2.4340755939483643,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "mTOR axis, relevant to exercise adaptation",
            "probability": 0.005161395742012525,
            "start_logit": 1.0978573560714722,
            "end_logit": -3.597137689590454,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K/AKT/mTOR axis, relevant to exercise adaptation",
            "probability": 0.004455235333317485,
            "start_logit": 0.9507302045822144,
            "end_logit": -3.597137689590454,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNAs are recognized as regulators of signalling pathways such as the IGF1/PI3K/AKT",
            "probability": 0.0040806468178122435,
            "start_logit": -3.1350677013397217,
            "end_logit": 0.4008358418941498,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K/AKT/mTOR axis",
            "probability": 0.00381312872797344,
            "start_logit": -0.36796173453330994,
            "end_logit": -2.4340755939483643,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNAs are recognized as regulators of signalling pathways such as the IGF1",
            "probability": 0.0030301420999584716,
            "start_logit": -3.1350677013397217,
            "end_logit": 0.1031898483633995,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "signalling pathways such as the IGF1/PI3K/AKT",
            "probability": 0.002046508743677205,
            "start_logit": -3.825187921524048,
            "end_logit": 0.4008358418941498,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "AKT/mTOR axis, relevant to exercise adaptation",
            "probability": 0.0020108228904437016,
            "start_logit": 0.15519435703754425,
            "end_logit": -3.597137689590454,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        }
    ],
    "56df03c751531f7e3300000a": [
        {
            "text": "stability",
            "probability": 0.7812614526445433,
            "start_logit": 3.342319965362549,
            "end_logit": 3.9121077060699463,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability of two phosphodiesterase genes",
            "probability": 0.06354774681972222,
            "start_logit": 3.342319965362549,
            "end_logit": 1.402989387512207,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "splicing pathways.By reducing m6A levels at the 3'UTR and the mRNA stability",
            "probability": 0.03564132531375371,
            "start_logit": 0.25491589307785034,
            "end_logit": 3.9121077060699463,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "demethylase",
            "probability": 0.02607585166143999,
            "start_logit": 2.1105868816375732,
            "end_logit": 1.7439405918121338,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability of two phosphodiesterase",
            "probability": 0.016509205237468665,
            "start_logit": 3.342319965362549,
            "end_logit": 0.0551159642636776,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNAs (mRNA).The fat mass- and obesity-associated protein (FTO) is an m6A demethylase",
            "probability": 0.012821422302816958,
            "start_logit": 1.4006946086883545,
            "end_logit": 1.7439405918121338,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNAs",
            "probability": 0.010254609245647101,
            "start_logit": 1.4006946086883545,
            "end_logit": 1.5205504894256592,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "demethylase with oncogenic properties",
            "probability": 0.010165158705335643,
            "start_logit": 2.1105868816375732,
            "end_logit": 0.8018969893455505,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "phosphodiesterase genes",
            "probability": 0.008810156439789682,
            "start_logit": 1.3664336204528809,
            "end_logit": 1.402989387512207,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNA transcription, and mRNA splicing pathways.By reducing m6A levels at the 3'UTR and the mRNA stability",
            "probability": 0.006498933125007026,
            "start_logit": -1.4469518661499023,
            "end_logit": 3.9121077060699463,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "By reducing m6A levels at the 3'UTR and the mRNA stability",
            "probability": 0.005601906294367971,
            "start_logit": -1.5954829454421997,
            "end_logit": 3.9121077060699463,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "the mRNA stability",
            "probability": 0.004046629121558306,
            "start_logit": -1.9207056760787964,
            "end_logit": 3.9121077060699463,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "demethylase with oncogenic",
            "probability": 0.00378125748245586,
            "start_logit": 2.1105868816375732,
            "end_logit": -0.1870124489068985,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mRNA stability",
            "probability": 0.0037320882642876666,
            "start_logit": -2.001621961593628,
            "end_logit": 3.9121077060699463,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "demethylase with oncogenic properties in leukemia",
            "probability": 0.0034439539540216143,
            "start_logit": 2.1105868816375732,
            "end_logit": -0.280448853969574,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "phosphodiesterase",
            "probability": 0.0022888094089522255,
            "start_logit": 1.3664336204528809,
            "end_logit": 0.0551159642636776,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "fat mass- and obesity-associated protein (FTO) is an m6A demethylase",
            "probability": 0.0019013830668273188,
            "start_logit": -0.5078412294387817,
            "end_logit": 1.7439405918121338,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "oncogenic properties",
            "probability": 0.0017159664963866178,
            "start_logit": 0.33159729838371277,
            "end_logit": 0.8018969893455505,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "obesity-associated protein (FTO) is an m6A demethylase",
            "probability": 0.0011489907145768611,
            "start_logit": -1.0115388631820679,
            "end_logit": 1.7439405918121338,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "splicing pathways.By reducing m6A levels at the 3'UTR and the mRNA stability of two phosphodiesterase",
            "probability": 0.0007531537010413092,
            "start_logit": 0.25491589307785034,
            "end_logit": 0.0551159642636776,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        }
    ],
    "517775c78ed59a060a000033": [
        {
            "text": "rapamycin",
            "probability": 0.4593882163185797,
            "start_logit": 4.680149555206299,
            "end_logit": 4.692870140075684,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rapamycin",
            "probability": 0.4421168195202642,
            "start_logit": 4.488535404205322,
            "end_logit": 4.846162796020508,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition of mTORC1 with rapamycin",
            "probability": 0.06673035474178987,
            "start_logit": 2.7509138584136963,
            "end_logit": 4.692870140075684,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mTORC1 with rapamycin",
            "probability": 0.029206851149858055,
            "start_logit": 1.9246572256088257,
            "end_logit": 4.692870140075684,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition of mTORC1",
            "probability": 0.0008573896026400043,
            "start_logit": 2.7509138584136963,
            "end_logit": 0.33834734559059143,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mTORC1",
            "probability": 0.00037526625774192423,
            "start_logit": 1.9246572256088257,
            "end_logit": 0.33834734559059143,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "cin",
            "probability": 0.0002254484727754686,
            "start_logit": -3.0927023887634277,
            "end_logit": 4.846162796020508,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rapamycin attenuated HG-induced tau hyperphosphorylation via the AKT",
            "probability": 0.00020690973561690723,
            "start_logit": 4.488535404205322,
            "end_logit": -2.8208839893341064,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rap",
            "probability": 0.00020595737683978414,
            "start_logit": 4.680149555206299,
            "end_logit": -3.0171115398406982,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rapamycin attenuated HG-induced tau hyperphosphorylation via the AKT/AMPK",
            "probability": 0.00020023782913741023,
            "start_logit": 4.488535404205322,
            "end_logit": -2.853660821914673,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "with rapamycin",
            "probability": 0.0001527464145343117,
            "start_logit": -3.3287222385406494,
            "end_logit": 4.692870140075684,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rap",
            "probability": 0.00014955280136326284,
            "start_logit": 4.488535404205322,
            "end_logit": -3.145517110824585,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "p70S6K in SH-SY5Y cells.Taken together, these data demonstrated that rapamycin",
            "probability": 6.640478829364891e-05,
            "start_logit": -3.1749699115753174,
            "end_logit": 3.7061078548431396,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition",
            "probability": 3.481755247022359e-05,
            "start_logit": 2.7509138584136963,
            "end_logit": -2.8654234409332275,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition of mTORC1 with rap",
            "probability": 2.9917199288099022e-05,
            "start_logit": 2.7509138584136963,
            "end_logit": -3.0171115398406982,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rapamycin improved STZ-induced AD-like tauopathies and memory deficit in mice via improving",
            "probability": 2.9513449279194757e-05,
            "start_logit": 3.420790195465088,
            "end_logit": -3.700575351715088,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mTORC1 with rap",
            "probability": 1.3094298536389147e-05,
            "start_logit": 1.9246572256088257,
            "end_logit": -3.0171115398406982,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "ycin",
            "probability": 1.0207345173311736e-05,
            "start_logit": -5.675001621246338,
            "end_logit": 4.333477973937988,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "AKT",
            "probability": 1.4999117901805368e-07,
            "start_logit": -2.7409260272979736,
            "end_logit": -2.8208839893341064,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "AKT/AMPK",
            "probability": 1.451546394701477e-07,
            "start_logit": -2.7409260272979736,
            "end_logit": -2.853660821914673,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        }
    ],
    "517539e68ed59a060a000028": [
        {
            "text": "MO25",
            "probability": 0.44269165211067807,
            "start_logit": 3.7105536460876465,
            "end_logit": 2.6282427310943604,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1",
            "probability": 0.3096539620310745,
            "start_logit": 3.0280799865722656,
            "end_logit": 2.953298330307007,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25",
            "probability": 0.22372101867280655,
            "start_logit": 3.0280799865722656,
            "end_logit": 2.6282427310943604,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB",
            "probability": 0.009016463497271915,
            "start_logit": 3.0280799865722656,
            "end_logit": -0.5831049084663391,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content with subsequent activation of AMPK",
            "probability": 0.0055827715397177525,
            "start_logit": 3.7105536460876465,
            "end_logit": -1.7449454069137573,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25 content with subsequent activation of AMPK",
            "probability": 0.0028213392548250447,
            "start_logit": 3.0280799865722656,
            "end_logit": -1.7449454069137573,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content",
            "probability": 0.0014934788159614817,
            "start_logit": 3.7105536460876465,
            "end_logit": -3.0635225772857666,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "cytochrome c",
            "probability": 0.0014028448733107545,
            "start_logit": 0.772711992263794,
            "end_logit": -0.18828687071800232,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content with subsequent activation of AMPK, phosphorylation of CREB",
            "probability": 0.0010732209015749284,
            "start_logit": 3.7105536460876465,
            "end_logit": -3.3939664363861084,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "uncoupling protein 3, cytochrome c",
            "probability": 0.0008626474512977901,
            "start_logit": 0.2864605784416199,
            "end_logit": -0.18828687071800232,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25 content",
            "probability": 0.0007547524342962427,
            "start_logit": 3.0280799865722656,
            "end_logit": -3.0635225772857666,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25 content with subsequent activation of AMPK, phosphorylation of CREB",
            "probability": 0.0005423686491862344,
            "start_logit": 3.0280799865722656,
            "end_logit": -3.3939664363861084,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "uncoupling protein 3",
            "probability": 8.544220702441841e-05,
            "start_logit": 0.2864605784416199,
            "end_logit": -2.500452756881714,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25, phospho-AMPK",
            "probability": 8.152451832702633e-05,
            "start_logit": 0.21273618936538696,
            "end_logit": -2.4736647605895996,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25, phospho-AMPK, phospho-CREB",
            "probability": 5.322086195003287e-05,
            "start_logit": 0.21273618936538696,
            "end_logit": -2.900118112564087,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25, phospho-AMPK, phospho-CREB, and PGC-1alpha",
            "probability": 4.4847830721776375e-05,
            "start_logit": 0.21273618936538696,
            "end_logit": -3.071293354034424,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1, MO25",
            "probability": 3.998626342312298e-05,
            "start_logit": -0.56842041015625,
            "end_logit": -2.4048759937286377,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1, MO25, phospho-AMPK",
            "probability": 3.732813059491431e-05,
            "start_logit": -0.56842041015625,
            "end_logit": -2.4736647605895996,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1, MO25, phospho-AMPK, phospho-CREB",
            "probability": 2.4368562072032998e-05,
            "start_logit": -0.56842041015625,
            "end_logit": -2.900118112564087,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "peroxisome proliferator-activated receptor-gamma coactivator-1alpha, uncoupling protein 3",
            "probability": 1.676139388572204e-05,
            "start_logit": -1.342301368713379,
            "end_logit": -2.500452756881714,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        }
    ],
    "518cb5ab310faafe08000008": [
        {
            "text": "levofloxacin",
            "probability": 0.3543574571590318,
            "start_logit": 5.875075817108154,
            "end_logit": 5.709771633148193,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based treatment (quadruple therapy) may be used afterwards, and then a levofloxacin",
            "probability": 0.25728327848884996,
            "start_logit": 5.554947376251221,
            "end_logit": 5.709771633148193,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole",
            "probability": 0.11667212151990812,
            "start_logit": 5.554947376251221,
            "end_logit": 4.918961524963379,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin",
            "probability": 0.10590232694479411,
            "start_logit": 5.214358329772949,
            "end_logit": 5.162700176239014,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin-based regimen was used, a second-line metronidazole",
            "probability": 0.08299485136528392,
            "start_logit": 5.214358329772949,
            "end_logit": 4.918961524963379,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin-based combination",
            "probability": 0.034201414739814376,
            "start_logit": 5.875075817108154,
            "end_logit": 3.371732473373413,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based treatment",
            "probability": 0.013635332167018429,
            "start_logit": 5.554947376251221,
            "end_logit": 2.7722582817077637,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin-based regimen was used, a second-line metronidazole-based treatment",
            "probability": 0.009699509632426375,
            "start_logit": 5.214358329772949,
            "end_logit": 2.7722582817077637,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based treatment (quadruple therapy",
            "probability": 0.00757039268496301,
            "start_logit": 5.554947376251221,
            "end_logit": 2.1838388442993164,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "a levofloxacin",
            "probability": 0.004408219877945315,
            "start_logit": 1.4882405996322632,
            "end_logit": 5.709771633148193,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin-based combination would be a third-line \"rescue\" option",
            "probability": 0.0028848513432650244,
            "start_logit": 5.875075817108154,
            "end_logit": 0.8989388346672058,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy) may be used afterwards, and then a levofloxacin",
            "probability": 0.0017044332737589738,
            "start_logit": 0.5380023121833801,
            "end_logit": 5.709771633148193,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based treatment (quadruple therapy)",
            "probability": 0.0016614357205495564,
            "start_logit": 5.554947376251221,
            "end_logit": 0.6672760248184204,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin-based combination would be a third-line \"rescue",
            "probability": 0.0016204284318121229,
            "start_logit": 5.875075817108154,
            "end_logit": 0.32215604186058044,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin-based regimen",
            "probability": 0.001390478253574977,
            "start_logit": 5.214358329772949,
            "end_logit": 0.8298307061195374,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "first-line clarithromycin",
            "probability": 0.000983503100694707,
            "start_logit": 0.5352066159248352,
            "end_logit": 5.162700176239014,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "second-line metronidazole",
            "probability": 0.0009349763876322587,
            "start_logit": 0.7283457517623901,
            "end_logit": 4.918961524963379,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "first-line clarithromycin-based regimen was used, a second-line metronidazole",
            "probability": 0.000770763929502737,
            "start_logit": 0.5352066159248352,
            "end_logit": 4.918961524963379,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin-based combination would be a third-line",
            "probability": 0.0007003832148682492,
            "start_logit": 5.875075817108154,
            "end_logit": -0.5166621804237366,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based",
            "probability": 0.0006238417643055739,
            "start_logit": 5.554947376251221,
            "end_logit": -0.312264621257782,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        }
    ],
    "54db7217c4c6ce8e1d000003": [
        {
            "text": "RYR2",
            "probability": 0.7222681865550512,
            "start_logit": 1.4859904050827026,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "ryanodine receptor gene (RYR2",
            "probability": 0.1229908826227919,
            "start_logit": -0.2842958867549896,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "(RYR2",
            "probability": 0.06895093135408016,
            "start_logit": -0.8630110025405884,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "Mutations in the cardiac calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.021379579451299983,
            "start_logit": -2.0339698791503906,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2)",
            "probability": 0.020755265455227677,
            "start_logit": 1.4859904050827026,
            "end_logit": -1.868588924407959,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.0077492780598058895,
            "start_logit": -3.0488064289093018,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "2",
            "probability": 0.007105366688862446,
            "start_logit": -3.1355557441711426,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT.",
            "probability": 0.00446717229456201,
            "start_logit": 1.4859904050827026,
            "end_logit": -3.4046332836151123,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "ryanodine receptor gene (RYR2)",
            "probability": 0.0035342944143563326,
            "start_logit": -0.2842958867549896,
            "end_logit": -1.868588924407959,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "gene (RYR2",
            "probability": 0.002903906384655055,
            "start_logit": -4.030349254608154,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "the cardiac calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.0027092279413057363,
            "start_logit": -4.099742412567139,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "cardiac calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.0026092671159194548,
            "start_logit": -4.137336730957031,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "receptor gene (RYR2",
            "probability": 0.002375093057846634,
            "start_logit": -4.231369495391846,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "R",
            "probability": 0.002043914596192299,
            "start_logit": 1.4859904050827026,
            "end_logit": -4.186522006988525,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "(RYR2)",
            "probability": 0.001981389891288029,
            "start_logit": -0.8630110025405884,
            "end_logit": -1.868588924407959,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "in the cardiac calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.0015015201969793654,
            "start_logit": -4.68992805480957,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR",
            "probability": 0.0013936040284967398,
            "start_logit": 1.4859904050827026,
            "end_logit": -4.569495677947998,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2) are identified",
            "probability": 0.0013380671680561032,
            "start_logit": 1.4859904050827026,
            "end_logit": -4.610162734985352,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "channel/ryanodine receptor gene (RYR2",
            "probability": 0.0010151837352898021,
            "start_logit": -5.081336498260498,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "odine receptor gene (RYR2",
            "probability": 0.0009278689879331468,
            "start_logit": -5.171270847320557,
            "end_logit": 1.6810076236724854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        }
    ],
    "532c0ac4d6d3ac6a3400001a": [
        {
            "text": "docking calculations",
            "probability": 0.3896595403417463,
            "start_logit": 2.0492324829101562,
            "end_logit": 1.7062032222747803,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking",
            "probability": 0.10598504981952504,
            "start_logit": 2.0492324829101562,
            "end_logit": 0.4042278826236725,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "dock",
            "probability": 0.07409204771392651,
            "start_logit": 2.0492324829101562,
            "end_logit": 0.046238046139478683,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses of binding free energy",
            "probability": 0.07043173311362742,
            "start_logit": 2.0492324829101562,
            "end_logit": -0.004426246043294668,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses of binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity",
            "probability": 0.06840546516377331,
            "start_logit": 2.0492324829101562,
            "end_logit": -0.03361744061112404,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses",
            "probability": 0.057541287041660005,
            "start_logit": 2.0492324829101562,
            "end_logit": -0.2065674364566803,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding free energy",
            "probability": 0.04568693044205665,
            "start_logit": 1.6164008378982544,
            "end_logit": -0.004426246043294668,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity",
            "probability": 0.0443725518404027,
            "start_logit": 1.6164008378982544,
            "end_logit": -0.03361744061112404,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses",
            "probability": 0.03732528879244757,
            "start_logit": 1.6164008378982544,
            "end_logit": -0.2065674364566803,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, docking calculations",
            "probability": 0.017843462947337276,
            "start_logit": -1.034403681755066,
            "end_logit": 1.7062032222747803,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "binding free energy",
            "probability": 0.016404862705971347,
            "start_logit": 0.5921663641929626,
            "end_logit": -0.004426246043294668,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity",
            "probability": 0.01593290715336213,
            "start_logit": 0.5921663641929626,
            "end_logit": -0.03361744061112404,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "calculations",
            "probability": 0.013019232818971665,
            "start_logit": -1.3496131896972656,
            "end_logit": 1.7062032222747803,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses of binding",
            "probability": 0.011843220899783808,
            "start_logit": 2.0492324829101562,
            "end_logit": -1.787314534187317,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity, which could be further optimized",
            "probability": 0.00812244194851773,
            "start_logit": 1.6164008378982544,
            "end_logit": -1.7316076755523682,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding",
            "probability": 0.00768233842244674,
            "start_logit": 1.6164008378982544,
            "end_logit": -1.787314534187317,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, docking",
            "probability": 0.004853314531367018,
            "start_logit": -1.034403681755066,
            "end_logit": 0.4042278826236725,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "combined a 3D pharmacophore-based search, docking calculations",
            "probability": 0.00418022706376906,
            "start_logit": -2.48567533493042,
            "end_logit": 1.7062032222747803,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, dock",
            "probability": 0.00339285599658691,
            "start_logit": -1.034403681755066,
            "end_logit": 0.046238046139478683,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, docking calculations, and analyses of binding free energy",
            "probability": 0.0032252412427206177,
            "start_logit": -1.034403681755066,
            "end_logit": -0.004426246043294668,
            "question_text": "What are the main benefits of pharmacophore models?"
        }
    ],
    "52e7b7cb98d023950500001c": [
        {
            "text": "anti-diabetic",
            "probability": 0.6645898610858137,
            "start_logit": 2.1711103916168213,
            "end_logit": 1.9291746616363525,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabetic",
            "probability": 0.21055815355661067,
            "start_logit": 1.0217021703720093,
            "end_logit": 1.9291746616363525,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabetic drugs",
            "probability": 0.08324036623797339,
            "start_logit": 2.1711103916168213,
            "end_logit": -0.14826303720474243,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabetic drugs",
            "probability": 0.026372562752925568,
            "start_logit": 1.0217021703720093,
            "end_logit": -0.14826303720474243,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-obesity or anti-diabetic",
            "probability": 0.00877149408765561,
            "start_logit": -2.15655255317688,
            "end_logit": 1.9291746616363525,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabe",
            "probability": 0.00194243413512475,
            "start_logit": 2.1711103916168213,
            "end_logit": -3.9060535430908203,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-obesity or anti-diabetic drugs",
            "probability": 0.0010986360506880996,
            "start_logit": -2.15655255317688,
            "end_logit": -0.14826303720474243,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti",
            "probability": 0.0008588806361825519,
            "start_logit": 2.1711103916168213,
            "end_logit": -4.722120761871338,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabe",
            "probability": 0.0006154101481912146,
            "start_logit": 1.0217021703720093,
            "end_logit": -3.9060535430908203,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "drugs",
            "probability": 0.0003799090901337176,
            "start_logit": -3.5005288124084473,
            "end_logit": 0.13382047414779663,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-di",
            "probability": 0.0003778582896457957,
            "start_logit": 2.1711103916168213,
            "end_logit": -5.54323148727417,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "tic",
            "probability": 0.0003142387363962113,
            "start_logit": -5.48566198348999,
            "end_logit": 1.9291746616363525,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabetic drugs effects on each co-culturing cell type.",
            "probability": 0.00028789701827211864,
            "start_logit": 2.1711103916168213,
            "end_logit": -5.815147876739502,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "abetic",
            "probability": 0.0002710857119921255,
            "start_logit": -5.633379936218262,
            "end_logit": 1.9291746616363525,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "di",
            "probability": 0.00011971465174610083,
            "start_logit": 1.0217021703720093,
            "end_logit": -5.54323148727417,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabetic drugs effects on each co-culturing cell type.",
            "probability": 9.121274357509916e-05,
            "start_logit": 1.0217021703720093,
            "end_logit": -5.815147876739502,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "tic drugs",
            "probability": 3.935863159429256e-05,
            "start_logit": -5.48566198348999,
            "end_logit": -0.14826303720474243,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "abetic drugs",
            "probability": 3.3953683721925774e-05,
            "start_logit": -5.633379936218262,
            "end_logit": -0.14826303720474243,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-obesity or anti-diabe",
            "probability": 2.5636938703925212e-05,
            "start_logit": -2.15655255317688,
            "end_logit": -3.9060535430908203,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-obesity or anti",
            "probability": 1.1335813053134094e-05,
            "start_logit": -2.15655255317688,
            "end_logit": -4.722120761871338,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        }
    ],
    "58a7fb2860087bc10a000034": [
        {
            "text": "ASH1L",
            "probability": 0.8392707403381958,
            "start_logit": 3.71665620803833,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L,",
            "probability": 0.10127648181381231,
            "start_logit": 3.71665620803833,
            "end_logit": 0.39690157771110535,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1",
            "probability": 0.02327133655572823,
            "start_logit": 3.71665620803833,
            "end_logit": -1.073730230331421,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based on a transmission disequilibrium test",
            "probability": 0.0068150055604458025,
            "start_logit": 3.71665620803833,
            "end_logit": -2.301825761795044,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH",
            "probability": 0.005823236524983138,
            "start_logit": 3.71665620803833,
            "end_logit": -2.4590964317321777,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based",
            "probability": 0.004343118060799448,
            "start_logit": 3.71665620803833,
            "end_logit": -2.7523601055145264,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated",
            "probability": 0.003384538874215825,
            "start_logit": 3.71665620803833,
            "end_logit": -3.001734972000122,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "risk gene, ASH1L",
            "probability": 0.0024384795748852266,
            "start_logit": -2.124502420425415,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based on a transmission disequilibrium test.",
            "probability": 0.002371376167345041,
            "start_logit": 3.71665620803833,
            "end_logit": -3.3574821949005127,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based on a transmission",
            "probability": 0.0023459397323525363,
            "start_logit": 3.71665620803833,
            "end_logit": -3.3682665824890137,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based on a transmission disequilibrium",
            "probability": 0.002239168415005275,
            "start_logit": 3.71665620803833,
            "end_logit": -3.4148480892181396,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated",
            "probability": 0.0015737695045622486,
            "start_logit": 3.71665620803833,
            "end_logit": -3.7674789428710938,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "a risk gene, ASH1L",
            "probability": 0.0013591235927880234,
            "start_logit": -2.7090370655059814,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "identified a risk gene, ASH1L",
            "probability": 0.0013030590446014957,
            "start_logit": -2.751162528991699,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "L",
            "probability": 0.0006697213449425427,
            "start_logit": -3.4167706966400146,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "1L",
            "probability": 0.0004592302348079239,
            "start_logit": -3.7940807342529297,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "quencing of a hundred trios (probands and their parents) with detailed records of their clinical presentations and identified a risk gene, ASH1L",
            "probability": 0.00033120673443594155,
            "start_logit": -4.120889663696289,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "risk gene, ASH1L,",
            "probability": 0.00029425621608076104,
            "start_logit": -2.124502420425415,
            "end_logit": 0.39690157771110535,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": ", ASH1L",
            "probability": 0.0002662035429074053,
            "start_logit": -4.339371204376221,
            "end_logit": 2.5115807056427,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "a risk gene, ASH1L,",
            "probability": 0.00016400816710499476,
            "start_logit": -2.7090370655059814,
            "end_logit": 0.39690157771110535,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        }
    ],
    "58846be0e56acf5176000005": [
        {
            "text": "high-intensity focused ultrasound thalamotomy",
            "probability": 0.19284368075067712,
            "start_logit": -3.558718681335449,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy",
            "probability": 0.11498525479325307,
            "start_logit": -4.075794696807861,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "gamma knife thalamotomy",
            "probability": 0.11276887406321263,
            "start_logit": -4.075794696807861,
            "end_logit": -2.1832082271575928,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "high-intensity focused ultrasound thalamotomy or sub-thalamotomy",
            "probability": 0.06589629468740758,
            "start_logit": -3.558718681335449,
            "end_logit": -3.2375423908233643,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "focused ultrasound thalamotomy",
            "probability": 0.06044202044471042,
            "start_logit": -4.718914031982422,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "thalamotomy",
            "probability": 0.046436914161756805,
            "start_logit": -4.982503890991211,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "New emerging, potentially less invasive, techniques, such as gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy",
            "probability": 0.041861434351953594,
            "start_logit": -5.086233615875244,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "New emerging, potentially less invasive, techniques, such as gamma knife thalamotomy",
            "probability": 0.04105454066287715,
            "start_logit": -5.086233615875244,
            "end_logit": -2.1832082271575928,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy or sub-thalamotomy",
            "probability": 0.039291420932579584,
            "start_logit": -4.075794696807861,
            "end_logit": -3.2375423908233643,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "potentially less invasive, techniques, such as gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy",
            "probability": 0.032016392296238975,
            "start_logit": -5.354350566864014,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "potentially less invasive, techniques, such as gamma knife thalamotomy",
            "probability": 0.03139926521278477,
            "start_logit": -5.354350566864014,
            "end_logit": -2.1832082271575928,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "high-intensity focused ultrasound",
            "probability": 0.02995403856536779,
            "start_logit": -3.558718681335449,
            "end_logit": -4.025960445404053,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "high-intensity focused ultrasound thalamotomy or sub-thalamotomy,",
            "probability": 0.02905834904366782,
            "start_logit": -3.558718681335449,
            "end_logit": -4.056318759918213,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "less invasive, techniques, such as gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy",
            "probability": 0.028354133192524902,
            "start_logit": -5.475825786590576,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "less invasive, techniques, such as gamma knife thalamotomy",
            "probability": 0.027807597425500628,
            "start_logit": -5.475825786590576,
            "end_logit": -2.1832082271575928,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "ultrasound thalamotomy",
            "probability": 0.023141924912845065,
            "start_logit": -5.678952693939209,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "sub-thalamotomy",
            "probability": 0.02119694028614499,
            "start_logit": -4.692944049835205,
            "end_logit": -3.2375423908233643,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "my",
            "probability": 0.021195848705465554,
            "start_logit": -5.766793251037598,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "focused ultrasound thalamotomy or sub-thalamotomy",
            "probability": 0.020653542678830905,
            "start_logit": -4.718914031982422,
            "end_logit": -3.2375423908233643,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "techniques, such as gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy",
            "probability": 0.01964153283220031,
            "start_logit": -5.842952251434326,
            "end_logit": -2.1637446880340576,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        }
    ],
    "58919aad621ea6ff7e00000d": [
        {
            "text": "2-chlorophenol by enrichment cultures under denitrifying conditions.",
            "probability": 0.18437312437294293,
            "start_logit": -6.74097204208374,
            "end_logit": -5.013306617736816,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": ".",
            "probability": 0.17638903687069535,
            "start_logit": -6.785241603851318,
            "end_logit": -5.013306617736816,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "enrichment cultures under denitrifying conditions.",
            "probability": 0.09277682120050608,
            "start_logit": -7.427736759185791,
            "end_logit": -5.013306617736816,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "chlorophenol",
            "probability": 0.0625826828459666,
            "start_logit": -6.316607475280762,
            "end_logit": -6.518144130706787,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "chlorophenol (CP) degradation has been studied,",
            "probability": 0.058066197116058794,
            "start_logit": -6.316607475280762,
            "end_logit": -6.593049049377441,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2-chlorophenol",
            "probability": 0.051640539887927606,
            "start_logit": -6.74097204208374,
            "end_logit": -6.285961151123047,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2-chlorophenol by enrichment cultures under denitrifying conditions. Although chlorophenol",
            "probability": 0.04094067391670507,
            "start_logit": -6.74097204208374,
            "end_logit": -6.518144130706787,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "chlorophenol (CP) degradation has been studied",
            "probability": 0.04088910967877268,
            "start_logit": -6.316607475280762,
            "end_logit": -6.9437689781188965,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": ". Although chlorophenol",
            "probability": 0.039167780366933844,
            "start_logit": -6.785241603851318,
            "end_logit": -6.518144130706787,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": ". Although chlorophenol (CP) degradation has been studied,",
            "probability": 0.03634110830599293,
            "start_logit": -6.785241603851318,
            "end_logit": -6.593049049377441,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "0.0139 d(-1).",
            "probability": 0.03128807386252532,
            "start_logit": -6.8056488037109375,
            "end_logit": -6.722354412078857,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2-chlorophenol by enrichment cultures under denitrifying conditions",
            "probability": 0.030300854037508356,
            "start_logit": -6.74097204208374,
            "end_logit": -6.819092273712158,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": ". Although chlorophenol (CP) degradation has been studied",
            "probability": 0.025590716065008946,
            "start_logit": -6.785241603851318,
            "end_logit": -6.9437689781188965,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "no bacterium responsible for degradation of CP under denitrifying conditions has been isolated.",
            "probability": 0.023840980329762743,
            "start_logit": -7.309163570404053,
            "end_logit": -6.490670680999756,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "anaerobic batch culture inoculated with activated sludge.",
            "probability": 0.021162101817459863,
            "start_logit": -7.560202121734619,
            "end_logit": -6.358826160430908,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "enrichment cultures under denitrifying conditions. Although chlorophenol",
            "probability": 0.02060140596259149,
            "start_logit": -7.427736759185791,
            "end_logit": -6.518144130706787,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "enrichment cultures under denitrifying conditions. Although chlorophenol (CP) degradation has been studied,",
            "probability": 0.019114637549752844,
            "start_logit": -7.427736759185791,
            "end_logit": -6.593049049377441,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "no bacterium responsible for degradation of CP under denitrifying conditions has been isolated",
            "probability": 0.015432153565556994,
            "start_logit": -7.309163570404053,
            "end_logit": -6.925623416900635,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "enrichment cultures under denitrifying conditions",
            "probability": 0.015247433305811547,
            "start_logit": -7.427736759185791,
            "end_logit": -6.819092273712158,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2,6-DCP] under denitrifying conditions was examined in anaerobic batch culture",
            "probability": 0.014254568941519812,
            "start_logit": -7.419032573699951,
            "end_logit": -6.895130157470703,
            "question_text": "List selective estrogen receptor degraders."
        }
    ],
    "587d2700fe8a08052f000001": [
        {
            "text": "H3K27ac samples",
            "probability": 0.08521832312061137,
            "start_logit": -2.152838945388794,
            "end_logit": -2.564127206802368,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "super-enhancer databases",
            "probability": 0.08312934863265709,
            "start_logit": -2.6520705223083496,
            "end_logit": -2.089714288711548,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "H3K27ac",
            "probability": 0.07342879787913573,
            "start_logit": -2.152838945388794,
            "end_logit": -2.7130274772644043,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "unlike existing super-enhancer databases",
            "probability": 0.07308914881129203,
            "start_logit": -2.7807884216308594,
            "end_logit": -2.089714288711548,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "we manually curated and classified 410 available H3K27ac samples",
            "probability": 0.055164993962444904,
            "start_logit": -2.5877268314361572,
            "end_logit": -2.564127206802368,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "410 available H3K27ac samples",
            "probability": 0.05345720421621026,
            "start_logit": -2.619174003601074,
            "end_logit": -2.564127206802368,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "super-enhancer databases, we manually curated and classified 410 available H3K27ac samples",
            "probability": 0.05172725889368026,
            "start_logit": -2.6520705223083496,
            "end_logit": -2.564127206802368,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "super-enhancer databases,",
            "probability": 0.048008324462300425,
            "start_logit": -2.6520705223083496,
            "end_logit": -2.638737678527832,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "we manually curated and classified 410 available H3K27ac",
            "probability": 0.047533195248855895,
            "start_logit": -2.5877268314361572,
            "end_logit": -2.7130274772644043,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "410 available H3K27ac",
            "probability": 0.046061669601503714,
            "start_logit": -2.619174003601074,
            "end_logit": -2.7130274772644043,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "unlike existing super-enhancer databases, we manually curated and classified 410 available H3K27ac samples",
            "probability": 0.04547974193310579,
            "start_logit": -2.7807884216308594,
            "end_logit": -2.564127206802368,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "super-enhancer databases, we manually curated and classified 410 available H3K27ac",
            "probability": 0.04457105349010445,
            "start_logit": -2.6520705223083496,
            "end_logit": -2.7130274772644043,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "unlike existing super-enhancer databases,",
            "probability": 0.04220997311444603,
            "start_logit": -2.7807884216308594,
            "end_logit": -2.638737678527832,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "H3K27ac samples from >2000 ChIP-seq samples",
            "probability": 0.03989537950493217,
            "start_logit": -2.152838945388794,
            "end_logit": -3.3230831623077393,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "unlike existing super-enhancer databases, we manually curated and classified 410 available H3K27ac",
            "probability": 0.03918784899433868,
            "start_logit": -2.7807884216308594,
            "end_logit": -2.7130274772644043,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "classified 410 available H3K27ac samples",
            "probability": 0.037022226056660876,
            "start_logit": -2.986536979675293,
            "end_logit": -2.564127206802368,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "we manually curated and classified 410",
            "probability": 0.03540587111281404,
            "start_logit": -2.5877268314361572,
            "end_logit": -3.007578134536743,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "410",
            "probability": 0.03430978137728116,
            "start_logit": -2.619174003601074,
            "end_logit": -3.007578134536743,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "super-enhancer databases, we manually curated and classified 410",
            "probability": 0.033199471800098745,
            "start_logit": -2.6520705223083496,
            "end_logit": -3.007578134536743,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "classified 410 available H3K27ac",
            "probability": 0.03190038778752633,
            "start_logit": -2.986536979675293,
            "end_logit": -2.7130274772644043,
            "question_text": "List all the available databases of super enhancers"
        }
    ],
    "58a2efec60087bc10a000008": [
        {
            "text": "subcellular relocalization",
            "probability": 0.2668925436944002,
            "start_logit": 4.25616979598999,
            "end_logit": 4.635253429412842,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "relocalization",
            "probability": 0.1723426900967827,
            "start_logit": 3.8188085556030273,
            "end_logit": 4.635253429412842,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "detachment from microtubules",
            "probability": 0.1675810907553276,
            "start_logit": 4.324825763702393,
            "end_logit": 4.1012187004089355,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "subcellular relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.1564617217043899,
            "start_logit": 4.25616979598999,
            "end_logit": 4.1012187004089355,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.10103329842959002,
            "start_logit": 3.8188085556030273,
            "end_logit": 4.1012187004089355,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "a process of subcellular relocalization",
            "probability": 0.023534393117904423,
            "start_logit": 1.8277865648269653,
            "end_logit": 4.635253429412842,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "detachment",
            "probability": 0.022307746241555796,
            "start_logit": 4.324825763702393,
            "end_logit": 2.0846853256225586,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "subcellular relocalization driven by Tau phosphorylation and detachment",
            "probability": 0.020827578866844745,
            "start_logit": 4.25616979598999,
            "end_logit": 2.0846853256225586,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "microtubules",
            "probability": 0.017841772013729912,
            "start_logit": 2.0849008560180664,
            "end_logit": 4.1012187004089355,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "a process of subcellular relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.01379668242328843,
            "start_logit": 1.8277865648269653,
            "end_logit": 4.1012187004089355,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "relocalization driven by Tau phosphorylation and detachment",
            "probability": 0.013449161675438134,
            "start_logit": 3.8188085556030273,
            "end_logit": 2.0846853256225586,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "detachment from microtubules has been proposed",
            "probability": 0.0050037608595670125,
            "start_logit": 4.324825763702393,
            "end_logit": 0.589941143989563,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "subcellular relocalization driven by Tau phosphorylation and detachment from microtubules has been proposed",
            "probability": 0.0046717504675270385,
            "start_logit": 4.25616979598999,
            "end_logit": 0.589941143989563,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "process of subcellular relocalization",
            "probability": 0.0035842987148246106,
            "start_logit": -0.0541134849190712,
            "end_logit": 4.635253429412842,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "relocalization driven by Tau phosphorylation and detachment from microtubules has been proposed",
            "probability": 0.0030167273760799526,
            "start_logit": 3.8188085556030273,
            "end_logit": 0.589941143989563,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "process of subcellular relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.0021012409723458947,
            "start_logit": -0.0541134849190712,
            "end_logit": 4.1012187004089355,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "a process of subcellular relocalization driven by Tau phosphorylation and detachment",
            "probability": 0.0018365609693005705,
            "start_logit": 1.8277865648269653,
            "end_logit": 2.0846853256225586,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "zation",
            "probability": 0.0015642923315271162,
            "start_logit": -0.8832427859306335,
            "end_logit": 4.635253429412842,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "Consequently, a process of subcellular relocalization",
            "probability": 0.001235646542514639,
            "start_logit": -1.119081974029541,
            "end_logit": 4.635253429412842,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "zation driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.0009170427470613602,
            "start_logit": -0.8832427859306335,
            "end_logit": 4.1012187004089355,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        }
    ],
    "58a0da5278275d0c4a000054": [
        {
            "text": "cutaneous lupus erythematosus",
            "probability": 0.5707220964752301,
            "start_logit": 3.263185501098633,
            "end_logit": 2.7458956241607666,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "cutaneous lupus erythematosus, and chronic graft-versus-host disease",
            "probability": 0.27275219875564244,
            "start_logit": 3.263185501098633,
            "end_logit": 2.007556915283203,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "chronic graft-versus-host disease",
            "probability": 0.04649728844527166,
            "start_logit": 1.4940158128738403,
            "end_logit": 2.007556915283203,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "lymphocytic skin infiltrations, cutaneous lupus erythematosus",
            "probability": 0.03361383850977768,
            "start_logit": 0.4312209486961365,
            "end_logit": 2.7458956241607666,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "graft-versus-host disease",
            "probability": 0.021972416371157388,
            "start_logit": 0.7444096803665161,
            "end_logit": 2.007556915283203,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "lymphocytic skin infiltrations, cutaneous lupus erythematosus, and chronic graft-versus-host disease",
            "probability": 0.01606429542290704,
            "start_logit": 0.4312209486961365,
            "end_logit": 2.007556915283203,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "skin diseases",
            "probability": 0.006885833893625244,
            "start_logit": 0.2977461516857147,
            "end_logit": 1.2938988208770752,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "cutaneous lupus",
            "probability": 0.006875725304413284,
            "start_logit": 3.263185501098633,
            "end_logit": -1.6730096340179443,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.006373347455389082,
            "start_logit": -1.231592059135437,
            "end_logit": 2.7458956241607666,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "lupus erythematosus, and chronic graft-versus-host disease",
            "probability": 0.003045868633135175,
            "start_logit": -1.231592059135437,
            "end_logit": 2.007556915283203,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "leprous erythema nodosum, severe mucosal ulcers",
            "probability": 0.002925196897656001,
            "start_logit": 0.500171422958374,
            "end_logit": 0.23536910116672516,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "skin diseases including leprous erythema nodosum, severe mucosal ulcers",
            "probability": 0.0023891472965196937,
            "start_logit": 0.2977461516857147,
            "end_logit": 0.23536910116672516,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "mucosal ulcers",
            "probability": 0.002140611476836633,
            "start_logit": 0.18790115416049957,
            "end_logit": 0.23536910116672516,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "leprous erythema nodosum",
            "probability": 0.0016645992797032806,
            "start_logit": 0.500171422958374,
            "end_logit": -0.32840827107429504,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "skin diseases including leprous erythema nodosum",
            "probability": 0.0013595573248688056,
            "start_logit": 0.2977461516857147,
            "end_logit": -0.32840827107429504,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Beh\u00e7et's disease), lymphocytic skin infiltrations, cutaneous lupus erythematosus",
            "probability": 0.0013166686356329894,
            "start_logit": -2.808612108230591,
            "end_logit": 2.7458956241607666,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "lymphocytic skin infiltrations",
            "probability": 0.001296353708035263,
            "start_logit": 0.4312209486961365,
            "end_logit": -0.509486734867096,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "mucosal ulcers (e.g., associated with HIV infection or Beh\u00e7et's disease",
            "probability": 0.0008950573178467289,
            "start_logit": 0.18790115416049957,
            "end_logit": -0.6365899443626404,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "treatment of a few skin diseases",
            "probability": 0.0007075787471253783,
            "start_logit": -1.9776264429092407,
            "end_logit": 1.2938988208770752,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "ankylosing spondylarthritis",
            "probability": 0.0005023200492260473,
            "start_logit": -0.3825819790363312,
            "end_logit": -0.6437571048736572,
            "question_text": "For what indications is thalidomide currently marketed?"
        }
    ],
    "589a246378275d0c4a00002c": [
        {
            "text": "Middle East Respiratory Syndrome",
            "probability": 0.22526546089862104,
            "start_logit": 0.412284791469574,
            "end_logit": 0.3005003035068512,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome",
            "probability": 0.13758119682371878,
            "start_logit": -0.08078047633171082,
            "end_logit": 0.3005003035068512,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome-Coronavirus",
            "probability": 0.10869347964764833,
            "start_logit": 0.412284791469574,
            "end_logit": -0.4282474219799042,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory",
            "probability": 0.09322440322972204,
            "start_logit": 0.412284791469574,
            "end_logit": -0.5817697048187256,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection",
            "probability": 0.06909812503320004,
            "start_logit": 0.412284791469574,
            "end_logit": -0.8812516331672668,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome-Coronavirus",
            "probability": 0.0663846954486644,
            "start_logit": -0.08078047633171082,
            "end_logit": -0.4282474219799042,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory",
            "probability": 0.05693693528673852,
            "start_logit": -0.08078047633171082,
            "end_logit": -0.5817697048187256,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Coronavirus",
            "probability": 0.05461402799513328,
            "start_logit": -0.27595624327659607,
            "end_logit": -0.4282474219799042,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome-Coronavirus (MERS-CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection",
            "probability": 0.04220177697201879,
            "start_logit": -0.08078047633171082,
            "end_logit": -0.8812516331672668,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Coronavirus (MERS-CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection",
            "probability": 0.03471898173844187,
            "start_logit": -0.27595624327659607,
            "end_logit": -0.8812516331672668,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle",
            "probability": 0.0249289531159975,
            "start_logit": 0.412284791469574,
            "end_logit": -1.9007493257522583,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East",
            "probability": 0.015549496083934857,
            "start_logit": 0.412284791469574,
            "end_logit": -2.372750997543335,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome-Coronavirus (MERS-CoV",
            "probability": 0.011371492537058653,
            "start_logit": 0.412284791469574,
            "end_logit": -2.6856696605682373,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)",
            "probability": 0.011350327136603961,
            "start_logit": 0.412284791469574,
            "end_logit": -2.687532663345337,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "East Respiratory Syndrome",
            "probability": 0.009170915756506633,
            "start_logit": -2.7889575958251953,
            "end_logit": 0.3005003035068512,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) infection",
            "probability": 0.008679253671315166,
            "start_logit": 0.412284791469574,
            "end_logit": -2.955843687057495,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "upper respiratory infection",
            "probability": 0.008095015756292059,
            "start_logit": -1.7319942712783813,
            "end_logit": -0.8812516331672668,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) infection among suspected cases presented with sign and symptoms of upper respiratory",
            "probability": 0.007957629487725165,
            "start_logit": 0.412284791469574,
            "end_logit": -3.0426480770111084,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Syndrome",
            "probability": 0.007199010475349881,
            "start_logit": -3.0310511589050293,
            "end_logit": 0.3005003035068512,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Coronavirus (MERS-CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection or exposure to the virus.",
            "probability": 0.006978822905308778,
            "start_logit": -0.27595624327659607,
            "end_logit": -2.4856579303741455,
            "question_text": "List symptoms of EAST syndrome."
        }
    ],
    "58a326da60087bc10a00000e": [
        {
            "text": "antiobesity drugs",
            "probability": 0.6476012537731566,
            "start_logit": 0.021781528368592262,
            "end_logit": -0.9665894508361816,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity",
            "probability": 0.1814176050831879,
            "start_logit": 0.021781528368592262,
            "end_logit": -2.239063024520874,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.Over the past several decades, many antiobesity drugs",
            "probability": 0.05825932132166571,
            "start_logit": -2.386589527130127,
            "end_logit": -0.9665894508361816,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often involving cardiotoxicity",
            "probability": 0.051450614091684985,
            "start_logit": -0.7100086808204651,
            "end_logit": -2.7674520015716553,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.Over the past several decades, many antiobesity",
            "probability": 0.01632063941564068,
            "start_logit": -2.386589527130127,
            "end_logit": -2.239063024520874,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events,",
            "probability": 0.008266956053022462,
            "start_logit": -0.7100086808204651,
            "end_logit": -4.595808029174805,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "cardiotoxicity.Over the past several decades, many antiobesity drugs",
            "probability": 0.005851942106085553,
            "start_logit": -3.2352118492126465,
            "end_logit": -2.416097640991211,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "cardiotoxicity",
            "probability": 0.005279854791961655,
            "start_logit": -2.9867324829101562,
            "end_logit": -2.7674520015716553,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs.Over the past several decades, many antiobesity drugs",
            "probability": 0.0051048592715685895,
            "start_logit": -3.967259407043457,
            "end_logit": -1.8206307888031006,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database",
            "probability": 0.0039013700096014957,
            "start_logit": -1.8637664318084717,
            "end_logit": -4.192988872528076,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "many antiobesity drugs",
            "probability": 0.003049944518329241,
            "start_logit": -4.48232889175415,
            "end_logit": -1.8206307888031006,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "drugs",
            "probability": 0.002793621746435574,
            "start_logit": -5.424154758453369,
            "end_logit": -0.9665894508361816,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs-analysis of signals in the FDA Adverse Event Report System",
            "probability": 0.0027526453719464955,
            "start_logit": -1.8637664318084717,
            "end_logit": -4.541754245758057,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs-analysis",
            "probability": 0.0026006156592276813,
            "start_logit": -1.8637664318084717,
            "end_logit": -4.598568439483643,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "cardiotoxicity.Over the past several decades, many antiobesity",
            "probability": 0.0012789062060454077,
            "start_logit": -3.2352118492126465,
            "end_logit": -3.936866044998169,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "many antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often involving cardiotoxicity",
            "probability": 0.0011832941326986618,
            "start_logit": -4.48232889175415,
            "end_logit": -2.7674520015716553,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs.Over the past several decades, many antiobesity",
            "probability": 0.0011812646161434733,
            "start_logit": -3.967259407043457,
            "end_logit": -3.28423810005188,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "many antiobesity",
            "probability": 0.0007057572695037365,
            "start_logit": -4.48232889175415,
            "end_logit": -3.28423810005188,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "analysis of signals in the FDA Adverse Event Report System Database",
            "probability": 0.0005471519941772819,
            "start_logit": -3.828122854232788,
            "end_logit": -4.192988872528076,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "drugs have been withdrawn from the market due to unanticipated adverse events, often involving cardiotoxicity",
            "probability": 0.0004523825679163736,
            "start_logit": -5.4438581466674805,
            "end_logit": -2.7674520015716553,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        }
    ],
    "589aec4778275d0c4a000037": [
        {
            "text": "bacterial",
            "probability": 0.44467308389372173,
            "start_logit": 0.6046599745750427,
            "end_logit": 0.27042314410209656,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis and avoiding unnecessary antibiotics and prolonged hospitalizations in children with viral meningitis.This article provides an overview of acute bacterial",
            "probability": 0.3337268877085816,
            "start_logit": 0.6046599745750427,
            "end_logit": -0.016593268141150475,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis",
            "probability": 0.11612473385656143,
            "start_logit": 0.6046599745750427,
            "end_logit": -1.072251319885254,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis and avoiding unnecessary antibiotics and prolonged hospitalizations in children with viral meningitis",
            "probability": 0.04908196974236896,
            "start_logit": 0.6046599745750427,
            "end_logit": -1.933424472808838,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial and viral meningitis in children,",
            "probability": 0.014520928514224749,
            "start_logit": 0.11143912374973297,
            "end_logit": -2.658104419708252,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Cerebrospinal fluid analysis is irreplaceable in appropriately diagnosing and treating bacterial",
            "probability": 0.006952564293683873,
            "start_logit": -3.5535688400268555,
            "end_logit": 0.27042314410209656,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral meningitis.This article provides an overview of acute bacterial",
            "probability": 0.004789920400498643,
            "start_logit": -3.6391491889953613,
            "end_logit": -0.016593268141150475,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "acute bacterial",
            "probability": 0.00412116759425164,
            "start_logit": -3.7895264625549316,
            "end_logit": -0.016593268141150475,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial and viral meningitis",
            "probability": 0.0031281621884532568,
            "start_logit": 0.11143912374973297,
            "end_logit": -4.193249702453613,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis and avoiding unnecessary antibiotics and prolonged hospitalizations in children with viral meningitis.This article provides an overview",
            "probability": 0.0030426681212667862,
            "start_logit": 0.6046599745750427,
            "end_logit": -4.714181423187256,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial and viral",
            "probability": 0.0028008098841934173,
            "start_logit": 0.11143912374973297,
            "end_logit": -4.303786754608154,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis and avoiding unnecessary antibiotics",
            "probability": 0.0027078185520893893,
            "start_logit": 0.6046599745750427,
            "end_logit": -4.830772876739502,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis and avoiding unnecessary antibiotics and prolonged hospitalizations in children with viral",
            "probability": 0.002621114710196002,
            "start_logit": 0.6046599745750427,
            "end_logit": -4.863316535949707,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis and avoiding unnecessary antibiotics and prolonged hospitalizations in children",
            "probability": 0.0022209923262785747,
            "start_logit": 0.6046599745750427,
            "end_logit": -5.028962135314941,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial meningitis and avoiding unnecessary antibiotics and prolonged hospitalizations in children with viral meningitis.This",
            "probability": 0.0018578715471833146,
            "start_logit": 0.6046599745750427,
            "end_logit": -5.207484722137451,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Cerebrospinal fluid analysis is irreplaceable in appropriately diagnosing and treating bacterial meningitis",
            "probability": 0.0018156364922182575,
            "start_logit": -3.5535688400268555,
            "end_logit": -1.072251319885254,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "analysis is irreplaceable in appropriately diagnosing and treating bacterial",
            "probability": 0.0015941905093739591,
            "start_logit": -5.026313304901123,
            "end_logit": 0.27042314410209656,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "antibiotics and prolonged hospitalizations in children with viral meningitis.This article provides an overview of acute bacterial",
            "probability": 0.0014153388498248853,
            "start_logit": -4.8582940101623535,
            "end_logit": -0.016593268141150475,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "overview of acute bacterial",
            "probability": 0.001414641864098916,
            "start_logit": -4.858786582946777,
            "end_logit": -0.016593268141150475,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial and viral meningitis in children",
            "probability": 0.0013894989509306013,
            "start_logit": 0.11143912374973297,
            "end_logit": -5.004752159118652,
            "question_text": "Which are the types of viral meningitis?"
        }
    ],
    "58a0c09778275d0c4a000052": [
        {
            "text": "linagliptin",
            "probability": 0.6977631959616628,
            "start_logit": 3.4370524883270264,
            "end_logit": 3.0238265991210938,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4) inhibitors",
            "probability": 0.23306717043912947,
            "start_logit": 2.1450066566467285,
            "end_logit": 3.2193193435668945,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "linagliptin, for which renal excretion is a minor elimination pathway.Thus, linagliptin",
            "probability": 0.0248329323448373,
            "start_logit": 1.7350214719772339,
            "end_logit": 1.3901485204696655,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "inhibitors",
            "probability": 0.011031727087080362,
            "start_logit": -0.905544638633728,
            "end_logit": 3.2193193435668945,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4)",
            "probability": 0.006524241484003365,
            "start_logit": 2.1450066566467285,
            "end_logit": -0.3564826548099518,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "linagliptin,",
            "probability": 0.0058147525888056556,
            "start_logit": 3.4370524883270264,
            "end_logit": -1.7636549472808838,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4) inhibitor",
            "probability": 0.003918071629686345,
            "start_logit": 2.1450066566467285,
            "end_logit": -0.8664077520370483,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "type 2 diabetes",
            "probability": 0.003657131759964114,
            "start_logit": 0.5318499803543091,
            "end_logit": 0.6778284907341003,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic therapeutics in order to achieve blood glucose goals.Thus, linagliptin",
            "probability": 0.002947094631878673,
            "start_logit": -1.2986940145492554,
            "end_logit": 2.292513132095337,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "(DPP-4) inhibitors",
            "probability": 0.0023956548081381845,
            "start_logit": -2.4326634407043457,
            "end_logit": 3.2193193435668945,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4",
            "probability": 0.002082059933810897,
            "start_logit": 2.1450066566467285,
            "end_logit": -1.4986495971679688,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "type 2 diabetes mellitus patients with impaired renal function require dose adjustment of any DPP-4 inhibitor administered except for linagliptin",
            "probability": 0.0015771571490271394,
            "start_logit": -2.655203342437744,
            "end_logit": 3.0238265991210938,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "type 2 diabetes mellitus",
            "probability": 0.0008991361327617208,
            "start_logit": 0.1654854714870453,
            "end_logit": -0.3588069975376129,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "inhibitors represent a highly promising novel class of oral agents used in the treatment of type 2 diabetes",
            "probability": 0.000739501386395173,
            "start_logit": -1.0666083097457886,
            "end_logit": 0.6778284907341003,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4) inhibitors represent a highly promising novel class of oral agents",
            "probability": 0.0005680313826722288,
            "start_logit": 2.1450066566467285,
            "end_logit": -2.797585964202881,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dip",
            "probability": 0.0004953230626363194,
            "start_logit": 2.1450066566467285,
            "end_logit": -2.9345524311065674,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "linagliptin is the drug most frequently chosen to treat type 2 diabetes",
            "probability": 0.0004796656306769841,
            "start_logit": 2.728775978088379,
            "end_logit": -3.550442695617676,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "diabetic nephropathy.Dipeptidyl peptidase-4 (DPP-4) inhibitors",
            "probability": 0.0004414348413006398,
            "start_logit": -4.124044895172119,
            "end_logit": 3.2193193435668945,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4) inhibitors represent a highly promising novel class",
            "probability": 0.0004291068942832053,
            "start_logit": 2.1450066566467285,
            "end_logit": -3.078056573867798,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "s",
            "probability": 0.00033661085124979943,
            "start_logit": -4.395147800445557,
            "end_logit": 3.2193193435668945,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        }
    ],
    "5884fe4ce56acf5176000010": [
        {
            "text": "breast cancer",
            "probability": 0.4737879946625104,
            "start_logit": 3.460336685180664,
            "end_logit": 3.468148946762085,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer.However, the biological function and regulatory mechanism of SPAG5 in breast cancer",
            "probability": 0.21086663670603964,
            "start_logit": 3.460336685180664,
            "end_logit": 2.6586148738861084,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer.Taken together, these findings demonstrate that SPAG5 promotes the proliferation and invasion of breast cancer",
            "probability": 0.09608023913462456,
            "start_logit": 2.2634501457214355,
            "end_logit": 3.0694591999053955,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cells, while the overexpression of SPAG5 promoted the proliferation and invasion of breast cancer",
            "probability": 0.06363289530850942,
            "start_logit": 2.3724756240844727,
            "end_logit": 2.5483806133270264,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cell lines.Functional experiments showed that silencing of SPAG5 inhibited the proliferation and invasion of breast cancer",
            "probability": 0.05141600676462605,
            "start_logit": 2.2841668128967285,
            "end_logit": 2.423508405685425,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer remain unclear.In this study, we aimed to investigate the potential biological function of SPAG5 in breast cancer",
            "probability": 0.047088469335390404,
            "start_logit": 2.730451822280884,
            "end_logit": 1.8893020153045654,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cells.Herein, we found that both the mRNA and protein expression of SPAG5 were significantly up-regulated in breast cancer",
            "probability": 0.033307699678515455,
            "start_logit": 2.1129310131073,
            "end_logit": 2.160583257675171,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast",
            "probability": 0.009949656614007991,
            "start_logit": 3.460336685180664,
            "end_logit": -0.39507296681404114,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer.",
            "probability": 0.005215490661368457,
            "start_logit": 3.460336685180664,
            "end_logit": -1.0409778356552124,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer.However, the biological function and regulatory mechanism of SPAG5 in breast",
            "probability": 0.0028498116962363358,
            "start_logit": 3.460336685180664,
            "end_logit": -1.6453580856323242,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer.Taken together, these findings demonstrate that SPAG5 promotes the proliferation and invasion of breast",
            "probability": 0.00211977046726626,
            "start_logit": 2.2634501457214355,
            "end_logit": -0.7444166541099548,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cells, while the overexpression of SPAG5 promoted the proliferation and invasion of breast",
            "probability": 0.0009470235746397788,
            "start_logit": 2.3724756240844727,
            "end_logit": -1.6591812372207642,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cell lines.Functional experiments showed that silencing of SPAG5 inhibited the proliferation and invasion of breast",
            "probability": 0.0009436154683934549,
            "start_logit": 2.2841668128967285,
            "end_logit": -1.5744776725769043,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.000594997312347502,
            "start_logit": -3.2196216583251953,
            "end_logit": 3.468148946762085,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancers.High expression of SPAG5 has been frequently detected in breast cancer",
            "probability": 0.0004765606100230761,
            "start_logit": -3.4415836334228516,
            "end_logit": 3.468148946762085,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "various cancers.High expression of SPAG5 has been frequently detected in breast cancer",
            "probability": 0.00043267536185133073,
            "start_logit": -3.5381908416748047,
            "end_logit": 3.468148946762085,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer.However, the biological function and regulatory mechanism of SPAG5 in breast cancer",
            "probability": 0.00026481270846303787,
            "start_logit": -3.2196216583251953,
            "end_logit": 2.6586148738861084,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancers.High expression of SPAG5 has been frequently detected in breast",
            "probability": 1.000788217284682e-05,
            "start_logit": -3.4415836334228516,
            "end_logit": -0.39507296681404114,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "various cancers.High expression of SPAG5 has been frequently detected in breast",
            "probability": 9.086281890339832e-06,
            "start_logit": -3.5381908416748047,
            "end_logit": -0.39507296681404114,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer.",
            "probability": 6.549771123470967e-06,
            "start_logit": -3.2196216583251953,
            "end_logit": -1.0409778356552124,
            "question_text": "SPAG5 was implicated in which cancers?"
        }
    ],
    "58a3275960087bc10a00000f": [
        {
            "text": "reproductive effects",
            "probability": 0.6782908800613932,
            "start_logit": 3.66286301612854,
            "end_logit": 2.876408815383911,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive",
            "probability": 0.24739181243889075,
            "start_logit": 3.66286301612854,
            "end_logit": 1.8678059577941895,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "health outcomes, including reproductive effects",
            "probability": 0.015747345822767034,
            "start_logit": -0.10004137456417084,
            "end_logit": 2.876408815383911,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health outcomes, including reproductive effects",
            "probability": 0.014856084522830902,
            "start_logit": -0.15830369293689728,
            "end_logit": 2.876408815383911,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "potentially serious health outcomes, including reproductive effects",
            "probability": 0.008797853469694824,
            "start_logit": -0.6822054386138916,
            "end_logit": 2.876408815383911,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "health outcomes, including reproductive",
            "probability": 0.00574350111244857,
            "start_logit": -0.10004137456417084,
            "end_logit": 1.8678059577941895,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health outcomes, including reproductive",
            "probability": 0.005418432981902742,
            "start_logit": -0.15830369293689728,
            "end_logit": 1.8678059577941895,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects,",
            "probability": 0.004283450147045968,
            "start_logit": 3.66286301612854,
            "end_logit": -2.188408613204956,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects, sometimes associated with Zika,",
            "probability": 0.003573192966323029,
            "start_logit": 3.66286301612854,
            "end_logit": -2.3697078227996826,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "health outcomes",
            "probability": 0.0035308825344309634,
            "start_logit": -0.10004137456417084,
            "end_logit": 1.3812848329544067,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health outcomes",
            "probability": 0.0033310432095709627,
            "start_logit": -0.15830369293689728,
            "end_logit": 1.3812848329544067,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "potentially serious health outcomes, including reproductive",
            "probability": 0.0032088252686555156,
            "start_logit": -0.6822054386138916,
            "end_logit": 1.8678059577941895,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "potentially serious health outcomes",
            "probability": 0.0019726617746412003,
            "start_logit": -0.6822054386138916,
            "end_logit": 1.3812848329544067,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects, sometimes associated with Zika",
            "probability": 0.0010843853757782742,
            "start_logit": 3.66286301612854,
            "end_logit": -3.5621540546417236,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "effects",
            "probability": 0.0010836570614550511,
            "start_logit": -2.776371717453003,
            "end_logit": 2.876408815383911,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "outcomes, including reproductive effects",
            "probability": 0.0005209443297221326,
            "start_logit": -3.5088253021240234,
            "end_logit": 2.876408815383911,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects, sometimes associated",
            "probability": 0.000499875039061339,
            "start_logit": 3.66286301612854,
            "end_logit": -4.336564540863037,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "Because of potentially serious health outcomes, including reproductive effects",
            "probability": 0.00028020746839204237,
            "start_logit": -4.1289381980896,
            "end_logit": 2.876408815383911,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects, sometimes",
            "probability": 0.00019496132679509547,
            "start_logit": 3.66286301612854,
            "end_logit": -5.278121471405029,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "outcomes, including reproductive",
            "probability": 0.00019000308820023735,
            "start_logit": -3.5088253021240234,
            "end_logit": 1.8678059577941895,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        }
    ],
    "58a94483ee23e0236b000003": [
        {
            "text": "type V",
            "probability": 0.6821916107760444,
            "start_logit": -0.6487211585044861,
            "end_logit": -1.3463799953460693,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V) of fimA from dental plaque samples.P. gingivalis with type V",
            "probability": 0.15360264614853056,
            "start_logit": -0.6487211585044861,
            "end_logit": -2.8373215198516846,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V)",
            "probability": 0.051545793501777036,
            "start_logit": -0.6487211585044861,
            "end_logit": -3.929219961166382,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin",
            "probability": 0.029022331700026306,
            "start_logit": -2.265061140060425,
            "end_logit": -2.887284994125366,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V) of fimA from dental plaque samples.P. gingivalis with type V fimA",
            "probability": 0.02497529707615715,
            "start_logit": -0.6487211585044861,
            "end_logit": -4.65380334854126,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "V",
            "probability": 0.012271469417862805,
            "start_logit": -4.666754722595215,
            "end_logit": -1.3463799953460693,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin (FimA), was classified into four typeable variants",
            "probability": 0.00842995228154335,
            "start_logit": -2.265061140060425,
            "end_logit": -4.123559474945068,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimA",
            "probability": 0.007029773874819348,
            "start_logit": -2.9964516162872314,
            "end_logit": -3.573805570602417,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin (FimA)",
            "probability": 0.006682283934708771,
            "start_logit": -2.265061140060425,
            "end_logit": -4.35589075088501,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin (FimA),",
            "probability": 0.005320361278963897,
            "start_logit": -2.265061140060425,
            "end_logit": -4.5838093757629395,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimA genotyping",
            "probability": 0.004520267369129249,
            "start_logit": -2.9964516162872314,
            "end_logit": -4.0153889656066895,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "V) of fimA from dental plaque samples.P. gingivalis with type V",
            "probability": 0.00276305094483681,
            "start_logit": -4.666754722595215,
            "end_logit": -2.8373215198516846,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V fimA",
            "probability": 0.002382689998938362,
            "start_logit": -2.998378276824951,
            "end_logit": -4.65380334854126,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimA gene encoding the subunit protein of fimbriae, fimbrillin",
            "probability": 0.0019881088367706182,
            "start_logit": -4.9459428787231445,
            "end_logit": -2.887284994125366,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbriae, fimbrillin",
            "probability": 0.001944269778284467,
            "start_logit": -4.968240261077881,
            "end_logit": -2.887284994125366,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "disease-associated genotypes of P. gingivalis involved in the development of adult periodontitis",
            "probability": 0.0017262729398775636,
            "start_logit": -4.226211071014404,
            "end_logit": -3.7482359409332275,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotyping",
            "probability": 0.001072715247797469,
            "start_logit": -4.4348297119140625,
            "end_logit": -4.0153889656066895,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "PCR assay.Thus, a new type of fimA gene is now established, and the fimA",
            "probability": 0.0009603341891978212,
            "start_logit": -4.987080097198486,
            "end_logit": -3.573805570602417,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "V)",
            "probability": 0.000927221353333506,
            "start_logit": -4.666754722595215,
            "end_logit": -3.929219961166382,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "HNA-99.However, in terms of serological specificities, type V",
            "probability": 0.0006435493514004068,
            "start_logit": -5.118319034576416,
            "end_logit": -3.8428492546081543,
            "question_text": "Which fimA genotypes are associated with disease?"
        }
    ],
    "58bc666702b8c60953000004": [
        {
            "text": "degradation",
            "probability": 0.2456881736184352,
            "start_logit": -3.1893134117126465,
            "end_logit": -3.0766055583953857,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation and disaggregation, as well as degradation",
            "probability": 0.13431361747257206,
            "start_logit": -3.793199062347412,
            "end_logit": -3.0766055583953857,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting, aggregation and disaggregation, as well as degradation",
            "probability": 0.09319545726276657,
            "start_logit": -4.158677577972412,
            "end_logit": -3.0766055583953857,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation and disaggregation",
            "probability": 0.06171697941161765,
            "start_logit": -3.793199062347412,
            "end_logit": -3.8542239665985107,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation",
            "probability": 0.04635933607667832,
            "start_logit": -3.793199062347412,
            "end_logit": -4.140360355377197,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "regulation, targeting, aggregation and disaggregation, as well as degradation",
            "probability": 0.04371954824370572,
            "start_logit": -4.915581226348877,
            "end_logit": -3.0766055583953857,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting, aggregation and disaggregation",
            "probability": 0.04282322392453624,
            "start_logit": -4.158677577972412,
            "end_logit": -3.8542239665985107,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "protein folding, unfolding, regulation, targeting, aggregation and disaggregation, as well as degradation",
            "probability": 0.040316551848815475,
            "start_logit": -4.996614456176758,
            "end_logit": -3.0766055583953857,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "degradation.",
            "probability": 0.03971771387601522,
            "start_logit": -3.1893134117126465,
            "end_logit": -4.898871421813965,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "folding, unfolding, regulation, targeting, aggregation and disaggregation, as well as degradation",
            "probability": 0.03284765746665467,
            "start_logit": -5.201496124267578,
            "end_logit": -3.0766055583953857,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting, aggregation",
            "probability": 0.03216709969818648,
            "start_logit": -4.158677577972412,
            "end_logit": -4.140360355377197,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting",
            "probability": 0.02836401206403985,
            "start_logit": -4.158677577972412,
            "end_logit": -4.266183376312256,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "disaggregation, as well as degradation",
            "probability": 0.027614138864973218,
            "start_logit": -5.375048637390137,
            "end_logit": -3.0766055583953857,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation and disaggregation, as well as degradation.",
            "probability": 0.021713010235132838,
            "start_logit": -3.793199062347412,
            "end_logit": -4.898871421813965,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "regulation, targeting, aggregation and disaggregation",
            "probability": 0.02008909081309654,
            "start_logit": -4.915581226348877,
            "end_logit": -3.8542239665985107,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Hsp100 AAA+ disaggregases,",
            "probability": 0.020069553910646427,
            "start_logit": -4.402042865753174,
            "end_logit": -4.368735313415527,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation and disaggregation,",
            "probability": 0.018933656600337117,
            "start_logit": -3.793199062347412,
            "end_logit": -5.035841941833496,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "protein folding, unfolding, regulation, targeting, aggregation and disaggregation",
            "probability": 0.01852541720804202,
            "start_logit": -4.996614456176758,
            "end_logit": -3.8542239665985107,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Hsp100",
            "probability": 0.016732294056676374,
            "start_logit": -4.402042865753174,
            "end_logit": -4.550598621368408,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "folding, unfolding, regulation, targeting, aggregation and disaggregation",
            "probability": 0.015093467347072068,
            "start_logit": -5.201496124267578,
            "end_logit": -3.8542239665985107,
            "question_text": "List diseases that could be targeted by disaggregases?"
        }
    ],
    "58bbb71f22d3005309000016": [
        {
            "text": "RNA CoSSMos",
            "probability": 0.5209498736315604,
            "start_logit": 2.475964307785034,
            "end_logit": 2.690624713897705,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.1455079400843478,
            "start_logit": 1.2005411386489868,
            "end_logit": 2.690624713897705,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs",
            "probability": 0.07691071892305001,
            "start_logit": 1.2005411386489868,
            "end_logit": 2.053039312362671,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "The RNA Characterization of Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.04209188402645285,
            "start_logit": -0.03983457386493683,
            "end_logit": 2.690624713897705,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA CoSSMos,",
            "probability": 0.02767773370306595,
            "start_logit": 2.475964307785034,
            "end_logit": -0.24440085887908936,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Characterization of Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.026818587749598066,
            "start_logit": -0.4905942976474762,
            "end_logit": 2.690624713897705,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "CoSSMos",
            "probability": 0.024780675602308854,
            "start_logit": -0.5696253776550293,
            "end_logit": 2.690624713897705,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "The RNA Characterization of Secondary Structure Motifs",
            "probability": 0.02224838767852483,
            "start_logit": -0.03983457386493683,
            "end_logit": 2.053039312362671,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.019883389829483736,
            "start_logit": -0.7898048162460327,
            "end_logit": 2.690624713897705,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA CoSSMos, database",
            "probability": 0.01771278681213324,
            "start_logit": 2.475964307785034,
            "end_logit": -0.6907423138618469,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Characterization of Secondary Structure Motifs",
            "probability": 0.01417542481274096,
            "start_logit": -0.4905942976474762,
            "end_logit": 2.053039312362671,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs,",
            "probability": 0.013745795011394333,
            "start_logit": 1.2005411386489868,
            "end_logit": 0.33112701773643494,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Secondary Structure Motifs",
            "probability": 0.010509706930950876,
            "start_logit": -0.7898048162460327,
            "end_logit": 2.053039312362671,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "secondary structure motifs in RNA three-dimensional structures.The RNA Characterization of Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.009506820402272223,
            "start_logit": -1.5276800394058228,
            "end_logit": 2.690624713897705,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs, RNA CoSSMos,",
            "probability": 0.007730743822359704,
            "start_logit": 1.2005411386489868,
            "end_logit": -0.24440085887908936,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "secondary structure motifs in RNA three-dimensional structures.The RNA Characterization of Secondary Structure Motifs",
            "probability": 0.005024993078640444,
            "start_logit": -1.5276800394058228,
            "end_logit": 2.053039312362671,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs, RNA CoSSMos, database",
            "probability": 0.004947407135776618,
            "start_logit": 1.2005411386489868,
            "end_logit": -0.6907423138618469,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "The RNA Characterization of Secondary Structure Motifs,",
            "probability": 0.003976321904740115,
            "start_logit": -0.03983457386493683,
            "end_logit": 0.33112701773643494,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA CoSSMos, database is a freely accessible online database that allows users to identify secondary structure motifs among RNA 3D structures",
            "probability": 0.003267319557627841,
            "start_logit": 2.475964307785034,
            "end_logit": -2.381059169769287,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Characterization of Secondary Structure Motifs,",
            "probability": 0.0025334893029711775,
            "start_logit": -0.4905942976474762,
            "end_logit": 0.33112701773643494,
            "question_text": "List RNA modifications databases"
        }
    ],
    "58bc9a5002b8c60953000008": [
        {
            "text": "Innate and Adaptive Immune Responses",
            "probability": 0.3996563233205094,
            "start_logit": -2.298863172531128,
            "end_logit": -2.027740240097046,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "immune responses during HELLP in order to update the current knowledge of the immune involvement in HELLP pathogenesis.Innate and Adaptive Immune Responses",
            "probability": 0.09920582056303191,
            "start_logit": -3.6922714710235596,
            "end_logit": -2.027740240097046,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "Adaptive Immune Responses",
            "probability": 0.08435955055180588,
            "start_logit": -3.8543801307678223,
            "end_logit": -2.027740240097046,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "innate and adaptive immune responses",
            "probability": 0.05844000448682115,
            "start_logit": -3.3269460201263428,
            "end_logit": -2.9222617149353027,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "adaptive immune responses during HELLP in order to update the current knowledge of the immune involvement in HELLP pathogenesis.Innate and Adaptive Immune Responses",
            "probability": 0.04590966962443165,
            "start_logit": -4.46279239654541,
            "end_logit": -2.027740240097046,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "immune responses",
            "probability": 0.04055565436991766,
            "start_logit": -3.6922714710235596,
            "end_logit": -2.9222617149353027,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "Innate and Adaptive Immune",
            "probability": 0.038786392672369434,
            "start_logit": -2.298863172531128,
            "end_logit": -4.360275745391846,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "innate and adaptive immune",
            "probability": 0.03494229313129175,
            "start_logit": -3.3269460201263428,
            "end_logit": -3.4365644454956055,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "Immune Responses",
            "probability": 0.02799632024932529,
            "start_logit": -4.957395076751709,
            "end_logit": -2.027740240097046,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "immune",
            "probability": 0.02424892974545526,
            "start_logit": -3.6922714710235596,
            "end_logit": -3.4365644454956055,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "Innate and Adaptive Immune Responses in HELLP Syndrome.",
            "probability": 0.022325615476892206,
            "start_logit": -2.298863172531128,
            "end_logit": -4.9126105308532715,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "adaptive immune responses",
            "probability": 0.01876801868034118,
            "start_logit": -4.46279239654541,
            "end_logit": -2.9222617149353027,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "innate and adaptive immune responses during HELLP in order to update the current knowledge of the immune involvement in HELLP pathogenesis.",
            "probability": 0.0170989453226703,
            "start_logit": -3.3269460201263428,
            "end_logit": -4.151245594024658,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "responses during HELLP in order to update the current knowledge of the immune involvement in HELLP pathogenesis.Innate and Adaptive Immune Responses",
            "probability": 0.013905010259561095,
            "start_logit": -5.657218933105469,
            "end_logit": -2.027740240097046,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "This review aims to summarize and discuss the recent and previous findings of the innate and adaptive immune responses",
            "probability": 0.013865268032566982,
            "start_logit": -4.765559673309326,
            "end_logit": -2.9222617149353027,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "Innate",
            "probability": 0.013094609347783665,
            "start_logit": -2.298863172531128,
            "end_logit": -5.4461445808410645,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "Innate and Adaptive Immune Responses in HELLP Syndrome.It was proposed that HELLP syndrome occurs in a circulatory inflammatory milieu",
            "probability": 0.012320266603196363,
            "start_logit": -2.298863172531128,
            "end_logit": -5.507099628448486,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "immune responses during HELLP in order to update the current knowledge of the immune involvement in HELLP pathogenesis.",
            "probability": 0.011866168093000735,
            "start_logit": -3.6922714710235596,
            "end_logit": -4.151245594024658,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "summarize and discuss the recent and previous findings of the innate and adaptive immune responses",
            "probability": 0.011433415309682123,
            "start_logit": -4.958406448364258,
            "end_logit": -2.9222617149353027,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "adaptive immune",
            "probability": 0.01122172415934585,
            "start_logit": -4.46279239654541,
            "end_logit": -3.4365644454956055,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        }
    ],
    "58bbbe6822d300530900001a": [
        {
            "text": "valine",
            "probability": 0.10879804934181837,
            "start_logit": -3.6950836181640625,
            "end_logit": -5.081523418426514,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine,",
            "probability": 0.09621981926637946,
            "start_logit": -3.6950836181640625,
            "end_logit": -5.204381465911865,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine, and valine",
            "probability": 0.08030248667068161,
            "start_logit": -3.998776435852051,
            "end_logit": -5.081523418426514,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine",
            "probability": 0.07794675161003993,
            "start_logit": -3.998776435852051,
            "end_logit": -5.111298084259033,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine, were significantly less abundant in the feces of mice transplanted with microbiota",
            "probability": 0.0731539095619124,
            "start_logit": -3.6950836181640625,
            "end_logit": -5.478451251983643,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine, and valine,",
            "probability": 0.07101865153683362,
            "start_logit": -3.998776435852051,
            "end_logit": -5.204381465911865,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine, were significantly less abundant in the feces of mice transplanted with microbiota from the affected patient.",
            "probability": 0.06149837025557901,
            "start_logit": -3.6950836181640625,
            "end_logit": -5.652006149291992,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine, and valine, were significantly less abundant in the feces of mice transplanted with microbiota",
            "probability": 0.053993990545249386,
            "start_logit": -3.998776435852051,
            "end_logit": -5.478451251983643,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate",
            "probability": 0.04876045931779322,
            "start_logit": -4.539175510406494,
            "end_logit": -5.040005207061768,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate, taurine, and valine",
            "probability": 0.046777462348284095,
            "start_logit": -4.539175510406494,
            "end_logit": -5.081523418426514,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate, taurine",
            "probability": 0.04540520959908086,
            "start_logit": -4.539175510406494,
            "end_logit": -5.111298084259033,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate, taurine, and valine,",
            "probability": 0.041369482266643554,
            "start_logit": -4.539175510406494,
            "end_logit": -5.204381465911865,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine, were significantly less abundant in the feces of mice",
            "probability": 0.03854941977629778,
            "start_logit": -3.6950836181640625,
            "end_logit": -6.119075775146484,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine, were significantly less abundant in the feces of mice transplanted with microbiota from the affected patient",
            "probability": 0.03687886361480493,
            "start_logit": -3.6950836181640625,
            "end_logit": -6.1633782386779785,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine, and valine, were significantly less abundant in the feces of mice",
            "probability": 0.028452847146394657,
            "start_logit": -3.998776435852051,
            "end_logit": -6.119075775146484,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine, and valine, were significantly less abundant in the feces of mice transplanted with microbiota from the affected patient",
            "probability": 0.027219830426862886,
            "start_logit": -3.998776435852051,
            "end_logit": -6.1633782386779785,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate, taurine, and valine, were significantly less abundant in the feces of mice",
            "probability": 0.016574231275678395,
            "start_logit": -4.539175510406494,
            "end_logit": -6.119075775146484,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "metabolites related to the nervous system, including \u03b3-aminobutyrate",
            "probability": 0.016287778418069755,
            "start_logit": -5.635680198669434,
            "end_logit": -5.040005207061768,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "metabolites related to the nervous system, including \u03b3-aminobutyrate, taurine, and valine",
            "probability": 0.0156253848373907,
            "start_logit": -5.635680198669434,
            "end_logit": -5.081523418426514,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "metabolites related to the nervous system, including \u03b3-aminobutyrate, taurine",
            "probability": 0.015167002184205698,
            "start_logit": -5.635680198669434,
            "end_logit": -5.111298084259033,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        }
    ],
    "58b53bf722d3005309000004": [
        {
            "text": "facial palsy",
            "probability": 0.8905073795629918,
            "start_logit": 3.6683950424194336,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial",
            "probability": 0.053734273018301165,
            "start_logit": 3.6683950424194336,
            "end_logit": 0.23809394240379333,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "the facial palsy",
            "probability": 0.013231573543889074,
            "start_logit": -0.5407904386520386,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy should lead to suspicion of another possible aetiology,",
            "probability": 0.011627640498034365,
            "start_logit": 3.6683950424194336,
            "end_logit": -1.292572021484375,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "palsy",
            "probability": 0.007354452016863293,
            "start_logit": -1.128090500831604,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy should lead to suspicion of another possible aetiology, as occurred in the case presented here.",
            "probability": 0.006778547715013908,
            "start_logit": 3.6683950424194336,
            "end_logit": -1.832194209098816,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy should lead to suspicion of another possible aetiology",
            "probability": 0.004433289643661035,
            "start_logit": 3.6683950424194336,
            "end_logit": -2.256815195083618,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "symptoms with the facial palsy",
            "probability": 0.001504049823604925,
            "start_logit": -2.7152349948883057,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "The presence of uncommon symptoms with the facial palsy",
            "probability": 0.0013196289713359325,
            "start_logit": -2.846045732498169,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "presence of uncommon symptoms with the facial palsy",
            "probability": 0.0012793921062503827,
            "start_logit": -2.877011299133301,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "uncommon symptoms with the facial palsy",
            "probability": 0.0012014367375760124,
            "start_logit": -2.939878225326538,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "with the facial palsy",
            "probability": 0.0011763525059575312,
            "start_logit": -2.960977792739868,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "y",
            "probability": 0.0010071786285399712,
            "start_logit": -3.116243362426758,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy should lead to suspicion",
            "probability": 0.0010030525432931283,
            "start_logit": 3.6683950424194336,
            "end_logit": -3.7429091930389404,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy should lead to suspicion of another possible aetiology, as occurred in the case presented here",
            "probability": 0.0009630424500519218,
            "start_logit": 3.6683950424194336,
            "end_logit": -3.7836148738861084,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "the facial",
            "probability": 0.0007984088639646956,
            "start_logit": -0.5407904386520386,
            "end_logit": 0.23809394240379333,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial pals",
            "probability": 0.0007271875173310931,
            "start_logit": 3.6683950424194336,
            "end_logit": -4.064527988433838,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "alsy",
            "probability": 0.0006424018915754378,
            "start_logit": -3.5659375190734863,
            "end_logit": 3.0458343029022217,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy should lead",
            "probability": 0.0005379430617840237,
            "start_logit": 3.6683950424194336,
            "end_logit": -4.365959644317627,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "the facial palsy should lead to suspicion of another possible aetiology,",
            "probability": 0.00017276889998053255,
            "start_logit": -0.5407904386520386,
            "end_logit": -1.292572021484375,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        }
    ],
    "58a8071760087bc10a000037": [
        {
            "text": "electron capture dissociation",
            "probability": 0.22475923925325772,
            "start_logit": 5.270560264587402,
            "end_logit": 4.949931621551514,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD) and electron capture dissociation",
            "probability": 0.20563720590947712,
            "start_logit": 5.181643962860107,
            "end_logit": 4.949931621551514,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation",
            "probability": 0.13960903239915926,
            "start_logit": 5.181643962860107,
            "end_logit": 4.562664031982422,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron capture dissociation (ECD)",
            "probability": 0.09514540965889595,
            "start_logit": 5.270560264587402,
            "end_logit": 4.09030818939209,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD) and electron capture dissociation (ECD)",
            "probability": 0.08705064255588485,
            "start_logit": 5.181643962860107,
            "end_logit": 4.09030818939209,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron capture dissociation (ECD) have become well-established fragmentation methods complementary to collision-induced dissociation",
            "probability": 0.06286237645103694,
            "start_logit": 5.270560264587402,
            "end_logit": 3.675849676132202,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron capture dissociation (ECD",
            "probability": 0.043960179143402556,
            "start_logit": 5.270560264587402,
            "end_logit": 3.318186044692993,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD) and electron capture dissociation (ECD",
            "probability": 0.04022014151837964,
            "start_logit": 5.181643962860107,
            "end_logit": 3.318186044692993,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD)",
            "probability": 0.026509205862724063,
            "start_logit": 5.181643962860107,
            "end_logit": 2.9013102054595947,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "collision-induced dissociation",
            "probability": 0.013395773533109785,
            "start_logit": 3.7245516777038574,
            "end_logit": 3.675849676132202,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ECD)",
            "probability": 0.011369948583016935,
            "start_logit": 3.146127700805664,
            "end_logit": 4.09030818939209,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation",
            "probability": 0.011363401159241898,
            "start_logit": 2.285928249359131,
            "end_logit": 4.949931621551514,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD",
            "probability": 0.010670929881951745,
            "start_logit": 5.181643962860107,
            "end_logit": 1.9913413524627686,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ECD) have become well-established fragmentation methods complementary to collision-induced dissociation",
            "probability": 0.007512101641234748,
            "start_logit": 3.146127700805664,
            "end_logit": 3.675849676132202,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ECD",
            "probability": 0.005253274733406622,
            "start_logit": 3.146127700805664,
            "end_logit": 3.318186044692993,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation (ECD)",
            "probability": 0.004810371586977031,
            "start_logit": 2.285928249359131,
            "end_logit": 4.09030818939209,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation (ECD) have become well-established fragmentation methods complementary to collision-induced dissociation",
            "probability": 0.0031782026127589336,
            "start_logit": 2.285928249359131,
            "end_logit": 3.675849676132202,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "(ETD) and electron capture dissociation",
            "probability": 0.003005135747201908,
            "start_logit": 0.9558532238006592,
            "end_logit": 4.949931621551514,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation (ECD",
            "probability": 0.0022225433414808184,
            "start_logit": 2.285928249359131,
            "end_logit": 3.318186044692993,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD)",
            "probability": 0.001464884427401072,
            "start_logit": 2.285928249359131,
            "end_logit": 2.9013102054595947,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        }
    ],
    "588f220e3b87a8a73800000d": [
        {
            "text": "RNase R",
            "probability": 0.5958916866298472,
            "start_logit": 1.6461917161941528,
            "end_logit": -0.4578297436237335,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA.Multiple bioinformatics",
            "probability": 0.11916861998934622,
            "start_logit": 1.6461917161941528,
            "end_logit": -2.0673491954803467,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA.Multiple bioinformatics tools",
            "probability": 0.056708318121668974,
            "start_logit": 1.6461917161941528,
            "end_logit": -2.8099677562713623,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase",
            "probability": 0.04262194903095088,
            "start_logit": 1.6461917161941528,
            "end_logit": -3.0955193042755127,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA.Multiple bioinformatics tools have also been developed",
            "probability": 0.03795202747724869,
            "start_logit": 1.6461917161941528,
            "end_logit": -3.2115657329559326,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment",
            "probability": 0.03787583452203082,
            "start_logit": 1.6461917161941528,
            "end_logit": -3.2135753631591797,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA.Multiple bio",
            "probability": 0.028619300832707886,
            "start_logit": 1.6461917161941528,
            "end_logit": -3.493807315826416,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA.Multiple bioinformatics tools have also been developed for circular RNA detection",
            "probability": 0.01808344418358148,
            "start_logit": 1.6461917161941528,
            "end_logit": -3.9528918266296387,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA.Multiple",
            "probability": 0.014297421309749586,
            "start_logit": 1.6461917161941528,
            "end_logit": -4.187809467315674,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "R",
            "probability": 0.014153590506063629,
            "start_logit": 1.6461917161941528,
            "end_logit": -4.197920322418213,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics",
            "probability": 0.008659725406506766,
            "start_logit": -0.9756647348403931,
            "end_logit": -2.0673491954803467,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment,",
            "probability": 0.008194341156911792,
            "start_logit": 1.6461917161941528,
            "end_logit": -4.744444847106934,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools",
            "probability": 0.0041208706053857775,
            "start_logit": -0.9756647348403931,
            "end_logit": -2.8099677562713623,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA.",
            "probability": 0.003987935953502664,
            "start_logit": 1.6461917161941528,
            "end_logit": -5.4646148681640625,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed",
            "probability": 0.002757891604371649,
            "start_logit": -0.9756647348403931,
            "end_logit": -3.2115657329559326,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bio",
            "probability": 0.0020797025807600808,
            "start_logit": -0.9756647348403931,
            "end_logit": -3.493807315826416,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed for circular RNA detection with high-throughput sequence data",
            "probability": 0.001736158707567588,
            "start_logit": -0.9756647348403931,
            "end_logit": -3.6743571758270264,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed for circular RNA detection",
            "probability": 0.0013140847065922848,
            "start_logit": -0.9756647348403931,
            "end_logit": -3.9528918266296387,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed for circular RNA detection with high-throughput sequence",
            "probability": 0.0009152476185142158,
            "start_logit": -0.9756647348403931,
            "end_logit": -4.3145928382873535,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "Multiple bioinformatics",
            "probability": 0.0008618490566918905,
            "start_logit": -3.283022880554199,
            "end_logit": -2.0673491954803467,
            "question_text": "List available circular RNA prediction tools."
        }
    ],
    "589a245878275d0c4a000025": [
        {
            "text": "grade",
            "probability": 0.12651257828046253,
            "start_logit": -4.944169521331787,
            "end_logit": -4.558383464813232,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "METHODS From June 2008 to September 2015,",
            "probability": 0.08199582689674706,
            "start_logit": -5.244863510131836,
            "end_logit": -4.6913628578186035,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "2015,",
            "probability": 0.07605243024389956,
            "start_logit": -5.320108890533447,
            "end_logit": -4.6913628578186035,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "grade was improved 1 grade or 2 grades",
            "probability": 0.07318007188622458,
            "start_logit": -4.944169521331787,
            "end_logit": -5.105802059173584,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "METHODS",
            "probability": 0.06130793426073003,
            "start_logit": -5.244863510131836,
            "end_logit": -4.98212194442749,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "METHODS From June 2008 to September 2015",
            "probability": 0.05572034715873854,
            "start_logit": -5.244863510131836,
            "end_logit": -5.077685832977295,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "METHODS From June 2008 to September 2015, a retrospective analysis was conducted in 15",
            "probability": 0.05303533561718143,
            "start_logit": -5.244863510131836,
            "end_logit": -5.127072811126709,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "2015",
            "probability": 0.05168150594776119,
            "start_logit": -5.320108890533447,
            "end_logit": -5.077685832977295,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "2015, a retrospective analysis was conducted in 15",
            "probability": 0.049191115147440616,
            "start_logit": -5.320108890533447,
            "end_logit": -5.127072811126709,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "1 grade or 2 grades",
            "probability": 0.04588873797753351,
            "start_logit": -5.410872936248779,
            "end_logit": -5.105802059173584,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "vertebroplasty",
            "probability": 0.04401998865318721,
            "start_logit": -5.15933895111084,
            "end_logit": -5.398911952972412,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "vertebroplasty in spinal metastasis from lung cancer.MATERIAL AND METHODS From June 2008 to September 2015,",
            "probability": 0.041939282278225895,
            "start_logit": -5.15933895111084,
            "end_logit": -5.447332859039307,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "15",
            "probability": 0.03908192456480292,
            "start_logit": -5.550161838531494,
            "end_logit": -5.127072811126709,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "grade was improved 1 grade",
            "probability": 0.03457648954748173,
            "start_logit": -4.944169521331787,
            "end_logit": -5.855551242828369,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "radiofrequency ablation followed by vertebroplasty",
            "probability": 0.0332225648600256,
            "start_logit": -5.44075345993042,
            "end_logit": -5.398911952972412,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "MATERIAL AND METHODS From June 2008 to September 2015,",
            "probability": 0.0316044301849465,
            "start_logit": -6.198234558105469,
            "end_logit": -4.6913628578186035,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "vertebroplasty in spinal metastasis from lung cancer.",
            "probability": 0.02837837683637989,
            "start_logit": -5.15933895111084,
            "end_logit": -5.837928295135498,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "analysis was conducted in 15",
            "probability": 0.024380344457113005,
            "start_logit": -6.022044658660889,
            "end_logit": -5.127072811126709,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "vertebroplasty in spinal metastasis from lung cancer.MATERIAL AND METHODS",
            "probability": 0.024120434452510327,
            "start_logit": -5.15933895111084,
            "end_logit": -6.0004963874816895,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "radiofrequency ablation",
            "probability": 0.024110280748607743,
            "start_logit": -5.44075345993042,
            "end_logit": -5.719502925872803,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        }
    ],
    "58ca746d02b8c6095300002d": [
        {
            "text": "mice",
            "probability": 0.25190816798442234,
            "start_logit": -1.815661072731018,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mice,",
            "probability": 0.08803126894291072,
            "start_logit": -1.815661072731018,
            "end_logit": -2.760864019393921,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "studies in humans and gene-targeting studies in mice",
            "probability": 0.07431121954192711,
            "start_logit": -3.036463737487793,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "fat metabolism, which contribute to a healthy metabolic phenotype in humans.Despite various studies in humans and gene-targeting studies in mice",
            "probability": 0.07097618743833314,
            "start_logit": -3.082381248474121,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "gene-targeting studies in mice",
            "probability": 0.07026438449470383,
            "start_logit": -3.0924606323242188,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "metabolic phenotype in humans.Despite various studies in humans and gene-targeting studies in mice",
            "probability": 0.06395159227472419,
            "start_logit": -3.1865992546081543,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mice, the physiological roles of CIDE proteins remains elusive",
            "probability": 0.062082886662654324,
            "start_logit": -1.815661072731018,
            "end_logit": -3.1100857257843018,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "studies in mice",
            "probability": 0.04800661992685959,
            "start_logit": -3.473386764526367,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mice, the physiological roles of CIDE proteins remains elusive.",
            "probability": 0.04301520756089746,
            "start_logit": -1.815661072731018,
            "end_logit": -3.4770023822784424,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "studies in humans and gene-targeting studies in mice,",
            "probability": 0.025968633749802027,
            "start_logit": -3.036463737487793,
            "end_logit": -2.760864019393921,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "fat metabolism, which contribute to a healthy metabolic phenotype in humans.Despite various studies in humans and gene-targeting studies in mice,",
            "probability": 0.024803180837362618,
            "start_logit": -3.082381248474121,
            "end_logit": -2.760864019393921,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "gene-targeting studies in mice,",
            "probability": 0.024554435761463125,
            "start_logit": -3.0924606323242188,
            "end_logit": -2.760864019393921,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "metabolic phenotype in humans.Despite various studies in humans and gene-targeting studies in mice,",
            "probability": 0.022348381411799848,
            "start_logit": -3.1865992546081543,
            "end_logit": -2.760864019393921,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "lipid droplet dynamics and fat metabolism",
            "probability": 0.02222860434736501,
            "start_logit": -2.723079204559326,
            "end_logit": -3.2297580242156982,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "various studies in humans and gene-targeting studies in mice",
            "probability": 0.018735846063986476,
            "start_logit": -4.414287090301514,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "studies in humans and gene-targeting studies in mice, the physiological roles of CIDE proteins remains elusive",
            "probability": 0.01831403506086541,
            "start_logit": -3.036463737487793,
            "end_logit": -3.1100857257843018,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "humans and gene-targeting studies in mice",
            "probability": 0.018236182061671005,
            "start_logit": -4.441318035125732,
            "end_logit": -1.709491491317749,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "lipid droplet dynamics and fat metabolism, which contribute to a healthy metabolic phenotype in humans.Despite various studies",
            "probability": 0.01817018843514461,
            "start_logit": -2.723079204559326,
            "end_logit": -3.4313557147979736,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "gene-targeting studies in mice, the physiological roles of CIDE proteins remains elusive",
            "probability": 0.01731669065719067,
            "start_logit": -3.0924606323242188,
            "end_logit": -3.1100857257843018,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "studies in mice,",
            "probability": 0.016776286785916403,
            "start_logit": -3.473386764526367,
            "end_logit": -2.760864019393921,
            "question_text": "Which cells express CIDEC protein in humans?"
        }
    ],
    "588f952994c1512c50000007": [
        {
            "text": "septo-optic dysplasia",
            "probability": 0.917944460508288,
            "start_logit": 4.843135356903076,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic dysplasia",
            "probability": 0.051846466355535754,
            "start_logit": 1.969285249710083,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "dysplasia",
            "probability": 0.01010738019484753,
            "start_logit": 0.33426433801651,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic dysplasia,",
            "probability": 0.008954227919725843,
            "start_logit": 4.843135356903076,
            "end_logit": 0.06269551068544388,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic dysplasia, is a rare, heterogeneous, complex condition with a highly variable phenotype.",
            "probability": 0.003357695995803657,
            "start_logit": 4.843135356903076,
            "end_logit": -0.9181752800941467,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic dysp",
            "probability": 0.0014222457190457309,
            "start_logit": 4.843135356903076,
            "end_logit": -1.7771931886672974,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "se",
            "probability": 0.0010335774008278897,
            "start_logit": 4.843135356903076,
            "end_logit": -2.0964043140411377,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic",
            "probability": 0.0008142048628669885,
            "start_logit": 4.843135356903076,
            "end_logit": -2.3349735736846924,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "tic dysplasia",
            "probability": 0.0007295745086586826,
            "start_logit": -2.294295310974121,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-op",
            "probability": 0.0005589760903673621,
            "start_logit": 4.843135356903076,
            "end_logit": -2.7110788822174072,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic dysplasia,",
            "probability": 0.000505744188839923,
            "start_logit": 1.969285249710083,
            "end_logit": 0.06269551068544388,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic d",
            "probability": 0.00039904869094164287,
            "start_logit": 4.843135356903076,
            "end_logit": -3.0481021404266357,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic dysplasia, is a rare, heterogeneous, complex condition with a highly variable phenotype",
            "probability": 0.00038553940330864035,
            "start_logit": 4.843135356903076,
            "end_logit": -3.0825421810150146,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "lasia",
            "probability": 0.00034277121943500095,
            "start_logit": -3.0496935844421387,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "De Morsier syndrome, or septo-optic dysplasia",
            "probability": 0.00031829942691445515,
            "start_logit": -3.1237642765045166,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo",
            "probability": 0.00030453133663780826,
            "start_logit": 4.843135356903076,
            "end_logit": -3.3184115886688232,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic dys",
            "probability": 0.0002499539312242822,
            "start_logit": 4.843135356903076,
            "end_logit": -3.51590895652771,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "ysplasia",
            "probability": 0.00024341349403341904,
            "start_logit": -3.3919951915740967,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pto-optic dysplasia",
            "probability": 0.00024260740051879049,
            "start_logit": -3.3953123092651367,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": ", or septo-optic dysplasia",
            "probability": 0.00023928135217913879,
            "start_logit": -3.409116744995117,
            "end_logit": 4.69270658493042,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        }
    ],
    "58c66a4b02b8c60953000025": [
        {
            "text": "neurobehavioral disorders",
            "probability": 0.8698647690142206,
            "start_logit": 2.3389358520507812,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "disorders",
            "probability": 0.051922936090828424,
            "start_logit": -0.47964128851890564,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "urobehavioral disorders",
            "probability": 0.037814603058768645,
            "start_logit": -0.7967065572738647,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurobehavioral",
            "probability": 0.01006102337778388,
            "start_logit": 2.3389358520507812,
            "end_logit": -1.4723477363586426,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "vioral disorders",
            "probability": 0.006971368846339591,
            "start_logit": -2.4875903129577637,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurobehavioral disorders.",
            "probability": 0.00622044715343685,
            "start_logit": 2.3389358520507812,
            "end_logit": -1.9531748294830322,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "disorders.We review existing evidence that support or refute the association between unconjugated hyperbilirubinemia and developmental disorders",
            "probability": 0.0036065324382062677,
            "start_logit": -0.47964128851890564,
            "end_logit": 0.32030728459358215,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "ne",
            "probability": 0.0032862728304601306,
            "start_logit": 2.3389358520507812,
            "end_logit": -2.5912625789642334,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurobehavior",
            "probability": 0.00259235667210647,
            "start_logit": 2.3389358520507812,
            "end_logit": -2.828449249267578,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "developmental disorders",
            "probability": 0.0019452461606138543,
            "start_logit": -1.0969995260238647,
            "end_logit": 0.32030728459358215,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neuro",
            "probability": 0.00169050662787716,
            "start_logit": 2.3389358520507812,
            "end_logit": -3.255988359451294,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "behavioral disorders",
            "probability": 0.0008718620854011178,
            "start_logit": -4.566525936126709,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders",
            "probability": 0.0005773182119052942,
            "start_logit": -4.978763580322266,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "unconjugated hyperbilirubinemia and neurobehavioral disorders",
            "probability": 0.0005285544525319562,
            "start_logit": -5.06701135635376,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "al disorders",
            "probability": 0.00047534596619908895,
            "start_logit": -5.17311429977417,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "urobehavioral",
            "probability": 0.0004373709787407995,
            "start_logit": -0.7967065572738647,
            "end_logit": -1.4723477363586426,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "disorders.",
            "probability": 0.00037130355373548527,
            "start_logit": -0.47964128851890564,
            "end_logit": -1.9531748294830322,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "urobehavioral disorders.",
            "probability": 0.0002704141475022957,
            "start_logit": -0.7967065572738647,
            "end_logit": -1.9531748294830322,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurobehavioral disorders.We",
            "probability": 0.00026960639695200445,
            "start_logit": 2.3389358520507812,
            "end_logit": -5.091808795928955,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "influence of unconjugated hyperbilirubinemia and neurobehavioral disorders",
            "probability": 0.00022216193639053978,
            "start_logit": -5.933750629425049,
            "end_logit": 2.987321138381958,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        }
    ],
    "58bfcb8702b8c60953000016": [
        {
            "text": "lichen planus",
            "probability": 0.9942645711989224,
            "start_logit": 5.732296466827393,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "in lichen planus",
            "probability": 0.001052209172157196,
            "start_logit": -1.1188149452209473,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen plan",
            "probability": 0.0010091301141482907,
            "start_logit": 5.732296466827393,
            "end_logit": -1.5897797346115112,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen",
            "probability": 0.0007748401490954272,
            "start_logit": 5.732296466827393,
            "end_logit": -1.8539669513702393,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "planus",
            "probability": 0.0007161221164907773,
            "start_logit": -1.503611445426941,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus on light and dark skin.",
            "probability": 0.0007091186450489218,
            "start_logit": 5.732296466827393,
            "end_logit": -1.9426008462905884,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "l",
            "probability": 0.00030787763896155984,
            "start_logit": 5.732296466827393,
            "end_logit": -2.776921272277832,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "ichen planus",
            "probability": 0.0002512276533075963,
            "start_logit": -2.551102638244629,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon in lichen planus",
            "probability": 0.00020960040361182395,
            "start_logit": -2.7322592735290527,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "us",
            "probability": 0.00017654626840434546,
            "start_logit": -2.903879165649414,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus on light and dark skin.The Koebner phenomenon",
            "probability": 0.00016239758438462657,
            "start_logit": 5.732296466827393,
            "end_logit": -3.4165761470794678,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus on light and dark skin",
            "probability": 6.373738507145171e-05,
            "start_logit": 5.732296466827393,
            "end_logit": -4.3518524169921875,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus on light and dark skin.The Koebner phenomenon is well described and well known in clinical practice.In this case,",
            "probability": 6.181239917460583e-05,
            "start_logit": 5.732296466827393,
            "end_logit": -4.382519721984863,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus on light and dark skin.The Koebner phenomenon is well described and well known in clinical practice.",
            "probability": 5.782210226882573e-05,
            "start_logit": 5.732296466827393,
            "end_logit": -4.449252605438232,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "n planus",
            "probability": 5.011280454302316e-05,
            "start_logit": -4.1631855964660645,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "liche",
            "probability": 3.578797268608428e-05,
            "start_logit": 5.732296466827393,
            "end_logit": -4.929011821746826,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "phenomenon in lichen planus",
            "probability": 2.771739136904859e-05,
            "start_logit": -4.755402088165283,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus on light",
            "probability": 2.4121982069011546e-05,
            "start_logit": 5.732296466827393,
            "end_logit": -5.323500156402588,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "features of Koebner phenomenon in lichen planus",
            "probability": 2.4065285164338036e-05,
            "start_logit": -4.896691799163818,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Dermatoscopic features of Koebner phenomenon in lichen planus",
            "probability": 2.118173312074048e-05,
            "start_logit": -5.024322986602783,
            "end_logit": 5.303134918212891,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        }
    ],
    "58c6a6c502b8c60953000027": [
        {
            "text": "vertigo",
            "probability": 0.9977719720228397,
            "start_logit": 6.071718692779541,
            "end_logit": 5.676792621612549,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration of the balance system",
            "probability": 0.0011013884369065216,
            "start_logit": 6.071718692779541,
            "end_logit": -1.1321605443954468,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant",
            "probability": 0.00031946836178615653,
            "start_logit": 6.071718692779541,
            "end_logit": -2.3698291778564453,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "ve",
            "probability": 0.00022596590098107356,
            "start_logit": 6.071718692779541,
            "end_logit": -2.7161033153533936,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "igo",
            "probability": 0.00020311515695891748,
            "start_logit": -2.427788257598877,
            "end_logit": 5.676792621612549,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration of the balance system.",
            "probability": 0.00012747564965041373,
            "start_logit": 6.025539875030518,
            "end_logit": -3.2423832416534424,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration of the balance system.Usefulness of Ultrasound",
            "probability": 6.835133197066939e-05,
            "start_logit": 6.071718692779541,
            "end_logit": -3.9118263721466064,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "rtigo",
            "probability": 6.82874806014917e-05,
            "start_logit": -3.5178349018096924,
            "end_logit": 5.676792621612549,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "fluctuating symptoms, whereby vertigo",
            "probability": 6.786029009357205e-05,
            "start_logit": -3.5241103172302246,
            "end_logit": 5.676792621612549,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration of the balance",
            "probability": 2.002426609764006e-05,
            "start_logit": 6.071718692779541,
            "end_logit": -5.139542579650879,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vert",
            "probability": 1.876671788853239e-05,
            "start_logit": 6.071718692779541,
            "end_logit": -5.204402446746826,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "M\u00e9ni\u00e8re's disease (MD) is composed of a set of fluctuating symptoms, whereby vertigo",
            "probability": 6.461369726930341e-06,
            "start_logit": -5.787237167358398,
            "end_logit": 5.5883097648620605,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "deterioration of the balance system",
            "probability": 2.704595133533908e-07,
            "start_logit": -2.240241050720215,
            "end_logit": -1.1321605443954468,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "igo is the most unpleasant among them and often accompanied by deterioration of the balance system",
            "probability": 2.242082274384473e-07,
            "start_logit": -2.427788257598877,
            "end_logit": -1.1321605443954468,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "rtigo is the most unpleasant among them and often accompanied by deterioration of the balance system",
            "probability": 7.537898801414692e-08,
            "start_logit": -3.5178349018096924,
            "end_logit": -1.1321605443954468,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "fluctuating symptoms, whereby vertigo is the most unpleasant among them and often accompanied by deterioration of the balance system",
            "probability": 7.490743469437881e-08,
            "start_logit": -3.5241103172302246,
            "end_logit": -1.1321605443954468,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "igo is the most unpleasant",
            "probability": 6.503376349212389e-08,
            "start_logit": -2.427788257598877,
            "end_logit": -2.3698291778564453,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "deterioration of the balance system.Usefulness of Ultrasound-Computer-Craniocorpography",
            "probability": 5.834584869669971e-08,
            "start_logit": -2.240241050720215,
            "end_logit": -2.6658947467803955,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "balance system",
            "probability": 5.419267789093914e-08,
            "start_logit": -3.8478176593780518,
            "end_logit": -1.1321605443954468,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "Ultrasound-Computer-Craniocorpography",
            "probability": 4.048804446209323e-08,
            "start_logit": -2.6056225299835205,
            "end_logit": -2.6658947467803955,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        }
    ],
    "58ce5c7c1f5fb2b734000001": [
        {
            "text": "structure-activity relationships",
            "probability": 0.15679295046053446,
            "start_logit": -3.7182059288024902,
            "end_logit": -4.211366176605225,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "lack of established structure-activity relationships",
            "probability": 0.11071992593990193,
            "start_logit": -4.066128253936768,
            "end_logit": -4.211366176605225,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure",
            "probability": 0.07981537451737014,
            "start_logit": -3.7182059288024902,
            "end_logit": -4.886576175689697,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure-activity relationships (SARs)",
            "probability": 0.06123410843320287,
            "start_logit": -3.7182059288024902,
            "end_logit": -5.151587963104248,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "lack of established structure",
            "probability": 0.056361923986200595,
            "start_logit": -4.066128253936768,
            "end_logit": -4.886576175689697,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure-activity relationships (SARs) for molecules that bind the metal",
            "probability": 0.048081999104672035,
            "start_logit": -3.7182059288024902,
            "end_logit": -5.3933844566345215,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "lack of established structure-activity relationships (SARs)",
            "probability": 0.04324069373531346,
            "start_logit": -4.066128253936768,
            "end_logit": -5.151587963104248,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "development of metalloenzyme inhibitors has been the lack of established structure-activity relationships",
            "probability": 0.04242151323685673,
            "start_logit": -5.025476455688477,
            "end_logit": -4.211366176605225,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure-activity relationships (SARs) for molecules that bind the metal ion",
            "probability": 0.03952451531744155,
            "start_logit": -3.7182059288024902,
            "end_logit": -5.589371204376221,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "A limitation to the early development of metalloenzyme inhibitors has been the lack of established structure-activity relationships",
            "probability": 0.03682972824891147,
            "start_logit": -5.1668267250061035,
            "end_logit": -4.211366176605225,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "metal",
            "probability": 0.036568322436314034,
            "start_logit": -3.991931438446045,
            "end_logit": -5.3933844566345215,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure-activity relationships (SARs) for molecules that bind the metal ion cofactor(s) of a metalloenzyme",
            "probability": 0.03398493311598756,
            "start_logit": -3.7182059288024902,
            "end_logit": -5.74037504196167,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "lack of established structure-activity relationships (SARs) for molecules that bind the metal",
            "probability": 0.03395328274820431,
            "start_logit": -4.066128253936768,
            "end_logit": -5.3933844566345215,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure-activity relationships (SARs) for molecules that bind the metal ion cofactor(s) of a metalloenzyme.",
            "probability": 0.0329874714043925,
            "start_logit": -3.7182059288024902,
            "end_logit": -5.770164489746094,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "metalloenzyme inhibitors has been the lack of established structure-activity relationships",
            "probability": 0.03243291784175259,
            "start_logit": -5.2939581871032715,
            "end_logit": -4.211366176605225,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure-activity relationships (SARs) for molecules that bind the metal ion cofactor",
            "probability": 0.03218297814541983,
            "start_logit": -3.7182059288024902,
            "end_logit": -5.794854640960693,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "structure-activity relationships (SARs) for molecules that bind the metal ion cofactor(s)",
            "probability": 0.03177004865746553,
            "start_logit": -3.7182059288024902,
            "end_logit": -5.80776834487915,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "development of metalloenzyme inhibitors",
            "probability": 0.030782765626120232,
            "start_logit": -5.025476455688477,
            "end_logit": -4.532066822052002,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "inhibitors has been the lack of established structure-activity relationships",
            "probability": 0.030254540239296305,
            "start_logit": -5.363485813140869,
            "end_logit": -4.211366176605225,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "metal ion",
            "probability": 0.030060006804642072,
            "start_logit": -3.991931438446045,
            "end_logit": -5.589371204376221,
            "question_text": "List metalloenzyme inhibitors."
        }
    ],
    "58c99acf02b8c60953000028": [
        {
            "text": "subscapularis",
            "probability": 0.21285392101820244,
            "start_logit": -1.3268259763717651,
            "end_logit": -2.123870611190796,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "subscapularis tendon",
            "probability": 0.2053217385742218,
            "start_logit": -1.3268259763717651,
            "end_logit": -2.159898519515991,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair",
            "probability": 0.09944461253283285,
            "start_logit": -1.5580525398254395,
            "end_logit": -2.65364933013916,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical",
            "probability": 0.07373645613682529,
            "start_logit": -1.5580525398254395,
            "end_logit": -2.9527528285980225,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "subscapularis tendon.",
            "probability": 0.06751862298592655,
            "start_logit": -1.3268259763717651,
            "end_logit": -3.272073268890381,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair of a rotator cuff tear.",
            "probability": 0.05721710352427326,
            "start_logit": -1.5580525398254395,
            "end_logit": -3.206397294998169,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair of a rotator cuff tear.This comparison allowed us to identify the specific features of rotator cuff tears",
            "probability": 0.029227420522998104,
            "start_logit": -1.5580525398254395,
            "end_logit": -3.878142833709717,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair of a rotator cuff tear.This comparison allowed us to identify the specific features",
            "probability": 0.025027781754175027,
            "start_logit": -1.5580525398254395,
            "end_logit": -4.033263683319092,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair of a rotator cuff tear",
            "probability": 0.02473089202167402,
            "start_logit": -1.5580525398254395,
            "end_logit": -4.045197010040283,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "laris",
            "probability": 0.023564732674000288,
            "start_logit": -3.5276808738708496,
            "end_logit": -2.123870611190796,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "laris tendon",
            "probability": 0.022730856253518363,
            "start_logit": -3.5276808738708496,
            "end_logit": -2.159898519515991,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "identify the specific features of rotator cuff tears involving the subscapularis",
            "probability": 0.022599220876715103,
            "start_logit": -3.569516658782959,
            "end_logit": -2.123870611190796,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "identify the specific features of rotator cuff tears involving the subscapularis tendon",
            "probability": 0.021799510662682084,
            "start_logit": -3.569516658782959,
            "end_logit": -2.159898519515991,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "the subscapularis",
            "probability": 0.02093509997065797,
            "start_logit": -3.6460049152374268,
            "end_logit": -2.123870611190796,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "the subscapularis tendon",
            "probability": 0.020194277383469243,
            "start_logit": -3.6460049152374268,
            "end_logit": -2.159898519515991,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair of a rotator cuff tear.This comparison allowed us to identify",
            "probability": 0.016909259111706453,
            "start_logit": -1.5580525398254395,
            "end_logit": -4.425388813018799,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "allowed us to identify the specific features of rotator cuff tears involving the subscapularis",
            "probability": 0.016367609275492658,
            "start_logit": -3.892127752304077,
            "end_logit": -2.123870611190796,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "allowed us to identify the specific features of rotator cuff tears involving the subscapularis tendon",
            "probability": 0.01578841478076565,
            "start_logit": -3.892127752304077,
            "end_logit": -2.159898519515991,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "tendon",
            "probability": 0.01297737461829866,
            "start_logit": -4.088196754455566,
            "end_logit": -2.159898519515991,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "rotator cuff tears involving the subscapularis",
            "probability": 0.01105509532156407,
            "start_logit": -4.28454065322876,
            "end_logit": -2.123870611190796,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        }
    ],
    "58cd59cb02b8c60953000039": [
        {
            "text": "dengue",
            "probability": 0.7508908159029254,
            "start_logit": 3.555048942565918,
            "end_logit": 3.2716832160949707,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "dengue virus",
            "probability": 0.2419070627312177,
            "start_logit": 3.555048942565918,
            "end_logit": 2.138976573944092,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "dengue virus replication",
            "probability": 0.0018746238861487262,
            "start_logit": 3.555048942565918,
            "end_logit": -2.7211689949035645,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV",
            "probability": 0.0017353939094630186,
            "start_logit": 0.541763186454773,
            "end_logit": 0.21494314074516296,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV infection",
            "probability": 0.0014603897943762437,
            "start_logit": 0.541763186454773,
            "end_logit": 0.04241209849715233,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "gue",
            "probability": 0.0010145591837517588,
            "start_logit": -3.0517570972442627,
            "end_logit": 3.2716832160949707,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "den",
            "probability": 0.0004482856304295643,
            "start_logit": 3.555048942565918,
            "end_logit": -4.151901721954346,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "gue virus",
            "probability": 0.0003268504913237594,
            "start_logit": -3.0517570972442627,
            "end_logit": 2.138976573944092,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "virus",
            "probability": 0.00024594967633846047,
            "start_logit": -3.3361330032348633,
            "end_logit": 2.138976573944092,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV infection.",
            "probability": 2.513063425238406e-05,
            "start_logit": 0.541763186454773,
            "end_logit": -4.019958972930908,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV infection.Antagonism",
            "probability": 1.7951372550356875e-05,
            "start_logit": 0.541763186454773,
            "end_logit": -4.356379985809326,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "infection",
            "probability": 7.528146877122098e-06,
            "start_logit": -4.726046562194824,
            "end_logit": 0.04241209849715233,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "the D4 dopamine receptor (DRD4), in DENV",
            "probability": 7.5055256895961976e-06,
            "start_logit": -4.901587009429932,
            "end_logit": 0.21494314074516296,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "D4 dopamine receptor (DRD4), in DENV",
            "probability": 7.477501561703171e-06,
            "start_logit": -4.905327796936035,
            "end_logit": 0.21494314074516296,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV infection.Ant",
            "probability": 6.7452504749211044e-06,
            "start_logit": 0.541763186454773,
            "end_logit": -5.335207939147949,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "the D4 dopamine receptor (DRD4), in DENV infection",
            "probability": 6.316141285701904e-06,
            "start_logit": -4.901587009429932,
            "end_logit": 0.04241209849715233,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "D4 dopamine receptor (DRD4), in DENV infection",
            "probability": 6.292558080673868e-06,
            "start_logit": -4.905327796936035,
            "end_logit": 0.04241209849715233,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "dopamine receptor (DRD4), in DENV",
            "probability": 4.479423157016339e-06,
            "start_logit": -5.417732238769531,
            "end_logit": 0.21494314074516296,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "dopamine receptor (DRD4), in DENV infection",
            "probability": 3.7695786688703255e-06,
            "start_logit": -5.417732238769531,
            "end_logit": 0.04241209849715233,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "(DRD4), in DENV",
            "probability": 2.8726614269168116e-06,
            "start_logit": -5.861987590789795,
            "end_logit": 0.21494314074516296,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        }
    ],
    "58b548d722d3005309000005": [
        {
            "text": "Corynebacterium diphtheriae",
            "probability": 0.9455142897096186,
            "start_logit": 5.988020420074463,
            "end_logit": 6.082729816436768,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium",
            "probability": 0.029698992659260945,
            "start_logit": 5.988020420074463,
            "end_logit": 2.6221139430999756,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphtheriae,",
            "probability": 0.01845279437896442,
            "start_logit": 5.988020420074463,
            "end_logit": 2.146216630935669,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae",
            "probability": 0.00410441199610925,
            "start_logit": 0.548353910446167,
            "end_logit": 6.082729816436768,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium dip",
            "probability": 0.000774818561615396,
            "start_logit": 5.988020420074463,
            "end_logit": -1.024125576019287,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacteri",
            "probability": 0.0003392594955393897,
            "start_logit": 5.420835971832275,
            "end_logit": -1.2828047275543213,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Co",
            "probability": 0.00032500347584754033,
            "start_logit": 5.988020420074463,
            "end_logit": -1.892918586730957,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheria toxin throughout the body.Diphtheria is an infectious disease caused by Corynebacterium diphtheriae",
            "probability": 0.00025448754936279784,
            "start_logit": -1.630377173423767,
            "end_logit": 5.480895042419434,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "iae",
            "probability": 0.00018335826715829673,
            "start_logit": -2.5600218772888184,
            "end_logit": 6.082729816436768,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae,",
            "probability": 8.010230139834175e-05,
            "start_logit": 0.548353910446167,
            "end_logit": 2.146216630935669,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "heriae",
            "probability": 6.348210259724556e-05,
            "start_logit": -3.6207058429718018,
            "end_logit": 6.082729816436768,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphther",
            "probability": 6.105482848496239e-05,
            "start_logit": 5.988020420074463,
            "end_logit": -3.5649821758270264,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "caused by Corynebacterium diphtheriae",
            "probability": 4.9427076408633164e-05,
            "start_logit": -3.8709654808044434,
            "end_logit": 6.082729816436768,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebact",
            "probability": 4.111879120855012e-05,
            "start_logit": 5.988020420074463,
            "end_logit": -3.960289239883423,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "um diphtheriae",
            "probability": 2.7003876850988264e-05,
            "start_logit": -4.475483417510986,
            "end_logit": 6.082729816436768,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheria toxin throughout the body.Diphtheria is an infectious disease caused by Corynebacterium",
            "probability": 1.301065126888105e-05,
            "start_logit": -1.630377173423767,
            "end_logit": 2.507411479949951,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "erium diphtheriae",
            "probability": 5.502282418255551e-06,
            "start_logit": -5.464466094970703,
            "end_logit": 5.480895042419434,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Diphtheria is an infectious disease caused by Corynebacterium diphtheriae",
            "probability": 4.940115609374439e-06,
            "start_logit": -5.572240352630615,
            "end_logit": 5.480895042419434,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "iae,",
            "probability": 3.578446606655082e-06,
            "start_logit": -2.5600218772888184,
            "end_logit": 2.146216630935669,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "dip",
            "probability": 3.3634336717206295e-06,
            "start_logit": 0.548353910446167,
            "end_logit": -1.024125576019287,
            "question_text": "Which bacteria cause diphtheria?"
        }
    ],
    "58cea0768acda34529000001": [
        {
            "text": "Tay-Sachs disease",
            "probability": 0.7867929417351197,
            "start_logit": 5.780833721160889,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs",
            "probability": 0.15794946074935975,
            "start_logit": 5.780833721160889,
            "end_logit": 4.665304660797119,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD)",
            "probability": 0.026592731362856344,
            "start_logit": 5.780833721160889,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD",
            "probability": 0.01948837350298908,
            "start_logit": 5.780833721160889,
            "end_logit": 2.572847604751587,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease",
            "probability": 0.0037698911472519837,
            "start_logit": 0.439914733171463,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD),",
            "probability": 0.002266331022284296,
            "start_logit": 5.780833721160889,
            "end_logit": 0.4211917817592621,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "TSD)",
            "probability": 0.0008279270806278389,
            "start_logit": 2.3113656044006348,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs",
            "probability": 0.0007568093741144665,
            "start_logit": 0.439914733171463,
            "end_logit": 4.665304660797119,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "TSD",
            "probability": 0.0006067429464222444,
            "start_logit": 2.3113656044006348,
            "end_logit": 2.572847604751587,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "disease",
            "probability": 0.00028608458421905647,
            "start_logit": -2.138599157333374,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease (TSD)",
            "probability": 0.0001274181518774133,
            "start_logit": 0.439914733171463,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease (TSD",
            "probability": 9.337786709326203e-05,
            "start_logit": 0.439914733171463,
            "end_logit": 2.572847604751587,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD), a deficiency of b-hexosaminidase A (Hex A),",
            "probability": 8.975744064494137e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -2.807614803314209,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "chs disease",
            "probability": 7.813889348571468e-05,
            "start_logit": -3.43639874458313,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Ta",
            "probability": 7.400338606945432e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -3.000614881515503,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "TSD),",
            "probability": 7.055901108514798e-05,
            "start_logit": 2.3113656044006348,
            "end_logit": 0.4211917817592621,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (",
            "probability": 5.1812797023583645e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -3.357088565826416,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "y-Sachs disease",
            "probability": 3.0164605214068485e-05,
            "start_logit": -4.388217449188232,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay",
            "probability": 2.385537484863159e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -4.132716178894043,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "(TSD)",
            "probability": 2.3618967412861197e-05,
            "start_logit": -1.245509386062622,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        }
    ],
    "58c1b2f702b8c6095300001e": [
        {
            "text": "antidepressant",
            "probability": 0.24250043042217062,
            "start_logit": 6.023683547973633,
            "end_logit": 5.605403900146484,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation",
            "probability": 0.2126767926406377,
            "start_logit": 6.395496368408203,
            "end_logit": 5.10236120223999,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation aid",
            "probability": 0.20999706493711906,
            "start_logit": 6.395496368408203,
            "end_logit": 5.089681148529053,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking cessation",
            "probability": 0.14663709419219245,
            "start_logit": 6.023683547973633,
            "end_logit": 5.10236120223999,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking cessation aid",
            "probability": 0.14478946672522072,
            "start_logit": 6.023683547973633,
            "end_logit": 5.089681148529053,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepress",
            "probability": 0.007986598583362833,
            "start_logit": 6.023683547973633,
            "end_logit": 2.1921653747558594,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant",
            "probability": 0.006527381451040941,
            "start_logit": 2.4086859226226807,
            "end_logit": 5.605403900146484,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant and smoking cessation",
            "probability": 0.003947029071240577,
            "start_logit": 2.4086859226226807,
            "end_logit": 5.10236120223999,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant and smoking cessation aid",
            "probability": 0.0038972965027855465,
            "start_logit": 2.4086859226226807,
            "end_logit": 5.089681148529053,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depressant",
            "probability": 0.0036960754655754277,
            "start_logit": 1.8399516344070435,
            "end_logit": 5.605403900146484,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation aid,",
            "probability": 0.0024180280777015613,
            "start_logit": 6.395496368408203,
            "end_logit": 0.6255399584770203,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking",
            "probability": 0.0022597801614153497,
            "start_logit": 6.395496368408203,
            "end_logit": 0.5578551292419434,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depressant and smoking cessation",
            "probability": 0.0022349723884757472,
            "start_logit": 1.8399516344070435,
            "end_logit": 5.10236120223999,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depressant and smoking cessation aid",
            "probability": 0.002206811735159344,
            "start_logit": 1.8399516344070435,
            "end_logit": 5.089681148529053,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking cessation aid,",
            "probability": 0.0016671899485921583,
            "start_logit": 6.023683547973633,
            "end_logit": 0.6255399584770203,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "pressant",
            "probability": 0.0015890116307141825,
            "start_logit": 0.9957922697067261,
            "end_logit": 5.605403900146484,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking",
            "probability": 0.001558080655010751,
            "start_logit": 6.023683547973633,
            "end_logit": 0.5578551292419434,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "cessation",
            "probability": 0.0012327861462906756,
            "start_logit": 1.2449995279312134,
            "end_logit": 5.10236120223999,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "cessation aid",
            "probability": 0.0012172530401735869,
            "start_logit": 1.2449995279312134,
            "end_logit": 5.089681148529053,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "pressant and smoking cessation",
            "probability": 0.0009608562251204239,
            "start_logit": 0.9957922697067261,
            "end_logit": 5.10236120223999,
            "question_text": "List 3 indications for Bupropion"
        }
    ],
    "587d2b7efe8a08052f000003": [
        {
            "text": "33",
            "probability": 0.1292477674370771,
            "start_logit": -2.186701774597168,
            "end_logit": -3.195359468460083,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs",
            "probability": 0.11492380232091723,
            "start_logit": -2.3681678771972656,
            "end_logit": -3.1313552856445312,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "33 PFMs",
            "probability": 0.09932721634267513,
            "start_logit": -2.186701774597168,
            "end_logit": -3.4586710929870605,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "PFMs",
            "probability": 0.07944025219696471,
            "start_logit": -2.9477081298828125,
            "end_logit": -2.921079158782959,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "322 new PFMs",
            "probability": 0.07222987706074538,
            "start_logit": -3.0428595542907715,
            "end_logit": -2.921079158782959,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "PFMs (60 for vertebrates and 262 for plants) and 33",
            "probability": 0.06038404320799601,
            "start_logit": -2.9477081298828125,
            "end_logit": -3.195359468460083,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TF flexible models (TFFMs",
            "probability": 0.05934772500928459,
            "start_logit": -3.0290234088897705,
            "end_logit": -3.1313552856445312,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "322 new PFMs (60 for vertebrates and 262 for plants) and 33",
            "probability": 0.05490330023789799,
            "start_logit": -3.0428595542907715,
            "end_logit": -3.195359468460083,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "PFMs) and TF flexible models (TFFMs",
            "probability": 0.049419709768723986,
            "start_logit": -3.212087869644165,
            "end_logit": -3.1313552856445312,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "PFMs (60 for vertebrates and 262 for plants) and 33 PFMs",
            "probability": 0.046405280665958254,
            "start_logit": -2.9477081298828125,
            "end_logit": -3.4586710929870605,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "322 new PFMs (60 for vertebrates and 262 for plants) and 33 PFMs",
            "probability": 0.0421933166722703,
            "start_logit": -3.0428595542907715,
            "end_logit": -3.4586710929870605,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "33 PFMs were updated",
            "probability": 0.037363920779085805,
            "start_logit": -2.186701774597168,
            "end_logit": -4.436385154724121,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "322",
            "probability": 0.03335552931990267,
            "start_logit": -3.0428595542907715,
            "end_logit": -3.693709373474121,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TF flexible models",
            "probability": 0.021379652015764125,
            "start_logit": -3.0290234088897705,
            "end_logit": -4.152329444885254,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "33 PFMs were updated (24 for vertebrates, 8 for plants and 1 for insects)",
            "probability": 0.019630539537110366,
            "start_logit": -2.186701774597168,
            "end_logit": -5.0800042152404785,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "PFMs) and TF flexible models",
            "probability": 0.017803145738275274,
            "start_logit": -3.212087869644165,
            "end_logit": -4.152329444885254,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "PFMs (60 for vertebrates and 262 for plants) and 33 PFMs were updated",
            "probability": 0.01745627527255244,
            "start_logit": -2.9477081298828125,
            "end_logit": -4.436385154724121,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "322 new PFMs (60 for vertebrates and 262 for plants) and 33 PFMs were updated",
            "probability": 0.01587186070040155,
            "start_logit": -3.0428595542907715,
            "end_logit": -4.436385154724121,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "60 for vertebrates and 262 for plants) and 33",
            "probability": 0.015165685399280284,
            "start_logit": -4.329397678375244,
            "end_logit": -3.195359468460083,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "262 for plants) and 33",
            "probability": 0.01415110031711708,
            "start_logit": -4.3986406326293945,
            "end_logit": -3.195359468460083,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        }
    ],
    "58dfd83a6fddd3e83e000003": [
        {
            "text": "Pnpla3",
            "probability": 0.879367300350536,
            "start_logit": 3.8414714336395264,
            "end_logit": 3.2607500553131104,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Pnpla3 as well as 'PCB",
            "probability": 0.07733589540349996,
            "start_logit": 3.8414714336395264,
            "end_logit": 0.8297055959701538,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "PCB",
            "probability": 0.015771177222859426,
            "start_logit": 2.251497268676758,
            "end_logit": 0.8297055959701538,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "hepatokines and Pnpla3",
            "probability": 0.012500388936149994,
            "start_logit": -0.41197147965431213,
            "end_logit": 3.2607500553131104,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "PCB pancreatopathy' that was associated with altered expression of pancreatic islet identity factors.It caused steatosis",
            "probability": 0.0039633363949539615,
            "start_logit": 2.251497268676758,
            "end_logit": -0.5513922572135925,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Pnpla3 as well as 'PCB pancreatopathy",
            "probability": 0.0032883770180599206,
            "start_logit": 3.8414714336395264,
            "end_logit": -2.3280584812164307,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Pnpla",
            "probability": 0.0018423523149246424,
            "start_logit": 3.8414714336395264,
            "end_logit": -2.907409429550171,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "3",
            "probability": 0.0011192544170344353,
            "start_logit": -2.825068473815918,
            "end_logit": 3.2607500553131104,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "hepatokines and Pnpla3 as well as 'PCB",
            "probability": 0.0010993458261227176,
            "start_logit": -0.41197147965431213,
            "end_logit": 0.8297055959701538,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "PCB pancreatopathy' that was associated with altered expression of pancreatic islet identity factors",
            "probability": 0.0007748550517970199,
            "start_logit": 2.251497268676758,
            "end_logit": -2.1835577487945557,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "PCB pancreatopathy",
            "probability": 0.0006706016198146191,
            "start_logit": 2.251497268676758,
            "end_logit": -2.3280584812164307,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "la3",
            "probability": 0.000507342789296814,
            "start_logit": -3.616299629211426,
            "end_logit": 3.2607500553131104,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "PCB pancreatopathy' that was associated with altered expression of pancreatic islet identity factors.",
            "probability": 0.0003512869373664998,
            "start_logit": 2.251497268676758,
            "end_logit": -2.974630355834961,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "lipid import",
            "probability": 0.00029762525713464895,
            "start_logit": 0.2333776354789734,
            "end_logit": -1.1222789287567139,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "steatosis",
            "probability": 0.00021637231957116737,
            "start_logit": -0.6563435792922974,
            "end_logit": -0.5513922572135925,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "lipid import with associated hypolipidemia",
            "probability": 0.00021215462184060778,
            "start_logit": 0.2333776354789734,
            "end_logit": -1.460798740386963,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "pancreatic islet identity factors.It caused steatosis",
            "probability": 0.00019762299569667433,
            "start_logit": -0.7469830513000488,
            "end_logit": -0.5513922572135925,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "hepatic lipid import",
            "probability": 0.00018568966602185917,
            "start_logit": -0.23838071525096893,
            "end_logit": -1.1222789287567139,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "PCB pancreatopathy' that was associated with altered expression of pancreatic islet identity factors.It",
            "probability": 0.00015368071587762696,
            "start_logit": 2.251497268676758,
            "end_logit": -3.801356554031372,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "lipid",
            "probability": 0.00014534014144115326,
            "start_logit": 0.2333776354789734,
            "end_logit": -1.839037299156189,
            "question_text": "List genes associated with hypolipidemia."
        }
    ],
    "58c6665602b8c60953000024": [
        {
            "text": "toxoplasmosis",
            "probability": 0.8809883805302894,
            "start_logit": 0.5439608097076416,
            "end_logit": 1.7048008441925049,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Toxoplasmosis",
            "probability": 0.10245152056419468,
            "start_logit": -0.6289119720458984,
            "end_logit": 0.7260189056396484,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case report",
            "probability": 0.005788759267024068,
            "start_logit": 0.5439608097076416,
            "end_logit": -3.3203256130218506,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency",
            "probability": 0.0027191237004366904,
            "start_logit": 0.5439608097076416,
            "end_logit": -4.075933933258057,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "is",
            "probability": 0.001744942148891806,
            "start_logit": -5.680362224578857,
            "end_logit": 1.7048008441925049,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "xoplasmosis",
            "probability": 0.001657310796504654,
            "start_logit": -5.731887340545654,
            "end_logit": 1.7048008441925049,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case report.",
            "probability": 0.001032704385437149,
            "start_logit": 0.5439608097076416,
            "end_logit": -5.044062614440918,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "mosis",
            "probability": 0.0006995013261560113,
            "start_logit": -5.615689277648926,
            "end_logit": 0.7260189056396484,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Patient with toxoplasmosis",
            "probability": 0.0005760025567727798,
            "start_logit": -6.788726806640625,
            "end_logit": 1.7048008441925049,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a",
            "probability": 0.0004383005717409481,
            "start_logit": 0.5439608097076416,
            "end_logit": -5.90109395980835,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency:",
            "probability": 0.0004181368032295572,
            "start_logit": 0.5439608097076416,
            "end_logit": -5.948190212249756,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "toxoplasmosis and glucose-6-phosphate dehydrogenase",
            "probability": 0.00035073827288887194,
            "start_logit": 0.5439608097076416,
            "end_logit": -6.123958587646484,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case",
            "probability": 0.0003050847887750941,
            "start_logit": 0.5439608097076416,
            "end_logit": -6.26340913772583,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Toxoplasmosis, a zoonotic protozoal disease caused by toxoplasma gondii",
            "probability": 0.0002859949764785383,
            "start_logit": -0.6289119720458984,
            "end_logit": -5.155151844024658,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Toxoplasmosis,",
            "probability": 0.00017674714380122705,
            "start_logit": -0.6289119720458984,
            "end_logit": -5.636405944824219,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Toxoplasmos",
            "probability": 0.00011800455208087772,
            "start_logit": -0.6289119720458984,
            "end_logit": -6.040402889251709,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Toxoplasmosis, a zoonotic protozoal disease",
            "probability": 9.889124404468127e-05,
            "start_logit": -0.6289119720458984,
            "end_logit": -6.217105388641357,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Toxoplasmosis, a zoonotic protozoal disease caused by toxoplasma gondii,",
            "probability": 8.019018927868434e-05,
            "start_logit": -0.6289119720458984,
            "end_logit": -6.426724910736084,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "a case report",
            "probability": 4.4687983854014535e-05,
            "start_logit": -4.320007801055908,
            "end_logit": -3.3203256130218506,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "deficiency: a case report",
            "probability": 2.4978198120552164e-05,
            "start_logit": -4.901709079742432,
            "end_logit": -3.3203256130218506,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        }
    ],
    "58d8e9bd8acda3452900000b": [
        {
            "text": "heart failure, arrhythmias and sudden cardiac death",
            "probability": 0.2302743668792133,
            "start_logit": 6.165853977203369,
            "end_logit": 5.7497334480285645,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure",
            "probability": 0.19550998416523746,
            "start_logit": 6.165853977203369,
            "end_logit": 5.586073398590088,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, arrhythmias",
            "probability": 0.17649687568316783,
            "start_logit": 6.165853977203369,
            "end_logit": 5.483765125274658,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "sudden cardiac death",
            "probability": 0.16782807811793307,
            "start_logit": 5.849522590637207,
            "end_logit": 5.7497334480285645,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmias and sudden cardiac death",
            "probability": 0.12647788035740706,
            "start_logit": 5.566649913787842,
            "end_logit": 5.7497334480285645,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmias",
            "probability": 0.09694066703403854,
            "start_logit": 5.566649913787842,
            "end_logit": 5.483765125274658,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "cardiac death",
            "probability": 0.0017471692669084394,
            "start_logit": 1.2845793962478638,
            "end_logit": 5.7497334480285645,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure,",
            "probability": 0.001242414593577384,
            "start_logit": 6.165853977203369,
            "end_logit": 0.5275186896324158,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "asymptomatic to heart failure, arrhythmias and sudden cardiac death",
            "probability": 0.0006165538121509736,
            "start_logit": 0.24297280609607697,
            "end_logit": 5.7497334480285645,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, arrhythmia",
            "probability": 0.0005555249472444642,
            "start_logit": 6.165853977203369,
            "end_logit": -0.2773798108100891,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "asymptomatic to heart failure",
            "probability": 0.0005234730538370441,
            "start_logit": 0.24297280609607697,
            "end_logit": 5.586073398590088,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "asymptomatic to heart failure, arrhythmias",
            "probability": 0.00047256593519274896,
            "start_logit": 0.24297280609607697,
            "end_logit": 5.483765125274658,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmia",
            "probability": 0.00030512131578238065,
            "start_logit": 5.566649913787842,
            "end_logit": -0.2773798108100891,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, arrhythmias and sudden cardiac death.",
            "probability": 0.00022797902950863347,
            "start_logit": 6.165853977203369,
            "end_logit": -1.1680396795272827,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "sudden cardiac death.",
            "probability": 0.00016615519517938724,
            "start_logit": 5.849522590637207,
            "end_logit": -1.1680396795272827,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "failure, arrhythmias and sudden cardiac death",
            "probability": 0.00015084045168764783,
            "start_logit": -1.1649501323699951,
            "end_logit": 5.7497334480285645,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "failure",
            "probability": 0.00012806815939004723,
            "start_logit": -1.1649501323699951,
            "end_logit": 5.586073398590088,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmias and sudden cardiac death.",
            "probability": 0.00012521716945297385,
            "start_logit": 5.566649913787842,
            "end_logit": -1.1680396795272827,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "failure, arrhythmias",
            "probability": 0.00011561368644853233,
            "start_logit": -1.1649501323699951,
            "end_logit": 5.483765125274658,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "death",
            "probability": 9.545114664236027e-05,
            "start_logit": -1.6225582361221313,
            "end_logit": 5.7497334480285645,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        }
    ],
    "5880b2a6c872c95565000004": [
        {
            "text": "JAK-STAT-pathway",
            "probability": 0.6037790616153348,
            "start_logit": 5.615909576416016,
            "end_logit": 4.365930080413818,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "JAK-STAT",
            "probability": 0.21236160744161123,
            "start_logit": 5.615909576416016,
            "end_logit": 3.321012258529663,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "JAK",
            "probability": 0.11224413400188395,
            "start_logit": 5.615909576416016,
            "end_logit": 2.6833980083465576,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "the JAK-STAT-pathway",
            "probability": 0.026851096318945143,
            "start_logit": 2.5030078887939453,
            "end_logit": 4.365930080413818,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "the JAK-STAT",
            "probability": 0.00944408698209136,
            "start_logit": 2.5030078887939453,
            "end_logit": 3.321012258529663,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "JAK-STAT-pathway.",
            "probability": 0.006414816643738752,
            "start_logit": 5.615909576416016,
            "end_logit": -0.1786678433418274,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT-pathway",
            "probability": 0.005137119809102632,
            "start_logit": 0.849193811416626,
            "end_logit": 4.365930080413818,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "the JAK",
            "probability": 0.004991690247187308,
            "start_logit": 2.5030078887939453,
            "end_logit": 2.6833980083465576,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 and IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT-pathway",
            "probability": 0.004707207663219205,
            "start_logit": 0.7617961168289185,
            "end_logit": 4.365930080413818,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "downstream the JAK-STAT-pathway",
            "probability": 0.003127832654436191,
            "start_logit": 0.35304155945777893,
            "end_logit": 4.365930080413818,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT",
            "probability": 0.0018068314879329211,
            "start_logit": 0.849193811416626,
            "end_logit": 3.321012258529663,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 and IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT",
            "probability": 0.0016556224776134443,
            "start_logit": 0.7617961168289185,
            "end_logit": 3.321012258529663,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "receptor signaling downstream the JAK-STAT-pathway",
            "probability": 0.0014726833528326464,
            "start_logit": -0.4002126157283783,
            "end_logit": 4.365930080413818,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "STAT-pathway",
            "probability": 0.0014622498409860216,
            "start_logit": -0.4073225259780884,
            "end_logit": 4.365930080413818,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "downstream the JAK-STAT",
            "probability": 0.0011001235593154945,
            "start_logit": 0.35304155945777893,
            "end_logit": 3.321012258529663,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-13 and thereby inhibits receptor signaling downstream the JAK",
            "probability": 0.0009550042406141029,
            "start_logit": 0.849193811416626,
            "end_logit": 2.6833980083465576,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 and IL-13 and thereby inhibits receptor signaling downstream the JAK",
            "probability": 0.0008750824288466056,
            "start_logit": 0.7617961168289185,
            "end_logit": 2.6833980083465576,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "downstream the JAK",
            "probability": 0.0005814724125423158,
            "start_logit": 0.35304155945777893,
            "end_logit": 2.6833980083465576,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "receptor signaling downstream the JAK-STAT",
            "probability": 0.0005179732520424642,
            "start_logit": -0.4002126157283783,
            "end_logit": 3.321012258529663,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "STAT",
            "probability": 0.0005143035697234341,
            "start_logit": -0.4073225259780884,
            "end_logit": 3.321012258529663,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        }
    ],
    "58e0035f6fddd3e83e000009": [
        {
            "text": "slit diaphragm",
            "probability": 0.3214017156331903,
            "start_logit": 4.444171905517578,
            "end_logit": 4.556956768035889,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal adhesions",
            "probability": 0.2897681949805779,
            "start_logit": 4.605133533477783,
            "end_logit": 4.292384624481201,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit diaphragm and focal adhesions",
            "probability": 0.2466868325413419,
            "start_logit": 4.444171905517578,
            "end_logit": 4.292384624481201,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit diaphragm",
            "probability": 0.0762524849689965,
            "start_logit": 3.0055301189422607,
            "end_logit": 4.556956768035889,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit diaphragm and focal adhesions",
            "probability": 0.058526395708092864,
            "start_logit": 3.0055301189422607,
            "end_logit": 4.292384624481201,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal adhesion",
            "probability": 0.0010487222917182086,
            "start_logit": 4.605133533477783,
            "end_logit": -1.329124093055725,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit",
            "probability": 0.000929338000927911,
            "start_logit": 4.444171905517578,
            "end_logit": -1.2890177965164185,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit diaphragm and focal adhesion",
            "probability": 0.0008928032297568137,
            "start_logit": 4.444171905517578,
            "end_logit": -1.329124093055725,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal adhesions.",
            "probability": 0.0008690550155556226,
            "start_logit": 4.605133533477783,
            "end_logit": -1.517045497894287,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit diaphragm and focal adhesions.",
            "probability": 0.000739848033031895,
            "start_logit": 4.444171905517578,
            "end_logit": -1.517045497894287,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "adhesions",
            "probability": 0.000559149199553263,
            "start_logit": -1.6452866792678833,
            "end_logit": 4.292384624481201,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin cytoskeleton: the slit diaphragm",
            "probability": 0.0003449779685386028,
            "start_logit": -2.392794609069824,
            "end_logit": 4.556956768035889,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "foot processes that regulate the actin cytoskeleton: the slit diaphragm",
            "probability": 0.0003151000094312251,
            "start_logit": -2.4833850860595703,
            "end_logit": 4.556956768035889,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "diaphragm",
            "probability": 0.00027928696098839396,
            "start_logit": -2.6040353775024414,
            "end_logit": 4.556956768035889,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin cytoskeleton: the slit diaphragm and focal adhesions",
            "probability": 0.00026478241470390715,
            "start_logit": -2.392794609069824,
            "end_logit": 4.292384624481201,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "foot processes that regulate the actin cytoskeleton: the slit diaphragm and focal adhesions",
            "probability": 0.00024185005704527359,
            "start_logit": -2.4833850860595703,
            "end_logit": 4.292384624481201,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal",
            "probability": 0.00023279807323017422,
            "start_logit": 4.605133533477783,
            "end_logit": -2.834280490875244,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit",
            "probability": 0.0002204852323431556,
            "start_logit": 3.0055301189422607,
            "end_logit": -1.2890177965164185,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "diaphragm and focal adhesions",
            "probability": 0.00021436231490112645,
            "start_logit": -2.6040353775024414,
            "end_logit": 4.292384624481201,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit diaphragm and focal adhesion",
            "probability": 0.00021181736607467157,
            "start_logit": 3.0055301189422607,
            "end_logit": -1.329124093055725,
            "question_text": "List the three main structures of the cytoskeleton."
        }
    ],
    "5880b583c872c95565000005": [
        {
            "text": "Deintensification",
            "probability": 0.4275574859696257,
            "start_logit": -3.3721933364868164,
            "end_logit": -2.1762712001800537,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification",
            "probability": 0.19892036831009594,
            "start_logit": -2.8815102577209473,
            "end_logit": -3.432138442993164,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification",
            "probability": 0.11312864342482927,
            "start_logit": -3.4458892345428467,
            "end_logit": -3.432138442993164,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment",
            "probability": 0.03677117917007681,
            "start_logit": -3.4458892345428467,
            "end_logit": -4.555949687957764,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification for HPV-related OPSCC,",
            "probability": 0.036604364534901346,
            "start_logit": -2.8815102577209473,
            "end_logit": -5.124875545501709,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification for HPV-related OPSCC, summarize available results from published clinical trials",
            "probability": 0.024534566171029632,
            "start_logit": -2.8815102577209473,
            "end_logit": -5.524960041046143,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "dei",
            "probability": 0.021467106921604875,
            "start_logit": -2.8815102577209473,
            "end_logit": -5.6585211753845215,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification for HPV-related OPSCC,",
            "probability": 0.020817386064789174,
            "start_logit": -3.4458892345428467,
            "end_logit": -5.124875545501709,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification for HPV-related OPSCC, summarize available results from published clinical trials,",
            "probability": 0.020759540472704674,
            "start_logit": -2.8815102577209473,
            "end_logit": -5.692037105560303,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions.",
            "probability": 0.015787483944144053,
            "start_logit": -3.3721933364868164,
            "end_logit": -5.475142478942871,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification for HPV-related OPSCC, summarize available results from published clinical trials",
            "probability": 0.013953132157982336,
            "start_logit": -3.4458892345428467,
            "end_logit": -5.524960041046143,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment dei",
            "probability": 0.012208627527328306,
            "start_logit": -3.4458892345428467,
            "end_logit": -5.6585211753845215,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification for HPV-related OPSCC, summarize available results from published clinical trials,",
            "probability": 0.011806225132958011,
            "start_logit": -3.4458892345428467,
            "end_logit": -5.692037105560303,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "de-escalation",
            "probability": 0.01067330841990065,
            "start_logit": -4.8717875480651855,
            "end_logit": -4.3670196533203125,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Deintensification of treatment",
            "probability": 0.00860445474051784,
            "start_logit": -3.3721933364868164,
            "end_logit": -6.082079887390137,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Dei",
            "probability": 0.008580739758813367,
            "start_logit": -3.3721933364868164,
            "end_logit": -6.084839820861816,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment de-escalation",
            "probability": 0.006259315855843229,
            "start_logit": -5.405462741851807,
            "end_logit": -4.3670196533203125,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "The purpose of this review is to describe the rationale for treatment deintensification",
            "probability": 0.004622100189904869,
            "start_logit": -6.643565654754639,
            "end_logit": -3.432138442993164,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "describe the rationale for treatment deintensification",
            "probability": 0.004575499723354779,
            "start_logit": -6.653698921203613,
            "end_logit": -3.432138442993164,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "de-escalation,",
            "probability": 0.0023684715095948048,
            "start_logit": -4.8717875480651855,
            "end_logit": -5.872520923614502,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        }
    ],
    "58add7699ef3c34033000009": [
        {
            "text": "CPSF",
            "probability": 0.3536049871428207,
            "start_logit": 4.718348026275635,
            "end_logit": 4.342161655426025,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF/CPSF",
            "probability": 0.3313714600689687,
            "start_logit": 4.653407573699951,
            "end_logit": 4.342161655426025,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF",
            "probability": 0.24328190972747243,
            "start_logit": 4.653407573699951,
            "end_logit": 4.033142566680908,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh1",
            "probability": 0.03343026283011357,
            "start_logit": 3.630023717880249,
            "end_logit": 3.0717670917510986,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh1 endonuclease into an eight-subunit \"CPF",
            "probability": 0.011509788955506244,
            "start_logit": 3.630023717880249,
            "end_logit": 2.0055034160614014,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "(CPF/CPSF",
            "probability": 0.006595886246757341,
            "start_logit": 0.7366137504577637,
            "end_logit": 4.342161655426025,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "(CPF",
            "probability": 0.0048424804058934835,
            "start_logit": 0.7366137504577637,
            "end_logit": 4.033142566680908,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPSF)",
            "probability": 0.003436684757141099,
            "start_logit": 4.718348026275635,
            "end_logit": -0.29151150584220886,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF/CPSF)",
            "probability": 0.0032205972403625835,
            "start_logit": 4.653407573699951,
            "end_logit": -0.29151150584220886,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "polyadenylation factor (CPF/CPSF",
            "probability": 0.0026664427518981104,
            "start_logit": -0.16908712685108185,
            "end_logit": 4.342161655426025,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "polyadenylation factor (CPF",
            "probability": 0.0019576136240753357,
            "start_logit": -0.16908712685108185,
            "end_logit": 4.033142566680908,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh1 endonuclease",
            "probability": 0.0010465715806182508,
            "start_logit": 3.630023717880249,
            "end_logit": -0.3921748101711273,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Cleavage and polyadenylation factor (CPF/CPSF",
            "probability": 0.0007774214095962924,
            "start_logit": -1.4016051292419434,
            "end_logit": 4.342161655426025,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh",
            "probability": 0.0006562104930589729,
            "start_logit": 3.630023717880249,
            "end_logit": -0.8589681386947632,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Cleavage and polyadenylation factor (CPF",
            "probability": 0.0005707569539943035,
            "start_logit": -1.4016051292419434,
            "end_logit": 4.033142566680908,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Polyadenylation Factor Complex.Cleavage and polyadenylation factor (CPF/CPSF",
            "probability": 0.0002902838973626348,
            "start_logit": -2.386728286743164,
            "end_logit": 4.342161655426025,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Polyadenylation Factor Complex.Cleavage and polyadenylation factor (CPF",
            "probability": 0.00021311678712106644,
            "start_logit": -2.386728286743164,
            "end_logit": 4.033142566680908,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "C",
            "probability": 0.0002045375326307176,
            "start_logit": 4.653407573699951,
            "end_logit": -3.048082113265991,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh1 endonuclease into an eight-subunit \"CPFActivation of the Endonuclease",
            "probability": 0.0001695549976513608,
            "start_logit": 3.630023717880249,
            "end_logit": -2.2122724056243896,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "PF/CPSF",
            "probability": 0.00015343259695686456,
            "start_logit": -3.0243263244628906,
            "end_logit": 4.342161655426025,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        }
    ],
    "587d30fb31b33e8760000001": [
        {
            "text": "chaos",
            "probability": 0.2662194860875322,
            "start_logit": 2.915482997894287,
            "end_logit": 2.0273640155792236,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization",
            "probability": 0.20656007371343402,
            "start_logit": 2.915482997894287,
            "end_logit": 1.7736341953277588,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm",
            "probability": 0.18118764139747684,
            "start_logit": 2.915482997894287,
            "end_logit": 1.6425760984420776,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm and deep artificial neural network",
            "probability": 0.05989254076359792,
            "start_logit": 2.915482997894287,
            "end_logit": 0.5355948805809021,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm optimization",
            "probability": 0.04899571739093123,
            "start_logit": 1.476624608039856,
            "end_logit": 1.7736341953277588,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm optimization algorithm",
            "probability": 0.042977417237737986,
            "start_logit": 1.476624608039856,
            "end_logit": 1.6425760984420776,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm and deep artificial neural network (CAPSO BP DNN)",
            "probability": 0.02205087559396283,
            "start_logit": 2.915482997894287,
            "end_logit": -0.46360477805137634,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced",
            "probability": 0.019879453094095653,
            "start_logit": 2.915482997894287,
            "end_logit": -0.5672703981399536,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm",
            "probability": 0.01965098691490904,
            "start_logit": 2.915482997894287,
            "end_logit": -0.5788295269012451,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm and deep artificial neural network (CAPSO BP DNN",
            "probability": 0.019565003763384006,
            "start_logit": 2.915482997894287,
            "end_logit": -0.5832146406173706,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Chaos",
            "probability": 0.015652487032128574,
            "start_logit": 1.9161317348480225,
            "end_logit": 0.19302399456501007,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep artificial neural network",
            "probability": 0.014973279714441155,
            "start_logit": 1.5291982889175415,
            "end_logit": 0.5355948805809021,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm and deep",
            "probability": 0.0147792418449474,
            "start_logit": 2.915482997894287,
            "end_logit": -0.8637334704399109,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Chaos-enhanced Accelerated Evolutionary algorithm",
            "probability": 0.014249453248228038,
            "start_logit": 1.9161317348480225,
            "end_logit": 0.09911271184682846,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm optimization algorithm and deep artificial neural network",
            "probability": 0.014206414377781196,
            "start_logit": 1.476624608039856,
            "end_logit": 0.5355948805809021,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated",
            "probability": 0.012455755250283184,
            "start_logit": 2.915482997894287,
            "end_logit": -1.0347743034362793,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "particle swarm optimization",
            "probability": 0.00845151766759336,
            "start_logit": -0.280762255191803,
            "end_logit": 1.7736341953277588,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "particle swarm optimization algorithm",
            "probability": 0.007413390811163104,
            "start_logit": -0.280762255191803,
            "end_logit": 1.6425760984420776,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep artificial neural network (CAPSO BP DNN)",
            "probability": 0.0055127721082994284,
            "start_logit": 1.5291982889175415,
            "end_logit": -0.46360477805137634,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "the chaos",
            "probability": 0.005326491988072958,
            "start_logit": -0.9961452484130859,
            "end_logit": 2.0273640155792236,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        }
    ],
    "58a6c94860087bc10a00002a": [
        {
            "text": "H3K27M",
            "probability": 0.666257848604321,
            "start_logit": 4.395185947418213,
            "end_logit": 4.169654369354248,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.Detection of H3K27M",
            "probability": 0.2847894244369205,
            "start_logit": 4.075417995452881,
            "end_logit": 3.639495611190796,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M mutation",
            "probability": 0.022892308479078798,
            "start_logit": 4.395185947418213,
            "end_logit": 0.7987785935401917,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.Detection of H3K27M mutation",
            "probability": 0.007218258492662776,
            "start_logit": 4.075417995452881,
            "end_logit": -0.035640716552734375,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M Mutation",
            "probability": 0.006103916007575238,
            "start_logit": 4.075417995452881,
            "end_logit": -0.20332390069961548,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "(p-value\u2009=\u20090.003).Histone H3K27M",
            "probability": 0.005111454018782996,
            "start_logit": -0.07994874566793442,
            "end_logit": 3.7745962142944336,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "(p-value\u2009=\u20090.003).Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.Detection of H3K27M",
            "probability": 0.004465509441364894,
            "start_logit": -0.07994874566793442,
            "end_logit": 3.639495611190796,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "HGG (p-value\u2009=\u20090.003).Histone H3K27M",
            "probability": 0.0008391383595072717,
            "start_logit": -1.8868123292922974,
            "end_logit": 3.7745962142944336,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H",
            "probability": 0.0006017450072054667,
            "start_logit": 4.395185947418213,
            "end_logit": -2.8399438858032227,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M",
            "probability": 0.00034930566030591217,
            "start_logit": -3.1582987308502197,
            "end_logit": 4.169654369354248,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M Mutation Overrides Histological Grading in Pediatric Gliomas.Detection of H3K27M",
            "probability": 0.00023464673019113458,
            "start_logit": -3.0260062217712402,
            "end_logit": 3.639495611190796,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "3K27M",
            "probability": 0.00018603469252204572,
            "start_logit": -3.7883129119873047,
            "end_logit": 4.169654369354248,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "M",
            "probability": 0.00016683434856861048,
            "start_logit": -3.897244691848755,
            "end_logit": 4.169654369354248,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.Detection of H",
            "probability": 0.00016458808016852445,
            "start_logit": 4.075417995452881,
            "end_logit": -3.816563844680786,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "Mutation Overrides Histological Grading in Pediatric Gliomas.Detection of H3K27M",
            "probability": 0.00015919209432952098,
            "start_logit": -3.413975715637207,
            "end_logit": 3.639495611190796,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27",
            "probability": 0.00010331584786023097,
            "start_logit": 4.395185947418213,
            "end_logit": -4.601986885070801,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M mutation was detected in 28 of 105 (26.7%) samples,",
            "probability": 9.63988642801675e-05,
            "start_logit": 4.395185947418213,
            "end_logit": -4.67128324508667,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "(p-value\u2009=\u20090.003).Histone H3K27M Mutation",
            "probability": 9.570964446807557e-05,
            "start_logit": -0.07994874566793442,
            "end_logit": -0.20332390069961548,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.Detection of H3K27M",
            "probability": 9.54929410676566e-05,
            "start_logit": -3.925034999847412,
            "end_logit": 3.639495611190796,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.",
            "probability": 6.88782488193271e-05,
            "start_logit": 4.075417995452881,
            "end_logit": -4.687669277191162,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        }
    ],
    "58da14178acda34529000011": [
        {
            "text": "rob(13;14",
            "probability": 0.10819143676802251,
            "start_logit": 2.703162431716919,
            "end_logit": 2.337726354598999,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;15) and rob(13;14",
            "probability": 0.10262066626537832,
            "start_logit": 2.650299549102783,
            "end_logit": 2.337726354598999,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13;15) and rob(13;14",
            "probability": 0.10222994520547013,
            "start_logit": 2.646484851837158,
            "end_logit": 2.337726354598999,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;15",
            "probability": 0.08741126508293472,
            "start_logit": 2.650299549102783,
            "end_logit": 2.1773111820220947,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13;15",
            "probability": 0.08707845276175179,
            "start_logit": 2.646484851837158,
            "end_logit": 2.1773111820220947,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22",
            "probability": 0.06667785758687995,
            "start_logit": 2.646484851837158,
            "end_logit": 1.910374641418457,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13",
            "probability": 0.0544277454786833,
            "start_logit": 2.703162431716919,
            "end_logit": 1.650698184967041,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;15) and rob(13",
            "probability": 0.0516252641724392,
            "start_logit": 2.650299549102783,
            "end_logit": 1.650698184967041,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13;15) and rob(13",
            "probability": 0.05142870456442288,
            "start_logit": 2.646484851837158,
            "end_logit": 1.650698184967041,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13",
            "probability": 0.042695157136095806,
            "start_logit": 2.646484851837158,
            "end_logit": 1.4645872116088867,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;15)",
            "probability": 0.03842185825157125,
            "start_logit": 2.650299549102783,
            "end_logit": 1.3553135395050049,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13;15)",
            "probability": 0.038275569694636004,
            "start_logit": 2.646484851837158,
            "end_logit": 1.3553135395050049,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22)",
            "probability": 0.02907804411666359,
            "start_logit": 2.646484851837158,
            "end_logit": 1.0804851055145264,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22), rob(13;15) and rob(13;14",
            "probability": 0.02441917887484446,
            "start_logit": 1.214629054069519,
            "end_logit": 2.337726354598999,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;14",
            "probability": 0.02149355308310488,
            "start_logit": 1.0870132446289062,
            "end_logit": 2.337726354598999,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;15) and rob(13;14",
            "probability": 0.02116406763818612,
            "start_logit": 1.07156503200531,
            "end_logit": 2.337726354598999,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22), rob(13;15",
            "probability": 0.02080001422147032,
            "start_logit": 1.214629054069519,
            "end_logit": 2.1773111820220947,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;15",
            "probability": 0.018027342774900538,
            "start_logit": 1.07156503200531,
            "end_logit": 2.1773111820220947,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14",
            "probability": 0.01800685485996878,
            "start_logit": 0.9100127220153809,
            "end_logit": 2.337726354598999,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22",
            "probability": 0.015927021462575366,
            "start_logit": 1.214629054069519,
            "end_logit": 1.910374641418457,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        }
    ],
    "58ea59273e8b6dc87c000012": [
        {
            "text": "Viral",
            "probability": 0.42095425349987187,
            "start_logit": -0.7592328190803528,
            "end_logit": -0.8420693874359131,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector",
            "probability": 0.13651779577970533,
            "start_logit": -0.7592328190803528,
            "end_logit": -1.968138575553894,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy",
            "probability": 0.05298807311809539,
            "start_logit": -0.7592328190803528,
            "end_logit": -2.9145267009735107,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": ".Viral",
            "probability": 0.05214002503518895,
            "start_logit": -2.8478240966796875,
            "end_logit": -0.8420693874359131,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic",
            "probability": 0.04004642728602635,
            "start_logit": -0.7592328190803528,
            "end_logit": -3.194554090499878,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Gene Therapy for Human Orthopaedic Regenerative Medicine.Viral",
            "probability": 0.039390305702576144,
            "start_logit": -3.128237247467041,
            "end_logit": -0.8420693874359131,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral Gene Therapy for Human Orthopaedic Regenerative Medicine.Viral",
            "probability": 0.036022621027102464,
            "start_logit": -3.2176098823547363,
            "end_logit": -0.8420693874359131,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is a potent strategy to enhance the intrinsic reparative abilities of human orthopaedic tissues.",
            "probability": 0.030826672880788424,
            "start_logit": -0.7592328190803528,
            "end_logit": -3.4562132358551025,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": ".",
            "probability": 0.027182705936970062,
            "start_logit": -2.8478240966796875,
            "end_logit": -1.4934213161468506,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Gene Therapy for Human Orthopaedic Regenerative Medicine.",
            "probability": 0.020535761077173444,
            "start_logit": -3.128237247467041,
            "end_logit": -1.4934213161468506,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based",
            "probability": 0.01892946891867783,
            "start_logit": -0.7592328190803528,
            "end_logit": -3.943873643875122,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral Gene Therapy for Human Orthopaedic Regenerative Medicine.",
            "probability": 0.018780050715314967,
            "start_logit": -3.2176098823547363,
            "end_logit": -1.4934213161468506,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": ".Viral vector",
            "probability": 0.016909298885858185,
            "start_logit": -2.8478240966796875,
            "end_logit": -1.968138575553894,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Regenerative Medicine.Viral",
            "probability": 0.015699754413030287,
            "start_logit": -4.048111915588379,
            "end_logit": -0.8420693874359131,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "vector",
            "probability": 0.013463441532105675,
            "start_logit": -3.075709819793701,
            "end_logit": -1.968138575553894,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Gene Therapy for Human Orthopaedic Regenerative Medicine.Viral vector",
            "probability": 0.01277449429455899,
            "start_logit": -3.128237247467041,
            "end_logit": -1.968138575553894,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is a potent strategy",
            "probability": 0.012661539850099678,
            "start_logit": -0.7592328190803528,
            "end_logit": -4.346024513244629,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene",
            "probability": 0.011693109079111814,
            "start_logit": -0.7592328190803528,
            "end_logit": -4.425593852996826,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral Gene Therapy for Human Orthopaedic Regenerative Medicine.Viral vector",
            "probability": 0.011682335503064798,
            "start_logit": -3.2176098823547363,
            "end_logit": -1.968138575553894,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is a potent strategy to enhance the intrinsic reparative abilities of human orthopaedic tissues",
            "probability": 0.010801865464679067,
            "start_logit": -0.7592328190803528,
            "end_logit": -4.5048747062683105,
            "question_text": "List viral vectors used in gene therapy."
        }
    ],
    "5895b7157d9090f353000009": [
        {
            "text": "microcephaly",
            "probability": 0.48569342978792374,
            "start_logit": 3.304159641265869,
            "end_logit": 4.020754337310791,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency, microcephaly",
            "probability": 0.26041725610383126,
            "start_logit": 2.6808671951293945,
            "end_logit": 4.020754337310791,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly and a distinctive facial gestalt",
            "probability": 0.05991639037312875,
            "start_logit": 3.304159641265869,
            "end_logit": 1.9281268119812012,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability, growth deficiency, microcephaly",
            "probability": 0.0397612772629315,
            "start_logit": 0.8014755249023438,
            "end_logit": 4.020754337310791,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency",
            "probability": 0.03728445626206394,
            "start_logit": 2.6808671951293945,
            "end_logit": 2.0770456790924072,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency, microcephaly and a distinctive facial gestalt",
            "probability": 0.03212574232974349,
            "start_logit": 2.6808671951293945,
            "end_logit": 1.9281268119812012,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "facial gestalt",
            "probability": 0.021823035368787727,
            "start_logit": 2.294175624847412,
            "end_logit": 1.9281268119812012,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "moderate to severe intellectual disability, growth deficiency, microcephaly",
            "probability": 0.01847916385248095,
            "start_logit": 0.03522583842277527,
            "end_logit": 4.020754337310791,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "malformations including moderate to severe intellectual disability, growth deficiency, microcephaly",
            "probability": 0.008095044460902394,
            "start_logit": -0.790165901184082,
            "end_logit": 4.020754337310791,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability, growth deficiency",
            "probability": 0.005692701110568828,
            "start_logit": 0.8014755249023438,
            "end_logit": 2.0770456790924072,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability, growth deficiency, microcephaly and a distinctive facial gestalt",
            "probability": 0.004905053402225881,
            "start_logit": 0.8014755249023438,
            "end_logit": 1.9281268119812012,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "distinctive facial gestalt",
            "probability": 0.004463371298460839,
            "start_logit": 0.7071139216423035,
            "end_logit": 1.9281268119812012,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly and a distinctive facial",
            "probability": 0.004404795535941522,
            "start_logit": 3.304159641265869,
            "end_logit": -0.682129442691803,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability",
            "probability": 0.004144358093946742,
            "start_logit": 0.8014755249023438,
            "end_logit": 1.7596087455749512,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "moderate to severe intellectual disability, growth deficiency",
            "probability": 0.0026456986250658933,
            "start_logit": 0.03522583842277527,
            "end_logit": 2.0770456790924072,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency, microcephaly and a distinctive facial",
            "probability": 0.002361746519134851,
            "start_logit": 2.6808671951293945,
            "end_logit": -0.682129442691803,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "moderate to severe intellectual disability, growth deficiency, microcephaly and a distinctive facial gestalt",
            "probability": 0.002279637168733609,
            "start_logit": 0.03522583842277527,
            "end_logit": 1.9281268119812012,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "recognizable pattern of malformations including moderate to severe intellectual disability, growth deficiency, microcephaly",
            "probability": 0.001976404750918771,
            "start_logit": -2.200138568878174,
            "end_logit": 4.020754337310791,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "moderate to severe intellectual disability",
            "probability": 0.001926101915060842,
            "start_logit": 0.03522583842277527,
            "end_logit": 1.7596087455749512,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "facial",
            "probability": 0.001604335778148622,
            "start_logit": 2.294175624847412,
            "end_logit": -0.682129442691803,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        }
    ],
    "58f4b73b70f9fc6f0f000014": [
        {
            "text": "rubella",
            "probability": 0.9958337931255533,
            "start_logit": 3.5406620502471924,
            "end_logit": 3.4449267387390137,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rub",
            "probability": 0.002093393432278163,
            "start_logit": 3.4099626541137695,
            "end_logit": -2.589167833328247,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella",
            "probability": 0.0014806811968242468,
            "start_logit": -2.9704160690307617,
            "end_logit": 3.4449267387390137,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella is lacking.However, a small percentage of the fully immunized will remain unprotected against wild viruses",
            "probability": 0.00019422741249985607,
            "start_logit": 3.5406620502471924,
            "end_logit": -5.097379207611084,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella is lacking.However, a small percentage of the fully immunized will remain unprotected against wild viruses.",
            "probability": 8.85303221369439e-05,
            "start_logit": 3.5406620502471924,
            "end_logit": -5.883063793182373,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.",
            "probability": 8.159862404197863e-05,
            "start_logit": 3.4099626541137695,
            "end_logit": -5.833897113800049,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella is lacking.However, a small percentage of the fully immunized will remain unprotected against wild",
            "probability": 4.7883440282974333e-05,
            "start_logit": 3.5406620502471924,
            "end_logit": -6.497639179229736,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.Moreover, protective levels of antibodies",
            "probability": 4.212384719418804e-05,
            "start_logit": 3.204632043838501,
            "end_logit": -6.289764881134033,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella is lacking",
            "probability": 3.7295893156482714e-05,
            "start_logit": 3.5406620502471924,
            "end_logit": -6.747525691986084,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two",
            "probability": 2.709741464426157e-05,
            "start_logit": 3.4099626541137695,
            "end_logit": -6.9362711906433105,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "two doses of the MMR vaccine.International guidelines recommend that healthcare workers (HCWs) have presumptive evidence of immunity to rubella",
            "probability": 2.686547224477998e-05,
            "start_logit": -6.579766750335693,
            "end_logit": 3.0448617935180664,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.Moreover, protective levels",
            "probability": 2.48553223262918e-05,
            "start_logit": 3.204632043838501,
            "end_logit": -6.817306995391846,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.Moreover, protective levels of antibodies induced",
            "probability": 2.0851663075517464e-05,
            "start_logit": 3.204632043838501,
            "end_logit": -6.992945194244385,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella is lacking.However, a small percentage of the fully immunized will remain unprotected against wild viruses",
            "probability": 2.887920449995261e-07,
            "start_logit": -2.9704160690307617,
            "end_logit": -5.097379207611084,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.",
            "probability": 1.4446261880451108e-07,
            "start_logit": -2.926584243774414,
            "end_logit": -5.833897113800049,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella is lacking.However, a small percentage of the fully immunized will remain unprotected against wild viruses.",
            "probability": 1.3163359613007145e-07,
            "start_logit": -2.9704160690307617,
            "end_logit": -5.883063793182373,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella is lacking.However, a small percentage of the fully immunized will remain unprotected against wild",
            "probability": 7.119672997210469e-08,
            "start_logit": -2.9704160690307617,
            "end_logit": -6.497639179229736,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.Moreover, protective levels of antibodies",
            "probability": 5.727944949446539e-08,
            "start_logit": -3.3957953453063965,
            "end_logit": -6.289764881134033,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella is lacking",
            "probability": 5.545436206000251e-08,
            "start_logit": -2.9704160690307617,
            "end_logit": -6.747525691986084,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "two doses of the MMR vaccine.International guidelines recommend that healthcare workers (HCWs) have presumptive evidence of immunity to rub",
            "probability": 5.4014939310818966e-08,
            "start_logit": -6.579766750335693,
            "end_logit": -3.1644747257232666,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        }
    ],
    "5895bfdc7d9090f35300000c": [
        {
            "text": "primary adrenal insufficiency",
            "probability": 0.28701524780070886,
            "start_logit": 3.9462528228759766,
            "end_logit": 4.726426601409912,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.20943185941963996,
            "start_logit": 3.6311159133911133,
            "end_logit": 4.726426601409912,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia",
            "probability": 0.1271307658147712,
            "start_logit": 3.887744188308716,
            "end_logit": 3.970616102218628,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrima",
            "probability": 0.10622479514129994,
            "start_logit": 3.887744188308716,
            "end_logit": 3.790957450866699,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance, achalasia",
            "probability": 0.0983554476651776,
            "start_logit": 3.6311159133911133,
            "end_logit": 3.970616102218628,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima",
            "probability": 0.0407261442877737,
            "start_logit": 2.9290568828582764,
            "end_logit": 3.790957450866699,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.03681109782794911,
            "start_logit": 3.9462528228759766,
            "end_logit": 2.6726906299591064,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.02686065191469807,
            "start_logit": 3.6311159133911133,
            "end_logit": 2.6726906299591064,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance, achalasia",
            "probability": 0.02241623006407099,
            "start_logit": 2.152313232421875,
            "end_logit": 3.970616102218628,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance, achalasia, and alacrima",
            "probability": 0.01873000159430744,
            "start_logit": 2.152313232421875,
            "end_logit": 3.790957450866699,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.006121822098156922,
            "start_logit": 2.152313232421875,
            "end_logit": 2.6726906299591064,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI)",
            "probability": 0.004828225351204396,
            "start_logit": 3.9462528228759766,
            "end_logit": 0.6413702368736267,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI) due to adrenocorticotropic hormone",
            "probability": 0.003773872036337712,
            "start_logit": 3.9462528228759766,
            "end_logit": 0.39499279856681824,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI)",
            "probability": 0.0035231027645677695,
            "start_logit": 3.6311159133911133,
            "end_logit": 0.6413702368736267,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone",
            "probability": 0.002753752784349592,
            "start_logit": 3.6311159133911133,
            "end_logit": 0.39499279856681824,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance,",
            "probability": 0.0015622631158689108,
            "start_logit": 3.9462528228759766,
            "end_logit": -0.48697325587272644,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "insufficiency",
            "probability": 0.0012390323684724673,
            "start_logit": -1.49895179271698,
            "end_logit": 4.726426601409912,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance,",
            "probability": 0.00113996615777825,
            "start_logit": 3.6311159133911133,
            "end_logit": -0.48697325587272644,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "cardinal features of primary adrenal insufficiency",
            "probability": 0.0007281128762394791,
            "start_logit": -2.0305817127227783,
            "end_logit": 4.726426601409912,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone",
            "probability": 0.0006276089166275165,
            "start_logit": 2.152313232421875,
            "end_logit": 0.39499279856681824,
            "question_text": "List cardinal features of the Triple A syndrome."
        }
    ],
    "58dbb3f18acda34529000019": [
        {
            "text": "monoclonal antibodies",
            "probability": 0.8534077425638745,
            "start_logit": -1.4698816537857056,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "antibodies",
            "probability": 0.08687515435064273,
            "start_logit": -3.7546470165252686,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food and Drug Administration (FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.012395204833269627,
            "start_logit": -5.701809406280518,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "mon",
            "probability": 0.009819662755722389,
            "start_logit": -1.4698816537857056,
            "end_logit": -6.136468887329102,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "in the form of monoclonal antibodies",
            "probability": 0.009281959415539574,
            "start_logit": -5.99104642868042,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "(FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.00910388855249529,
            "start_logit": -6.010417461395264,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Current Food and Drug Administration (FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.006335320534067904,
            "start_logit": -6.372978687286377,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.004831901909977924,
            "start_logit": -6.643878936767578,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.004051381322649461,
            "start_logit": -6.820061206817627,
            "end_logit": -1.6716182231903076,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Drug Administration (FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0009402730902702916,
            "start_logit": -6.974325656890869,
            "end_logit": -2.977996587753296,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0009133172380489471,
            "start_logit": -7.00341272354126,
            "end_logit": -2.977996587753296,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "antibodies which display an unparalleled degree of low-density lipoprotein cholesterol (LDL-C) lowering",
            "probability": 0.0007033929953663631,
            "start_logit": -3.7546470165252686,
            "end_logit": -6.487929821014404,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food and Drug Administration",
            "probability": 0.0003213186945687302,
            "start_logit": -5.701809406280518,
            "end_logit": -5.324249744415283,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food and Drug Administration (FDA) approved modalities",
            "probability": 0.00016596841520477468,
            "start_logit": -5.701809406280518,
            "end_logit": -5.9848856925964355,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Current Food and Drug Administration",
            "probability": 0.00016422938959566996,
            "start_logit": -6.372978687286377,
            "end_logit": -5.324249744415283,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food and Drug Administration (FDA) approved modalities to inhibit PCSK9",
            "probability": 0.00015519741150675213,
            "start_logit": -5.701809406280518,
            "end_logit": -6.051985263824463,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food",
            "probability": 0.00014863074541516348,
            "start_logit": -5.701809406280518,
            "end_logit": -6.095218181610107,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food and Drug Administration (FDA) approved modalities to inhibit PCSK9 are in the form of mon",
            "probability": 0.00014262435783056872,
            "start_logit": -5.701809406280518,
            "end_logit": -6.136468887329102,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "(FDA) approved modalities",
            "probability": 0.00012189858704093479,
            "start_logit": -6.010417461395264,
            "end_logit": -5.9848856925964355,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food and Drug Administration (FDA)",
            "probability": 0.00012093283691252176,
            "start_logit": -5.701809406280518,
            "end_logit": -6.301447868347168,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        }
    ],
    "5895e4637d9090f353000012": [
        {
            "text": "SAPHO syndrome",
            "probability": 0.3464386773346188,
            "start_logit": 1.278359293937683,
            "end_logit": 0.3517026901245117,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO",
            "probability": 0.17614269004720362,
            "start_logit": 1.278359293937683,
            "end_logit": -0.3247087299823761,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively assess the clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.10864988641276661,
            "start_logit": 1.278359293937683,
            "end_logit": -0.807872474193573,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively assess the clinical and imaging features in patients with SAPHO",
            "probability": 0.09150434283666015,
            "start_logit": 1.278359293937683,
            "end_logit": -0.9796167016029358,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively assess the clinical and imaging features",
            "probability": 0.040572375701459135,
            "start_logit": 1.278359293937683,
            "end_logit": -1.79291570186615,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "radiological features in SAPHO syndrome",
            "probability": 0.039947661673827226,
            "start_logit": -0.8817763924598694,
            "end_logit": 0.3517026901245117,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively assess the clinical",
            "probability": 0.03439995189637513,
            "start_logit": 1.278359293937683,
            "end_logit": -1.9579479694366455,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively assess the clinical and imaging",
            "probability": 0.02611813059310604,
            "start_logit": 1.278359293937683,
            "end_logit": -2.2333734035491943,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "radiological features in SAPHO",
            "probability": 0.020310920946990826,
            "start_logit": -0.8817763924598694,
            "end_logit": -0.3247087299823761,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively",
            "probability": 0.018465304506921392,
            "start_logit": 1.278359293937683,
            "end_logit": -2.5801095962524414,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively assess the clinical and imaging features in patients with SAPHO syndrome.",
            "probability": 0.015047870127492608,
            "start_logit": 1.278359293937683,
            "end_logit": -2.784766674041748,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "radiological features in SAPHO syndrome. The aim was to comparatively assess the clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.012528361257783968,
            "start_logit": -0.8817763924598694,
            "end_logit": -0.807872474193573,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to comparatively assess",
            "probability": 0.012249595427977582,
            "start_logit": 1.278359293937683,
            "end_logit": -2.9905102252960205,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome.",
            "probability": 0.011955160299763283,
            "start_logit": 1.278359293937683,
            "end_logit": -3.0148401260375977,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "clinical and radiological features in SAPHO syndrome",
            "probability": 0.010625512922482233,
            "start_logit": -2.2060885429382324,
            "end_logit": 0.3517026901245117,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "radiological features in SAPHO syndrome. The aim was to comparatively assess the clinical and imaging features in patients with SAPHO",
            "probability": 0.010551317645731934,
            "start_logit": -0.8817763924598694,
            "end_logit": -0.9796167016029358,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome. The aim was to",
            "probability": 0.008135061369542347,
            "start_logit": 1.278359293937683,
            "end_logit": -3.399819850921631,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "radiological",
            "probability": 0.006276382034039802,
            "start_logit": -0.8817763924598694,
            "end_logit": -1.4990737438201904,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "clinical and radiological features in SAPHO",
            "probability": 0.00540241766218728,
            "start_logit": -2.2060885429382324,
            "end_logit": -0.3247087299823761,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "radiological features in SAPHO syndrome. The aim was to comparatively assess the clinical and imaging features",
            "probability": 0.004678379303070207,
            "start_logit": -0.8817763924598694,
            "end_logit": -1.79291570186615,
            "question_text": "List clinical features of the IMAGe syndrome."
        }
    ],
    "5a6d0b2db750ff445500002d": [
        {
            "text": "mitosis",
            "probability": 0.4152545417742926,
            "start_logit": -2.1176419258117676,
            "end_logit": -2.2995569705963135,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "replicative helicase",
            "probability": 0.06965775619864811,
            "start_logit": -2.5074222087860107,
            "end_logit": -3.6950743198394775,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mit",
            "probability": 0.06303210608215465,
            "start_logit": -2.1176419258117676,
            "end_logit": -4.184804439544678,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "DNA in mitosis",
            "probability": 0.055633715638336974,
            "start_logit": -4.127744197845459,
            "end_logit": -2.2995569705963135,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links (ICLs",
            "probability": 0.052974332768588886,
            "start_logit": -2.1176419258117676,
            "end_logit": -4.358641147613525,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "under-replicated DNA in mitosis",
            "probability": 0.05227221092113524,
            "start_logit": -4.19006872177124,
            "end_logit": -2.2995569705963135,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links",
            "probability": 0.040229246954678395,
            "start_logit": -2.1176419258117676,
            "end_logit": -4.633854389190674,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "replicative helicase during termination",
            "probability": 0.027100239067525962,
            "start_logit": -2.5074222087860107,
            "end_logit": -4.639125823974609,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links (ICLs)",
            "probability": 0.02646653684523021,
            "start_logit": -2.1176419258117676,
            "end_logit": -5.052567481994629,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links (ICLs) in S phase.",
            "probability": 0.02532965683879472,
            "start_logit": -2.1176419258117676,
            "end_logit": -5.09647274017334,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter-strand cross-links (ICLs",
            "probability": 0.024774216752412263,
            "start_logit": -2.877645969390869,
            "end_logit": -4.358641147613525,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links (ICLs) in S phase",
            "probability": 0.02017375484166531,
            "start_logit": -2.1176419258117676,
            "end_logit": -5.324066162109375,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter-strand cross-links",
            "probability": 0.018813792109383314,
            "start_logit": -2.877645969390869,
            "end_logit": -4.633854389190674,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "osis",
            "probability": 0.018366831926421846,
            "start_logit": -5.235987186431885,
            "end_logit": -2.2995569705963135,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "in mitosis",
            "probability": 0.016913106989401436,
            "start_logit": -5.318444728851318,
            "end_logit": -2.2995569705963135,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "DNA lesions, such as under-replicated DNA in mitosis",
            "probability": 0.01656198411068724,
            "start_logit": -5.339423656463623,
            "end_logit": -2.2995569705963135,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "DNA",
            "probability": 0.01609626832022163,
            "start_logit": -4.127744197845459,
            "end_logit": -3.5397589206695557,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "under-replicated DNA",
            "probability": 0.015123698336949034,
            "start_logit": -4.19006872177124,
            "end_logit": -3.5397589206695557,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "helicase",
            "probability": 0.012848542851079996,
            "start_logit": -4.1977858543396,
            "end_logit": -3.6950743198394775,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter-strand cross-links (ICLs)",
            "probability": 0.012377460672392433,
            "start_logit": -2.877645969390869,
            "end_logit": -5.052567481994629,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        }
    ],
    "5a894f6abc7bade53a000004": [
        {
            "text": "oxidative stress",
            "probability": 0.7534137708492243,
            "start_logit": 5.485806465148926,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance oxidative stress",
            "probability": 0.18518782027710043,
            "start_logit": 4.082562446594238,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxidative stress in vivo",
            "probability": 0.029500089917251438,
            "start_logit": 5.485806465148926,
            "end_logit": 2.397967576980591,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "xidative stress",
            "probability": 0.013295243954395877,
            "start_logit": 1.4485982656478882,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance oxidative stress in vivo",
            "probability": 0.007251071802943654,
            "start_logit": 4.082562446594238,
            "end_logit": 2.397967576980591,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "may enhance oxidative stress",
            "probability": 0.004189420120195215,
            "start_logit": 0.2937542200088501,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "stress",
            "probability": 0.001971461896754528,
            "start_logit": -0.46003276109695435,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxidative stress in vivo.",
            "probability": 0.0012244138417493616,
            "start_logit": 5.485806465148926,
            "end_logit": -0.7839635014533997,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "o",
            "probability": 0.0006655571688458599,
            "start_logit": 5.485806465148926,
            "end_logit": -1.3935564756393433,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance",
            "probability": 0.0006603243714228843,
            "start_logit": 4.082562446594238,
            "end_logit": 0.0017941913101822138,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "xidative stress in vivo",
            "probability": 0.0005205783426076539,
            "start_logit": 1.4485982656478882,
            "end_logit": 2.397967576980591,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "tive stress",
            "probability": 0.00031345509344924923,
            "start_logit": -2.2989072799682617,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxidative",
            "probability": 0.0003021776188322842,
            "start_logit": 5.485806465148926,
            "end_logit": -2.183166027069092,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance oxidative stress in vivo.",
            "probability": 0.00030095883463225436,
            "start_logit": 4.082562446594238,
            "end_logit": -0.7839635014533997,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "dative stress",
            "probability": 0.00028283726927011665,
            "start_logit": -2.4016916751861572,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxi",
            "probability": 0.0002814775117759381,
            "start_logit": 5.485806465148926,
            "end_logit": -2.2541284561157227,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "may enhance oxidative stress in vivo",
            "probability": 0.000164037710788849,
            "start_logit": 0.2937542200088501,
            "end_logit": 2.397967576980591,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance o",
            "probability": 0.00016359281730334702,
            "start_logit": 4.082562446594238,
            "end_logit": -1.3935564756393433,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "results indicate that the ALDH2 deficiency may enhance oxidative stress",
            "probability": 0.0001623723104167973,
            "start_logit": -2.9566714763641357,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "These results indicate that the ALDH2 deficiency may enhance oxidative stress",
            "probability": 0.00014933829103986937,
            "start_logit": -3.040349245071411,
            "end_logit": 5.63818883895874,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        }
    ],
    "5a76196faacfb9cd4c000001": [
        {
            "text": "immune thrombocytopenic purpura",
            "probability": 0.7403787310155878,
            "start_logit": 2.957181692123413,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.05868719975611462,
            "start_logit": 0.4222414791584015,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "splenic infarction",
            "probability": 0.04823430997485541,
            "start_logit": 1.22171950340271,
            "end_logit": 2.2961504459381104,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "thrombocytopenic purpura",
            "probability": 0.02138674280873338,
            "start_logit": -0.5872089266777039,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemoperitoneum with splenic infarction",
            "probability": 0.020060367477702734,
            "start_logit": 0.3443950116634369,
            "end_logit": 2.2961504459381104,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Massive hemoperitoneum with splenic infarction",
            "probability": 0.01978227973846871,
            "start_logit": 0.33043548464775085,
            "end_logit": 2.2961504459381104,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "direct Coombs' positive hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.018838133599833686,
            "start_logit": -0.7140969634056091,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "anemia and immune thrombocytopenic purpura",
            "probability": 0.009994310631372797,
            "start_logit": -1.3479641675949097,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "characterized by a direct Coombs' positive hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.00997461691293777,
            "start_logit": -1.349936604499817,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenic purpura without a known underlying etiology",
            "probability": 0.00919476537727731,
            "start_logit": 2.957181692123413,
            "end_logit": -1.0967479944229126,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemoperitoneum",
            "probability": 0.008141869772466325,
            "start_logit": 0.3443950116634369,
            "end_logit": 1.3944242000579834,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Massive hemoperitoneum",
            "probability": 0.008029002739463083,
            "start_logit": 0.33043548464775085,
            "end_logit": 1.3944242000579834,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "purpura",
            "probability": 0.007900638823054456,
            "start_logit": -1.5830365419387817,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.005505052176977735,
            "start_logit": 0.4222414791584015,
            "end_logit": 0.9252241253852844,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenic",
            "probability": 0.004862565547044224,
            "start_logit": 2.957181692123413,
            "end_logit": -1.733816146850586,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "a direct Coombs' positive hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.004099908197461822,
            "start_logit": -2.239015579223633,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "direct Coombs' positive hemolytic anemia",
            "probability": 0.0017670788317542254,
            "start_logit": -0.7140969634056091,
            "end_logit": 0.9252241253852844,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune",
            "probability": 0.001108368016187025,
            "start_logit": 2.957181692123413,
            "end_logit": -3.212493658065796,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenic purpura without a known underlying etiology.",
            "probability": 0.0010885401975200696,
            "start_logit": 2.957181692123413,
            "end_logit": -3.2305448055267334,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Coombs' positive hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.0009655184051866296,
            "start_logit": -3.685070276260376,
            "end_logit": 3.2917795181274414,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        }
    ],
    "5a82fc89faa1ab7d2e000028": [
        {
            "text": "H2A.Z-rich\u00a0+1",
            "probability": 0.815211660602246,
            "start_logit": 3.475973606109619,
            "end_logit": 3.336560010910034,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ",
            "probability": 0.11068516297754401,
            "start_logit": 2.3581466674804688,
            "end_logit": 2.4576289653778076,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A.Z-rich\u00a0+1 nucleosomes",
            "probability": 0.06822055565602109,
            "start_logit": 3.475973606109619,
            "end_logit": 0.8558581471443176,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "nucleosomes",
            "probability": 0.0018814396806748341,
            "start_logit": -0.11473504453897476,
            "end_logit": 0.8558581471443176,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "Z",
            "probability": 0.0013231734226080546,
            "start_logit": 2.3581466674804688,
            "end_logit": -1.9690278768539429,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic ZZ",
            "probability": 0.0008893392896740213,
            "start_logit": -2.4658195972442627,
            "end_logit": 2.4576289653778076,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ nucleosomes",
            "probability": 0.0006026820083940472,
            "start_logit": 2.3581466674804688,
            "end_logit": -2.7554264068603516,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A.Z-rich\u00a0+1 nucleosomes in yeast",
            "probability": 0.0005482882707895182,
            "start_logit": 3.475973606109619,
            "end_logit": -3.967841863632202,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A.Z-rich\u00a0+1 nucleosomes in yeast have more G/C runs,",
            "probability": 0.0004040130065510397,
            "start_logit": 3.433490037918091,
            "end_logit": -4.230712413787842,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ nucleosomes at promoters",
            "probability": 0.00011067710388655212,
            "start_logit": 2.3581466674804688,
            "end_logit": -4.450199127197266,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "nucleosome",
            "probability": 5.602293052191585e-05,
            "start_logit": -0.11473504453897476,
            "end_logit": -2.6581733226776123,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "s",
            "probability": 1.9472498392053013e-05,
            "start_logit": -4.6855244636535645,
            "end_logit": 0.8558581471443176,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "nucleosomes in yeast",
            "probability": 1.5121121474198113e-05,
            "start_logit": -0.11473504453897476,
            "end_logit": -3.967841863632202,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "n",
            "probability": 1.227826141915151e-05,
            "start_logit": -0.11473504453897476,
            "end_logit": -4.1761040687561035,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic Z",
            "probability": 1.0631507242000736e-05,
            "start_logit": -2.4658195972442627,
            "end_logit": -1.9690278768539429,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic ZZ nucleosomes",
            "probability": 4.842462845297673e-06,
            "start_logit": -2.4658195972442627,
            "end_logit": -2.7554264068603516,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "nucleosomes in yeast have more G/C runs",
            "probability": 1.908063453238843e-06,
            "start_logit": -1.9218682050704956,
            "end_logit": -4.230712413787842,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic",
            "probability": 1.0135026956876354e-06,
            "start_logit": -2.4658195972442627,
            "end_logit": -4.319437503814697,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic ZZ nucleosomes at promoters",
            "probability": 8.892745360425015e-07,
            "start_logit": -2.4658195972442627,
            "end_logit": -4.450199127197266,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "G/C runs",
            "probability": 8.283590309668643e-07,
            "start_logit": -2.756265640258789,
            "end_logit": -4.230712413787842,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        }
    ],
    "5a882b5761bb38fb24000013": [
        {
            "text": "type I interferonopathies",
            "probability": 0.46114669953370463,
            "start_logit": 0.12384907901287079,
            "end_logit": -0.9545196890830994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I",
            "probability": 0.22792970270129093,
            "start_logit": 0.12384907901287079,
            "end_logit": -1.6591986417770386,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopathies: a brief summary",
            "probability": 0.06960087615873078,
            "start_logit": 0.12384907901287079,
            "end_logit": -2.845458745956421,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies",
            "probability": 0.031506626141185295,
            "start_logit": -2.559669256210327,
            "end_logit": -0.9545196890830994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopathies: a brief summary, update",
            "probability": 0.03018049494900019,
            "start_logit": 0.12384907901287079,
            "end_logit": -3.681040048599243,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopath",
            "probability": 0.02257495541676793,
            "start_logit": 0.12384907901287079,
            "end_logit": -3.9713947772979736,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopathies: a brief summary, update and beyond.",
            "probability": 0.019812279962038274,
            "start_logit": 0.12384907901287079,
            "end_logit": -4.10193395614624,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopathies:",
            "probability": 0.019240830978635066,
            "start_logit": 0.12384907901287079,
            "end_logit": -4.131201267242432,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopathies: a brief summary,",
            "probability": 0.017882361899505612,
            "start_logit": 0.12384907901287079,
            "end_logit": -4.204421043395996,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "understanding of type I interferonopathies",
            "probability": 0.016087748094250915,
            "start_logit": -3.231809139251709,
            "end_logit": -0.9545196890830994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "better understanding of type I interferonopathies",
            "probability": 0.01470483126666301,
            "start_logit": -3.3216910362243652,
            "end_logit": -0.9545196890830994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopathies: a brief",
            "probability": 0.013361223301847419,
            "start_logit": 0.12384907901287079,
            "end_logit": -4.495879173278809,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I inter",
            "probability": 0.008480531150880523,
            "start_logit": 0.12384907901287079,
            "end_logit": -4.950462818145752,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "a better understanding of type I interferonopathies",
            "probability": 0.008212651885259459,
            "start_logit": -3.904191255569458,
            "end_logit": -0.9545196890830994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferonopathies: a",
            "probability": 0.00809072477414536,
            "start_logit": 0.12384907901287079,
            "end_logit": -4.9975175857543945,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "understanding of type I",
            "probability": 0.007951646718850396,
            "start_logit": -3.231809139251709,
            "end_logit": -1.6591986417770386,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "better understanding of type I",
            "probability": 0.007268116246461779,
            "start_logit": -3.3216910362243652,
            "end_logit": -1.6591986417770386,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Toward a better understanding of type I interferonopathies",
            "probability": 0.007153158695181089,
            "start_logit": -4.042313098907471,
            "end_logit": -0.9545196890830994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies: a brief summary",
            "probability": 0.004755295411307162,
            "start_logit": -2.559669256210327,
            "end_logit": -2.845458745956421,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "a better understanding of type I",
            "probability": 0.004059244714294153,
            "start_logit": -3.904191255569458,
            "end_logit": -1.6591986417770386,
            "question_text": "List the four most important interferonopathies"
        }
    ],
    "5a43b2d7966455904c00000c": [
        {
            "text": "inductive matrix completion",
            "probability": 0.9221151488225783,
            "start_logit": 3.3170909881591797,
            "end_logit": 2.5479018688201904,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "completion",
            "probability": 0.023364254385249666,
            "start_logit": -0.3583718538284302,
            "end_logit": 2.5479018688201904,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "inductive matrix",
            "probability": 0.01948751615151694,
            "start_logit": 3.3170909881591797,
            "end_logit": -1.308994174003601,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "based on inductive matrix completion",
            "probability": 0.0119287435676302,
            "start_logit": -1.0306282043457031,
            "end_logit": 2.5479018688201904,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "matrix completion",
            "probability": 0.010440754912521983,
            "start_logit": -1.1638622283935547,
            "end_logit": 2.5479018688201904,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "in",
            "probability": 0.006136780369752636,
            "start_logit": 3.3170909881591797,
            "end_logit": -2.464468002319336,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "inductive matrix completion.",
            "probability": 0.0026461515004738197,
            "start_logit": 2.979187488555908,
            "end_logit": -2.9677584171295166,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "Prediction of circRNA-disease associations based on inductive matrix completion",
            "probability": 0.0011818201871156028,
            "start_logit": -3.3425233364105225,
            "end_logit": 2.5479018688201904,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "inductive matrix completion.Currently, numerous studies indicate that circular RNA (circRNA) is associated with various human complex diseases.Prediction",
            "probability": 0.00100483479412818,
            "start_logit": 2.979187488555908,
            "end_logit": -3.9360415935516357,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "inductive matrix completion.Currently, numerous studies indicate that circular RNA (circRNA) is associated with various human complex diseases.",
            "probability": 0.0004715411697929415,
            "start_logit": 2.979187488555908,
            "end_logit": -4.69261360168457,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "on inductive matrix completion",
            "probability": 0.00031774642977028917,
            "start_logit": -4.656080722808838,
            "end_logit": 2.5479018688201904,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "based on inductive matrix",
            "probability": 0.0002520960459638048,
            "start_logit": -1.0306282043457031,
            "end_logit": -1.308994174003601,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "matrix",
            "probability": 0.0002206496447342826,
            "start_logit": -1.1638622283935547,
            "end_logit": -1.308994174003601,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "ductive matrix completion",
            "probability": 0.00015198681536140687,
            "start_logit": -5.175920009613037,
            "end_logit": 2.3302812576293945,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "based on in",
            "probability": 7.938713451906542e-05,
            "start_logit": -1.0306282043457031,
            "end_logit": -2.464468002319336,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "based",
            "probability": 7.412768450038818e-05,
            "start_logit": -1.0306282043457031,
            "end_logit": -2.533015251159668,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "matrix completion.",
            "probability": 3.6285336112686466e-05,
            "start_logit": -1.3102604150772095,
            "end_logit": -2.9677584171295166,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "completion.",
            "probability": 3.573417312975116e-05,
            "start_logit": -1.3255666494369507,
            "end_logit": -2.9677584171295166,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "based on inductive matrix completion.",
            "probability": 2.9464883793794267e-05,
            "start_logit": -1.5184749364852905,
            "end_logit": -2.9677584171295166,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "Prediction of circRNA-disease associations based on inductive matrix",
            "probability": 2.497599135423744e-05,
            "start_logit": -3.3425233364105225,
            "end_logit": -1.308994174003601,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        }
    ],
    "590c740d70f9fc6f0f00001d": [
        {
            "text": "STARD1",
            "probability": 0.21938815713213253,
            "start_logit": 4.260776996612549,
            "end_logit": 3.53314471244812,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD1",
            "probability": 0.14399635205207975,
            "start_logit": 3.8397223949432373,
            "end_logit": 3.53314471244812,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "STARD1; yeast START-kins Lam4S2",
            "probability": 0.10112004167058417,
            "start_logit": 4.260776996612549,
            "end_logit": 2.758610486984253,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2",
            "probability": 0.07366928457629635,
            "start_logit": 3.8397223949432373,
            "end_logit": 2.862942695617676,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD1; yeast START-kins Lam4S2",
            "probability": 0.06637057036378084,
            "start_logit": 3.8397223949432373,
            "end_logit": 2.758610486984253,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Lam4S2",
            "probability": 0.06348028019706833,
            "start_logit": 3.7951979637145996,
            "end_logit": 2.758610486984253,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "STARD1; yeast START-kins Lam4S2 and Lam2S2",
            "probability": 0.060019626556999335,
            "start_logit": 4.260776996612549,
            "end_logit": 2.236973762512207,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Lam2S2",
            "probability": 0.04250500186402542,
            "start_logit": 3.915727138519287,
            "end_logit": 2.236973762512207,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD1; yeast START-kins Lam4S2 and Lam2S2",
            "probability": 0.039394137717884116,
            "start_logit": 3.8397223949432373,
            "end_logit": 2.236973762512207,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Lam4S2 and Lam2S2",
            "probability": 0.03767861096787966,
            "start_logit": 3.7951979637145996,
            "end_logit": 2.236973762512207,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh4) and some other sterol-binding proteins (human LXR\u03b2 and STARD1",
            "probability": 0.036431571570996794,
            "start_logit": 2.4653701782226562,
            "end_logit": 3.53314471244812,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Atf2p",
            "probability": 0.030373109458006232,
            "start_logit": 2.893481731414795,
            "end_logit": 2.9231550693511963,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "STARD",
            "probability": 0.026692168157531764,
            "start_logit": 4.260776996612549,
            "end_logit": 1.426672339439392,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh4) and some other sterol-binding proteins (human LXR\u03b2",
            "probability": 0.018638581987512975,
            "start_logit": 2.4653701782226562,
            "end_logit": 2.862942695617676,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD",
            "probability": 0.017519518342689566,
            "start_logit": 3.8397223949432373,
            "end_logit": 1.426672339439392,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh4",
            "probability": 0.005267432344498378,
            "start_logit": 2.4653701782226562,
            "end_logit": 1.5992519855499268,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Atf2",
            "probability": 0.0052151952613858354,
            "start_logit": 2.893481731414795,
            "end_logit": 1.161173939704895,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR",
            "probability": 0.005007432388154985,
            "start_logit": 3.8397223949432373,
            "end_logit": 0.17428003251552582,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh4) and some other sterol-binding proteins (human LXR\u03b2 and STARD",
            "probability": 0.004432498304958744,
            "start_logit": 2.4653701782226562,
            "end_logit": 1.426672339439392,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "STARD1; yeast START-kins Lam4",
            "probability": 0.0028004290855339602,
            "start_logit": 4.260776996612549,
            "end_logit": -0.8279252052307129,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        }
    ],
    "5a67afb7b750ff445500000d": [
        {
            "text": "electrophysiological features of POEMS syndrome to distinguish from CIDP",
            "probability": 0.1983243876469997,
            "start_logit": -0.8749268054962158,
            "end_logit": -0.9805983901023865,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electrophysiological",
            "probability": 0.16081965717635854,
            "start_logit": -0.8749268054962158,
            "end_logit": -1.1902188062667847,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electrophysiological features",
            "probability": 0.09066966477329987,
            "start_logit": -0.8749268054962158,
            "end_logit": -1.7632795572280884,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electrophysiological features of POEMS syndrome",
            "probability": 0.0777392755504859,
            "start_logit": -0.8749268054962158,
            "end_logit": -1.9171417951583862,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "clinical and electrophysiological features of POEMS syndrome to distinguish from CIDP",
            "probability": 0.05848921071562028,
            "start_logit": -2.0959885120391846,
            "end_logit": -0.9805983901023865,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "CIDP",
            "probability": 0.057134486693428695,
            "start_logit": -2.1194229125976562,
            "end_logit": -0.9805983901023865,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "clinical and electrophysiological",
            "probability": 0.047428432415201,
            "start_logit": -2.0959885120391846,
            "end_logit": -1.1902188062667847,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electrophysiological features of POEMS syndrome to distinguish from CIDP.",
            "probability": 0.046129666001863086,
            "start_logit": -0.8749268054962158,
            "end_logit": -2.4390461444854736,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "POEMS syndrome to distinguish from CIDP",
            "probability": 0.043739237452731054,
            "start_logit": -2.386585235595703,
            "end_logit": -0.9805983901023865,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "clinical and electrophysiological features",
            "probability": 0.026740015140646355,
            "start_logit": -2.0959885120391846,
            "end_logit": -1.7632795572280884,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "determine the clinical and electrophysiological features of POEMS syndrome to distinguish from CIDP",
            "probability": 0.02652134031981174,
            "start_logit": -2.886881113052368,
            "end_logit": -0.9805983901023865,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "clinical and electrophysiological features of POEMS syndrome",
            "probability": 0.02292662502326816,
            "start_logit": -2.0959885120391846,
            "end_logit": -1.9171417951583862,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electrophysiological features of POEMS",
            "probability": 0.021986002784351272,
            "start_logit": -0.8749268054962158,
            "end_logit": -3.180096387863159,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "determine the clinical and electrophysiological",
            "probability": 0.021505942404225462,
            "start_logit": -2.886881113052368,
            "end_logit": -1.1902188062667847,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electrophysio",
            "probability": 0.01947847710956732,
            "start_logit": -0.8749268054962158,
            "end_logit": -3.301192283630371,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "POEMS syndrome",
            "probability": 0.01714492439910192,
            "start_logit": -2.386585235595703,
            "end_logit": -1.9171417951583862,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electro",
            "probability": 0.01681804837779437,
            "start_logit": -0.8749268054962158,
            "end_logit": -3.448049783706665,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "features of POEMS syndrome to distinguish from CIDP",
            "probability": 0.016178372609267494,
            "start_logit": -3.381155490875244,
            "end_logit": -0.9805983901023865,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "electrophysiological features of POEMS syndrome to distinguish",
            "probability": 0.015717993116503036,
            "start_logit": -0.8749268054962158,
            "end_logit": -3.5156962871551514,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "clinical",
            "probability": 0.014508240289474927,
            "start_logit": -2.0959885120391846,
            "end_logit": -2.3747239112854004,
            "question_text": "List main clinical features of the POEMS syndrome."
        }
    ],
    "5a678d63b750ff4455000003": [
        {
            "text": "hormones",
            "probability": 0.42687122346181716,
            "start_logit": -4.7129693031311035,
            "end_logit": -3.8818695545196533,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "driven by very well-defined signals and hormones",
            "probability": 0.08376761971221668,
            "start_logit": -6.301398754119873,
            "end_logit": -3.9218759536743164,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "inflammation resolves",
            "probability": 0.07332077407514719,
            "start_logit": -5.211544513702393,
            "end_logit": -5.144932746887207,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "resolves",
            "probability": 0.05186286290559031,
            "start_logit": -5.557785511016846,
            "end_logit": -5.144932746887207,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "signals and hormones",
            "probability": 0.041801975665219857,
            "start_logit": -7.036508083343506,
            "end_logit": -3.8818695545196533,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "hormones.",
            "probability": 0.030663459185369023,
            "start_logit": -5.012278079986572,
            "end_logit": -6.21597146987915,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "hormones.In other words, inflammation resolves",
            "probability": 0.02901089124279668,
            "start_logit": -6.138717174530029,
            "end_logit": -5.144932746887207,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "inflammation resolve",
            "probability": 0.028211322851077615,
            "start_logit": -5.211544513702393,
            "end_logit": -6.100053310394287,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "inflammation resolves.When it does not, inflammation persists",
            "probability": 0.026571250122226872,
            "start_logit": -5.211544513702393,
            "end_logit": -6.159946918487549,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "These are Celsus' four cardinal signs of inflammation that are driven by very well-defined signals and hormones",
            "probability": 0.024029924303765948,
            "start_logit": -7.590151786804199,
            "end_logit": -3.8818695545196533,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "disappear.These are Celsus' four cardinal signs of inflammation that are driven by very well-defined signals and hormones",
            "probability": 0.023969443107716475,
            "start_logit": -7.592671871185303,
            "end_logit": -3.8818695545196533,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "inflammation",
            "probability": 0.023186224529937113,
            "start_logit": -5.211544513702393,
            "end_logit": -6.296218395233154,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "inflammation resolves.When it does not, inflammation persists, resulting in damaging chronic conditions",
            "probability": 0.020887741706201373,
            "start_logit": -5.211544513702393,
            "end_logit": -6.400614261627197,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "four cardinal signs of inflammation that are driven by very well-defined signals and hormones",
            "probability": 0.020607573951352758,
            "start_logit": -7.74379301071167,
            "end_logit": -3.8818695545196533,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "resolve",
            "probability": 0.019955053501088504,
            "start_logit": -5.557785511016846,
            "end_logit": -6.100053310394287,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "resolves.When it does not, inflammation persists",
            "probability": 0.01879496117848965,
            "start_logit": -5.557785511016846,
            "end_logit": -6.159946918487549,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "inflammation resolves.When it does not, inflammation persists,",
            "probability": 0.017893617170773753,
            "start_logit": -5.211544513702393,
            "end_logit": -6.555332660675049,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "resolves.When it does not, inflammation persists, resulting in damaging chronic conditions",
            "probability": 0.014774776973928561,
            "start_logit": -5.557785511016846,
            "end_logit": -6.400614261627197,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "resolves.When it does not, inflammation persists,",
            "probability": 0.012656906939659759,
            "start_logit": -5.557785511016846,
            "end_logit": -6.555332660675049,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "hormones.In other words, inflammation resolve",
            "probability": 0.01116239741562486,
            "start_logit": -6.138717174530029,
            "end_logit": -6.100053310394287,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        }
    ],
    "5a70dbe599e2c3af26000004": [
        {
            "text": "SMAD4",
            "probability": 0.8175528394612718,
            "start_logit": 4.135681629180908,
            "end_logit": 3.895991086959839,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene",
            "probability": 0.12391948894882183,
            "start_logit": 4.135681629180908,
            "end_logit": 2.009307622909546,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "Mutations of the SMAD4",
            "probability": 0.023260345294711885,
            "start_logit": 0.5761160850524902,
            "end_logit": 3.895991086959839,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "the SMAD4",
            "probability": 0.021312921977404364,
            "start_logit": 0.4886796474456787,
            "end_logit": 3.895991086959839,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "Mutations of the SMAD4 gene",
            "probability": 0.0035256560341631253,
            "start_logit": 0.5761160850524902,
            "end_logit": 2.009307622909546,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "the SMAD4 gene",
            "probability": 0.0032304779238323134,
            "start_logit": 0.4886796474456787,
            "end_logit": 2.009307622909546,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD",
            "probability": 0.0031855342634059505,
            "start_logit": 4.135681629180908,
            "end_logit": -1.6517044305801392,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "4",
            "probability": 0.0009825968055942212,
            "start_logit": -2.5881903171539307,
            "end_logit": 3.895991086959839,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "MAD4",
            "probability": 0.0009813449655716295,
            "start_logit": -2.5894651412963867,
            "end_logit": 3.895991086959839,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "S",
            "probability": 0.00043899900041828376,
            "start_logit": 4.135681629180908,
            "end_logit": -3.633582592010498,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "of the SMAD4",
            "probability": 0.00019795223788161018,
            "start_logit": -4.19036340713501,
            "end_logit": 3.895991086959839,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with combined clinical features of both juvenile polyposis syndrome (JPS)",
            "probability": 0.000188233456161603,
            "start_logit": 4.135681629180908,
            "end_logit": -4.480396747589111,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can",
            "probability": 0.00018290142433579043,
            "start_logit": 4.135681629180908,
            "end_logit": -4.509132385253906,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with",
            "probability": 0.0001658763208405385,
            "start_logit": 4.135681629180908,
            "end_logit": -4.606837272644043,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in",
            "probability": 0.00015735835549927636,
            "start_logit": 4.135681629180908,
            "end_logit": -4.6595540046691895,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "4 gene",
            "probability": 0.00014893580954622657,
            "start_logit": -2.5881903171539307,
            "end_logit": 2.009307622909546,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "MAD4 gene",
            "probability": 0.00014874606355262516,
            "start_logit": -2.5894651412963867,
            "end_logit": 2.009307622909546,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with combined clinical features",
            "probability": 0.0001448098626500829,
            "start_logit": 4.135681629180908,
            "end_logit": -4.7426581382751465,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with combined clinical features of both juvenile polyposis",
            "probability": 0.00014080949586166405,
            "start_logit": 4.135681629180908,
            "end_logit": -4.770671844482422,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result",
            "probability": 0.0001341722984750338,
            "start_logit": 4.135681629180908,
            "end_logit": -4.818954944610596,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        }
    ],
    "5a70ce4ab750ff4455000064": [
        {
            "text": "WNT1",
            "probability": 0.8716477001133756,
            "start_logit": 2.184206247329712,
            "end_logit": 1.904021978378296,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Ptosis as a unique hallmark for autosomal recessive WNT1",
            "probability": 0.08557647302413049,
            "start_logit": -0.13676868379116058,
            "end_logit": 1.904021978378296,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Ptosis",
            "probability": 0.026097492308415002,
            "start_logit": -0.13676868379116058,
            "end_logit": 0.7164508104324341,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "WNT1-associated osteogenesis imperfecta",
            "probability": 0.005910658837239679,
            "start_logit": 2.184206247329712,
            "end_logit": -3.0896060466766357,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "WNT",
            "probability": 0.004002892854503159,
            "start_logit": 2.184206247329712,
            "end_logit": -3.4793460369110107,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "autosomal recessive WNT1",
            "probability": 0.0032266662585179453,
            "start_logit": -3.414729595184326,
            "end_logit": 1.904021978378296,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "1",
            "probability": 0.0013581125457926577,
            "start_logit": -4.280083179473877,
            "end_logit": 1.904021978378296,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Ptosis as a unique hallmark for autosomal recessive WNT1-associated osteogenesis imperfecta",
            "probability": 0.0005802956130947039,
            "start_logit": -0.13676868379116058,
            "end_logit": -3.0896060466766357,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Ptosis as a unique hallmark for autosomal recessive WNT",
            "probability": 0.0003929953034205427,
            "start_logit": -0.13676868379116058,
            "end_logit": -3.4793460369110107,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "tosis as a unique hallmark for autosomal recessive WNT1",
            "probability": 0.00033997900091993396,
            "start_logit": -5.665050506591797,
            "end_logit": 1.904021978378296,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Ptosis as a unique hallmark for autosomal recessive",
            "probability": 0.0003325956686674281,
            "start_logit": -0.13676868379116058,
            "end_logit": -3.6462161540985107,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "collagen metabolism, bone mineralization, or osteoblast differentiation.Bi-allelic mutations in WNT1",
            "probability": 0.00020714769592551521,
            "start_logit": -3.418851375579834,
            "end_logit": -0.837628960609436,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "tosis",
            "probability": 0.00011182872992060361,
            "start_logit": -5.519674777984619,
            "end_logit": 0.646730899810791,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "osteoblast differentiation.Bi-allelic mutations in WNT1",
            "probability": 9.028290528927947e-05,
            "start_logit": -4.249335289001465,
            "end_logit": -0.837628960609436,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "bone mineralization, or osteoblast differentiation.Bi-allelic mutations in WNT1",
            "probability": 3.973245388256906e-05,
            "start_logit": -5.070115089416504,
            "end_logit": -0.837628960609436,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Bi-allelic mutations in WNT1",
            "probability": 2.31567019905667e-05,
            "start_logit": -5.609999179840088,
            "end_logit": -0.837628960609436,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "autosomal recessive WNT1-associated osteogenesis imperfecta",
            "probability": 2.1880082323685955e-05,
            "start_logit": -3.414729595184326,
            "end_logit": -3.0896060466766357,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "autosomal recessive WNT",
            "probability": 1.4817912452941638e-05,
            "start_logit": -3.414729595184326,
            "end_logit": -3.4793460369110107,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "type I procollagen-encoding genes account for the majority of OI, but increasingly more rare autosomal recessive",
            "probability": 1.2751449684878761e-05,
            "start_logit": -2.255262613296509,
            "end_logit": -4.789004802703857,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "autosomal recessive",
            "probability": 1.2540540453400029e-05,
            "start_logit": -3.414729595184326,
            "end_logit": -3.6462161540985107,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        }
    ],
    "5a736efc3b9d13c708000006": [
        {
            "text": "11",
            "probability": 0.38051565178914815,
            "start_logit": 2.136795997619629,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 and 22",
            "probability": 0.2535188059209397,
            "start_logit": 2.136795997619629,
            "end_logit": 2.352321147918701,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22",
            "probability": 0.24671909433361405,
            "start_logit": 2.0346460342407227,
            "end_logit": 2.427283525466919,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "chromosomes 11",
            "probability": 0.049363484163618576,
            "start_logit": 0.09447965025901794,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "chromosomes 11 and 22",
            "probability": 0.032888454134318734,
            "start_logit": 0.09447965025901794,
            "end_logit": 2.352321147918701,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "unbalanced translocation of chromosomes 11",
            "probability": 0.004961485824857713,
            "start_logit": -2.203026056289673,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "translocation of chromosomes 11",
            "probability": 0.003813234558939077,
            "start_logit": -2.4662535190582275,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.0033055932285502585,
            "start_logit": -2.203026056289673,
            "end_logit": 2.352321147918701,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "an unbalanced translocation of chromosomes 11",
            "probability": 0.0031722521026087067,
            "start_logit": -2.650289535522461,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "translocation of chromosomes 11 and 22",
            "probability": 0.0025405700594265694,
            "start_logit": -2.4662535190582275,
            "end_logit": 2.352321147918701,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "caused by an unbalanced translocation of chromosomes 11",
            "probability": 0.002450213905549695,
            "start_logit": -2.9085559844970703,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22.",
            "probability": 0.0023584840434101905,
            "start_logit": 2.0346460342407227,
            "end_logit": -2.222947835922241,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "caused by an unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.0022215789790443995,
            "start_logit": -2.6753861904144287,
            "end_logit": 2.427283525466919,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "by an unbalanced translocation of chromosomes 11",
            "probability": 0.0021952822311466402,
            "start_logit": -3.018420696258545,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 and 22.",
            "probability": 0.002185259899890589,
            "start_logit": 1.9583617448806763,
            "end_logit": -2.222947835922241,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "an unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.0021135150718561988,
            "start_logit": -2.650289535522461,
            "end_logit": 2.352321147918701,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "syndrome is a rare inherited chromosomal abnormality caused by an unbalanced translocation of chromosomes 11",
            "probability": 0.0016968324339009207,
            "start_logit": -3.275968074798584,
            "end_logit": 2.7584104537963867,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "by an unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.0014626082456343907,
            "start_logit": -3.018420696258545,
            "end_logit": 2.352321147918701,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 and 22.Neuroimaging findings in Emanuel Syndrome.",
            "probability": 0.001342603238925451,
            "start_logit": 2.136795997619629,
            "end_logit": -2.8885064125061035,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 and 22.Neuroimaging findings in Emanuel Syndrome.Emanuel syndrome",
            "probability": 0.001174995834620336,
            "start_logit": 2.136795997619629,
            "end_logit": -3.0218522548675537,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        }
    ],
    "5a8a9abdfcd1d6a10c000019": [
        {
            "text": "DIAP2, IMD",
            "probability": 0.28267822231070144,
            "start_logit": 3.7919275760650635,
            "end_logit": 4.052558422088623,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD",
            "probability": 0.2475587983543322,
            "start_logit": 3.659266471862793,
            "end_logit": 4.052558422088623,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2, IMD is rapidly conjugated with K63",
            "probability": 0.1305833973975557,
            "start_logit": 3.7919275760650635,
            "end_logit": 3.280261278152466,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD is rapidly conjugated with K63",
            "probability": 0.1143599555725001,
            "start_logit": 3.659266471862793,
            "end_logit": 3.280261278152466,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2",
            "probability": 0.10842859488525314,
            "start_logit": 3.7919275760650635,
            "end_logit": 3.0943410396575928,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "K63",
            "probability": 0.0843496417750691,
            "start_logit": 3.354886054992676,
            "end_logit": 3.280261278152466,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "K63-linked polyubiquitin chains.Caspase-mediated cleavage, IAP",
            "probability": 0.014848672867423448,
            "start_logit": 3.354886054992676,
            "end_logit": 1.543201208114624,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IAP",
            "probability": 0.0062171520831061375,
            "start_logit": 2.4842875003814697,
            "end_logit": 1.543201208114624,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2,",
            "probability": 0.0036581498971864903,
            "start_logit": 3.7919275760650635,
            "end_logit": -0.2947932779788971,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP",
            "probability": 0.0036485367273092453,
            "start_logit": 3.7919275760650635,
            "end_logit": -0.2974246144294739,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD and Toll.These results mechanistically connect caspase-mediated cleavage and K63",
            "probability": 0.001022199965545869,
            "start_logit": 1.8811110258102417,
            "end_logit": 0.34102287888526917,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "Through its association with DIAP2, IMD",
            "probability": 0.00037593491444729704,
            "start_logit": -2.830720901489258,
            "end_logit": 4.052558422088623,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2, IMD is rapidly conjugated with K63-linked polyubiquitin chains",
            "probability": 0.0003518666435370848,
            "start_logit": 3.7919275760650635,
            "end_logit": -2.636253833770752,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "2, IMD",
            "probability": 0.00034624722245310454,
            "start_logit": -2.9129838943481445,
            "end_logit": 4.052558422088623,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD is rapidly conjugated with K63-linked polyubiquitin chains",
            "probability": 0.0003081513770072807,
            "start_logit": 3.659266471862793,
            "end_logit": -2.636253833770752,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "D",
            "probability": 0.0002932280778577261,
            "start_logit": -3.079186201095581,
            "end_logit": 4.052558422088623,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "association with DIAP2, IMD",
            "probability": 0.0002567003844422672,
            "start_logit": -3.2122273445129395,
            "end_logit": 4.052558422088623,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD is rapidly conjugated with K63-linked polyubiquitin chains.Caspase-mediated cleavage",
            "probability": 0.0002521455489519407,
            "start_logit": 3.659266471862793,
            "end_logit": -2.836838483810425,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2, IMD is rapidly conjugated with K",
            "probability": 0.00023511763329835453,
            "start_logit": 3.7919275760650635,
            "end_logit": -3.0394201278686523,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "K63-linked polyubiquitin chains",
            "probability": 0.00022728636202188889,
            "start_logit": 3.354886054992676,
            "end_logit": -2.636253833770752,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        }
    ],
    "5a7723b79e632bc06600000b": [
        {
            "text": "deflazacort",
            "probability": 0.558096783477091,
            "start_logit": -3.8616943359375,
            "end_logit": -3.258862257003784,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "Deflazacort",
            "probability": 0.14483033225288658,
            "start_logit": -3.888282060623169,
            "end_logit": -4.581243991851807,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort).Deflazacort",
            "probability": 0.13079455198434756,
            "start_logit": -3.8616943359375,
            "end_logit": -4.709766864776611,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids (prednisone, deflazacort",
            "probability": 0.033896588042111236,
            "start_logit": -6.662912368774414,
            "end_logit": -3.258862257003784,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "corticosteroids (prednisone, deflazacort",
            "probability": 0.023218321628642447,
            "start_logit": -7.041285037994385,
            "end_logit": -3.258862257003784,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "Deflazacort received FDA approval for DMD in 2016,",
            "probability": 0.01055450187003776,
            "start_logit": -3.888282060623169,
            "end_logit": -7.200254440307617,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort)",
            "probability": 0.010345333803362588,
            "start_logit": -3.8616943359375,
            "end_logit": -7.246859073638916,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "def",
            "probability": 0.010150719445417716,
            "start_logit": -3.8616943359375,
            "end_logit": -7.265850067138672,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "(prednisone, deflazacort",
            "probability": 0.010035318739255727,
            "start_logit": -7.880115985870361,
            "end_logit": -3.258862257003784,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort).Deflazacort received FDA approval for DMD in 2016,",
            "probability": 0.009740532483533586,
            "start_logit": -3.8616943359375,
            "end_logit": -7.307098865509033,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "prednisone, deflazacort",
            "probability": 0.00930361755461764,
            "start_logit": -7.9558234214782715,
            "end_logit": -3.258862257003784,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "off-label prescription of high-dose, daily corticosteroids (prednisone, deflazacort",
            "probability": 0.009153335663710276,
            "start_logit": -7.972108364105225,
            "end_logit": -3.258862257003784,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "Translarna",
            "probability": 0.008693174483382653,
            "start_logit": -5.386234760284424,
            "end_logit": -5.896316051483154,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort).",
            "probability": 0.008403789519339417,
            "start_logit": -3.8616943359375,
            "end_logit": -7.4547119140625,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids (prednisone, deflazacort).Deflazacort",
            "probability": 0.007943943018528292,
            "start_logit": -6.662912368774414,
            "end_logit": -4.709766864776611,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "corticosteroids (prednisone, deflazacort).Deflazacort",
            "probability": 0.005441403830221919,
            "start_logit": -7.041285037994385,
            "end_logit": -4.709766864776611,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "chronic inflammation and the fibrofatty replacement of muscle.In Europe, EMA has given conditional marketing authorization for prescription of Translarna",
            "probability": 0.0027684531548458776,
            "start_logit": -6.621198654174805,
            "end_logit": -5.805601596832275,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "(prednisone, deflazacort).Deflazacort",
            "probability": 0.0023518591351547533,
            "start_logit": -7.880115985870361,
            "end_logit": -4.709766864776611,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "prednisone, deflazacort).Deflazacort",
            "probability": 0.0021803789699495306,
            "start_logit": -7.9558234214782715,
            "end_logit": -4.709766864776611,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids",
            "probability": 0.002097060943563336,
            "start_logit": -6.662912368774414,
            "end_logit": -6.041639804840088,
            "question_text": "What are the prednisone side effects in DMD patients?"
        }
    ],
    "5a7727f39e632bc06600000d": [
        {
            "text": "inflammation",
            "probability": 0.4382120483177398,
            "start_logit": -3.452746868133545,
            "end_logit": -2.897078275680542,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic inflammation",
            "probability": 0.4181293057155759,
            "start_logit": -3.4996590614318848,
            "end_logit": -2.897078275680542,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "dystrophin in patient muscle while also targeting both chronic inflammation",
            "probability": 0.025804345959143538,
            "start_logit": -6.28490686416626,
            "end_logit": -2.897078275680542,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "Translarna",
            "probability": 0.017502301572691246,
            "start_logit": -4.6323370933532715,
            "end_logit": -4.937858581542969,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic",
            "probability": 0.014244972893474957,
            "start_logit": -3.4996590614318848,
            "end_logit": -6.276464939117432,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "inflammation and the fibrofatty replacement of muscle.",
            "probability": 0.011904725633208735,
            "start_logit": -3.452746868133545,
            "end_logit": -6.502845764160156,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "inflammation and the fibrofatty replacement of muscle",
            "probability": 0.011816831424503255,
            "start_logit": -3.452746868133545,
            "end_logit": -6.510256290435791,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic inflammation and the fibrofatty replacement of muscle.",
            "probability": 0.011359146063776717,
            "start_logit": -3.4996590614318848,
            "end_logit": -6.502845764160156,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic inflammation and the fibrofatty replacement of muscle",
            "probability": 0.011275279943245514,
            "start_logit": -3.4996590614318848,
            "end_logit": -6.510256290435791,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic inflammation and the fibrofatty replacement of muscle.In Europe, EMA has given conditional marketing authorization for prescription of Translarna",
            "probability": 0.008937745222787702,
            "start_logit": -4.815260410308838,
            "end_logit": -5.4269843101501465,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "inflammation and the fibrofatty replacement",
            "probability": 0.006689084235477723,
            "start_logit": -3.452746868133545,
            "end_logit": -7.079304218292236,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic inflammation and the fibrofatty replacement",
            "probability": 0.0063825313749139995,
            "start_logit": -3.4996590614318848,
            "end_logit": -7.079304218292236,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "inflammation and the fibrofatty replacement of muscle.In Europe, EMA has given conditional marketing authorization for prescription of Translarna",
            "probability": 0.004294217019741046,
            "start_logit": -5.548274517059326,
            "end_logit": -5.4269843101501465,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "Translarna (a stop codon read-through drug prescribed to ~10% of DMD patients),",
            "probability": 0.004130803168542893,
            "start_logit": -4.556676387786865,
            "end_logit": -6.4573798179626465,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "fibrofatty replacement of muscle.In Europe, EMA has given conditional marketing authorization for prescription of Translarna",
            "probability": 0.0019514207373739012,
            "start_logit": -6.336986064910889,
            "end_logit": -5.4269843101501465,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "corticosteroid",
            "probability": 0.0016697037991828178,
            "start_logit": -5.53921365737915,
            "end_logit": -6.3806681632995605,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "fibrofatty replacement of muscle.",
            "probability": 0.0016157000380981298,
            "start_logit": -5.44991397857666,
            "end_logit": -6.502845764160156,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "fibrofatty replacement of muscle",
            "probability": 0.0016037711049391916,
            "start_logit": -5.44991397857666,
            "end_logit": -6.510256290435791,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "corticosteroid use",
            "probability": 0.0013892102194661155,
            "start_logit": -5.854434967041016,
            "end_logit": -6.2493577003479,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "Deflazacort received FDA approval for DMD in 2016,",
            "probability": 0.001086855556116873,
            "start_logit": -6.060764312744141,
            "end_logit": -6.288475036621094,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        }
    ],
    "5a86f074faa1ab7d2e00003a": [
        {
            "text": "renal medullary carcinoma",
            "probability": 0.9207115848934301,
            "start_logit": 5.093307018280029,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary",
            "probability": 0.053147662108835966,
            "start_logit": 5.093307018280029,
            "end_logit": 1.7477126121520996,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "medullary carcinoma",
            "probability": 0.008780200804363151,
            "start_logit": 0.44065946340560913,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary carcinoma.",
            "probability": 0.004991634982078016,
            "start_logit": 5.093307018280029,
            "end_logit": -0.6175979971885681,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "carcinoma",
            "probability": 0.0024377816470203292,
            "start_logit": -0.8407513499259949,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal",
            "probability": 0.002315638544496848,
            "start_logit": 5.093307018280029,
            "end_logit": -1.3856760263442993,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary car",
            "probability": 0.0020420695637102366,
            "start_logit": 5.093307018280029,
            "end_logit": -1.5113977193832397,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary carcin",
            "probability": 0.001960293003365739,
            "start_logit": 5.093307018280029,
            "end_logit": -1.5522675514221191,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "re",
            "probability": 0.0005873869760769091,
            "start_logit": 5.093307018280029,
            "end_logit": -2.7574329376220703,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "oma",
            "probability": 0.0005583244619949174,
            "start_logit": -2.31465482711792,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "medullary",
            "probability": 0.0005068331421636622,
            "start_logit": 0.44065946340560913,
            "end_logit": 1.7477126121520996,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary carcinoma:",
            "probability": 0.0004378337993924869,
            "start_logit": 4.321425914764404,
            "end_logit": -2.2793962955474854,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "nal medullary carcinoma",
            "probability": 0.0002667669146761446,
            "start_logit": -3.053219795227051,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal me",
            "probability": 0.0002531270410708329,
            "start_logit": 5.093307018280029,
            "end_logit": -3.5992252826690674,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "y carcinoma",
            "probability": 0.00023777452169199947,
            "start_logit": -3.1682722568511963,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "llary carcinoma",
            "probability": 0.00020406004181315775,
            "start_logit": -3.321180820465088,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "dullary carcinoma",
            "probability": 0.00019660115956631456,
            "start_logit": -3.3584179878234863,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medu",
            "probability": 0.00016592107873935323,
            "start_logit": 5.093307018280029,
            "end_logit": -4.021604537963867,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "we demonstrate that different molecular mechanisms underlie the loss of SMARCB1 expression in renal medullary carcinoma",
            "probability": 0.00012257569491134422,
            "start_logit": -3.8308663368225098,
            "end_logit": 4.599785327911377,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary carcinoma: morphologic and molecular analysis of 20 cases.",
            "probability": 7.592962060242635e-05,
            "start_logit": 4.321425914764404,
            "end_logit": -4.031428813934326,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        }
    ],
    "5a75fbf383b0d9ea6600000a": [
        {
            "text": "Tofacitinib, a pan-JAK inhibitor,",
            "probability": 0.2066683737628585,
            "start_logit": -3.5483922958374023,
            "end_logit": -3.98919939994812,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib,",
            "probability": 0.20598951575231414,
            "start_logit": -3.5483922958374023,
            "end_logit": -3.9924895763397217,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, a pan-JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.10644422094531582,
            "start_logit": -3.5483922958374023,
            "end_logit": -4.652693748474121,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, a pan-JAK inhibitor",
            "probability": 0.08711265375909402,
            "start_logit": -3.5483922958374023,
            "end_logit": -4.853112697601318,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, a pan-JAK",
            "probability": 0.054570870873326294,
            "start_logit": -3.5483922958374023,
            "end_logit": -5.320814609527588,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative colitis",
            "probability": 0.04536916333701116,
            "start_logit": -4.401180744171143,
            "end_logit": -4.652693748474121,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "JAK inhibitor,",
            "probability": 0.04153822975353692,
            "start_logit": -5.152893543243408,
            "end_logit": -3.98919939994812,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib",
            "probability": 0.0325330927017078,
            "start_logit": -3.5483922958374023,
            "end_logit": -5.838057041168213,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "pan-JAK inhibitor,",
            "probability": 0.029514317990442858,
            "start_logit": -5.494632244110107,
            "end_logit": -3.98919939994812,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "a pan-JAK inhibitor,",
            "probability": 0.02772502533093984,
            "start_logit": -5.5571722984313965,
            "end_logit": -3.98919939994812,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": ", a pan-JAK inhibitor,",
            "probability": 0.02145101113455524,
            "start_logit": -5.8137359619140625,
            "end_logit": -3.98919939994812,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.021394199920672083,
            "start_logit": -5.152893543243408,
            "end_logit": -4.652693748474121,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": ",",
            "probability": 0.021380549503305955,
            "start_logit": -5.8137359619140625,
            "end_logit": -3.9924895763397217,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "JAK inhibitor",
            "probability": 0.01750875259916455,
            "start_logit": -5.152893543243408,
            "end_logit": -4.853112697601318,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "pan-JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.015201303073250431,
            "start_logit": -5.494632244110107,
            "end_logit": -4.652693748474121,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Inhibition of Janus kinases",
            "probability": 0.014839510422497272,
            "start_logit": -5.122344970703125,
            "end_logit": -5.049068927764893,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "a pan-JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.014279730702421625,
            "start_logit": -5.5571722984313965,
            "end_logit": -4.652693748474121,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "pan-JAK inhibitor",
            "probability": 0.012440561258721772,
            "start_logit": -5.494632244110107,
            "end_logit": -4.853112697601318,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Crohn's disease [CD] patients has shown conflicting results in clinical trials.Tofacitinib,",
            "probability": 0.012352559522188411,
            "start_logit": -6.362354278564453,
            "end_logit": -3.9924895763397217,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "a pan-JAK inhibitor",
            "probability": 0.011686357656675589,
            "start_logit": -5.5571722984313965,
            "end_logit": -4.853112697601318,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        }
    ],
    "5a76155c83b0d9ea6600001e": [
        {
            "text": "tofacitinib",
            "probability": 0.3572993048882088,
            "start_logit": -0.13479097187519073,
            "end_logit": 0.4926755726337433,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib",
            "probability": 0.26119529052866364,
            "start_logit": 0.1810080111026764,
            "end_logit": -0.1364288628101349,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib, ruxolitinib",
            "probability": 0.19046517779417477,
            "start_logit": -0.13479097187519073,
            "end_logit": -0.1364288628101349,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib",
            "probability": 0.03333330697425342,
            "start_logit": 0.1810080111026764,
            "end_logit": -2.1951401233673096,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib, filgotinib, upadacitinib",
            "probability": 0.026587524930947983,
            "start_logit": 0.1810080111026764,
            "end_logit": -2.421255111694336,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib, ruxolitinib, peficitinib",
            "probability": 0.024306848054070337,
            "start_logit": -0.13479097187519073,
            "end_logit": -2.1951401233673096,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib",
            "probability": 0.023335541375634178,
            "start_logit": -0.13479097187519073,
            "end_logit": -2.2359206676483154,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "baricitinib, ruxolitinib",
            "probability": 0.02116238453444012,
            "start_logit": -2.3320350646972656,
            "end_logit": -0.1364288628101349,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib, filgotinib",
            "probability": 0.013620859781865047,
            "start_logit": 0.1810080111026764,
            "end_logit": -3.090094804763794,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib, ruxolitinib, peficitinib, filgotinib",
            "probability": 0.009932412926785723,
            "start_logit": -0.13479097187519073,
            "end_logit": -3.090094804763794,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "peficitinib",
            "probability": 0.006603235401796783,
            "start_logit": -1.437989354133606,
            "end_logit": -2.1951401233673096,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "filgotinib, upadacitinib",
            "probability": 0.006346851683989974,
            "start_logit": -1.251475214958191,
            "end_logit": -2.421255111694336,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib, filgotinib, upadacitinib, solcitinib",
            "probability": 0.0053664371617923165,
            "start_logit": 0.1810080111026764,
            "end_logit": -4.021533012390137,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "peficitinib, filgotinib, upadacitinib",
            "probability": 0.005266914741036505,
            "start_logit": -1.437989354133606,
            "end_logit": -2.421255111694336,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "filgotinib",
            "probability": 0.0032515090091478896,
            "start_logit": -1.251475214958191,
            "end_logit": -3.090094804763794,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "baricitinib, ruxolitinib, peficitinib",
            "probability": 0.0027007081887499554,
            "start_logit": -2.3320350646972656,
            "end_logit": -2.1951401233673096,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "peficitinib, filgotinib",
            "probability": 0.00269825443914077,
            "start_logit": -1.437989354133606,
            "end_logit": -3.090094804763794,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "baricitinib",
            "probability": 0.002592787330627802,
            "start_logit": -2.3320350646972656,
            "end_logit": -2.2359206676483154,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "baricitinib, ruxolitinib, peficitinib, filgotinib, upadacitinib",
            "probability": 0.002154156092435322,
            "start_logit": -2.3320350646972656,
            "end_logit": -2.421255111694336,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ib",
            "probability": 0.00178049416223865,
            "start_logit": -5.436473846435547,
            "end_logit": 0.4926755726337433,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        }
    ],
    "5a89a20ffcd1d6a10c00000e": [
        {
            "text": "transforming growth factor-\u03b2",
            "probability": 0.2954722722020135,
            "start_logit": 5.357986927032471,
            "end_logit": 4.083969593048096,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor-C",
            "probability": 0.25227594497687233,
            "start_logit": 5.0759501457214355,
            "end_logit": 4.2079548835754395,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein",
            "probability": 0.2106167073139811,
            "start_logit": 5.357986927032471,
            "end_logit": 3.745434522628784,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein (TGFBIp",
            "probability": 0.14993389689500772,
            "start_logit": 5.357986927032471,
            "end_logit": 3.4055891036987305,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein (TGFBIp)",
            "probability": 0.0529892934087348,
            "start_logit": 5.357986927032471,
            "end_logit": 2.3654844760894775,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "TGFBIp",
            "probability": 0.014444432357738788,
            "start_logit": 3.018101453781128,
            "end_logit": 3.4055891036987305,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein (TGFBIp),",
            "probability": 0.00984706302580857,
            "start_logit": 5.357986927032471,
            "end_logit": 0.682567834854126,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "TGFBIp)",
            "probability": 0.005104918101760675,
            "start_logit": 3.018101453781128,
            "end_logit": 2.3654844760894775,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.0024440046031659703,
            "start_logit": 5.0759501457214355,
            "end_logit": -0.42893069982528687,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "extracellular matrix protein, transforming growth factor-\u03b2",
            "probability": 0.001331392477951067,
            "start_logit": -0.04436270147562027,
            "end_logit": 4.083969593048096,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "(TGFBIp",
            "probability": 0.0010240167359594186,
            "start_logit": 0.37152528762817383,
            "end_logit": 3.4055891036987305,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "extracellular matrix protein, transforming growth factor-\u03b2 induced protein",
            "probability": 0.0009490349052344853,
            "start_logit": -0.04436270147562027,
            "end_logit": 3.745434522628784,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "TGFBIp),",
            "probability": 0.0009486529647013963,
            "start_logit": 3.018101453781128,
            "end_logit": 0.682567834854126,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "extracellular matrix protein, transforming growth factor-\u03b2 induced protein (TGFBIp",
            "probability": 0.0006755993076041461,
            "start_logit": -0.04436270147562027,
            "end_logit": 3.4055891036987305,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "a versatile extracellular matrix protein, transforming growth factor-\u03b2",
            "probability": 0.0004731875821564342,
            "start_logit": -1.0788514614105225,
            "end_logit": 4.083969593048096,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "(TGFBIp)",
            "probability": 0.00036190564242591415,
            "start_logit": 0.37152528762817383,
            "end_logit": 2.3654844760894775,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "a versatile extracellular matrix protein, transforming growth factor-\u03b2 induced protein",
            "probability": 0.0003372946292148659,
            "start_logit": -1.0788514614105225,
            "end_logit": 3.745434522628784,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "versatile extracellular matrix protein, transforming growth factor-\u03b2",
            "probability": 0.0002915006931558811,
            "start_logit": -1.5633009672164917,
            "end_logit": 4.083969593048096,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "a versatile extracellular matrix protein, transforming growth factor-\u03b2 induced protein (TGFBIp",
            "probability": 0.0002401134212232769,
            "start_logit": -1.0788514614105225,
            "end_logit": 3.4055891036987305,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "extracellular matrix protein, transforming growth factor-\u03b2 induced protein (TGFBIp)",
            "probability": 0.0002387687552898265,
            "start_logit": -0.04436270147562027,
            "end_logit": 2.3654844760894775,
            "question_text": "List factors that promote lymphangiogenesis."
        }
    ],
    "5a86ebf2faa1ab7d2e000038": [
        {
            "text": "clock",
            "probability": 0.8173683667607489,
            "start_logit": 2.3622517585754395,
            "end_logit": 2.857523202896118,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcriptional clock",
            "probability": 0.09774036505492405,
            "start_logit": 0.23847651481628418,
            "end_logit": 2.857523202896118,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "The transcriptional clock",
            "probability": 0.08007448517527395,
            "start_logit": 0.03911915421485901,
            "end_logit": 2.857523202896118,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors,",
            "probability": 0.0010277145447010188,
            "start_logit": 2.3622517585754395,
            "end_logit": -3.8212292194366455,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox-sensitive transcription factors and enzymes",
            "probability": 0.000517370560344589,
            "start_logit": -0.9010687470436096,
            "end_logit": -1.2442420721054077,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcription factors and enzymes",
            "probability": 0.0004161991911283566,
            "start_logit": -1.1186641454696655,
            "end_logit": -1.2442420721054077,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcription",
            "probability": 0.00030624218440580446,
            "start_logit": 0.23847651481628418,
            "end_logit": -2.908170461654663,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox-sensitive transcription factors",
            "probability": 0.0003012349396073451,
            "start_logit": -0.9010687470436096,
            "end_logit": -1.7851109504699707,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins",
            "probability": 0.0002528573535009389,
            "start_logit": 2.3622517585754395,
            "end_logit": -5.223496437072754,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "The transcription",
            "probability": 0.0002508910749562491,
            "start_logit": 0.03911915421485901,
            "end_logit": -2.908170461654663,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "enzymes",
            "probability": 0.00024924295080834704,
            "start_logit": -1.6313999891281128,
            "end_logit": -1.2442420721054077,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcription factors",
            "probability": 0.00024232870560062907,
            "start_logit": -1.1186641454696655,
            "end_logit": -1.7851109504699707,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors, and",
            "probability": 0.00019173579126194798,
            "start_logit": 2.3622517585754395,
            "end_logit": -5.500203609466553,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors",
            "probability": 0.00019162263834740628,
            "start_logit": 2.3622517585754395,
            "end_logit": -5.500793933868408,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors, and, conversely, the cellular redox",
            "probability": 0.00017786919717813142,
            "start_logit": 2.3622517585754395,
            "end_logit": -5.575273513793945,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors, and, conversely, the cellular",
            "probability": 0.0001698332652326409,
            "start_logit": 2.3622517585754395,
            "end_logit": -5.621504783630371,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox poise has been shown to feed back to the transcriptional oscillator via redox-sensitive transcription factors and enzymes",
            "probability": 0.00015012490020036218,
            "start_logit": -2.1383605003356934,
            "end_logit": -1.2442420721054077,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "cellular redox poise has been shown to feed back to the transcriptional oscillator via redox-sensitive transcription factors and enzymes",
            "probability": 0.00014794098675086626,
            "start_logit": -2.153014659881592,
            "end_logit": -1.2442420721054077,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcriptional clock controls the levels of many antioxidant proteins and redox-active cofactors,",
            "probability": 0.00012289342095463674,
            "start_logit": 0.23847651481628418,
            "end_logit": -3.8212292194366455,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "The transcriptional clock controls the levels of many antioxidant proteins and redox-active cofactors,",
            "probability": 0.00010068130407371547,
            "start_logit": 0.03911915421485901,
            "end_logit": -3.8212292194366455,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        }
    ],
    "5a7600b983b0d9ea6600000c": [
        {
            "text": "Oral Psoriatic Arthritis triaL",
            "probability": 0.21378662305007434,
            "start_logit": 2.6588187217712402,
            "end_logit": 2.7449395656585693,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriatic Arthritis triaL",
            "probability": 0.2118480788981701,
            "start_logit": 2.649709701538086,
            "end_logit": 2.7449395656585693,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral Psoriatic Arthritis",
            "probability": 0.20149369992588548,
            "start_logit": 2.6588187217712402,
            "end_logit": 2.6857192516326904,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriatic Arthritis",
            "probability": 0.19966662380641573,
            "start_logit": 2.649709701538086,
            "end_logit": 2.6857192516326904,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral Psoriatic Arthritis triaL (OPAL)",
            "probability": 0.023234110404938037,
            "start_logit": 2.6588187217712402,
            "end_logit": 0.5255826115608215,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriatic Arthritis triaL (OPAL)",
            "probability": 0.02302343141947298,
            "start_logit": 2.649709701538086,
            "end_logit": 0.5255826115608215,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial",
            "probability": 0.02214589591404979,
            "start_logit": 1.6475709676742554,
            "end_logit": 1.488861083984375,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "The Oral Psoriatic Arthritis triaL",
            "probability": 0.018324330094036206,
            "start_logit": 0.2020699828863144,
            "end_logit": 2.7449395656585693,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "The Oral Psoriatic Arthritis",
            "probability": 0.017270664631087732,
            "start_logit": 0.2020699828863144,
            "end_logit": 2.6857192516326904,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial",
            "probability": 0.010150205097662056,
            "start_logit": 0.8674126863479614,
            "end_logit": 1.488861083984375,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral Psoriatic Arthritis triaL (OPAL",
            "probability": 0.009364003075271597,
            "start_logit": 2.6588187217712402,
            "end_logit": -0.38316598534584045,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriatic Arthritis triaL (OPAL",
            "probability": 0.009279093490466895,
            "start_logit": 2.649709701538086,
            "end_logit": -0.38316598534584045,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral Psoriatic Arthritis triaL (OPAL) study series demonstrated that tofacitinib significantly improved psoriatic arthritis",
            "probability": 0.00681459194339549,
            "start_logit": 2.6588187217712402,
            "end_logit": -0.7009726762771606,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriatic Arthritis triaL (OPAL) study series demonstrated that tofacitinib significantly improved psoriatic arthritis",
            "probability": 0.00675279954885269,
            "start_logit": 2.649709701538086,
            "end_logit": -0.7009726762771606,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Arthritis triaL",
            "probability": 0.006082345255186072,
            "start_logit": -0.9007693529129028,
            "end_logit": 2.7449395656585693,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Arthritis",
            "probability": 0.005732604932007553,
            "start_logit": -0.9007693529129028,
            "end_logit": 2.6857192516326904,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment",
            "probability": 0.004616103878903967,
            "start_logit": 1.6475709676742554,
            "end_logit": -0.07924007624387741,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis",
            "probability": 0.004127116736127569,
            "start_logit": 1.6475709676742554,
            "end_logit": -0.19121207296848297,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial (OPT)",
            "probability": 0.003665365904192169,
            "start_logit": 1.6475709676742554,
            "end_logit": -0.3098629415035248,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "(OPAL)",
            "probability": 0.002622311993803777,
            "start_logit": 0.47725361585617065,
            "end_logit": 0.5255826115608215,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        }
    ],
    "5a7244aa2dc08e987e00000f": [
        {
            "text": "interleukin 12",
            "probability": 0.46129302261500005,
            "start_logit": 3.2414145469665527,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 12 and 23",
            "probability": 0.39742362590357444,
            "start_logit": 3.2414145469665527,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12",
            "probability": 0.05920175093461766,
            "start_logit": 1.188332200050354,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12 and 23",
            "probability": 0.05100483502416411,
            "start_logit": 1.188332200050354,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "23",
            "probability": 0.010454013062231772,
            "start_logit": -0.3966023027896881,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "ukin 12",
            "probability": 0.006390094057298607,
            "start_logit": -1.037869930267334,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "ukin 12 and 23",
            "probability": 0.005505338744817847,
            "start_logit": -1.037869930267334,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "n 12",
            "probability": 0.0014510376949711972,
            "start_logit": -2.5203399658203125,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "n 12 and 23",
            "probability": 0.001250130901155031,
            "start_logit": -2.5203399658203125,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin",
            "probability": 0.001218102425153258,
            "start_logit": 3.2414145469665527,
            "end_logit": -2.675870895385742,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inter",
            "probability": 0.001067317123518358,
            "start_logit": 3.2414145469665527,
            "end_logit": -2.8080170154571533,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "psoriasis.Ustekinumab is a biological agent that inhibits interleukin 12",
            "probability": 0.0009448838282798178,
            "start_logit": -2.949312210083008,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "psoriasis.Ustekinumab is a biological agent that inhibits interleukin 12 and 23",
            "probability": 0.0008140577435224458,
            "start_logit": -2.949312210083008,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 12 and 23 and has been approved for the treatment of moderate and severe plaque psoriasis",
            "probability": 0.0006562309775504775,
            "start_logit": 3.2414145469665527,
            "end_logit": -3.294407606124878,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inhibits interleukin 12",
            "probability": 0.0003276009898006054,
            "start_logit": -4.008577823638916,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inhibits interleukin 12 and 23",
            "probability": 0.0002822422339668028,
            "start_logit": -4.008577823638916,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleuki",
            "probability": 0.00021512927205892781,
            "start_logit": 3.2414145469665527,
            "end_logit": -4.40968132019043,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "leukin 12",
            "probability": 0.0001805362521507415,
            "start_logit": -4.604442596435547,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "Ustekinumab is a biological agent that inhibits interleukin 12",
            "probability": 0.0001645105300701456,
            "start_logit": -4.697399616241455,
            "end_logit": 3.2608683109283447,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "leukin 12 and 23",
            "probability": 0.00015553968609811913,
            "start_logit": -4.604442596435547,
            "end_logit": 3.11183762550354,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        }
    ],
    "5a8842a261bb38fb24000015": [
        {
            "text": "tumour destruction",
            "probability": 0.4690669279551815,
            "start_logit": -0.482248455286026,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "immune cells capable of tumour destruction",
            "probability": 0.10612874410523573,
            "start_logit": -1.9683409929275513,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "tumour destruction.",
            "probability": 0.0948764405967807,
            "start_logit": -0.482248455286026,
            "end_logit": -3.203078031539917,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "Immune checkpoint proteins dampen the immune response by inactivating immune cells capable of tumour destruction",
            "probability": 0.06614456827600963,
            "start_logit": -2.4411511421203613,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "inactivating immune cells capable of tumour destruction",
            "probability": 0.03849009200063413,
            "start_logit": -2.982593059539795,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "tumour",
            "probability": 0.030227238393683003,
            "start_logit": -0.482248455286026,
            "end_logit": -4.346909999847412,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "immune response by inactivating immune cells capable of tumour destruction",
            "probability": 0.02614032688623646,
            "start_logit": -3.3695147037506104,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "immune cells capable of tumour destruction.",
            "probability": 0.021466270345696647,
            "start_logit": -1.9683409929275513,
            "end_logit": -3.203078031539917,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "immune cells",
            "probability": 0.01923582782944844,
            "start_logit": -1.9683409929275513,
            "end_logit": -3.312786340713501,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "by inactivating immune cells capable of tumour destruction",
            "probability": 0.0165799856925122,
            "start_logit": -3.8247976303100586,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "destruction",
            "probability": 0.014532413501806105,
            "start_logit": -3.9566123485565186,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "dampen the immune response by inactivating immune cells capable of tumour destruction",
            "probability": 0.013705047766526757,
            "start_logit": -4.01522970199585,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "Immune checkpoint proteins dampen the immune response by inactivating immune cells capable of tumour destruction.",
            "probability": 0.013378818306794273,
            "start_logit": -2.4411511421203613,
            "end_logit": -3.203078031539917,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "tumour-cell or immune-cell populations.Immune checkpoint proteins dampen the immune response by inactivating immune cells capable of tumour destruction",
            "probability": 0.012892694989937427,
            "start_logit": -4.076333045959473,
            "end_logit": -1.6049079895019531,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "Immune checkpoint proteins",
            "probability": 0.012107423059074463,
            "start_logit": -2.4411511421203613,
            "end_logit": -3.302932024002075,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "Immune checkpoint proteins dampen the immune response by inactivating immune cells",
            "probability": 0.011988698612591506,
            "start_logit": -2.4411511421203613,
            "end_logit": -3.312786340713501,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "Immune checkpoint proteins dampen the immune response",
            "probability": 0.011437841626218878,
            "start_logit": -2.4411511421203613,
            "end_logit": -3.35982346534729,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "inactivating immune cells capable of tumour destruction.",
            "probability": 0.007785249203524557,
            "start_logit": -2.982593059539795,
            "end_logit": -3.203078031539917,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "inactivating immune cells",
            "probability": 0.006976326622028712,
            "start_logit": -2.982593059539795,
            "end_logit": -3.312786340713501,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "immune cells capable of tumour",
            "probability": 0.006839064230078605,
            "start_logit": -1.9683409929275513,
            "end_logit": -4.346909999847412,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        }
    ],
    "5a86c938faa1ab7d2e000034": [
        {
            "text": "ETTIN",
            "probability": 0.7035757136764462,
            "start_logit": 3.2809736728668213,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARF), ETTIN",
            "probability": 0.220738477573498,
            "start_logit": 2.121776819229126,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "(ARF), ETTIN",
            "probability": 0.019096689773970173,
            "start_logit": -0.32568681240081787,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARF",
            "probability": 0.018057223817139614,
            "start_logit": 2.121776819229126,
            "end_logit": -0.1518288403749466,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARF)",
            "probability": 0.011465311350888557,
            "start_logit": 2.121776819229126,
            "end_logit": -0.606048583984375,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin response factor (ARF), ETTIN",
            "probability": 0.009384536557485132,
            "start_logit": -1.0361385345458984,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin directly affects the activity of the atypical auxin response factor (ARF), ETTIN",
            "probability": 0.005549994839361878,
            "start_logit": -1.561404824256897,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin whereby auxin directly affects the activity of the atypical auxin response factor (ARF), ETTIN",
            "probability": 0.0029502182882505173,
            "start_logit": -2.1933226585388184,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "(ARF",
            "probability": 0.001562179848324104,
            "start_logit": -0.32568681240081787,
            "end_logit": -0.1518288403749466,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ETTIN towards target genes without the requirement for protein degradation.",
            "probability": 0.0012302987881491578,
            "start_logit": 3.2809736728668213,
            "end_logit": -3.997314453125,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "(ARF)",
            "probability": 0.000991895461256841,
            "start_logit": -0.32568681240081787,
            "end_logit": -0.606048583984375,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ET",
            "probability": 0.0009320920705905723,
            "start_logit": 3.2809736728668213,
            "end_logit": -4.274895191192627,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "atypical auxin response factor (ARF), ETTIN",
            "probability": 0.0007893512533901769,
            "start_logit": -3.5117456912994385,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin response factor (ARF",
            "probability": 0.0007676897970006804,
            "start_logit": -1.0361385345458984,
            "end_logit": -0.1518288403749466,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "RF), ETTIN",
            "probability": 0.0005703271651273388,
            "start_logit": -3.83674693107605,
            "end_logit": 2.3516039848327637,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARF),",
            "probability": 0.0005069166111355464,
            "start_logit": 2.121776819229126,
            "end_logit": -3.724783420562744,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ETTIN towards target genes",
            "probability": 0.000503642061924118,
            "start_logit": 3.2809736728668213,
            "end_logit": -4.890460968017578,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin response factor (ARF)",
            "probability": 0.0004874394110992139,
            "start_logit": -1.0361385345458984,
            "end_logit": -0.606048583984375,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin directly affects the activity of the atypical auxin response factor (ARF",
            "probability": 0.00045401010326782937,
            "start_logit": -1.561404824256897,
            "end_logit": -0.1518288403749466,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARF), ETTIN towards target genes without the requirement for protein degradation.",
            "probability": 0.00038599155169453963,
            "start_logit": 2.121776819229126,
            "end_logit": -3.997314453125,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        }
    ],
    "5a76018c83b0d9ea6600000e": [
        {
            "text": "thoracopagus",
            "probability": 0.8329509975701851,
            "start_logit": 4.574970722198486,
            "end_logit": 4.57049036026001,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.Conjoined twins are either symmetrical twins or asymmetrical or heteropagus",
            "probability": 0.09630020945671555,
            "start_logit": 4.574970722198486,
            "end_logit": 2.4129860401153564,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.Conjoined twins are either symmetrical twins",
            "probability": 0.02275412493428877,
            "start_logit": 4.574970722198486,
            "end_logit": 0.9702619910240173,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical twins or asymmetrical or heteropagus",
            "probability": 0.009867097456834279,
            "start_logit": 2.296705961227417,
            "end_logit": 2.4129860401153564,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "heteropagus",
            "probability": 0.006551984345402249,
            "start_logit": 1.8872681856155396,
            "end_logit": 2.4129860401153564,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.Conjoined twins are either symmetrical",
            "probability": 0.006336612533052186,
            "start_logit": 4.574970722198486,
            "end_logit": -0.3081401288509369,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.Conjoined twins are either symmetrical twins or asymmetrical",
            "probability": 0.006177702435246903,
            "start_logit": 4.574970722198486,
            "end_logit": -0.3335380256175995,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "asymmetrical or heteropagus",
            "probability": 0.0060125190793227186,
            "start_logit": 1.8013440370559692,
            "end_logit": 2.4129860401153564,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.",
            "probability": 0.004775180633988827,
            "start_logit": 4.574970722198486,
            "end_logit": -0.5910526514053345,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical twins",
            "probability": 0.002331429698213946,
            "start_logit": 2.296705961227417,
            "end_logit": 0.9702619910240173,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.Conjoined twins are either symmetrical twins or asymmetrical or heteropagus.",
            "probability": 0.0012325352765081132,
            "start_logit": 4.574970722198486,
            "end_logit": -1.945411205291748,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "either symmetrical twins or asymmetrical or heteropagus",
            "probability": 0.0010352413090246597,
            "start_logit": 0.04213477671146393,
            "end_logit": 2.4129860401153564,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical",
            "probability": 0.0006492610323752863,
            "start_logit": 2.296705961227417,
            "end_logit": -0.3081401288509369,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.Conjoined twins",
            "probability": 0.0006487169014081459,
            "start_logit": 4.574970722198486,
            "end_logit": -2.5872433185577393,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical twins or asymmetrical",
            "probability": 0.0006329788100336561,
            "start_logit": 2.296705961227417,
            "end_logit": -0.3335380256175995,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "th",
            "probability": 0.0005357888406507747,
            "start_logit": 4.574970722198486,
            "end_logit": -2.7784996032714844,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "asymmetrical",
            "probability": 0.0003857058459981387,
            "start_logit": 1.8013440370559692,
            "end_logit": -0.3335380256175995,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "most common types of conjoined twins are thoracopagus",
            "probability": 0.00030742269216388096,
            "start_logit": -3.329535722732544,
            "end_logit": 4.57049036026001,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "The most common types of conjoined twins are thoracopagus",
            "probability": 0.00026988098402371983,
            "start_logit": -3.459778308868408,
            "end_logit": 4.57049036026001,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "either symmetrical twins",
            "probability": 0.00024461016456326165,
            "start_logit": 0.04213477671146393,
            "end_logit": 0.9702619910240173,
            "question_text": "List the ten types of conjoined twins."
        }
    ],
    "5a7636d39e632bc066000004": [
        {
            "text": "maftools",
            "probability": 0.6081228516431572,
            "start_logit": 4.458755016326904,
            "end_logit": 3.742327928543091,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR",
            "probability": 0.28272390611549353,
            "start_logit": 4.458755016326904,
            "end_logit": 2.97642183303833,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "GenVisR",
            "probability": 0.09421200530794768,
            "start_logit": 3.3598318099975586,
            "end_logit": 2.97642183303833,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "Deseq2",
            "probability": 0.004585888189143091,
            "start_logit": 2.0615837574005127,
            "end_logit": 1.2521060705184937,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R package maftools",
            "probability": 0.002636801100797903,
            "start_logit": -0.9820554256439209,
            "end_logit": 3.742327928543091,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "ma",
            "probability": 0.0016045281299109772,
            "start_logit": 4.458755016326904,
            "end_logit": -2.1952192783355713,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R package maftools and GenVisR",
            "probability": 0.001225881752104694,
            "start_logit": -0.9820554256439209,
            "end_logit": 2.97642183303833,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftool",
            "probability": 0.0011122162073668124,
            "start_logit": 4.458755016326904,
            "end_logit": -2.561694383621216,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "TCGA",
            "probability": 0.0008494635578621456,
            "start_logit": 1.3689289093017578,
            "end_logit": 0.25862687826156616,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and G",
            "probability": 0.000529083537104047,
            "start_logit": 4.458755016326904,
            "end_logit": -3.3046579360961914,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "TCGA), FireHose",
            "probability": 0.0004777442540363318,
            "start_logit": 1.3689289093017578,
            "end_logit": -0.31690260767936707,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maft",
            "probability": 0.0003608369168963366,
            "start_logit": 4.458755016326904,
            "end_logit": -3.687378168106079,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR were applied to analyze frequently mutated genes",
            "probability": 0.0002338611789013472,
            "start_logit": 4.458755016326904,
            "end_logit": -4.121076583862305,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "RNA-seq data, mutation data and clinical data were downloaded and collected from The Cancer Genome Atlas (TCGA",
            "probability": 0.00022112762286656605,
            "start_logit": 0.02306388132274151,
            "end_logit": 0.25862687826156616,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "TCGA)",
            "probability": 0.00021728858140179053,
            "start_logit": 1.3689289093017578,
            "end_logit": -1.1047518253326416,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR were applied to analyze frequently mutated genes and mutant-allele tumor heterogeneity",
            "probability": 0.00021199458760033071,
            "start_logit": 4.458755016326904,
            "end_logit": -4.21924352645874,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "C",
            "probability": 0.00018265281406321197,
            "start_logit": 1.4554330110549927,
            "end_logit": -1.3648951053619385,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "G",
            "probability": 0.0001763063537528799,
            "start_logit": 3.3598318099975586,
            "end_logit": -3.3046579360961914,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "TCGA), FireHose and C",
            "probability": 0.00016751670174935224,
            "start_logit": 1.3689289093017578,
            "end_logit": -1.3648951053619385,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "FireHose",
            "probability": 0.00014804544784408825,
            "start_logit": 0.1973726600408554,
            "end_logit": -0.31690260767936707,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        }
    ],
    "5a981e66fcd1d6a10c00002f": [
        {
            "text": "hyper-low density lipoproteinaemia",
            "probability": 0.33321750902484426,
            "start_logit": 1.1879392862319946,
            "end_logit": 0.3530924618244171,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension",
            "probability": 0.2445070683715588,
            "start_logit": 1.025020956993103,
            "end_logit": 0.20645955204963684,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia, hypertension",
            "probability": 0.16306560013487809,
            "start_logit": 0.619929313659668,
            "end_logit": 0.20645955204963684,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia",
            "probability": 0.054685159898530844,
            "start_logit": 0.619929313659668,
            "end_logit": -0.8861006498336792,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia (88.4 cm), hypertension",
            "probability": 0.053092886385324084,
            "start_logit": 0.07537892460823059,
            "end_logit": -0.37109968066215515,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension and dyslipidaemia",
            "probability": 0.04786103578942248,
            "start_logit": 1.025020956993103,
            "end_logit": -1.4244829416275024,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia, hypertension and dyslipidaemia",
            "probability": 0.03191927569234591,
            "start_logit": 0.619929313659668,
            "end_logit": -1.4244829416275024,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dyslipidaemia",
            "probability": 0.02126332946249798,
            "start_logit": 0.2137032002210617,
            "end_logit": -1.4244829416275024,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension (90.1 cm), hypo-high density lipoproteinaemia",
            "probability": 0.01898227048706244,
            "start_logit": 0.4684883654117584,
            "end_logit": -1.792746663093567,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypo-high density lipoproteinaemia (87.6 cm) and hyper-low density lipoproteinaemia",
            "probability": 0.0060991599061328665,
            "start_logit": -0.6815645098686218,
            "end_logit": -1.7780481576919556,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypo-high density lipoproteinaemia",
            "probability": 0.006010167004835539,
            "start_logit": -0.6815645098686218,
            "end_logit": -1.792746663093567,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hyper-low density lipoproteinaemia (90.5 cm)",
            "probability": 0.005284334750669156,
            "start_logit": 1.1879392862319946,
            "end_logit": -3.7909562587738037,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance, dysglycaemia, hypertension",
            "probability": 0.004061505288118047,
            "start_logit": -2.0487492084503174,
            "end_logit": -0.817460834980011,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance, dysglycaemia",
            "probability": 0.0025476599590193295,
            "start_logit": -2.0487492084503174,
            "end_logit": -1.283839225769043,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance (89.0 cm), dysglycaemia (88.4 cm), hypertension",
            "probability": 0.001993900810150123,
            "start_logit": -3.206571102142334,
            "end_logit": -0.37109968066215515,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "mia",
            "probability": 0.001334881593019256,
            "start_logit": -4.887852668762207,
            "end_logit": 0.9089315533638,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "low density lipoproteinaemia",
            "probability": 0.0011914582018608996,
            "start_logit": -4.445678234100342,
            "end_logit": 0.3530924618244171,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance, dysglycaemia, hypertension and dyslipidaemia",
            "probability": 0.0010755931277420345,
            "start_logit": -2.0487492084503174,
            "end_logit": -2.1461422443389893,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "lipoproteinaemia",
            "probability": 0.000988965249295683,
            "start_logit": -5.187791347503662,
            "end_logit": 0.9089315533638,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "metabolic syndrome (as defined using the new harmonised guidelines), insulin resistance, dysglycaemia, hypertension",
            "probability": 0.0008182388626921193,
            "start_logit": -4.674824237823486,
            "end_logit": 0.20645955204963684,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        }
    ],
    "5a8861eb8cb19eca6b000001": [
        {
            "text": "gap detection",
            "probability": 0.08703698241049387,
            "start_logit": -3.318513870239258,
            "end_logit": -4.528827667236328,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "two short markers",
            "probability": 0.08190028906995171,
            "start_logit": -4.946442604064941,
            "end_logit": -2.9617295265197754,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "markers",
            "probability": 0.07678635722344575,
            "start_logit": -5.010918140411377,
            "end_logit": -2.9617295265197754,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker",
            "probability": 0.07659548500430008,
            "start_logit": -4.516167163848877,
            "end_logit": -3.4589693546295166,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "When a gap is bounded by two short markers",
            "probability": 0.07279195833784839,
            "start_logit": -5.064339637756348,
            "end_logit": -2.9617295265197754,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap is bounded by two short markers",
            "probability": 0.06504916983643667,
            "start_logit": -5.176801681518555,
            "end_logit": -2.9617295265197754,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap",
            "probability": 0.05861721551977548,
            "start_logit": -3.318513870239258,
            "end_logit": -4.924132347106934,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "two short markers, a gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker",
            "probability": 0.04981233739932708,
            "start_logit": -4.946442604064941,
            "end_logit": -3.4589693546295166,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "second marker with minimal contribution from the offset of the first marker",
            "probability": 0.04834584398173955,
            "start_logit": -4.976325035095215,
            "end_logit": -3.4589693546295166,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was evoked by the onset of the second marker",
            "probability": 0.04822695574676951,
            "start_logit": -4.516167163848877,
            "end_logit": -3.9215893745422363,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "markers, a gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker",
            "probability": 0.04670200773543852,
            "start_logit": -5.010918140411377,
            "end_logit": -3.4589693546295166,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker.",
            "probability": 0.040797439365917745,
            "start_logit": -4.516167163848877,
            "end_logit": -4.088888168334961,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "Gap Termination Responses",
            "probability": 0.03685505999928352,
            "start_logit": -3.9477171897888184,
            "end_logit": -4.758964538574219,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "first marker",
            "probability": 0.03651112877270808,
            "start_logit": -5.2570881843566895,
            "end_logit": -3.4589693546295166,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "two short markers, a gap termination response was evoked by the onset of the second marker",
            "probability": 0.031363433383385896,
            "start_logit": -4.946442604064941,
            "end_logit": -3.9215893745422363,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "second marker",
            "probability": 0.03044008244241396,
            "start_logit": -4.976325035095215,
            "end_logit": -3.9215893745422363,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "markers, a gap termination response was evoked by the onset of the second marker",
            "probability": 0.02940507081084266,
            "start_logit": -5.010918140411377,
            "end_logit": -3.9215893745422363,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "When a gap is bounded by two short markers, a gap termination response was evoked by the onset of the second marker",
            "probability": 0.02787542952657195,
            "start_logit": -5.064339637756348,
            "end_logit": -3.9215893745422363,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "Gap Termination Responses in Auditory Cortex. The ability to detect short gaps",
            "probability": 0.027756467780732073,
            "start_logit": -3.9477171897888184,
            "end_logit": -5.0424885749816895,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap-related responses. When a gap is bounded by two short markers",
            "probability": 0.027131285652617486,
            "start_logit": -6.051257610321045,
            "end_logit": -2.9617295265197754,
            "question_text": "List the two most important synaptic markers."
        }
    ],
    "5a68fd01b750ff445500001b": [
        {
            "text": "integrative literature review",
            "probability": 0.13166828760882204,
            "start_logit": -5.744231700897217,
            "end_logit": -5.729096412658691,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "integrative literature review is to identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.10664907699387063,
            "start_logit": -5.744231700897217,
            "end_logit": -5.939838409423828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "integrative literature review is to",
            "probability": 0.06386407042716982,
            "start_logit": -5.744231700897217,
            "end_logit": -6.452625274658203,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "An Integrative Literature Review.",
            "probability": 0.06222473631804775,
            "start_logit": -6.4540534019470215,
            "end_logit": -5.768807888031006,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "to identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.06048962578300879,
            "start_logit": -6.311303615570068,
            "end_logit": -5.939838409423828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "in",
            "probability": 0.057876118241884024,
            "start_logit": -5.744231700897217,
            "end_logit": -6.551077365875244,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "The main aim of this integrative literature review",
            "probability": 0.05497258212949127,
            "start_logit": -6.617682933807373,
            "end_logit": -5.729096412658691,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "review",
            "probability": 0.05268592612365532,
            "start_logit": -6.6601691246032715,
            "end_logit": -5.729096412658691,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "Integrative Literature Review.",
            "probability": 0.049529544058008225,
            "start_logit": -6.682236671447754,
            "end_logit": -5.768807888031006,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "integrative literature review is to identify facilitators, barriers",
            "probability": 0.0442763264843971,
            "start_logit": -5.744231700897217,
            "end_logit": -6.818932056427002,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "review is to identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.04267470545640042,
            "start_logit": -6.6601691246032715,
            "end_logit": -5.939838409423828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "An Integrative Literature Review",
            "probability": 0.03969114330563397,
            "start_logit": -6.4540534019470215,
            "end_logit": -6.218432426452637,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "to",
            "probability": 0.03622266436812428,
            "start_logit": -6.311303615570068,
            "end_logit": -6.452625274658203,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "Integrative Literature Review",
            "probability": 0.03159329146886121,
            "start_logit": -6.682236671447754,
            "end_logit": -6.218432426452637,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "Testing: An Integrative Literature Review.",
            "probability": 0.030251202388552577,
            "start_logit": -7.175270080566406,
            "end_logit": -5.768807888031006,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "this integrative literature review",
            "probability": 0.0283751124091126,
            "start_logit": -7.27900505065918,
            "end_logit": -5.729096412658691,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "An",
            "probability": 0.027266188562687345,
            "start_logit": -6.4540534019470215,
            "end_logit": -6.5939130783081055,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.02688609758134211,
            "start_logit": -7.122166156768799,
            "end_logit": -5.939838409423828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "The main aim of this integrative literature review is to",
            "probability": 0.026663769389266206,
            "start_logit": -6.617682933807373,
            "end_logit": -6.452625274658203,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "Self-Initiated HIV Testing: An Integrative Literature Review.",
            "probability": 0.026139530901664144,
            "start_logit": -7.321357250213623,
            "end_logit": -5.768807888031006,
            "question_text": "What is included in the fourth generation HIV test?"
        }
    ],
    "5a6f7e6ab750ff4455000052": [
        {
            "text": "beneficence, justice and autonomy or individual freedom",
            "probability": 0.251336729109111,
            "start_logit": 4.7364630699157715,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, justice and autonomy",
            "probability": 0.18910763615242185,
            "start_logit": 4.7364630699157715,
            "end_logit": 4.14075231552124,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence",
            "probability": 0.17650117902109322,
            "start_logit": 4.7364630699157715,
            "end_logit": 4.071763515472412,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, justice",
            "probability": 0.1713595754880605,
            "start_logit": 4.7364630699157715,
            "end_logit": 4.042200088500977,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "individual freedom",
            "probability": 0.05215086528381345,
            "start_logit": 3.1638102531433105,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "justice and autonomy or individual freedom",
            "probability": 0.040910257675334336,
            "start_logit": 2.9210503101348877,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "autonomy or individual freedom",
            "probability": 0.032931470312164236,
            "start_logit": 2.7040982246398926,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "justice and autonomy",
            "probability": 0.030781184074415102,
            "start_logit": 2.9210503101348877,
            "end_logit": 4.14075231552124,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "justice",
            "probability": 0.02789231965101727,
            "start_logit": 2.9210503101348877,
            "end_logit": 4.042200088500977,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "autonomy",
            "probability": 0.024777884743831035,
            "start_logit": 2.7040982246398926,
            "end_logit": 4.14075231552124,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence, justice and autonomy or individual freedom",
            "probability": 0.00036185586720076737,
            "start_logit": -1.8068398237228394,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence, justice and autonomy",
            "probability": 0.00027226306285109213,
            "start_logit": -1.8068398237228394,
            "end_logit": 4.14075231552124,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence",
            "probability": 0.00025411322659852487,
            "start_logit": -1.8068398237228394,
            "end_logit": 4.071763515472412,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "freedom",
            "probability": 0.00025201589332264325,
            "start_logit": -2.168593645095825,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence, justice",
            "probability": 0.00024671072951088115,
            "start_logit": -1.8068398237228394,
            "end_logit": 4.042200088500977,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence,",
            "probability": 0.00020662197342917086,
            "start_logit": 4.7364630699157715,
            "end_logit": -2.6784284114837646,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, justice and autonomy or individual freedom.",
            "probability": 0.0001748624754419948,
            "start_logit": 4.7364630699157715,
            "end_logit": -2.8453195095062256,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "principles of ethics are beneficence, justice and autonomy or individual freedom",
            "probability": 0.0001737478216729259,
            "start_logit": -2.540480852127075,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "ben",
            "probability": 0.0001549141745910533,
            "start_logit": 4.7364630699157715,
            "end_logit": -2.9664480686187744,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "ethics are beneficence, justice and autonomy or individual freedom",
            "probability": 0.00015379326411904385,
            "start_logit": -2.6624765396118164,
            "end_logit": 4.425229549407959,
            "question_text": "List four principles of medical ethics."
        }
    ],
    "5a70d12899e2c3af26000001": [
        {
            "text": "uveitis",
            "probability": 0.18127338093384388,
            "start_logit": 4.722564697265625,
            "end_logit": 5.058589458465576,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis, or facial paralysis",
            "probability": 0.14158276712486148,
            "start_logit": 4.722564697265625,
            "end_logit": 4.81146764755249,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever, uveitis",
            "probability": 0.1373167256794601,
            "start_logit": 4.444848537445068,
            "end_logit": 5.058589458465576,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever, uveitis, or facial paralysis",
            "probability": 0.10725061723937707,
            "start_logit": 4.444848537445068,
            "end_logit": 4.81146764755249,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial paralysis",
            "probability": 0.10640898399746714,
            "start_logit": 4.436970233917236,
            "end_logit": 4.81146764755249,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever, uveitis",
            "probability": 0.08935271762070975,
            "start_logit": 4.01515007019043,
            "end_logit": 5.058589458465576,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever, uveitis, or facial paralysis",
            "probability": 0.06978854228731682,
            "start_logit": 4.01515007019043,
            "end_logit": 4.81146764755249,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever",
            "probability": 0.06344606355205686,
            "start_logit": 4.444848537445068,
            "end_logit": 4.286489486694336,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever",
            "probability": 0.041284688173718415,
            "start_logit": 4.01515007019043,
            "end_logit": 4.286489486694336,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis",
            "probability": 0.04064067490489851,
            "start_logit": 4.01515007019043,
            "end_logit": 4.2707672119140625,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis,",
            "probability": 0.004202855231867717,
            "start_logit": 4.722564697265625,
            "end_logit": 1.2943472862243652,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever, uveitis,",
            "probability": 0.0031837124456540306,
            "start_logit": 4.444848537445068,
            "end_logit": 1.2943472862243652,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever,",
            "probability": 0.0027615876735710364,
            "start_logit": 4.444848537445068,
            "end_logit": 1.1521050930023193,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever, uveitis,",
            "probability": 0.0020716584795803616,
            "start_logit": 4.01515007019043,
            "end_logit": 1.2943472862243652,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis, or facial paralysis, the condition is referred to as Heerfordt's syndrome.",
            "probability": 0.0018770519908840387,
            "start_logit": 4.722564697265625,
            "end_logit": 0.488285630941391,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever,",
            "probability": 0.0017969796640609484,
            "start_logit": 4.01515007019043,
            "end_logit": 1.1521050930023193,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis,",
            "probability": 0.0017065396678539989,
            "start_logit": 4.01515007019043,
            "end_logit": 1.1004655361175537,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever, uveitis, or facial paralysis, the condition is referred to as Heerfordt's syndrome.",
            "probability": 0.001421889038481467,
            "start_logit": 4.444848537445068,
            "end_logit": 0.488285630941391,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial paralysis, the condition is referred to as Heerfordt's syndrome.",
            "probability": 0.0014107309760675007,
            "start_logit": 4.436970233917236,
            "end_logit": 0.488285630941391,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "paralysis",
            "probability": 0.0012218333182688246,
            "start_logit": -0.029967324808239937,
            "end_logit": 4.81146764755249,
            "question_text": "List symptoms of Heerfordt syndrome."
        }
    ],
    "5a8dc6b4fcd1d6a10c000026": [
        {
            "text": "infliximab",
            "probability": 0.994617541979163,
            "start_logit": 5.621201992034912,
            "end_logit": 5.468698024749756,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab",
            "probability": 0.0035091834044943503,
            "start_logit": 0.03317415714263916,
            "end_logit": 5.409750938415527,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "liximab",
            "probability": 0.00043101840731851765,
            "start_logit": -2.122760772705078,
            "end_logit": 5.468698024749756,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "inflixima",
            "probability": 0.0003031687433101848,
            "start_logit": 5.621201992034912,
            "end_logit": -2.6271259784698486,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab de-escalation",
            "probability": 0.00022415540446322184,
            "start_logit": 5.1063923835754395,
            "end_logit": -2.414266347885132,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "There are limited data concerning infliximab",
            "probability": 0.00015640180638936454,
            "start_logit": -3.1364831924438477,
            "end_logit": 5.468698024749756,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "inflix",
            "probability": 0.00014736200214948456,
            "start_logit": 5.621201992034912,
            "end_logit": -3.3485233783721924,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "in",
            "probability": 0.00014014844569898422,
            "start_logit": 5.621201992034912,
            "end_logit": -3.3987133502960205,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "b",
            "probability": 0.00013907016882011014,
            "start_logit": -3.2539329528808594,
            "end_logit": 5.468698024749756,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug monitoring",
            "probability": 9.592085504681958e-05,
            "start_logit": 5.621201992034912,
            "end_logit": -3.7778921127319336,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "limited data concerning infliximab",
            "probability": 7.820739161767982e-05,
            "start_logit": -3.82954740524292,
            "end_logit": 5.468698024749756,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug monitoring during de-escalation of the treatment of inflammatory bowel disease (IBD).",
            "probability": 6.403865612224943e-05,
            "start_logit": 5.505827903747559,
            "end_logit": -4.066554546356201,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "therapeutic drug monitoring.There are limited data concerning infliximab",
            "probability": 4.956971434955858e-05,
            "start_logit": -4.285531520843506,
            "end_logit": 5.468698024749756,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "imab",
            "probability": 4.091415051016841e-05,
            "start_logit": -4.47743558883667,
            "end_logit": 5.468698024749756,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab de-escalation",
            "probability": 1.1910120988637836e-06,
            "start_logit": -0.1311437487602234,
            "end_logit": -2.414266347885132,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "flixima",
            "probability": 8.854398607333485e-07,
            "start_logit": -0.21475830674171448,
            "end_logit": -2.6271259784698486,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "flix",
            "probability": 4.3038800516162447e-07,
            "start_logit": -0.21475830674171448,
            "end_logit": -3.3485233783721924,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab drug monitoring",
            "probability": 2.8014810368225177e-07,
            "start_logit": -0.21475830674171448,
            "end_logit": -3.7778921127319336,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab drug monitoring during de-escalation of the treatment of inflammatory bowel disease (IBD).",
            "probability": 2.689669300187694e-07,
            "start_logit": 0.03317415714263916,
            "end_logit": -4.066554546356201,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "liximab de-escalation",
            "probability": 2.429155483767778e-07,
            "start_logit": -1.7209886312484741,
            "end_logit": -2.414266347885132,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        }
    ],
    "5a75dff883b0d9ea66000003": [
        {
            "text": "manually",
            "probability": 0.25430685883945414,
            "start_logit": 1.8500983715057373,
            "end_logit": 1.775674819946289,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories",
            "probability": 0.23976165850428766,
            "start_logit": 1.8500983715057373,
            "end_logit": 1.7167785167694092,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data",
            "probability": 0.08860747674841804,
            "start_logit": 1.8500983715057373,
            "end_logit": 0.7213494181632996,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions",
            "probability": 0.05000486552300712,
            "start_logit": 1.8500983715057373,
            "end_logit": 0.1492534875869751,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "interactions derived from ChIP-seq binding data",
            "probability": 0.0431354462698361,
            "start_logit": 1.1302272081375122,
            "end_logit": 0.7213494181632996,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding",
            "probability": 0.037036769566157,
            "start_logit": 1.8500983715057373,
            "end_logit": -0.15095563232898712,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "interactions derived from ChIP-seq binding data, (3) in silico prediction of TF binding on gene promoters",
            "probability": 0.035475259052177424,
            "start_logit": 1.1302272081375122,
            "end_logit": 0.5258398652076721,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated",
            "probability": 0.027274793173742075,
            "start_logit": 1.8500983715057373,
            "end_logit": -0.456903874874115,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "ChIP-seq binding data",
            "probability": 0.02572861822007005,
            "start_logit": 0.6134860515594482,
            "end_logit": 0.7213494181632996,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "(1) manually",
            "probability": 0.024595752734101032,
            "start_logit": -0.48586949706077576,
            "end_logit": 1.775674819946289,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "interactions",
            "probability": 0.024343117185498264,
            "start_logit": 1.1302272081375122,
            "end_logit": 0.1492534875869751,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "(1) manually curated repositories",
            "probability": 0.02318898709457273,
            "start_logit": -0.48586949706077576,
            "end_logit": 1.7167785167694092,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "repositories",
            "probability": 0.021203017721700836,
            "start_logit": -0.5754034519195557,
            "end_logit": 1.7167785167694092,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "ChIP-seq binding data, (3) in silico prediction of TF binding on gene promoters",
            "probability": 0.021159614084016412,
            "start_logit": 0.6134860515594482,
            "end_logit": 0.5258398652076721,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "interactions derived from ChIP-seq binding",
            "probability": 0.018030053921581614,
            "start_logit": 1.1302272081375122,
            "end_logit": -0.15095563232898712,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "literature",
            "probability": 0.017967441367203855,
            "start_logit": 0.37779560685157776,
            "end_logit": 0.59799724817276,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories,",
            "probability": 0.01528256373540326,
            "start_logit": 1.8500983715057373,
            "end_logit": -1.0361542701721191,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data,",
            "probability": 0.012074453449445086,
            "start_logit": 1.8500983715057373,
            "end_logit": -1.2717748880386353,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "ChIP-seq binding",
            "probability": 0.010754226835484014,
            "start_logit": 0.6134860515594482,
            "end_logit": -0.15095563232898712,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "binding data",
            "probability": 0.010069025973843243,
            "start_logit": -0.32465389370918274,
            "end_logit": 0.7213494181632996,
            "question_text": "Name curated data resources for ChIP-seq data"
        }
    ],
    "5a75df9883b0d9ea66000002": [
        {
            "text": "gastric stromal sarcomas",
            "probability": 0.1803517190456739,
            "start_logit": 5.949914455413818,
            "end_logit": 5.248433589935303,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcoma",
            "probability": 0.17787323340459255,
            "start_logit": 5.949914455413818,
            "end_logit": 5.234595775604248,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcomas",
            "probability": 0.1544640924717694,
            "start_logit": 5.794967174530029,
            "end_logit": 5.248433589935303,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcoma",
            "probability": 0.1523413678463557,
            "start_logit": 5.794967174530029,
            "end_logit": 5.234595775604248,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas",
            "probability": 0.14342852751992632,
            "start_logit": 5.794967174530029,
            "end_logit": 5.174308776855469,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paraganglioma",
            "probability": 0.09751200008944351,
            "start_logit": 5.794967174530029,
            "end_logit": 4.788447380065918,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis and renal cancer",
            "probability": 0.02091601278671578,
            "start_logit": 5.949914455413818,
            "end_logit": 3.0940396785736084,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis",
            "probability": 0.019488664305349047,
            "start_logit": 5.949914455413818,
            "end_logit": 3.023357629776001,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis",
            "probability": 0.016691267825677623,
            "start_logit": 5.794967174530029,
            "end_logit": 3.023357629776001,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome",
            "probability": 0.007551003261497471,
            "start_logit": 5.949914455413818,
            "end_logit": 2.075205087661743,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcomas or Carney-Stratakis syndrome",
            "probability": 0.006467134731015225,
            "start_logit": 5.794967174530029,
            "end_logit": 2.075205087661743,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "renal cancer",
            "probability": 0.006172322077390304,
            "start_logit": 4.7294745445251465,
            "end_logit": 3.0940396785736084,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis and renal cancer syndrome",
            "probability": 0.004026223277632896,
            "start_logit": 5.949914455413818,
            "end_logit": 1.4463534355163574,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric",
            "probability": 0.0026700405359347907,
            "start_logit": 5.949914455413818,
            "end_logit": 1.0356183052062988,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "leiomyomatosis and renal cancer",
            "probability": 0.00239542919079805,
            "start_logit": 3.782961845397949,
            "end_logit": 3.0940396785736084,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric",
            "probability": 0.002286783793513817,
            "start_logit": 5.794967174530029,
            "end_logit": 1.0356183052062988,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "leiomyomatosis",
            "probability": 0.002231960548252627,
            "start_logit": 3.782961845397949,
            "end_logit": 3.023357629776001,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "renal cancer syndrome",
            "probability": 0.0011881397797203384,
            "start_logit": 4.7294745445251465,
            "end_logit": 1.4463534355163574,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "Carney-Stratakis syndrome, hereditary leiomyomatosis and renal cancer",
            "probability": 0.0010062263747510263,
            "start_logit": 2.9156064987182617,
            "end_logit": 3.0940396785736084,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis and renal",
            "probability": 0.0009378511339898305,
            "start_logit": 5.949914455413818,
            "end_logit": -0.01063939742743969,
            "question_text": "Which cancers compose Carney's triad?"
        }
    ],
    "5a981bcffcd1d6a10c00002d": [
        {
            "text": "lactic acidosis",
            "probability": 0.9695126036117384,
            "start_logit": 2.8760311603546143,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "Lactic Acidosis",
            "probability": 0.01694039955432994,
            "start_logit": 1.1871411800384521,
            "end_logit": 1.1510658264160156,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lactic acidosis and neurological symptoms",
            "probability": 0.007682038705057987,
            "start_logit": 2.8760311603546143,
            "end_logit": -1.3286404609680176,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "acidosis",
            "probability": 0.001911460350519385,
            "start_logit": -3.3528947830200195,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lactic acidosis and neurological",
            "probability": 0.0013619650952736131,
            "start_logit": 2.8760311603546143,
            "end_logit": -3.0585968494415283,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "osis",
            "probability": 0.0006064033279609808,
            "start_logit": -4.500972270965576,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lactic acidosis and neurological symptoms due to improper vitamin replacement,",
            "probability": 0.000499234948762748,
            "start_logit": 2.8760311603546143,
            "end_logit": -4.062203884124756,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "la",
            "probability": 0.00038368949769831674,
            "start_logit": 2.8760311603546143,
            "end_logit": -4.325447082519531,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "report a 6-year-old girl on total parenteral nutrition (TPN) who developed lactic acidosis",
            "probability": 0.00016374662112935893,
            "start_logit": -5.810197353363037,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lactic acidosis and neurological symptoms due to improper vitamin replacement, which responded to thiamine injection",
            "probability": 0.00011854042070271888,
            "start_logit": 2.8760311603546143,
            "end_logit": -5.500026702880859,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lactic acidosis and neurological symptoms due to improper vitamin replacement",
            "probability": 0.00011708449068208321,
            "start_logit": 2.8760311603546143,
            "end_logit": -5.51238489151001,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "neurological symptoms",
            "probability": 0.00010583089178344944,
            "start_logit": -1.4087666273117065,
            "end_logit": -1.3286404609680176,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ctic acidosis",
            "probability": 9.503055749571813e-05,
            "start_logit": -6.354319095611572,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "total parenteral nutrition (TPN) who developed lactic acidosis",
            "probability": 9.489905641457048e-05,
            "start_logit": -6.355703830718994,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lactic acidosis and neurological symptoms due to improper vitamin replacement, which responded to thiamine injection.",
            "probability": 8.376465774193415e-05,
            "start_logit": 2.8760311603546143,
            "end_logit": -5.847269535064697,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "thiamine injection.Wernicke Encephalopathy and Lactic Acidosis",
            "probability": 7.85229108324485e-05,
            "start_logit": -4.186924934387207,
            "end_logit": 1.1510658264160156,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "we report a 6-year-old girl on total parenteral nutrition (TPN) who developed lactic acidosis",
            "probability": 7.479556063614281e-05,
            "start_logit": -6.593759059906006,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "Herein we report a 6-year-old girl on total parenteral nutrition (TPN) who developed lactic acidosis",
            "probability": 6.539198193278157e-05,
            "start_logit": -6.728117942810059,
            "end_logit": 3.509268045425415,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "Lactic Acidosis in Thiamine Deficiency",
            "probability": 5.3066959979624e-05,
            "start_logit": 1.1871411800384521,
            "end_logit": -4.6148362159729,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "symptoms due to improper vitamin replacement, which responded to thiamine injection.Wernicke Encephalopathy and Lactic Acidosis",
            "probability": 5.1530799327481865e-05,
            "start_logit": -4.60813570022583,
            "end_logit": 1.1510658264160156,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        }
    ],
    "5a7240aa2dc08e987e00000d": [
        {
            "text": "Fully",
            "probability": 0.41861735481270124,
            "start_logit": -0.8746311664581299,
            "end_logit": -1.0564091205596924,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Fully human monoclonal antibodies",
            "probability": 0.2662253048350855,
            "start_logit": -0.8746311664581299,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Fully human monoclonal antibodies directed against the binding domains of these toxins were developed",
            "probability": 0.08051985454203883,
            "start_logit": -0.8746311664581299,
            "end_logit": -2.704862594604492,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Fully human monoclonal antibodies directed against the binding domains of these toxins were developed.Fully",
            "probability": 0.03234633602092964,
            "start_logit": -3.4350876808166504,
            "end_logit": -1.0564091205596924,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "monoclonal antibodies directed against the binding domains of these toxins were developed.Fully",
            "probability": 0.03146822883584848,
            "start_logit": -3.4626100063323975,
            "end_logit": -1.0564091205596924,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "monoclonal antibodies",
            "probability": 0.024586530398537493,
            "start_logit": -3.256775379180908,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Fully human",
            "probability": 0.024331840876669286,
            "start_logit": -0.8746311664581299,
            "end_logit": -3.901580572128296,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Fully human monoclonal antibodies directed against the binding domains of these toxins were developed.Fully human monoclonal antibodies",
            "probability": 0.020571084950176132,
            "start_logit": -3.4350876808166504,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "monoclonal antibodies directed against the binding domains of these toxins were developed.Fully human monoclonal antibodies",
            "probability": 0.020012640943164746,
            "start_logit": -3.4626100063323975,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "antibodies",
            "probability": 0.013318772596204438,
            "start_logit": -3.8697996139526367,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Fully human monoclonal antibodies directed against the binding domains of these toxins",
            "probability": 0.011971461289806945,
            "start_logit": -0.8746311664581299,
            "end_logit": -4.610840797424316,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "developed.Fully",
            "probability": 0.008700104954305149,
            "start_logit": -4.748253345489502,
            "end_logit": -1.0564091205596924,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "monoclonal antibodies directed against the binding domains of these toxins were developed",
            "probability": 0.007436197143656165,
            "start_logit": -3.256775379180908,
            "end_logit": -2.704862594604492,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "human monoclonal antibodies",
            "probability": 0.007162099553585864,
            "start_logit": -4.490170955657959,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "human monoclonal antibodies directed against the binding domains of these toxins were developed.Fully",
            "probability": 0.0069524049361841716,
            "start_logit": -4.972500801086426,
            "end_logit": -1.0564091205596924,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "antibodies directed against the binding domains of these toxins were developed.Fully",
            "probability": 0.006885786350630295,
            "start_logit": -4.982129096984863,
            "end_logit": -1.0564091205596924,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "developed.Fully human monoclonal antibodies",
            "probability": 0.005532948089534989,
            "start_logit": -4.748253345489502,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "developed.Clostridium difficile infection (CDI) is mediated by actions of toxin A and toxin B.Fully",
            "probability": 0.004560466068188454,
            "start_logit": -4.160523414611816,
            "end_logit": -2.2900493144989014,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "human monoclonal antibodies directed against the binding domains of these toxins were developed.Fully human monoclonal antibodies",
            "probability": 0.004421474891552743,
            "start_logit": -4.972500801086426,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "antibodies directed against the binding domains of these toxins were developed.Fully human monoclonal antibodies",
            "probability": 0.00437910791119977,
            "start_logit": -4.982129096984863,
            "end_logit": -1.5090234279632568,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        }
    ],
    "5aa80873d6d6b54f79000013": [
        {
            "text": "Rpl22",
            "probability": 0.8455328487529133,
            "start_logit": 2.869701623916626,
            "end_logit": 2.606295585632324,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 0.09710677228953461,
            "start_logit": 2.869701623916626,
            "end_logit": 0.4421396851539612,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit,",
            "probability": 0.0237606452215902,
            "start_logit": 2.869701623916626,
            "end_logit": -0.9656407833099365,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit",
            "probability": 0.01544770616963854,
            "start_logit": 2.869701623916626,
            "end_logit": -1.3962109088897705,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22,",
            "probability": 0.006873075925054271,
            "start_logit": 2.869701623916626,
            "end_logit": -2.206059694290161,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 0.0025707889200923093,
            "start_logit": -0.7618966698646545,
            "end_logit": 0.4421396851539612,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum;",
            "probability": 0.0025332676424171135,
            "start_logit": 2.869701623916626,
            "end_logit": -3.2041614055633545,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 0.0018134563376874877,
            "start_logit": -1.110874891281128,
            "end_logit": 0.4421396851539612,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "22",
            "probability": 0.0006449893498991999,
            "start_logit": -4.308786869049072,
            "end_logit": 2.606295585632324,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "large 60S subunit,",
            "probability": 0.0006290354630239468,
            "start_logit": -0.7618966698646545,
            "end_logit": -0.9656407833099365,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein",
            "probability": 0.0006266243562473081,
            "start_logit": 2.869701623916626,
            "end_logit": -4.60107946395874,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "ribosomal protein component of the large 60S subunit,",
            "probability": 0.00044372695795265814,
            "start_logit": -1.110874891281128,
            "end_logit": -0.9656407833099365,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "large 60S subunit",
            "probability": 0.00040896006452917897,
            "start_logit": -0.7618966698646545,
            "end_logit": -1.3962109088897705,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component",
            "probability": 0.00033377856270471606,
            "start_logit": 2.869701623916626,
            "end_logit": -5.2309489250183105,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large",
            "probability": 0.0003259774133144476,
            "start_logit": 2.869701623916626,
            "end_logit": -5.254598617553711,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "R",
            "probability": 0.0003129107013605061,
            "start_logit": 2.869701623916626,
            "end_logit": -5.295508861541748,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "ribosomal protein component of the large 60S subunit",
            "probability": 0.0002884839027759984,
            "start_logit": -1.110874891281128,
            "end_logit": -1.3962109088897705,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "l22",
            "probability": 0.00019767113123948508,
            "start_logit": -5.491415977478027,
            "end_logit": 2.606295585632324,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22 is dispensable for both ribosome biogenesis and protein synthesis",
            "probability": 7.520585202962813e-05,
            "start_logit": 0.48228567838668823,
            "end_logit": -4.333781719207764,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 7.407498599517984e-05,
            "start_logit": -4.308786869049072,
            "end_logit": 0.4421396851539612,
            "question_text": "List ribosomal biogenesis proteins."
        }
    ],
    "5aacdcf1fcf4565872000009": [
        {
            "text": "protein partners of BET proteins have been described",
            "probability": 0.10146599717208275,
            "start_logit": -0.9178789854049683,
            "end_logit": -1.0874626636505127,
            "question_text": "List BET proteins."
        },
        {
            "text": "protein partners of BET proteins have been described,",
            "probability": 0.08508154364543209,
            "start_logit": -0.9178789854049683,
            "end_logit": -1.2635762691497803,
            "question_text": "List BET proteins."
        },
        {
            "text": "protein partners of BET proteins",
            "probability": 0.07653017063480842,
            "start_logit": -0.9178789854049683,
            "end_logit": -1.3695013523101807,
            "question_text": "List BET proteins."
        },
        {
            "text": "BET proteins have been described",
            "probability": 0.07075681905060803,
            "start_logit": -1.2783538103103638,
            "end_logit": -1.0874626636505127,
            "question_text": "List BET proteins."
        },
        {
            "text": "protein partners",
            "probability": 0.06887445280207054,
            "start_logit": -0.9178789854049683,
            "end_logit": -1.4749010801315308,
            "question_text": "List BET proteins."
        },
        {
            "text": "BET proteins have been described,",
            "probability": 0.059331200166065204,
            "start_logit": -1.2783538103103638,
            "end_logit": -1.2635762691497803,
            "question_text": "List BET proteins."
        },
        {
            "text": "protein partners of BET",
            "probability": 0.057827822935042524,
            "start_logit": -0.9178789854049683,
            "end_logit": -1.6497163772583008,
            "question_text": "List BET proteins."
        },
        {
            "text": "Genomic distributions and protein partners of BET proteins have been described",
            "probability": 0.05405648485591009,
            "start_logit": -1.547573208808899,
            "end_logit": -1.0874626636505127,
            "question_text": "List BET proteins."
        },
        {
            "text": "BET proteins",
            "probability": 0.053367941837062845,
            "start_logit": -1.2783538103103638,
            "end_logit": -1.3695013523101807,
            "question_text": "List BET proteins."
        },
        {
            "text": "Genomic distributions and protein partners of BET proteins have been described,",
            "probability": 0.04532759056008346,
            "start_logit": -1.547573208808899,
            "end_logit": -1.2635762691497803,
            "question_text": "List BET proteins."
        },
        {
            "text": "Genomic distributions and protein partners of BET proteins",
            "probability": 0.0407718065681118,
            "start_logit": -1.547573208808899,
            "end_logit": -1.3695013523101807,
            "question_text": "List BET proteins."
        },
        {
            "text": "BET",
            "probability": 0.040325950737624974,
            "start_logit": -1.2783538103103638,
            "end_logit": -1.6497163772583008,
            "question_text": "List BET proteins."
        },
        {
            "text": "Genomic distributions and protein partners",
            "probability": 0.03669318706383928,
            "start_logit": -1.547573208808899,
            "end_logit": -1.4749010801315308,
            "question_text": "List BET proteins."
        },
        {
            "text": "protein partners of BET proteins have been",
            "probability": 0.03495761118574888,
            "start_logit": -0.9178789854049683,
            "end_logit": -2.153050184249878,
            "question_text": "List BET proteins."
        },
        {
            "text": "described",
            "probability": 0.031581008918608516,
            "start_logit": -2.0850467681884766,
            "end_logit": -1.0874626636505127,
            "question_text": "List BET proteins."
        },
        {
            "text": "Genomic distributions and protein partners of BET",
            "probability": 0.03080804330377637,
            "start_logit": -1.547573208808899,
            "end_logit": -1.6497163772583008,
            "question_text": "List BET proteins."
        },
        {
            "text": "Genomic distributions",
            "probability": 0.03014756117279174,
            "start_logit": -1.547573208808899,
            "end_logit": -1.6713881492614746,
            "question_text": "List BET proteins."
        },
        {
            "text": "protein partners of BET proteins have been described, but the basis for differences in BET protein function within a given lineage remains unclear.",
            "probability": 0.028722142531925683,
            "start_logit": -0.9178789854049683,
            "end_logit": -2.349518060684204,
            "question_text": "List BET proteins."
        },
        {
            "text": "distributions and protein partners of BET proteins have been described",
            "probability": 0.026891271450146505,
            "start_logit": -2.2458009719848633,
            "end_logit": -1.0874626636505127,
            "question_text": "List BET proteins."
        },
        {
            "text": "described,",
            "probability": 0.026481393408260497,
            "start_logit": -2.0850467681884766,
            "end_logit": -1.2635762691497803,
            "question_text": "List BET proteins."
        }
    ],
    "5aa55b65d6d6b54f7900000e": [
        {
            "text": "Izumi fever",
            "probability": 0.9677812101606431,
            "start_logit": 3.892580986022949,
            "end_logit": 2.9626753330230713,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi",
            "probability": 0.02534330013195739,
            "start_logit": 3.892580986022949,
            "end_logit": -0.6798163056373596,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "I",
            "probability": 0.0018388940234288385,
            "start_logit": 3.892580986022949,
            "end_logit": -3.303166389465332,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever,",
            "probability": 0.001832381795549028,
            "start_logit": 3.892580986022949,
            "end_logit": -3.3067140579223633,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet fever",
            "probability": 0.001045781651254573,
            "start_logit": 3.892580986022949,
            "end_logit": -3.8675661087036133,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "pseudotuberculosis that were collected as the causative agent of an outbreak of Izumi fever",
            "probability": 0.0006438575737171649,
            "start_logit": -3.4227027893066406,
            "end_logit": 2.9626753330230713,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet fever,",
            "probability": 0.0005441886038532934,
            "start_logit": 3.892580986022949,
            "end_logit": -4.520790100097656,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "fever",
            "probability": 0.00041639290876674065,
            "start_logit": -3.858551025390625,
            "end_logit": 2.9626753330230713,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms",
            "probability": 0.000219917054040378,
            "start_logit": 3.892580986022949,
            "end_logit": -5.426835536956787,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical",
            "probability": 0.0001471685548787085,
            "start_logit": 3.892580986022949,
            "end_logit": -5.828507423400879,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet fever, in Japan.",
            "probability": 0.00014294296702452118,
            "start_logit": 3.892580986022949,
            "end_logit": -5.857640266418457,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Y. pseudotuberculosis that were collected as the causative agent of an outbreak of Izumi fever",
            "probability": 2.2018183215218098e-05,
            "start_logit": -6.798311710357666,
            "end_logit": 2.9626753330230713,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "pseudotuberculosis that were collected as the causative agent of an outbreak of Izumi",
            "probability": 1.68607073185885e-05,
            "start_logit": -3.4227027893066406,
            "end_logit": -0.6798163056373596,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "pseudotuberculosis that were collected as the causative agent of an outbreak of I",
            "probability": 1.2234023886983261e-06,
            "start_logit": -3.4227027893066406,
            "end_logit": -3.303166389465332,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "pseudotuberculosis that were collected as the causative agent of an outbreak of Izumi fever,",
            "probability": 1.219069852378994e-06,
            "start_logit": -3.4227027893066406,
            "end_logit": -3.3067140579223633,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "fever,",
            "probability": 7.883918160523423e-07,
            "start_logit": -3.858551025390625,
            "end_logit": -3.3067140579223633,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Y. pseudotuberculosis that were collected as the causative agent of an outbreak of Izumi",
            "probability": 5.765904728518892e-07,
            "start_logit": -6.798311710357666,
            "end_logit": -0.6798163056373596,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "30 clinical isolates of Y. pseudotuberculosis that were collected as the causative agent of an outbreak of Izumi",
            "probability": 4.6948638005682363e-07,
            "start_logit": -7.003804683685303,
            "end_logit": -0.6798163056373596,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "fever, a disease showing clinical symptoms characteristic of atypical scarlet fever",
            "probability": 4.49953005006674e-07,
            "start_logit": -3.858551025390625,
            "end_logit": -3.8675661087036133,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "atypical scarlet fever",
            "probability": 3.587904369976914e-07,
            "start_logit": -4.08495569229126,
            "end_logit": -3.8675661087036133,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        }
    ],
    "5a736f0c3b9d13c708000007": [
        {
            "text": "iron",
            "probability": 0.6051502254498305,
            "start_logit": -0.7026804685592651,
            "end_logit": -0.6865358948707581,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin",
            "probability": 0.14771071142274883,
            "start_logit": -0.1252051442861557,
            "end_logit": -2.674232244491577,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, ferritin",
            "probability": 0.08291204806708555,
            "start_logit": -0.7026804685592651,
            "end_logit": -2.674232244491577,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "serum iron",
            "probability": 0.03630697771668182,
            "start_logit": -3.2154173851013184,
            "end_logit": -0.9872657656669617,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, TIBC, ferritin",
            "probability": 0.02718858734364259,
            "start_logit": -0.7166115045547485,
            "end_logit": -3.7752842903137207,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin, TIBC",
            "probability": 0.018447606532892024,
            "start_logit": -0.1252051442861557,
            "end_logit": -4.754553318023682,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, TIBC",
            "probability": 0.015078856596500009,
            "start_logit": -0.7166115045547485,
            "end_logit": -4.364788055419922,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV, Mentzer index, serum iron",
            "probability": 0.0122059144501484,
            "start_logit": -4.305506706237793,
            "end_logit": -0.9872657656669617,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, ferritin, TIBC",
            "probability": 0.010354894542483823,
            "start_logit": -0.7026804685592651,
            "end_logit": -4.754553318023682,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "f",
            "probability": 0.0080939580094681,
            "start_logit": -0.07973967492580414,
            "end_logit": -5.623835563659668,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin, TIBC, MCV",
            "probability": 0.006788731663380939,
            "start_logit": -0.1252051442861557,
            "end_logit": -5.754223823547363,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "TIBC, ferritin",
            "probability": 0.0046451977294956585,
            "start_logit": -2.483574867248535,
            "end_logit": -3.7752842903137207,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, TIBC, f",
            "probability": 0.004281254306613141,
            "start_logit": -0.7166115045547485,
            "end_logit": -5.623835563659668,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin were significantly different between IDA and \u03b2-TT patients (P<0.001",
            "probability": 0.004239521368619389,
            "start_logit": -0.07973967492580414,
            "end_logit": -6.270503044128418,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, ferritin, TIBC, MCV",
            "probability": 0.003810608185196914,
            "start_logit": -0.7026804685592651,
            "end_logit": -5.754223823547363,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, f",
            "probability": 0.0028870046492380412,
            "start_logit": -0.7026804685592651,
            "end_logit": -6.031793117523193,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RBC, MCV, Mentzer index, serum iron",
            "probability": 0.0025973359763891172,
            "start_logit": -5.852941036224365,
            "end_logit": -0.9872657656669617,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "TIBC",
            "probability": 0.0025762379464643525,
            "start_logit": -2.483574867248535,
            "end_logit": -4.364788055419922,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "serum iron, ferritin",
            "probability": 0.002481856671741599,
            "start_logit": -4.211453914642334,
            "end_logit": -2.674232244491577,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, TIBC, ferritin were significantly different between IDA and \u03b2-TT patients (P<0.001",
            "probability": 0.002242471371379522,
            "start_logit": -0.7166115045547485,
            "end_logit": -6.270503044128418,
            "question_text": "What is included in the Mentzer index?"
        }
    ],
    "5aa13fd3d6d6b54f79000003": [
        {
            "text": "buprenorphine/naloxone",
            "probability": 0.22459053265261475,
            "start_logit": 3.655561685562134,
            "end_logit": 3.227231740951538,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine",
            "probability": 0.20467125906541783,
            "start_logit": 3.655561685562134,
            "end_logit": 3.1343579292297363,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine/naloxone and methadone",
            "probability": 0.19449025738112816,
            "start_logit": 3.655561685562134,
            "end_logit": 3.0833349227905273,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone",
            "probability": 0.1824522535890927,
            "start_logit": 3.591668128967285,
            "end_logit": 3.0833349227905273,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone",
            "probability": 0.0914337488105719,
            "start_logit": 2.756897449493408,
            "end_logit": 3.227231740951538,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone and methadone",
            "probability": 0.07917953232247484,
            "start_logit": 2.756897449493408,
            "end_logit": 3.0833349227905273,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone and buprenorphine/naloxone",
            "probability": 0.010974576704491494,
            "start_logit": 1.8816672563552856,
            "end_logit": 1.9824286699295044,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone and buprenorphine",
            "probability": 0.010907945442697402,
            "start_logit": 1.8816672563552856,
            "end_logit": 1.9763387441635132,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone for the treatment of patients with failed back surgery syndrome and opioid addiction.Opioid analgesic",
            "probability": 0.000310830975479725,
            "start_logit": 3.591668128967285,
            "end_logit": -3.2916595935821533,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine/naloxone and methadone for the treatment of patients with failed back surgery syndrome and opioid addiction",
            "probability": 0.0002941776638947129,
            "start_logit": 3.655561685562134,
            "end_logit": -3.410618543624878,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone for the treatment of patients with failed back surgery syndrome and opioid addiction",
            "probability": 0.00027596949305273063,
            "start_logit": 3.591668128967285,
            "end_logit": -3.410618543624878,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone and methadone for the treatment of patients with failed back surgery syndrome and opioid addiction.Opioid analgesic",
            "probability": 0.0001348925583854481,
            "start_logit": 2.756897449493408,
            "end_logit": -3.2916595935821533,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone and methadone for the treatment of patients with failed back surgery syndrome and opioid addiction",
            "probability": 0.00011976358178834782,
            "start_logit": 2.756897449493408,
            "end_logit": -3.410618543624878,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "e",
            "probability": 6.443930986111165e-05,
            "start_logit": -4.500748634338379,
            "end_logit": 3.227231740951538,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "e and methadone",
            "probability": 5.5802966457784765e-05,
            "start_logit": -4.500748634338379,
            "end_logit": 3.0833349227905273,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone for the treatment of patients with failed back surgery syndrome and opioid addiction.Opioid",
            "probability": 2.753569767851159e-05,
            "start_logit": 1.9083036184310913,
            "end_logit": -4.0320611000061035,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone and methadone for the treatment of patients with failed back surgery syndrome and opioid addiction.Opioid",
            "probability": 9.745642193687313e-06,
            "start_logit": 0.869640588760376,
            "end_logit": -4.0320611000061035,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "opioid medications presents a clinical dilemma.Continuing opioid medication could result in hyperalgesia rendering opioids",
            "probability": 3.0071598601326588e-06,
            "start_logit": -2.12583065032959,
            "end_logit": -2.212414026260376,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "opioids",
            "probability": 2.030777843770354e-06,
            "start_logit": -2.5184078216552734,
            "end_logit": -2.212414026260376,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "opioid medications",
            "probability": 1.6982050145211403e-06,
            "start_logit": -3.2039265632629395,
            "end_logit": -1.705742359161377,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        }
    ],
    "5aa82388fcf4565872000001": [
        {
            "text": "NFE2L2/NRF2 is a transcription factor and master regulator of cellular antioxidant response",
            "probability": 0.27534799904316615,
            "start_logit": 1.2197074890136719,
            "end_logit": -0.3866969048976898,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2",
            "probability": 0.20732796962685834,
            "start_logit": 1.2197074890136719,
            "end_logit": -0.6704307198524475,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NRF2",
            "probability": 0.1619361106193658,
            "start_logit": 0.8065658807754517,
            "end_logit": -0.5043891668319702,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "antioxidant response",
            "probability": 0.08783300125607445,
            "start_logit": 0.07710903882980347,
            "end_logit": -0.3866969048976898,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "RNA complexes, global protein synthesis, and NRF2",
            "probability": 0.04984336581441267,
            "start_logit": -0.3717505931854248,
            "end_logit": -0.5043891668319702,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "ribosome-RNA complexes, global protein synthesis, and NRF2",
            "probability": 0.041740268660904835,
            "start_logit": -0.549169659614563,
            "end_logit": -0.5043891668319702,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2/NRF2",
            "probability": 0.03720438061159378,
            "start_logit": 1.2197074890136719,
            "end_logit": -2.388306140899658,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2/NRF2 is a transcription factor and master regulator of cellular antioxidant",
            "probability": 0.017155647182092896,
            "start_logit": 1.2197074890136719,
            "end_logit": -3.162405252456665,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NRF2 protein levels.Collectively our data illuminate the BRSK2 and BRSK1",
            "probability": 0.01388582918977545,
            "start_logit": 0.8065658807754517,
            "end_logit": -2.9607222080230713,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2/NRF2 is a transcription",
            "probability": 0.01386452668266828,
            "start_logit": 1.2197074890136719,
            "end_logit": -3.375399112701416,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2/NRF2 is a transcription factor and master regulator of cellular antioxidant response.",
            "probability": 0.013843925221414997,
            "start_logit": 1.2197074890136719,
            "end_logit": -3.3768861293792725,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NRF2 protein levels in an activity-dependent manner.As a result, BRSK2 kinase activation suppressed ribosome-RNA",
            "probability": 0.012329342359500029,
            "start_logit": 0.1549532115459442,
            "end_logit": -2.4279963970184326,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "BRSK2",
            "probability": 0.010904463615425289,
            "start_logit": -1.9327768087387085,
            "end_logit": -0.4630761444568634,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "cellular antioxidant response",
            "probability": 0.01005646841036459,
            "start_logit": -2.0901122093200684,
            "end_logit": -0.3866969048976898,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "BRSK2 as an inhibitor of the NRF2 transcription factor.NFE2L2",
            "probability": 0.008862400245669564,
            "start_logit": -1.9327768087387085,
            "end_logit": -0.6704307198524475,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2/NRF2 is a transcription factor and master regulator",
            "probability": 0.008174789372927505,
            "start_logit": 1.2197074890136719,
            "end_logit": -3.9036777019500732,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "Brain Specific Kinase 2 (BRSK2) and the related BRSK1",
            "probability": 0.0077897326639733405,
            "start_logit": -1.5673149824142456,
            "end_logit": -1.1649036407470703,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NRF2 is a transcription factor and master regulator of cellular antioxidant response",
            "probability": 0.007620622012284216,
            "start_logit": -2.3674702644348145,
            "end_logit": -0.3866969048976898,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "RNA",
            "probability": 0.0072810725117808,
            "start_logit": -0.3717505931854248,
            "end_logit": -2.4279963970184326,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NRF2 protein levels in an activity-dependent manner.As a result, BRSK2",
            "probability": 0.006998084899746981,
            "start_logit": 0.1549532115459442,
            "end_logit": -2.9943418502807617,
            "question_text": "Which proteins are regulated by Nrf2?"
        }
    ],
    "5a9d96564e03427e73000001": [
        {
            "text": "disease-modifying therapies",
            "probability": 0.4609077037213464,
            "start_logit": -2.6820852756500244,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "In the absence of disease-modifying therapies",
            "probability": 0.09387725809460608,
            "start_logit": -4.273294925689697,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease",
            "probability": 0.08202565323110082,
            "start_logit": -2.6820852756500244,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "absence of disease-modifying therapies",
            "probability": 0.07259324303209398,
            "start_logit": -4.530411243438721,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "therapies",
            "probability": 0.04210780909113921,
            "start_logit": -5.075049877166748,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable risk factors",
            "probability": 0.03492715642191096,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.357529163360596,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease",
            "probability": 0.03208677335560523,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.442349910736084,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease,",
            "probability": 0.031741771456086317,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.453160285949707,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify",
            "probability": 0.019185833421820012,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.9566216468811035,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer",
            "probability": 0.01902328887178501,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.965129852294922,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "In the absence of disease-modifying therapies for Alzheimer disease",
            "probability": 0.016706909770833753,
            "start_logit": -4.273294925689697,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable",
            "probability": 0.016330921453316532,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.117733478546143,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable risk",
            "probability": 0.014122900293775654,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.262996196746826,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "absence of disease-modifying therapies for Alzheimer disease",
            "probability": 0.01291909016012351,
            "start_logit": -4.530411243438721,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "ies",
            "probability": 0.011837779879392404,
            "start_logit": -6.343986988067627,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there",
            "probability": 0.008272139106993748,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.797900676727295,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need",
            "probability": 0.008239838014973215,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.801813125610352,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therap",
            "probability": 0.008144171080373073,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.813491344451904,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "therapies for Alzheimer disease",
            "probability": 0.007493735771705253,
            "start_logit": -5.075049877166748,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable risk factors that",
            "probability": 0.00745602377101865,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.901771545410156,
            "question_text": "List major risk factors for Alzheimer's disease. "
        }
    ],
    "5a9d2dd21d1251d03b00001a": [
        {
            "text": "V3-glycan regions of the HIV-1 envelope glycoprotein",
            "probability": 0.11917185542546574,
            "start_logit": 2.738924026489258,
            "end_logit": 1.8702971935272217,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan",
            "probability": 0.10142586957368874,
            "start_logit": 2.738924026489258,
            "end_logit": 1.7090587615966797,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan regions of the HIV-1 envelope glycoprotein",
            "probability": 0.09912430537209425,
            "start_logit": 2.554732084274292,
            "end_logit": 1.8702971935272217,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions of the HIV-1 envelope glycoprotein (Env)",
            "probability": 0.08914613363177205,
            "start_logit": 2.738924026489258,
            "end_logit": 1.580007553100586,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan",
            "probability": 0.08436361783878163,
            "start_logit": 2.554732084274292,
            "end_logit": 1.7090587615966797,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope glycoprotein",
            "probability": 0.07326502007204282,
            "start_logit": 2.2524406909942627,
            "end_logit": 1.8702971935272217,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan",
            "probability": 0.06306369027834886,
            "start_logit": 2.554732084274292,
            "end_logit": 1.4180676937103271,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope glycoprotein (Env)",
            "probability": 0.05480566906136399,
            "start_logit": 2.2524406909942627,
            "end_logit": 1.580007553100586,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions",
            "probability": 0.04685689703533119,
            "start_logit": 2.738924026489258,
            "end_logit": 0.9368287920951843,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan regions",
            "probability": 0.03897444873990301,
            "start_logit": 2.554732084274292,
            "end_logit": 0.9368287920951843,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "HIV-1 envelope glycoprotein",
            "probability": 0.03601642621291039,
            "start_logit": 1.5423325300216675,
            "end_logit": 1.8702971935272217,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3",
            "probability": 0.033669736208773955,
            "start_logit": 2.738924026489258,
            "end_logit": 0.6063299775123596,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3",
            "probability": 0.028005683068715422,
            "start_logit": 2.554732084274292,
            "end_logit": 0.6063299775123596,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "HIV-1 envelope glycoprotein (Env)",
            "probability": 0.026941974954170847,
            "start_logit": 1.5423325300216675,
            "end_logit": 1.580007553100586,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions of the HIV-1 envelope glycoprotein (Env",
            "probability": 0.026843336535558388,
            "start_logit": 2.738924026489258,
            "end_logit": 0.3797481954097748,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions of the HIV-1 envelope",
            "probability": 0.021244937549564955,
            "start_logit": 2.738924026489258,
            "end_logit": 0.14584921300411224,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan regions of the HIV-1 envelope",
            "probability": 0.017671032054974133,
            "start_logit": 2.554732084274292,
            "end_logit": 0.14584921300411224,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope glycoprotein (Env",
            "probability": 0.016502869600014868,
            "start_logit": 2.2524406909942627,
            "end_logit": 0.3797481954097748,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope",
            "probability": 0.013061060184396213,
            "start_logit": 2.2524406909942627,
            "end_logit": 0.14584921300411224,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "glycoprotein",
            "probability": 0.009845436602128865,
            "start_logit": 0.2453654706478119,
            "end_logit": 1.8702971935272217,
            "question_text": "What do the trispecific HIV antibodies target?"
        }
    ],
    "5ac721230340b9f058000005": [
        {
            "text": "EpCAM",
            "probability": 0.39667824145570363,
            "start_logit": 3.3593738079071045,
            "end_logit": 3.3236818313598633,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Epithelial cell adhesion molecule (EpCAM",
            "probability": 0.3414995617863588,
            "start_logit": 3.2095947265625,
            "end_logit": 3.3236818313598633,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Epithelial cell adhesion molecule",
            "probability": 0.12399913879398951,
            "start_logit": 3.2095947265625,
            "end_logit": 2.310610055923462,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "EpCAM)",
            "probability": 0.041899428953413,
            "start_logit": 3.3593738079071045,
            "end_logit": 1.0758285522460938,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Epithelial cell adhesion molecule (EpCAM)",
            "probability": 0.03607114061557881,
            "start_logit": 3.2095947265625,
            "end_logit": 1.0758285522460938,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "(EpCAM",
            "probability": 0.029416514720621456,
            "start_logit": 0.7578045725822449,
            "end_logit": 3.3236818313598633,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Epithelial cell adhesion",
            "probability": 0.015416866359251585,
            "start_logit": 3.2095947265625,
            "end_logit": 0.22579756379127502,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "adhesion molecule (EpCAM",
            "probability": 0.0036203434933664187,
            "start_logit": -1.3371827602386475,
            "end_logit": 3.3236818313598633,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "(EpCAM)",
            "probability": 0.0031071408506567685,
            "start_logit": 0.7578045725822449,
            "end_logit": 1.0758285522460938,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "adhesion molecule",
            "probability": 0.0013145535911308203,
            "start_logit": -1.3371827602386475,
            "end_logit": 2.310610055923462,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "cell adhesion molecule (EpCAM",
            "probability": 0.0010422346218523415,
            "start_logit": -2.5823845863342285,
            "end_logit": 3.3236818313598633,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "E",
            "probability": 0.0010153312855749035,
            "start_logit": 3.3593738079071045,
            "end_logit": -2.64422869682312,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "CAM",
            "probability": 0.0009306438293613701,
            "start_logit": -2.6956303119659424,
            "end_logit": 3.3236818313598633,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Epithelial cell adhesion molecule (E",
            "probability": 0.0008740968191736052,
            "start_logit": 3.2095947265625,
            "end_logit": -2.64422869682312,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "molecule (EpCAM",
            "probability": 0.0007133758706416875,
            "start_logit": -2.961498498916626,
            "end_logit": 3.3236818313598633,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "EpCAM) is highly expressed during liver development and carcinogenesis, However, its functions and underlying mechanisms remain unclear",
            "probability": 0.0005867595586350058,
            "start_logit": 3.3593738079071045,
            "end_logit": -3.1925837993621826,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "EpCAM) is highly expressed",
            "probability": 0.0005662795699540363,
            "start_logit": 3.3593738079071045,
            "end_logit": -3.2281110286712646,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Epithelial cell adhesion molecule (EpCAM) is highly expressed",
            "probability": 0.00048750903068996783,
            "start_logit": 3.2095947265625,
            "end_logit": -3.2281110286712646,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "adhesion molecule (EpCAM)",
            "probability": 0.00038240142547419314,
            "start_logit": -1.3371827602386475,
            "end_logit": 1.0758285522460938,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "cell adhesion molecule",
            "probability": 0.00037843736857214326,
            "start_logit": -2.5823845863342285,
            "end_logit": 2.310610055923462,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        }
    ],
    "5ace20fa0340b9f05800000c": [
        {
            "text": "CYP4F2",
            "probability": 0.20461338219805725,
            "start_logit": 4.46100378036499,
            "end_logit": 3.9189698696136475,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1",
            "probability": 0.19469071503953123,
            "start_logit": 4.320197582244873,
            "end_logit": 4.010066032409668,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2",
            "probability": 0.17773897827979315,
            "start_logit": 4.320197582244873,
            "end_logit": 3.9189698696136475,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A",
            "probability": 0.13240498581520257,
            "start_logit": 4.4716105461120605,
            "end_logit": 3.4731061458587646,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A",
            "probability": 0.13100801889430513,
            "start_logit": 4.46100378036499,
            "end_logit": 3.4731061458587646,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2, and THSD7A",
            "probability": 0.11380111688977652,
            "start_logit": 4.320197582244873,
            "end_logit": 3.4731061458587646,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A genes",
            "probability": 0.01463542654598938,
            "start_logit": 4.4716105461120605,
            "end_logit": 1.2706859111785889,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A genes",
            "probability": 0.014481012370178003,
            "start_logit": 4.46100378036499,
            "end_logit": 1.2706859111785889,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2, and THSD7A genes",
            "probability": 0.012579042071848037,
            "start_logit": 4.320197582244873,
            "end_logit": 1.2706859111785889,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A genes, related to hypoxia and circulation.Population Genomics",
            "probability": 0.0005117527502511824,
            "start_logit": 4.4716105461120605,
            "end_logit": -2.0826728343963623,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A genes, related to hypoxia and circulation.Population Genomics",
            "probability": 0.0005063533941817896,
            "start_logit": 4.46100378036499,
            "end_logit": -2.0826728343963623,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1,",
            "probability": 0.0003996724758104301,
            "start_logit": 4.320197582244873,
            "end_logit": -2.1784560680389404,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A genes,",
            "probability": 0.0003994689895904036,
            "start_logit": 4.4716105461120605,
            "end_logit": -2.330378293991089,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A genes,",
            "probability": 0.0003952543071828923,
            "start_logit": 4.46100378036499,
            "end_logit": -2.330378293991089,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2,",
            "probability": 0.00036195133313784707,
            "start_logit": 4.46100378036499,
            "end_logit": -2.418397903442383,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2, and THSD7A genes,",
            "probability": 0.0003433406748116488,
            "start_logit": 4.320197582244873,
            "end_logit": -2.330378293991089,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2,",
            "probability": 0.00031441179187712383,
            "start_logit": 4.320197582244873,
            "end_logit": -2.418397903442383,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A genes, related to hypoxia and circulation.Population Genomics Analysis",
            "probability": 0.0003028518419647349,
            "start_logit": 4.4716105461120605,
            "end_logit": -2.6072707176208496,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A genes, related to hypoxia and circulation.Population Genomics Analysis",
            "probability": 0.00029965653929125345,
            "start_logit": 4.46100378036499,
            "end_logit": -2.6072707176208496,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "DNA repair.Three of loci with strong signals of selection are associated with EPAS1",
            "probability": 0.00021260779721939393,
            "start_logit": -2.499520778656006,
            "end_logit": 4.010066032409668,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        }
    ],
    "5abd2ce0fcf456587200002a": [
        {
            "text": "Bacteroidetes",
            "probability": 0.4201793463782491,
            "start_logit": 5.53241491317749,
            "end_logit": 5.309408187866211,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and Bacteroidetes",
            "probability": 0.29562759542841077,
            "start_logit": 5.18083381652832,
            "end_logit": 5.309408187866211,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes",
            "probability": 0.28365176691494287,
            "start_logit": 5.18083381652832,
            "end_logit": 5.268054962158203,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes -",
            "probability": 0.00012010302605515632,
            "start_logit": 4.638288974761963,
            "end_logit": -1.9565528631210327,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and Bacteroidetes -",
            "probability": 8.414699004490721e-05,
            "start_logit": 5.18083381652832,
            "end_logit": -2.8548824787139893,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "B",
            "probability": 7.271638032602369e-05,
            "start_logit": 5.53241491317749,
            "end_logit": -3.35246205329895,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and B",
            "probability": 5.1161412024018006e-05,
            "start_logit": 5.18083381652832,
            "end_logit": -3.35246205329895,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bact",
            "probability": 3.354627409928388e-05,
            "start_logit": 5.53241491317749,
            "end_logit": -4.126102924346924,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "utes and Bacteroidetes",
            "probability": 2.8910051146496607e-05,
            "start_logit": -4.051832675933838,
            "end_logit": 5.309408187866211,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "utes",
            "probability": 2.7738909412098294e-05,
            "start_logit": -4.051832675933838,
            "end_logit": 5.268054962158203,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and Bact",
            "probability": 2.360231275771969e-05,
            "start_logit": 5.18083381652832,
            "end_logit": -4.126102924346924,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firm",
            "probability": 2.1884985869582483e-05,
            "start_logit": 5.18083381652832,
            "end_logit": -4.20164680480957,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "tes",
            "probability": 2.161616049112552e-05,
            "start_logit": -4.342580795288086,
            "end_logit": 5.309408187866211,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroide",
            "probability": 1.6867989204005786e-05,
            "start_logit": 4.638288974761963,
            "end_logit": -3.919485092163086,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "acteroidetes",
            "probability": 1.4734461383497029e-05,
            "start_logit": -4.725832939147949,
            "end_logit": 5.309408187866211,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and Bacteroide",
            "probability": 1.0682243775075594e-05,
            "start_logit": 4.181454181671143,
            "end_logit": -3.919485092163086,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "- Firmicutes",
            "probability": 4.395611835557336e-06,
            "start_logit": -5.049875736236572,
            "end_logit": 4.423868656158447,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "- Firmicutes and Bacteroidetes",
            "probability": 3.7610714263631664e-06,
            "start_logit": -5.049875736236572,
            "end_logit": 4.267965793609619,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "phyla - Firmicutes",
            "probability": 2.7421270822778507e-06,
            "start_logit": -5.5217485427856445,
            "end_logit": 4.423868656158447,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "two bacterial phyla - Firmicutes",
            "probability": 2.6812714641564236e-06,
            "start_logit": -5.544191360473633,
            "end_logit": 4.423868656158447,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        }
    ],
    "5aac5469fcf4565872000005": [
        {
            "text": "Perinatal Yellow Fever",
            "probability": 0.2951094031683581,
            "start_logit": -3.577819585800171,
            "end_logit": -2.1583364009857178,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "polymerase chain reaction",
            "probability": 0.23320136674729677,
            "start_logit": -2.8758058547973633,
            "end_logit": -3.0957939624786377,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "Yellow fever polymerase chain reaction",
            "probability": 0.10592568593355632,
            "start_logit": -3.6649703979492188,
            "end_logit": -3.0957939624786377,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "polymerase chain reaction was positive for both.",
            "probability": 0.03969480087601888,
            "start_logit": -2.8758058547973633,
            "end_logit": -4.866476058959961,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "pregnant woman was admitted to hospital with yellow fever symptoms.Perinatal Yellow Fever",
            "probability": 0.03962444184502266,
            "start_logit": -5.585719585418701,
            "end_logit": -2.1583364009857178,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "symptoms.Perinatal Yellow Fever",
            "probability": 0.03871889215218799,
            "start_logit": -5.608838081359863,
            "end_logit": -2.1583364009857178,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "Fever",
            "probability": 0.02837694914452714,
            "start_logit": -5.919588565826416,
            "end_logit": -2.1583364009857178,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "polymerase chain",
            "probability": 0.024487918807183148,
            "start_logit": -2.8758058547973633,
            "end_logit": -5.34951639175415,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "polymer",
            "probability": 0.02385809556313624,
            "start_logit": -2.8758058547973633,
            "end_logit": -5.375572681427002,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "Perinatal Yellow Fever: A Case Report.An outbreak of yellow fever",
            "probability": 0.02321656228239093,
            "start_logit": -3.577819585800171,
            "end_logit": -4.700816631317139,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "Yellow Fever",
            "probability": 0.020763613359875078,
            "start_logit": -6.231963634490967,
            "end_logit": -2.1583364009857178,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "Yellow fever polymerase chain reaction was positive for both.",
            "probability": 0.018030336054353214,
            "start_logit": -3.6649703979492188,
            "end_logit": -4.866476058959961,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fever symptoms.Perinatal Yellow Fever",
            "probability": 0.017671125069922005,
            "start_logit": -6.393233776092529,
            "end_logit": -2.1583364009857178,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "reaction",
            "probability": 0.01658689207260164,
            "start_logit": -5.519095420837402,
            "end_logit": -3.0957939624786377,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "polymerase chain reaction was positive",
            "probability": 0.0151837240481465,
            "start_logit": -2.8758058547973633,
            "end_logit": -5.82747220993042,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "admitted to hospital with yellow fever symptoms.Perinatal Yellow Fever",
            "probability": 0.013564177240919857,
            "start_logit": -6.65773344039917,
            "end_logit": -2.1583364009857178,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": ".Yellow fever polymerase chain reaction",
            "probability": 0.013089509723711892,
            "start_logit": -5.755897045135498,
            "end_logit": -3.0957939624786377,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "Yellow fever polymerase chain",
            "probability": 0.011123003406523462,
            "start_logit": -3.6649703979492188,
            "end_logit": -5.34951639175415,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "symptoms.Yellow fever polymerase chain reaction",
            "probability": 0.010936580007445608,
            "start_logit": -5.9355950355529785,
            "end_logit": -3.0957939624786377,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "Yellow fever polymer",
            "probability": 0.010836922496822532,
            "start_logit": -3.6649703979492188,
            "end_logit": -5.375572681427002,
            "question_text": "What are 7 symptoms of yellow fever?"
        }
    ],
    "5a7d5580faa1ab7d2e00001a": [
        {
            "text": "imaging",
            "probability": 0.7195873315394509,
            "start_logit": -0.19402500987052917,
            "end_logit": -0.17017033696174622,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "in vivo imaging",
            "probability": 0.091553840211948,
            "start_logit": -2.2557756900787354,
            "end_logit": -0.17017033696174622,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "monoamine oxidase B: evidence from in silico modelling and in vivo imaging",
            "probability": 0.07502309252418184,
            "start_logit": -2.454906940460205,
            "end_logit": -0.17017033696174622,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "imaging.",
            "probability": 0.02497404014132455,
            "start_logit": -0.19402500987052917,
            "end_logit": -3.5310113430023193,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "in silico modelling and in vivo imaging",
            "probability": 0.019717048596089984,
            "start_logit": -3.7912192344665527,
            "end_logit": -0.17017033696174622,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "evidence from in silico modelling and in vivo imaging",
            "probability": 0.01948737519125505,
            "start_logit": -3.80293607711792,
            "end_logit": -0.17017033696174622,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "monoamine oxidase B",
            "probability": 0.011916231509408128,
            "start_logit": -2.454906940460205,
            "end_logit": -2.0100648403167725,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "modelling and in vivo imaging",
            "probability": 0.010001485523526005,
            "start_logit": -4.469969272613525,
            "end_logit": -0.17017033696174622,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "from in silico modelling and in vivo imaging",
            "probability": 0.007560259860778885,
            "start_logit": -4.749797344207764,
            "end_logit": -0.17017033696174622,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Cross-interaction of tau PET tracers with monoamine oxidase B",
            "probability": 0.003233713591761201,
            "start_logit": -3.7591772079467773,
            "end_logit": -2.0100648403167725,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "in vivo imaging.",
            "probability": 0.0031774729491888627,
            "start_logit": -2.2557756900787354,
            "end_logit": -3.5310113430023193,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "monoamine oxidase B: evidence from in silico modelling and in vivo imaging.",
            "probability": 0.0026037558501994036,
            "start_logit": -2.454906940460205,
            "end_logit": -3.5310113430023193,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "imaging.Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.Cross-interaction of tau PET",
            "probability": 0.0018607427522390918,
            "start_logit": -2.957827091217041,
            "end_logit": -3.364070415496826,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "monoamine oxidase B: evidence from in silico modelling",
            "probability": 0.0016462537613276982,
            "start_logit": -2.454906940460205,
            "end_logit": -3.989464044570923,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "imaging.Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.",
            "probability": 0.0015737933176670363,
            "start_logit": -2.957827091217041,
            "end_logit": -3.531557321548462,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "in vivo imaging.Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.",
            "probability": 0.0015210377444905133,
            "start_logit": -2.9919230937957764,
            "end_logit": -3.531557321548462,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.",
            "probability": 0.0013935920562652391,
            "start_logit": -3.138798952102661,
            "end_logit": -3.4721896648406982,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.Cross-interaction of tau PET",
            "probability": 0.0012100306611785236,
            "start_logit": -3.138798952102661,
            "end_logit": -3.6134285926818848,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.Cross-interaction of tau PET tracers",
            "probability": 0.001088835743119026,
            "start_logit": -3.138798952102661,
            "end_logit": -3.7189652919769287,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "imaging.Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.Cross-interaction",
            "probability": 0.0008700664746001266,
            "start_logit": -2.957827091217041,
            "end_logit": -4.124231815338135,
            "question_text": "What in vivo tau tracers are being used?"
        }
    ],
    "5ac2776195d0062724000006": [
        {
            "text": "celiac disease",
            "probability": 0.8934993492188905,
            "start_logit": 4.378100872039795,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac",
            "probability": 0.09923004230175125,
            "start_logit": 4.378100872039795,
            "end_logit": 1.8480429649353027,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac disease.",
            "probability": 0.0028410337171685604,
            "start_logit": 4.378100872039795,
            "end_logit": -1.7052298784255981,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "ac disease",
            "probability": 0.0014354171949447503,
            "start_logit": -2.055589199066162,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Wheat gluten proteins are the known cause of celiac disease",
            "probability": 0.000645695231394468,
            "start_logit": -2.8544723987579346,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Directed-Mutagenesis of Wheat gluten proteins are the known cause of celiac disease",
            "probability": 0.0006337408568781744,
            "start_logit": -2.873159885406494,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "disease",
            "probability": 0.00045970191942542845,
            "start_logit": -3.1942217350006104,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "c",
            "probability": 0.00024190496432945993,
            "start_logit": 4.378100872039795,
            "end_logit": -4.16860818862915,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "eliac disease",
            "probability": 0.00018718771362461403,
            "start_logit": -4.092688083648682,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "gluten proteins are the known cause of celiac disease",
            "probability": 0.00018503955430723427,
            "start_logit": -4.1042304039001465,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "ac",
            "probability": 0.00015941422800089185,
            "start_logit": -2.055589199066162,
            "end_logit": 1.8480429649353027,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "proteins are the known cause of celiac disease",
            "probability": 7.619325430975567e-05,
            "start_logit": -4.991527080535889,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Wheat gluten proteins are the known cause of celiac",
            "probability": 7.170947038889851e-05,
            "start_logit": -2.8544723987579346,
            "end_logit": 1.8480429649353027,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Directed-Mutagenesis of Wheat gluten proteins are the known cause of celiac",
            "probability": 7.038184425242756e-05,
            "start_logit": -2.873159885406494,
            "end_logit": 1.8480429649353027,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac disease. The repetitive tracts of proline",
            "probability": 6.332194692156706e-05,
            "start_logit": 4.378100872039795,
            "end_logit": -5.508921146392822,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac disease. The repetitive tracts of proline and glutamine residues",
            "probability": 5.844984965224394e-05,
            "start_logit": 4.378100872039795,
            "end_logit": -5.58898401260376,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Mutagenesis of Wheat gluten proteins are the known cause of celiac disease",
            "probability": 5.2115907518006034e-05,
            "start_logit": -5.3713297843933105,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "cause of celiac disease",
            "probability": 4.178822143235426e-05,
            "start_logit": -5.5921854972839355,
            "end_logit": 4.045747756958008,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "allergic reaction or celiac disease",
            "probability": 2.672395537426104e-05,
            "start_logit": -4.4701924324035645,
            "end_logit": 2.4767005443573,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "eliac",
            "probability": 2.0788649435029542e-05,
            "start_logit": -4.092688083648682,
            "end_logit": 1.8480429649353027,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        }
    ],
    "5abd44b1fcf4565872000030": [
        {
            "text": "MCFAs",
            "probability": 0.4366365194248822,
            "start_logit": -0.990799605846405,
            "end_logit": -1.7319371700286865,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFAs and LCFAs",
            "probability": 0.2833234787051449,
            "start_logit": -0.990799605846405,
            "end_logit": -2.1644489765167236,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "LCFAs",
            "probability": 0.07079205170355536,
            "start_logit": -2.3776421546936035,
            "end_logit": -2.1644489765167236,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "proteins harboring HEAT and ARM repeats bind to lysine myristoylated peptides.Lipidomic experiments suggest that MCFAs",
            "probability": 0.04946120141195116,
            "start_logit": -3.1687121391296387,
            "end_logit": -1.7319371700286865,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "lysine myristoylated peptides.Lipidomic experiments suggest that MCFAs",
            "probability": 0.03335178357195763,
            "start_logit": -3.5627894401550293,
            "end_logit": -1.7319371700286865,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "lysine myristoylated peptides.Lipidomic experiments suggest that MCFAs and LCFAs",
            "probability": 0.02164121167664671,
            "start_logit": -3.5627894401550293,
            "end_logit": -2.1644489765167236,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFAs and LCFAs interact with HEAT and ARM repeat proteins in mammalian cells",
            "probability": 0.017721447835171995,
            "start_logit": -0.990799605846405,
            "end_logit": -4.936262607574463,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFAs and LCFAs interact with HEAT and ARM repeat proteins in mammalian cells.",
            "probability": 0.015049330621903102,
            "start_logit": -0.990799605846405,
            "end_logit": -5.099704742431641,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "myristoylated peptides.Lipidomic experiments suggest that MCFAs",
            "probability": 0.009750798450527778,
            "start_logit": -4.792551517486572,
            "end_logit": -1.7319371700286865,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFAs and LCFAs interact with HEAT and ARM repeat proteins in mammalian cells.Taken together,",
            "probability": 0.009472341499338427,
            "start_logit": -0.990799605846405,
            "end_logit": -5.562662124633789,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "ARM repeats bind to lysine myristoylated peptides.Lipidomic experiments suggest that MCFAs",
            "probability": 0.008878296157478609,
            "start_logit": -4.886291027069092,
            "end_logit": -1.7319371700286865,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "proteins harboring HEAT and ARM repeats bind to lysine myristoylated peptides",
            "probability": 0.006729937420389486,
            "start_logit": -3.1687121391296387,
            "end_logit": -3.72655987739563,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "myristoylated peptides.Lipidomic experiments suggest that MCFAs and LCFAs",
            "probability": 0.006327070719588636,
            "start_logit": -4.792551517486572,
            "end_logit": -2.1644489765167236,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "ARM repeats bind to lysine myristoylated peptides.Lipidomic experiments suggest that MCFAs and LCFAs",
            "probability": 0.005760923881549281,
            "start_logit": -4.886291027069092,
            "end_logit": -2.1644489765167236,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "bind to lysine myristoylated peptides.Lipidomic experiments suggest that MCFAs",
            "probability": 0.005270379657619633,
            "start_logit": -5.4077982902526855,
            "end_logit": -1.7319371700286865,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "lysine myristoylated peptides",
            "probability": 0.004538009791315229,
            "start_logit": -3.5627894401550293,
            "end_logit": -3.72655987739563,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "LCFAs interact with HEAT and ARM repeat proteins in mammalian cells",
            "probability": 0.004427933954301592,
            "start_logit": -2.3776421546936035,
            "end_logit": -4.936262607574463,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "LCFAs interact with HEAT and ARM repeat proteins in mammalian cells.",
            "probability": 0.0037602707560935975,
            "start_logit": -2.3776421546936035,
            "end_logit": -5.099704742431641,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "proteins",
            "probability": 0.003687183606897599,
            "start_logit": -3.1687121391296387,
            "end_logit": -4.328262805938721,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "bind to lysine myristoylated peptides.Lipidomic experiments suggest that MCFAs and LCFAs",
            "probability": 0.003419829153686983,
            "start_logit": -5.4077982902526855,
            "end_logit": -2.1644489765167236,
            "question_text": "List proteins with HEAT repeats"
        }
    ],
    "5ace34eb0340b9f058000010": [
        {
            "text": "intraepidermal",
            "probability": 0.3917192721526061,
            "start_logit": -3.8508849143981934,
            "end_logit": -3.945294141769409,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "epidermolysis bullosa simplex (intraepidermal",
            "probability": 0.08676436098752123,
            "start_logit": -5.358234405517578,
            "end_logit": -3.945294141769409,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "(intraepidermal",
            "probability": 0.06014581512033363,
            "start_logit": -5.724658489227295,
            "end_logit": -3.945294141769409,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "16",
            "probability": 0.05969732377398305,
            "start_logit": -4.855555057525635,
            "end_logit": -4.821882247924805,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "intraepidermal)",
            "probability": 0.05408802944368346,
            "start_logit": -3.8508849143981934,
            "end_logit": -5.92522668838501,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "intraepidermal), junctional epidermolysis bullosa",
            "probability": 0.04147630756795682,
            "start_logit": -3.8508849143981934,
            "end_logit": -6.1907172203063965,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Pathogenic variants in at least 16",
            "probability": 0.0333052579403631,
            "start_logit": -5.439126968383789,
            "end_logit": -4.821882247924805,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "intraepidermal),",
            "probability": 0.03298027321326862,
            "start_logit": -3.8508849143981934,
            "end_logit": -6.4199299812316895,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "simplex (intraepidermal",
            "probability": 0.03220110432523245,
            "start_logit": -6.349429607391357,
            "end_logit": -3.945294141769409,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "in",
            "probability": 0.027998190394616183,
            "start_logit": -3.8508849143981934,
            "end_logit": -6.583699703216553,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "16 genes",
            "probability": 0.023783225206123366,
            "start_logit": -4.855555057525635,
            "end_logit": -5.742188930511475,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "intraepidermal), junctional epidermolysis bullosa (within the lamina lucida of the basement membrane",
            "probability": 0.02373491747959482,
            "start_logit": -3.8508849143981934,
            "end_logit": -6.748892307281494,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "epidermolysis bullosa simplex",
            "probability": 0.021310536629147576,
            "start_logit": -5.358234405517578,
            "end_logit": -5.349288463592529,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "variants in at least 16",
            "probability": 0.019603262320988527,
            "start_logit": -5.969146251678467,
            "end_logit": -4.821882247924805,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Pathogenic variants",
            "probability": 0.019070368887016974,
            "start_logit": -5.439126968383789,
            "end_logit": -5.379461765289307,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "traepidermal",
            "probability": 0.01821414451756367,
            "start_logit": -6.91923189163208,
            "end_logit": -3.945294141769409,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "in at least 16",
            "probability": 0.016021222468261792,
            "start_logit": -6.077719211578369,
            "end_logit": -4.915091037750244,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Pathogenic variants in at least 16 genes",
            "probability": 0.013268709551246172,
            "start_logit": -5.439126968383789,
            "end_logit": -5.742188930511475,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "at least 16",
            "probability": 0.012637380788838025,
            "start_logit": -6.314974308013916,
            "end_logit": -4.915091037750244,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "epidermolysis bullosa simplex (intraepidermal)",
            "probability": 0.011980297231654108,
            "start_logit": -5.358234405517578,
            "end_logit": -5.92522668838501,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        }
    ],
    "5aae6a86fcf456587200000e": [
        {
            "text": "ultraviolet A",
            "probability": 0.6449491530087069,
            "start_logit": 0.7403693199157715,
            "end_logit": 0.18608403205871582,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A",
            "probability": 0.1271230170481414,
            "start_logit": -0.8836469054222107,
            "end_logit": 0.18608403205871582,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet radiation in the ultraviolet A",
            "probability": 0.0531104169469411,
            "start_logit": -1.7564290761947632,
            "end_logit": 0.18608403205871582,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "sunglasses to avoid delayed health effects from solar ultraviolet radiation in the ultraviolet A",
            "probability": 0.04065701141931037,
            "start_logit": -2.0236308574676514,
            "end_logit": 0.18608403205871582,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A) band",
            "probability": 0.027332255292273195,
            "start_logit": 0.7403693199157715,
            "end_logit": -2.975019931793213,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "solar ultraviolet radiation in the ultraviolet A",
            "probability": 0.017185391006646806,
            "start_logit": -2.884742498397827,
            "end_logit": 0.18608403205871582,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A) band. The longer-wavelength limit for UV-A",
            "probability": 0.015211642891179787,
            "start_logit": 0.7403693199157715,
            "end_logit": -3.5610263347625732,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A",
            "probability": 0.011168934296957308,
            "start_logit": 0.7403693199157715,
            "end_logit": -3.8699512481689453,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet",
            "probability": 0.010743095226395561,
            "start_logit": 0.7403693199157715,
            "end_logit": -3.9088242053985596,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A)",
            "probability": 0.010037171505306544,
            "start_logit": 0.7403693199157715,
            "end_logit": -3.976792097091675,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A) band.",
            "probability": 0.007425777511879176,
            "start_logit": 0.7403693199157715,
            "end_logit": -4.278130054473877,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A (UV-A) band",
            "probability": 0.0053873374967233914,
            "start_logit": -0.8836469054222107,
            "end_logit": -2.975019931793213,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet radiation",
            "probability": 0.004897698784916453,
            "start_logit": -1.7564290761947632,
            "end_logit": -2.197523593902588,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "radiation in the ultraviolet A",
            "probability": 0.004748747198355241,
            "start_logit": -4.170921325683594,
            "end_logit": 0.18608403205871582,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "sunglasses",
            "probability": 0.003960746883146992,
            "start_logit": -2.0236308574676514,
            "end_logit": -2.1426546573638916,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "sunglasses to avoid delayed health effects from solar ultraviolet radiation",
            "probability": 0.003749279461044778,
            "start_logit": -2.0236308574676514,
            "end_logit": -2.197523593902588,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "Sunglasses",
            "probability": 0.0033169323671714624,
            "start_logit": -2.2748775482177734,
            "end_logit": -2.068800210952759,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "Sunglasses. There is substantial scientific uncertainty about the necessary levels of protection in sunglasses",
            "probability": 0.0030807895871260782,
            "start_logit": -2.2748775482177734,
            "end_logit": -2.1426546573638916,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A (UV-A) band. The longer-wavelength limit for UV-A",
            "probability": 0.002998298283771188,
            "start_logit": -0.8836469054222107,
            "end_logit": -3.5610263347625732,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "Sunglasses. There is substantial scientific uncertainty about the necessary levels of protection in sunglasses to avoid delayed health effects from solar ultraviolet radiation",
            "probability": 0.0029163037840062227,
            "start_logit": -2.2748775482177734,
            "end_logit": -2.197523593902588,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        }
    ],
    "5aaef38dfcf456587200000f": [
        {
            "text": "obstructive sleep apnea",
            "probability": 0.5602324336793332,
            "start_logit": 3.4351959228515625,
            "end_logit": 3.1851909160614014,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about obstructive sleep apnea",
            "probability": 0.39750455266489987,
            "start_logit": 3.4351959228515625,
            "end_logit": 2.842045545578003,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea and cardiovascular risk among atrial fibrillation patients.Diagnosed Sleep Apnea",
            "probability": 0.011975424789735022,
            "start_logit": 2.8869948387145996,
            "end_logit": -0.11210314184427261,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnea",
            "probability": 0.00923152121316285,
            "start_logit": -0.6705319881439209,
            "end_logit": 3.1851909160614014,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnea are common conditions, but little is known about obstructive sleep apnea",
            "probability": 0.006550087945024668,
            "start_logit": -0.6705319881439209,
            "end_logit": 2.842045545578003,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "Atrial fibrillation and obstructive sleep apnea",
            "probability": 0.0038335559457659814,
            "start_logit": -1.5493630170822144,
            "end_logit": 3.1851909160614014,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about obstructive sleep",
            "probability": 0.002657916172673475,
            "start_logit": 3.4351959228515625,
            "end_logit": -2.165618419647217,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep",
            "probability": 0.002616220555640504,
            "start_logit": 3.4351959228515625,
            "end_logit": -2.1814301013946533,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about obstructive",
            "probability": 0.0012284715478784447,
            "start_logit": 3.4351959228515625,
            "end_logit": -2.937390089035034,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive",
            "probability": 0.0012274670516777394,
            "start_logit": 3.4351959228515625,
            "end_logit": -2.9382081031799316,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea and cardiovascular risk among atrial fibrillation patients.",
            "probability": 0.0005990044824230596,
            "start_logit": 2.8869948387145996,
            "end_logit": -3.1074459552764893,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea and cardiovascular risk among atrial fibrillation patients.Diagnosed Sleep Apnea and Cardiovascular Disease",
            "probability": 0.0004488129330739989,
            "start_logit": 2.8869948387145996,
            "end_logit": -3.396108865737915,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "Measurement Error from Administrative Data.Atrial fibrillation and obstructive sleep apnea",
            "probability": 0.0003849880084663814,
            "start_logit": -3.4323675632476807,
            "end_logit": 2.769859552383423,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "nea",
            "probability": 0.0003553010648356023,
            "start_logit": -3.927945613861084,
            "end_logit": 3.1851909160614014,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "Administrative Data.Atrial fibrillation and obstructive sleep apnea",
            "probability": 0.0003090773968354939,
            "start_logit": -3.6519880294799805,
            "end_logit": 2.769859552383423,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "nea are common conditions, but little is known about obstructive sleep apnea",
            "probability": 0.00025209856186169744,
            "start_logit": -3.927945613861084,
            "end_logit": 2.842045545578003,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnea and cardiovascular risk among atrial fibrillation patients.Diagnosed Sleep Apnea",
            "probability": 0.00017213044905798952,
            "start_logit": -1.355364441871643,
            "end_logit": -0.11210314184427261,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "apnea",
            "probability": 0.00014349191859315002,
            "start_logit": -4.834632396697998,
            "end_logit": 3.1851909160614014,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "Sleep Apnea",
            "probability": 0.00014250717038121234,
            "start_logit": -1.544224739074707,
            "end_logit": -0.11210314184427261,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "tion and obstructive sleep apnea",
            "probability": 0.00013493644867970878,
            "start_logit": -4.896107196807861,
            "end_logit": 3.1851909160614014,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        }
    ],
    "5abce6acfcf4565872000022": [
        {
            "text": "simvastatin",
            "probability": 0.44793003898463374,
            "start_logit": 5.434791088104248,
            "end_logit": 5.361927509307861,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastatin",
            "probability": 0.27395309674596113,
            "start_logit": 5.434791088104248,
            "end_logit": 4.8702473640441895,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastatin",
            "probability": 0.2725539659204757,
            "start_logit": 5.429670810699463,
            "end_logit": 4.8702473640441895,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastatin,",
            "probability": 0.0006470559626256642,
            "start_logit": 5.434791088104248,
            "end_logit": -1.1780320405960083,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastatin,",
            "probability": 0.0006437513241533231,
            "start_logit": 5.429670810699463,
            "end_logit": -1.1780320405960083,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvas",
            "probability": 0.0005213802153104167,
            "start_logit": 5.434791088104248,
            "end_logit": -1.3939852714538574,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvas",
            "probability": 0.0004362391052804781,
            "start_logit": 5.434791088104248,
            "end_logit": -1.5722743272781372,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvas",
            "probability": 0.0004340111487918311,
            "start_logit": 5.429670810699463,
            "end_logit": -1.5722743272781372,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "sim",
            "probability": 0.00040897661617776134,
            "start_logit": 5.434791088104248,
            "end_logit": -1.636806845664978,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastat",
            "probability": 0.0003561867581363009,
            "start_logit": 5.434791088104248,
            "end_logit": -1.7750096321105957,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastat",
            "probability": 0.0003132116855934577,
            "start_logit": 5.434791088104248,
            "end_logit": -1.9035855531692505,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastat",
            "probability": 0.00031161205365127007,
            "start_logit": 5.429670810699463,
            "end_logit": -1.9035855531692505,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin,",
            "probability": 0.0003047547608389012,
            "start_logit": 5.434791088104248,
            "end_logit": -1.9309574365615845,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and ator",
            "probability": 0.00029254973818429865,
            "start_logit": 5.434791088104248,
            "end_logit": -1.971830129623413,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "ator",
            "probability": 0.00029105563075662865,
            "start_logit": 5.429670810699463,
            "end_logit": -1.971830129623413,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastatin, and many HIV antiretroviral medications",
            "probability": 0.00015246203343471237,
            "start_logit": 5.434791088104248,
            "end_logit": -2.623549222946167,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastatin, and many HIV antiretroviral medications",
            "probability": 0.00015168338069003286,
            "start_logit": 5.429670810699463,
            "end_logit": -2.623549222946167,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "mvastatin",
            "probability": 0.00010526536200447977,
            "start_logit": -2.921116828918457,
            "end_logit": 5.361927509307861,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "in",
            "probability": 0.00010234518487086112,
            "start_logit": -2.9492499828338623,
            "end_logit": 5.361927509307861,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and at",
            "probability": 9.035738842876996e-05,
            "start_logit": 5.434791088104248,
            "end_logit": -3.1466920375823975,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        }
    ],
    "5c34ad63da8336e21a000007": [
        {
            "text": "non-essential genes",
            "probability": 0.48072045975555494,
            "start_logit": -2.1016757488250732,
            "end_logit": -1.7711251974105835,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "4-6 base pairs in non-essential genes",
            "probability": 0.12950278897999853,
            "start_logit": -3.413259267807007,
            "end_logit": -1.7711251974105835,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "genes",
            "probability": 0.08698272781501218,
            "start_logit": -3.8112521171569824,
            "end_logit": -1.7711251974105835,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "6 base pairs in non-essential genes",
            "probability": 0.08080903445829773,
            "start_logit": -3.8848729133605957,
            "end_logit": -1.7711251974105835,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertions occurring as frequently as every 4-6 base pairs in non-essential genes",
            "probability": 0.06079503134473982,
            "start_logit": -4.1694536209106445,
            "end_logit": -1.7711251974105835,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "4-6 base pairs",
            "probability": 0.025693553915203015,
            "start_logit": -3.413259267807007,
            "end_logit": -3.388587474822998,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "in non-essential genes",
            "probability": 0.025554992211266503,
            "start_logit": -5.036128997802734,
            "end_logit": -1.7711251974105835,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "6 base pairs",
            "probability": 0.016032637598333475,
            "start_logit": -3.8848729133605957,
            "end_logit": -3.388587474822998,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "non",
            "probability": 0.015812003522856527,
            "start_logit": -2.1016757488250732,
            "end_logit": -5.185641765594482,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Transposon mutagenesis",
            "probability": 0.015606791559026278,
            "start_logit": -3.018683910369873,
            "end_logit": -4.281696796417236,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertions occurring as frequently as every 4-6 base pairs",
            "probability": 0.012061828381733029,
            "start_logit": -4.1694536209106445,
            "end_logit": -3.388587474822998,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "4-6",
            "probability": 0.010019646220774166,
            "start_logit": -3.413259267807007,
            "end_logit": -4.33027982711792,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "unique",
            "probability": 0.007297425753231071,
            "start_logit": -3.725806951522827,
            "end_logit": -4.334758281707764,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "6",
            "probability": 0.00625220462888676,
            "start_logit": -3.8848729133605957,
            "end_logit": -4.33027982711792,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "4",
            "probability": 0.006185350106744177,
            "start_logit": -3.413259267807007,
            "end_logit": -4.812644004821777,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "unique genomic positions",
            "probability": 0.006148454406380704,
            "start_logit": -3.725806951522827,
            "end_logit": -4.506079196929932,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertions occurring as frequently as every 4-6",
            "probability": 0.004703718822219733,
            "start_logit": -4.1694536209106445,
            "end_logit": -4.33027982711792,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "4-6 base pairs in non",
            "probability": 0.004259645109785283,
            "start_logit": -3.413259267807007,
            "end_logit": -5.185641765594482,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertions occurring as frequently as every 4",
            "probability": 0.0029037100789835535,
            "start_logit": -4.1694536209106445,
            "end_logit": -4.812644004821777,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "6 base pairs in non",
            "probability": 0.002657995330972541,
            "start_logit": -3.8848729133605957,
            "end_logit": -5.185641765594482,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        }
    ],
    "5ad4eddf133db5eb78000009": [
        {
            "text": "GPS-Prot",
            "probability": 0.14400835868082315,
            "start_logit": -1.258078932762146,
            "end_logit": -2.004561424255371,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, APID, and HIPPIE",
            "probability": 0.12841434456352846,
            "start_logit": -1.258078932762146,
            "end_logit": -2.119170665740967,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "APID, and HIPPIE",
            "probability": 0.11814961406254314,
            "start_logit": -1.3413892984390259,
            "end_logit": -2.119170665740967,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "125",
            "probability": 0.0935148578805831,
            "start_logit": -1.5022093057632446,
            "end_logit": -2.1921820640563965,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HIPPIE",
            "probability": 0.08107959624374882,
            "start_logit": -1.7179096937179565,
            "end_logit": -2.119170665740967,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, APID",
            "probability": 0.07159759486626638,
            "start_logit": -1.258078932762146,
            "end_logit": -2.703371286392212,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING",
            "probability": 0.06895826703485261,
            "start_logit": -1.258078932762146,
            "end_logit": -2.740931272506714,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "APID",
            "probability": 0.0658744802226576,
            "start_logit": -1.3413892984390259,
            "end_logit": -2.703371286392212,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "STRING, APID, and HIPPIE",
            "probability": 0.056000655038407454,
            "start_logit": -2.087977647781372,
            "end_logit": -2.119170665740967,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "STRING, APID",
            "probability": 0.03122324242913432,
            "start_logit": -2.087977647781372,
            "end_logit": -2.703371286392212,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "STRING",
            "probability": 0.030072248839417795,
            "start_logit": -2.087977647781372,
            "end_logit": -2.740931272506714,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, APID, and HIPPIE,",
            "probability": 0.02255476506214779,
            "start_logit": -1.258078932762146,
            "end_logit": -3.8584864139556885,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "APID, and HIPPIE,",
            "probability": 0.020751862234874855,
            "start_logit": -1.3413892984390259,
            "end_logit": -3.8584864139556885,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "375 PPI resources, short-listed 125",
            "probability": 0.014955894239332588,
            "start_logit": -3.335224151611328,
            "end_logit": -2.1921820640563965,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HIPPIE,",
            "probability": 0.014240864218302769,
            "start_logit": -1.7179096937179565,
            "end_logit": -3.8584864139556885,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "STRING, APID, and HIPPIE,",
            "probability": 0.00983598539564089,
            "start_logit": -2.087977647781372,
            "end_logit": -3.8584864139556885,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "protein-protein interaction (PPI) databases and tools.We compiled 375 PPI resources, short-listed 125",
            "probability": 0.008851859296522553,
            "start_logit": -3.8597021102905273,
            "end_logit": -2.1921820640563965,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "G",
            "probability": 0.007344495667838745,
            "start_logit": -1.258078932762146,
            "end_logit": -4.9804816246032715,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "375",
            "probability": 0.006436553688469169,
            "start_logit": -3.335224151611328,
            "end_logit": -3.0352942943573,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "compiled 375 PPI resources, short-listed 125",
            "probability": 0.0061344603349077365,
            "start_logit": -4.226407527923584,
            "end_logit": -2.1921820640563965,
            "question_text": "List the main PPI databases."
        }
    ],
    "5c34a029da8336e21a000003": [
        {
            "text": "autoimmune disease of uncertain etiology that affects multiple tissues",
            "probability": 0.1970667803857301,
            "start_logit": -3.4673848152160645,
            "end_logit": -2.7878918647766113,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues",
            "probability": 0.13919640635995045,
            "start_logit": -3.743403196334839,
            "end_logit": -2.859530210494995,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "autoimmune disease of uncertain etiology that affects multiple tissues and organs",
            "probability": 0.09852664797709026,
            "start_logit": -3.4673848152160645,
            "end_logit": -3.481107473373413,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs",
            "probability": 0.0689313395134353,
            "start_logit": -3.9062399864196777,
            "end_logit": -3.399468421936035,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues",
            "probability": 0.061297197573191665,
            "start_logit": -4.635193347930908,
            "end_logit": -2.7878918647766113,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Systemic lupus erythematosus (SLE) is an autoimmune disease of uncertain etiology that affects multiple tissues",
            "probability": 0.06020276393476722,
            "start_logit": -4.653209209442139,
            "end_logit": -2.7878918647766113,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "autoimmune disease of uncertain etiology that affects multiple tissues and organs.",
            "probability": 0.04863719034864507,
            "start_logit": -3.4673848152160645,
            "end_logit": -4.187046051025391,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues and organs",
            "probability": 0.04387747903214844,
            "start_logit": -4.357949733734131,
            "end_logit": -3.399468421936035,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "autoimmune disease of uncertain etiology",
            "probability": 0.0389810809945243,
            "start_logit": -3.4673848152160645,
            "end_logit": -4.408358097076416,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs.",
            "probability": 0.03321928893832555,
            "start_logit": -3.848642587661743,
            "end_logit": -4.187046051025391,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "organs.Systemic lupus erythematosus (SLE) is an autoimmune disease of uncertain etiology that affects multiple tissues",
            "probability": 0.030620332924326615,
            "start_logit": -5.329263210296631,
            "end_logit": -2.7878918647766113,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Systemic lupus erythematosus (SLE) is an autoimmune disease of uncertain etiology that affects multiple tissues and organs",
            "probability": 0.03009932225938061,
            "start_logit": -4.653209209442139,
            "end_logit": -3.481107473373413,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs.Systemic lupus erythematosus (SLE) is an autoimmune disease of uncertain etiology",
            "probability": 0.025133993548811604,
            "start_logit": -3.9062399864196777,
            "end_logit": -4.408358097076416,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "autoimmune",
            "probability": 0.023707954150296834,
            "start_logit": -3.4673848152160645,
            "end_logit": -4.905623912811279,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs.Systemic lupus erythematosus",
            "probability": 0.02290034962665255,
            "start_logit": -3.9062399864196777,
            "end_logit": -4.501427173614502,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "organs",
            "probability": 0.01661137506858191,
            "start_logit": -5.329263210296631,
            "end_logit": -3.399468421936035,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues and organs.Systemic lupus erythematosus (SLE) is an autoimmune disease of uncertain etiology",
            "probability": 0.01599876460716663,
            "start_logit": -4.357949733734131,
            "end_logit": -4.408358097076416,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs.Systemic lupus erythematosus (SLE) is an autoimmune",
            "probability": 0.015286276097699423,
            "start_logit": -3.9062399864196777,
            "end_logit": -4.905623912811279,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues and organs.",
            "probability": 0.01512849329740057,
            "start_logit": -4.635193347930908,
            "end_logit": -4.187046051025391,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues and organs.Systemic lupus erythematosus",
            "probability": 0.01457696336187504,
            "start_logit": -4.357949733734131,
            "end_logit": -4.501427173614502,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        }
    ],
    "5be94f3d133db5eb78000022": [
        {
            "text": "hepatocellular carcinoma",
            "probability": 0.9916420360045255,
            "start_logit": 4.8173604011535645,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "patocellular carcinoma",
            "probability": 0.0023534602280964535,
            "start_logit": -1.226115107536316,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "carcinoma",
            "probability": 0.002347432115777264,
            "start_logit": -1.2286797761917114,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "oma",
            "probability": 0.0008053633050234318,
            "start_logit": -2.2984635829925537,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "he",
            "probability": 0.0006972449556075345,
            "start_logit": 4.8173604011535645,
            "end_logit": -2.2251124382019043,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cellular carcinoma",
            "probability": 0.0006835409302728333,
            "start_logit": -2.462470531463623,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular carcinoma.",
            "probability": 0.0005892571215820549,
            "start_logit": 4.8173604011535645,
            "end_logit": -2.3933866024017334,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "tocellular carcinoma",
            "probability": 0.00019118969530177216,
            "start_logit": -3.7364909648895264,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular car",
            "probability": 0.00019110128438933248,
            "start_logit": 4.8173604011535645,
            "end_logit": -3.5194456577301025,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular",
            "probability": 0.00015467030314808295,
            "start_logit": 4.8173604011535645,
            "end_logit": -3.7309534549713135,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cinoma",
            "probability": 0.00014931707313431452,
            "start_logit": -3.98368501663208,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular carcin",
            "probability": 0.00010744335885488573,
            "start_logit": 4.8173604011535645,
            "end_logit": -4.095285415649414,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "treatment of hepatocellular carcinoma",
            "probability": 8.299250431718043e-05,
            "start_logit": -4.571006774902344,
            "end_logit": 5.034868240356445,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "patocellular carcinoma.",
            "probability": 1.3984816591212292e-06,
            "start_logit": -1.226115107536316,
            "end_logit": -2.3933866024017334,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "carcinoma.",
            "probability": 1.3948996123898391e-06,
            "start_logit": -1.2286797761917114,
            "end_logit": -2.3933866024017334,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "oma.",
            "probability": 4.785658995034295e-07,
            "start_logit": -2.2984635829925537,
            "end_logit": -2.3933866024017334,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "patocellular car",
            "probability": 4.535399428613887e-07,
            "start_logit": -1.226115107536316,
            "end_logit": -3.5194456577301025,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "car",
            "probability": 4.523782534968658e-07,
            "start_logit": -1.2286797761917114,
            "end_logit": -3.5194456577301025,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cellular carcinoma.",
            "probability": 4.0617616683431085e-07,
            "start_logit": -2.462470531463623,
            "end_logit": -2.3933866024017334,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "patocellular",
            "probability": 3.670784352721547e-07,
            "start_logit": -1.226115107536316,
            "end_logit": -3.7309534549713135,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        }
    ],
    "5c34a761da8336e21a000005": [
        {
            "text": "immune cell metabolism",
            "probability": 0.20400721663375856,
            "start_logit": -2.362504482269287,
            "end_logit": -3.1028811931610107,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell metabolism signatures",
            "probability": 0.17253284755014034,
            "start_logit": -2.362504482269287,
            "end_logit": -3.270448923110962,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell",
            "probability": 0.1065162303275448,
            "start_logit": -2.362504482269287,
            "end_logit": -3.752739191055298,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients, are discussed herein.Recent insights into the immune cell metabolism",
            "probability": 0.07921357140762972,
            "start_logit": -2.825529098510742,
            "end_logit": -3.585864305496216,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell metabolism signatures,",
            "probability": 0.07872429853939006,
            "start_logit": -2.362504482269287,
            "end_logit": -4.055084705352783,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients, are discussed herein.Recent insights into the immune cell metabolism signatures",
            "probability": 0.04991045392724977,
            "start_logit": -2.825529098510742,
            "end_logit": -4.047781467437744,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "metabolism",
            "probability": 0.04539069919566273,
            "start_logit": -3.8653526306152344,
            "end_logit": -3.1028811931610107,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "metabolism signatures",
            "probability": 0.03838779193080583,
            "start_logit": -3.8653526306152344,
            "end_logit": -3.270448923110962,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress",
            "probability": 0.03146633311756107,
            "start_logit": -2.825529098510742,
            "end_logit": -4.509093761444092,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell metabolism signatures, specifically",
            "probability": 0.0268302408737604,
            "start_logit": -2.362504482269287,
            "end_logit": -5.13150691986084,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients, are discussed herein.Recent insights into the immune cell",
            "probability": 0.02396371217325573,
            "start_logit": -2.825529098510742,
            "end_logit": -4.781471252441406,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune",
            "probability": 0.019795986133462777,
            "start_logit": -2.362504482269287,
            "end_logit": -5.4355573654174805,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients, are discussed herein.Recent insights into the immune cell metabolism signatures,",
            "probability": 0.017895008209395633,
            "start_logit": -2.825529098510742,
            "end_logit": -5.073490142822266,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "metabolism signatures,",
            "probability": 0.01751580661387101,
            "start_logit": -3.8653526306152344,
            "end_logit": -4.055084705352783,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "Recent insights into the immune cell metabolism",
            "probability": 0.01722487508193299,
            "start_logit": -4.834305286407471,
            "end_logit": -3.1028811931610107,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "insights into the immune cell metabolism",
            "probability": 0.01560390932518778,
            "start_logit": -4.933138370513916,
            "end_logit": -3.1028811931610107,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients, are discussed herein.Recent insights",
            "probability": 0.01552020182822493,
            "start_logit": -2.825529098510742,
            "end_logit": -5.215869426727295,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "Recent insights into the immune cell metabolism signatures",
            "probability": 0.014567409896663337,
            "start_logit": -4.834305286407471,
            "end_logit": -3.270448923110962,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "insights into the immune cell metabolism signatures",
            "probability": 0.013196527815101524,
            "start_logit": -4.933138370513916,
            "end_logit": -3.270448923110962,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients,",
            "probability": 0.011736879419400601,
            "start_logit": -2.825529098510742,
            "end_logit": -5.495275974273682,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        }
    ],
    "5be44d8b133db5eb78000015": [
        {
            "text": "Bifidobacterium",
            "probability": 0.10317365441961639,
            "start_logit": 6.324368000030518,
            "end_logit": 5.7076191902160645,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium, Propionibacterium, and Bifidobacterium",
            "probability": 0.08520614572783723,
            "start_logit": 6.133028030395508,
            "end_logit": 5.7076191902160645,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium",
            "probability": 0.08161723404265528,
            "start_logit": 6.133028030395508,
            "end_logit": 5.664586067199707,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "lactic acid bacteria",
            "probability": 0.0767311071554478,
            "start_logit": 5.889000415802002,
            "end_logit": 5.8468804359436035,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Propionibacterium, and Bifidobacterium",
            "probability": 0.07616092291338276,
            "start_logit": 6.020802974700928,
            "end_logit": 5.7076191902160645,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, lactic acid bacteria",
            "probability": 0.06675981066309107,
            "start_logit": 5.7497944831848145,
            "end_logit": 5.8468804359436035,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus",
            "probability": 0.06658705102502058,
            "start_logit": 5.7497944831848145,
            "end_logit": 5.844289302825928,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "lactic acid bacteria, and other gram-positive bacteria (Corynebacterium",
            "probability": 0.0639443277941582,
            "start_logit": 5.889000415802002,
            "end_logit": 5.664586067199707,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium, Propionibacterium",
            "probability": 0.06302853427612568,
            "start_logit": 6.133028030395508,
            "end_logit": 5.40613317489624,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Propionibacterium",
            "probability": 0.05633761859949062,
            "start_logit": 6.020802974700928,
            "end_logit": 5.40613317489624,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, lactic acid bacteria, and other gram-positive bacteria (Corynebacterium",
            "probability": 0.055634688130699654,
            "start_logit": 5.7497944831848145,
            "end_logit": 5.664586067199707,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, lactic acid bacteria",
            "probability": 0.05077944387144624,
            "start_logit": 5.476184844970703,
            "end_logit": 5.8468804359436035,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus",
            "probability": 0.050648037891448415,
            "start_logit": 5.476184844970703,
            "end_logit": 5.844289302825928,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "lactic acid bacteria, and other gram-positive bacteria (Corynebacterium, Propionibacterium",
            "probability": 0.04938071356389716,
            "start_logit": 5.889000415802002,
            "end_logit": 5.40613317489624,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus",
            "probability": 0.041587627744927524,
            "start_logit": 5.476184844970703,
            "end_logit": 5.647191524505615,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Bifidobacter",
            "probability": 0.003135141056881621,
            "start_logit": 6.324368000030518,
            "end_logit": 2.2138798236846924,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium, Propionibacterium, and Bifidobacter",
            "probability": 0.0025891618095015448,
            "start_logit": 6.133028030395508,
            "end_logit": 2.2138798236846924,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "lactic acid bacteria, and other gram-positive bacteria",
            "probability": 0.002344577789838193,
            "start_logit": 5.889000415802002,
            "end_logit": 2.3586785793304443,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Propionibacterium, and Bifidobacter",
            "probability": 0.0023143043415388047,
            "start_logit": 6.020802974700928,
            "end_logit": 2.2138798236846924,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, lactic acid bacteria, and other gram-positive bacteria",
            "probability": 0.0020398971829950117,
            "start_logit": 5.7497944831848145,
            "end_logit": 2.3586785793304443,
            "question_text": "What are the 3 main bacteria found in human milk?"
        }
    ],
    "5c0e82b2133db5eb7800002d": [
        {
            "text": "CD8 Cellular senescence",
            "probability": 0.40798331349649186,
            "start_logit": 2.095752239227295,
            "end_logit": 2.141944169998169,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CD8",
            "probability": 0.11956807507294386,
            "start_logit": 2.095752239227295,
            "end_logit": 0.9146037697792053,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype (SASP).Human CD8 Cellular senescence",
            "probability": 0.10800989270181857,
            "start_logit": 1.2167447805404663,
            "end_logit": 1.6919481754302979,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence",
            "probability": 0.08486508726446147,
            "start_logit": 0.5255887508392334,
            "end_logit": 2.141944169998169,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CD8 Cellular senescence is accompanied by a senescence-associated secretory phenotype (SASP).Human CD8",
            "probability": 0.06372912418972795,
            "start_logit": 1.4665080308914185,
            "end_logit": 0.9146037697792053,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype (SASP).Human CD8 Cellular senescence",
            "probability": 0.05411258547351343,
            "start_logit": 0.5255887508392334,
            "end_logit": 1.6919481754302979,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "Human CD8 Cellular senescence",
            "probability": 0.04050060397045042,
            "start_logit": -0.21415714919567108,
            "end_logit": 2.141944169998169,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CD8 Cellular senescence is accompanied by a senescence-associated secretory phenotype",
            "probability": 0.04030858983952931,
            "start_logit": 2.095752239227295,
            "end_logit": -0.17271751165390015,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype",
            "probability": 0.016735917107692348,
            "start_logit": 1.2167447805404663,
            "end_logit": -0.17271751165390015,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype (SASP).Human CD8",
            "probability": 0.013631425572771432,
            "start_logit": 1.2167447805404663,
            "end_logit": -0.37789681553840637,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "Human CD8",
            "probability": 0.011869552248440237,
            "start_logit": -0.21415714919567108,
            "end_logit": 0.9146037697792053,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CD8 Cellular senescence is accompanied by a senescence",
            "probability": 0.009864331655992003,
            "start_logit": 2.095752239227295,
            "end_logit": -1.5803567171096802,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype",
            "probability": 0.008384637020867901,
            "start_logit": 0.5255887508392334,
            "end_logit": -0.17271751165390015,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype (SASP).Human CD8",
            "probability": 0.008191906470845566,
            "start_logit": -0.5849869847297668,
            "end_logit": 0.9146037697792053,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "Human CD8 Cellular senescence is accompanied by a senescence-associated secretory phenotype",
            "probability": 0.00400144363676809,
            "start_logit": -0.21415714919567108,
            "end_logit": -0.17271751165390015,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "Cellular senescence",
            "probability": 0.0027296981077566335,
            "start_logit": -2.911283016204834,
            "end_logit": 2.141944169998169,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence",
            "probability": 0.0020518911903943575,
            "start_logit": 0.5255887508392334,
            "end_logit": -1.5803567171096802,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CD8 Cellular senescence is accompanied by a se",
            "probability": 0.0013373448975071611,
            "start_logit": 2.095752239227295,
            "end_logit": -3.5785958766937256,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "secretory phenotype (SASP).Human CD8 Cellular senescence",
            "probability": 0.00111752616492586,
            "start_logit": -3.354360580444336,
            "end_logit": 1.6919481754302979,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CD8 Cellular senescence is accompanied by a senescence-associated secretory phenotype (SASP).",
            "probability": 0.0010070539171014377,
            "start_logit": 2.095752239227295,
            "end_logit": -3.862252950668335,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        }
    ],
    "5c61f379e842deac67000006": [
        {
            "text": "c.1482delinsGCCAGG",
            "probability": 0.4535693641307882,
            "start_logit": 1.1590489149093628,
            "end_logit": 0.21141596138477325,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.27284111910782916,
            "start_logit": 1.1590489149093628,
            "end_logit": -0.2968426048755646,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.1058192001006459,
            "start_logit": -0.2963673174381256,
            "end_logit": 0.21141596138477325,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG",
            "probability": 0.050907663289076734,
            "start_logit": -1.0280858278274536,
            "end_logit": 0.21141596138477325,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.030623108440258562,
            "start_logit": -1.0280858278274536,
            "end_logit": -0.2968426048755646,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter)",
            "probability": 0.02194673678017137,
            "start_logit": -0.2963673174381256,
            "end_logit": -1.3616975545883179,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23",
            "probability": 0.017224764447397,
            "start_logit": 1.1590489149093628,
            "end_logit": -3.0593841075897217,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T",
            "probability": 0.011445914611634023,
            "start_logit": -0.2963673174381256,
            "end_logit": -2.012683153152466,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.011001710004371959,
            "start_logit": -2.5600485801696777,
            "end_logit": 0.21141596138477325,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delins",
            "probability": 0.005590423951408102,
            "start_logit": 1.1590489149093628,
            "end_logit": -4.1846771240234375,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter),",
            "probability": 0.002564262619019629,
            "start_logit": -0.2963673174381256,
            "end_logit": -3.5086450576782227,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter",
            "probability": 0.002429692623613931,
            "start_logit": -0.2963673174381256,
            "end_logit": -3.562551259994507,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1558C>T (p.Gln520Ter)",
            "probability": 0.0022817374670010913,
            "start_logit": -2.5600485801696777,
            "end_logit": -1.3616975545883179,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "p.Ile494MetfsTer23)",
            "probability": 0.0021650603726390658,
            "start_logit": -3.6773924827575684,
            "end_logit": -0.2968426048755646,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23",
            "probability": 0.0019332710232803497,
            "start_logit": -1.0280858278274536,
            "end_logit": -3.0593841075897217,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.001860455604856049,
            "start_logit": -4.337277889251709,
            "end_logit": 0.21141596138477325,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "GG",
            "probability": 0.0015990647596534394,
            "start_logit": -4.488680362701416,
            "end_logit": 0.21141596138477325,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.0015970682740722294,
            "start_logit": -4.489929676055908,
            "end_logit": 0.21141596138477325,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter), and c.1482delins",
            "probability": 0.0013042639947589473,
            "start_logit": -0.2963673174381256,
            "end_logit": -4.1846771240234375,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "three",
            "probability": 0.0012951183975244932,
            "start_logit": -2.6421024799346924,
            "end_logit": -1.8459787368774414,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        }
    ],
    "5c53131e7e3cb0e231000012": [
        {
            "text": "clinical symptoms",
            "probability": 0.3678533721488237,
            "start_logit": -4.191562175750732,
            "end_logit": -3.7417783737182617,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "clinical",
            "probability": 0.3213062584586921,
            "start_logit": -3.920126438140869,
            "end_logit": -4.14850378036499,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "symptoms",
            "probability": 0.047825343877750386,
            "start_logit": -6.231690883636475,
            "end_logit": -3.7417783737182617,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Elimination.",
            "probability": 0.03491613485273026,
            "start_logit": -5.198086738586426,
            "end_logit": -5.089989185333252,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Elimination",
            "probability": 0.03359712923377168,
            "start_logit": -5.198086738586426,
            "end_logit": -5.12849760055542,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "clinical symptoms while anticipating that weaker symptoms than those in typical cases would be seen;",
            "probability": 0.028166059432022262,
            "start_logit": -4.191562175750732,
            "end_logit": -6.311345100402832,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "classifying measles patients based on their clinical symptoms",
            "probability": 0.021938228249701784,
            "start_logit": -7.011015892028809,
            "end_logit": -3.7417783737182617,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "strategies for classifying measles patients based on their clinical symptoms",
            "probability": 0.019033379608382195,
            "start_logit": -7.15305233001709,
            "end_logit": -3.7417783737182617,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "classifying measles patients based on their clinical",
            "probability": 0.017529589092268566,
            "start_logit": -6.8286309242248535,
            "end_logit": -4.14850378036499,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "catch-up vaccination and they can be summarized as strategies for classifying measles patients based on their clinical",
            "probability": 0.013030636881658848,
            "start_logit": -7.125217914581299,
            "end_logit": -4.14850378036499,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Quarantine and Elimination.",
            "probability": 0.012557497162790726,
            "start_logit": -6.220717906951904,
            "end_logit": -5.089989185333252,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Quarantine and Elimination",
            "probability": 0.012083120219648573,
            "start_logit": -6.220717906951904,
            "end_logit": -5.12849760055542,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Korea: Quarantine and Elimination.",
            "probability": 0.010581150919784338,
            "start_logit": -6.391961574554443,
            "end_logit": -5.089989185333252,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Korea: Quarantine and Elimination",
            "probability": 0.010181433208270432,
            "start_logit": -6.391961574554443,
            "end_logit": -5.12849760055542,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Measles in Korea: Quarantine and Elimination.",
            "probability": 0.009304480116004838,
            "start_logit": -6.5205397605896,
            "end_logit": -5.089989185333252,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Measles in Korea: Quarantine and Elimination",
            "probability": 0.008952990422020593,
            "start_logit": -6.5205397605896,
            "end_logit": -5.12849760055542,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "strategies for classifying measles patients based on their clinical",
            "probability": 0.00869944815835372,
            "start_logit": -7.15305233001709,
            "end_logit": -4.524713039398193,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Korea",
            "probability": 0.00789331944141789,
            "start_logit": -6.391961574554443,
            "end_logit": -5.383046627044678,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Measles",
            "probability": 0.007609479053157358,
            "start_logit": -6.5205397605896,
            "end_logit": -5.291090488433838,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Measles in Korea",
            "probability": 0.006940949462749375,
            "start_logit": -6.5205397605896,
            "end_logit": -5.383046627044678,
            "question_text": "Please list symptoms of measles."
        }
    ],
    "5c5315727e3cb0e231000014": [
        {
            "text": "MERTK",
            "probability": 0.6375014084289606,
            "start_logit": 5.742965221405029,
            "end_logit": 5.184601306915283,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and MERTK",
            "probability": 0.17009256078808993,
            "start_logit": 4.531553745269775,
            "end_logit": 5.074799060821533,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO) and MERTK",
            "probability": 0.09120660586304975,
            "start_logit": 3.9083383083343506,
            "end_logit": 5.074799060821533,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL",
            "probability": 0.05683319658109148,
            "start_logit": 4.531553745269775,
            "end_logit": 3.978576898574829,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL",
            "probability": 0.03047495396913206,
            "start_logit": 3.9083383083343506,
            "end_logit": 3.978576898574829,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3",
            "probability": 0.010766837458090076,
            "start_logit": 3.9083383083343506,
            "end_logit": 2.9381425380706787,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERT",
            "probability": 0.001828113948607792,
            "start_logit": 5.54674768447876,
            "end_logit": -0.4734528362751007,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and MERT",
            "probability": 0.00027302601116780594,
            "start_logit": 4.531553745269775,
            "end_logit": -1.359731912612915,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO)",
            "probability": 0.0001665989063739915,
            "start_logit": 4.531553745269775,
            "end_logit": -1.8537098169326782,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "ME",
            "probability": 0.00016411438740082473,
            "start_logit": 5.747244834899902,
            "end_logit": -3.0844264030456543,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO) and MERT",
            "probability": 0.00014640132217167692,
            "start_logit": 3.9083383083343506,
            "end_logit": -1.359731912612915,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "The TYRO3, AXL (also known as UFO) and MERTK",
            "probability": 0.00012897425954189965,
            "start_logit": -2.6529314517974854,
            "end_logit": 5.074799060821533,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO)",
            "probability": 8.933324726528387e-05,
            "start_logit": 3.9083383083343506,
            "end_logit": -1.8537098169326782,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (TAM)",
            "probability": 8.041158823976695e-05,
            "start_logit": 5.742965221405029,
            "end_logit": -3.7935521602630615,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "K",
            "probability": 7.30192415780834e-05,
            "start_logit": -3.3316235542297363,
            "end_logit": 5.184601306915283,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and ME",
            "probability": 4.866074167461046e-05,
            "start_logit": 4.531553745269775,
            "end_logit": -3.0844264030456543,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "The TYRO3, AXL",
            "probability": 4.309429767229863e-05,
            "start_logit": -2.6529314517974854,
            "end_logit": 3.978576898574829,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "L (also known as UFO) and MERTK",
            "probability": 2.976188873702187e-05,
            "start_logit": -4.1193156242370605,
            "end_logit": 5.074799060821533,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "UFO) and MERTK",
            "probability": 2.6834330435728158e-05,
            "start_logit": -4.222862243652344,
            "end_logit": 5.074799060821533,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO) and ME",
            "probability": 2.6092740719267488e-05,
            "start_logit": 3.9083383083343506,
            "end_logit": -3.0844264030456543,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        }
    ],
    "5c658a8f7c78d69471000007": [
        {
            "text": "ivosidenib",
            "probability": 0.25752977442237757,
            "start_logit": -2.7778172492980957,
            "end_logit": -3.2005488872528076,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib",
            "probability": 0.2007265116130544,
            "start_logit": -2.7778172492980957,
            "end_logit": -3.4497408866882324,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib, glasdegib",
            "probability": 0.08360833449662662,
            "start_logit": -2.7778172492980957,
            "end_logit": -4.325541019439697,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib, ivosidenib",
            "probability": 0.07645735569071756,
            "start_logit": -3.9922194480895996,
            "end_logit": -3.2005488872528076,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "gilteritinib",
            "probability": 0.06964061345997126,
            "start_logit": -3.8364126682281494,
            "end_logit": -3.4497408866882324,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib, ivosidenib, gilteritinib",
            "probability": 0.059593180358964735,
            "start_logit": -3.9922194480895996,
            "end_logit": -3.4497408866882324,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib",
            "probability": 0.033383362093411,
            "start_logit": -3.9922194480895996,
            "end_logit": -4.029224395751953,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin, enasidenib, ivosidenib",
            "probability": 0.029686545913367807,
            "start_logit": -4.938258647918701,
            "end_logit": -3.2005488872528076,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "gilteritinib, glasdegib",
            "probability": 0.029007307793680014,
            "start_logit": -3.8364126682281494,
            "end_logit": -4.325541019439697,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib, ivosidenib, gilteritinib, glasdegib",
            "probability": 0.024822264468855958,
            "start_logit": -3.9922194480895996,
            "end_logit": -4.325541019439697,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin, enasidenib, ivosidenib, gilteritinib",
            "probability": 0.02313859364959437,
            "start_logit": -4.938258647918701,
            "end_logit": -3.4497408866882324,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "glasdegib",
            "probability": 0.0226434301368219,
            "start_logit": -4.084090709686279,
            "end_logit": -4.325541019439697,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib, glasdegib, and venetoclax",
            "probability": 0.019133018875461358,
            "start_logit": -2.7778172492980957,
            "end_logit": -5.800268650054932,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib, glasdegib, and venetoclax.",
            "probability": 0.01867904038362439,
            "start_logit": -2.7778172492980957,
            "end_logit": -5.824282169342041,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin, enasidenib",
            "probability": 0.012961953792092062,
            "start_logit": -4.938258647918701,
            "end_logit": -4.029224395751953,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin, enasidenib, ivosidenib, gilteritinib, glasdegib",
            "probability": 0.009637886206910945,
            "start_logit": -4.938258647918701,
            "end_logit": -4.325541019439697,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Since 2017, eight novel agents have been introduced, 6 of which are oral: midostaurin, enasidenib, ivosidenib",
            "probability": 0.00855067477682184,
            "start_logit": -6.1829423904418945,
            "end_logit": -3.2005488872528076,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib, glasdegib,",
            "probability": 0.007681531004729536,
            "start_logit": -2.7778172492980957,
            "end_logit": -6.712865352630615,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "gilteritinib, glasdegib, and venetoclax",
            "probability": 0.006638062710903418,
            "start_logit": -3.8364126682281494,
            "end_logit": -5.800268650054932,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "gilteritinib, glasdegib, and venetoclax.",
            "probability": 0.006480558152013338,
            "start_logit": -3.8364126682281494,
            "end_logit": -5.824282169342041,
            "question_text": "Name 4 side effects of enasidenib"
        }
    ],
    "5c76c1457c78d694710000a6": [
        {
            "text": "inflammatory bowel disease",
            "probability": 0.24675327639162917,
            "start_logit": -2.853653907775879,
            "end_logit": -3.261364221572876,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "autoimmune disorders. The study examined the level and function of MAIT cells in patients with inflammatory bowel disease",
            "probability": 0.1255980750337606,
            "start_logit": -3.5289559364318848,
            "end_logit": -3.261364221572876,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1)-dependent and -independent stimulations was decreased",
            "probability": 0.05700319001696801,
            "start_logit": -3.4149856567382812,
            "end_logit": -4.165314197540283,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1)-dependent and -independent stimulations was decreased in IBD patients,",
            "probability": 0.053383824599089594,
            "start_logit": -3.4149856567382812,
            "end_logit": -4.2309136390686035,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1",
            "probability": 0.04963691496378612,
            "start_logit": -3.4149856567382812,
            "end_logit": -4.303686618804932,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "autoimmune disorders",
            "probability": 0.047028441282976535,
            "start_logit": -3.5289559364318848,
            "end_logit": -4.243698596954346,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1)-dependent and -independent stimulations was decreased",
            "probability": 0.039182875121823245,
            "start_logit": -3.789853096008301,
            "end_logit": -4.165314197540283,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "inflammatory bowel disease (IBD).",
            "probability": 0.03894224040015407,
            "start_logit": -2.853653907775879,
            "end_logit": -5.107673645019531,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "inflammatory bowel disease (IBD). Circulating MAIT cell levels were significantly reduced in IBD patients.",
            "probability": 0.0371474476776953,
            "start_logit": -2.853653907775879,
            "end_logit": -5.154858112335205,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1)-dependent and -independent stimulations was decreased in IBD patients,",
            "probability": 0.03669499430064883,
            "start_logit": -3.789853096008301,
            "end_logit": -4.2309136390686035,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1",
            "probability": 0.03411944208525263,
            "start_logit": -3.789853096008301,
            "end_logit": -4.303686618804932,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1)",
            "probability": 0.0336546632316695,
            "start_logit": -3.4149856567382812,
            "end_logit": -4.692269802093506,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "inflammatory bowel disease (IBD)",
            "probability": 0.032682210552430285,
            "start_logit": -2.853653907775879,
            "end_logit": -5.282922267913818,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "play an important role in autoimmune disorders. The study examined the level and function of MAIT cells in patients with inflammatory bowel disease",
            "probability": 0.028764178752098236,
            "start_logit": -5.0029120445251465,
            "end_logit": -3.261364221572876,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b",
            "probability": 0.026982979238591862,
            "start_logit": -3.4149856567382812,
            "end_logit": -4.913215160369873,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "decreased",
            "probability": 0.024675991644483135,
            "start_logit": -4.252262115478516,
            "end_logit": -4.165314197540283,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1)",
            "probability": 0.02313355561822052,
            "start_logit": -3.789853096008301,
            "end_logit": -4.692269802093506,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "decreased in IBD patients,",
            "probability": 0.023109212122436842,
            "start_logit": -4.252262115478516,
            "end_logit": -4.2309136390686035,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein",
            "probability": 0.021684782860526795,
            "start_logit": -3.4149856567382812,
            "end_logit": -5.131810665130615,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "autoimmune disorders. The study examined the level and function of MAIT cells in patients with inflammatory bowel disease (IBD).",
            "probability": 0.01982170410575841,
            "start_logit": -3.5289559364318848,
            "end_logit": -5.107673645019531,
            "question_text": "List MHC-I-associated inflammatory disorders."
        }
    ],
    "5c6c46677c78d69471000035": [
        {
            "text": "limma",
            "probability": 0.6695152124127838,
            "start_logit": 3.5764153003692627,
            "end_logit": 2.547623872756958,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package",
            "probability": 0.171194702829289,
            "start_logit": 3.5764153003692627,
            "end_logit": 1.1838715076446533,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R/Bioconductor",
            "probability": 0.0732585650731663,
            "start_logit": 3.5764153003692627,
            "end_logit": 0.33506515622138977,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R",
            "probability": 0.02623731689548724,
            "start_logit": 3.5764153003692627,
            "end_logit": -0.6917473077774048,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R/Bioconductor)",
            "probability": 0.013903634642108522,
            "start_logit": 3.5764153003692627,
            "end_logit": -1.3267797231674194,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "l",
            "probability": 0.011145860793129049,
            "start_logit": 3.5764153003692627,
            "end_logit": -1.5478618144989014,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "the limma",
            "probability": 0.0073194505073195006,
            "start_logit": -0.939603328704834,
            "end_logit": 2.547623872756958,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "lim",
            "probability": 0.004613354362141869,
            "start_logit": 3.5764153003692627,
            "end_logit": -2.4299747943878174,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "Bioconductor",
            "probability": 0.004246529459311447,
            "start_logit": 0.7285221815109253,
            "end_logit": 0.33506515622138977,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R/Bio",
            "probability": 0.003563148004124984,
            "start_logit": 3.5764153003692627,
            "end_logit": -2.6882855892181396,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "R/Bioconductor",
            "probability": 0.002501900127912088,
            "start_logit": 0.1994706243276596,
            "end_logit": 0.33506515622138977,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "mRNA counts were normalized, log2 transformed for differential expression analysis using linear models in the limma",
            "probability": 0.002141032957651096,
            "start_logit": -2.1688501834869385,
            "end_logit": 2.547623872756958,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "in the limma",
            "probability": 0.00207800957817457,
            "start_logit": -2.198728084564209,
            "end_logit": 2.547623872756958,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "the limma package",
            "probability": 0.001871579810649161,
            "start_logit": -0.939603328704834,
            "end_logit": 1.1838715076446533,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (",
            "probability": 0.0018262912865010148,
            "start_logit": 3.5764153003692627,
            "end_logit": -3.356642723083496,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "linear models in the limma",
            "probability": 0.001073193362975569,
            "start_logit": -2.859499931335449,
            "end_logit": 2.547623872756958,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "using linear models in the limma",
            "probability": 0.0009207811583104897,
            "start_logit": -3.01267147064209,
            "end_logit": 2.547623872756958,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "R",
            "probability": 0.0008960473963874262,
            "start_logit": 0.1994706243276596,
            "end_logit": -0.6917473077774048,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "analysis using linear models in the limma",
            "probability": 0.000887446801384042,
            "start_logit": -3.0495452880859375,
            "end_logit": 2.547623872756958,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "Bioconductor)",
            "probability": 0.0008059425411929537,
            "start_logit": 0.7285221815109253,
            "end_logit": -1.3267797231674194,
            "question_text": "List available R packages for processing NanoString data"
        }
    ],
    "5c76e6d27c78d694710000ac": [
        {
            "text": "acridine orange",
            "probability": 0.9482117501842225,
            "start_logit": 2.4190874099731445,
            "end_logit": 3.1165988445281982,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (AO)",
            "probability": 0.017441799845888704,
            "start_logit": 2.4190874099731445,
            "end_logit": -0.8791093826293945,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (AO), the electronopaque colloidal Thorotrast",
            "probability": 0.017090160474059944,
            "start_logit": 2.4190874099731445,
            "end_logit": -0.8994761109352112,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "orange",
            "probability": 0.006341134170296349,
            "start_logit": -2.588432788848877,
            "end_logit": 3.1165988445281982,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "cridine orange",
            "probability": 0.003983095968455029,
            "start_logit": -3.0534310340881348,
            "end_logit": 3.1165988445281982,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Candida albicans.The macrophages were labeled with acridine orange",
            "probability": 0.002470295911551336,
            "start_logit": -3.5311524868011475,
            "end_logit": 3.1165988445281982,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "macrophages infected with Candida albicans.The macrophages were labeled with acridine orange",
            "probability": 0.0009630267152291553,
            "start_logit": -4.4731645584106445,
            "end_logit": 3.1165988445281982,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (AO), the electronopaque colloidal Thorotrast, or both markers.",
            "probability": 0.0007644442932327232,
            "start_logit": 2.4190874099731445,
            "end_logit": -4.006585121154785,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Thorotrast",
            "probability": 0.0007190310122084439,
            "start_logit": -0.7492662668228149,
            "end_logit": -0.8994761109352112,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "murine macrophages infected with Candida albicans.The macrophages were labeled with acridine orange",
            "probability": 0.0007038031726303679,
            "start_logit": -4.786746978759766,
            "end_logit": 3.1165988445281982,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Thorotrast, or both markers.After phagocytosis of heat-killed C. albicans",
            "probability": 0.00045090962771831373,
            "start_logit": -0.7492662668228149,
            "end_logit": -1.3661136627197266,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "colloidal Thorotrast",
            "probability": 0.00022401268042622507,
            "start_logit": -1.9154680967330933,
            "end_logit": -0.8994761109352112,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "colloidal Thorotrast, or both markers.After phagocytosis of heat-killed C. albicans",
            "probability": 0.0001404799968570598,
            "start_logit": -1.9154680967330933,
            "end_logit": -1.3661136627197266,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "orange (AO)",
            "probability": 0.00011664144952089709,
            "start_logit": -2.588432788848877,
            "end_logit": -0.8791093826293945,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "orange (AO), the electronopaque colloidal Thorotrast",
            "probability": 0.0001142898730551006,
            "start_logit": -2.588432788848877,
            "end_logit": -0.8994761109352112,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "cridine orange (AO)",
            "probability": 7.326671772972807e-05,
            "start_logit": -3.0534310340881348,
            "end_logit": -0.8791093826293945,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "cridine orange (AO), the electronopaque colloidal Thorotrast",
            "probability": 7.178960740705056e-05,
            "start_logit": -3.0534310340881348,
            "end_logit": -0.8994761109352112,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Candida albicans.The macrophages were labeled with acridine orange (AO)",
            "probability": 4.5439646620097876e-05,
            "start_logit": -3.5311524868011475,
            "end_logit": -0.8791093826293945,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Thorotrast, or both markers.After phagocytosis of heat-killed C. albicans,",
            "probability": 4.246633617229272e-05,
            "start_logit": -0.7492662668228149,
            "end_logit": -3.7286689281463623,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Thorotrast, or both markers.",
            "probability": 3.216231671869821e-05,
            "start_logit": -0.7492662668228149,
            "end_logit": -4.006585121154785,
            "question_text": "List phagosomal markers."
        }
    ],
    "5c5214207e3cb0e231000003": [
        {
            "text": "Large-scale investigation of the reasons why potentially important genes are ignored",
            "probability": 0.3265466180977045,
            "start_logit": -1.9995704889297485,
            "end_logit": -1.9584499597549438,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation of the reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.1738048377422766,
            "start_logit": -1.9995704889297485,
            "end_logit": -2.5890896320343018,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation",
            "probability": 0.10646714910876177,
            "start_logit": -1.9995704889297485,
            "end_logit": -3.079186201095581,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "ignored",
            "probability": 0.05095717130346792,
            "start_logit": -3.8571577072143555,
            "end_logit": -1.9584499597549438,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "investigation of the reasons why potentially important genes are ignored",
            "probability": 0.048726074968089575,
            "start_logit": -3.9019289016723633,
            "end_logit": -1.9584499597549438,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation of the reasons why potentially important genes are ignored",
            "probability": 0.03923006042546354,
            "start_logit": -4.045507907867432,
            "end_logit": -2.031641960144043,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "potentially important genes are ignored",
            "probability": 0.03466154928018888,
            "start_logit": -4.242512226104736,
            "end_logit": -1.9584499597549438,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.02712201688628326,
            "start_logit": -3.8571577072143555,
            "end_logit": -2.5890896320343018,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "reasons why potentially important genes are ignored",
            "probability": 0.0264642350121816,
            "start_logit": -4.439157009124756,
            "end_logit": -2.031641960144043,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "investigation of the reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.025934513127044218,
            "start_logit": -3.9019289016723633,
            "end_logit": -2.5890896320343018,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation of the reasons why potentially important genes are ignored\"",
            "probability": 0.023649318566217457,
            "start_logit": -2.594839096069336,
            "end_logit": -3.988419771194458,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation of the reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.019551359113352967,
            "start_logit": -4.1844587326049805,
            "end_logit": -2.5890896320343018,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation of the reasons",
            "probability": 0.01908509046203489,
            "start_logit": -1.9995704889297485,
            "end_logit": -4.798115253448486,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.01844865209027103,
            "start_logit": -4.242512226104736,
            "end_logit": -2.5890896320343018,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "investigation",
            "probability": 0.016458526106150912,
            "start_logit": -3.901238441467285,
            "end_logit": -3.044511079788208,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.013082302777591344,
            "start_logit": -4.586243152618408,
            "end_logit": -2.5890896320343018,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation",
            "probability": 0.011976522017683584,
            "start_logit": -4.1844587326049805,
            "end_logit": -3.079186201095581,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "unknown",
            "probability": 0.0062544942397304015,
            "start_logit": -5.175323486328125,
            "end_logit": -2.737969398498535,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation of the reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown.",
            "probability": 0.006035790150715157,
            "start_logit": -2.594839096069336,
            "end_logit": -5.3540472984313965,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation of the reasons why potentially important genes are ignored\"",
            "probability": 0.005543718524790255,
            "start_logit": -4.045507907867432,
            "end_logit": -3.988419771194458,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        }
    ],
    "5c7ab080d774d0424000000b": [
        {
            "text": "cyclic GMP-AMP (cGAMP",
            "probability": 0.3023369056078345,
            "start_logit": 3.9103593826293945,
            "end_logit": 3.516530752182007,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP",
            "probability": 0.1927708375996564,
            "start_logit": 3.4603195190429688,
            "end_logit": 3.516530752182007,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP",
            "probability": 0.19039602684104875,
            "start_logit": 3.986846685409546,
            "end_logit": 2.9776077270507812,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP (cGAMP)",
            "probability": 0.12594659326949853,
            "start_logit": 3.986846685409546,
            "end_logit": 2.564359426498413,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP-AMP (cGAMP",
            "probability": 0.056833838312981666,
            "start_logit": 2.2389492988586426,
            "end_logit": 3.516530752182007,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP)",
            "probability": 0.04735291740948025,
            "start_logit": 3.4603195190429688,
            "end_logit": 2.112657070159912,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP",
            "probability": 0.030759387450751675,
            "start_logit": 3.9103593826293945,
            "end_logit": 1.2311840057373047,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP-AMP",
            "probability": 0.023069656462387893,
            "start_logit": 2.2389492988586426,
            "end_logit": 2.614917039871216,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP-AMP (cGAMP)",
            "probability": 0.013960867137422096,
            "start_logit": 2.2389492988586426,
            "end_logit": 2.112657070159912,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP",
            "probability": 0.005782205283432911,
            "start_logit": 2.2389492988586426,
            "end_logit": 1.2311840057373047,
            "question_text": "List STING agonists."
        },
        {
            "text": "AMP (cGAMP",
            "probability": 0.003388342333804557,
            "start_logit": -0.5808417797088623,
            "end_logit": 3.516530752182007,
            "question_text": "List STING agonists."
        },
        {
            "text": "(cGAMP",
            "probability": 0.0028508719999922314,
            "start_logit": -0.7535576820373535,
            "end_logit": 3.516530752182007,
            "question_text": "List STING agonists."
        },
        {
            "text": "AMP",
            "probability": 0.0013753759369087358,
            "start_logit": -0.5808417797088623,
            "end_logit": 2.614917039871216,
            "question_text": "List STING agonists."
        },
        {
            "text": "AMP (cGAMP)",
            "probability": 0.0008323245190276577,
            "start_logit": -0.5808417797088623,
            "end_logit": 2.112657070159912,
            "question_text": "List STING agonists."
        },
        {
            "text": "c",
            "probability": 0.0007037936244691926,
            "start_logit": 3.986846685409546,
            "end_logit": -2.6227686405181885,
            "question_text": "List STING agonists."
        },
        {
            "text": "(cGAMP)",
            "probability": 0.0007002983855939449,
            "start_logit": -0.7535576820373535,
            "end_logit": 2.112657070159912,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP (c",
            "probability": 0.0004005518178867678,
            "start_logit": 3.9103593826293945,
            "end_logit": -3.1099233627319336,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP (cGAM",
            "probability": 0.00024578366580834917,
            "start_logit": 3.9103593826293945,
            "end_logit": -3.5983147621154785,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAM",
            "probability": 0.000156712337287882,
            "start_logit": 3.4603195190429688,
            "end_logit": -3.5983147621154785,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic G",
            "probability": 0.0001367100047257194,
            "start_logit": 3.9103593826293945,
            "end_logit": -4.1849045753479,
            "question_text": "List STING agonists."
        }
    ],
    "5c6e01af7c78d69471000048": [
        {
            "text": "Antiviral drugs including maribavir",
            "probability": 0.4148471339347422,
            "start_logit": -2.468647003173828,
            "end_logit": -0.7095279097557068,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "maribavir",
            "probability": 0.3206170201760946,
            "start_logit": -2.7263097763061523,
            "end_logit": -0.7095279097557068,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "viral drugs including maribavir",
            "probability": 0.06539738385243866,
            "start_logit": -4.316074848175049,
            "end_logit": -0.7095279097557068,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral",
            "probability": 0.03488092126034085,
            "start_logit": -2.468647003173828,
            "end_logit": -3.185497999191284,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "drugs including maribavir",
            "probability": 0.03386099871247242,
            "start_logit": -4.974293231964111,
            "end_logit": -0.7095279097557068,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "vir",
            "probability": 0.017221348211425746,
            "start_logit": -5.650407314300537,
            "end_logit": -0.7095279097557068,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral drugs including maribavir and letermovir are in development and prospective clinical trials have recently been completed.",
            "probability": 0.013465127383430532,
            "start_logit": -2.468647003173828,
            "end_logit": -4.137334823608398,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral drugs including maribavir and letermovir are in development",
            "probability": 0.012833108901337513,
            "start_logit": -2.468647003173828,
            "end_logit": -4.1854095458984375,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "al drugs including maribavir",
            "probability": 0.012126783382484307,
            "start_logit": -6.001140594482422,
            "end_logit": -0.7095279097557068,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral drugs including maribavir and letermovir are in development and prospective clinical trials",
            "probability": 0.011484758101968723,
            "start_logit": -2.468647003173828,
            "end_logit": -4.296417236328125,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral drugs",
            "probability": 0.010872819376839126,
            "start_logit": -2.468647003173828,
            "end_logit": -4.351171970367432,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "maribavir and letermovir are in development and prospective clinical trials have recently been completed.",
            "probability": 0.010406602010286863,
            "start_logit": -2.7263097763061523,
            "end_logit": -4.137334823608398,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "maribavir and letermovir are in development",
            "probability": 0.009918142850637085,
            "start_logit": -2.7263097763061523,
            "end_logit": -4.1854095458984375,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "maribavir and letermovir are in development and prospective clinical trials",
            "probability": 0.008876062093454658,
            "start_logit": -2.7263097763061523,
            "end_logit": -4.296417236328125,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "viral",
            "probability": 0.0054987025585863936,
            "start_logit": -4.316074848175049,
            "end_logit": -3.185497999191284,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral drugs including maribavir and letermovir are in development and prospective clinical trials have recently been completed",
            "probability": 0.0042411603599924455,
            "start_logit": -2.468647003173828,
            "end_logit": -5.292601108551025,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral drugs including maribavir and letermovir",
            "probability": 0.004162259603177062,
            "start_logit": -2.468647003173828,
            "end_logit": -5.311379909515381,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "maribavir and letermovir are in development and prospective clinical trials have recently been completed",
            "probability": 0.0032778054504376862,
            "start_logit": -2.7263097763061523,
            "end_logit": -5.292601108551025,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "maribavir and letermovir",
            "probability": 0.0032168265416530196,
            "start_logit": -2.7263097763061523,
            "end_logit": -5.311379909515381,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antivir",
            "probability": 0.0027950352382002603,
            "start_logit": -2.468647003173828,
            "end_logit": -5.709593296051025,
            "question_text": "List two indications of Letermovir?"
        }
    ],
    "5c6b7daa7c78d6947100002b": [
        {
            "text": "telangiectasias",
            "probability": 0.18106076562663706,
            "start_logit": 4.032914638519287,
            "end_logit": 4.336306095123291,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, (2) elevated erythropoietin and erythrocytosis",
            "probability": 0.14238510291054277,
            "start_logit": 4.032914638519287,
            "end_logit": 4.096008777618408,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, (2) elevated erythropoietin",
            "probability": 0.09413021702872638,
            "start_logit": 4.032914638519287,
            "end_logit": 3.682152509689331,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin and erythrocytosis",
            "probability": 0.07498947056895747,
            "start_logit": 3.3917269706726074,
            "end_logit": 4.096008777618408,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis",
            "probability": 0.07328993507321957,
            "start_logit": 3.368802547454834,
            "end_logit": 4.096008777618408,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy",
            "probability": 0.05830629211575596,
            "start_logit": 3.4618823528289795,
            "end_logit": 3.7742156982421875,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin and erythrocytosis, (3) monoclonal gammopathy",
            "probability": 0.05435597982479599,
            "start_logit": 3.3917269706726074,
            "end_logit": 3.7742156982421875,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, (3) monoclonal gammopathy",
            "probability": 0.05312407464641625,
            "start_logit": 3.368802547454834,
            "end_logit": 3.7742156982421875,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin",
            "probability": 0.04957523642034462,
            "start_logit": 3.3917269706726074,
            "end_logit": 3.682152509689331,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin and erythrocytosis",
            "probability": 0.04311943819475723,
            "start_logit": 2.838353157043457,
            "end_logit": 4.096008777618408,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin and erythrocytosis, (3) monoclonal gammopathy",
            "probability": 0.031255045472223894,
            "start_logit": 2.838353157043457,
            "end_logit": 3.7742156982421875,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin",
            "probability": 0.02850608660921029,
            "start_logit": 2.838353157043457,
            "end_logit": 3.682152509689331,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy, (4) perinephric fluid collections",
            "probability": 0.025468829052536498,
            "start_logit": 3.4618823528289795,
            "end_logit": 2.9459609985351562,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, (3) monoclonal gammopathy, (4) perinephric fluid collections",
            "probability": 0.02320517952089332,
            "start_logit": 3.368802547454834,
            "end_logit": 2.9459609985351562,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(1) telangiectasias",
            "probability": 0.01683799848697133,
            "start_logit": 1.6577200889587402,
            "end_logit": 4.336306095123291,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(1) telangiectasias, (2) elevated erythropoietin and erythrocytosis",
            "probability": 0.013241301278482316,
            "start_logit": 1.6577200889587402,
            "end_logit": 4.096008777618408,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "perinephric fluid collections",
            "probability": 0.012014831757522597,
            "start_logit": 2.710568904876709,
            "end_logit": 2.9459609985351562,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias,",
            "probability": 0.009261911850580095,
            "start_logit": 4.032914638519287,
            "end_logit": 1.3633838891983032,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(1) telangiectasias, (2) elevated erythropoietin",
            "probability": 0.008753770848270417,
            "start_logit": 1.6577200889587402,
            "end_logit": 3.682152509689331,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(2) elevated erythropoietin and erythrocytosis",
            "probability": 0.007118532713156147,
            "start_logit": 1.0370808839797974,
            "end_logit": 4.096008777618408,
            "question_text": "List major features of TEMPI Syndrome."
        }
    ],
    "5c56bbb107647bbc4b000011": [
        {
            "text": "standard (ST) mutation mentions",
            "probability": 0.14341610451571588,
            "start_logit": -4.1397809982299805,
            "end_logit": -4.192384719848633,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation",
            "probability": 0.1033572292019365,
            "start_logit": -4.1397809982299805,
            "end_logit": -4.519943714141846,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation mentions",
            "probability": 0.08623071967322123,
            "start_logit": -4.648504734039307,
            "end_logit": -4.192384719848633,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing methods primarily target standard (ST) mutation mentions",
            "probability": 0.07819358510416846,
            "start_logit": -4.746343612670898,
            "end_logit": -4.192384719848633,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation",
            "probability": 0.06214482179395969,
            "start_logit": -4.648504734039307,
            "end_logit": -4.519943714141846,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "mutation mentions",
            "probability": 0.05775470425879418,
            "start_logit": -5.049326419830322,
            "end_logit": -4.192384719848633,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods",
            "probability": 0.05675271240450921,
            "start_logit": -4.648504734039307,
            "end_logit": -4.610707759857178,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing methods primarily target standard (ST) mutation",
            "probability": 0.05635261343224559,
            "start_logit": -4.746343612670898,
            "end_logit": -4.519943714141846,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing methods",
            "probability": 0.05146307561981888,
            "start_logit": -4.746343612670898,
            "end_logit": -4.610707759857178,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "mutation",
            "probability": 0.04162270496555086,
            "start_logit": -5.049326419830322,
            "end_logit": -4.519943714141846,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g.The extraction of sequence variants from the literature remains an important task.The extraction",
            "probability": 0.03416521590199136,
            "start_logit": -4.1397809982299805,
            "end_logit": -5.626926898956299,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g.The extraction",
            "probability": 0.031777526214804605,
            "start_logit": -4.1397809982299805,
            "end_logit": -5.699375629425049,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g.The extraction of sequence variants from the literature remains an important task",
            "probability": 0.03133308290436142,
            "start_logit": -4.1397809982299805,
            "end_logit": -5.713460445404053,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard",
            "probability": 0.02827362651872549,
            "start_logit": -4.1397809982299805,
            "end_logit": -5.8162055015563965,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "primarily target standard (ST) mutation mentions",
            "probability": 0.02801491307660834,
            "start_logit": -5.772794246673584,
            "end_logit": -4.192384719848633,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing",
            "probability": 0.025153895834596627,
            "start_logit": -4.746343612670898,
            "end_logit": -5.326559543609619,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g.The extraction of sequence variants from the literature remains an important task.",
            "probability": 0.0241547640564611,
            "start_logit": -4.1397809982299805,
            "end_logit": -5.973653316497803,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation mentions (e.g.The extraction of sequence variants from the literature remains an important task.The extraction",
            "probability": 0.020542261728332314,
            "start_logit": -4.648504734039307,
            "end_logit": -5.626926898956299,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "primarily target standard (ST) mutation",
            "probability": 0.02018980923871095,
            "start_logit": -5.772794246673584,
            "end_logit": -4.519943714141846,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation mentions (e.g.The extraction",
            "probability": 0.019106633555487328,
            "start_logit": -4.648504734039307,
            "end_logit": -5.699375629425049,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        }
    ],
    "5c6f107c7c78d69471000051": [
        {
            "text": "FAK",
            "probability": 0.9460551278753122,
            "start_logit": 6.318504333496094,
            "end_logit": 5.562373161315918,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor",
            "probability": 0.043448688008765286,
            "start_logit": 6.318504333496094,
            "end_logit": 2.4816529750823975,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor defactinib and the NF\u2011\u03baB",
            "probability": 0.007002905140531405,
            "start_logit": 6.318504333496094,
            "end_logit": 0.6563974022865295,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor defactinib",
            "probability": 0.0012024878877413654,
            "start_logit": 6.318504333496094,
            "end_logit": -1.1055350303649902,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK and PROX1",
            "probability": 0.0008278693598839422,
            "start_logit": 3.3879833221435547,
            "end_logit": 1.4516934156417847,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "F",
            "probability": 0.0005092502693142404,
            "start_logit": 6.318504333496094,
            "end_logit": -1.9647433757781982,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "PROX1",
            "probability": 0.0003686660097522758,
            "start_logit": 2.579019069671631,
            "end_logit": 1.4516934156417847,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "AK",
            "probability": 0.0002448299681737451,
            "start_logit": -1.9409878253936768,
            "end_logit": 5.562373161315918,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "inhibitor",
            "probability": 6.403011040819205e-05,
            "start_logit": -0.20147815346717834,
            "end_logit": 2.4816529750823975,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK and PROX1 (the target of SOX18",
            "probability": 5.0767333687793174e-05,
            "start_logit": 3.3879833221435547,
            "end_logit": -1.3399088382720947,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor defactinib and the NF\u2011\u03baB inhibitor Bay11\u20117082 attenuated LEC retraction",
            "probability": 4.6027695221597886e-05,
            "start_logit": 6.318504333496094,
            "end_logit": -4.368439674377441,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor defactinib and the NF\u2011\u03baB inhibitor",
            "probability": 3.301080252560785e-05,
            "start_logit": 6.318504333496094,
            "end_logit": -4.70084810256958,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor def",
            "probability": 3.0243430031461607e-05,
            "start_logit": 6.318504333496094,
            "end_logit": -4.7884039878845215,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011",
            "probability": 2.7824047280290817e-05,
            "start_logit": 6.318504333496094,
            "end_logit": -4.871782302856445,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "The FAK",
            "probability": 2.4954114880165173e-05,
            "start_logit": -4.224513053894043,
            "end_logit": 5.562373161315918,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "PROX1 (the target of SOX18",
            "probability": 2.260766159900494e-05,
            "start_logit": 2.579019069671631,
            "end_logit": -1.3399088382720947,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "AK\u2011inhibitor",
            "probability": 1.1244102578110004e-05,
            "start_logit": -1.9409878253936768,
            "end_logit": 2.4816529750823975,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "inhibitor defactinib and the NF\u2011\u03baB",
            "probability": 1.0320145667824597e-05,
            "start_logit": -0.20147815346717834,
            "end_logit": 0.6563974022865295,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "NF\u2011\u03baB",
            "probability": 9.943278233958298e-06,
            "start_logit": -0.23867926001548767,
            "end_logit": 0.6563974022865295,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK and PROX",
            "probability": 9.202758412006717e-06,
            "start_logit": 3.3879833221435547,
            "end_logit": -3.047658681869507,
            "question_text": "Which molecules are targeted by defactinib?"
        }
    ],
    "5c6ffa257c78d69471000056": [
        {
            "text": "autosomal recessive",
            "probability": 0.13322038048918314,
            "start_logit": -1.8701359033584595,
            "end_logit": -3.851515531539917,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis",
            "probability": 0.10944332324355739,
            "start_logit": -2.090149164199829,
            "end_logit": -3.8281002044677734,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III",
            "probability": 0.09906904136832966,
            "start_logit": -2.090149164199829,
            "end_logit": -3.927690029144287,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "autosomal recessive lysosomal storage disorder.",
            "probability": 0.09563243977105597,
            "start_logit": -1.8701359033584595,
            "end_logit": -4.183008193969727,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III, Sanfilippo Syndrome,",
            "probability": 0.0888333754638214,
            "start_logit": -2.090149164199829,
            "end_logit": -4.036744594573975,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III, Sanfilippo Syndrome",
            "probability": 0.08484773266655331,
            "start_logit": -2.090149164199829,
            "end_logit": -4.082648754119873,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III,",
            "probability": 0.07064928617320392,
            "start_logit": -2.090149164199829,
            "end_logit": -4.2657790184021,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "autosomal recessive lysosomal storage disorder",
            "probability": 0.06760089105754101,
            "start_logit": -1.8701359033584595,
            "end_logit": -4.5298991203308105,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "autosomal recessive lysosomal storage",
            "probability": 0.050769109056301005,
            "start_logit": -1.8701359033584595,
            "end_logit": -4.816232204437256,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS)",
            "probability": 0.03515008237117286,
            "start_logit": -2.090149164199829,
            "end_logit": -4.9638800621032715,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type II",
            "probability": 0.020753407659894064,
            "start_logit": -2.090149164199829,
            "end_logit": -5.4907965660095215,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "auto",
            "probability": 0.02036682715270076,
            "start_logit": -1.8701359033584595,
            "end_logit": -5.729612827301025,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "lysosomal storage disorder.",
            "probability": 0.01749768451344177,
            "start_logit": -3.5685794353485107,
            "end_logit": -4.183008193969727,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type",
            "probability": 0.017135013844985583,
            "start_logit": -2.090149164199829,
            "end_logit": -5.682383060455322,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Sanfilippo Syndrome, is an autosomal recessive",
            "probability": 0.01688347504705052,
            "start_logit": -3.935805320739746,
            "end_logit": -3.851515531539917,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III, Sanfilippo Syndrome, is an auto",
            "probability": 0.01634454490104069,
            "start_logit": -2.090149164199829,
            "end_logit": -5.729612827301025,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "M",
            "probability": 0.014840995577318506,
            "start_logit": -2.090149164199829,
            "end_logit": -5.826113700866699,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Sanfilippo Syndrome,",
            "probability": 0.014028714609911138,
            "start_logit": -3.935805320739746,
            "end_logit": -4.036744594573975,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (",
            "probability": 0.01353437977186894,
            "start_logit": -2.090149164199829,
            "end_logit": -5.91827392578125,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Sanfilippo Syndrome",
            "probability": 0.013399295261068613,
            "start_logit": -3.935805320739746,
            "end_logit": -4.082648754119873,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        }
    ],
    "5c78174b7c78d694710000b1": [
        {
            "text": "Bolt",
            "probability": 0.9689668084569915,
            "start_logit": 1.5466482639312744,
            "end_logit": 2.0292513370513916,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt,",
            "probability": 0.02006827124877713,
            "start_logit": 1.5466482639312744,
            "end_logit": -1.8478389978408813,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics search engine",
            "probability": 0.0030890880655633115,
            "start_logit": 1.5466482639312744,
            "end_logit": -3.7191030979156494,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud",
            "probability": 0.0022908230972341573,
            "start_logit": 1.5466482639312744,
            "end_logit": -4.018067836761475,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics search",
            "probability": 0.0021192571167950947,
            "start_logit": 1.5466482639312744,
            "end_logit": -4.095913410186768,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics",
            "probability": 0.0015269903633424596,
            "start_logit": 1.5466482639312744,
            "end_logit": -4.423680305480957,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics search engine to search for the presence of over 2.3 million known cancer mutations",
            "probability": 0.0009427273193229149,
            "start_logit": 1.5466482639312744,
            "end_logit": -4.905957221984863,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "shotgun proteomics remains challenging due to the large increase in proteomics search space.We present and examine the abilities of Bolt",
            "probability": 0.0008562776932264142,
            "start_logit": -5.484742641448975,
            "end_logit": 2.0292513370513916,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud-based proteomics search engine",
            "probability": 2.631824702626107e-05,
            "start_logit": -3.2187204360961914,
            "end_logit": -3.7191030979156494,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud",
            "probability": 1.9517231910149107e-05,
            "start_logit": -3.2187204360961914,
            "end_logit": -4.018067836761475,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud-based proteomics search",
            "probability": 1.8055533260365054e-05,
            "start_logit": -3.2187204360961914,
            "end_logit": -4.095913410186768,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "shotgun proteomics remains challenging due to the large increase in proteomics search space.We present and examine the abilities of Bolt,",
            "probability": 1.7734367020588797e-05,
            "start_logit": -5.484742641448975,
            "end_logit": -1.8478389978408813,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud-based proteomics",
            "probability": 1.3009570700548661e-05,
            "start_logit": -3.2187204360961914,
            "end_logit": -4.423680305480957,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "search engine",
            "probability": 1.2069785622959207e-05,
            "start_logit": -3.9982776641845703,
            "end_logit": -3.7191030979156494,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "search",
            "probability": 8.280430514363778e-06,
            "start_logit": -3.9982776641845703,
            "end_logit": -4.095913410186768,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud-based proteomics search engine to search for the presence of over 2.3 million known cancer mutations",
            "probability": 8.031797715621606e-06,
            "start_logit": -3.2187204360961914,
            "end_logit": -4.905957221984863,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "new cloud-based proteomics search engine",
            "probability": 4.672070779974335e-06,
            "start_logit": -4.947380542755127,
            "end_logit": -3.7191030979156494,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "a new cloud-based proteomics search engine",
            "probability": 4.330701322451814e-06,
            "start_logit": -5.023253440856934,
            "end_logit": -3.7191030979156494,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "proteomics search engine",
            "probability": 4.053447949945341e-06,
            "start_logit": -5.089415073394775,
            "end_logit": -3.7191030979156494,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "search engine to search for the presence of over 2.3 million known cancer mutations",
            "probability": 3.683454923794689e-06,
            "start_logit": -3.9982776641845703,
            "end_logit": -4.905957221984863,
            "question_text": "List search engines used in proteomics."
        }
    ],
    "5c62a276e842deac6700000a": [
        {
            "text": "TNFAIP3",
            "probability": 0.9280390635961187,
            "start_logit": 3.943096160888672,
            "end_logit": 3.916425943374634,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3 (TNFAIP3",
            "probability": 0.040118029171530574,
            "start_logit": 2.4950664043426514,
            "end_logit": 2.223207712173462,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3",
            "probability": 0.021981186433628955,
            "start_logit": 2.4950664043426514,
            "end_logit": 1.6215687990188599,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "TNFAIP",
            "probability": 0.005067470646713742,
            "start_logit": 3.943096160888672,
            "end_logit": -1.2938060760498047,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)",
            "probability": 0.001031917797827338,
            "start_logit": 2.4950664043426514,
            "end_logit": -1.4371991157531738,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "3",
            "probability": 0.0008704498798951784,
            "start_logit": -3.0287227630615234,
            "end_logit": 3.916425943374634,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "TNFAIP3 Impairs A20",
            "probability": 0.0005726366014693975,
            "start_logit": 3.943096160888672,
            "end_logit": -3.474151849746704,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha",
            "probability": 0.0005015038020785512,
            "start_logit": 2.4950664043426514,
            "end_logit": -2.158762216567993,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "TNFAIP3, A20)",
            "probability": 0.00030221843338831627,
            "start_logit": 1.2670421600341797,
            "end_logit": -1.4371991157531738,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "(TNFAIP3",
            "probability": 0.0002637958212813988,
            "start_logit": -2.52933931350708,
            "end_logit": 2.223207712173462,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "NFAIP3",
            "probability": 0.00024008016327428436,
            "start_logit": -4.316760063171387,
            "end_logit": 3.916425943374634,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "A De Novo Frameshift Mutation in TNFAIP3",
            "probability": 0.0002386445540660168,
            "start_logit": -4.322757720947266,
            "end_logit": 3.916425943374634,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "3 (TNFAIP3",
            "probability": 0.0001810669260486139,
            "start_logit": -2.9056479930877686,
            "end_logit": 2.223207712173462,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "TNFAIP3 in a Chinese patient with neuropsychiatric SLE (NPSLE).",
            "probability": 0.0001239034886033778,
            "start_logit": 3.225403070449829,
            "end_logit": -4.287207126617432,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "protein 3 (TNFAIP3",
            "probability": 0.00010176698968663074,
            "start_logit": -3.4818289279937744,
            "end_logit": 2.223207712173462,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3 (TNFAIP3,",
            "probability": 9.160920406723578e-05,
            "start_logit": 2.4950664043426514,
            "end_logit": -3.85884165763855,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor",
            "probability": 7.642318985895153e-05,
            "start_logit": 2.4950664043426514,
            "end_logit": -4.0400872230529785,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "Genome-wide association study of systemic lupus erythematosus (SLE) revealed tumor necrosis factor alpha-induced protein 3",
            "probability": 6.804583078456563e-05,
            "start_logit": -3.2826943397521973,
            "end_logit": 1.6215687990188599,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "induced protein 3 (TNFAIP3",
            "probability": 6.777242524666056e-05,
            "start_logit": -3.888359308242798,
            "end_logit": 2.223207712173462,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein",
            "probability": 6.241504443157938e-05,
            "start_logit": 2.4950664043426514,
            "end_logit": -4.24256706237793,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        }
    ],
    "5c72fb4a7c78d69471000082": [
        {
            "text": "achalasia",
            "probability": 0.17122006246804627,
            "start_logit": 4.65021276473999,
            "end_logit": 4.661755084991455,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrimia",
            "probability": 0.1643015123765171,
            "start_logit": 4.65021276473999,
            "end_logit": 4.620508670806885,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "alacrimia",
            "probability": 0.143839567599265,
            "start_logit": 4.517208099365234,
            "end_logit": 4.620508670806885,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, achalasia",
            "probability": 0.12760815472015694,
            "start_logit": 4.356227397918701,
            "end_logit": 4.661755084991455,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, achalasia, and alacrimia",
            "probability": 0.12245184652944024,
            "start_logit": 4.356227397918701,
            "end_logit": 4.620508670806885,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.09138352916831718,
            "start_logit": 4.356227397918701,
            "end_logit": 4.327856063842773,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Achalasia",
            "probability": 0.030954438558119867,
            "start_logit": 3.7431583404541016,
            "end_logit": 3.8583762645721436,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Achalasia, Alacrimia",
            "probability": 0.028169698680579912,
            "start_logit": 3.7431583404541016,
            "end_logit": 3.7641067504882812,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency, Achalasia",
            "probability": 0.02410272607707473,
            "start_logit": 3.492966890335083,
            "end_logit": 3.8583762645721436,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency, Achalasia, Alacrimia",
            "probability": 0.021934383648953202,
            "start_logit": 3.492966890335083,
            "end_logit": 3.7641067504882812,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Alacrimia",
            "probability": 0.018966033445382044,
            "start_logit": 3.3475611209869385,
            "end_logit": 3.7641067504882812,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency",
            "probability": 0.014101582532383665,
            "start_logit": 3.492966890335083,
            "end_logit": 3.322338342666626,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Achalasia, Alacrimia and Autonomic dysfunction",
            "probability": 0.011269346063904659,
            "start_logit": 3.7431583404541016,
            "end_logit": 2.8479461669921875,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency, Achalasia, Alacrimia and Autonomic dysfunction",
            "probability": 0.008774895423674331,
            "start_logit": 3.492966890335083,
            "end_logit": 2.8479461669921875,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Alacrimia and Autonomic dysfunction",
            "probability": 0.007587400801803686,
            "start_logit": 3.3475611209869385,
            "end_logit": 2.8479461669921875,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Autonomic dysfunction",
            "probability": 0.005833349434917512,
            "start_logit": 3.0846633911132812,
            "end_logit": 2.8479461669921875,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrimia.",
            "probability": 0.0023297690454688238,
            "start_logit": 4.65021276473999,
            "end_logit": 0.3645745813846588,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "alacrimia.",
            "probability": 0.002039621956360544,
            "start_logit": 4.517208099365234,
            "end_logit": 0.3645745813846588,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, achalasia, and alacrimia.",
            "probability": 0.0017363475081776751,
            "start_logit": 4.356227397918701,
            "end_logit": 0.3645745813846588,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency,",
            "probability": 0.0013957339614565697,
            "start_logit": 4.356227397918701,
            "end_logit": 0.14621122181415558,
            "question_text": "List features of the Triple A syndrome."
        }
    ],
    "5c8d00980101eac870000006": [
        {
            "text": "Arboviruses",
            "probability": 0.34868704247169247,
            "start_logit": -3.241690158843994,
            "end_logit": -1.7403082847595215,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Antiviral against Arboviruses",
            "probability": 0.15389401054118668,
            "start_logit": -4.059600830078125,
            "end_logit": -1.7403082847595215,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Arboviruses.Sirtuin inhibitors block infection of arboviruses",
            "probability": 0.08838738095862354,
            "start_logit": -3.241690158843994,
            "end_logit": -3.1127538681030273,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "arboviruses",
            "probability": 0.055646215008815066,
            "start_logit": -3.7044053077697754,
            "end_logit": -3.1127538681030273,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Arboviruses.",
            "probability": 0.05025336362152332,
            "start_logit": -3.241690158843994,
            "end_logit": -3.677405595779419,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "against Arboviruses",
            "probability": 0.0441210055678985,
            "start_logit": -5.308928966522217,
            "end_logit": -1.7403082847595215,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses",
            "probability": 0.04041518489426827,
            "start_logit": -5.3966593742370605,
            "end_logit": -1.7403082847595215,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Antiviral against Arboviruses.Sirtuin inhibitors block infection of arboviruses",
            "probability": 0.03901002010437072,
            "start_logit": -4.059600830078125,
            "end_logit": -3.1127538681030273,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Broadly Antiviral against Arboviruses",
            "probability": 0.02641063307742168,
            "start_logit": -5.822098255157471,
            "end_logit": -1.7403082847595215,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Antiviral against Arboviruses.",
            "probability": 0.022179463900006097,
            "start_logit": -4.059600830078125,
            "end_logit": -3.677405595779419,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Arboviruses.Sirtuin inhibitors block infection of arboviruses in multiple human cell types.",
            "probability": 0.02144540605460128,
            "start_logit": -3.241690158843994,
            "end_logit": -4.528972625732422,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Inhibitors Are Broadly Antiviral against Arboviruses",
            "probability": 0.019000654883204647,
            "start_logit": -6.151391506195068,
            "end_logit": -1.7403082847595215,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "infection of arboviruses",
            "probability": 0.01507535114244957,
            "start_logit": -5.0103583335876465,
            "end_logit": -3.1127538681030273,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "arboviruses in multiple human cell types.",
            "probability": 0.013501425919887006,
            "start_logit": -3.7044053077697754,
            "end_logit": -4.528972625732422,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "against Arboviruses.Sirtuin inhibitors block infection of arboviruses",
            "probability": 0.01118406953055615,
            "start_logit": -5.308928966522217,
            "end_logit": -3.1127538681030273,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Sirtuin inhibitors block infection of arboviruses",
            "probability": 0.01084501790756563,
            "start_logit": -5.3397135734558105,
            "end_logit": -3.1127538681030273,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Arboviruses.Sirtuin inhibitors block infection of arboviruses in multiple human cell types",
            "probability": 0.010597335041749036,
            "start_logit": -3.241690158843994,
            "end_logit": -5.233880519866943,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses.Sirtuin inhibitors block infection of arboviruses",
            "probability": 0.01024469483706983,
            "start_logit": -5.3966593742370605,
            "end_logit": -3.1127538681030273,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Arboviruses.Sirtuin inhibitors block infection",
            "probability": 0.009573250704354094,
            "start_logit": -3.241690158843994,
            "end_logit": -5.33551025390625,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Antiviral",
            "probability": 0.009528473832756167,
            "start_logit": -4.059600830078125,
            "end_logit": -4.522287845611572,
            "question_text": "List sirtuin inhibitors."
        }
    ],
    "5c8d0a980101eac870000008": [
        {
            "text": "p16INK4a",
            "probability": 0.6988726538128074,
            "start_logit": 4.95059061050415,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16",
            "probability": 0.21785602024004824,
            "start_logit": 4.95059061050415,
            "end_logit": 3.591987133026123,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a protein",
            "probability": 0.07120031428960225,
            "start_logit": 4.95059061050415,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "overexpression of p16INK4a",
            "probability": 0.004176614633129451,
            "start_logit": -0.1693769097328186,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16INK4a",
            "probability": 0.0030121954684205893,
            "start_logit": -0.49620872735977173,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "overexpression of p16",
            "probability": 0.0013019548512677214,
            "start_logit": -0.1693769097328186,
            "end_logit": 3.591987133026123,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "INK4a",
            "probability": 0.0009887676693148665,
            "start_logit": -1.6101738214492798,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16",
            "probability": 0.0009389763834012985,
            "start_logit": -0.49620872735977173,
            "end_logit": 3.591987133026123,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "overexpression of p16INK4a protein",
            "probability": 0.0004255085285180163,
            "start_logit": -0.1693769097328186,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16INK4a protein",
            "probability": 0.0003068788897135859,
            "start_logit": -0.49620872735977173,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p",
            "probability": 0.00029437141228185116,
            "start_logit": 4.95059061050415,
            "end_logit": -3.0147602558135986,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "a",
            "probability": 0.00019609947959814365,
            "start_logit": -3.228011131286621,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "4a",
            "probability": 0.0001096387564230536,
            "start_logit": -3.8094422817230225,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "INK4a protein",
            "probability": 0.00010073447348459673,
            "start_logit": -1.6101738214492798,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4",
            "probability": 8.235689405386146e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -4.288540363311768,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK",
            "probability": 3.3702253433296366e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -5.182037830352783,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a protein depends on the presence of transcriptionally-active",
            "probability": 3.366438052133537e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -5.183162212371826,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a protein depends on the presence of transcriptionally-active HPV,",
            "probability": 2.5803967639775486e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -5.4490742683410645,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "ion of p16INK4a",
            "probability": 2.37652347241132e-05,
            "start_logit": -5.338409423828125,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "a protein",
            "probability": 1.997838161679606e-05,
            "start_logit": -3.228011131286621,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        }
    ],
    "5c5f0f581a4c55d80b000012": [
        {
            "text": "peripheral blood",
            "probability": 0.24745346678626218,
            "start_logit": 1.4088423252105713,
            "end_logit": 1.2354328632354736,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer.The phenotype of peripheral blood",
            "probability": 0.20980971745834595,
            "start_logit": 1.4088423252105713,
            "end_logit": 1.0704113245010376,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer.The phenotype",
            "probability": 0.12929076946961596,
            "start_logit": 1.4088423252105713,
            "end_logit": 0.5862742066383362,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer.The phenotype of peripheral blood lymphocytes",
            "probability": 0.08892778967449909,
            "start_logit": 1.4088423252105713,
            "end_logit": 0.21203500032424927,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes",
            "probability": 0.08731547171389258,
            "start_logit": 1.4088423252105713,
            "end_logit": 0.19373798370361328,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "phenotype of peripheral blood",
            "probability": 0.04986560768321499,
            "start_logit": -0.19304868578910828,
            "end_logit": 1.2354328632354736,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "phenotype of peripheral blood lymphocytes was analyzed using an 8-color flow cytometer.The phenotype of peripheral blood",
            "probability": 0.042279824141404576,
            "start_logit": -0.19304868578910828,
            "end_logit": 1.0704113245010376,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "phenotype of peripheral blood lymphocytes was analyzed using an 8-color flow cytometer.The phenotype",
            "probability": 0.026054041073514618,
            "start_logit": -0.19304868578910828,
            "end_logit": 0.5862742066383362,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "phenotype",
            "probability": 0.025346340123081474,
            "start_logit": -0.19304868578910828,
            "end_logit": 0.5587356686592102,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "phenotype of peripheral blood lymphocytes",
            "probability": 0.01759538515950808,
            "start_logit": -0.19304868578910828,
            "end_logit": 0.19373798370361328,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Peripheral Blood Lymphocytes: A Case Report.The phenotype of peripheral blood",
            "probability": 0.01744551905591769,
            "start_logit": -0.6293530464172363,
            "end_logit": 0.6214885115623474,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Peripheral Blood Lymphocytes: A Case Report.The phenotype",
            "probability": 0.011723212714366701,
            "start_logit": -0.6293530464172363,
            "end_logit": 0.22397655248641968,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Type 1 Diabetes with Diversity in Peripheral Blood Lymphocytes: A Case Report.The phenotype of peripheral blood",
            "probability": 0.008526487709503112,
            "start_logit": -1.345258355140686,
            "end_logit": 0.6214885115623474,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Peripheral Blood Lymphocytes: A Case Report.The phenotype of peripheral blood lymphocytes",
            "probability": 0.007929161621005048,
            "start_logit": -0.6293530464172363,
            "end_logit": -0.16704700887203217,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Type 1 Diabetes with Diversity in Peripheral Blood Lymphocytes: A Case Report.The phenotype",
            "probability": 0.005729713676305414,
            "start_logit": -1.345258355140686,
            "end_logit": 0.22397655248641968,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer.",
            "probability": 0.0056267478118579494,
            "start_logit": 1.4088423252105713,
            "end_logit": -2.548258066177368,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "The phenotype of peripheral blood",
            "probability": 0.0054677269405230145,
            "start_logit": -2.403517246246338,
            "end_logit": 1.2354328632354736,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "lymphocytes was analyzed using an 8-color flow cytometer.The phenotype of peripheral blood",
            "probability": 0.005101692471937077,
            "start_logit": -2.4728078842163086,
            "end_logit": 1.2354328632354736,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "The phenotype of peripheral blood lymphocytes was analyzed using an 8-color flow cytometer.The phenotype of peripheral blood",
            "probability": 0.0046359513949400365,
            "start_logit": -2.403517246246338,
            "end_logit": 1.0704113245010376,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Type 1 Diabetes with Diversity in Peripheral Blood Lymphocytes: A Case Report.The phenotype of peripheral blood lymphocytes",
            "probability": 0.0038753733203042793,
            "start_logit": -1.345258355140686,
            "end_logit": -0.16704700887203217,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        }
    ],
    "5c851a8175a4a5d219000005": [
        {
            "text": "cytotoxin",
            "probability": 0.7874983142745794,
            "start_logit": 0.44332507252693176,
            "end_logit": -0.5452842116355896,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin and cytotoxin",
            "probability": 0.0932486580545314,
            "start_logit": -1.690266489982605,
            "end_logit": -0.5452842116355896,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin",
            "probability": 0.07997355642496091,
            "start_logit": -1.690266489982605,
            "end_logit": -0.698857843875885,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "cytotoxin were produced in their intestinal tract.",
            "probability": 0.011675405128495419,
            "start_logit": 0.44332507252693176,
            "end_logit": -4.7566609382629395,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "c",
            "probability": 0.008883916496736907,
            "start_logit": 0.44332507252693176,
            "end_logit": -5.029902935028076,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "cytotoxin were produced in their intestinal tract",
            "probability": 0.0039454787220902544,
            "start_logit": 0.44332507252693176,
            "end_logit": -5.8415751457214355,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "xin and cytotoxin",
            "probability": 0.0029289720616481303,
            "start_logit": -5.150884628295898,
            "end_logit": -0.5452842116355896,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "xin",
            "probability": 0.002511996604845167,
            "start_logit": -5.150884628295898,
            "end_logit": -0.698857843875885,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "both enterotoxin and cytotoxin",
            "probability": 0.002047396033097049,
            "start_logit": -5.508967399597168,
            "end_logit": -0.5452842116355896,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "both enterotoxin",
            "probability": 0.0017559238448383353,
            "start_logit": -5.508967399597168,
            "end_logit": -0.698857843875885,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin and cytotoxin were produced in their intestinal tract.",
            "probability": 0.001382499290145256,
            "start_logit": -1.690266489982605,
            "end_logit": -4.7566609382629395,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin and c",
            "probability": 0.0010519556379651944,
            "start_logit": -1.690266489982605,
            "end_logit": -5.029902935028076,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "died 3 days after inoculation and both enterotoxin and cytotoxin",
            "probability": 0.0007215278824474594,
            "start_logit": -6.551920413970947,
            "end_logit": -0.5452842116355896,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "died 3 days after inoculation and both enterotoxin",
            "probability": 0.0006188094501622737,
            "start_logit": -6.551920413970947,
            "end_logit": -0.698857843875885,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enter",
            "probability": 0.0005261498988808242,
            "start_logit": -1.690266489982605,
            "end_logit": -5.722723007202148,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "strains of Clostridium difficile, 100% of them died 3 days after inoculation and both enterotoxin",
            "probability": 0.0005179402471991108,
            "start_logit": -6.729857921600342,
            "end_logit": -0.698857843875885,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin and cytotoxin were produced in their intestinal tract",
            "probability": 0.00046718905875567786,
            "start_logit": -1.690266489982605,
            "end_logit": -5.8415751457214355,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "production",
            "probability": 9.523359046984168e-05,
            "start_logit": -4.858906269073486,
            "end_logit": -4.263336658477783,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "Effect of various diets on toxin production",
            "probability": 7.657176136153706e-05,
            "start_logit": -5.077010631561279,
            "end_logit": -4.263336658477783,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin production",
            "probability": 7.25055367897211e-05,
            "start_logit": -5.131576061248779,
            "end_logit": -4.263336658477783,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        }
    ],
    "5c7d520ed774d0424000000f": [
        {
            "text": "Diabetes",
            "probability": 0.22569584748086416,
            "start_logit": -2.271998167037964,
            "end_logit": -1.817124366760254,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes",
            "probability": 0.1662088341263638,
            "start_logit": -2.577941417694092,
            "end_logit": -1.817124366760254,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes.The Special Issue \"Pathogenetic and Therapeutic Significance of Adipokines in Diabetes",
            "probability": 0.06123406666267157,
            "start_logit": -2.271998167037964,
            "end_logit": -3.1216089725494385,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines",
            "probability": 0.05490246660481143,
            "start_logit": -2.577941417694092,
            "end_logit": -2.9248111248016357,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes.",
            "probability": 0.048809021308391036,
            "start_logit": -2.271998167037964,
            "end_logit": -3.3483974933624268,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes.The Special Issue \"Pathogenetic and Therapeutic Significance of Adipokines in Diabetes\"",
            "probability": 0.045665951794397114,
            "start_logit": -2.271998167037964,
            "end_logit": -3.414959669113159,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes.The Special Issue \"Pathogenetic and Therapeutic Significance of Adipokines in Diabetes",
            "probability": 0.04509450635631037,
            "start_logit": -2.577941417694092,
            "end_logit": -3.1216089725494385,
            "question_text": "List adipokines."
        },
        {
            "text": "adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes.",
            "probability": 0.04391100950926495,
            "start_logit": -3.4460816383361816,
            "end_logit": -2.280064105987549,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes\" focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes.",
            "probability": 0.04097713179683625,
            "start_logit": -3.515232563018799,
            "end_logit": -2.280064105987549,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes.",
            "probability": 0.035944349960644925,
            "start_logit": -2.577941417694092,
            "end_logit": -3.3483974933624268,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes.The Special Issue \"Pathogenetic and Therapeutic Significance of Adipokines in Diabetes\"",
            "probability": 0.03362970427562257,
            "start_logit": -2.577941417694092,
            "end_logit": -3.414959669113159,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes.The Special Issue \"Pathogenetic and Therapeutic Significance of Adipokines",
            "probability": 0.030708986323684444,
            "start_logit": -2.271998167037964,
            "end_logit": -3.8117573261260986,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes.The Special Issue \"Pathogenetic and Therapeutic Significance of Adipokines in Diabetes\" focused on adipokines",
            "probability": 0.02882104769907016,
            "start_logit": -2.271998167037964,
            "end_logit": -3.875206708908081,
            "question_text": "List adipokines."
        },
        {
            "text": ".",
            "probability": 0.02563794332192453,
            "start_logit": -3.98417329788208,
            "end_logit": -2.280064105987549,
            "question_text": "List adipokines."
        },
        {
            "text": "diabetes.",
            "probability": 0.025045999557532287,
            "start_logit": -4.007532596588135,
            "end_logit": -2.280064105987549,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes.The Special Issue \"Pathogenetic and Therapeutic Significance of Adipokines",
            "probability": 0.02261496997411439,
            "start_logit": -2.577941417694092,
            "end_logit": -3.8117573261260986,
            "question_text": "List adipokines."
        },
        {
            "text": "type 2 diabetes.",
            "probability": 0.01946997479923336,
            "start_logit": -4.259373188018799,
            "end_logit": -2.280064105987549,
            "question_text": "List adipokines."
        },
        {
            "text": "Insights into Adipokines in Diabetes",
            "probability": 0.016492222307318838,
            "start_logit": -4.8882975578308105,
            "end_logit": -1.817124366760254,
            "question_text": "List adipokines."
        },
        {
            "text": "adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes",
            "probability": 0.014903133438973246,
            "start_logit": -3.4460816383361816,
            "end_logit": -3.3606576919555664,
            "question_text": "List adipokines."
        },
        {
            "text": "The Latest Insights into Adipokines in Diabetes",
            "probability": 0.014232832701970753,
            "start_logit": -5.035634994506836,
            "end_logit": -1.817124366760254,
            "question_text": "List adipokines."
        }
    ],
    "5c73ace67c78d69471000083": [
        {
            "text": "blepharophimosis",
            "probability": 0.11688220069202149,
            "start_logit": 2.871554374694824,
            "end_logit": 2.6245534420013428,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "blepharophimosis, hypertelorism",
            "probability": 0.09471020961806494,
            "start_logit": 2.871554374694824,
            "end_logit": 2.4142086505889893,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly",
            "probability": 0.07711816413769534,
            "start_logit": 2.4334185123443604,
            "end_logit": 2.6468615531921387,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly, ptosis, blepharophimosis",
            "probability": 0.0754168506569919,
            "start_logit": 2.4334185123443604,
            "end_logit": 2.6245534420013428,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly, ptosis",
            "probability": 0.06863013030457318,
            "start_logit": 2.4334185123443604,
            "end_logit": 2.530254364013672,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hypertelorism",
            "probability": 0.064884290530299,
            "start_logit": 2.493338108062744,
            "end_logit": 2.4142086505889893,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "ptosis, blepharophimosis",
            "probability": 0.06258458354765652,
            "start_logit": 2.2469067573547363,
            "end_logit": 2.6245534420013428,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly, ptosis, blepharophimosis, hypertelorism",
            "probability": 0.06111063696754618,
            "start_logit": 2.4334185123443604,
            "end_logit": 2.4142086505889893,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "ptosis",
            "probability": 0.05695263175955634,
            "start_logit": 2.2469067573547363,
            "end_logit": 2.530254364013672,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "ptosis, blepharophimosis, hypertelorism",
            "probability": 0.05071258918435523,
            "start_logit": 2.2469067573547363,
            "end_logit": 2.4142086505889893,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "blepharophimosis, hypertelorism, short palpebral fissures, cleft palate",
            "probability": 0.04889676138420176,
            "start_logit": 2.871554374694824,
            "end_logit": 1.7530980110168457,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "blepharophimosis, hypertelorism, short palpebral fissures",
            "probability": 0.03530134263037569,
            "start_logit": 2.871554374694824,
            "end_logit": 1.4273078441619873,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hypertelorism, short palpebral fissures, cleft palate",
            "probability": 0.03349830693477957,
            "start_logit": 2.493338108062744,
            "end_logit": 1.7530980110168457,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hypertelorism, short palpebral fissures, cleft palate and developmental delay",
            "probability": 0.03205686762299441,
            "start_logit": 2.493338108062744,
            "end_logit": 1.7091145515441895,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "cleft palate",
            "probability": 0.024279362679576148,
            "start_logit": 2.1714699268341064,
            "end_logit": 1.7530980110168457,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hypertelorism, short palpebral fissures",
            "probability": 0.02418432585648123,
            "start_logit": 2.493338108062744,
            "end_logit": 1.4273078441619873,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "cleft palate and developmental delay",
            "probability": 0.023234616510775158,
            "start_logit": 2.1714699268341064,
            "end_logit": 1.7091145515441895,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "ptosis, blepharophimosis, hypertelorism, short palpebral fissures",
            "probability": 0.018902106686172326,
            "start_logit": 2.2469067573547363,
            "end_logit": 1.4273078441619873,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "short palpebral fissures, cleft palate",
            "probability": 0.015658914365014303,
            "start_logit": 1.7328835725784302,
            "end_logit": 1.7530980110168457,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "short palpebral fissures, cleft palate and developmental delay",
            "probability": 0.014985107930869587,
            "start_logit": 1.7328835725784302,
            "end_logit": 1.7091145515441895,
            "question_text": "List features of the DOOR syndrome."
        }
    ],
    "5c6d783e7c78d6947100003a": [
        {
            "text": "in\u00a0Toxins\u00a0[3].[...",
            "probability": 1.0,
            "start_logit": -1.4322870969772339,
            "end_logit": -0.4592132866382599,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        }
    ],
    "5c851c2675a4a5d219000006": [
        {
            "text": "bezlotoxumab",
            "probability": 0.2416812344848026,
            "start_logit": 6.4508748054504395,
            "end_logit": 6.65018892288208,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab",
            "probability": 0.23808423672790968,
            "start_logit": 6.435879707336426,
            "end_logit": 6.65018892288208,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab",
            "probability": 0.20275940314633498,
            "start_logit": 6.435879707336426,
            "end_logit": 6.489584445953369,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively.Bezlotoxumab",
            "probability": 0.13657431949850604,
            "start_logit": 6.4508748054504395,
            "end_logit": 6.079438209533691,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotoxumab",
            "probability": 0.08910100887970325,
            "start_logit": 6.14740514755249,
            "end_logit": 5.955809593200684,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI.Bezlotoxumab",
            "probability": 0.07504130599752008,
            "start_logit": 5.975673198699951,
            "end_logit": 5.955809593200684,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Actoxumab",
            "probability": 0.008589115603245347,
            "start_logit": 5.029205322265625,
            "end_logit": 4.734734535217285,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB",
            "probability": 0.0018635944109414296,
            "start_logit": 6.4508748054504395,
            "end_logit": 1.785076379776001,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB",
            "probability": 0.001835858103940995,
            "start_logit": 6.435879707336426,
            "end_logit": 1.785076379776001,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "TcdB, respectively.Bezlotoxumab",
            "probability": 0.0011950705941573068,
            "start_logit": 1.7122111320495605,
            "end_logit": 6.079438209533691,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively.",
            "probability": 0.00045943869158079974,
            "start_logit": 6.4508748054504395,
            "end_logit": 0.38481950759887695,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively.",
            "probability": 0.00045260075918373616,
            "start_logit": 6.435879707336426,
            "end_logit": 0.38481950759887695,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA",
            "probability": 0.00042303261952381636,
            "start_logit": 6.4508748054504395,
            "end_logit": 0.3022632896900177,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab bind to and neutralize TcdA",
            "probability": 0.0004167365271244067,
            "start_logit": 6.435879707336426,
            "end_logit": 0.3022632896900177,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI.",
            "probability": 0.00040965118355833387,
            "start_logit": 5.975673198699951,
            "end_logit": 0.7453216314315796,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotox",
            "probability": 0.0003101046553557236,
            "start_logit": 6.4508748054504395,
            "end_logit": -0.008276162669062614,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotox",
            "probability": 0.0003054892959874449,
            "start_logit": 6.435879707336426,
            "end_logit": -0.008276162669062614,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively.Bezlotox",
            "probability": 0.0001919764669543621,
            "start_logit": 6.4508748054504395,
            "end_logit": -0.48781320452690125,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "TcdA and TcdB, respectively.Bezlotoxumab",
            "probability": 0.00018645912453667507,
            "start_logit": -0.1455373615026474,
            "end_logit": 6.079438209533691,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotox",
            "probability": 0.00011936322913317614,
            "start_logit": 5.975673198699951,
            "end_logit": -0.48781320452690125,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        }
    ],
    "5c8bfe25d558e5f23200000f": [
        {
            "text": "calcium ionophore-induced acrosome reaction",
            "probability": 0.16932208868877516,
            "start_logit": 1.9234893321990967,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.15233807954104242,
            "start_logit": 1.81778883934021,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.12247019808315328,
            "start_logit": 1.9234893321990967,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "protein tyrosine phosphorylation",
            "probability": 0.1111533866079705,
            "start_logit": 1.8265327215194702,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.11018571127651958,
            "start_logit": 1.81778883934021,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "acrosome reaction",
            "probability": 0.10309679981881485,
            "start_logit": 1.4273549318313599,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.07456962994802986,
            "start_logit": 1.4273549318313599,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "functionality, particularly a decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.023878377111232526,
            "start_logit": -0.035340093076229095,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "functionality, particularly a decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.017271164071759684,
            "start_logit": -0.035340093076229095,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "upregulated molecules by LNG. In this study, LTF exhibited significant dose-related effects on sperm functionality",
            "probability": 0.017139211276950585,
            "start_logit": -0.0064599234610795975,
            "end_logit": 2.3734700679779053,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "functionality",
            "probability": 0.016651307235409824,
            "start_logit": -0.035340093076229095,
            "end_logit": 2.3734700679779053,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "sperm functionality, particularly a decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.01559180213839789,
            "start_logit": -0.461568146944046,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "a decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.01284360201511245,
            "start_logit": -0.6554676294326782,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "sperm functionality, particularly a decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.011277507330261928,
            "start_logit": -0.461568146944046,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "sperm functionality",
            "probability": 0.010872761015155198,
            "start_logit": -0.461568146944046,
            "end_logit": 2.3734700679779053,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "a decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.00928974178781368,
            "start_logit": -0.6554676294326782,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "decrease",
            "probability": 0.008108780337538996,
            "start_logit": 1.81778883934021,
            "end_logit": -0.1992001235485077,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "LTF exhibited significant dose-related effects on sperm functionality, particularly a decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.005190295218158519,
            "start_logit": -1.5615228414535522,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "induced acrosome reaction",
            "probability": 0.005077218447804229,
            "start_logit": -1.5835498571395874,
            "end_logit": 2.733954668045044,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.003672338050098985,
            "start_logit": -1.5835498571395874,
            "end_logit": 2.410019636154175,
            "question_text": "List the functions of the protein lactotransferrin."
        }
    ],
    "5c900983ecadf2e73f000002": [
        {
            "text": "givosiran",
            "probability": 0.9471206517815316,
            "start_logit": 5.495474338531494,
            "end_logit": 5.172083377838135,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "Givosiran",
            "probability": 0.05243208451537179,
            "start_logit": 4.188880920410156,
            "end_logit": 3.5847690105438232,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "g",
            "probability": 0.0001863628612919066,
            "start_logit": 5.495474338531494,
            "end_logit": -3.361402750015259,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "an",
            "probability": 9.52932604754614e-05,
            "start_logit": -3.7087483406066895,
            "end_logit": 5.172083377838135,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "2019 givosiran",
            "probability": 4.320422186841255e-05,
            "start_logit": -4.49976921081543,
            "end_logit": 5.172083377838135,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "givosir",
            "probability": 2.8058600824397238e-05,
            "start_logit": 5.495474338531494,
            "end_logit": -5.25480318069458,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siran",
            "probability": 2.6968797033857527e-05,
            "start_logit": -4.97102689743042,
            "end_logit": 5.172083377838135,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "G",
            "probability": 2.2768045541869656e-05,
            "start_logit": 4.188880920410156,
            "end_logit": -4.15714693069458,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "In November 2019 givosiran",
            "probability": 1.8772177337354876e-05,
            "start_logit": -5.33333158493042,
            "end_logit": 5.172083377838135,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "givosiran became the second small interfering RNA (siRNA)-based drug to receive US Food and Drug Administration (FDA) approval",
            "probability": 1.837345074936252e-05,
            "start_logit": 5.495474338531494,
            "end_logit": -5.678191661834717,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "acute intermittent porphyria (AIP), a disorder characterized by life-threatening acute neurovisceral attacks.Givosiran",
            "probability": 5.379063917416547e-06,
            "start_logit": -4.99587869644165,
            "end_logit": 3.5847690105438232,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "placebo-controlled randomized controlled trial.The clinical performance of givosiran",
            "probability": 1.2051490408193586e-06,
            "start_logit": -5.281938076019287,
            "end_logit": 2.3749172687530518,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "Givosiran makes use of a new hepatic-delivery system that conjugates three GalNac",
            "probability": 8.270568327730673e-07,
            "start_logit": 2.0378971099853516,
            "end_logit": -5.3214030265808105,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "an became the second small interfering RNA (siRNA)-based drug to receive US Food and Drug Administration (FDA) approval,",
            "probability": 2.0129797091836954e-08,
            "start_logit": -3.7087483406066895,
            "end_logit": -3.2904298305511475,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "2019 g",
            "probability": 8.501200340360617e-09,
            "start_logit": -4.49976921081543,
            "end_logit": -3.361402750015259,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "NCT03338816",
            "probability": 6.766379545796656e-09,
            "start_logit": -4.069892883300781,
            "end_logit": -4.019520282745361,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siran became the second small interfering RNA (siRNA)-based drug to receive US Food and Drug Administration (FDA) approval,",
            "probability": 5.696902481810665e-09,
            "start_logit": -4.97102689743042,
            "end_logit": -3.2904298305511475,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "In November 2019 g",
            "probability": 3.693760319435532e-09,
            "start_logit": -5.33333158493042,
            "end_logit": -3.361402750015259,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "03338816",
            "probability": 3.3562885815957233e-09,
            "start_logit": -4.771023273468018,
            "end_logit": -4.019520282745361,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "small interfering RNA (siRNA)-based drug to receive US Food and Drug Administration (FDA) approval,",
            "probability": 2.8738544087233885e-09,
            "start_logit": -5.655295372009277,
            "end_logit": -3.2904298305511475,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        }
    ],
    "5c6bda9d7c78d69471000031": [
        {
            "text": "manually curated repositories",
            "probability": 0.3515972524037715,
            "start_logit": 2.531069278717041,
            "end_logit": 2.4936814308166504,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually",
            "probability": 0.2153830679113934,
            "start_logit": 2.531069278717041,
            "end_logit": 2.003613233566284,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data",
            "probability": 0.055841695913680885,
            "start_logit": 2.531069278717041,
            "end_logit": 0.6537159085273743,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions",
            "probability": 0.05297321425243349,
            "start_logit": 2.531069278717041,
            "end_logit": 0.6009814739227295,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated",
            "probability": 0.04573306304408426,
            "start_logit": 2.531069278717041,
            "end_logit": 0.4540165960788727,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding data, (3) in silico prediction of TF binding on gene promoters",
            "probability": 0.04163611309032753,
            "start_logit": 1.665334701538086,
            "end_logit": 1.2258975505828857,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "repositories",
            "probability": 0.03250109912894179,
            "start_logit": 0.149856835603714,
            "end_logit": 2.4936814308166504,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding",
            "probability": 0.027617272979592093,
            "start_logit": 2.531069278717041,
            "end_logit": -0.050363510847091675,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories,",
            "probability": 0.02352253081281128,
            "start_logit": 2.531069278717041,
            "end_logit": -0.2108462005853653,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding data",
            "probability": 0.02349496755827212,
            "start_logit": 1.665334701538086,
            "end_logit": 0.6537159085273743,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions",
            "probability": 0.022288075781978577,
            "start_logit": 1.665334701538086,
            "end_logit": 0.6009814739227295,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "(1) manually curated repositories",
            "probability": 0.020329923416293742,
            "start_logit": -0.31932321190834045,
            "end_logit": 2.4936814308166504,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "in silico prediction of TF binding on gene promoters",
            "probability": 0.018609710472516378,
            "start_logit": 0.8600503206253052,
            "end_logit": 1.2258975505828857,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data,",
            "probability": 0.015049156434056793,
            "start_logit": 2.531069278717041,
            "end_logit": -0.6574829816818237,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "(1) manually",
            "probability": 0.012453798332805324,
            "start_logit": -0.31932321190834045,
            "end_logit": 2.003613233566284,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding",
            "probability": 0.011619756923329632,
            "start_logit": 1.665334701538086,
            "end_logit": -0.050363510847091675,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "ChIP-seq binding data, (3) in silico prediction of TF binding on gene promoters",
            "probability": 0.00924573908347772,
            "start_logit": 0.16052961349487305,
            "end_logit": 1.2258975505828857,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "reverse-engineered regulons from large gene expression data sets",
            "probability": 0.007807974447840835,
            "start_logit": 1.1815578937530518,
            "end_logit": 0.035852041095495224,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding data,",
            "probability": 0.006331817764705489,
            "start_logit": 1.665334701538086,
            "end_logit": -0.6574829816818237,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "binding data, (3) in silico prediction of TF binding on gene promoters",
            "probability": 0.005963770247687191,
            "start_logit": -0.2779303193092346,
            "end_logit": 1.2258975505828857,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        }
    ],
    "5c6c497d7c78d69471000036": [
        {
            "text": "tools",
            "probability": 0.11932678887927506,
            "start_logit": -3.406972646713257,
            "end_logit": -2.875375986099243,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "requires tools",
            "probability": 0.08439724297518668,
            "start_logit": -3.7533037662506104,
            "end_logit": -2.875375986099243,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "tools for manipulating small groups of DA neurons.",
            "probability": 0.07413782532941812,
            "start_logit": -3.406972646713257,
            "end_logit": -3.351315975189209,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "tools for manipulating small groups of DA neurons",
            "probability": 0.06550555092255315,
            "start_logit": -3.406972646713257,
            "end_logit": -3.475106954574585,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "manipulating small groups of DA neurons.",
            "probability": 0.057717166808972015,
            "start_logit": -3.657343864440918,
            "end_logit": -3.351315975189209,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "requires tools for manipulating small groups of DA neurons.",
            "probability": 0.052436071704813854,
            "start_logit": -3.7533037662506104,
            "end_logit": -3.351315975189209,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "manipulating small groups of DA neurons",
            "probability": 0.05099683990879591,
            "start_logit": -3.657343864440918,
            "end_logit": -3.475106954574585,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "DA neurons.",
            "probability": 0.05075885747035091,
            "start_logit": -3.7858123779296875,
            "end_logit": -3.351315975189209,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "tools for manipulating small groups",
            "probability": 0.049744027768709786,
            "start_logit": -3.406972646713257,
            "end_logit": -3.7503514289855957,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "requires tools for manipulating small groups of DA neurons",
            "probability": 0.04633065172840147,
            "start_logit": -3.7533037662506104,
            "end_logit": -3.475106954574585,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "DA neurons",
            "probability": 0.044848724763920524,
            "start_logit": -3.7858123779296875,
            "end_logit": -3.475106954574585,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "manipulating small groups",
            "probability": 0.0387263092182649,
            "start_logit": -3.657343864440918,
            "end_logit": -3.7503514289855957,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "small groups of DA neurons.",
            "probability": 0.0384055950644005,
            "start_logit": -4.064695358276367,
            "end_logit": -3.351315975189209,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "DA neural networks tune the activity of local neural circuits to regulate behavior requires tools",
            "probability": 0.037783596650331035,
            "start_logit": -4.5569634437561035,
            "end_logit": -2.875375986099243,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "requires tools for manipulating small groups",
            "probability": 0.03518286914104161,
            "start_logit": -3.7533037662506104,
            "end_logit": -3.7503514289855957,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "small groups of DA neurons",
            "probability": 0.03393382058380627,
            "start_logit": -4.064695358276367,
            "end_logit": -3.475106954574585,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "groups of DA neurons.",
            "probability": 0.032330839160346084,
            "start_logit": -4.236876964569092,
            "end_logit": -3.351315975189209,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "tools for manipulating small groups of DA",
            "probability": 0.030904256253674062,
            "start_logit": -3.406972646713257,
            "end_logit": -4.226347923278809,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "groups of DA neurons",
            "probability": 0.028566381891789273,
            "start_logit": -4.236876964569092,
            "end_logit": -3.475106954574585,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "requires",
            "probability": 0.02796658377594869,
            "start_logit": -3.7533037662506104,
            "end_logit": -3.979900360107422,
            "question_text": "Which tools have been developed for computing split-networks?"
        }
    ],
    "5c88550075a4a5d219000008": [
        {
            "text": "L-5F",
            "probability": 0.4830112797234731,
            "start_logit": 2.0318315029144287,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L-5F",
            "probability": 0.4394426760285974,
            "start_logit": 1.9372987747192383,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F",
            "probability": 0.06783477273318966,
            "start_logit": 1.9372987747192383,
            "end_logit": 0.873137891292572,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D",
            "probability": 0.0024231799345254585,
            "start_logit": 1.9372987747192383,
            "end_logit": -2.4588563442230225,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "L",
            "probability": 0.0015447672137413747,
            "start_logit": 2.0318315029144287,
            "end_logit": -3.003596544265747,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L",
            "probability": 0.0014054260567918583,
            "start_logit": 1.9372987747192383,
            "end_logit": -3.003596544265747,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "F",
            "probability": 0.0009831968218782208,
            "start_logit": -4.165154457092285,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "peptides D-4F and L-5F",
            "probability": 0.0006349464037846546,
            "start_logit": -4.602423191070557,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "s D-4F and L-5F",
            "probability": 0.0006223679958603627,
            "start_logit": -4.622432231903076,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "F and L-5F",
            "probability": 0.0004222183003368207,
            "start_logit": -5.010441303253174,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.",
            "probability": 0.0002735705819072716,
            "start_logit": 2.0318315029144287,
            "end_logit": -4.734665393829346,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "mimetic peptides D-4F and L-5F",
            "probability": 0.0002554350226969321,
            "start_logit": -5.512995719909668,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.",
            "probability": 0.0002488939568137164,
            "start_logit": 1.9372987747192383,
            "end_logit": -4.734665393829346,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Apolipoprotein-AI mimetic peptides D-4F and L-5F",
            "probability": 0.00022591787030870419,
            "start_logit": -5.635792255401611,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "5F",
            "probability": 0.00017907009279718466,
            "start_logit": -5.8681864738464355,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "4F and L-5F",
            "probability": 0.00011587590966112886,
            "start_logit": -6.303443908691406,
            "end_logit": 2.741570234298706,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "peptides D-4F",
            "probability": 9.801379644721895e-05,
            "start_logit": -4.602423191070557,
            "end_logit": 0.873137891292572,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "s D-4F",
            "probability": 9.607212466740715e-05,
            "start_logit": -4.622432231903076,
            "end_logit": 0.873137891292572,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "L-5",
            "probability": 9.546529869761847e-05,
            "start_logit": 2.0318315029144287,
            "end_logit": -5.78746223449707,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L-5",
            "probability": 8.685413382388987e-05,
            "start_logit": 1.9372987747192383,
            "end_logit": -5.78746223449707,
            "question_text": "List 3 apoE mimetics."
        }
    ],
    "5ca60a77ecadf2e73f00004d": [
        {
            "text": "biochar",
            "probability": 0.8714656862068939,
            "start_logit": 0.395553857088089,
            "end_logit": -1.548726201057434,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "phase change material-biochar",
            "probability": 0.08952122721662835,
            "start_logit": -1.880146861076355,
            "end_logit": -1.548726201057434,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "bio",
            "probability": 0.01450820407795442,
            "start_logit": 0.395553857088089,
            "end_logit": -5.644188404083252,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites of phase change material-biochar",
            "probability": 0.007206219002521999,
            "start_logit": -4.3996782302856445,
            "end_logit": -1.548726201057434,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "biochar as feasible eco-friendly building materials.",
            "probability": 0.006666442390908317,
            "start_logit": 0.395553857088089,
            "end_logit": -6.421816349029541,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "phase change material",
            "probability": 0.0035021063908898063,
            "start_logit": -1.880146861076355,
            "end_logit": -4.78983736038208,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "phase change material-bio",
            "probability": 0.0014903538421814886,
            "start_logit": -1.880146861076355,
            "end_logit": -5.644188404083252,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Latent heat storage biocomposites of phase change material-biochar",
            "probability": 0.0013681281240807432,
            "start_logit": -6.061179161071777,
            "end_logit": -1.548726201057434,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "r",
            "probability": 0.0011840845212024106,
            "start_logit": -6.205652713775635,
            "end_logit": -1.548726201057434,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "biocomposites of phase change material-biochar",
            "probability": 0.0011431732498733442,
            "start_logit": -6.240814685821533,
            "end_logit": -1.548726201057434,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "phase change material-biochar as feasible eco-friendly building materials.",
            "probability": 0.0006848096413303687,
            "start_logit": -1.880146861076355,
            "end_logit": -6.421816349029541,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites of phase change material",
            "probability": 0.0002819101838473921,
            "start_logit": -4.3996782302856445,
            "end_logit": -4.78983736038208,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "biochar.",
            "probability": 0.00023362083177359366,
            "start_logit": -3.8466482162475586,
            "end_logit": -5.53075647354126,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat",
            "probability": 0.00019351581434632175,
            "start_logit": -3.7917213439941406,
            "end_logit": -5.774023532867432,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage",
            "probability": 0.00012984704253296805,
            "start_logit": -3.7917213439941406,
            "end_logit": -6.173025608062744,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites of phase change material-bio",
            "probability": 0.00011996949228612699,
            "start_logit": -4.3996782302856445,
            "end_logit": -5.644188404083252,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposite",
            "probability": 0.00011715140372556576,
            "start_logit": -3.7917213439941406,
            "end_logit": -6.275915622711182,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "biochar.Experimental results showed that latent heat storage biocomposite",
            "probability": 7.060139282467433e-05,
            "start_logit": -3.8466482162475586,
            "end_logit": -6.727406024932861,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites",
            "probability": 5.782383237846458e-05,
            "start_logit": -4.3996782302856445,
            "end_logit": -6.374024868011475,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites of phase change material-biochar as feasible eco-friendly building materials.",
            "probability": 5.512534182002962e-05,
            "start_logit": -4.3996782302856445,
            "end_logit": -6.421816349029541,
            "question_text": "Which enhancers are characterized as latent?"
        }
    ],
    "5c8c095e0101eac870000002": [
        {
            "text": "adipose derived stem cells",
            "probability": 0.5112422540476204,
            "start_logit": -0.13162508606910706,
            "end_logit": -1.3570826053619385,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "LX-2",
            "probability": 0.20965036660343542,
            "start_logit": -0.7308447360992432,
            "end_logit": -1.6492652893066406,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "FGF21_ADSCs",
            "probability": 0.06552348909692428,
            "start_logit": -1.294306755065918,
            "end_logit": -2.248835802078247,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "adipose derived stem",
            "probability": 0.039970361493517854,
            "start_logit": -0.13162508606910706,
            "end_logit": -3.905787944793701,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "LX-2 cells",
            "probability": 0.036343913823122236,
            "start_logit": -0.7308447360992432,
            "end_logit": -3.401679754257202,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "stem cells",
            "probability": 0.033820367462350794,
            "start_logit": -2.847405433654785,
            "end_logit": -1.3570826053619385,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "adipose derived stem cells (FGF21_ADSCs)",
            "probability": 0.027539927024930952,
            "start_logit": -0.13162508606910706,
            "end_logit": -4.278289318084717,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "adipose derived stem cells (FGF21_ADSCs",
            "probability": 0.019703317233786613,
            "start_logit": -0.13162508606910706,
            "end_logit": -4.6131391525268555,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "LX-2 cells.\u03b1-lactoalbumin",
            "probability": 0.017239284081768533,
            "start_logit": -0.7308447360992432,
            "end_logit": -4.147515773773193,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "LX-2 cells.\u03b1-lactoalbumin (LA) and lactotransferrin (LTF",
            "probability": 0.007196786455102028,
            "start_logit": -0.7308447360992432,
            "end_logit": -5.021071910858154,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "FGF21",
            "probability": 0.007104515392958767,
            "start_logit": -1.4173861742019653,
            "end_logit": -4.3474345207214355,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "LX-2 cells.\u03b1-lactoalbumin (LA) and lactotransferrin (LTF)",
            "probability": 0.006684953865048947,
            "start_logit": -0.7308447360992432,
            "end_logit": -5.094847202301025,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "FGF21-secreting adipose derived stem cells",
            "probability": 0.0034556139098991826,
            "start_logit": -5.1284685134887695,
            "end_logit": -1.3570826053619385,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "stem",
            "probability": 0.0026441717260480076,
            "start_logit": -2.847405433654785,
            "end_logit": -3.905787944793701,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "cells",
            "probability": 0.0025492482859294442,
            "start_logit": -5.4326701164245605,
            "end_logit": -1.3570826053619385,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "liver fibrosis mice via the tail vein.\u03b1-lactoalbumin",
            "probability": 0.002339801985660234,
            "start_logit": -4.297887802124023,
            "end_logit": -2.577597141265869,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "lactotransferrin (LTF), secretory factors produced from FGF21_ADSCs",
            "probability": 0.0022030420353387876,
            "start_logit": -4.68687629699707,
            "end_logit": -2.248835802078247,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "stem cells (FGF21_ADSCs)",
            "probability": 0.0018218573376815067,
            "start_logit": -2.847405433654785,
            "end_logit": -4.278289318084717,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "\u03b1-lactoalbumin",
            "probability": 0.0015131387262130606,
            "start_logit": -4.733767986297607,
            "end_logit": -2.577597141265869,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "collagen in LX-2",
            "probability": 0.0014535894126630343,
            "start_logit": -5.702250003814697,
            "end_logit": -1.6492652893066406,
            "question_text": "Which cells secrete lactotransferrin?"
        }
    ],
    "5c9d18f1ecadf2e73f000033": [
        {
            "text": "anti-inflammatory",
            "probability": 0.23095372058725536,
            "start_logit": -2.895935535430908,
            "end_logit": -2.4654107093811035,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "inflammatory",
            "probability": 0.15950486286877666,
            "start_logit": -3.266078472137451,
            "end_logit": -2.4654107093811035,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs, with the aim of developing novel anti-inflammatory",
            "probability": 0.10722317922354069,
            "start_logit": -3.663240432739258,
            "end_logit": -2.4654107093811035,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen moiety (1a-o) was designed and synthesized to create naproxen",
            "probability": 0.053658033836017395,
            "start_logit": -3.5940122604370117,
            "end_logit": -3.2269201278686523,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen",
            "probability": 0.050069048906072215,
            "start_logit": -3.663240432739258,
            "end_logit": -3.2269201278686523,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "in vivo pharmacological evaluation",
            "probability": 0.04951773419919159,
            "start_logit": -3.3411264419555664,
            "end_logit": -3.5601062774658203,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "evaluation",
            "probability": 0.04499099166772419,
            "start_logit": -3.436995029449463,
            "end_logit": -3.5601062774658203,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "anti-inflammatory/analgesic agents with improved safety profiles.",
            "probability": 0.04052857538447464,
            "start_logit": -2.895935535430908,
            "end_logit": -4.205620765686035,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "anti-inflammatory/analgesic agents with improved safety profiles. Target compounds were synthesized using classical Mannich reaction",
            "probability": 0.03072163979618769,
            "start_logit": -2.895935535430908,
            "end_logit": -4.48266077041626,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "inflammatory/analgesic agents with improved safety profiles.",
            "probability": 0.02799047723730082,
            "start_logit": -3.266078472137451,
            "end_logit": -4.205620765686035,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "evaluation of novel mannich bases derived from 1,2,4-triazole containing a naproxen",
            "probability": 0.02535127667239321,
            "start_logit": -3.436995029449463,
            "end_logit": -4.133739471435547,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "characterization, and in vivo pharmacological evaluation",
            "probability": 0.02391087960730168,
            "start_logit": -4.0691237449646,
            "end_logit": -3.5601062774658203,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "anti",
            "probability": 0.021550680359557504,
            "start_logit": -2.895935535430908,
            "end_logit": -4.837220668792725,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "inflammatory/analgesic agents with improved safety profiles. Target compounds were synthesized using classical Mannich reaction",
            "probability": 0.02121745833033044,
            "start_logit": -3.266078472137451,
            "end_logit": -4.48266077041626,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Mannich reaction",
            "probability": 0.02085686199913367,
            "start_logit": -3.283219814300537,
            "end_logit": -4.48266077041626,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "in vivo",
            "probability": 0.020357816154028267,
            "start_logit": -3.3411264419555664,
            "end_logit": -4.448972225189209,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Mannich reaction (i.e. one-pot three component condensation reaction),",
            "probability": 0.020039321059069515,
            "start_logit": -3.283219814300537,
            "end_logit": -4.522647380828857,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs, with the aim of developing novel anti-inflammatory/analgesic agents with improved safety profiles.",
            "probability": 0.018815902558636268,
            "start_logit": -3.663240432739258,
            "end_logit": -4.205620765686035,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "anti-inflammatory/analgesic agents with improved safety profiles. Target compounds were synthesized using classical Mannich",
            "probability": 0.01650356579072875,
            "start_logit": -2.895935535430908,
            "end_logit": -5.10405158996582,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "anti-inflammatory/analgesic",
            "probability": 0.016237973762279336,
            "start_logit": -2.895935535430908,
            "end_logit": -5.120275497436523,
            "question_text": "List targets of classical analgesics."
        }
    ],
    "5c961603ecadf2e73f000022": [
        {
            "text": "Membranous Nephropathy",
            "probability": 0.9243832179834353,
            "start_logit": 1.9442126750946045,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Nephropathy",
            "probability": 0.035551440511541244,
            "start_logit": -1.3139333724975586,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous Nephropathy Treated With Rituximab.",
            "probability": 0.019237598705652798,
            "start_logit": 1.9442126750946045,
            "end_logit": -1.5798745155334473,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "phropathy",
            "probability": 0.004935842670454927,
            "start_logit": -3.288390636444092,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous",
            "probability": 0.0037900130214730127,
            "start_logit": 1.9442126750946045,
            "end_logit": -3.204371690750122,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "ropathy",
            "probability": 0.0017511660508682826,
            "start_logit": -4.324632167816162,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Rituximab a chimeric monoclonal antibody induces remission",
            "probability": 0.0012057733688547844,
            "start_logit": -1.3011282682418823,
            "end_logit": -1.1042790412902832,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy",
            "probability": 0.001138494197669952,
            "start_logit": -4.755207538604736,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous Ne",
            "probability": 0.0009883452957511454,
            "start_logit": 1.9442126750946045,
            "end_logit": -4.548464298248291,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous Nephropathy Treated With Rituximab.Rituximab",
            "probability": 0.0009169616916550049,
            "start_logit": 1.9442126750946045,
            "end_logit": -4.6234307289123535,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Me",
            "probability": 0.0009118910829390176,
            "start_logit": 1.9442126750946045,
            "end_logit": -4.628975868225098,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "athy",
            "probability": 0.0008119707785431376,
            "start_logit": -5.093204975128174,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Nephropathy Treated With Rituximab.",
            "probability": 0.0007398710109221975,
            "start_logit": -1.3139333724975586,
            "end_logit": -1.5798745155334473,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy",
            "probability": 0.0007236536885114892,
            "start_logit": -5.2083563804626465,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "remission",
            "probability": 0.0007163725149352775,
            "start_logit": -1.821804404258728,
            "end_logit": -1.1042790412902832,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Antibodies and Relapse in Membranous Nephropathy",
            "probability": 0.0007150305442458912,
            "start_logit": -5.220344066619873,
            "end_logit": 2.2923855781555176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous Neph",
            "probability": 0.0007144888045684226,
            "start_logit": 1.9442126750946045,
            "end_logit": -4.872929096221924,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "induces remission",
            "probability": 0.0003995067222266143,
            "start_logit": -2.4057741165161133,
            "end_logit": -1.1042790412902832,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Rituximab a chimeric monoclonal antibody induces remission in 60-80% of primary MN patients",
            "probability": 0.00020308580728292127,
            "start_logit": -1.3011282682418823,
            "end_logit": -2.8855268955230713,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "phropathy Treated With Rituximab.Rituximab a chimeric monoclonal antibody induces remission",
            "probability": 0.00016527554846879546,
            "start_logit": -3.288390636444092,
            "end_logit": -1.1042790412902832,
            "question_text": "List off label uses for Rituximab."
        }
    ],
    "5c979ffcecadf2e73f000028": [
        {
            "text": "ocular toxocariasis (OT), or visceral larva",
            "probability": 0.18069812917558523,
            "start_logit": 2.142853021621704,
            "end_logit": 1.3388551473617554,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "larva",
            "probability": 0.16514834698812564,
            "start_logit": 2.0528693199157715,
            "end_logit": 1.3388551473617554,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "visceral larva",
            "probability": 0.15936470533464797,
            "start_logit": 2.0172204971313477,
            "end_logit": 1.3388551473617554,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "ocular toxocariasis (OT), or visceral larva migrans",
            "probability": 0.1092748891112418,
            "start_logit": 2.142853021621704,
            "end_logit": 0.8358939290046692,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "larva migrans",
            "probability": 0.0998713566452942,
            "start_logit": 2.0528693199157715,
            "end_logit": 0.8358939290046692,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "visceral larva migrans",
            "probability": 0.0963737731161985,
            "start_logit": 2.0172204971313477,
            "end_logit": 0.8358939290046692,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "ocular",
            "probability": 0.0793329683963729,
            "start_logit": 2.142853021621704,
            "end_logit": 0.5156810879707336,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "ocular toxocariasis",
            "probability": 0.07716956375283376,
            "start_logit": 2.142853021621704,
            "end_logit": 0.48803243041038513,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara canis",
            "probability": 0.022898149869787766,
            "start_logit": 0.1955084502696991,
            "end_logit": 1.2204279899597168,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "migrans",
            "probability": 0.004714560686134542,
            "start_logit": -1.0003578662872314,
            "end_logit": 0.8358939290046692,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. canis",
            "probability": 0.001661021301500951,
            "start_logit": -0.6227865815162659,
            "end_logit": -0.584900438785553,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "toxocariasis (OT), or visceral larva",
            "probability": 0.0008253377976972351,
            "start_logit": -3.2459373474121094,
            "end_logit": 1.3388551473617554,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "ocular toxocariasis (OT),",
            "probability": 0.0005935221427596222,
            "start_logit": 2.142853021621704,
            "end_logit": -4.379653453826904,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "toxocariasis (OT), or visceral larva migrans",
            "probability": 0.0004991125073300847,
            "start_logit": -3.2459373474121094,
            "end_logit": 0.8358939290046692,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. canis L3 larvae",
            "probability": 0.00041591757320053936,
            "start_logit": -0.6227865815162659,
            "end_logit": -1.9696012735366821,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "toxocariasis",
            "probability": 0.00035247159496118186,
            "start_logit": -3.2459373474121094,
            "end_logit": 0.48803243041038513,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "canis",
            "probability": 0.0002933525840968832,
            "start_logit": -4.161927700042725,
            "end_logit": 1.2204279899597168,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "neurotoxocariasis (NT), ocular",
            "probability": 0.00017977811309329657,
            "start_logit": -3.9468326568603516,
            "end_logit": 0.5156810879707336,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "neurotoxocariasis (NT), ocular toxocariasis",
            "probability": 0.00017487557619678832,
            "start_logit": -3.9468326568603516,
            "end_logit": 0.48803243041038513,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "is",
            "probability": 0.00015816773294143117,
            "start_logit": -4.779646873474121,
            "end_logit": 1.2204279899597168,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        }
    ],
    "5c97f579ecadf2e73f00002a": [
        {
            "text": "neuroendocrine cells",
            "probability": 0.27140099303988025,
            "start_logit": -0.9160056114196777,
            "end_logit": -2.358433485031128,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells",
            "probability": 0.18288628631398335,
            "start_logit": -1.310738444328308,
            "end_logit": -2.358433485031128,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells",
            "probability": 0.17038209398215753,
            "start_logit": -1.310738444328308,
            "end_logit": -2.4292545318603516,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells mediating inflammation and immune responses",
            "probability": 0.10542670479479312,
            "start_logit": -0.9160056114196777,
            "end_logit": -3.3040149211883545,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells mediating inflammation and immune responses",
            "probability": 0.07104284439890435,
            "start_logit": -1.310738444328308,
            "end_logit": -3.3040149211883545,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells mediating inflammation",
            "probability": 0.05858934356984875,
            "start_logit": -0.9160056114196777,
            "end_logit": -3.8914780616760254,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells mediating inflammation",
            "probability": 0.039481017895498946,
            "start_logit": -1.310738444328308,
            "end_logit": -3.8914780616760254,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells mediating inflammation and immune responses.",
            "probability": 0.021910922005631342,
            "start_logit": -1.1468709707260132,
            "end_logit": -4.6441802978515625,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve",
            "probability": 0.017442582703073507,
            "start_logit": -1.310738444328308,
            "end_logit": -4.708383560180664,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells mediating inflammation and immune responses.",
            "probability": 0.012973620074456056,
            "start_logit": -1.6709381341934204,
            "end_logit": -4.6441802978515625,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells mediating inflammation and immune responses.Somatostatin receptor scintigraphy",
            "probability": 0.010584698868151164,
            "start_logit": -1.1468709707260132,
            "end_logit": -5.371756076812744,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "uroendocrine cells",
            "probability": 0.006845453459750726,
            "start_logit": -4.596018314361572,
            "end_logit": -2.358433485031128,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells mediating inflammation and immune responses.Somatostatin receptor scintigraphy",
            "probability": 0.006267279016493466,
            "start_logit": -1.6709381341934204,
            "end_logit": -5.371756076812744,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "inflammation and immune responses",
            "probability": 0.005534778060330373,
            "start_logit": -3.8629701137542725,
            "end_logit": -3.3040149211883545,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "many neuroendocrine cells",
            "probability": 0.005280102129567592,
            "start_logit": -4.3827714920043945,
            "end_logit": -2.831319570541382,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "inflammation",
            "probability": 0.003075871658805492,
            "start_logit": -3.8629701137542725,
            "end_logit": -3.8914780616760254,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "immune responses",
            "probability": 0.0029254907711647737,
            "start_logit": -4.500559329986572,
            "end_logit": -3.3040149211883545,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "cells",
            "probability": 0.0028532394665243674,
            "start_logit": -5.4711480140686035,
            "end_logit": -2.358433485031128,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "uroendocrine cells, and cells mediating inflammation and immune responses",
            "probability": 0.002659141342867481,
            "start_logit": -4.596018314361572,
            "end_logit": -3.3040149211883545,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "many neuroendocrine cells, and cells mediating inflammation and immune responses",
            "probability": 0.0024375364481176295,
            "start_logit": -4.3827714920043945,
            "end_logit": -3.6042771339416504,
            "question_text": "List places in the body where somatostatin is produced."
        }
    ],
    "5c9fb583ecadf2e73f000042": [
        {
            "text": "disease",
            "probability": 0.39791972674725523,
            "start_logit": -1.6860252618789673,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "disease states and quantitatively monitor the course of the disease",
            "probability": 0.19696207747135328,
            "start_logit": -2.3892643451690674,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "quantitatively monitor the course of the disease",
            "probability": 0.0927425715129345,
            "start_logit": -3.1424479484558105,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "monitor the course of the disease",
            "probability": 0.06645117128833283,
            "start_logit": -3.4758081436157227,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "mimic human disease states and quantitatively monitor the course of the disease",
            "probability": 0.05669232923281511,
            "start_logit": -3.634636640548706,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "The ability to control numerous variables in performing the model allows us to mimic human disease states and quantitatively monitor the course of the disease",
            "probability": 0.02934521268740191,
            "start_logit": -4.293146133422852,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "human disease states and quantitatively monitor the course of the disease",
            "probability": 0.02263168515046194,
            "start_logit": -4.552924633026123,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "to mimic human disease states and quantitatively monitor the course of the disease",
            "probability": 0.020762268676953237,
            "start_logit": -4.639138221740723,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "disease states",
            "probability": 0.02059133237722364,
            "start_logit": -2.3892643451690674,
            "end_logit": -2.8407342433929443,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "disease.Thus, the choice of which animal model to use must be made carefully, addressing issues of the type of human disease",
            "probability": 0.019371820454487022,
            "start_logit": -1.6860252618789673,
            "end_logit": -3.6050240993499756,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "allows us to mimic human disease states and quantitatively monitor the course of the disease",
            "probability": 0.016558626239923217,
            "start_logit": -4.865368366241455,
            "end_logit": -0.5825932621955872,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "diseases",
            "probability": 0.016255607317484357,
            "start_logit": -2.8552145957946777,
            "end_logit": -2.6112163066864014,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "mimic human disease",
            "probability": 0.007903733165159717,
            "start_logit": -3.634636640548706,
            "end_logit": -2.5528969764709473,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "fungal infection",
            "probability": 0.006089249414000398,
            "start_logit": -3.3647027015686035,
            "end_logit": -3.083641290664673,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "mimic human disease states",
            "probability": 0.005926879983491612,
            "start_logit": -3.634636640548706,
            "end_logit": -2.8407342433929443,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "disease states and quantitatively monitor the course",
            "probability": 0.005604855978213583,
            "start_logit": -2.3892643451690674,
            "end_logit": -4.141971111297607,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "fungal infection will continue to be valuable tools in addressing questions concerning fungal infections",
            "probability": 0.0055344327130229165,
            "start_logit": -3.3647027015686035,
            "end_logit": -3.1791770458221436,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "disease to mimic, the parameters to follow and collection of the appropriate data to answer those questions being asked.It focuses on the most clinically important diseases",
            "probability": 0.004334315830686719,
            "start_logit": -4.177088737487793,
            "end_logit": -2.6112163066864014,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "disease.Thus, the choice of which animal model to use must be made carefully, addressing issues of the type of human disease to mimic",
            "probability": 0.004230955381323964,
            "start_logit": -1.6860252618789673,
            "end_logit": -5.126415729522705,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "The ability to control numerous variables in performing the model allows us to mimic human disease",
            "probability": 0.004091148377474545,
            "start_logit": -4.293146133422852,
            "end_logit": -2.5528969764709473,
            "question_text": "What are 5 key questions in human performance modeling?"
        }
    ],
    "5ca9f932ecadf2e73f000054": [
        {
            "text": "ROBO1",
            "probability": 0.11158105132407178,
            "start_logit": 4.097346782684326,
            "end_logit": 3.5062975883483887,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO1, DCDC2",
            "probability": 0.10679346863005915,
            "start_logit": 4.097346782684326,
            "end_logit": 3.4624431133270264,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DCDC2",
            "probability": 0.09877921065084916,
            "start_logit": 4.019337177276611,
            "end_logit": 3.4624431133270264,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO1",
            "probability": 0.07451451292474877,
            "start_logit": 3.693589448928833,
            "end_logit": 3.5062975883483887,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO1, DCDC2",
            "probability": 0.07131733573114808,
            "start_logit": 3.693589448928833,
            "end_logit": 3.4624431133270264,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO1, DCDC2, KIAA0319",
            "probability": 0.058263369981921324,
            "start_logit": 4.097346782684326,
            "end_logit": 2.856519937515259,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia",
            "probability": 0.056429139799579635,
            "start_logit": 3.3019704818725586,
            "end_logit": 3.619908332824707,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DCDC2, KIAA0319",
            "probability": 0.05389102695604972,
            "start_logit": 4.019337177276611,
            "end_logit": 2.856519937515259,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1",
            "probability": 0.05060318754479249,
            "start_logit": 3.693589448928833,
            "end_logit": 3.1193182468414307,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia risk genes--DYX1C1, ROBO1",
            "probability": 0.05036895150691847,
            "start_logit": 3.3019704818725586,
            "end_logit": 3.5062975883483887,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia risk genes--DYX1C1, ROBO1, DCDC2",
            "probability": 0.04820778240438231,
            "start_logit": 3.3019704818725586,
            "end_logit": 3.4624431133270264,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "developmental dyslexia",
            "probability": 0.04246038974018952,
            "start_logit": 2.9967551231384277,
            "end_logit": 3.640709638595581,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO1, DCDC2, KIAA0319",
            "probability": 0.03890863712108343,
            "start_logit": 3.693589448928833,
            "end_logit": 2.856519937515259,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "KIAA0319",
            "probability": 0.03443444101193408,
            "start_logit": 3.5714304447174072,
            "end_logit": 2.856519937515259,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia risk genes--DYX1C1",
            "probability": 0.03420581306239207,
            "start_logit": 3.3019704818725586,
            "end_logit": 3.1193182468414307,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO",
            "probability": 0.024898558133243962,
            "start_logit": 4.097346782684326,
            "end_logit": 2.0063562393188477,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO",
            "probability": 0.016627410387438823,
            "start_logit": 3.693589448928833,
            "end_logit": 2.0063562393188477,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia risk genes--DYX1C1, ROBO",
            "probability": 0.011239491403994335,
            "start_logit": 3.3019704818725586,
            "end_logit": 2.0063562393188477,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C",
            "probability": 0.009406136864990084,
            "start_logit": 3.693589448928833,
            "end_logit": 1.4366660118103027,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO1, DCDC2, KIAA",
            "probability": 0.0070700848202127865,
            "start_logit": 4.097346782684326,
            "end_logit": 0.7474188208580017,
            "question_text": "What are acoustic reported genes used to detect?"
        }
    ],
    "5ca64b5becadf2e73f000051": [
        {
            "text": "moesin",
            "probability": 0.32221324109567256,
            "start_logit": 3.116762161254883,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin",
            "probability": 0.3094360814202133,
            "start_logit": 3.0763001441955566,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin",
            "probability": 0.12356405333815224,
            "start_logit": 2.158308267593384,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin",
            "probability": 0.09374963802386287,
            "start_logit": 3.0763001441955566,
            "end_logit": 1.6792376041412354,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin",
            "probability": 0.06531790410109514,
            "start_logit": 3.0763001441955566,
            "end_logit": 1.3178759813308716,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin",
            "probability": 0.03743611675809035,
            "start_logit": 2.158308267593384,
            "end_logit": 1.6792376041412354,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin proteins",
            "probability": 0.019116774345503813,
            "start_logit": 3.116762161254883,
            "end_logit": 0.04871397092938423,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin proteins",
            "probability": 0.018358710904468188,
            "start_logit": 3.0763001441955566,
            "end_logit": 0.04871397092938423,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin proteins",
            "probability": 0.007331002651687668,
            "start_logit": 2.158308267593384,
            "end_logit": 0.04871397092938423,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "e",
            "probability": 0.0011708873708929362,
            "start_logit": 3.0763001441955566,
            "end_logit": -2.7036283016204834,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "m",
            "probability": 0.00040954989752207635,
            "start_logit": 3.116762161254883,
            "end_logit": -3.794548749923706,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/m",
            "probability": 0.0003933094586812846,
            "start_logit": 3.0763001441955566,
            "end_logit": -3.794548749923706,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin proteins (ERM)",
            "probability": 0.00027837475033091726,
            "start_logit": 3.116762161254883,
            "end_logit": -4.180639266967773,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin proteins (ERM)",
            "probability": 0.000267335977925105,
            "start_logit": 3.0763001441955566,
            "end_logit": -4.180639266967773,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "phosphorylation of ezrin/radixin/moesin",
            "probability": 0.0002598049168757972,
            "start_logit": -4.006275653839111,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/m",
            "probability": 0.00015705638045776846,
            "start_logit": 2.158308267593384,
            "end_logit": -3.794548749923706,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "in",
            "probability": 0.00014637697318041335,
            "start_logit": -4.580021381378174,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "xin/moesin",
            "probability": 0.00014286702332136868,
            "start_logit": -4.604292392730713,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "rin/radixin/moesin",
            "probability": 0.00012896636810852307,
            "start_logit": -4.706655025482178,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "glutamate induces phosphorylation of ezrin/radixin/moesin",
            "probability": 0.00012194824395762349,
            "start_logit": -4.762609958648682,
            "end_logit": 2.873361349105835,
            "question_text": "List the ERM proteins."
        }
    ],
    "5c9007460101eac870000012": [
        {
            "text": "actin",
            "probability": 0.20597409220787563,
            "start_logit": -0.8306528329849243,
            "end_logit": -3.699997901916504,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin binding partners",
            "probability": 0.1804735102253296,
            "start_logit": -0.8306528329849243,
            "end_logit": -3.8321642875671387,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin binding partners modulate the dynamics in active actin networks.",
            "probability": 0.12184437034502783,
            "start_logit": -0.8306528329849243,
            "end_logit": -4.225003719329834,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin binding",
            "probability": 0.07599308978445035,
            "start_logit": -0.8306528329849243,
            "end_logit": -4.697105884552002,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin binding partners modulate the dynamics in active actin networks",
            "probability": 0.06745487608721301,
            "start_logit": -0.8306528329849243,
            "end_logit": -4.81628942489624,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "act",
            "probability": 0.06501887165326589,
            "start_logit": -0.8306528329849243,
            "end_logit": -4.8530707359313965,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin binding partners modulate the dynamics",
            "probability": 0.06467878862670465,
            "start_logit": -0.8306528329849243,
            "end_logit": -4.8583149909973145,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers",
            "probability": 0.04728921722609681,
            "start_logit": -2.775341033935547,
            "end_logit": -3.2267777919769287,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers and actin",
            "probability": 0.02946084795685219,
            "start_logit": -2.775341033935547,
            "end_logit": -3.699997901916504,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers and actin binding partners",
            "probability": 0.025813453468807403,
            "start_logit": -2.775341033935547,
            "end_logit": -3.8321642875671387,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers and actin binding partners modulate the dynamics in active actin networks.",
            "probability": 0.01742762126369989,
            "start_logit": -2.775341033935547,
            "end_logit": -4.225003719329834,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin networks.",
            "probability": 0.015327972326123231,
            "start_logit": -2.9037179946899414,
            "end_logit": -4.225003719329834,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "we analyze growth and intrinsic turnover by means of FRAP measurements and thereby demonstrate how the depletion of monomers",
            "probability": 0.013218267601380689,
            "start_logit": -4.050023555755615,
            "end_logit": -3.2267777919769287,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers and actin binding",
            "probability": 0.010869429450630226,
            "start_logit": -2.775341033935547,
            "end_logit": -4.697105884552002,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "demonstrate how the depletion of monomers",
            "probability": 0.01073261025199971,
            "start_logit": -4.258336544036865,
            "end_logit": -3.2267777919769287,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "depletion of monomers",
            "probability": 0.01038894417811967,
            "start_logit": -4.290881156921387,
            "end_logit": -3.2267777919769287,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "system we analyze growth and intrinsic turnover by means of FRAP measurements and thereby demonstrate how the depletion of monomers",
            "probability": 0.009834952519971341,
            "start_logit": -4.3456807136535645,
            "end_logit": -3.2267777919769287,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers and actin binding partners modulate the dynamics in active actin networks",
            "probability": 0.00964819326086925,
            "start_logit": -2.775341033935547,
            "end_logit": -4.81628942489624,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers and act",
            "probability": 0.009299767128818113,
            "start_logit": -2.775341033935547,
            "end_logit": -4.8530707359313965,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "monomers and actin binding partners modulate the dynamics",
            "probability": 0.00925112443676481,
            "start_logit": -2.775341033935547,
            "end_logit": -4.8583149909973145,
            "question_text": "Name three binding partners of cofilin 2."
        }
    ],
    "5c990afbecadf2e73f000030": [
        {
            "text": "Mdm2 and MdmX",
            "probability": 0.3347553714704584,
            "start_logit": 2.8349740505218506,
            "end_logit": 2.4846315383911133,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX",
            "probability": 0.3143459100150558,
            "start_logit": 2.7720680236816406,
            "end_logit": 2.4846315383911133,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2",
            "probability": 0.23763259805676268,
            "start_logit": 2.8349740505218506,
            "end_logit": 2.1419572830200195,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "p53.To investigate the role of the RING domain of Mdm2",
            "probability": 0.04029297457123514,
            "start_logit": 0.9375952482223511,
            "end_logit": 2.264787435531616,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "p53.To investigate the role of the RING domain of Mdm2 and MdmX",
            "probability": 0.036650723115649396,
            "start_logit": 0.9375952482223511,
            "end_logit": 2.170043468475342,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm",
            "probability": 0.007292409770357333,
            "start_logit": 1.1816850900650024,
            "end_logit": 0.31135451793670654,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm RING domains showed oncogenic activity in a colony formation assay, suggesting that the Mdm",
            "probability": 0.006021509500899854,
            "start_logit": 0.9901890158653259,
            "end_logit": 0.31135451793670654,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX, an analysis of the distinct functionalities of individual RING domains of the Mdm",
            "probability": 0.005508330790017528,
            "start_logit": 2.6954665184020996,
            "end_logit": -1.482999324798584,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 and MdmX, an analysis of the distinct functionalities of individual RING domains of the Mdm",
            "probability": 0.004578362147141064,
            "start_logit": 2.5105462074279785,
            "end_logit": -1.482999324798584,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm proteins on p53 regulation was conducted in human osteosarcoma (U2OS) cell line.Mdm2",
            "probability": 0.00260839038603097,
            "start_logit": 0.398070365190506,
            "end_logit": 0.06686851382255554,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "p53",
            "probability": 0.0018873557556271967,
            "start_logit": 0.9375952482223511,
            "end_logit": -0.796212911605835,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2",
            "probability": 0.0018199590687563853,
            "start_logit": 0.7554841637611389,
            "end_logit": -0.6504645943641663,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2",
            "probability": 0.0015272031755050462,
            "start_logit": 0.5801082253456116,
            "end_logit": -0.6504645943641663,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 RING domain was observed mainly localized in the cell nucleus, contrasting the localization of MdmX",
            "probability": 0.001472558458819432,
            "start_logit": 0.25833046436309814,
            "end_logit": -0.36512356996536255,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX",
            "probability": 0.0011356258568721621,
            "start_logit": 0.5801082253456116,
            "end_logit": -0.9467187523841858,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 and MdmX RING domains were able to dimerize with endogenous full-length Mdm2",
            "probability": 0.000749591612028328,
            "start_logit": -0.24308063089847565,
            "end_logit": -0.5389405488967896,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING domains were able to dimerize with endogenous full-length Mdm2",
            "probability": 0.0005119762788382284,
            "start_logit": -0.6243308782577515,
            "end_logit": -0.5389405488967896,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING domains were able to dimerize with endogenous full-length Mdm2 and MdmX",
            "probability": 0.0005013612222092036,
            "start_logit": -0.6243308782577515,
            "end_logit": -0.5598919987678528,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 or MdmX RING domains interfered with the endogenous full-length Mdm2 and MdmX",
            "probability": 0.0004013137298751546,
            "start_logit": -0.5990564227104187,
            "end_logit": -0.8077498078346252,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 or MdmX",
            "probability": 0.00030647501786089983,
            "start_logit": -0.5990564227104187,
            "end_logit": -1.0773570537567139,
            "question_text": "List proteins with RING domain."
        }
    ],
    "5c961281ecadf2e73f000021": [
        {
            "text": "rheumatoid arthritis",
            "probability": 0.49002010765877363,
            "start_logit": 4.077597141265869,
            "end_logit": 3.782191514968872,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma",
            "probability": 0.46719132749772063,
            "start_logit": 3.8955302238464355,
            "end_logit": 3.916550874710083,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "lymphoma",
            "probability": 0.021858566849952365,
            "start_logit": 0.8333842754364014,
            "end_logit": 3.916550874710083,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "arthritis",
            "probability": 0.007972608379764216,
            "start_logit": -0.040837571024894714,
            "end_logit": 3.782191514968872,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma orphan indication",
            "probability": 0.004290348696650098,
            "start_logit": 3.8955302238464355,
            "end_logit": -0.7738199830055237,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "Hodgkin lymphoma",
            "probability": 0.003801315145520422,
            "start_logit": -0.9158615469932556,
            "end_logit": 3.916550874710083,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma orphan",
            "probability": 0.001778218128561175,
            "start_logit": 3.8955302238464355,
            "end_logit": -1.6545761823654175,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "oma",
            "probability": 0.0005421827067463445,
            "start_logit": -2.86336088180542,
            "end_logit": 3.916550874710083,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "heumatoid arthritis",
            "probability": 0.00042160568746429965,
            "start_logit": -2.980534076690674,
            "end_logit": 3.782191514968872,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "itis",
            "probability": 0.0003010282483073078,
            "start_logit": -3.3174004554748535,
            "end_logit": 3.782191514968872,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "hritis",
            "probability": 0.00025142618411398964,
            "start_logit": -3.49745512008667,
            "end_logit": 3.782191514968872,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "umatoid arthritis",
            "probability": 0.00023955885068176834,
            "start_logit": -3.5458054542541504,
            "end_logit": 3.782191514968872,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "r",
            "probability": 0.00022086502758886898,
            "start_logit": 4.077597141265869,
            "end_logit": -3.9224584102630615,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "lymphoma orphan indication",
            "probability": 0.00020073333616362927,
            "start_logit": 0.8333842754364014,
            "end_logit": -0.7738199830055237,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non",
            "probability": 0.00020029859386965713,
            "start_logit": 3.8955302238464355,
            "end_logit": -3.8381340503692627,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "a non-Hodgkin lymphoma",
            "probability": 0.00016281473948850578,
            "start_logit": -4.066350936889648,
            "end_logit": 3.916550874710083,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "id arthritis",
            "probability": 0.0001616175111566429,
            "start_logit": -3.9393720626831055,
            "end_logit": 3.782191514968872,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid",
            "probability": 0.00014083935577034116,
            "start_logit": 4.077597141265869,
            "end_logit": -4.372390270233154,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid arthritis as the only FDA-approved, nonorphan indication",
            "probability": 0.00012245399986882024,
            "start_logit": 4.077597141265869,
            "end_logit": -4.512274742126465,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "ymphoma",
            "probability": 0.0001220834018377958,
            "start_logit": -4.354259490966797,
            "end_logit": 3.916550874710083,
            "question_text": "List 3 indications for rituximab."
        }
    ]
}
